Citrus Sinensis ID: 005616
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 688 | 2.2.26 [Sep-21-2011] | |||||||
| Q8GUH1 | 834 | U-box domain-containing p | yes | no | 0.943 | 0.778 | 0.396 | 1e-131 | |
| Q94A51 | 805 | U-box domain-containing p | no | no | 0.928 | 0.793 | 0.331 | 8e-94 | |
| Q9FKG5 | 796 | U-box domain-containing p | no | no | 0.655 | 0.566 | 0.396 | 6e-92 | |
| Q8S8S7 | 801 | U-box domain-containing p | no | no | 0.633 | 0.544 | 0.411 | 7e-92 | |
| Q9LU47 | 819 | Putative U-box domain-con | no | no | 0.777 | 0.653 | 0.363 | 5e-89 | |
| Q9SW11 | 835 | U-box domain-containing p | no | no | 0.651 | 0.536 | 0.408 | 1e-88 | |
| Q9FKG6 | 845 | U-box domain-containing p | no | no | 0.655 | 0.533 | 0.378 | 6e-87 | |
| Q0DR28 | 518 | U-box domain-containing p | no | no | 0.587 | 0.779 | 0.375 | 6e-79 | |
| Q9FGD7 | 765 | Putative U-box domain-con | no | no | 0.686 | 0.616 | 0.325 | 1e-59 | |
| C0LGU1 | 959 | Probable LRR receptor-lik | no | no | 0.408 | 0.293 | 0.394 | 1e-50 |
| >sp|Q8GUH1|PUB33_ARATH U-box domain-containing protein 33 OS=Arabidopsis thaliana GN=PUB33 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 471 bits (1211), Expect = e-131, Method: Compositional matrix adjust.
Identities = 281/709 (39%), Positives = 396/709 (55%), Gaps = 60/709 (8%)
Query: 5 GIQKLVMGAFPDNCMKVKMG---SRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNS 61
GI+KLVMGA D +M SRKA + + AP C+IWF KG + T+EA+
Sbjct: 154 GIRKLVMGAAADRHYSRRMTDLKSRKAIFVRREAPTLCQIWFTCKGYLIHTREAT----- 208
Query: 62 FLPFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHMVF 121
E+ A S S + T PES ++ V TD VQ +V
Sbjct: 209 ---MDDTESEYASPRPSISASDLLQT-FSTPES----EHQHISRVQSTDSVQ----QLVS 256
Query: 122 PSSPT-----ISCSDMNLFSPRSSSAGS------GYMSEKRESTDSDSKVEEDPLYVQHR 170
S T +S +N S GS MS S S +D V+ R
Sbjct: 257 NGSSTEQSGRVSDGSLNTDEEERESDGSEVTGSATVMSSGHSSPSSFPDGVDDSFNVKIR 316
Query: 171 EVSIKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQ 230
+ + +A + AFAE LRR+K E A++AI + K ESAY+ E+ RK+ E A+ +
Sbjct: 317 KATSEAHSSKQEAFAETLRRQKAEKNALDAIRRAKQSESAYSEELKRRKDTEIAVAKEKE 376
Query: 231 DQEKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQR 290
+K E+ + +EL M A+L S+ +++ ++ +L + + L+ E++
Sbjct: 377 RFITIKNEQEVIMEELQSAMAQKAMLESQIAKSDGTMEKLNQKLDIAVKLLQKLRDEREE 436
Query: 291 IRRQKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKV 350
++ ++ A+R E RS + + +FS ++++ AT +F + K+
Sbjct: 437 LQTERDRALREAEELRSHAETSTLQLPQYF---------TDFSFSEIEEATNHFDSTLKI 487
Query: 351 GQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAW 410
G+GG+G +Y G + VAIKML ++ QG +E+QQEV VLSK++HP+++TL+GACPE W
Sbjct: 488 GEGGYGSIYVGLLRHTQVAIKMLNPNSSQGPVEYQQEVDVLSKMRHPNIITLIGACPEGW 547
Query: 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQ 470
SLVYEYLP GSL+DRL K N PL W++R RIA EI + L FLHS+K +VHGDLKP
Sbjct: 548 SLVYEYLPGGSLEDRLTCKDNSPPLSWQNRVRIATEICAALVFLHSNKAHSLVHGDLKPA 607
Query: 471 NILLDSELSSKICDFGICRLVTEDTLYLPSFHRS--TAPKGSFPYADPEYHRTGVLTPKS 528
NILLDS L SK+ DFG C L+ P+ +S T G+ Y DPE +G LTPKS
Sbjct: 608 NILLDSNLVSKLSDFGTCSLLH------PNGSKSVRTDVTGTVAYLDPEASSSGELTPKS 661
Query: 529 DSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQC 588
D YSFG+I+L+LLTGR + ++ EV+ A+ G L+ +LDPLAGDWP A +L L L+C
Sbjct: 662 DVYSFGIILLRLLTGRPALRISNEVKYALDNGTLNDLLDPLAGDWPFVQAEQLARLALRC 721
Query: 589 CELYGRERPDITPSLVKELEQLHVA------------EERPVPSFFLCPILQEIMHDPQV 636
CE RPD+ + + LE + + E R P +F+CPI QE+M DP V
Sbjct: 722 CETVSENRPDLGTEVWRVLEPMRASSGGSSSFHLGRNEHRIAPPYFICPIFQEVMQDPHV 781
Query: 637 AADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWL 685
AADGFTYE +AIR WL++ +TSPMTN++LSH L NHALR AIQ+WL
Sbjct: 782 AADGFTYEAEAIRAWLDSEHDTSPMTNVKLSHTSLIANHALRSAIQEWL 830
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q94A51|PUB32_ARATH U-box domain-containing protein 32 OS=Arabidopsis thaliana GN=PUB32 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 345 bits (884), Expect = 8e-94, Method: Compositional matrix adjust.
Identities = 239/721 (33%), Positives = 371/721 (51%), Gaps = 82/721 (11%)
Query: 4 HGIQKLVMGAFPDNCMKVKM---GSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPN 60
H I+ LVMGA D KM S+KA + K AP C IWF+ KG ++T+ +++ N
Sbjct: 123 HKIKWLVMGAASDKHYSWKMTDLKSKKAIFVCKKAPDSCHIWFLCKGYLIFTRASNDDSN 182
Query: 61 ---SFLPFC----GAETRSAKMLRS----------RSLENCNG---TSLFNPESILSRSA 100
+ P ETR ++ L S RSL +G T E + R+
Sbjct: 183 NRQTMPPLVQLDSDNETRKSEKLESSYMRRRLRYWRSLLEQDGEKDTGQLEREKVEPRAP 242
Query: 101 TTLTHVGITDWVQSDPVHMVFPSSPTISCSDMNLFSPRSSSAGSGYMSEKRESTDSDSKV 160
+ + +PV P SP + SD + + + EK D KV
Sbjct: 243 PLFSSGSSS--SFGEPVGPE-PVSPELVDSD---------TLNTSNVEEKEREGDVARKV 290
Query: 161 EEDPLYVQHREVSIKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKE 220
++ + + + + E ++ + ++ EA+ K KA E +E RK
Sbjct: 291 H------RYDKAMHDIGQSDRTVYGEAGKKWEEDASTTEALCKAKALEGLCIKESSQRKR 344
Query: 221 AEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQAS 280
E+ L+ + + + ++ +EL L S+ ++ E +
Sbjct: 345 LEELLEKEKLEVKMVIEQNNGFMKELQMVQGRNLKLESQMRKLQDLEKEHGEKFDTAMEL 404
Query: 281 IATLQQEKQRIRRQKVEAVRWLERWRS--RGQAGAANYDGFIGLVEDLPESAEFSLADLQ 338
+ + +Q++ IR AV+ + R +G+ G ++ E ++S ++
Sbjct: 405 LKSFRQKRDEIRIDHENAVKEVNALRRLVKGETGESSGS----------EMLDYSFMEIN 454
Query: 339 TATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH 398
AT F S+K+G+G +G VYKG + VA+KML S+ EF++ V +LS+++HP+
Sbjct: 455 EATNEFDPSWKLGEGKYGSVYKGNLQHLQVAVKMLPSYGSLNHFEFERRVEILSRVRHPN 514
Query: 399 LVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
LVTL+GACPE+ SL+Y+Y+PNGSL+D ++NV L W+ R RIA+EI S L FLHS+
Sbjct: 515 LVTLMGACPESRSLIYQYIPNGSLEDCFSSENNVPALSWESRIRIASEICSALLFLHSNI 574
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
P I+HG+LKP ILLDS L +KI D+GI +L+ D L S P+ DP Y
Sbjct: 575 P-CIIHGNLKPSKILLDSNLVTKINDYGISQLIPIDGL-----------DKSDPHVDPHY 622
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA 578
+ +T +SD Y+FG+I+LQLLT R G+ +V+ A+ +S++LD AGDWP
Sbjct: 623 FVSREMTLESDIYAFGIILLQLLTRRPVSGILRDVKCALENDNISAVLDNSAGDWPVARG 682
Query: 579 RRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAE---------------ERPVPSFFL 623
++L ++ ++CC+ RPD+ +++ ++++ E RP PS +L
Sbjct: 683 KKLANVAIRCCKKNPMNRPDLA-VVLRFIDRMKAPEVPSSETSSYANQNVPRRP-PSHYL 740
Query: 624 CPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQD 683
CPI QE+M DP +AADGFTYE +AIR+WL NG +TSPMTNL++ +L PNHAL AIQD
Sbjct: 741 CPIFQEVMKDPLIAADGFTYEAEAIREWLANGHDTSPMTNLKMEDCNLIPNHALHLAIQD 800
Query: 684 W 684
W
Sbjct: 801 W 801
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q9FKG5|PUB51_ARATH U-box domain-containing protein 51 OS=Arabidopsis thaliana GN=PUB51 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 338 bits (868), Expect = 6e-92, Method: Compositional matrix adjust.
Identities = 195/492 (39%), Positives = 280/492 (56%), Gaps = 41/492 (8%)
Query: 233 EKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQA------SIATLQQ 286
EKLK E + V + + Q+ N+RR E LK + + +++
Sbjct: 300 EKLKIELRHIKGMYAVAQSEVIDASKKMQDLNQRRSEEATRLKNLTIREEEADEVVEMER 359
Query: 287 EKQRIRRQKVEAVR-WLERW---RSRGQAGAANYDGFIGLVEDLPESA--------EFSL 334
E+Q + E VR +ER R +A A +ED E +F
Sbjct: 360 ERQEDAENEAELVRECIERETEERLEAEARAEEVRKEKQRLEDALEGGPLQRQQYMKFEW 419
Query: 335 ADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL 394
++ AT +FS+ K+G GG+G VY+ + TVA+K+L+S +F QE+ +LSK+
Sbjct: 420 EEIVEATSSFSDELKIGVGGYGSVYRCNLHHTTVAVKVLHSDKSSLTKQFHQELEILSKI 479
Query: 395 QHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLF-RKSNVS-----PLLWKDRARIAAEIA 448
+HPHL+ LLGACPE SLVYEY+ NGSL++RL R+ NV PL W +R RIA EIA
Sbjct: 480 RHPHLLLLLGACPERGSLVYEYMHNGSLEERLMKRRPNVDTPQPPPLRWFERFRIAWEIA 539
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 508
S L FLH+++P IVH DLKP NILLD SKI D G+ ++V D + + T P
Sbjct: 540 SALYFLHTNEPRPIVHRDLKPANILLDRNNVSKIGDVGLSKMVNLDPSHASTVFNETGPV 599
Query: 509 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV--SCGKLSSIL 566
G+F Y DPEY RTGV+TP+SD Y+FG+I+LQL+T R +GLA + +A+ GK + IL
Sbjct: 600 GTFFYIDPEYQRTGVVTPESDIYAFGIILLQLVTARSAMGLAHSIEKALRDQTGKFTEIL 659
Query: 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH--------------V 612
D AGDWP A+ +V +GL+C E+ R+RPD+ ++ LE+L +
Sbjct: 660 DKTAGDWPVKEAKEMVMIGLRCAEMRKRDRPDLGKEILPVLERLKEVASIARNMFADNLI 719
Query: 613 AEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLT 672
P+ F CPI +++M +P VA+DG+TYE +AI++WL+ + SPMT+L L
Sbjct: 720 DHHHNAPTHFYCPITKDVMENPCVASDGYTYEKRAIKEWLQKNHK-SPMTDLPFPSDSLL 778
Query: 673 PNHALRHAIQDW 684
PNH+L AI++W
Sbjct: 779 PNHSLLSAIKEW 790
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S8S7|PUB34_ARATH U-box domain-containing protein 34 OS=Arabidopsis thaliana GN=PUB34 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 338 bits (868), Expect = 7e-92, Method: Compositional matrix adjust.
Identities = 190/462 (41%), Positives = 265/462 (57%), Gaps = 26/462 (5%)
Query: 244 QELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVR-WL 302
+EL T V +L++ ++R + A E + +Q + A L++E+ ++VE + L
Sbjct: 334 EELFSTQNKVKMLSTEYLNESKRVNNAV-EKEELQRNTAALEKERYMKAVKEVETAKALL 392
Query: 303 ERWRSRGQAGAAN-----------YDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVG 351
R + Q N D +G ++++ ++ TAT FS +G
Sbjct: 393 AREFCQRQIAEVNALRTYLEKKKVIDQLLGTDH---RYRKYTIEEIVTATEGFSPEKVIG 449
Query: 352 QGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWS 411
+GG+G VY+ + A+K++ + + EF +EV VLS+L+HPH+V LLGACPE
Sbjct: 450 EGGYGKVYQCSLDSTPAAVKVVRLDTPEKKQEFLKEVEVLSQLRHPHVVLLLGACPENGC 509
Query: 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQN 471
LVYEYL NGSL++ +F + N PL W R R+ E+A GL FLHSSKPE IVH DLKP N
Sbjct: 510 LVYEYLENGSLEEYIFHRKNKPPLPWFIRFRVIFEVACGLAFLHSSKPEPIVHRDLKPGN 569
Query: 472 ILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSY 531
ILL+ SKI D G+ +LVT+ + +R++ G+ Y DPEYHRTG + PKSD Y
Sbjct: 570 ILLNRNYVSKIADVGLAKLVTDVAPDNVTMYRNSVLAGTLHYIDPEYHRTGTIRPKSDLY 629
Query: 532 SFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCEL 591
+FG+IILQLLT R P G+ V AV G L+ +LD DWP L +GL+C E
Sbjct: 630 AFGIIILQLLTARNPSGIVPAVENAVKKGTLTEMLDKSVTDWPLAETEELARIGLKCAEF 689
Query: 592 YGRERPDITPSLVKELEQLHVAEERPV---------PSFFLCPILQEIMHDPQVAADGFT 642
R+RPD+ ++ L++L V PS + CPIL+EIM +P++AADGFT
Sbjct: 690 RCRDRPDLKSEVIPVLKRLVETANSKVKKEGSNLRAPSHYFCPILREIMEEPEIAADGFT 749
Query: 643 YEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 684
YE KAI WLE SP+T +L H LTPNH LR AI+DW
Sbjct: 750 YERKAILAWLEK-HNISPVTRQKLDHFKLTPNHTLRSAIRDW 790
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LU47|PUB53_ARATH Putative U-box domain-containing protein 53 OS=Arabidopsis thaliana GN=PUB53 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 329 bits (843), Expect = 5e-89, Method: Compositional matrix adjust.
Identities = 214/588 (36%), Positives = 318/588 (54%), Gaps = 53/588 (9%)
Query: 142 AGSGYMSEKRES---TDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKLESEAM 198
A S MS +S T S+ +++ P V R VS+ E ++ E KK S+A
Sbjct: 235 ANSDVMSNALKSNPHTLSNKRMQNLPTIV--RGVSVPME----TSSTESDETKKRSSDAA 288
Query: 199 EAIGKVKAFESAYA-------REMHLRKEAEDALQTTIQ-------------DQEKLKQE 238
E K + E++ + R+ RK+A ++ + + D + E
Sbjct: 289 EEASKRSSPETSRSVSWNPQFRDFDERKDAMSSMSSNFEYGNVVTPLGHYFTDNQDTLNE 348
Query: 239 KAFVTQELHRTMRNVALLNSRAQEANRRRDEAT-GELKLIQ---ASIATLQQEK--QRIR 292
+ + EL A+ +A+R+ +E EL L++ IA + EK Q+ R
Sbjct: 349 ISKLRAELRHAHEMYAVAQVETLDASRKLNELKFEELTLLEHETKGIAKKETEKFEQKRR 408
Query: 293 RQKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQ 352
++ A R ++ +A LV + EF+ ++ AT +FSE K+G
Sbjct: 409 EEREAAQRREAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSSFSEDLKIGM 468
Query: 353 GGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSL 412
G +G VYK + A+K+L+S +F QE+ +LSK++HPHLV LLGACP+ +L
Sbjct: 469 GAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLLGACPDHGAL 528
Query: 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNI 472
VYEY+ NGSL+DRLF+ ++ P+ W R RIA E+AS L FLH SKP I+H DLKP NI
Sbjct: 529 VYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPIIHRDLKPANI 588
Query: 473 LLDSELSSKICDFGICRLV-TEDTLYLP-SFHRSTAPKGSFPYADPEYHRTGVLTPKSDS 530
LL+ SK+ D G+ ++ D L + ++ T+P G+ Y DPEY RTG ++PKSD
Sbjct: 589 LLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRTGRISPKSDV 648
Query: 531 YSFGLIILQLLTGRLPVGLAGEVRRAVSCG---KLSSILDPLAGDWPTFVARRLVDLGLQ 587
Y+FG+IILQLLTG+ + L V A+ +L ILD AG+WP R+L L LQ
Sbjct: 649 YAFGMIILQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEETRQLAALALQ 708
Query: 588 CCELYGRERPDITPSLVKELEQLH-----------VAEERPVPSFFLCPILQEIMHDPQV 636
C EL ++RPD+ ++ LE L A +P PS F CP+L+++M +P +
Sbjct: 709 CTELRSKDRPDLEDQILPVLESLKKVADKARNSLSAAPSQP-PSHFFCPLLKDVMKEPCI 767
Query: 637 AADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 684
AADG+TY+ +AI +W+EN R TSP+TN L +++L PNH L AI +W
Sbjct: 768 AADGYTYDRRAIEEWMENHR-TSPVTNSPLQNVNLLPNHTLYAAIVEW 814
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SW11|PUB35_ARATH U-box domain-containing protein 35 OS=Arabidopsis thaliana GN=PUB35 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 328 bits (840), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 197/482 (40%), Positives = 276/482 (57%), Gaps = 34/482 (7%)
Query: 233 EKLKQEKAFVTQELHRTMRNVALLNSRA-QEANRRR-DEATG--ELKLIQASIATL-QQE 287
EKL+ E V QE++ + SR E N+RR +EA ELKL + L ++E
Sbjct: 354 EKLRAELRHV-QEMYAVAQTETFDASRKLGELNQRRLEEAIKLEELKLKEYEARELAEKE 412
Query: 288 KQRIRRQKVEAV-------------RWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSL 334
KQ + + +A R ER +R +G +G + + F+
Sbjct: 413 KQNFEKARRDAESMRERAEREIAQRREAERKSARDTKEKEKLEGTLGSPQ--LQYQHFAW 470
Query: 335 ADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL 394
++ AT +FSE K+G G +G VYK + T +K+L S Q +FQQE+ +LSK+
Sbjct: 471 EEIMAATSSFSEELKIGMGAYGAVYKCNLHHTTAVVKVLQSAENQLSKQFQQELEILSKI 530
Query: 395 QHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
+HPHLV LLGACPE +LVYEY+ NGSL+DRLF+ +N PL W +R RIA E+A+ L FL
Sbjct: 531 RHPHLVLLLGACPEQGALVYEYMENGSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFL 590
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP-SFHRSTAPKGSFPY 513
H SKP+ I+H DLKP NILLD SK+ D G+ +V D L + ++ T+P G+ Y
Sbjct: 591 HKSKPKPIIHRDLKPANILLDHNFVSKVGDVGLSTMVQVDPLSTKFTIYKQTSPVGTLCY 650
Query: 514 ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV-SCGKLSSILDPLAGD 572
DPEY RTG ++ KSD YSFG+I+LQLLT + + L V A+ S + ILD AG+
Sbjct: 651 IDPEYQRTGRISSKSDIYSFGMILLQLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGN 710
Query: 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPSF----------F 622
WP R L L L C EL G++RPD+ ++ LE L E+ SF F
Sbjct: 711 WPIEETRELAALALCCTELRGKDRPDLKDQILPALENLKKVAEKARNSFSGVSTQPPTHF 770
Query: 623 LCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQ 682
+CP+L+++M++P VAADG+TY+ AI +WL+ TSPMT+ L +L PN+ L AI
Sbjct: 771 ICPLLKDVMNEPCVAADGYTYDRHAIEEWLKE-HNTSPMTDSPLHSKNLLPNYTLYTAIM 829
Query: 683 DW 684
+W
Sbjct: 830 EW 831
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FKG6|PUB52_ARATH U-box domain-containing protein 52 OS=Arabidopsis thaliana GN=PUB52 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 322 bits (825), Expect = 6e-87, Method: Compositional matrix adjust.
Identities = 181/478 (37%), Positives = 268/478 (56%), Gaps = 27/478 (5%)
Query: 233 EKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLI----QASIATLQQEK 288
EKL+ E V + + + E N+RR E + +L + + + T +EK
Sbjct: 364 EKLRAELKHVQEMYAMAQTETVGASKKLTELNQRRFEESEKLVELKEKEEVAKDTASKEK 423
Query: 289 QRIRR-----QKVEAVRWLERWRSRGQAGAANYDGF------IGLVEDLPESAEFSLADL 337
QR +KV+ + E R A D LV + ++ ++
Sbjct: 424 QRYEEAMKEAEKVKELMMKEALHRREAEFKAERDAREKDKLQASLVSPGVQYQHYTWEEI 483
Query: 338 QTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP 397
AT +F+E+ K+G G +G VYK + T A+K+L++ Q +F QE+ +LSK++HP
Sbjct: 484 AAATSDFAENLKIGIGAYGSVYKCNLHHTTGAVKVLHAGETQLSKQFDQELEILSKIRHP 543
Query: 398 HLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
HLV LLGACPE LVYEY+ NGSL DRL ++ P+ W +R RIA E+AS L FLH S
Sbjct: 544 HLVLLLGACPERGCLVYEYMDNGSLDDRLMLVNDTPPIPWFERFRIALEVASALVFLHKS 603
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
KP I+H DLKP NILLD SK+ D G+ +V +D + + + T+P G+ Y DPE
Sbjct: 604 KPRPIIHRDLKPGNILLDHNFVSKLGDVGLSTMVNQDDVSSRTIFKQTSPVGTLCYIDPE 663
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV-SCGKLSSILDPLAGDWPTF 576
Y RTG+++PKSD YS G++ILQL+T + + + V A+ + +ILD AG WP
Sbjct: 664 YQRTGIISPKSDVYSLGVVILQLITAKPAIAITHMVEEAIGDDAEFMAILDKKAGSWPIS 723
Query: 577 VARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPV----------PSFFLCPI 626
R L LGL C E+ R+RPD+ ++ LE+L ++ PS F+CP+
Sbjct: 724 DTRELAALGLCCTEMRRRDRPDLKDQIIPALERLRKVADKAQNLLSRTPSGPPSHFICPL 783
Query: 627 LQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 684
L+ +M++P VAADG+TY+ +AI +WL ++TSP+TNL L + +L N+ L AI +W
Sbjct: 784 LKGVMNEPCVAADGYTYDREAIEEWLRQ-KDTSPVTNLPLPNKNLIANYTLYSAIMEW 840
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q0DR28|PUB57_ORYSJ U-box domain-containing protein 57 OS=Oryza sativa subsp. japonica GN=PUB57 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (756), Expect = 6e-79, Method: Compositional matrix adjust.
Identities = 165/440 (37%), Positives = 247/440 (56%), Gaps = 36/440 (8%)
Query: 264 NRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQAGAANYDGFIGLV 323
+R+ E ++ +++ I TL+ + QK +AV ++ + D + V
Sbjct: 81 DRKTYEEVRKVHILEEEIVTLKHQADTYLVQKEKAVTAYDQLKHER-------DNAVQQV 133
Query: 324 EDLPESA-----EFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNM 378
+L + + +FS D++ AT +F + +VG +G YKG + V IK+ S +
Sbjct: 134 NELRDQSTHIILDFSRKDMEQATEHFKNAREVGDTEYGHTYKGMIHNMKVLIKLSSSQKL 193
Query: 379 QGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWK 438
FQQEV +L + +HP+++T +G C E +LVYE+LPNG+L+DR+ +N +PL W
Sbjct: 194 -----FQQEVSILRQWRHPNIITFIGVCSEVSALVYEWLPNGNLEDRIICTNNSAPLSWY 248
Query: 439 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498
+R +I EI L FLHS+K +VHGDL+P NIL+D+ SKIC+FG+ L + +
Sbjct: 249 NRTQIIGEICCALLFLHSNKSTALVHGDLRPCNILIDANYRSKICNFGMSNLFLQLGTFP 308
Query: 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS 558
P+ PY DPE++ TG LT SD YS G+IIL+LLTG P+ L+ +V A+
Sbjct: 309 PNL------TARLPYMDPEFNTTGELTTLSDVYSLGVIILRLLTGMPPLTLSEKVAEALG 362
Query: 559 CGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL-------- 610
L ++D AGDWP A++L +GL C + ++RPD+ + +E L
Sbjct: 363 SDSLHLLIDKSAGDWPYIEAKQLALIGLSCTGMTRKKRPDLLNEVWIVIEPLTRKPPAAT 422
Query: 611 -----HVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLR 665
+ + VP+ F+CPI EIM DPQVA+DGFTYE +AIR W + G SPMTNL
Sbjct: 423 WPYLQSASGDSSVPAAFICPISMEIMKDPQVASDGFTYEAEAIRCWFDRGISRSPMTNLA 482
Query: 666 LSHLHLTPNHALRHAIQDWL 685
L +L+L PN LR I +L
Sbjct: 483 LPNLNLVPNRVLRSFIHGYL 502
|
Possesses E3 ubiquitin-protein ligase in vitro. May be involved in cell death signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q9FGD7|PUB50_ARATH Putative U-box domain-containing protein 50 OS=Arabidopsis thaliana GN=PUB50 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 231 bits (589), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 184/565 (32%), Positives = 284/565 (50%), Gaps = 93/565 (16%)
Query: 159 KVEEDPLYV--QHREVSIKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMH 216
KV E L + + REV + AE + +A L ++ FE A+ +E
Sbjct: 251 KVNEAKLMIDEKSREVKVNAERSNRAEWAISL-----------CNSRIGEFE-AWIKEES 298
Query: 217 LRKEAEDALQTTIQ-DQEKLKQEKAFVTQ---ELHRTMRNVALLNSRAQEANRRRDEATG 272
R+E LQ T+ D+E +++ K +V + +LH +L+S+ + + +A
Sbjct: 299 ERREK---LQATLDSDKECIEEAKNYVEKGKTKLHSLAELQEVLSSKVKTMMEAKSQAEV 355
Query: 273 ELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEF 332
EL+ + + E +++R Q+ R +E + R G+ + + E E+
Sbjct: 356 ELERVVLQRGEMITEIEKLRSQRDVFNRRIEFCKEREVIGSVSKE------EVKCGYREY 409
Query: 333 SLADLQTATCNFSESFKVGQGG-FGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVL 391
D++ AT +S+ ++ GG + VY+G + TVA+K++ + F +V++L
Sbjct: 410 VAEDIRLATETYSDRLRLKSGGNWTNVYRGRIKHTTVAVKVI--GDSLSDEAFGAKVKLL 467
Query: 392 SKLQHPHLVTLLGACPE-AWSLVYEYLPNGSLQDRLF---RKSNVSPLL-WKDRARIAAE 446
++++HP+LV + G C + L++EY+ NG+L+D LF RKS S +L W DR RIA +
Sbjct: 468 NEIRHPNLVAIAGFCSQRPKCLLFEYMHNGNLRDNLFTSQRKSRRSKILKWHDRIRIAHQ 527
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 506
+ SGL FLHS KP+ IVHG L P ILLD L KI FG L + S T
Sbjct: 528 VCSGLGFLHSVKPKPIVHGRLTPSKILLDRNLVPKITGFG---------LIMHSDQSDTK 578
Query: 507 PKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSI- 565
P D +FG+++L LLTGR GL +A+S + S +
Sbjct: 579 P---------------------DVMAFGVLLLHLLTGRNWHGLL----KAMSMNQTSILR 613
Query: 566 -LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDI-TPSLVKELEQL------------- 610
LD AG WP +A+ L ++C + D T +++EL ++
Sbjct: 614 DLDQTAGKWPLELAKEFGALAVKCSSVNRGGNMDFSTKEIMEELGKIREKADEFKTKGGY 673
Query: 611 ------HVAEERP--VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMT 662
++ E P +PS F+CPILQE+M +P VAADGF+YE +AI++WL G +TSPMT
Sbjct: 674 EEATNSNMDEGDPNDIPSVFMCPILQEVMKNPHVAADGFSYELEAIQEWLSMGHDTSPMT 733
Query: 663 NLRLSHLHLTPNHALRHAIQDWLCK 687
NLRL + LTPNH LR IQDW K
Sbjct: 734 NLRLDYQMLTPNHTLRSLIQDWHSK 758
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|C0LGU1|Y5374_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g37450 OS=Arabidopsis thaliana GN=At5g37450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 202 bits (513), Expect = 1e-50, Method: Compositional matrix adjust.
Identities = 118/299 (39%), Positives = 178/299 (59%), Gaps = 18/299 (6%)
Query: 332 FSLADLQTATCNFSESFKVGQGGFGCVYKGEMLG-RTVAIKMLYSHNMQGQLEFQQEVRV 390
++ +L +AT +FS+ ++G+GG+G VYKG + G VA+K ++QGQ EF E+ +
Sbjct: 619 YNFTELDSATSSFSDLSQIGRGGYGKVYKGHLPGGLVVAVKRAEQGSLQGQKEFFTEIEL 678
Query: 391 LSKLQHPHLVTLLGACPEAWS--LVYEYLPNGSLQDRL---FRKSNVSPLLWKDRARIAA 445
LS+L H +LV+LLG C + LVYEY+PNGSLQD L FR+ PL R RIA
Sbjct: 679 LSRLHHRNLVSLLGYCDQKGEQMLVYEYMPNGSLQDALSARFRQ----PLSLALRLRIAL 734
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505
A G+ +LH+ I+H D+KP NILLDS+++ K+ DFGI +L+ D + H +T
Sbjct: 735 GSARGILYLHTEADPPIIHRDIKPSNILLDSKMNPKVADFGISKLIALDGGGVQRDHVTT 794
Query: 506 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV----GLAGEVRRAVSCGK 561
KG+ Y DPEY+ + LT KSD YS G++ L++LTG P+ + EV A G
Sbjct: 795 IVKGTPGYVDPEYYLSHRLTEKSDVYSLGIVFLEILTGMRPISHGRNIVREVNEACDAGM 854
Query: 562 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH---VAEERP 617
+ S++D G + +R ++L ++CC+ RP + +V+ELE ++ EE+P
Sbjct: 855 MMSVIDRSMGQYSEECVKRFMELAIRCCQDNPEARPWML-EIVRELENIYGLIPKEEKP 912
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 688 | ||||||
| 255587037 | 673 | receptor protein kinase, putative [Ricin | 0.968 | 0.989 | 0.694 | 0.0 | |
| 359478641 | 836 | PREDICTED: U-box domain-containing prote | 0.981 | 0.807 | 0.671 | 0.0 | |
| 297746091 | 820 | unnamed protein product [Vitis vinifera] | 0.957 | 0.803 | 0.661 | 0.0 | |
| 356547247 | 659 | PREDICTED: U-box domain-containing prote | 0.954 | 0.996 | 0.639 | 0.0 | |
| 356557439 | 780 | PREDICTED: U-box domain-containing prote | 0.972 | 0.857 | 0.630 | 0.0 | |
| 224059500 | 736 | predicted protein [Populus trichocarpa] | 0.797 | 0.745 | 0.749 | 0.0 | |
| 356541238 | 776 | PREDICTED: U-box domain-containing prote | 0.962 | 0.853 | 0.593 | 0.0 | |
| 224106491 | 439 | predicted protein [Populus trichocarpa] | 0.638 | 1.0 | 0.806 | 0.0 | |
| 449450906 | 671 | PREDICTED: U-box domain-containing prote | 0.954 | 0.979 | 0.561 | 0.0 | |
| 449496721 | 650 | PREDICTED: U-box domain-containing prote | 0.924 | 0.978 | 0.549 | 0.0 |
| >gi|255587037|ref|XP_002534109.1| receptor protein kinase, putative [Ricinus communis] gi|223525841|gb|EEF28277.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 946 bits (2445), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/675 (69%), Positives = 543/675 (80%), Gaps = 9/675 (1%)
Query: 17 NCMKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFLPFCGAETRSAKML 76
+CMKVK S KA Y AK+AP FCEIWF+NKGKH+WTKEA E + + S L
Sbjct: 5 SCMKVKKSSDKADYVAKSAPYFCEIWFINKGKHIWTKEAFERSSH------SGGASDDTL 58
Query: 77 RSRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHMVFPSSPTISCSDMNLF- 135
S+SL PE + S SAT + ++DWVQ + + P T S + F
Sbjct: 59 GSKSLRYSKNIMPLYPEYLQSTSATGIPCASVSDWVQIESNNSEEPVLHTRSSTTNGCFP 118
Query: 136 --SPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKL 193
+ S+S+ S +E+R S DSDSKVEE+ LY Q E I+AE RN AF E LRRKK+
Sbjct: 119 QSAFSSTSSSSRASTERRVSLDSDSKVEEESLYCQLAEARIEAEASRNEAFEELLRRKKI 178
Query: 194 ESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNV 253
E + +EAI KVK FESAY E+ LRKEAEDAL+ TI++Q KL +EK VT+EL RTMRN+
Sbjct: 179 EFQTLEAISKVKIFESAYENEVKLRKEAEDALRITIEEQVKLLKEKEEVTRELQRTMRNL 238
Query: 254 ALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQAGA 313
ALL++R +EANRR+DEA GELKLIQ SIA+L+QEKQRI+RQK+EAVRWLERWR+RG AGA
Sbjct: 239 ALLDNRGKEANRRQDEAAGELKLIQTSIASLRQEKQRIQRQKMEAVRWLERWRNRGPAGA 298
Query: 314 ANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKML 373
N +GF+G VE+LPE AEF L+DL+TATCNFSESFK+GQGG+GCVYKGEMLGRTVAIK L
Sbjct: 299 PNCNGFLGFVEELPELAEFLLSDLETATCNFSESFKLGQGGYGCVYKGEMLGRTVAIKKL 358
Query: 374 YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVS 433
+ HNMQGQ EFQ+EV+VL KLQHPHLVTLLG+CPEAWSLVYEYLPNGSL + LFR+SN+S
Sbjct: 359 HPHNMQGQSEFQKEVQVLGKLQHPHLVTLLGSCPEAWSLVYEYLPNGSLHECLFRRSNIS 418
Query: 434 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493
PL WK RARI AEI+S +CFLHSS PEKIVHGDLKPQNILLDSELS KIC+FGICRLVT+
Sbjct: 419 PLTWKVRARIIAEISSAVCFLHSSNPEKIVHGDLKPQNILLDSELSCKICEFGICRLVTD 478
Query: 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV 553
DTLY P FHR PKG+FPY DPE+HR GVLT KSD YSFG+IILQLLTGR PVGL GEV
Sbjct: 479 DTLYCPRFHRGNEPKGAFPYTDPEFHRVGVLTTKSDIYSFGVIILQLLTGRPPVGLVGEV 538
Query: 554 RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVA 613
RR + CGKL+SILDP AG+WPTF+A RLVDLGLQ CEL RERP++TP+LV+ELEQLHV+
Sbjct: 539 RRTMLCGKLASILDPSAGEWPTFIASRLVDLGLQFCELNSRERPELTPALVRELEQLHVS 598
Query: 614 EERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTP 673
EERPVPSFFLCPILQEIMHDPQVAADGFTYEG+A+R WLENGRETSPMTNL+LSHL+LTP
Sbjct: 599 EERPVPSFFLCPILQEIMHDPQVAADGFTYEGEAMRGWLENGRETSPMTNLKLSHLYLTP 658
Query: 674 NHALRHAIQDWLCKS 688
NHALR AIQDWLCKS
Sbjct: 659 NHALRFAIQDWLCKS 673
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478641|ref|XP_003632149.1| PREDICTED: U-box domain-containing protein 33-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 923 bits (2386), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/695 (67%), Positives = 552/695 (79%), Gaps = 20/695 (2%)
Query: 1 MNIHGIQKLVMGA-FPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESP 59
+N HGI+KLVMG P+NCMKVKM S KA+YAAK AP FCEIWF++KGKHVWTKEA ++P
Sbjct: 155 VNRHGIRKLVMGGTVPENCMKVKMSSSKANYAAKKAPEFCEIWFIHKGKHVWTKEAFKAP 214
Query: 60 NSFLPFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSA-TTLTHVGITDWVQSDPVH 118
P +T + + L F PE + S S+ ++ G + V+S+ V
Sbjct: 215 GFLPPISHPKTETGEDLG------------FQPECLPSGSSPVSVLSGGDRNGVESELVR 262
Query: 119 MVFPSSPTISCSD-----MNLFSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVS 173
SSP +S S + S+ +G G +EKR S DS SK EE+ LY Q E +
Sbjct: 263 TRVTSSPALSDSTSRNDPQFSPTSSSTFSGYGSSAEKR-SMDSYSKTEEESLYYQLAEAT 321
Query: 174 IKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQE 233
I+AE RN AF E L+R+KLESEAMEAI KVKAFESA+ARE+ LRK+AEDAL++TIQ+Q+
Sbjct: 322 IEAEASRNEAFLELLKRQKLESEAMEAIAKVKAFESAHAREVELRKDAEDALRSTIQEQD 381
Query: 234 KLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRR 293
KL +E+ +T+E+ +TMRNVALL+SRAQEANRR DEAT ELKLIQASIATLQ EKQ+IRR
Sbjct: 382 KLLEEREKLTREIQKTMRNVALLDSRAQEANRRCDEATEELKLIQASIATLQYEKQKIRR 441
Query: 294 QKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQG 353
QK+EA+ WL+RWRSRGQAG ++ +GFIG+ EDLPE AEFSL+DL+TATCNFSESFK+GQG
Sbjct: 442 QKMEAMHWLDRWRSRGQAGTSHCNGFIGVFEDLPELAEFSLSDLETATCNFSESFKIGQG 501
Query: 354 GFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLV 413
G G VYKGEML +TVAIK L+ HNMQGQ EFQ+EV+VL K+QHPHLVTL+GA PEAWSLV
Sbjct: 502 GNGSVYKGEMLDKTVAIKKLHPHNMQGQSEFQREVQVLGKIQHPHLVTLIGASPEAWSLV 561
Query: 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNIL 473
YEYLPNGSLQDRLFRKSN SPL WK RARI EI+S L FLHS KPEKIVHG+L+P+NIL
Sbjct: 562 YEYLPNGSLQDRLFRKSNNSPLTWKVRARIITEISSALLFLHSCKPEKIVHGNLRPENIL 621
Query: 474 LDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSF 533
L S+L KICDFGICRLV+++TL PSF R+ PKG+FPY DPE +RTGVLT KSD YSF
Sbjct: 622 LGSDLRCKICDFGICRLVSDETLRCPSFRRNAEPKGAFPYEDPELYRTGVLTTKSDIYSF 681
Query: 534 GLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYG 593
G+IILQLLTGR PVGLA EVR+AVSCGKL+SILD AG WPT VA RL DL L+CCEL
Sbjct: 682 GVIILQLLTGRPPVGLASEVRKAVSCGKLASILDSSAGVWPTHVASRLADLALRCCELNS 741
Query: 594 RERPDITPSLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLE 653
R+RP++ P+LV+ELEQLHV+EE+PVPSFFLCPILQ+IMHDP VAADGFTYE +A+ WLE
Sbjct: 742 RDRPELKPTLVRELEQLHVSEEQPVPSFFLCPILQDIMHDPHVAADGFTYEKEALLGWLE 801
Query: 654 NGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCKS 688
NGRETSPMTNLRLSHLHLTPNH+LR IQDWLCKS
Sbjct: 802 NGRETSPMTNLRLSHLHLTPNHSLRSTIQDWLCKS 836
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297746091|emb|CBI16147.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 900 bits (2326), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/695 (66%), Positives = 541/695 (77%), Gaps = 36/695 (5%)
Query: 1 MNIHGIQKLVMGA-FPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESP 59
+N HGI+KLVMG P+NCMKVKM S KA+YAAK AP FCEIWF++KGKHVWTKEA ++P
Sbjct: 155 VNRHGIRKLVMGGTVPENCMKVKMSSSKANYAAKKAPEFCEIWFIHKGKHVWTKEAFKAP 214
Query: 60 NSFLPFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSA-TTLTHVGITDWVQSDPVH 118
P +T + + L F PE + S S+ ++ G + V+S+ V
Sbjct: 215 GFLPPISHPKTETGEDLG------------FQPECLPSGSSPVSVLSGGDRNGVESELVR 262
Query: 119 MVFPSSPTISCSD-----MNLFSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVS 173
SSP +S S + S+ +G G +EKR S DS SK EE+ LY Q E +
Sbjct: 263 TRVTSSPALSDSTSRNDPQFSPTSSSTFSGYGSSAEKR-SMDSYSKTEEESLYYQLAEAT 321
Query: 174 IKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQE 233
I+AE RN AF E L+R+KLESEAMEAI KVKAFESA+ARE+ LRK+AEDAL++TIQ+Q+
Sbjct: 322 IEAEASRNEAFLELLKRQKLESEAMEAIAKVKAFESAHAREVELRKDAEDALRSTIQEQD 381
Query: 234 KLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRR 293
KL +E+ +T+E+ +TMRNVALL+SRAQEANRR DEAT ELKLIQASIATLQ EKQ+IRR
Sbjct: 382 KLLEEREKLTREIQKTMRNVALLDSRAQEANRRCDEATEELKLIQASIATLQYEKQKIRR 441
Query: 294 QKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQG 353
QK+EA+ WL+RWRSRGQAG ++ +GFIG+ EDLPE AEFSL+DL+TATCNFSESFK+GQG
Sbjct: 442 QKMEAMHWLDRWRSRGQAGTSHCNGFIGVFEDLPELAEFSLSDLETATCNFSESFKIGQG 501
Query: 354 GFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLV 413
G G VYKGEML +TVAIK L+ HNMQGQ EFQ+EV+VL K+QHPHLVTL+GA PEAWSLV
Sbjct: 502 GNGSVYKGEMLDKTVAIKKLHPHNMQGQSEFQREVQVLGKIQHPHLVTLIGASPEAWSLV 561
Query: 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNIL 473
YEYLPNGSLQDRLFRKSN SPL WK RARI EI+S L FLHS KPEKIVHG+L+P+NIL
Sbjct: 562 YEYLPNGSLQDRLFRKSNNSPLTWKVRARIITEISSALLFLHSCKPEKIVHGNLRPENIL 621
Query: 474 LDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSF 533
L S+L KICDFGICRL PKG+FPY DPE +RTGVLT KSD YSF
Sbjct: 622 LGSDLRCKICDFGICRL----------------PKGAFPYEDPELYRTGVLTTKSDIYSF 665
Query: 534 GLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYG 593
G+IILQLLTGR PVGLA EVR+AVSCGKL+SILD AG WPT VA RL DL L+CCEL
Sbjct: 666 GVIILQLLTGRPPVGLASEVRKAVSCGKLASILDSSAGVWPTHVASRLADLALRCCELNS 725
Query: 594 RERPDITPSLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLE 653
R+RP++ P+LV+ELEQLHV+EE+PVPSFFLCPILQ+IMHDP VAADGFTYE +A+ WLE
Sbjct: 726 RDRPELKPTLVRELEQLHVSEEQPVPSFFLCPILQDIMHDPHVAADGFTYEKEALLGWLE 785
Query: 654 NGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCKS 688
NGRETSPMTNLRLSHLHLTPNH+LR IQDWLCKS
Sbjct: 786 NGRETSPMTNLRLSHLHLTPNHSLRSTIQDWLCKS 820
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547247|ref|XP_003542027.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 866 bits (2237), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/672 (63%), Positives = 509/672 (75%), Gaps = 15/672 (2%)
Query: 19 MKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFLPFCGAETRSAKMLRS 78
MKVK S KA+Y AKNAP FCE+WF+ KGKH+WT+EASE+P S E + + LR
Sbjct: 1 MKVKRNSSKANYTAKNAPPFCEVWFIYKGKHIWTREASETPCSSSSCTQPEIATTESLRC 60
Query: 79 RSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHM--VFPSSPTISCSDMNLFS 136
RS + LF+ E + SA T GI WVQ + + F S + CS S
Sbjct: 61 RSFQY-GKNELFDSEYLWPNSARTTAVSGIRSWVQGEIIETEATFSSKASSCCSHC---S 116
Query: 137 PRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKLESE 196
P++SS R D+ +V E+ + Q E +AE + + AF E L+ +KLE E
Sbjct: 117 PQNSS---------RAYFDTYLEVMEERINKQLIETKREAEAVTDEAFTELLKCEKLEVE 167
Query: 197 AMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALL 256
AMEAI KV FESA+ RE+ LRKEA+DAL+ T+Q+Q+KL E + EL TMRN+ALL
Sbjct: 168 AMEAIRKVNLFESAHVREVKLRKEADDALRDTVQEQQKLLNESEEIAGELQMTMRNIALL 227
Query: 257 NSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQAGAANY 316
+SRAQEANRRRDEA EL LIQ SI+TL QE+Q+IRRQK EA+RWLERWRSRGQ GAA+
Sbjct: 228 DSRAQEANRRRDEAADELSLIQESISTLWQERQQIRRQKTEALRWLERWRSRGQVGAAHC 287
Query: 317 DGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSH 376
+G IG E+LPE AEFSL+DLQ ATCNFS SFK+ QGG+ C+YKGEMLGRTVAIK + H
Sbjct: 288 NGVIGFAEELPELAEFSLSDLQNATCNFSNSFKIEQGGYSCIYKGEMLGRTVAIKKFHQH 347
Query: 377 NMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLL 436
NMQG LEF+QEV+VL LQHPHL+TLLG CPEAWS+VYEYLPNG+LQD LFRKSN SPL
Sbjct: 348 NMQGPLEFRQEVQVLGSLQHPHLITLLGVCPEAWSIVYEYLPNGTLQDYLFRKSNNSPLT 407
Query: 437 WKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496
W RAR+ AEIAS LCFLHS KPE I+HGDLKP+ +LLDS L K+C FG+CRLV+E++L
Sbjct: 408 WNTRARMIAEIASALCFLHSFKPETIIHGDLKPETVLLDSSLGCKMCGFGLCRLVSEESL 467
Query: 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA 556
PSF ST PKG+F Y DPE+ RTG+LT KSD YSFGLIILQLLTGR PVGLA VR A
Sbjct: 468 LRPSFRLSTEPKGAFTYTDPEFQRTGILTTKSDIYSFGLIILQLLTGRTPVGLAVLVRNA 527
Query: 557 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 616
VSCGKLSSILD AG+WP+ VA +LV+LGLQCC+ Y R+RP++TP+LV+ELEQLH +EER
Sbjct: 528 VSCGKLSSILDSSAGEWPSAVAMQLVELGLQCCQQYHRDRPELTPTLVRELEQLHASEER 587
Query: 617 PVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHA 676
PVPSFF CPILQEIMHDPQVAADGFTYEG AIR+WLENG +TSPMTNL+LSHL LTPN+A
Sbjct: 588 PVPSFFSCPILQEIMHDPQVAADGFTYEGDAIREWLENGHDTSPMTNLKLSHLFLTPNYA 647
Query: 677 LRHAIQDWLCKS 688
LR AIQDWLCKS
Sbjct: 648 LRLAIQDWLCKS 659
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356557439|ref|XP_003547023.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 865 bits (2236), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/684 (63%), Positives = 514/684 (75%), Gaps = 15/684 (2%)
Query: 4 HGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFL 63
H I+KLV+GA P+NCMKVK S KA+Y AKNAP FCE+WF+ KGKH+WT+EASE+P
Sbjct: 111 HNIEKLVIGAIPENCMKVKRNSGKANYTAKNAPPFCEVWFIYKGKHIWTREASETPCYSS 170
Query: 64 PFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHMVFPS 123
E + + LR RS + G LF+ E + SA T T G WVQ + + +
Sbjct: 171 SCTQPEIATRESLRCRSFQY--GNELFDSEYLQPNSARTTTGSGSRSWVQGE----IIET 224
Query: 124 SPTISCSDMNLFSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSA 183
S S + SP++SS R D+ + E+ + Q E +AE + + A
Sbjct: 225 EAIFSSSCSSHCSPQNSS---------RAYLDTYLEAMEERINKQLIETKREAEAVTDEA 275
Query: 184 FAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVT 243
FAE L+ +KLE EAMEAI KV FESA+ RE+ LRKEAEDAL T+Q+Q+KL +
Sbjct: 276 FAELLKCEKLEVEAMEAIRKVNLFESAHVREVKLRKEAEDALTDTVQEQQKLLNASEEIA 335
Query: 244 QELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLE 303
EL TMRN+ALL+SRAQEA+RR DEA EL LIQ SI+TL QE+Q+IRRQK+EA+RWLE
Sbjct: 336 GELQMTMRNIALLDSRAQEAHRRCDEAADELSLIQESISTLWQERQQIRRQKMEALRWLE 395
Query: 304 RWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEM 363
RWRSRG+ GAA+ +G IG E+LPE AEFSL+DLQ ATCNFS SF + QGG+ C+YKGEM
Sbjct: 396 RWRSRGKVGAAHCNGVIGFAEELPELAEFSLSDLQNATCNFSNSFIIEQGGYVCIYKGEM 455
Query: 364 LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQ 423
LGRTVAIK + HNMQG LEF+QEV+VL LQHPHL+TLLG CPEAWS+VYEYLPNG+LQ
Sbjct: 456 LGRTVAIKKFHQHNMQGPLEFRQEVQVLGSLQHPHLITLLGVCPEAWSIVYEYLPNGTLQ 515
Query: 424 DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKIC 483
D LFRKSN SPL W RAR+ AEIAS LCFLHS +PE I+HGDLKP+ +LLDS L K+C
Sbjct: 516 DYLFRKSNNSPLTWNTRARMIAEIASALCFLHSFRPESIIHGDLKPETVLLDSSLGCKMC 575
Query: 484 DFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG 543
FG CRLV+E++L PSF ST PKG+F Y DPE+ RTG+LT KSD YSFGLIILQLLTG
Sbjct: 576 GFGFCRLVSEESLLRPSFRLSTEPKGAFTYTDPEFQRTGILTTKSDIYSFGLIILQLLTG 635
Query: 544 RLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603
R PVGLA VR A+SCGKLSSILD AG+WP+ VA RLV+LGLQCC+ Y R+RP++TP+L
Sbjct: 636 RTPVGLAVLVRNAISCGKLSSILDSSAGEWPSAVAMRLVELGLQCCQQYRRDRPELTPTL 695
Query: 604 VKELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTN 663
V+ELEQLH +EERPVPSFF C IL EIMHDPQVAADGFTYEG AIR+WLENG +TSPMTN
Sbjct: 696 VRELEQLHASEERPVPSFFSCQILLEIMHDPQVAADGFTYEGDAIREWLENGHDTSPMTN 755
Query: 664 LRLSHLHLTPNHALRHAIQDWLCK 687
L+LSHL LTPNHALR AIQDWLCK
Sbjct: 756 LKLSHLFLTPNHALRLAIQDWLCK 779
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224059500|ref|XP_002299877.1| predicted protein [Populus trichocarpa] gi|222847135|gb|EEE84682.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 837 bits (2163), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/554 (74%), Positives = 463/554 (83%), Gaps = 5/554 (0%)
Query: 135 FSPRSSSAGSGYMS-EKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKL 193
FS SS SG S E R S+ SD KVEE+ Y EVS++AE L N AF E L+ K L
Sbjct: 186 FSSTISSCASGCTSTEMRVSSGSDPKVEEESSYSHIEEVSLEAEALGNEAFEELLKCKTL 245
Query: 194 ESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNV 253
E EAMEA KVK +ESA E+ LRKEAEDAL TIQDQEKL +EK V ++L RTMRNV
Sbjct: 246 ELEAMEAFSKVKIYESALVHEVKLRKEAEDALNNTIQDQEKLLKEKDEVARKLERTMRNV 305
Query: 254 ALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQAGA 313
ALL+ RAQEANRR +EA+GELKLIQ SI +L+QE+QRIRRQK+EAV WLERWRS GQAG
Sbjct: 306 ALLDIRAQEANRRCEEASGELKLIQTSILSLRQEEQRIRRQKMEAVHWLERWRSPGQAGT 365
Query: 314 ANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKML 373
AN +GF+G+ E+LPE AEFSL+DLQTATCNFSESFK+GQGG G VYKGEMLGRTVAIK L
Sbjct: 366 ANCNGFLGITEELPELAEFSLSDLQTATCNFSESFKLGQGGCGQVYKGEMLGRTVAIKRL 425
Query: 374 YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVS 433
+ +NMQGQ EFQ+EV+VL KLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLF+K+N++
Sbjct: 426 HPNNMQGQSEFQKEVQVLGKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFQKNNIA 485
Query: 434 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493
PL WK R RI AEI+S LCFLHSSKPEKIVHGDLKPQNILL+SELS KIC+FGICRLVTE
Sbjct: 486 PLTWKIRTRIIAEISSALCFLHSSKPEKIVHGDLKPQNILLNSELSCKICEFGICRLVTE 545
Query: 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV 553
D+LY PSFH ST PKGSFPY DPE+ R GVLTPKSD Y+FG+IILQLLTG+ P GL GEV
Sbjct: 546 DSLYQPSFHWSTIPKGSFPYTDPEFQRIGVLTPKSDIYAFGVIILQLLTGKPPAGLVGEV 605
Query: 554 RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVA 613
RR KL+SILDP + +WP VARRLVDL LQ CEL R RPD+TP+LV+ELE LHV+
Sbjct: 606 RRT---RKLTSILDP-SAEWPMIVARRLVDLALQFCELSSRGRPDLTPTLVRELEHLHVS 661
Query: 614 EERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTP 673
EERPVPSFFLCPILQEIMHDPQVAADGFTYEG+A+R WL NGRETSPMTNLRL HLHLTP
Sbjct: 662 EERPVPSFFLCPILQEIMHDPQVAADGFTYEGEALRGWLANGRETSPMTNLRLDHLHLTP 721
Query: 674 NHALRHAIQDWLCK 687
NHALR AIQDWLCK
Sbjct: 722 NHALRLAIQDWLCK 735
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356541238|ref|XP_003539086.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 799 bits (2064), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/688 (59%), Positives = 494/688 (71%), Gaps = 26/688 (3%)
Query: 1 MNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPN 60
+ +H ++KLV+GA P+NCMK+K S KA+YAAKNAP FCEIWFV GKH+WT+EASE+P
Sbjct: 115 VTVHNVRKLVIGAIPENCMKIKRNSSKANYAAKNAPPFCEIWFVYNGKHIWTREASETPR 174
Query: 61 SFLPFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHMV 120
S ET +A+ L RS + GT L ++T T VQS+ +
Sbjct: 175 SLSSRAQPETTTAESLSCRSFHD--GTKELLHSECLQLNSTKTTR----SMVQSE----I 224
Query: 121 FPSSPTISCSDMNLFSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELR 180
+ T S + S S +G+ D+ S+ EE+ + Q E +A+
Sbjct: 225 IEAEATFSSKSSSCNSHCSPQHSAGWY------LDTHSEFEEETIDSQLIETKREAKAAT 278
Query: 181 NSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKA 240
+ A AE L+ K+LE +A+EAI KV FESA+A E+ LRKEAEDAL+ TIQ+Q+ EK
Sbjct: 279 DKALAELLKSKRLEVKAIEAISKVNFFESAHAHEVKLRKEAEDALRATIQEQQMFLDEKE 338
Query: 241 FVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVR 300
+ +EL RT+R+++LL + A E N +RDEA EL LIQASI+ L EKQ+IR+QK+EA+
Sbjct: 339 EIARELERTVRSISLLGNCAHETNHKRDEAENELSLIQASISNLWHEKQQIRQQKMEALH 398
Query: 301 WLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYK 360
WLERW+S GQ GA + +G IG E+ PE AEFSL+DLQ ATCNFSESFKV +GG+G +YK
Sbjct: 399 WLERWKSCGQVGADHCNGVIGFAEEFPELAEFSLSDLQNATCNFSESFKVMEGGYGSIYK 458
Query: 361 GEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNG 420
GEMLGRTVAI+ L+ HNMQG EF QE ++L LQHPHLVTLLG CPEAWS VYEYLP+G
Sbjct: 459 GEMLGRTVAIRKLHPHNMQGSSEFHQEAQILGSLQHPHLVTLLGVCPEAWSFVYEYLPSG 518
Query: 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480
SLQD LFRKS+ PL RA+ AEIA+ LCFLHSSKPE I+HG L + +LLDS LS
Sbjct: 519 SLQDYLFRKSSFLPLTRNIRAQWIAEIATALCFLHSSKPETIIHGGLTLETVLLDSALSC 578
Query: 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQL 540
KIC+FG RLV ED T PKGSF Y DPE+ RTGVLTPKSD YSFG+IILQL
Sbjct: 579 KICEFGFSRLVKED----------TEPKGSFTYTDPEFQRTGVLTPKSDIYSFGIIILQL 628
Query: 541 LTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600
LTGR PVGL GEVRRAVSCGKL ILD AG+W + +A RL +LGLQCC+L R RP++T
Sbjct: 629 LTGRTPVGLVGEVRRAVSCGKLYPILDSSAGEWNSTMATRLAELGLQCCQLNSRVRPELT 688
Query: 601 PSLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSP 660
PSLV+EL+QL V EERPVPSFFLCPI QEIMHDPQVAADGFTYEGKAI +WLENG ETSP
Sbjct: 689 PSLVRELKQLLVLEERPVPSFFLCPIFQEIMHDPQVAADGFTYEGKAISEWLENGHETSP 748
Query: 661 MTNLRLSHLHLTPNHALRHAIQDWLCKS 688
MTNL+L+HL+LTPNHALR AIQ WLCKS
Sbjct: 749 MTNLKLTHLNLTPNHALRLAIQGWLCKS 776
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106491|ref|XP_002314184.1| predicted protein [Populus trichocarpa] gi|222850592|gb|EEE88139.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 752 bits (1942), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/439 (80%), Positives = 397/439 (90%)
Query: 250 MRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRG 309
MRNVALL+SRAQEANRR +EA GELKLIQ SI++L+QEKQRIR+QK+EAV WLERWRS G
Sbjct: 1 MRNVALLDSRAQEANRRSEEAAGELKLIQTSISSLRQEKQRIRQQKIEAVHWLERWRSHG 60
Query: 310 QAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVA 369
QAGA+N +G +G+ E+LPE AEFSL+DLQTATCNFSESFK+GQGG GCVYKGEMLGRTVA
Sbjct: 61 QAGASNCNGILGITEELPELAEFSLSDLQTATCNFSESFKLGQGGCGCVYKGEMLGRTVA 120
Query: 370 IKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRK 429
IK L+ +N QGQLEFQ+EV+VL KLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLF+K
Sbjct: 121 IKRLHPNNTQGQLEFQKEVQVLGKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFQK 180
Query: 430 SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
SN+SPL WK R RI AEI+S LCFLHSSKPEKIVHGDLKPQNILL+SELS KIC+FGICR
Sbjct: 181 SNISPLTWKIRTRIIAEISSTLCFLHSSKPEKIVHGDLKPQNILLNSELSCKICEFGICR 240
Query: 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGL 549
LVTED+LY PS HRS PKGSFPY DPE+ R GVLTPKSD Y+FG+IILQLLTG+ PVGL
Sbjct: 241 LVTEDSLYCPSIHRSNEPKGSFPYTDPEFQRIGVLTPKSDIYAFGVIILQLLTGKPPVGL 300
Query: 550 AGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609
G+VRR +SCGKL+SILDP AG+WP FVAR+LV L LQ CEL R+RPD+TP+LV+ELEQ
Sbjct: 301 VGKVRRTLSCGKLASILDPSAGEWPMFVARQLVYLSLQFCELRSRDRPDLTPTLVRELEQ 360
Query: 610 LHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHL 669
LHV+EERPVPS FLCPILQEIMHDPQVAADGFTYEG+A+R+WL NGRETSPMTNLRLSHL
Sbjct: 361 LHVSEERPVPSIFLCPILQEIMHDPQVAADGFTYEGEALREWLANGRETSPMTNLRLSHL 420
Query: 670 HLTPNHALRHAIQDWLCKS 688
LTPNHALR AIQDWLC++
Sbjct: 421 LLTPNHALRLAIQDWLCQT 439
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450906|ref|XP_004143203.1| PREDICTED: U-box domain-containing protein 33-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 747 bits (1928), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/682 (56%), Positives = 491/682 (71%), Gaps = 25/682 (3%)
Query: 19 MKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFLPFCGAETRSAKMLRS 78
MKVK S KA YAA+N P+ CEIWFV+KG H+WT+EA E G+ + S +LR
Sbjct: 1 MKVKKSSSKADYAARNIPLPCEIWFVDKGNHIWTREAVE---------GSCSASPSLLRE 51
Query: 79 RSL--ENCNGTSL------FNPESILSRSATTLTHVGITDWVQSDPVHM--VFPSSPTIS 128
++ ENC+ +SL FN + S SA + + + + +P H+ V SS I
Sbjct: 52 LAITKENCSQSSLVDNSHSFNQQYSHSSSANGI--IEGFNCIDKEPFHVEGVMSSSLDIH 109
Query: 129 CS---DMNLFSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFA 185
+ ++ S +SS E RE T SDSKVEE L + ++ ++ E RN A A
Sbjct: 110 FTYPLRISSSSASTSSDSGYSSVEGREPTSSDSKVEERGLNGELKDAILETEASRNEAIA 169
Query: 186 EFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQE 245
L +K+E EA E+I K K F+ E+ LR+E E+ L+T I+ ++ L +E+ + +E
Sbjct: 170 MHLICRKMEQEAAESIKKFKVFKCVNEHEIDLRRETEELLRTIIEKKQTLSEERTEIHEE 229
Query: 246 LHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERW 305
L TM+ +ALL+S+AQE N++ +EAT EL+ IQASIA L++EKQ ++ QK+ A+ WL +W
Sbjct: 230 LESTMKTLALLDSQAQEVNQKHEEATAELRNIQASIAALKKEKQTMQSQKMNALNWLSQW 289
Query: 306 RSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLG 365
+S+ +A NY+ I ++E + EF+ +LQ ATC+FSESFK+ GG+GC+YKGEMLG
Sbjct: 290 KSQ-EASLENYNASIRVMEHQTQLIEFTFLELQMATCDFSESFKISHGGYGCLYKGEMLG 348
Query: 366 RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDR 425
+TVAI+ L+ H + G EF++EV VL KLQHPHLVTLLG C EAWSL+YEYLP+G+LQ
Sbjct: 349 KTVAIRKLHPHYILGPAEFREEVEVLGKLQHPHLVTLLGVCTEAWSLIYEYLPHGNLQSH 408
Query: 426 LFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485
LF+K N PL WK RARI AEI S LCFLHSSKPEKIVHGDLKP+NILLDSE SKICDF
Sbjct: 409 LFQKGNTPPLTWKTRARIIAEIGSALCFLHSSKPEKIVHGDLKPENILLDSEFISKICDF 468
Query: 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL 545
GI RLV+E+TLY PSF RST PKG+F + DPE R GVLTPKSD YSFGLIILQLL+G+
Sbjct: 469 GIYRLVSEETLYCPSFRRSTEPKGAFSHTDPECQRDGVLTPKSDIYSFGLIILQLLSGKP 528
Query: 546 PVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605
VGL E+R+A+S G+L S+LD AG+WP VARRLVD+GLQCCEL G +RP++TP++V+
Sbjct: 529 IVGLVIELRKAISFGRLESVLDLSAGEWPIDVARRLVDIGLQCCELKGSDRPELTPTIVR 588
Query: 606 ELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLR 665
EL+QL EERPVPS+FLCPILQEIM DPQVAADGFTYEG+AIR+W NGRETSPMTNL+
Sbjct: 589 ELKQLQNFEERPVPSYFLCPILQEIMQDPQVAADGFTYEGEAIREWFNNGRETSPMTNLK 648
Query: 666 LSHLHLTPNHALRHAIQDWLCK 687
LSHLHLTPNHA+R AIQDWLC+
Sbjct: 649 LSHLHLTPNHAVRLAIQDWLCR 670
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449496721|ref|XP_004160207.1| PREDICTED: U-box domain-containing protein 33-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 720 bits (1859), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/682 (54%), Positives = 480/682 (70%), Gaps = 46/682 (6%)
Query: 19 MKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFLPFCGAETRSAKMLRS 78
MKVK S KA YAA+N P+ CEIWFV+KG H+WT+EA E G+ + S +LR
Sbjct: 1 MKVKKSSSKADYAARNIPLPCEIWFVDKGNHIWTREAVE---------GSCSASPSLLRE 51
Query: 79 RSL--ENCNGTSL------FNPESILSRSATTLTHVGITDWVQSDPVHM--VFPSSPTIS 128
++ ENC+ +SL FN + S SA + + + + +P H+ V SS I
Sbjct: 52 LAITKENCSQSSLVDNSHSFNQQYSHSSSANGI--IEGFNCIDKEPFHVEGVMSSSLDIH 109
Query: 129 CS---DMNLFSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFA 185
+ ++ S +SS E RE T SDSKVEE L + ++ ++ E RN
Sbjct: 110 FTYPLRISSSSASTSSDSGYSSVEGREPTSSDSKVEERGLNGELKDAILETEASRN---- 165
Query: 186 EFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQE 245
EF K F+ E+ LR+E E+ L+T I+ ++ L +E+ + +E
Sbjct: 166 EF-----------------KVFKCVNEHEIDLRRETEELLRTIIEKKQTLSEERTEIHEE 208
Query: 246 LHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERW 305
L TM+ +ALL+S+AQE N++ +EAT EL+ IQASIA L++EKQ ++ QK+ A+ WL +W
Sbjct: 209 LESTMKTLALLDSQAQEVNQKHEEATAELRNIQASIAALKKEKQTMQSQKMNALNWLSQW 268
Query: 306 RSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLG 365
+S+ +A NY+ I ++E + EF+ +LQ ATC+FSESFK+ GG+GC+YKGEMLG
Sbjct: 269 KSQ-EASLENYNASIRVMEHQTQLIEFTFLELQMATCDFSESFKISHGGYGCLYKGEMLG 327
Query: 366 RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDR 425
+TVAI+ L+ H + G EF++EV VL KLQHPHLVTLLG C EAWSL+YEYLP+G+LQ
Sbjct: 328 KTVAIRKLHPHYILGPAEFREEVEVLGKLQHPHLVTLLGVCTEAWSLIYEYLPHGNLQSH 387
Query: 426 LFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485
LF+K N PL WK RARI AEI S LCFLHSSKPEKIVHGDLKP+NILLDSE SKICDF
Sbjct: 388 LFQKGNTPPLTWKTRARIIAEIGSALCFLHSSKPEKIVHGDLKPENILLDSEFISKICDF 447
Query: 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL 545
GI RLV+E+TLY PSF RST PKG+F + DPE R GVLTPKSD YSFGLIILQLL+G+
Sbjct: 448 GIYRLVSEETLYCPSFRRSTEPKGAFSHTDPECQRDGVLTPKSDIYSFGLIILQLLSGKP 507
Query: 546 PVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605
VGL E+R+A+S G+L S+LD AG+WP VARRLVD+GLQCCEL G +RP++TP++V+
Sbjct: 508 IVGLVIELRKAISFGRLESVLDLSAGEWPIDVARRLVDIGLQCCELKGSDRPELTPTIVR 567
Query: 606 ELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLR 665
EL+QL EERPVPS+FLCPILQEIM DPQVAADGFTYEG+AIR+W NGRETSPMTNL+
Sbjct: 568 ELKQLQNFEERPVPSYFLCPILQEIMQDPQVAADGFTYEGEAIREWFNNGRETSPMTNLK 627
Query: 666 LSHLHLTPNHALRHAIQDWLCK 687
LSHLHLTPNHA+R AIQDWLC+
Sbjct: 628 LSHLHLTPNHAVRLAIQDWLCR 649
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 688 | ||||||
| TAIR|locus:2050669 | 834 | AT2G45910 [Arabidopsis thalian | 0.954 | 0.787 | 0.396 | 2.8e-121 | |
| TAIR|locus:2101353 | 805 | AT3G49060 [Arabidopsis thalian | 0.933 | 0.797 | 0.353 | 1.9e-90 | |
| TAIR|locus:2117343 | 835 | AT4G25160 [Arabidopsis thalian | 0.940 | 0.774 | 0.345 | 3.5e-88 | |
| TAIR|locus:2047605 | 801 | AT2G19410 [Arabidopsis thalian | 0.683 | 0.586 | 0.400 | 9.1e-88 | |
| TAIR|locus:2176177 | 819 | AT5G51270 [Arabidopsis thalian | 0.658 | 0.553 | 0.402 | 2.4e-85 | |
| TAIR|locus:2151641 | 796 | AT5G61560 [Arabidopsis thalian | 0.949 | 0.820 | 0.330 | 3.4e-84 | |
| TAIR|locus:504954932 | 789 | AT5G57035 [Arabidopsis thalian | 0.699 | 0.609 | 0.381 | 2.9e-80 | |
| TAIR|locus:2061012 | 788 | AT2G24370 [Arabidopsis thalian | 0.590 | 0.515 | 0.392 | 1.8e-75 | |
| TAIR|locus:2143094 | 701 | AT5G12000 [Arabidopsis thalian | 0.511 | 0.502 | 0.423 | 5.9e-74 | |
| TAIR|locus:2015656 | 758 | AT1G16760 [Arabidopsis thalian | 0.920 | 0.835 | 0.323 | 1.1e-73 |
| TAIR|locus:2050669 AT2G45910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1193 (425.0 bits), Expect = 2.8e-121, P = 2.8e-121
Identities = 278/701 (39%), Positives = 400/701 (57%)
Query: 5 GIQKLVMGAFPDNCMKVKMG---SRKASYAAKNAPMFCEIWFVNKGKHVWTKEAS-ESPN 60
GI+KLVMGA D +M SRKA + + AP C+IWF KG + T+EA+ +
Sbjct: 154 GIRKLVMGAAADRHYSRRMTDLKSRKAIFVRREAPTLCQIWFTCKGYLIHTREATMDDTE 213
Query: 61 SFLPFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHMV 120
S ++ +L++ S + +S + S L G + QS V
Sbjct: 214 SEYASPRPSISASDLLQTFSTPESEHQHISRVQS--TDSVQQLVSNG-SSTEQSGRV--- 267
Query: 121 FPSSPTISCSDMNLFSPRSSSAGSG-YMSEKRESTDSDSKVEEDPLYVQHREVSIKAEEL 179
S +++ + S S GS MS S S +D V+ R+ + +A
Sbjct: 268 --SDGSLNTDEEERESDGSEVTGSATVMSSGHSSPSSFPDGVDDSFNVKIRKATSEAHSS 325
Query: 180 RNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEK 239
+ AFAE LRR+K E A++AI + K ESAY+ E+ RK+ E A+ + +K E+
Sbjct: 326 KQEAFAETLRRQKAEKNALDAIRRAKQSESAYSEELKRRKDTEIAVAKEKERFITIKNEQ 385
Query: 240 AFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAV 299
+ +EL M A+L S+ +++ ++ +L + + L+ E++ ++ ++ A+
Sbjct: 386 EVIMEELQSAMAQKAMLESQIAKSDGTMEKLNQKLDIAVKLLQKLRDEREELQTERDRAL 445
Query: 300 RWLERWRSRGQAGAANYDGFIGLVEDLPES-AEFSLADLQTATCNFSESFKVGQGGFGCV 358
R E RS + LP+ +FS ++++ AT +F + K+G+GG+G +
Sbjct: 446 REAEELRSHAETSTLQ----------LPQYFTDFSFSEIEEATNHFDSTLKIGEGGYGSI 495
Query: 359 YKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLP 418
Y G + VAIKML ++ QG +E+QQEV VLSK++HP+++TL+GACPE WSLVYEYLP
Sbjct: 496 YVGLLRHTQVAIKMLNPNSSQGPVEYQQEVDVLSKMRHPNIITLIGACPEGWSLVYEYLP 555
Query: 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL 478
GSL+DRL K N PL W++R RIA EI + L FLHS+K +VHGDLKP NILLDS L
Sbjct: 556 GGSLEDRLTCKDNSPPLSWQNRVRIATEICAALVFLHSNKAHSLVHGDLKPANILLDSNL 615
Query: 479 SSKICDFGICRLVTEDTLYLPSFHRS--TAPKGSFPYADPEYHRTGVLTPKSDSYSFGLI 536
SK+ DFG C L+ P+ +S T G+ Y DPE +G LTPKSD YSFG+I
Sbjct: 616 VSKLSDFGTCSLLH------PNGSKSVRTDVTGTVAYLDPEASSSGELTPKSDVYSFGII 669
Query: 537 ILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRER 596
+L+LLTGR + ++ EV+ A+ G L+ +LDPLAGDWP A +L L L+CCE R
Sbjct: 670 LLRLLTGRPALRISNEVKYALDNGTLNDLLDPLAGDWPFVQAEQLARLALRCCETVSENR 729
Query: 597 PDITPSLVKELEQL----------HVA--EERPVPSFFLCPILQEIMHDPQVAADGFTYE 644
PD+ + + LE + H+ E R P +F+CPI QE+M DP VAADGFTYE
Sbjct: 730 PDLGTEVWRVLEPMRASSGGSSSFHLGRNEHRIAPPYFICPIFQEVMQDPHVAADGFTYE 789
Query: 645 GKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWL 685
+AIR WL++ +TSPMTN++LSH L NHALR AIQ+WL
Sbjct: 790 AEAIRAWLDSEHDTSPMTNVKLSHTSLIANHALRSAIQEWL 830
|
|
| TAIR|locus:2101353 AT3G49060 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 902 (322.6 bits), Expect = 1.9e-90, P = 1.9e-90
Identities = 254/718 (35%), Positives = 377/718 (52%)
Query: 4 HGIQKLVMGAFPDNCMKVKMG---SRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPN 60
H I+ LVMGA D KM S+KA + K AP C IWF+ KG ++T+ +++ N
Sbjct: 123 HKIKWLVMGAASDKHYSWKMTDLKSKKAIFVCKKAPDSCHIWFLCKGYLIFTRASNDDSN 182
Query: 61 S---FLPFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPV 117
+ P ++ + + +S LE+ S RS L G D Q +
Sbjct: 183 NRQTMPPLVQLDSDN-ETRKSEKLES----SYMRRRLRYWRSL--LEQDGEKDTGQLER- 234
Query: 118 HMVFPSSPTISCSDMNLFSPRSSSA-GSGYMSE--KRESTDSD----SKVEE-----DPL 165
V P +P LFS SSS+ G E E DSD S VEE D
Sbjct: 235 EKVEPRAPP-------LFSSGSSSSFGEPVGPEPVSPELVDSDTLNTSNVEEKEREGDVA 287
Query: 166 YVQHREVSIKAE--ELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAED 223
HR + + + + E ++ + ++ EA+ K KA E +E RK E+
Sbjct: 288 RKVHRYDKAMHDIGQSDRTVYGEAGKKWEEDASTTEALCKAKALEGLCIKESSQRKRLEE 347
Query: 224 ALQTT-IQDQEKLKQEKAFVTQELHRTM-RNVALLNSRAQEANRRRDEATGELKLIQASI 281
L+ ++ + ++Q F+ +EL RN+ L S+ ++ E + +
Sbjct: 348 LLEKEKLEVKMVIEQNNGFM-KELQMVQGRNLKL-ESQMRKLQDLEKEHGEKFDTAMELL 405
Query: 282 ATLQQEKQRIRRQKVEAVRWLERWRS--RGQAGAANYDGFIGLVEDLPESAEFSLADLQT 339
+ +Q++ IR AV+ + R +G+ G ++ G E ++S ++
Sbjct: 406 KSFRQKRDEIRIDHENAVKEVNALRRLVKGETGESS-----G-----SEMLDYSFMEINE 455
Query: 340 ATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL 399
AT F S+K+G+G +G VYKG + VA+KML S+ EF++ V +LS+++HP+L
Sbjct: 456 ATNEFDPSWKLGEGKYGSVYKGNLQHLQVAVKMLPSYGSLNHFEFERRVEILSRVRHPNL 515
Query: 400 VTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
VTL+GACPE+ SL+Y+Y+PNGSL+D ++NV L W+ R RIA+EI S L FLHS+ P
Sbjct: 516 VTLMGACPESRSLIYQYIPNGSLEDCFSSENNVPALSWESRIRIASEICSALLFLHSNIP 575
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
I+HG+LKP ILLDS L +KI D+GI +L+ D L S P+ DP Y
Sbjct: 576 -CIIHGNLKPSKILLDSNLVTKINDYGISQLIPIDGL-----------DKSDPHVDPHYF 623
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVAR 579
+ +T +SD Y+FG+I+LQLLT R G+ +V+ A+ +S++LD AGDWP +
Sbjct: 624 VSREMTLESDIYAFGIILLQLLTRRPVSGILRDVKCALENDNISAVLDNSAGDWPVARGK 683
Query: 580 RLVDLGLQCCELYGRERPDITPSL----------VKELEQLHVAEE---RPVPSFFLCPI 626
+L ++ ++CC+ RPD+ L V E A + R PS +LCPI
Sbjct: 684 KLANVAIRCCKKNPMNRPDLAVVLRFIDRMKAPEVPSSETSSYANQNVPRRPPSHYLCPI 743
Query: 627 LQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 684
QE+M DP +AADGFTYE +AIR+WL NG +TSPMTNL++ +L PNHAL AIQDW
Sbjct: 744 FQEVMKDPLIAADGFTYEAEAIREWLANGHDTSPMTNLKMEDCNLIPNHALHLAIQDW 801
|
|
| TAIR|locus:2117343 AT4G25160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 860 (307.8 bits), Expect = 3.5e-88, Sum P(2) = 3.5e-88
Identities = 241/698 (34%), Positives = 359/698 (51%)
Query: 25 SRKA---SYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFLPFCGAETRSAKMLRSRSL 81
SRKA S + P FC ++ V+KGK + + N+ + G+E ++ S
Sbjct: 147 SRKADICSVISALMPNFCTVYVVSKGKLSCVRPSDSDGNATIREDGSERTNSSSGSSGPT 206
Query: 82 ENCNG--TSLFNPESI-LSRSATTLTHVGITDWVQSDPVHMVFPSSPTISCSDMNLFSPR 138
+ + +S + +S LS + H S P+ S C ++ R
Sbjct: 207 SDSSDVMSSAHDSQSRPLSLPVRRMQHFPAIAGQASVPMETSSVGSDETRCMSLDAEEAR 266
Query: 139 SSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKLESEAM 198
S S R STD+ S+ + R+ ++ + N + F R +
Sbjct: 267 DVS------SINRSSTDTTSRWTPRRRDYEERKEAMSSSS-SNREYGNFGTRFSWSGMGV 319
Query: 199 EAIGKVKAFESAYAREMHLRKEAEDALQTTIQ-DQEKLKQEKAFVTQELHRTMRNVALLN 257
+ +A + A L +++ Q + + EKL+ E V QE++ +
Sbjct: 320 DTTHS-RASQQASNMSDALSEQSYTDNQVNLNFEVEKLRAELRHV-QEMYAVAQTETFDA 377
Query: 258 SRAQ-EANRRR-DEATG--ELKLIQASIATL-QQEKQRIR--RQKVEAVRW--------- 301
SR E N+RR +EA ELKL + L ++EKQ R+ E++R
Sbjct: 378 SRKLGELNQRRLEEAIKLEELKLKEYEARELAEKEKQNFEKARRDAESMRERAEREIAQR 437
Query: 302 --LERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVY 359
ER +R +G +G + + F+ ++ AT +FSE K+G G +G VY
Sbjct: 438 REAERKSARDTKEKEKLEGTLGSPQ--LQYQHFAWEEIMAATSSFSEELKIGMGAYGAVY 495
Query: 360 KGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPN 419
K + T +K+L S Q +FQQE+ +LSK++HPHLV LLGACPE +LVYEY+ N
Sbjct: 496 KCNLHHTTAVVKVLQSAENQLSKQFQQELEILSKIRHPHLVLLLGACPEQGALVYEYMEN 555
Query: 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 479
GSL+DRLF+ +N PL W +R RIA E+A+ L FLH SKP+ I+H DLKP NILLD
Sbjct: 556 GSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFLHKSKPKPIIHRDLKPANILLDHNFV 615
Query: 480 SKICDFGICRLVTEDTLYLP-SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIIL 538
SK+ D G+ +V D L + ++ T+P G+ Y DPEY RTG ++ KSD YSFG+I+L
Sbjct: 616 SKVGDVGLSTMVQVDPLSTKFTIYKQTSPVGTLCYIDPEYQRTGRISSKSDIYSFGMILL 675
Query: 539 QLLTGRLPVGLAGEVRRAV-SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERP 597
QLLT + + L V A+ S + ILD AG+WP R L L L C EL G++RP
Sbjct: 676 QLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGNWPIEETRELAALALCCTELRGKDRP 735
Query: 598 DITPSLVKELEQLH-VAEE----------RPVPSFFLCPILQEIMHDPQVAADGFTYEGK 646
D+ ++ LE L VAE+ +P P+ F+CP+L+++M++P VAADG+TY+
Sbjct: 736 DLKDQILPALENLKKVAEKARNSFSGVSTQP-PTHFICPLLKDVMNEPCVAADGYTYDRH 794
Query: 647 AIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 684
AI +WL+ TSPMT+ L +L PN+ L AI +W
Sbjct: 795 AIEEWLKE-HNTSPMTDSPLHSKNLLPNYTLYTAIMEW 831
|
|
| TAIR|locus:2047605 AT2G19410 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 855 (306.0 bits), Expect = 9.1e-88, Sum P(2) = 9.1e-88
Identities = 198/494 (40%), Positives = 287/494 (58%)
Query: 209 SAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRD 268
S ++++ + +E E L+ +Q K ++A +EL T V +L++ ++R +
Sbjct: 303 SRKSKKVEIEEEVE-RLKNELQSTV-FKYKQA--CEELFSTQNKVKMLSTEYLNESKRVN 358
Query: 269 EATGELKLIQASIATLQQEKQRIRRQKVEAVR-WLERWRSRGQAGAAN----YDGFIGLV 323
A E + +Q + A L++E+ ++VE + L R + Q N Y ++
Sbjct: 359 NAV-EKEELQRNTAALEKERYMKAVKEVETAKALLAREFCQRQIAEVNALRTYLEKKKVI 417
Query: 324 EDLPES----AEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQ 379
+ L + ++++ ++ TAT FS +G+GG+G VY+ + A+K++ +
Sbjct: 418 DQLLGTDHRYRKYTIEEIVTATEGFSPEKVIGEGGYGKVYQCSLDSTPAAVKVVRLDTPE 477
Query: 380 GQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKD 439
+ EF +EV VLS+L+HPH+V LLGACPE LVYEYL NGSL++ +F + N PL W
Sbjct: 478 KKQEFLKEVEVLSQLRHPHVVLLLGACPENGCLVYEYLENGSLEEYIFHRKNKPPLPWFI 537
Query: 440 RARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499
R R+ E+A GL FLHSSKPE IVH DLKP NILL+ SKI D G+ +LVT+
Sbjct: 538 RFRVIFEVACGLAFLHSSKPEPIVHRDLKPGNILLNRNYVSKIADVGLAKLVTDVAPDNV 597
Query: 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC 559
+ +R++ G+ Y DPEYHRTG + PKSD Y+FG+IILQLLT R P G+ V AV
Sbjct: 598 TMYRNSVLAGTLHYIDPEYHRTGTIRPKSDLYAFGIIILQLLTARNPSGIVPAVENAVKK 657
Query: 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL------HVA 613
G L+ +LD DWP L +GL+C E R+RPD+ ++ L++L V
Sbjct: 658 GTLTEMLDKSVTDWPLAETEELARIGLKCAEFRCRDRPDLKSEVIPVLKRLVETANSKVK 717
Query: 614 EERP---VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLH 670
+E PS + CPIL+EIM +P++AADGFTYE KAI WLE SP+T +L H
Sbjct: 718 KEGSNLRAPSHYFCPILREIMEEPEIAADGFTYERKAILAWLEK-HNISPVTRQKLDHFK 776
Query: 671 LTPNHALRHAIQDW 684
LTPNH LR AI+DW
Sbjct: 777 LTPNHTLRSAIRDW 790
|
|
| TAIR|locus:2176177 AT5G51270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 823 (294.8 bits), Expect = 2.4e-85, Sum P(2) = 2.4e-85
Identities = 191/475 (40%), Positives = 279/475 (58%)
Query: 231 DQEKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEAT-GELKLIQ---ASIATLQQ 286
D + E + + EL A+ +A+R+ +E EL L++ IA +
Sbjct: 341 DNQDTLNEISKLRAELRHAHEMYAVAQVETLDASRKLNELKFEELTLLEHETKGIAKKET 400
Query: 287 EK-QRIRRQKVEAVRWLE-RWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNF 344
EK ++ RR++ EA + E ++ +A LV + EF+ ++ AT +F
Sbjct: 401 EKFEQKRREEREAAQRREAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSSF 460
Query: 345 SESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
SE K+G G +G VYK + A+K+L+S +F QE+ +LSK++HPHLV LLG
Sbjct: 461 SEDLKIGMGAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLLG 520
Query: 405 ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
ACP+ +LVYEY+ NGSL+DRLF+ ++ P+ W R RIA E+AS L FLH SKP I+H
Sbjct: 521 ACPDHGALVYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPIIH 580
Query: 465 GDLKPQNILLDSELSSKICDFGICRLV-TEDTLYLP-SFHRSTAPKGSFPYADPEYHRTG 522
DLKP NILL+ SK+ D G+ ++ D L + ++ T+P G+ Y DPEY RTG
Sbjct: 581 RDLKPANILLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRTG 640
Query: 523 VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCG---KLSSILDPLAGDWPTFVAR 579
++PKSD Y+FG+IILQLLTG+ + L V A+ +L ILD AG+WP R
Sbjct: 641 RISPKSDVYAFGMIILQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEETR 700
Query: 580 RLVDLGLQCCELYGRERPDITPSLVKELEQLH-VAEER-------PV--PSFFLCPILQE 629
+L L LQC EL ++RPD+ ++ LE L VA++ P PS F CP+L++
Sbjct: 701 QLAALALQCTELRSKDRPDLEDQILPVLESLKKVADKARNSLSAAPSQPPSHFFCPLLKD 760
Query: 630 IMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 684
+M +P +AADG+TY+ +AI +W+EN R TSP+TN L +++L PNH L AI +W
Sbjct: 761 VMKEPCIAADGYTYDRRAIEEWMENHR-TSPVTNSPLQNVNLLPNHTLYAAIVEW 814
|
|
| TAIR|locus:2151641 AT5G61560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 843 (301.8 bits), Expect = 3.4e-84, P = 3.4e-84
Identities = 234/709 (33%), Positives = 371/709 (52%)
Query: 4 HGIQKLVMGAFPDNCMKVKMG-SRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSF 62
HGI +LV+GA K+ S +S A P FC + ++KGK + +++ +
Sbjct: 110 HGISELVIGASSSIIFSWKLKRSNLSSRIADATPRFCSVHVISKGKLLNVRKSDMDTETS 169
Query: 63 LPFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHMVFP 122
+ +E+R + S ++ + + F+ +L + LT V V
Sbjct: 170 IADDRSESRFSSDSHSGTVSSTSSHQ-FSSTPLLFQRIQALTTVN----------QKVGT 218
Query: 123 SSPTISCSDMNLFSPRSSSAG---SGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEEL 179
+ + + R+ S S +++K S S + + S E
Sbjct: 219 NIGKQNNEPHHHHHNRAGSLDVDESKLLNQKGFYRTSSSGIGYGGSDISSWRSSQMEEAS 278
Query: 180 RNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAE--DALQTTIQDQEKLKQ 237
+S +++ + E + K+K E + + M+ ++E DA + +QD + +
Sbjct: 279 SSSTYSDPTSSSSQIHKDFE-LEKLK-IELRHIKGMYAVAQSEVIDASKK-MQDLNQRRS 335
Query: 238 EKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVE 297
E+A T+ + T+R + + R+++A E +L++ I +R +++E
Sbjct: 336 EEA--TRLKNLTIREEEA-DEVVEMERERQEDAENEAELVRECI-------ERETEERLE 385
Query: 298 AVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGC 357
A E R Q +G G ++ + +F ++ AT +FS+ K+G GG+G
Sbjct: 386 AEARAEEVRKEKQRLEDALEG--GPLQR-QQYMKFEWEEIVEATSSFSDELKIGVGGYGS 442
Query: 358 VYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYL 417
VY+ + TVA+K+L+S +F QE+ +LSK++HPHL+ LLGACPE SLVYEY+
Sbjct: 443 VYRCNLHHTTVAVKVLHSDKSSLTKQFHQELEILSKIRHPHLLLLLGACPERGSLVYEYM 502
Query: 418 PNGSLQDRLF-RKSNVS-----PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQN 471
NGSL++RL R+ NV PL W +R RIA EIAS L FLH+++P IVH DLKP N
Sbjct: 503 HNGSLEERLMKRRPNVDTPQPPPLRWFERFRIAWEIASALYFLHTNEPRPIVHRDLKPAN 562
Query: 472 ILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSY 531
ILLD SKI D G+ ++V D + + T P G+F Y DPEY RTGV+TP+SD Y
Sbjct: 563 ILLDRNNVSKIGDVGLSKMVNLDPSHASTVFNETGPVGTFFYIDPEYQRTGVVTPESDIY 622
Query: 532 SFGLIILQLLTGRLPVGLAGEVRRAV--SCGKLSSILDPLAGDWPTFVARRLVDLGLQCC 589
+FG+I+LQL+T R +GLA + +A+ GK + ILD AGDWP A+ +V +GL+C
Sbjct: 623 AFGIILLQLVTARSAMGLAHSIEKALRDQTGKFTEILDKTAGDWPVKEAKEMVMIGLRCA 682
Query: 590 ELYGRERPDITPSLVKELEQL-HVAE-------------ERPVPSFFLCPILQEIMHDPQ 635
E+ R+RPD+ ++ LE+L VA P+ F CPI +++M +P
Sbjct: 683 EMRKRDRPDLGKEILPVLERLKEVASIARNMFADNLIDHHHNAPTHFYCPITKDVMENPC 742
Query: 636 VAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 684
VA+DG+TYE +AI++WL+ + SPMT+L L PNH+L AI++W
Sbjct: 743 VASDGYTYEKRAIKEWLQKNHK-SPMTDLPFPSDSLLPNHSLLSAIKEW 790
|
|
| TAIR|locus:504954932 AT5G57035 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 806 (288.8 bits), Expect = 2.9e-80, P = 2.9e-80
Identities = 189/496 (38%), Positives = 281/496 (56%)
Query: 204 VKAFESAYAREMH-LRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQE 262
+K +S E+ LRKE + L Q E+L ++ V ++ + + ++
Sbjct: 287 LKTPKSGVRAEVEQLRKEVQTTLSMYKQACEELVHKQTQVQSLSSECIKETERVITALEK 346
Query: 263 ANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEA-VRWLERWRSRGQAGAANYDGFIG 321
RR A E + ++ +++ K + ++ E + L+ + + F+
Sbjct: 347 EEMRRKAAAEEKEKHLKAVKEVEEAKSMLAKEFCERQLAELDALKQSIEKQKVIEQLFL- 405
Query: 322 LVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQ 381
D +++ ++ AT NFS +G+GG+G VYK + VA+K+L +++ +
Sbjct: 406 --RD-GRYRKYTKEEIAAATDNFSSRKIIGEGGYGKVYKCSLDHTPVALKVLKPDSVEKK 462
Query: 382 LEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRA 441
EF +E+ VLS+L+HPH+V LLGACPE LVYEY+ NGSL + K L W R
Sbjct: 463 EEFLKEISVLSQLRHPHVVLLLGACPENGCLVYEYMENGSLDCHISPKKGKPSLSWFIRF 522
Query: 442 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501
RI E A GL FLH+SKPE IVH DLKP NILLD SKI D G+ +L++++ +
Sbjct: 523 RIIYETACGLAFLHNSKPEPIVHRDLKPGNILLDRNFVSKIGDVGLAKLMSDEAPDSVTV 582
Query: 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGK 561
+R++ G+ Y DPEY RTG + PKSD Y+FG+IILQLLT R P GL V AV G
Sbjct: 583 YRNSIIAGTLYYMDPEYQRTGTIRPKSDLYAFGIIILQLLTARHPNGLLFCVEDAVKRGC 642
Query: 562 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT----PSLVKELEQLH--VAEE 615
+LD DWP A+ L + ++C +L R+RPD++ P+L + LE + + E
Sbjct: 643 FEDMLDGSVKDWPIAEAKELARIAIRCSQLKCRDRPDLSTQVLPALKRILESANSRLKTE 702
Query: 616 RP---VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLT 672
+ P+ + CPIL+EIM DPQ+AADGFTYE KAI++W++ ++ SP+T RL H LT
Sbjct: 703 QANARAPTHYYCPILKEIMEDPQIAADGFTYERKAIKEWIQKHQDVSPVTKHRLKHSDLT 762
Query: 673 PNHALRHAIQDWLCKS 688
PNH LR AI++W +S
Sbjct: 763 PNHTLRSAIREWRSRS 778
|
|
| TAIR|locus:2061012 AT2G24370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 691 (248.3 bits), Expect = 1.8e-75, Sum P(3) = 1.8e-75
Identities = 168/428 (39%), Positives = 243/428 (56%)
Query: 195 SEAMEAIGKVKA------FESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHR 248
S A ++I V+A E EM+ ++AL T Q +L++ K ++L
Sbjct: 340 SSASQSIDDVEAEMRRLKLELKQTMEMY-STACKEAL-TAKQKATELQRWKLEEERKLEE 397
Query: 249 TMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSR 308
RN E + + +A E IA L+ +K R+ + ++A++ E +++
Sbjct: 398 A-RNAEEAALAIAEKEKAKSKAAMEAAEAAQRIAELEAKK-RVNAE-MKALKESEE-KTK 453
Query: 309 GQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTV 368
AN D ++S+ D++ AT F+E +K+G+GG+G VYK + V
Sbjct: 454 ALTALANSD---------VRYRKYSIEDIELATEFFAEKYKIGEGGYGPVYKCYLDHTPV 504
Query: 369 AIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFR 428
A+K+L QG+ +FQQEV VLS ++HP++V LLGACPE LVYE++ NGSL+DRLFR
Sbjct: 505 AVKVLRPDAAQGRSQFQQEVEVLSCIRHPNMVLLLGACPECGCLVYEFMANGSLEDRLFR 564
Query: 429 KSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488
N PL W+ R RIAAEI +GL FLH +KPE +VH DLKP NILLD SKI D G+
Sbjct: 565 LGNSPPLSWQMRFRIAAEIGTGLLFLHQAKPEPLVHRDLKPGNILLDRNFVSKISDVGLA 624
Query: 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVG 548
RLV + +R T+ G+F Y DPEY +TG+L KSD YS G++ LQL+T + P+G
Sbjct: 625 RLVPPTVADTVTQYRMTSTAGTFCYIDPEYQQTGMLGVKSDIYSLGIMFLQLITAKPPMG 684
Query: 549 LAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608
L V RA+ G L +LDP+ DWP L L+C EL ++RPD+ ++ EL
Sbjct: 685 LTHYVERALEKGTLVDLLDPVVSDWPMEDTEEFAKLALKCAELRRKDRPDLAKVILPELN 744
Query: 609 QLH-VAEE 615
+L +A+E
Sbjct: 745 RLRTLADE 752
|
|
| TAIR|locus:2143094 AT5G12000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 703 (252.5 bits), Expect = 5.9e-74, Sum P(2) = 5.9e-74
Identities = 155/366 (42%), Positives = 217/366 (59%)
Query: 256 LNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRR-----QKVEAVRWLERWRSRGQ 310
LN E RR +EA +A++A + EK + R +K + + LE R +
Sbjct: 326 LNQWKMEEARRFEEARNAE---EAALAVAEMEKAKCRAALEAAEKAQRMAELEGQRRKQA 382
Query: 311 AGAANYDG------FIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEML 364
A + LV++ ++S+ +++ AT F+ + K+G+GG+G VY G +
Sbjct: 383 EMKARRESQEKDRALSALVQNDVRYRKYSIDEIEVATERFANNRKIGEGGYGPVYHGTLD 442
Query: 365 GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQD 424
VAIK+L QG+ +FQQEV VLS ++HPH+V LLGACPE LVYE++ NGSL+D
Sbjct: 443 HTPVAIKVLRPDAAQGKKQFQQEVEVLSSIRHPHMVLLLGACPEYGCLVYEFMDNGSLED 502
Query: 425 RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICD 484
RLFR+ N PL W+ R +IAAEIA+ L FLH +KPE +VH DLKP NILLD SKI D
Sbjct: 503 RLFRRGNSPPLSWRKRFQIAAEIATALSFLHQAKPEPLVHRDLKPANILLDKNYVSKISD 562
Query: 485 FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
G+ RLV + + T+ G+F Y DPEY +TG LT KSD +S G+++LQ++T +
Sbjct: 563 VGLARLVPASVANTVTQYHMTSAAGTFCYIDPEYQQTGKLTTKSDIFSLGIMLLQIITAK 622
Query: 545 LPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604
P+GLA V RA+ G +LDP+ DWP A L L+C EL R+RPD+ +V
Sbjct: 623 SPMGLAHHVSRAIDKGTFKDMLDPVVPDWPVEEALNFAKLCLRCAELRKRDRPDLGKEIV 682
Query: 605 KELEQL 610
EL +L
Sbjct: 683 PELLRL 688
|
|
| TAIR|locus:2015656 AT1G16760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 744 (267.0 bits), Expect = 1.1e-73, P = 1.1e-73
Identities = 216/667 (32%), Positives = 331/667 (49%)
Query: 1 MNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASE-SP 59
+ + I+ LV+GA N + + + +K AP FC ++ ++KGK + AS +P
Sbjct: 111 VTVSAIENLVLGAPSRNSFMRRFKTDLPTSVSKAAPDFCNVYVISKGKISSLRNASRLAP 170
Query: 60 NSFLPFCGAETRSAKMLR-SRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVH 118
+ P +E + + R + N +L P+ S + +T +G+ + H
Sbjct: 171 --YHPSVLSEVDDHETIAIERKHKTANTPAL--PKGRRSIDSD-VTRLGLP---KPPHGH 222
Query: 119 MVFPSSPTISCSDMNLFSP-RSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAE 177
M + S S+ + S + S+ ++S R S D S + P + +S +E
Sbjct: 223 MKLMGDFSDSESEFSFISASQQESSDLSFISSGRPSVDRSSFTYDLPESARTSRMSTSSE 282
Query: 178 ELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQ 237
+ S + L K + + V ES + D + + +LKQ
Sbjct: 283 Q---SIGSHRLGIKFTDLSYLNGSSSVSD-ESGRTSCSFSSQSLNDVEAQMKRLRLELKQ 338
Query: 238 EKAFVTQELHR--TMRNVALLNSRAQEANRRRDEATGELKLIQA---SIATLQQEKQRIR 292
+ T RN A + + RR E ELK+ + SI ++ K +
Sbjct: 339 TMDMYSSACREALTARNEATELQKLRTEEERRLE---ELKMTEETAMSIVENERAKAKTA 395
Query: 293 RQKVEAVRWLERWRSRGQAGAA-----NYDGFIGLVEDLPESAEFSLADLQTATCNFSES 347
+ EA L ++ + A D F + ++S+ +++ T NF+ES
Sbjct: 396 LEAAEAANRLAEVEAKRRVHAEMKVLKESDSFSR--HSIVRYRKYSVQEIEEGTANFAES 453
Query: 348 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
KVG+GG+G V++G + +VA+K+L QG+ +F +EV VLS ++HP++V LLGACP
Sbjct: 454 RKVGEGGYGPVFRGHLDHTSVAVKVLRPDAAQGRSQFHKEVEVLSCIRHPNMVLLLGACP 513
Query: 408 EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDL 467
E LVYEY+ GSL DRLFR+ N P+ W+ R RIAAEIA+GL FLH +KPE IVH DL
Sbjct: 514 EYGILVYEYMARGSLDDRLFRRGNTPPISWQLRFRIAAEIATGLLFLHQTKPEPIVHRDL 573
Query: 468 KPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPK 527
KP N+LLD SKI D G+ RLV + + R T+ G+F Y DPEY +TG+L K
Sbjct: 574 KPGNVLLDHNYVSKISDVGLARLVPAVAENVTQY-RVTSAAGTFCYIDPEYQQTGMLGVK 632
Query: 528 SDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQ 587
SD YS G+++LQLLT + P+GLA V +A+ G L +LDP DWP A L L LQ
Sbjct: 633 SDVYSLGIMLLQLLTAKQPMGLAYYVEQAIEEGTLKDMLDPAVPDWPLEEALSLAKLSLQ 692
Query: 588 CCELYGRERPDITPSLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGF-TYEGK 646
C EL ++RPD+ ++ EL +L E + S + + H QV+ + GK
Sbjct: 693 CAELRRKDRPDLGKEVMPELSRLREIGEESLDSVYYAGQGRS-SHPSQVSYTSVRVFNGK 751
Query: 647 AIR-DWL 652
+ DW+
Sbjct: 752 TLTSDWM 758
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 6.3.2 | 0.691 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00024341001 | SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (820 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 688 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-37 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-33 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-31 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-21 | |
| smart00504 | 63 | smart00504, Ubox, Modified RING finger domain | 7e-21 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-17 | |
| pfam04564 | 73 | pfam04564, U-box, U-box domain | 3e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-10 | |
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 7e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 2e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-04 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 8e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.001 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.001 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 0.002 | |
| pfam13445 | 55 | pfam13445, zf-RING_LisH, RING-type zinc-finger, Li | 0.002 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| PRK01156 | 895 | PRK01156, PRK01156, chromosome segregation protein | 0.002 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 0.003 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.003 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-49
Identities = 75/198 (37%), Positives = 104/198 (52%), Gaps = 18/198 (9%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGAC 406
+G+GGFG VY G+ VAIK++ + LE +E+ +L KL HP++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
LV EY GSL+D L K N L + RI +I GL +LHS I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 465 GDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR-TG 522
DLKP+NILLDS+ K+ DFG+ +L+T D L + G+ Y PE G
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI------VGTPAYMAPEVLLGKG 169
Query: 523 VLTPKSDSYSFGLIILQL 540
+ KSD +S G+I+ +L
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 4e-44
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 405
K+G+G FG VY G+ VAIK++ ++ E +E+++L KL+HP++V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 406 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
+ LV EY G L D L ++ +S + +I S L +LHS + IV
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE---DEARFYLRQILSALEYLHS---KGIV 119
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 523
H DLKP+NILLD + K+ DFG+ R + T G+ Y PE
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-------TTFVGTPEYMAPEVLLGKG 172
Query: 524 LTPKSDSYSFGLIILQLLTGRLP 546
D +S G+I+ +LLTG+ P
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 76/211 (36%), Positives = 107/211 (50%), Gaps = 25/211 (11%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVT 401
K+G+G FG VYKG + G VA+K L + + EF +E ++ KL HP++V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 402 LLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
LLG C E +V EY+P G L D L + + L KD ++A +IA G+ +L S
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLESKN- 122
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADP 516
VH DL +N L+ L KI DFG+ R + ED Y G P A P
Sbjct: 123 --FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR------KRGGGKLPIKWMA-P 173
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
E + G T KSD +SFG+++ ++ T G P
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 2e-43
Identities = 82/262 (31%), Positives = 122/262 (46%), Gaps = 25/262 (9%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSH--NMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
K+G G FG VYK + G+ VA+K+L + ++E+R+L +L HP++V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 405 AC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
A + LV EY G L D L R +S + +IA +I GL +LHS I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLS---EDEAKKIALQILRGLEYLHS---NGI 119
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
+H DLKP+NILLD KI DFG+ + + + + T G+ Y PE G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSS------SSLTTFVGTPWYMAPEVLLGG 173
Query: 523 VL-TPKSDSYSFGLIILQLLTGRLPVGLAGEVR-RAVSCGKLSSILDPLAGDWPTF--VA 578
PK D +S G+I+ +LLTG+ P + + L L+ D P + +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEF---DEPKWSSGS 230
Query: 579 RRLVDLGLQCCELYGRERPDIT 600
DL +C +RP
Sbjct: 231 EEAKDLIKKCLNKDPSKRPTAE 252
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 6e-42
Identities = 75/210 (35%), Positives = 107/210 (50%), Gaps = 23/210 (10%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
K+G+G FG VYKG + G+ VA+K L + Q EF +E R++ KL HP++V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 402 LLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
LLG C E +V EY+P G L D L RK+ L D A +IA G+ +L S
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLES--- 121
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA--DPE 517
+ +H DL +N L+ L KI DFG+ R + +D Y + P PE
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGK-------LPIRWMAPE 174
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
+ G T KSD +SFG+++ ++ T G P
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 9e-42
Identities = 98/280 (35%), Positives = 136/280 (48%), Gaps = 39/280 (13%)
Query: 349 KVGQGGFGCVYKGEMLG-----RTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
K+G+G FG VYKG++ G VA+K L + + + +F +E RV+ KL HP++V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 403 LGACPEA--WSLVYEYLPNGSLQDRL------FRKSNVSPLLWKDRARIAAEIASGLCFL 454
LG C E LV EY+ G L D L F S L KD A +IA G+ +L
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP-- 512
S +K VH DL +N L+ +L KI DFG+ R V +D Y G P
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY------RKKTGGKLPIR 172
Query: 513 -YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGL-AGEVRRAVSCGKLSSILDP 568
A PE + G+ T KSD +SFG+++ ++ T G P GL EV + G L
Sbjct: 173 WMA-PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR---LPK 228
Query: 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608
P + L +L L C +L +RP + LV+ LE
Sbjct: 229 -----PEYCPDELYELMLSCWQLDPEDRPTFS-ELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 73/210 (34%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
K+G+G FG VYKG++ G+ VA+K L + Q EF +E R++ KL HP++V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 402 LLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
LLG C E +V EY+ G L L + N L D A +IA G+ +L S
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLES--- 120
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA--DPE 517
+ +H DL +N L+ L KI DFG+ R + +D Y G P PE
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY-------RKRGGKLPIRWMAPE 173
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
+ G T KSD +SFG+++ ++ T G P
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLG 404
+G+G FG VY G +A+K + + ++E+R+LS LQHP++V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 405 AC----PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
+ ++ EY+ GSL L + + + + R +I GL +LHS
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTR---QILEGLAYLHS---N 120
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
IVH D+K NIL+DS+ K+ DFG + + D + +G+ + PE R
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRL-GDIETGEGTG---SVRGTPYWMAPEVIR 176
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLP 546
+D +S G ++++ TG+ P
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 76/277 (27%), Positives = 124/277 (44%), Gaps = 20/277 (7%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHP-HLVTLLG 404
K+G+G FG VY + VA+K+L + F +E+++L+ L HP ++V L
Sbjct: 7 KLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 405 AC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
+ LV EY+ GSL+D L + PL + I A+I S L +LHS I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---I 122
Query: 463 VHGDLKPQNILLDSELS-SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
+H D+KP+NILLD + K+ DFG+ +L+ + + G+ Y PE
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 522 GVL---TPKSDSYSFGLIILQLLTGRLPV------GLAGEVRRAVSCGKLSSILDPLAGD 572
L + SD +S G+ + +LLTG P + + + S+ PL+
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609
P +++ DL + + R + L +L
Sbjct: 243 NPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA- 405
K+G+GGFG VYK G+ VAIK++ + + + + E+++L K +HP++V G+
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 406 -CP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
E W +V E+ GSL+D L KS L A + E+ GL +LHS I+
Sbjct: 67 LKKDELW-IVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS---NGII 120
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 523
H D+K NILL S+ K+ DFG+ ++ + R+T G+ + PE
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLS------DTKARNT-MVGTPYWMAPEVINGKP 173
Query: 524 LTPKSDSYSFGLIILQLLTGRLP 546
K+D +S G+ ++L G+ P
Sbjct: 174 YDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 82/221 (37%), Positives = 114/221 (51%), Gaps = 22/221 (9%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 406
K+G G FG V+ G G T VA+K L M + F QE +++ KL+H LV L C
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 407 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
E +V EY+ GSL D L + L +AA+IA G+ +L S +H
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHR 127
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRTG 522
DL +NIL+ L KI DFG+ RL+ ED Y TA +G+ FP + PE G
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLI-EDDEY-------TAREGAKFPIKWTAPEAANYG 179
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLPV-GLAG-EVRRAVSCG 560
T KSD +SFG+++ +++T GR+P G+ EV V G
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG 220
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 79/234 (33%), Positives = 118/234 (50%), Gaps = 39/234 (16%)
Query: 331 EFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQL 382
E L+ ++ F E ++G+G FG VYKGE+ G +VAIK L + + Q
Sbjct: 1 EIPLSAVR-----FLE--ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ 53
Query: 383 EFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVS------- 433
EF+QE ++S LQHP++V LLG C + +++EYL +G L + L R S S
Sbjct: 54 EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 434 ------PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487
L D IA +IA+G+ +L S VH DL +N L+ L+ KI DFG+
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGL 170
Query: 488 CRLV-TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQL 540
R + + D Y +S P P PE G T +SD +SFG+++ ++
Sbjct: 171 SRDIYSAD--YYRVQSKSLLPVRWMP---PEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 34/212 (16%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 405
+GQG G VYK + G+ A+K ++ + + + + +E++ L + P++V GA
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 406 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
S+V EY+ GSL D L + + A IA +I GL +LH+ + I+
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPE---PVLAYIARQILKGLDYLHTKR--HII 122
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF----PYADPEYH 519
H D+KP N+L++S+ KI DFGI +++ + +F Y PE
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLE----------NTLDQCNTFVGTVTYMSPE-- 170
Query: 520 RTGVLTPKSDSY-----SFGLIILQLLTGRLP 546
R + +S SY S GL +L+ G+ P
Sbjct: 171 R---IQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 69/206 (33%), Positives = 113/206 (54%), Gaps = 22/206 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+G G FG V++G R VAIK+L S ++ Q +FQ+EV+ L +L+H HL++L C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 408 --EAWSLVYEYLPNGSLQDRLF----RKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
E ++ E + GSL L + V+ L+ +A ++A G+ +L +
Sbjct: 73 VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLID-----MACQVAEGMAYLEE---QN 124
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
+H DL +NIL+ +L K+ DFG+ RL+ ED +YL S K + + PE
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKED-VYLSSDK-----KIPYKWTAPEAASH 178
Query: 522 GVLTPKSDSYSFGLIILQLLT-GRLP 546
G + KSD +SFG+++ ++ T G++P
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 68/219 (31%), Positives = 107/219 (48%), Gaps = 25/219 (11%)
Query: 350 VGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEA 409
+G+G FG V G+ G+ VA+K L + Q F E V++ L+HP+LV LLG +
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 410 WSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDL 467
L V EY+ GSL D L R + + + A ++ G+ +L + VH DL
Sbjct: 73 NPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDL 128
Query: 468 KPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP--YADPEYHRTGVLT 525
+N+L+ +L +K+ DFG L E + S G P + PE R +
Sbjct: 129 AARNVLVSEDLVAKVSDFG---LAKEASQGQDS--------GKLPVKWTAPEALREKKFS 177
Query: 526 PKSDSYSFGLIILQLLT-GRLP---VGLAGEVRRAVSCG 560
KSD +SFG+++ ++ + GR+P + L +V V G
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPHVEKG 215
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQL-EFQQEVRVLSKLQHPH 398
N+ +G+G FG VYKG L G VAIK + + + L QE+ +L L+HP+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 399 LVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
+V +G+ + SL + EY NGSL+ + + L A ++ GL +LH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL---VAVYVYQVLQGLAYLHE 117
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY-AD 515
+ ++H D+K NIL + K+ DFG+ + + + + G+ PY
Sbjct: 118 ---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS------KDDASVVGT-PYWMA 167
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE + SD +S G +++LLTG P
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 72/214 (33%), Positives = 104/214 (48%), Gaps = 18/214 (8%)
Query: 349 KVGQGGFGCVYKGE---MLGRT--VAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTL 402
K+G G FG V +GE G+ VA+K L S + +F +E ++ L H +L+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 403 LGAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
G +V E P GSL DRL RK + L A +IA+G+ +L S +
Sbjct: 62 YGVVLTHPLMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICR-LVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
+H DL +NILL S+ KI DFG+ R L + Y+ H K F + PE R
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL----KVPFAWCAPESLR 173
Query: 521 TGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAGE 552
T + SD + FG+ + ++ T G P GL+G
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS 207
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKML-----YSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
+G+G FG V + + G+ A+K+L E +LS++ HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHT--LTERNILSRINHPFIVKL 58
Query: 403 LGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKP 459
A E LV EY P G L L ++ S +RAR AAEI L +LHS
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE----ERARFYAAEIVLALEYLHS--- 111
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
I++ DLKP+NILLD++ K+ DFG+ + ++ + R+ G+ Y PE
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE------GSRTNTFCGTPEYLAPEVL 165
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLP 546
D +S G+++ ++LTG+ P
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 69/207 (33%), Positives = 110/207 (53%), Gaps = 23/207 (11%)
Query: 349 KVGQGGFGCVYK------GEMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
++G+G FG V G+ G VA+K L +S Q + +F++E+ +L L H ++V
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 402 LLGACPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
G C + L+ EYLP+GSL+D L R + + K +++I G+ +L S
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGS- 127
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS--FPYAD 515
++ +H DL +NIL++SE KI DFG+ +++ ED Y + P S F YA
Sbjct: 128 --QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY----YYVKEPGESPIFWYA- 180
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLT 542
PE RT + SD +SFG+ + +L T
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 23/210 (10%)
Query: 350 VGQGGFGCVYKGEMLGR-----TVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
+G G FG V KG L + VA+K L H G+ EF +E V+++L HP +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 404 GAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
G C E LV E P G L L ++ + D +A ++A G+ +L S
Sbjct: 63 GVCKGEPLMLVMELAPLGPLLKYLKKRREIPV---SDLKELAHQVAMGMAYLESK---HF 116
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEYH 519
VH DL +N+LL + +KI DFG+ R + + Y +R+T G +P YA PE
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY----YRATT-AGRWPLKWYA-PECI 170
Query: 520 RTGVLTPKSDSYSFGLIILQLLT-GRLPVG 548
G + KSD +S+G+ + + + G P G
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYG 200
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEF-QQEVRVLSKLQHPHLVTLLG 404
++G+G FG VY G+ +K + NM + + E EV++L KL HP+++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 405 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRA-RIAAEIASGLCFLHSSKPEK 461
+ E L V EY G L ++ ++ +++ ++ L +LHS K
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RK 123
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 517
I+H D+KPQNI L S K+ DFGI ++++ + G+ Y PE
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV------VGTPYYLSPELCQN 177
Query: 518 --YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y KSD +S G ++ +L T + P
Sbjct: 178 KPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 65/205 (31%), Positives = 108/205 (52%), Gaps = 20/205 (9%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+G G FG V++G T VA+K L M + +F E +++ KL+HP L+ L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 408 --EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
E +V E + GSL + L + L +AA++ASG+ +L + + +H
Sbjct: 72 LEEPIYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHR 127
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRTG 522
DL +N+L+ K+ DFG+ R++ ED +Y A +G+ FP + PE
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKED-IY-------EAREGAKFPIKWTAPEAALYN 179
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLP 546
+ KSD +SFG+++ +++T GR+P
Sbjct: 180 RFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 76/204 (37%), Positives = 108/204 (52%), Gaps = 19/204 (9%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+G G FG V+ G G T VAIK L +M + F E ++ +LQHP LV L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 408 -EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466
E ++ EY+ NGSL D L + L +AA+IA G+ F+ + +H D
Sbjct: 72 QEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRD 127
Query: 467 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRTGV 523
L+ NIL+ L KI DFG+ RL+ ED Y TA +G+ FP + PE G
Sbjct: 128 LRAANILVSETLCCKIADFGLARLI-EDNEY-------TAREGAKFPIKWTAPEAINYGT 179
Query: 524 LTPKSDSYSFGLIILQLLT-GRLP 546
T KSD +SFG+++ +++T GR+P
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 81/270 (30%), Positives = 126/270 (46%), Gaps = 39/270 (14%)
Query: 350 VGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVT 401
+GQG FG VY+G G VAIK + + +M+ ++EF E V+ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 402 LLGACPEAWS--LVYEYLPNGSLQDRLFRK-------SNVSPLLWKDRARIAAEIASGLC 452
LLG +V E + G L+ L + + P + ++AAEIA G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 512
+L + +K VH DL +N ++ +L+ KI DFG+ R + E Y KG P
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG------GKGLLP 184
Query: 513 --YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAGE-VRRAVSCGKLSSILD 567
+ PE + GV T KSD +SFG+++ ++ T P GL+ E V + V G LD
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG---HLD 241
Query: 568 PLAGDWPTFVARRLVDLGLQCCELYGRERP 597
P +L++L C + + RP
Sbjct: 242 L-----PENCPDKLLELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 94/256 (36%), Positives = 123/256 (48%), Gaps = 27/256 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+GQG FG V+ G G T VAIK L M + F QE +V+ KL+H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 408 E-AWSLVYEYLPNGSLQDRLFRKSNVSPLL-WKDRARIAAEIASGLCFLHSSKPEKIVHG 465
E +V EY+ GSL D F K + L +AA+IASG+ ++ VH
Sbjct: 72 EEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 126
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRTG 522
DL+ NIL+ L K+ DFG+ RL+ ED Y TA +G+ FP + PE G
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLI-EDNEY-------TARQGAKFPIKWTAPEAALYG 178
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRL 581
T KSD +SFG+++ +L T GR+P G V R V L + P L
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVP--YPGMVNREV----LDQVERGYRMPCPPECPESL 232
Query: 582 VDLGLQCCELYGRERP 597
DL QC ERP
Sbjct: 233 HDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 69/251 (27%), Positives = 111/251 (44%), Gaps = 36/251 (14%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLG 404
++G+G G V+K + G TVA+K + ++G + +E++ L QHP++V LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
+ LV EY+P L + L + PL + G+ ++H+ I
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLRDEER--PLPEAQVKSYMRMLLKGVAYMHA---NGI 120
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST----APKGSFPYADPEY 518
+H DLKP N+L+ ++ KI DFG+ RL +E+ L S +T AP+ Y +Y
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE--LLYGARKY 178
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILD----PLAGDWP 574
P D ++ G I +LL G P+ GE +L+ + P WP
Sbjct: 179 ------DPGVDLWAVGCIFAELLNGS-PL-FPGENDIE----QLAIVFRTLGTPNEETWP 226
Query: 575 TFVARRLVDLG 585
L D
Sbjct: 227 GL--TSLPDYN 235
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 76/272 (27%), Positives = 124/272 (45%), Gaps = 27/272 (9%)
Query: 343 NFSESFKVGQGGFGCVYKG--EMLGRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHPH 398
+F K+G+G FG V+K + R A+K L N + + E E RVL+KL +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 399 LVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
++ + + L V EY NG L L + PL R +I GL LHS
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
+KI+H D+K N+ LD+ + KI D G+ +L++++T F + G+ Y P
Sbjct: 120 ---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN----FANTIV--GTPYYLSP 170
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTF 576
E KSD ++ G+++ + TG+ P + A+ + + P++ +
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALILKIIRGVFPPVSQMY--- 225
Query: 577 VARRLVDLGLQCCELYGRERPDIT-----PSL 603
+++L L QC R+RPD PSL
Sbjct: 226 -SQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 34/222 (15%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKML-----YSHNMQGQLEFQQEVRVLSKL-QHPHLVT 401
+G+G F V + + AIK+L + + E VL++L HP ++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYV--KIEKEVLTRLNGHPGIIK 66
Query: 402 LLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSK 458
L + +L V EY PNG L + + ++ + R AAEI L +LHS
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD----EKCTRFYAAEILLALEYLHS-- 120
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF----------HRSTAPK 508
+ I+H DLKP+NILLD ++ KI DFG +++ ++ + ++
Sbjct: 121 -KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 509 GSF----PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
SF Y PE SD ++ G II Q+LTG+ P
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 9e-22
Identities = 63/201 (31%), Positives = 106/201 (52%), Gaps = 20/201 (9%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G G +G VY+G + TVA+K L M+ + EF +E V+ +++HP+LV LLG C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 407 PE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
+ ++ E++ G+L D L R+ N + +A +I+S + +L + +H
Sbjct: 72 TREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 127
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRT 521
DL +N L+ K+ DFG+ RL+T DT TA G+ FP + PE
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY--------TAHAGAKFPIKWTAPESLAY 179
Query: 522 GVLTPKSDSYSFGLIILQLLT 542
+ KSD ++FG+++ ++ T
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 69/223 (30%), Positives = 113/223 (50%), Gaps = 29/223 (13%)
Query: 350 VGQGGFGCVYKGEMLG-RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 408
+G G FG V+ G+ G VAIKM+ M + +F +E +V+ KL HP+LV L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 409 AWSL--VYEYLPNGSLQDRLFR---KSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
+ V EY+ NG L + L K LL + +++ + +L S+ +
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL-----DMCSDVCEAMEYLESN---GFI 122
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHR 520
H DL +N L+ + K+ DFG+ R V +D + T+ +G+ FP +A PE
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDD--------QYTSSQGTKFPVKWAPPEVFD 174
Query: 521 TGVLTPKSDSYSFGLIILQLLT-GRLPVG--LAGEVRRAVSCG 560
+ KSD +SFG+++ ++ + G++P EV +VS G
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
++G G FG V+ G L + VAIK + M + +F +E +V+ KL HP LV L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE-DFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 408 E--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
E LV+E++ +G L D + ++ + + ++ G+ +L SS ++H
Sbjct: 70 ERSPICLVFEFMEHGCLSD--YLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHR 124
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLT 525
DL +N L+ K+ DFG+ R V +D + ST K ++ PE +
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDD-----QYTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 526 PKSDSYSFGLIILQLLT-GRLP 546
KSD +SFG+++ ++ + G+ P
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 4e-21
Identities = 80/215 (37%), Positives = 113/215 (52%), Gaps = 21/215 (9%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+GQG FG V+ G G T VAIK L M + F QE +++ KL+H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 408 E-AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466
E +V E++ GSL D L ++ + L +AA+IA G+ ++ +H D
Sbjct: 72 EEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRD 127
Query: 467 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRTGV 523
L+ NIL+ L KI DFG+ RL+ ED Y TA +G+ FP + PE G
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLI-EDNEY-------TARQGAKFPIKWTAPEAALYGR 179
Query: 524 LTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAV 557
T KSD +SFG+++ +L+T GR+P G V R V
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVP--YPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 6e-21
Identities = 89/257 (34%), Positives = 127/257 (49%), Gaps = 29/257 (11%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+G G FG V+ G G T VA+K L M + F +E +++ KL+H LV L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 408 E-AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466
E +V EY+ GSL D L + L + +AA++A+G+ ++ +H D
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127
Query: 467 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRTGV 523
L+ NIL+ L KI DFG+ RL+ ED Y TA +G+ FP + PE G
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLI-EDNEY-------TARQGAKFPIKWTAPEAALYGR 179
Query: 524 LTPKSDSYSFGLIILQLLT-GRLPV-GLAG-EVRRAVSCGKLSSILDPLAGDWPTFVARR 580
T KSD +SFG+++ +L+T GR+P G+ EV V G P D P
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM----PCPQDCPI----S 231
Query: 581 LVDLGLQCCELYGRERP 597
L +L LQC + ERP
Sbjct: 232 LHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|128780 smart00504, Ubox, Modified RING finger domain | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 7e-21
Identities = 31/63 (49%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 622 FLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAI 681
FLCPI E+M DP + G TYE AI WL + T P+T L+H L PN AL+ AI
Sbjct: 2 FLCPISLEVMKDPVILPSGQTYERSAIEKWLLS-HGTDPVTGQPLTHEDLIPNLALKSAI 60
Query: 682 QDW 684
Q+W
Sbjct: 61 QEW 63
|
Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. Length = 63 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-20
Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 30/202 (14%)
Query: 363 MLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLL--GACPEAWSL-VYEY 416
M G VAIK+L + + + + F++E + ++L HP++V LL G P V+EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL-- 474
+P +L++ L + L + R+ ++ L H+ + IVH DLKPQNI++
Sbjct: 61 VPGRTLREVL---AADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQ 114
Query: 475 -DSELSSKICDFGICRLVTEDTLYLPSFH--------RSTAPKGSFPYADPEYHRTGVLT 525
+K+ DFGI L LP R+T G+ Y PE R +T
Sbjct: 115 TGVRPHAKVLDFGIGTL-------LPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT 167
Query: 526 PKSDSYSFGLIILQLLTGRLPV 547
P SD Y++GLI L+ LTG+ V
Sbjct: 168 PNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 72/214 (33%), Positives = 102/214 (47%), Gaps = 42/214 (19%)
Query: 350 VGQGGFGCVYKGEML------GRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHLV 400
+G G FG V ML G+ A+K+L + Q+E E R+L ++HP LV
Sbjct: 9 LGTGSFGRV----MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLV 64
Query: 401 TLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSS 457
L G+ + +L V EY+P G L L RKS P AR AA++ L +LHS
Sbjct: 65 NLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPE---PVARFYAAQVVLALEYLHS- 119
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
IV+ DLKP+N+LLDS+ KI DFG + V T L G+ Y PE
Sbjct: 120 --LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC---------GTPEYLAPE 168
Query: 518 YHRTGVLTPK-----SDSYSFGLIILQLLTGRLP 546
++ K D ++ G++I ++L G P
Sbjct: 169 -----IILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 349 KVGQGGFGCVYKGEML----GRTVAIK-MLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
++G G G V K +L G+ +A+K + N Q + +E+ +L K P++V
Sbjct: 8 ELGAGNSGVVSK--VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 404 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
GA S+ EY+ GSL K + + +IA + GL +LH K
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDK--ILKEVQGRIPERILGKIAVAVLKGLTYLHEKH--K 121
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
I+H D+KP NIL++S K+CDFG+ + + G+ Y PE +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--------AKTFVGTSSYMAPERIQG 173
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLPVG 548
+ KSD +S GL +++L TGR P
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 350 VGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVT 401
+G+G FG V+ GE VA+K L + + + +F++E +L+ QH ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 402 LLGACPE--AWSLVYEYLPNGSLQDRLFR-----------KSNVSPLLWKDRARIAAEIA 448
G C E +V+EY+ +G L L S + L +IA +IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 508
SG+ +L S + VH DL +N L+ +L KI DFG+ R V Y H +
Sbjct: 133 SGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 509 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
+ PE T +SD +SFG+++ ++ T G+ P
Sbjct: 190 ----WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-20
Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLE---------FQQEVRVLSKLQHPH 398
+G G FG VY G G +A+K + ++ + +E+ +L +LQH +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 399 LVTLLGACPEAWSLVY--EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
+V LG+ +A L EY+P GS+ L L ++ R +I GL +LH+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR---QILKGLNYLHN 124
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
I+H D+K NIL+D++ KI DFGI + + ++L + + +GS + P
Sbjct: 125 ---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E + T K+D +S G +++++LTG+ P
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 84/300 (28%), Positives = 135/300 (45%), Gaps = 56/300 (18%)
Query: 350 VGQGGFGCVYKG---EMLGR----TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVT 401
+G+G FG V K + GR TVA+KML + +L + E +L ++ HPH++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 402 LLGACP--EAWSLVYEYLPNGSLQD--RLFRK-------------------SNVSPLLWK 438
L GAC L+ EY GSL+ R RK + L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 439 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498
D A +I+ G+ +L K +VH DL +N+L+ KI DFG+ R V E+ Y+
Sbjct: 128 DLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 499 PSFHRSTAPKGSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA 556
RS KG P + E + T +SD +SFG+++ +++T L G
Sbjct: 185 ---KRS---KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------LGGNPYPG 232
Query: 557 VSCGKLSSILDP-LAGDWPTFVARRLVDLGLQCCELYGRERPDITPS---LVKELEQLHV 612
++ +L ++L + P + + +L L C ++ PD P+ + KELE++ V
Sbjct: 233 IAPERLFNLLKTGYRMERPENCSEEMYNLMLTCW----KQEPDKRPTFADISKELEKMMV 288
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 70/213 (32%), Positives = 106/213 (49%), Gaps = 38/213 (17%)
Query: 350 VGQGGFG----CVYK--GEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
+G+G FG C Y + G VA+K L + +F++E+ +L LQH ++V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 404 GACPEA----WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI--------AAEIASGL 451
G C A LV EYLP GSL+D L K R R+ A++I G+
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRD----------YLQKHRERLDHRKLLLYASQICKGM 121
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS- 510
+L S ++ VH DL +NIL++SE KI DFG+ +++ +D Y ++ P S
Sbjct: 122 EYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY----YKVREPGESP 174
Query: 511 -FPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
F YA PE + SD +SFG+++ +L T
Sbjct: 175 IFWYA-PESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 351 GQGGFGCVYKG------EMLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G G FG VYKG E + VAIK+L + + E E V++ + HPH+V LL
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 404 GACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
G C L+ + +P G L D + +++ + + +IA G+ +L +++
Sbjct: 76 GICLSSQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRL 130
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
VH DL +N+L+ + KI DFG+ +L+ D + + K + E
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE----KEYHAEGGKVPIKWMALESILHR 186
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLP 546
+ T KSD +S+G+ + +L+T G P
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 350 VGQGGFGCVYKGEMLG-----RTVAIKMLYS-HNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
+G+G FGCVY G ++ A+K L +++ +F +E ++ HP++++LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 404 GAC--PEAWSLV-YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
G C E LV Y+ +G L++ R +P + KD ++A G+ +L S +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRN-FIRSETHNPTV-KDLIGFGLQVAKGMEYLAS---K 117
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
K VH DL +N +LD + K+ DFG+ R + + Y S H T K + E +
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY--SVHNHTGAKLPVKWMALESLQ 175
Query: 521 TGVLTPKSDSYSFGLIILQLLT 542
T T KSD +SFG+++ +L+T
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGAC 406
K+G+G FG VYKG + G T VA+K S F QE +L + HP++V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 407 PEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
+ + V E +P GSL L +K N + K +++ + A+G+ +L S + +H
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLES---KNCIH 116
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 524
DL +N L+ KI DFG+ R E +Y S P + PE G
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIP---IKWTAPEALNYGRY 172
Query: 525 TPKSDSYSFGLIILQLLTG 543
T +SD +S+G+++ + +
Sbjct: 173 TSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 64/215 (29%), Positives = 94/215 (43%), Gaps = 42/215 (19%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQ------QEVRVLSKLQHPHLVT 401
+G+G FG C+ + + A+K + N Q +E E R+L +L HP LV
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYM---NKQKCVEKGSVRNVLNERRILQELNHPFLVN 64
Query: 402 LLGACPEAWS---------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGL 451
L W LV + L G L+ L +K S +++ + EI L
Sbjct: 65 L-------WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS----EEQVKFWICEIVLAL 113
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
+LHS + I+H D+KP NILLD + I DF I VT DTL +T+ G+
Sbjct: 114 EYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-------TTSTSGTP 163
Query: 512 PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y PE + D +S G+ + L G+ P
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (218), Expect = 4e-19
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 49/218 (22%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQQ----EVRVLSKLQHPHLVTL 402
K+G+G +G VYK + G VA+K + + E+ +L +L+HP++V L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 403 LG--ACPEAWSLVYEYLPN--GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
L LV+EY D+ R +SP L K I ++ GL + HS
Sbjct: 64 LDVIHTERKLYLVFEYCDMDLKKYLDK--RPGPLSPNLIK---SIMYQLLRGLAYCHS-- 116
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED---------TLYLPSFHRSTAPK- 508
+I+H DLKPQNIL++ + K+ DFG+ R TL+ +R AP+
Sbjct: 117 -HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW----YR--APEI 169
Query: 509 --GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
GS Y+ T V D +S G I +++TG+
Sbjct: 170 LLGSKHYS------TAV-----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 71/206 (34%), Positives = 105/206 (50%), Gaps = 22/206 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+G G FG V+ G T VA+K L M Q F +E ++ LQH LV L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 408 --EAWSLVYEYLPNGSLQDRLFRKSNV-SPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
E ++ EY+ GSL D F KS+ +L +A+IA G+ ++ + +H
Sbjct: 72 KEEPIYIITEYMAKGSLLD--FLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIH 126
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRT 521
DL+ N+L+ L KI DFG+ R V ED Y TA +G+ FP + PE
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLAR-VIEDNEY-------TAREGAKFPIKWTAPEAINF 178
Query: 522 GVLTPKSDSYSFGLIILQLLT-GRLP 546
G T KSD +SFG+++ +++T G++P
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 350 VGQGGFGCVYKGEMLGRT-------VAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
+G G FG VY+G GR VA+K L S + Q + +F E ++SK H ++V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 402 LLGACPEA--WSLVYEYLPNGSLQDRLF----RKSNVSPLLWKDRARIAAEIASGLCFLH 455
L+G E ++ E + G L+ L R S L KD A ++A G +L
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 456 SSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 512
+ +H D+ +N LL + KI DFG+ R +Y S++R + P
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASYYRKGG-RAMLP 184
Query: 513 --YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
+ PE G+ T K+D +SFG+++ ++ + G +P
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 349 KVGQGGFGCVYKGE----MLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
++G G FG V GE M V +K L S QL F QEV+ +L HP+++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 404 GACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDR---ARIAAEIASGLCFLHSSK 458
G C E+ + LV E+ P G L++ L R + + R+A E+ASGL +LH +
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGI--CR-----LVTEDTLYLPSFHRSTAPKGSF 511
+H DL +N L ++LS KI D+G+ + +T+D +P R AP+
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPL--RWLAPELVE 175
Query: 512 PYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
T KS+ +S G+ + +L T
Sbjct: 176 IRGQD--LLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 21/205 (10%)
Query: 349 KVGQGGFGCVYKGEMLGR-TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
++G G FG V G+ G+ VAIKM+ +M + EF +E +V+ KL H LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 408 EAWSL--VYEYLPNGSLQDRL---FRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
+ + V EY+ NG L + L ++ S LL + ++ G+ +L S ++
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL-----EMCKDVCEGMAYLES---KQF 121
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
+H DL +N L+D + K+ DFG+ R V +D + S K ++ PE
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVLLYS 176
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLP 546
+ KSD ++FG+++ ++ + G++P
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 35/216 (16%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
+ +G +G V+ K + G AIK++ +M + + Q E +LS+ Q P++V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 405 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 455
+S LV EYLP G L L +D ARI AEI L +LH
Sbjct: 60 -----YSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLD---EDVARIYIAEIVLALEYLH 110
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL-VTEDTLYLPSFHRSTAPK----GS 510
S+ I+H DLKP NIL+DS K+ DFG+ ++ + + L G+
Sbjct: 111 SNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND---DEKEDKRIVGT 164
Query: 511 FPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y PE + D +S G I+ + L G P
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 80/261 (30%), Positives = 121/261 (46%), Gaps = 34/261 (13%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIK--MLYSHNMQGQL---EFQQEVRVLSKLQHPHLVTL 402
+G G FG VY+G L G A+K L GQ + +QE+ +LSKLQHP++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 403 LGACPEAWSL-VY-EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
LG E +L ++ E +P GSL L + + + + R +I GL +LH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR---QILLGLEYLHD---R 121
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY-H 519
VH D+K NIL+D+ K+ DFG+ + V E SF +S KGS + PE
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF-----SFAKSF--KGSPYWMAPEVIA 174
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR---RAVSCGKLSSILDPLAGDWPTF 576
+ G +D +S G +L++ TG+ P V + +L I D L+ + F
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDF 234
Query: 577 VARRLVDLGLQCCELYGRERP 597
+ L+C + RP
Sbjct: 235 I--------LKCLQRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 85/297 (28%), Positives = 131/297 (44%), Gaps = 39/297 (13%)
Query: 350 VGQGGFGCVY------KGEMLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTL 402
+G+G FG V + G VA+K L Q +++E+ +L L H ++V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 403 LGACPE----AWSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSS 457
G C E L+ EY+P GSL+D L + N++ LL A +I G+ +LHS
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL-----FAQQICEGMAYLHS- 125
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
+ +H DL +N+LLD++ KI DFG+ + V E Y +P F YA E
Sbjct: 126 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP--VFWYA-VE 180
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577
+ + SD +SFG+ + +LLT + K ++ P G
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLTHCDS--------KQSPPKKFEEMIGPKQG---QMT 229
Query: 578 ARRLVDLGLQCCELYGRERPDITPSLVKEL-EQLHVAEERPVPSF-FLCPILQEIMH 632
RL++L + L P P V L + E + P+F L PIL+E+ H
Sbjct: 230 VVRLIELLERGMRL---PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 79/298 (26%), Positives = 132/298 (44%), Gaps = 43/298 (14%)
Query: 349 KVGQGGFGCVYKGEMLGRT-------VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
++G+G FG V+ E + VA+K L + + +FQ+E +L+ LQH H+V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 402 LLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKD--------------RARIAA 445
G C + L V+EY+ +G L ++ R ++ D IA+
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505
+IASG+ +L S + VH DL +N L+ + L KI DFG+ R V Y H +
Sbjct: 131 QIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH-TM 186
Query: 506 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSS 564
P P PE T +SD +SFG+I+ ++ T G+ P + C
Sbjct: 187 LPIRWMP---PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-EVIECITQGR 242
Query: 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPSFF 622
+L+ P + + D+ L C + ++R +I KE+ ++ A + P +
Sbjct: 243 VLER-----PRVCPKEVYDIMLGCWQREPQQRLNI-----KEIYKILHALGKATPIYL 290
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 12/151 (7%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIK-MLYSHNMQGQLEF-QQEVRVLSKLQHPHLVTLLG 404
VG+G +G V K G VAIK S + + + +EV+VL +L+H ++V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 405 ACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
A LV+EY+ L+ + P + ++ + + HS I
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVR---SYIWQLLQAIAYCHS---HNI 121
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTE 493
+H D+KP+NIL+ K+CDFG R +
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRA 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 68/270 (25%), Positives = 115/270 (42%), Gaps = 39/270 (14%)
Query: 350 VGQGGFGCVY------KGEMLGRTVAIKML---------YSHNMQGQLE-FQQEVRVLSK 393
+G+G +G VY GEM+ A+K + + + ++ + E+ L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMM----AVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 394 LQHPHLVTLLG--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 451
L H ++V LG E S+ EY+P GS+ L L + ++ GL
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE---QVLEGL 121
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
+LHS + I+H DLK N+L+D++ KI DFGI + D +Y ++ + +GS
Sbjct: 122 AYLHS---KGILHRDLKADNLLVDADGICKISDFGISK--KSDDIY--DNDQNMSMQGSV 174
Query: 512 PYADPE----YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILD 567
+ PE Y + + K D +S G ++L++ GR P + G S
Sbjct: 175 FWMAPEVIHSYSQG--YSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS-AP 231
Query: 568 PLAGDWPTFVARRLVDLGLQCCELYGRERP 597
P+ D ++ +D C + RP
Sbjct: 232 PIPPDVSMNLSPVALDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 54/176 (30%), Positives = 80/176 (45%), Gaps = 34/176 (19%)
Query: 343 NFSESFKVGQGGFGCVYKGEMLG------------------RTVAIKMLY-SHNMQGQLE 383
NF E K+G+G FG V+ E G VA+K+L + + +
Sbjct: 8 NFVE--KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 384 FQQEVRVLSKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFR--------KSNVS 433
F +EV++LS+L P++ LLG C L + EY+ NG L L + N
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 434 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
L + +A +IASG+ +L S VH DL +N L+ + KI DFG+ R
Sbjct: 126 SLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 29/206 (14%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC-P 407
+G+G FG V +GE G+ VA+K + ++ Q F +E V++KL H +LV LLG
Sbjct: 13 IIGEGEFGAVLQGEYTGQKVAVKNIKC-DVTAQ-AFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 408 EAWSLVYEYLPNGSLQDRLFRKS----NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
+V E + G+L + L + +V LL + + ++A G+ +L S +K+V
Sbjct: 71 NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLL-----QFSLDVAEGMEYLES---KKLV 122
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTE--DTLYLPSFHRSTAPKGSFPYADPEYHRT 521
H DL +NIL+ + +K+ DFG+ R+ + D LP + PE +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP-----------VKWTAPEALKH 171
Query: 522 GVLTPKSDSYSFGLIILQLLT-GRLP 546
+ KSD +S+G+++ ++ + GR P
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 70/225 (31%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 348 FKVGQGGFGCVYKGE----------MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP 397
+++G+G FG V+ E ML VA+K L + + +FQ+E +L+ LQH
Sbjct: 11 WELGEGAFGKVFLAECHNLLPEQDKML---VAVKALKEASESARQDFQREAELLTVLQHQ 67
Query: 398 HLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRAR 442
H+V G C E L V+EY+ +G L +R R L
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502
IA++IASG+ +L S VH DL +N L+ L KI DFG+ R + T Y
Sbjct: 127 IASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-TDYYRVGG 182
Query: 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
R+ P P PE T +SD +SFG+++ ++ T G+ P
Sbjct: 183 RTMLPIRWMP---PESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 33/217 (15%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLL 403
+G+G FG V K G+ + K + NM + E QQ EV +L +L+HP++V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-EKQQLVSEVNILRELKHPNIVRYY 65
Query: 404 GAC--PEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIA--------AEIASGL 451
+L V EY G L +L +K K+R I ++ L
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLA-QLIQKCK------KERKYIEEEFIWRILTQLLLAL 118
Query: 452 --CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 509
C S ++H DLKP NI LD+ + K+ DFG+ +++ D+ + ++ G
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY------VG 172
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ Y PE KSD +S G +I +L P
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 31/209 (14%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPHLVTLL 403
K+GQG G VY G+ VAIK + N+Q Q + + E+ V+ + +HP++V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMRENKHPNIVNYL 82
Query: 404 GA---CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCFLHSS 457
+ E W +V EYL GSL D V D +IAA E L FLHS+
Sbjct: 83 DSYLVGDELW-VVMEYLAGGSLTD-------VVTETCMDEGQIAAVCRECLQALEFLHSN 134
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
+ ++H D+K NILL + S K+ DFG C +T P + + G+ + PE
Sbjct: 135 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------PEQSKRSTMVGTPYWMAPE 185
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PK D +S G++ ++++ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 68/219 (31%), Positives = 106/219 (48%), Gaps = 34/219 (15%)
Query: 349 KVGQGGFGCVYKGEML------GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVT 401
++G+ FG +YKG + + VAIK L N Q EFQQE ++++L HP++V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 402 LLGACPEAWS--LVYEYLPNGSLQDRLFRKSN--------------VSPLLWKDRARIAA 445
LLG + +++EYL G L + L +S S L D IA
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505
+IA+G+ +L S VH DL +NIL+ +L KI D G+ R +Y ++R
Sbjct: 132 QIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSR-----EIYSADYYR-V 182
Query: 506 APKGSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
PK P + PE G + SD +SFG+++ ++ +
Sbjct: 183 QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 82/294 (27%), Positives = 141/294 (47%), Gaps = 44/294 (14%)
Query: 349 KVGQGGFGCVY--------KGEMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHL 399
++GQG FG VY KGE R VA+K + S +++ ++EF E V+ H+
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 400 VTLLGACPEAWS--LVYEYLPNGSLQD--RLFRKSNVS-----PLLWKDRARIAAEIASG 450
V LLG + +V E + +G L+ R R + P ++ ++AAEIA G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS 510
+ +L++ +K VH DL +N ++ + + KI DFG+ R + E Y KG
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY------RKGGKGL 182
Query: 511 FP--YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGK-LSSILD 567
P + PE + GV T SD +SFG+++ ++ + LA + + +S + L ++D
Sbjct: 183 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQGLSNEQVLKFVMD 236
Query: 568 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPSF 621
D P R+ DL ++ C + P + P+ ++ + L ++ PSF
Sbjct: 237 GGYLDQPDNCPERVTDL-MRMCWQFN---PKMRPTFLEIVNLL---KDDLHPSF 283
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|203049 pfam04564, U-box, U-box domain | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-17
Identities = 26/70 (37%), Positives = 34/70 (48%)
Query: 618 VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHAL 677
+P FL PI E+M DP + G TY+ I L + T P T L+H L PN L
Sbjct: 1 IPDEFLDPITLELMKDPVILPSGITYDRSTIERHLLSVDPTDPFTREPLTHDQLIPNLEL 60
Query: 678 RHAIQDWLCK 687
+ I WL +
Sbjct: 61 KEKIDAWLEE 70
|
This domain is related to the Ring finger pfam00097 but lacks the zinc binding residues. Length = 73 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 28/208 (13%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
K+G+G G VYK G+ VAIK L N + + E+ ++ +HP++V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYD 82
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDR--ARIAAEIASGLCFLHSSKPE 460
+ + +V EY+ GSL D + + + + A + E+ GL +LHS +
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDII----TQNFVRMNEPQIAYVCREVLQGLEYLHS---Q 135
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEY 518
++H D+K NILL + S K+ DFG +T++ R++ G+ PY A PE
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-----SKRNSV-VGT-PYWMA-PEV 187
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ PK D +S G++ +++ G P
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 28/213 (13%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLV 400
++GQG FG VY+G G VAIK + + +M+ ++EF E V+ + H+V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 401 TLLGACPEAWS--LVYEYLPNG-------SLQDRLFRKSNVSPLLWKDRARIAAEIASGL 451
LLG + ++ E + G SL+ + +P K ++A EIA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
+L+++K VH DL +N ++ + + KI DFG+ R + E Y KG
Sbjct: 133 AYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY------RKGGKGLL 183
Query: 512 P--YADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
P + PE + GV T SD +SFG+++ ++ T
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 350 VGQGGFGCVYKGEMLGR-----TVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
+G G FG V +G + VAIK L S + L+F E ++ + HP+++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQR--LDFLTEASIMGQFDHPNIIR 69
Query: 402 LLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
L G ++ + + EY+ NGSL D+ R+ N + IASG+ +L
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSL-DKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLV--TEDTLYLPSFHRSTAPKGSFP--YAD 515
VH DL +NIL++S L K+ DFG+ R + +E T T G P +
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY--------TTKGGKIPIRWTA 176
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLT 542
PE T SD +SFG+++ ++++
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 350 VGQGGFG----CVY--KGEMLGRTVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTL 402
+G+G FG C Y +G+ G VA+K L + + + ++E+ +L L H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 403 LGACPE----AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G C E L+ E+LP+GSL++ L R N + + K + + A +I G+ +L S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGS-- 127
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
+ VH DL +N+L++SE KI DFG+ + + D Y +P F YA PE
Sbjct: 128 -RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP--VFWYA-PEC 183
Query: 519 HRTGVLTPKSDSYSFGLIILQLLT 542
SD +SFG+ + +LLT
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 25/204 (12%)
Query: 350 VGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEA 409
+G+G FG V G+ G VA+K + ++ Q F E V+++L+H +LV LLG E
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 410 WS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDR-ARIAAEIASGLCFLHSSKPEKIVHG 465
+V EY+ GSL D L +S +L D + + ++ + +L ++ VH
Sbjct: 72 KGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 466 DLKPQNILLDSELSSKICDFGICRLV--TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 523
DL +N+L+ + +K+ DFG+ + T+DT LP + PE R
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----------VKWTAPEALREKK 175
Query: 524 LTPKSDSYSFGLIILQLLT-GRLP 546
+ KSD +SFG+++ ++ + GR+P
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 69/260 (26%), Positives = 121/260 (46%), Gaps = 45/260 (17%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLY---SHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
+G G G V K + + G +A K+++ +++ Q+ +E++++ + + P++V+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQI--LRELQIMHECRSPYIVSFYG 70
Query: 405 AC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
A + E++ GSL DR+++K P+ + +IA + GL +L++ +
Sbjct: 71 AFLNENNI-CMCMEFMDCGSL-DRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNV--HR 124
Query: 462 IVHGDLKPQNILLDSELSSKICDFGIC-RLVTE--DTLYLPSFHRSTAPKGSFPYADPEY 518
I+H D+KP NIL++S K+CDFG+ L+ DT G+ Y PE
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----------GTSTYMSPER 173
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPL--------- 569
+ G T KSD +S G+ I++L G+ P + ILD L
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD--DPMGILDLLQQIVQEPPP 231
Query: 570 ---AGDWPTFVARRLVDLGL 586
+ D+P R VD L
Sbjct: 232 RLPSSDFPE-DLRDFVDACL 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 5e-17
Identities = 72/237 (30%), Positives = 104/237 (43%), Gaps = 35/237 (14%)
Query: 387 EVRVLSKLQHPHLVTLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI 443
E+ + KLQHP++V L+G C A+ L++EY+ +L + L N+S W+ R +I
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAY-LIHEYIEGKNLSEVL---RNLS---WERRRKI 785
Query: 444 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS-FH 502
A IA L FLH +V G+L P+ I++D + + L LP
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR------------LSLPGLLC 833
Query: 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--------R 554
T S Y PE T +T KSD Y FGLI+++LLTG+ P V R
Sbjct: 834 TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR 893
Query: 555 RAVSCGKLSSILDPLAGDWPTFVARRLV---DLGLQCCELYGRERPDITPSLVKELE 608
S L +DP + +V +L L C RP ++K LE
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP-CANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 67/231 (29%), Positives = 110/231 (47%), Gaps = 34/231 (14%)
Query: 336 DLQTATCNFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQL--EFQQ 386
++ +T F E ++G+ FG VYKG + G + VAIK L +G L EF+
Sbjct: 1 EINLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKH 57
Query: 387 EVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-- 442
E + S+LQHP++V LLG + S+++ Y + L + L +S S + D +
Sbjct: 58 EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 443 -----------IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491
I +IA+G+ FL S +VH DL +N+L+ +L+ KI D G+ R V
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
Y S P + PE G + SD +S+G+++ ++ +
Sbjct: 175 YAAD-YYKLMGNSLLP---IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 9e-17
Identities = 67/207 (32%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 350 VGQGGFGCVYKG------EMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
+G G FG VYKG E + VAIK+L + + +EF E +++ + HPHLV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 403 LGAC-PEAWSLVYEYLPNGSLQDRLFR-KSNVSPLL---WKDRARIAAEIASGLCFLHSS 457
LG C LV + +P+G L D + K N+ L W +IA G+ +L
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE- 127
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP--YAD 515
++VH DL +N+L+ S KI DFG+ RL+ D A G P +
Sbjct: 128 --RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE------KEYNADGGKMPIKWMA 179
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLT 542
E T +SD +S+G+ I +L+T
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 350 VGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQLE-FQQEVRVLSKL-QHPHLV 400
+G G FG V + G VA+KML + E E++++S L H ++V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 401 TLLGACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
LLGAC ++ EY G L + L RK L D + ++A G+ FL S
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLE-DLLSFSYQVAKGMAFLAS-- 159
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS--FP--YA 514
+ +H DL +N+LL KICDFG+ R + D+ Y+ KG+ P +
Sbjct: 160 -KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV--------VKGNARLPVKWM 210
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLT 542
PE V T +SD +S+G+++ ++ +
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 33/227 (14%)
Query: 338 QTATCNFSESFKV---GQGGFGCVYK--GEMLGRTVAIKMLY-SHNMQGQLEFQQEVRVL 391
+A + SE +V G G G VYK GR A+K++Y +H + + +E+ +L
Sbjct: 67 PSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEIL 126
Query: 392 SKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDR--ARIAAEI 447
+ HP++V + + E++ GSL+ + ++ A +A +I
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH---------IADEQFLADVARQI 177
Query: 448 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP 507
SG+ +LH IVH D+KP N+L++S + KI DFG+ R++ + + +
Sbjct: 178 LSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ------TMDPCNSS 228
Query: 508 KGSFPYADPEYHRTGVLTPKSDSY-----SFGLIILQLLTGRLPVGL 549
G+ Y PE T + D Y S G+ IL+ GR P G+
Sbjct: 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275
|
Length = 353 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 22/199 (11%)
Query: 349 KVGQGGFGCVYKG--EML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTL 402
++G G FG V KG +M +TVA+K+L + N L E +E V+ +L +P++V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 403 LGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+G C E+W LV E G L L + +V+ K+ + +++ G+ +L +
Sbjct: 62 IGICEAESWMLVMELAELGPLNKFLQKNKHVTE---KNITELVHQVSMGMKYLEETN--- 115
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---Y 518
VH DL +N+LL ++ +KI DFG+ + + D Y + T K + PE Y
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY---YKAKTHGKWPVKWYAPECMNY 172
Query: 519 HRTGVLTPKSDSYSFGLII 537
++ + KSD +SFG+++
Sbjct: 173 YK---FSSKSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 343 NFSESFKVGQGGFGCVYKGEM--LGRTVAIK-MLYSHNMQGQLEFQQEVRVLSKLQHPHL 399
E ++G+G G V K + G A+K + N Q + +E+ + + P++
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 400 VTLLGAC-PEAWSLVY---EYLPNGSLQDRLFRK--SNVSPLLWKDRARIAAEIASGLCF 453
V GA E+ S + EY GSL D +++K + K +IA + GL +
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC-RLVTEDTLYLPSFHRSTAPKGSFP 512
LHS KI+H D+KP NILL + K+CDFG+ LV S T SF
Sbjct: 121 LHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN-------SL-AGTFTGTSF- 168
Query: 513 YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y PE + + SD +S GL +L++ R P
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 28/161 (17%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIK-MLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGA 405
+G+G +G VYK + G+ VAIK M + + E ++E +L K HP++ T GA
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE--EIKEEYNILRKYSNHPNIATFYGA 71
Query: 406 C---------PEAWSLVYEYLPNGSLQD--RLFRKSNVS---PLLWKDRARIAAEIASGL 451
+ W LV E GS+ D + RK + A I E GL
Sbjct: 72 FIKKNPPGNDDQLW-LVMELCGGGSVTDLVKGLRKKGKRLKEEWI----AYILRETLRGL 126
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492
+LH +K ++H D+K QNILL K+ DFG+ +
Sbjct: 127 AYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 3e-16
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 344 FSESFKVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLV 400
F++ K+G+G FG V+KG + VAIK++ + ++E QQE+ VLS+ P++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 401 TLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
G+ + W ++ EYL GS D L PL A I EI GL +LHS
Sbjct: 66 KYYGSYLKDTKLW-IIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS- 119
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
EK +H D+K N+LL K+ DFG+ +T+ + +F G+ + PE
Sbjct: 120 --EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF------VGTPFWMAPE 171
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ K+D +S G+ ++L G P
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 71/235 (30%), Positives = 113/235 (48%), Gaps = 39/235 (16%)
Query: 350 VGQGGFGCVYKGEM----LGRTVAIKMLYSHNMQG-QLEFQQEVRVLSKL-QHPHLVTLL 403
+G+G FG V + + L AIKML + +F E+ VL KL HP+++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 404 GACPEAWSL--VYEYLPNGSLQDRLFRKSNV--------------SPLLWKDRARIAAEI 447
GAC L EY P G+L D L RKS V S L + + A+++
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 448 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP 507
A+G+ +L ++ +H DL +N+L+ L+SKI DFG+ R + +Y+ + T
Sbjct: 129 ATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYV----KKTMG 178
Query: 508 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKL 562
+ + E V T KSD +SFG+++ ++ V L G ++C +L
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI------VSLGGTPYCGMTCAEL 227
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 344 FSESFKVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEF-QQEVRVLSKLQHPHLV 400
F+ +G+G FG VYK + + VAIK++ + ++E QQE++ LS+ + P++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 401 TLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G+ + L + EY GS D L K L A I E+ GL +LH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLL--KP--GKLDETYIAFILREVLLGLEYLHE-- 116
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADP 516
E +H D+K NILL E K+ DFG+ +T +F G+ P+ A P
Sbjct: 117 -EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF------VGT-PFWMA-P 167
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E + K+D +S G+ ++L G P
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
K+G+G +G VYK + L + A+K L S + + + + E+R+L+ + HP++++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 405 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRA--RIAAEIASGLCFLHSSKPE 460
A + L V EY P G L + K L ++ RI ++ GL LH +
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLS-KAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---Q 122
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
KI+H DLK NILL + KI D GI +++ ++ G+ Y PE +
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK--------TQIGTPHYMAPEVWK 174
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLP 546
+ KSD +S G ++ ++ T P
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 35/211 (16%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIK-MLYSHNMQGQLEFQQ----EVRVLSKLQHPHLVT 401
K+G+G +G VYK + G VAIK + +G + E+++L +L HP+++
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG---IPKTALREIKLLKELNHPNIIK 62
Query: 402 LLGACPE--AWSLVYEYLPNGSLQ-----DRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
LL LV+E++ + R +S + L+ ++ GL F
Sbjct: 63 LLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLY--------QLLQGLAFC 114
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
HS I+H DLKP+N+L+++E K+ DFG+ R T + Y
Sbjct: 115 HSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY------THYVVTRWYR 165
Query: 515 DPE-YHRTGVLTPKSDSYSFGLIILQLLTGR 544
PE + D +S G I +LL+ R
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 31/208 (14%)
Query: 350 VGQGGFGCVYKG------EMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLV 400
+G G FG V+KG + + VAIK + + G+ FQ+ + + L H ++V
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 401 TLLGACPEA-WSLVYEYLPNGSLQDRLF-RKSNVSP---LLWKDRARIAAEIASGLCFLH 455
LLG CP A LV + P GSL D + + ++ P L W +IA G+ +L
Sbjct: 73 RLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLE 126
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV-TEDTLYLPSFHRSTAPKGSFPYA 514
++VH +L +NILL S+ +I DFG+ L+ +D Y S H K +
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH-----KTPIKWM 178
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLT 542
E G T +SD +S+G+ + ++++
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 66/221 (29%), Positives = 109/221 (49%), Gaps = 23/221 (10%)
Query: 349 KVGQGGFGCVYKGEMLGR-TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
++G G FG V+ G+ + VAIK + M + +F +E +V+ KL HP LV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-DFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 408 EAWSL--VYEYLPNGSLQDRLF-RKSNVSP--LLWKDRARIAAEIASGLCFLHSSKPEKI 462
+ L V E++ NG L + L R+ +S LL + ++ G+ +L +
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL-----SMCQDVCEGMEYLERN---SF 121
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
+H DL +N L+ S K+ DFG+ R V +D + S+ K ++ PE
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-----EYTSSSGAKFPVKWSPPEVFNFS 176
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCG 560
+ KSD +SFG+++ ++ T G++P EV +S G
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 350 VGQGGFGCVYKGEMLG--------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLV 400
+G G FG VY+G VA+K L Q + EF +E ++S HP++V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 401 TLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNV----SPLL-WKDRARIAAEIASGLCF 453
LLG C E ++ E + G L L R + V PLL K+ I ++A G +
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSS-----KICDFGICRLVTEDTLYLPSFHRSTAPK 508
L +H DL +N L+ + KI DFG+ R +Y ++R +
Sbjct: 122 LEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-----DIYKSDYYRKEG-E 172
Query: 509 GSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
G P + PE G T +SD +SFG+++ ++LT
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 344 FSESFKVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLV 400
F++ ++G+G FG VYKG VAIK++ + ++E QQE+ VLS+ P++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 401 TLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G+ + L + EYL GS D L PL A I EI GL +LHS
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHS-- 119
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
E+ +H D+K N+LL + K+ DFG+ +T+ + +F G+ + PE
Sbjct: 120 -ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF------VGTPFWMAPEV 172
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ K+D +S G+ ++L G P
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 54/161 (33%), Positives = 86/161 (53%), Gaps = 23/161 (14%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIK-MLYSHNMQG-QLEFQQEVRVLSKLQ---HPHLVTL 402
+G+G +G VYK L GR VA+K + + +G L +E+ +L +L+ HP++V L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 403 LGAC--PEAW-----SLVYEYLPNGSLQD-RLFRKSNVSPLLWKDRAR-IAAEIASGLCF 453
L C P +LV+E++ QD + P L + + + ++ G+ F
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVD----QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494
LHS +IVH DLKPQNIL+ S+ KI DFG+ R+ + +
Sbjct: 123 LHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-16
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 29/208 (13%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPHLVTLL 403
K+GQG G V+ G+ VAIK + N+Q Q + + E+ V+ +L++P++V L
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKELKNPNIVNFL 82
Query: 404 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCFLHSSK 458
+ + +V EYL GSL D V D A+IAA E L FLH+++
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTD-------VVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
++H D+K N+LL + S K+ DFG C +T P + + G+ + PE
Sbjct: 136 ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT------PEQSKRSTMVGTPYWMAPEV 186
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PK D +S G++ ++++ G P
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 60/226 (26%), Positives = 106/226 (46%), Gaps = 44/226 (19%)
Query: 350 VGQGGFGCVYKGEMLG-------RTVAIKMLYSH-NMQGQLEFQQEVRVLSKLQHPHLVT 401
+GQG FG V++ G VA+KML + Q +FQ+E ++++ HP++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 402 LLGACPEA--WSLVYEYLPNGSLQDRLFRKS-------------------NVSPLLWKDR 440
LLG C L++EY+ G L + L +S N PL ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 441 ARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500
IA ++A+G+ +L K VH DL +N L+ + KI DFG+ R +Y
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIYSAD 184
Query: 501 FHRSTA----PKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
+++++ P P Y+R T +SD +++G+++ ++ +
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 73/258 (28%), Positives = 114/258 (44%), Gaps = 24/258 (9%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGA 405
VG+G FG V+ + + + V IK + M +L Q E +VL L HP+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 406 CPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
E A +V EY P G+L + + ++ N LL D I L LH + I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCN--SLL--DEDTILHFFVQILLALHHVHTKLIL 123
Query: 464 HGDLKPQNILLDS-ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
H DLK QNILLD ++ KI DFGI ++ L S ++ G+ Y PE
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKI-------LSSKSKAYTVVGTPCYISPELCEGK 176
Query: 523 VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 582
KSD ++ G ++ +L + L A+ +S P+ D + R+L+
Sbjct: 177 PYNQKSDIWALGCVLYELAS--LKRAFEAANLPALVLKIMSGTFAPI-SDRYSPDLRQLI 233
Query: 583 DLGLQCCELYGRERPDIT 600
L L +RP ++
Sbjct: 234 ---LSMLNLDPSKRPQLS 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 7e-16
Identities = 68/235 (28%), Positives = 108/235 (45%), Gaps = 39/235 (16%)
Query: 350 VGQGGFGCVY----KGEMLGRTVAIKMLYSHNMQG-QLEFQQEVRVLSKL-QHPHLVTLL 403
+G+G FG V K + L AIK + + + +F E+ VL KL HP+++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 404 GACPEAWSL--VYEYLPNGSLQDRLFRKSNV--------------SPLLWKDRARIAAEI 447
GAC L EY P+G+L D L RKS V S L + AA++
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 448 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP 507
A G+ +L ++ +H DL +NIL+ +KI DFG+ R +Y+ + T
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV----KKTMG 171
Query: 508 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKL 562
+ + E V T SD +S+G+++ ++ V L G ++C +L
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI------VSLGGTPYCGMTCAEL 220
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 37/287 (12%)
Query: 343 NFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQG-QLEFQQEVRVLSKL 394
N E +G+G FG V+ + G V +K L + Q EF++E+ + KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 395 QHPHLVTLLGACPEA--WSLVYEYLPNGSLQDRL------FRKSNVSPLLWKDRARIAAE 446
H ++V LLG C EA ++ EY G L+ L K PL K + + +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST- 505
IA G+ L ++ + VH DL +N L+ S+ K+ + + V Y R+
Sbjct: 126 IALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK---LRNAL 179
Query: 506 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPV-GLAG-EVRRAVSCGKL 562
P PE + + KSD +SFG+++ ++ T G LP GL+ EV + GKL
Sbjct: 180 IPLRWLA---PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236
Query: 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609
P+ P+ RL L +C + ++RP + LV L +
Sbjct: 237 EL---PVPEGCPS----RLYKLMTRCWAVNPKDRPSFS-ELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 64/227 (28%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPHLVTLLG 404
++G+G +G VYK G VA+K + N + +E+++L KL+HP++V L
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 405 ACPEAWS----LVYEYLP---NGSLQDRLFR------KSNVSPLLWKDRARIAAEIASGL 451
+V+EY+ G L + K ++ GL
Sbjct: 66 IVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKC------------YMKQLLEGL 113
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED----------TL-YLPS 500
+LHS+ I+H D+K NIL++++ K+ DFG+ R T+ TL Y P
Sbjct: 114 QYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRP- 169
Query: 501 FHRSTAPK---GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
P+ G+ Y P+ D +S G I+ +L G+
Sbjct: 170 ------PELLLGATRY-----------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLG 404
K+G G FG VY L G +A+K + + + E E++VL L+HP+LV G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
E + EY G+L++ L + + + ++ GL +LHS I
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIR---VYTLQLLEGLAYLHSHG---I 120
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
VH D+KP NI LD K+ DFG + +T + +S A G+ Y PE G
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA--GTPAYMAPEVITGG 178
Query: 523 VLTPK---SDSYSFGLIILQLLTGRLP 546
+D +S G ++L++ TG+ P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 35/219 (15%)
Query: 350 VGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPHLV 400
+G+G FG V K E +G TVA+KML + L + E+ ++ + +H +++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 401 TLLGACPEAWSL--VYEYLPNGSLQDRLFRK-------------SNVSPLLWKDRARIAA 445
LLG C + L V EY +G+L+D L + L KD A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505
++A G+ FL S +K +H DL +N+L+ + KI DFG+ R + Y R T
Sbjct: 140 QVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY-----RKT 191
Query: 506 APKGSFPYA--DPEYHRTGVLTPKSDSYSFGLIILQLLT 542
G P PE V T +SD +SFG+++ ++ T
Sbjct: 192 T-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 39/224 (17%)
Query: 349 KVGQGGFG----CVYKG--EMLGRT----------VAIKMLYSH-NMQGQLEFQQEVRVL 391
K+G+G FG C +G E LG VA+KML + + +F +E++++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 392 SKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRL--------FRKSNVSPLL-WKDR 440
S+L++P+++ LLG C + ++ EY+ NG L L F +N P + +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 441 ARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500
+A +IASG+ +L S VH DL +N L+ + + KI DFG+ R LY
Sbjct: 132 LYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSR-----NLYSGD 183
Query: 501 FHRSTAPKGSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
++R + P + E G T SD ++FG+ + ++ T
Sbjct: 184 YYRIQG-RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 77/223 (34%), Positives = 115/223 (51%), Gaps = 27/223 (12%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+G G FG V+ T VA+K + +M + F E V+ LQH LV L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 408 -EAWSLVYEYLPNGSLQDRLFRKS---NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
E ++ E++ GSL D F KS + PL +A+IA G+ F+ +
Sbjct: 72 KEPIYIITEFMAKGSLLD--FLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQ---RNYI 124
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHR 520
H DL+ NIL+ + L KI DFG+ R++ ED Y TA +G+ FP + PE
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVI-EDNEY-------TAREGAKFPIKWTAPEAIN 176
Query: 521 TGVLTPKSDSYSFGLIILQLLT-GRLPV-GLAG-EVRRAVSCG 560
G T KSD +SFG+++++++T GR+P G++ EV RA+ G
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 344 FSESFKVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLV 400
F++ ++G+G FG V+KG + VAIK++ + ++E QQE+ VLS+ P++
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 401 TLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G+ + L + EYL GS D L P A + EI GL +LHS
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLDYLHS-- 119
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
EK +H D+K N+LL + K+ DFG+ +T+ + +F G+ + PE
Sbjct: 120 -EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF------VGTPFWMAPEV 172
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ K+D +S G+ ++L G P
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 350 VGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
+G+G +G VY L +AIK + + + +E+ + S L+H ++V LG+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 408 EA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI--AAEIASGLCFLHSSKPEKIV 463
E + + E +P GSL L +S PL ++ I +I GL +LH +IV
Sbjct: 76 ENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIV 130
Query: 464 HGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
H D+K N+L+++ KI DFG + + +F G+ Y PE G
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF------TGTLQYMAPEVIDKG 184
Query: 523 V--LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV 557
+D +S G I+++ TG+ P GE + A+
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM 221
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 350 VGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTLLGACP 407
+G+G FG V+KG + +T VA+K Q +++F E R+L + HP++V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 408 EAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
+ +V E +P G L +K + L K + A + A+G+ +L S + +H
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLES---KNCIHR 117
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLT 525
DL +N L+ KI DFG+ R +D +Y S + K + PE G +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIK----WTAPEALNYGRYS 172
Query: 526 PKSDSYSFGLIILQLLT 542
+SD +S+G+++ + +
Sbjct: 173 SESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 349 KVGQGGFGCVYKGEMLGRT-------VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
++G+G FG V+ E VA+K L + + +F +E +L+ LQH H+V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 402 LLGACPEAWSL--VYEYLPNGSLQ--------DRLFRKSNVSP--LLWKDRARIAAEIAS 449
G C E L V+EY+ +G L D + P L IA +IA+
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 509
G+ +L S + VH DL +N L+ L KI DFG+ R V Y H + P
Sbjct: 132 GMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH-TMLPIR 187
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
P PE T +SD +S G+++ ++ T G+ P
Sbjct: 188 WMP---PESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 9e-15
Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 35/160 (21%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKML----YSHNMQGQLEFQ--QEVRVLSKLQHPHLV 400
K+G+G + VYK GR VAIK + G + F +E+++L +L+HP+++
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDG-INFTALREIKLLQELKHPNII 65
Query: 401 TLLGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI--AAEIAS------- 449
LL +LV+E++ L+ + KD++ + A+I S
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLE-----------KVIKDKSIVLTPADIKSYMLMTLR 113
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
GL +LHS+ I+H DLKP N+L+ S+ K+ DFG+ R
Sbjct: 114 GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 63/215 (29%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF-QQEVRVLSKLQHPHLVTLLGA 405
+G G VY L VAIK + Q ++ ++EV+ +S+ HP++V +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 406 CPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCFLHSSKPE 460
L V YL GSL D + L D A IA E+ GL +LHS
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGL---DEAIIATVLKEVLKGLEYLHS---N 121
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK---GSFPYADPE 517
+H D+K NILL + S KI DFG+ +L K G+ + PE
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGV-----SASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 518 YHRTGVLTP------KSDSYSFGLIILQLLTGRLP 546
V+ K+D +SFG+ ++L TG P
Sbjct: 177 -----VMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 36/215 (16%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-----FQQEVRVLSKLQHPHLVTL 402
+GQG FG VY + GR +A+K + + + + E+++L LQH +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 403 LGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
G E S+ EY+P GS++D+L ++ + + R +I G+ +LHS+
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR---QILEGVEYLHSNM-- 124
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGIC-RLVT--EDTLYLPSFHRSTAPKGSFPYADPE 517
IVH D+K NIL DS + K+ DFG RL T + S G+ + PE
Sbjct: 125 -IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT------GTPYWMSPE 177
Query: 518 ------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y R K+D +S G ++++LT + P
Sbjct: 178 VISGEGYGR------KADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 32/211 (15%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ----LEFQQEVRVLSKLQH---PHLV 400
+G+G +G VY+G+ + GR VA+K++ N+ + Q+EV +LS+L+ P++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKII---NLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 401 TLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
G+ P W ++ EY GS+ R K+ P+ K + I E+ L ++H
Sbjct: 66 KYYGSYLKGPRLW-IIMEYAEGGSV--RTLMKA--GPIAEKYISVIIREVLVALKYIHKV 120
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY-ADP 516
++H D+K NIL+ + + K+CDFG+ L+ +++ RST G+ PY P
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-----KRSTF-VGT-PYWMAP 170
Query: 517 EYHRTGVL-TPKSDSYSFGLIILQLLTGRLP 546
E G K+D +S G+ I ++ TG P
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 1e-14
Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 31/209 (14%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPHLVTLL 403
K+GQG G VY + G+ VAIK + N+Q Q + + E+ V+ + ++P++V L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILVMRENKNPNIVNYL 82
Query: 404 GAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCFLHSS 457
+ E W +V EYL GSL D V D +IAA E L FLHS+
Sbjct: 83 DSYLVGDELW-VVMEYLAGGSLTD-------VVTETCMDEGQIAAVCRECLQALDFLHSN 134
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
+ ++H D+K NILL + S K+ DFG C +T P + + G+ + PE
Sbjct: 135 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------PEQSKRSTMVGTPYWMAPE 185
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PK D +S G++ ++++ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 48/145 (33%), Positives = 79/145 (54%), Gaps = 15/145 (10%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTLLGA 405
K+G+G +G VYK + G+ VAIK++ ++ L E +E+ +L + P++V G+
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 406 C---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
+ W +V EY GS+ D + K L ++ A I + GL +LHS+K
Sbjct: 67 YFKNTDLW-IVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHSNK---K 120
Query: 463 VHGDLKPQNILLDSELSSKICDFGI 487
+H D+K NILL+ E +K+ DFG+
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGV 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 55/168 (32%), Positives = 85/168 (50%), Gaps = 21/168 (12%)
Query: 349 KVGQGGFGCVYKGEML-----GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
++G G FG V GE+ + V ++ S ++Q Q++F +E + LQH +L+ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 404 GACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDR---ARIAAEIASGLCFLHSSK 458
G C E + LV E+ P G L+ R + L+ D R+A EIA GL LH +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLK-GYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRL-------VTEDTLYLP 499
+H DL +N LL ++L+ KI D+G+ VT D L++P
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVP 165
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 44/222 (19%)
Query: 343 NFSESFKVGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ------EVRVLSKL 394
+ VG G FG V+ + + A+K++ + + +Q E RVL ++
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVM---AIPEVIRLKQEQHVHNEKRVLKEV 58
Query: 395 QHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLF---RKSNVSPLLWKDRARIAAEIAS 449
HP ++ L + L + EY+P G L L R SN + L + A+EI
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY------ASEIVC 112
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 509
L +LHS ++IV+ DLKP+NILLD E K+ DFG + + + T L G
Sbjct: 113 ALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC---------G 160
Query: 510 SFPYADPEY-----HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ Y PE H V D ++ G++I ++L G P
Sbjct: 161 TPEYLAPEVIQSKGHNKAV-----DWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 31/209 (14%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPHLVTLL 403
K+GQG G VY G+ VAI+ + N+Q Q + + E+ V+ + ++P++V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 404 GAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCFLHSS 457
+ E W +V EYL GSL D V D +IAA E L FLHS+
Sbjct: 84 DSYLVGDELW-VVMEYLAGGSLTD-------VVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
+ ++H D+K NILL + S K+ DFG C +T P + + G+ + PE
Sbjct: 136 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------PEQSKRSTMVGTPYWMAPE 186
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PK D +S G++ ++++ G P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 55/203 (27%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 349 KVGQGGFGCVYKG--EMLGRT--VAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTLL 403
++G G FGCV KG +M + VAIK+L + N + + E +E ++ +L +P++V ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 404 GAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
G C EA LV E G L L K + + + + +++ G+ +L +
Sbjct: 62 GVCEAEALMLVMEMASGGPLNKFLSGKKDEITV--SNVVELMHQVSMGMKYLEG---KNF 116
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---YH 519
VH DL +N+LL ++ +KI DFG+ + + D Y + +A K + PE +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY---YKARSAGKWPLKWYAPECINFR 173
Query: 520 RTGVLTPKSDSYSFGLIILQLLT 542
+ + +SD +S+G+ + + +
Sbjct: 174 K---FSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 3e-14
Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 350 VGQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
+G+G FG V + + G+ A+K+L + + E E RVL +HP L +L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
+ + V EY+ G L L R+ S +DR R AEI S L +LHS K
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFS----EDRTRFYGAEIVSALDYLHSGK--- 115
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
IV+ DLK +N++LD + KI DFG+C+ D + +F G+ Y PE
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC------GTPEYLAPEVLED 169
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
D + G+++ +++ GRLP
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 64/259 (24%), Positives = 111/259 (42%), Gaps = 21/259 (8%)
Query: 350 VGQGGFGCVYKGE--MLGRTVAIKML-YSHNMQGQLE-----FQQEVRVLSKLQHPHLVT 401
+G G F Y+ G +A+K + Y N + E ++E+R++++L HPH++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 402 LLGACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
+LGA E ++L E++ GS+ L S ++ GL +LH +
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 460 EKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
+I+H D+K N+L+DS +I DFG + F G+ + PE
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL--GTIAFMAPEV 179
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA 578
R D +S G +I+++ T + P K++S P ++
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA--PSIPEHLS 237
Query: 579 RRLVDLGLQCCELYGRERP 597
L D+ L+C EL +RP
Sbjct: 238 PGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 40/225 (17%)
Query: 349 KVGQGGFGCVYKGEMLGRT------------------VAIKMLYSH-NMQGQLEFQQEVR 389
K+G+G FG V+ E G VA+KML N + +F +E++
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 390 VLSKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFR--------KSNVSPLLWKD 439
++S+L+ P+++ LL C + L + EY+ NG L L R K++V + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 440 RARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499
+A +IASG+ +L S VH DL +N L+ + KI DFG+ R LY
Sbjct: 132 LIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSR-----NLYSG 183
Query: 500 SFHRSTAPKGSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
++R + P + E G T SD ++FG+ + ++LT
Sbjct: 184 DYYRIQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 34/212 (16%)
Query: 350 VGQGGFGCVYKGEMLG--RTVAIKMLYSH--NMQGQLEF-QQEVRVLSKL-QHPHLVTLL 403
+G+G FG V E+ G A+K+L +E E RVL+ +HP L L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 404 GAC---PEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFL 454
+C + V EY+ G L + F + RAR AAEI GL FL
Sbjct: 63 -SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP---------RARFYAAEIVLGLQFL 112
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
H I++ DLK N+LLDSE KI DFG+C+ E L ++ G+ Y
Sbjct: 113 HE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILG---GVTTSTFCGTPDYI 163
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE P D ++ G+++ ++L G+ P
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 26/207 (12%)
Query: 350 VGQGGFGCVYKGEM--LGR---TVAIKMLYS-HNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
+G G FG V +G + G+ VAIK L S + + + +F E ++ + HP+++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 404 G----ACPEAWSLVYEYLPNGSLQDRLFRKSN----VSPLLWKDRARIAAEIASGLCFLH 455
G + P ++ E++ NG+L D R+++ V L+ R IA+G+ +L
Sbjct: 72 GVVTKSRPVM--IITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRG-----IAAGMKYLS 123
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
VH DL +NIL++S L K+ DFG+ R + +DT P++ S K +
Sbjct: 124 EMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD-PTYTSSLGGKIPIRWTA 179
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLT 542
PE T SD +S+G+++ ++++
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 350 VGQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
+G+G FG V K + GR A+K+L + + E E RVL +HP L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
+ + V EY G L L R+ S +DRAR AEI S L +LHS K
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFS----EDRARFYGAEIVSALDYLHSEK--N 116
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
+V+ DLK +N++LD + KI DFG+C+ +D + +F G+ Y PE
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC------GTPEYLAPEVLED 170
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
D + G+++ +++ GRLP
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 350 VGQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
+G+G FG V + + GR A+K+L + + E E RVL +HP L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A + V EY G L L R+ + ++RAR AEI S L +LHS
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFT----EERARFYGAEIVSALEYLHS---RD 115
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
+V+ D+K +N++LD + KI DFG+C+ D + +F G+ Y PE
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC------GTPEYLAPEVLED 169
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
D + G+++ +++ GRLP
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 349 KVGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLE--FQQEVRVLSKLQHPHLVTLLG 404
K+G+G FG +Y K + IK + M + + ++EV +L+K++HP++VT
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 405 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
+ E L V EY G L R+ R+ V L +D+ +I+ GL +H K
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGV--LFSEDQILSWFVQISLGLKHIHD---RK 121
Query: 462 IVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
I+H D+K QNI L + +K+ DFGI R + + + G+ Y PE +
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM----ELAYTCV--GTPYYLSPEICQ 175
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLP 546
K+D +S G ++ +L T + P
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 2e-13
Identities = 51/155 (32%), Positives = 67/155 (43%), Gaps = 27/155 (17%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKM----LYSHNMQGQLEFQQEVRVLSKLQ-HPHLVT 401
++G G FG VY G VAIK YS L +EV+ L KL HP++V
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL---REVKSLRKLNEHPNIVK 62
Query: 402 LLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSK 458
L E L V+EY+ G+L K + R I +I GL +H
Sbjct: 63 LKEVFRENDELYFVFEYM-EGNLYQ--LMKDRKGKPFSESVIRSIIYQILQGLAHIHK-- 117
Query: 459 PEKIVHG----DLKPQNILLDSELSSKICDFGICR 489
HG DLKP+N+L+ KI DFG+ R
Sbjct: 118 -----HGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 47/292 (16%)
Query: 350 VGQGGFGCVYKGEM----LGRTVAIKMLYSHNMQG-QLEFQQEVRVLSKL-QHPHLVTLL 403
+G+G FG V K + L AIK + + + +F E+ VL KL HP+++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 404 GACPEA--WSLVYEYLPNGSLQDRLFRKSNV--------------SPLLWKDRARIAAEI 447
GAC L EY P+G+L D L RKS V S L + AA++
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 448 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP 507
A G+ +L ++ +H DL +NIL+ +KI DFG+ R +Y+ + T
Sbjct: 134 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV----KKTMG 183
Query: 508 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILD 567
+ + E V T SD +S+G+++ ++ V L G ++C +L L
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI------VSLGGTPYCGMTCAELYEKL- 236
Query: 568 PLAG--DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL-HVAEER 616
P + P + DL QC RE+P PS + L L + EER
Sbjct: 237 PQGYRLEKPLNCDDEVYDLMRQCW----REKPYERPSFAQILVSLNRMLEER 284
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 350 VGQGGFGCVYKG------EMLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
+G G FG VYKG E + VAIK L + + + E E V++ + +PH+ L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 403 LGAC-PEAWSLVYEYLPNGSLQDRLFR-KSNVSP---LLWKDRARIAAEIASGLCFLHSS 457
LG C L+ + +P G L D + K N+ L W +IA G+ +L
Sbjct: 75 LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEE- 127
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA--- 514
++VH DL +N+L+ + KI DFG+ +L+ D +H A G P
Sbjct: 128 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE---KEYH---AEGGKVPIKWMA 179
Query: 515 -DPEYHRTGVLTPKSDSYSFGLIILQLLT 542
+ HR T +SD +S+G+ + +L+T
Sbjct: 180 LESILHRI--YTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 33/212 (15%)
Query: 350 VGQGGFGCVY-----KGEMLGRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTL 402
+GQG FG V+ G G+ A+K+L ++ ++ + E +L+++ HP +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 403 LGA--CPEAWSLVYEYLPNGSLQDRL-----FRKSNVSPLLWKDRARIAAEIASGLCFLH 455
A L+ ++L G L RL F + +V L AE+A L LH
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL--------AELALALDHLH 115
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
S I++ DLKP+NILLD E K+ DFG+ + + SF G+ Y
Sbjct: 116 SLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEYMA 166
Query: 516 PE-YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE +R G T +D +SFG+++ ++LTG LP
Sbjct: 167 PEVVNRRG-HTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 55/180 (30%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 349 KVGQGGFGCV-----YKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
++G G FG V Y + R V ++ + + + Q EF Q+ LQHP+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 404 GACPEA--WSLVYEYLPNGSL------QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
G C EA + LV+EY G L + R S + L R+A EIA+G+ +H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL-----QRMACEIAAGVTHMH 116
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGIC-------RLVTEDTLYLPSFHRSTAPK 508
+H DL +N L S+L+ K+ D+GI + TED +P R AP+
Sbjct: 117 K---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPL--RWLAPE 171
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 50/157 (31%), Positives = 80/157 (50%), Gaps = 31/157 (19%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ---------QEVRVLSKLQHP 397
K+G+G +G VYK G VA+K + +LE + +E+ +L +L HP
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKI-------RLETEDEGVPSTAIREISLLKELNHP 58
Query: 398 HLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLC 452
++V LL LV+E+L D L + + SPL D I + ++ G+
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFLD----LD-LKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+ HS +++H DLKPQN+L+D E + K+ DFG+ R
Sbjct: 114 YCHS---HRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 350 VGQGGFGCVYKGEM--LGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLG 404
+G+GGFG V ++ G+ A K L + +G+ E ++L K+ +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNV-SPLLWKDRARI-AAEIASGLCFLHSSKPE 460
A + LV + G L+ + NV P + RA AA+I GL LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLK---YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---R 114
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
+IV+ DLKP+N+LLD + +I D G+ + L + G+ Y PE +
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGL-------AVELKGGKKIKGRAGTPGYMAPEVLQ 167
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLP 546
V D ++ G + +++ GR P
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 350 VGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPH 398
+G+G FG V E LG TVA+KML + L + E+ ++ + +H +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 399 LVTLLGACPEAWSL--VYEYLPNGSLQDRL-----------FRKSNVS--PLLWKDRARI 443
++ LLGAC + L + EY G+L++ L + + V + +KD
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 444 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503
++A G+ +L S +K +H DL +N+L+ KI DFG+ R D + + +
Sbjct: 143 TYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR----DVNNIDYYKK 195
Query: 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
+T + + PE V T +SD +SFG+++ ++ T
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 38/222 (17%)
Query: 350 VGQGGFGCVYKGEM-----LGRTVAIKMLYSHNM-QGQLE-FQQEVRVLSKLQHPHLVTL 402
+G+G FG V +G++ VA+K + ++E F E + HP+++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 403 LGACPEAWSL--------VYEYLPNGSLQDRLFR--------KSNVSPLLWKDRARIAAE 446
+G C EA SL + ++ +G L L K + LL + +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL-----KFMVD 121
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST- 505
IA G+ +L + +H DL +N +L +++ + DFG+ + +Y ++R
Sbjct: 122 IALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSK-----KIYSGDYYRQGR 173
Query: 506 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
K + E V T KSD ++FG+ + ++ T G+ P
Sbjct: 174 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 38/214 (17%)
Query: 350 VGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQGQLEFQQ--------EVRVLSKLQHPHL 399
+G+G FG V E G AIK+L + + Q E RVL+ P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKIL-----KKDVIIQDDDVECTMVEKRVLALPGKPPF 62
Query: 400 VTLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
+T L +C + V EY+ G L ++ V AAEIA GL FLHS
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
+ I++ DLK N++LD+E KI DFG+C+ + ++ R+ G+ Y P
Sbjct: 120 ---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTTRTFC--GTPDYIAP 170
Query: 517 E---YHRTGVLTPKS-DSYSFGLIILQLLTGRLP 546
E Y G KS D ++FG+++ ++L G+ P
Sbjct: 171 EIIAYQPYG----KSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 54/149 (36%), Positives = 80/149 (53%), Gaps = 16/149 (10%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSK-LQHPHLVTLL 403
+G+G FG V K + G+ A+K+L + + E + E VL K ++HP LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 404 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPE 460
+ + V +Y+ G L L R+ + + RAR AAEIAS L +LHS
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYLHS---L 115
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICR 489
I++ DLKP+NILLDS+ + DFG+C+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 36/161 (22%)
Query: 349 KVGQGGFGCVYK--GEMLGRTVAIKMLYS---HNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
VG+G +G V K + G+ VAIK M ++ + E+R+L +L+H +LV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLI 66
Query: 404 GAC--PEAWSLVYEYL-----------PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG 450
+ LV+E++ PNG L + RK L+ +I G
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRK-----YLF--------QILRG 112
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491
+ F HS I+H D+KP+NIL+ K+CDFG R +
Sbjct: 113 IEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 349 KVGQGGFGCVYKGEMLGR-----TVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTL 402
+G+G FG VY+G + VA+K + E F QE ++ + HPH+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 403 LGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
+G E W +V E P G L+ L L + ++++ L +L S +
Sbjct: 73 IGVITENPVW-IVMELAPLGELRSYLQVNKYSLDLA--SLILYSYQLSTALAYLESKR-- 127
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP--YADPE- 517
VH D+ +N+L+ S K+ DFG+ R + +++ Y A KG P + PE
Sbjct: 128 -FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY-------KASKGKLPIKWMAPES 179
Query: 518 --YHRTGVLTPKSDSYSFGLIILQLL 541
+ R T SD + FG+ + ++L
Sbjct: 180 INFRR---FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 350 VGQGGFGCVYKG------EMLGRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTL 402
+G G FG VYKG E + VAIK+L + + E E V++ + P++ L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 403 LGAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
LG C LV + +P G L D + + N + +D +IA G+ +L +
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYV--RENKDRIGSQDLLNWCVQIAKGMSYLEEVR--- 129
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA----DPE 517
+VH DL +N+L+ S KI DFG+ RL+ D +H A G P +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE---TEYH---ADGGKVPIKWMALESI 183
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT 542
HR T +SD +S+G+ + +L+T
Sbjct: 184 LHRR--FTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 77/275 (28%), Positives = 129/275 (46%), Gaps = 34/275 (12%)
Query: 350 VGQGGFGCVYKG--EMLGR---TVAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVTLL 403
+G G FG V++G +M GR VAIK L + Q +F E ++ + H +++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 404 GACPE--AWSLVYEYLPNGSLQDRLFRKSN--VSPLLWKDRARIAAEIASGLCFLHSSKP 459
G + ++ EY+ NG+L D+ R + S R IA+G+ +L
Sbjct: 73 GVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSDMN- 127
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
VH DL +NIL++S L K+ DFG+ R++ +D + ++ K + PE
Sbjct: 128 --YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP---EGTYTTSGGKIPIRWTAPEAI 182
Query: 520 RTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCG-KLSSILDPLAGDWPT 575
T SD +SFG+++ ++++ G P EV +A++ G +L P D P+
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL-----PAPMDCPS 237
Query: 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
V + L LQC + RP +V L++L
Sbjct: 238 AVYQ----LMLQCWQQDRARRPRF-VDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 46/165 (27%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHP 397
K+G+G +G VYKG G+ VA+K + +LE ++ E+ +L +LQHP
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKI-------RLESEEEGVPSTAIREISLLKELQHP 59
Query: 398 HLVTLLGAC--PEAWSLVYEYL-----------PNGSLQDRLFRKSNVSPLLWKDRARIA 444
++V L L++E+L P G D KS +
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLY----------- 108
Query: 445 AEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+I G+ F HS +++H DLKPQN+L+D++ K+ DFG+ R
Sbjct: 109 -QILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 350 VGQGGFGCVYKGEM-LGRTVAIKMLY---SHNMQGQLEF---QQEVRVLSKLQHPHLVTL 402
+G+G +G VY G G+ +A+K + S+ + + E+ Q+EV +L L+H ++V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 403 LGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
LG C + S+ E++P GS+ L R PL + +I G+ +LH++
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNN--- 121
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
+VH D+K N++L K+ DFG R + L+ + + G+ + PE
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLP 546
KSD +S G + ++ TG+ P
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 60/230 (26%), Positives = 104/230 (45%), Gaps = 35/230 (15%)
Query: 327 PESAEFSLADLQTATCNFSESFKVGQGGFG----CVYKGEMLGRTVAIKMLYSHN---MQ 379
P+++ + L+D + +G G FG +KG G AIK L M+
Sbjct: 10 PDTSSWKLSDFEMGE-------TLGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMK 60
Query: 380 GQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLW 437
QE +L +L HP +V ++ + + + + E++ G L L RK+ P
Sbjct: 61 QVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-RKAGRFP--- 116
Query: 438 KDRARI-AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496
D A+ AE+ +LHS + I++ DLKP+N+LLD++ K+ DFG + V + T
Sbjct: 117 NDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173
Query: 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
L G+ Y PE ++ D ++ G+++ + + G P
Sbjct: 174 TLC---------GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 69/208 (33%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSH---NMQGQLEFQQEVRVLSK-LQHPHLVTLL 403
+G+G FG V K ++ G+ A+K+L N + Q E VL K ++HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 404 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPE 460
+ E V +++ G L L R+ + + RAR AAEIAS L +LHS
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYLHSIN-- 116
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
IV+ DLKP+NILLDS+ + DFG+C+ + DT +T G+ Y PE
Sbjct: 117 -IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--------TTTFCGTPEYLAPEV 167
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
R D + G ++ ++L G P
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 33/215 (15%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQQ--------EVRVLSKLQHPH 398
++G+G +G VYK G T+A+K + +LE + E+ +L K P+
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEI-------RLELDESKFNQIIMELDILHKAVSPY 60
Query: 399 LVTLLGACPEAWSLVY--EYLPNGSLQDRLFRKSNVSPLLWKDR-ARIAAEIASGLCFLH 455
+V GA ++ EY+ GSL D+L+ + + +D RI + GL FL
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFL- 118
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGIC-RLV---TEDTLYLPSFHRSTAPKGSF 511
+ I+H D+KP N+L++ K+CDFG+ LV + + S+ K
Sbjct: 119 -KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGG 177
Query: 512 PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
P +P Y T +SD +S GL IL++ GR P
Sbjct: 178 PNQNPTY------TVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 2e-12
Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 36/165 (21%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQ---------QEVRVLSKLQHPH 398
+G G +G V + GR VAIK + F +E+++L L+H +
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 399 LVTLLGAC-PEAWS------LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRARIAAEIAS 449
++ LL P + +V E + D ++ + PL +I
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMET----DLHKVIKSPQ--PLTDDHIQYFLYQILR 114
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494
GL +LHS+ ++H DLKP NIL++S KICDFG+ R V D
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 68/215 (31%), Positives = 96/215 (44%), Gaps = 41/215 (19%)
Query: 351 GQGGFGCV----YKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVL---SKLQHPHLV 400
G+G FG V YK G AIK L ++ + E + E R+ + +HP LV
Sbjct: 8 GRGHFGKVLLAEYKKT--GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 401 TLLGACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHS 456
L AC + V EY G L + P RA AA + GL +LH
Sbjct: 66 NLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFYAACVVLGLQYLHE 119
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
+K IV+ DLK N+LLD+E KI DFG+C+ E + R++ G+ P
Sbjct: 120 NK---IVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGF---GDRTSTFCGT-----P 165
Query: 517 EYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
E+ VLT S D + G++I ++L G P
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 33/214 (15%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHP 397
NF K+G+G F VYK L GR VA+K + M Q +E+ +L +L HP
Sbjct: 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 398 HLVTLLGACPEAWSL--VYEYLPNGSL---------QDRLFRKSNVSPLLWKDRARIAAE 446
+++ L + E L V E G L Q RL + +WK +
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE----RTIWK----YFVQ 114
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 506
+ S L +HS ++I+H D+KP N+ + + K+ D G+ R + T S
Sbjct: 115 LCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL----- 166
Query: 507 PKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQL 540
G+ Y PE KSD +S G ++ ++
Sbjct: 167 -VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 48/232 (20%)
Query: 349 KVGQGGFGCVYKGEML----------------GRT--VAIKMLYSH-NMQGQLEFQQEVR 389
K+G+G FG V+ E++ GR VA+K+L N + +F +EV+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 390 VLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLF------RKSNVSPLLWKDRA 441
+LS+L+ P+++ LLG C + ++ EY+ NG L L ++ N + +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 442 ----------RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491
+A +IASG+ +L S VH DL +N L+ L+ KI DFG+ R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSR-- 186
Query: 492 TEDTLYLPSFHRSTAPKGSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLL 541
LY ++R + P + E G T SD ++FG+ + ++L
Sbjct: 187 ---NLYAGDYYRIQG-RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 23/202 (11%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA- 405
+G G G VYK L R +A+K++ ++ Q + E+ +L K P+++ GA
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 406 -CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
S+ E++ GSL ++RK +L RIA + GL +L S K I+H
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIP-EHVL----GRIAVAVVKGLTYLWSLK---ILH 118
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 524
D+KP N+L+++ K+CDFG+ + + G+ Y PE
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--------AKTYVGTNAYMAPERISGEQY 170
Query: 525 TPKSDSYSFGLIILQLLTGRLP 546
SD +S G+ ++L GR P
Sbjct: 171 GIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 30/175 (17%)
Query: 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF--QQEVRVLSKL 394
+ ++ K+G+G FG VYK + GR VA+K + HN + +E+++L KL
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL 64
Query: 395 QHPHLVTLLGACPEAWSLVYEYLPNGSLQDRL-------FRKSNVSPLLWKDRAR----- 442
+HP++V L+ + E P+ S + R + ++S LL +
Sbjct: 65 KHPNVVPLI-------DMAVER-PDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ 116
Query: 443 ---IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494
++ G+ +LH + I+H D+K NIL+D++ KI DFG+ R
Sbjct: 117 IKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 350 VGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPHLVTLLG 404
+G+G FG V E G AIK+L + + + E RVL+ P +T L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 405 ACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+C + +Y EY+ G L +++ V AAEIA GL FLHS +
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS---KG 121
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
I++ DLK N++LDSE KI DFG+C+ D + +F G+ Y PE
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC------GTPDYIAPEIIAY 175
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
D ++FG+++ ++L G+ P
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 48/147 (32%), Positives = 75/147 (51%), Gaps = 17/147 (11%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF---QQEVRVLSKLQHPHLVTLL 403
++G G +G VYK + G VAIK++ ++ +F QQE+ +L + +HP++V
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 404 GA---CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
G+ + W +V EY GSLQD + PL A + E GL +LH +
Sbjct: 67 GSYLRRDKLW-IVMEYCGGGSLQDIY--QVTRGPLSELQIAYVCRETLKGLAYLHETG-- 121
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGI 487
+H D+K NILL + K+ DFG+
Sbjct: 122 -KIHRDIKGANILLTEDGDVKLADFGV 147
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 50/171 (29%), Positives = 84/171 (49%), Gaps = 29/171 (16%)
Query: 386 QEVRVLSKLQHPHLVTLLGACPEAW-----SLVYEYLPNGSLQDRLFRKSNVSP--LLWK 438
+E++VL + P++V GA + S+ E++ GSL D++ +K+ P +L
Sbjct: 48 RELKVLHECNSPYIVGFYGA---FYSDGEISICMEHMDGGSL-DQVLKKAGRIPENIL-- 101
Query: 439 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498
+I+ + GL +L KI+H D+KP NIL++S K+CDFG+
Sbjct: 102 --GKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS---------- 147
Query: 499 PSFHRSTAPK--GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 547
S A G+ Y PE + T +SD +S GL ++++ GR P+
Sbjct: 148 GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 31/210 (14%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
+G+G FG V + + G+ A+K+L + + E E RVL +HP L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 405 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
+ L V EY G L L R+ S +DRAR AEI S L +LHS
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFS----EDRARFYGAEIVSALGYLHS---CD 115
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
+V+ DLK +N++LD + KI DFG+C+ E S + +F PEY
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK---EGI----SDGATMK---TF-CGTPEYLAP 164
Query: 522 GVLTPKS-----DSYSFGLIILQLLTGRLP 546
VL D + G+++ +++ GRLP
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 69/256 (26%), Positives = 107/256 (41%), Gaps = 52/256 (20%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQ---HPHLVT 401
++G G +G VYK G VA+K + + L +EV +L +L+ HP++V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 402 LLGACPEAWS-------LVYEYLPNGSLQD-RLFRKSNVSPLLWKDRAR-IAAEIASGLC 452
L+ C + + LV+E++ QD R + P L + + + + GL
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVD----QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP-KGSF 511
FLH++ IVH DLKP+NIL+ S K+ DFG+ R+ S + P +
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY--------SCQMALTPVVVTL 171
Query: 512 PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCG-----KLSSIL 566
Y PE D +S G I ++ R+ + CG +L I
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-----------RKPLFCGNSEADQLGKIF 220
Query: 567 D----PLAGDWPTFVA 578
D P DWP V
Sbjct: 221 DLIGLPPEDDWPRDVT 236
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 37/223 (16%)
Query: 350 VGQGGFGCVYKGEML-----GRTVAIKMLYS----HNMQGQLEFQQEVRVLSKLQHPHLV 400
+G+GG+G V++ + G+ A+K+L N + + E +L ++HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 401 TLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSS 457
L+ A L + EYL G L L R+ + +D A +EI+ L LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQ- 118
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
+ I++ DLKP+NILLD++ K+ DFG+C+ + +F G+ Y PE
Sbjct: 119 --QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC------GTIEYMAPE 170
Query: 518 Y-----HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR 555
H V D +S G ++ +LTG P E R+
Sbjct: 171 ILMRSGHGKAV-----DWWSLGALMYDMLTGAPP--FTAENRK 206
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 33/219 (15%)
Query: 350 VGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPH 398
+G+G FG V E +G VA+KML S + L + E+ ++ + +H +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 399 LVTLLGACPEAWSL--VYEYLPNGSLQDRL-----------FRKSNV--SPLLWKDRARI 443
++ LLGAC + L + EY G+L++ L + + V L +KD
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 444 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503
A ++A G+ +L S +K +H DL +N+L+ + KI DFG+ R D ++ + +
Sbjct: 146 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 198
Query: 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
+T + + PE + T +SD +SFG+++ ++ T
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 350 VGQGGFGCVYKGEML--GR---TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTLL 403
+G G FG V G + G+ VAIK L + + Q +F E ++ + HP+++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 404 GACPEAWS--LVYEYLPNGSLQDRLFRKSN----VSPLLWKDRARIAAEIASGLCFLHSS 457
G ++ +V EY+ NGSL D RK + V L+ R IASG+ +L
Sbjct: 72 GVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRG-----IASGMKYLSDM 125
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
VH DL +NIL++S L K+ DFG+ R++ +D + + + K + PE
Sbjct: 126 G---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP---EAAYTTRGGKIPIRWTAPE 179
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT 542
T SD +S+G+++ ++++
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 350 VGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPH 398
+G+G FG V + E G TVA+KML + L + E+ ++ + +H +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 399 LVTLLGACPEAWSL--VYEYLPNGSLQDRL-------------FRKSNVSPLLWKDRARI 443
++ LLG C + L + EY G+L++ L K L +KD
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 444 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503
A ++A G+ +L S + +H DL +N+L+ + KI DFG+ R V + Y +
Sbjct: 140 AYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY----KK 192
Query: 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
++ + + PE V T +SD +SFG+++ ++ T
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 52/156 (33%), Positives = 83/156 (53%), Gaps = 17/156 (10%)
Query: 343 NFSESFKVGQGGFGCVYKGE--MLGRTVAIKML-YSHNMQGQLEFQ-QEVRVLSKLQHPH 398
NF + K+G+G +G VYK + G VA+K + +G +E+ +L +L HP+
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 399 LVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCF 453
+V LL L V+E+L QD L + + SPL I + ++ GL F
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLH----QD-LKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
HS +++H DLKPQN+L+++E + K+ DFG+ R
Sbjct: 116 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 66/206 (32%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSK-LQHPHLVTLL 403
+G+G FG V K + G A+K+L + + Q E VL K L+HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 404 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPE 460
+ E V +Y+ G L L R+ + RAR AAE+AS + +LHS
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFL----EPRARFYAAEVASAIGYLHS---L 115
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
I++ DLKP+NILLDS+ + DFG+C+ E +F G+ Y PE R
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC------GTPEYLAPEVLR 169
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLP 546
D + G ++ ++L G P
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 37/221 (16%)
Query: 350 VGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPH 398
+G+G FG V E +G TVA+KML L + E+ ++ + +H +
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 399 LVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSP---------------LLWKDRA 441
++ LLGAC + L + EY G+L R + ++ P L +KD
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNL--REYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 442 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501
A ++A G+ +L S +K +H DL +N+L+ + KI DFG+ R D + +
Sbjct: 138 SCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLAR----DVHNIDYY 190
Query: 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
++T + + PE V T +SD +SFG+++ ++ T
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 350 VGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQ---QEVRVLS-KLQHPHLVTLL 403
+G+G FG V + GR A+K+L + + + E R+LS HP L T L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL-TQL 61
Query: 404 GAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKP 459
C P+ V E++ G L + + + RAR AAEI S L FLH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD----EARARFYAAEITSALMFLHD--- 114
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
+ I++ DLK N+LLD E K+ DFG+C+ + +F G+ Y PE
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC------GTPDYIAPEIL 168
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ + P D ++ G+++ ++L G P
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 49/221 (22%)
Query: 351 GQGGFGCVYK--GEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-------HPHLVT 401
G+G +G V K G +A+K ++ + Q++ R+L L P+ VT
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVK-----RIRATVNSQEQKRLLMDLDISMRSVDCPYTVT 64
Query: 402 LLGA---------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDR--ARIAAEIASG 450
GA C E + + SL D+ ++K L + +IA I
Sbjct: 65 FYGALFREGDVWICME--------VMDTSL-DKFYKKVYDKGLTIPEDILGKIAVSIVKA 115
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS 510
L +LHS ++H D+KP N+L++ K+CDFGI + YL T G
Sbjct: 116 LEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI-------SGYLVDSVAKTIDAGC 166
Query: 511 FPYA-----DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PY +PE ++ G KSD +S G+ +++L TGR P
Sbjct: 167 KPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 71/271 (26%), Positives = 121/271 (44%), Gaps = 34/271 (12%)
Query: 349 KVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQ--LEFQQEVRVLSKLQHPHLVTLLG 404
K+G+G FG + K + G+ IK + M + E ++EV VLS ++HP++V
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 405 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIA--AEIASGLCFLHSSKPE 460
+ E +L V +Y G L ++ + V L+ + + +I L +H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGV---LFPEDQILDWFVQICLALKHVHD---R 120
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
KI+H D+K QNI L + + K+ DFGI R V T+ L R+ G+ Y PE
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELA---RTCI--GTPYYLSPEICE 174
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSS-ILDPLAGDWPTFVAR 579
KSD ++ G ++ ++ T ++ A G + + +L + G +P +
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCT----------LKHAFEAGNMKNLVLKIIRGSYPPVSSH 224
Query: 580 RLVDLGLQCCELYGR---ERPDITPSLVKEL 607
DL +L+ R +RP + L K
Sbjct: 225 YSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 69/205 (33%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 350 VGQGGFGCVYKGEMLG--RTVAIKMLYSHN--MQGQLEFQQ-EVRVLS-KLQHPHLVTLL 403
+G+G FG V+ E+ G + AIK L M +E E RVLS +HP L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 404 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
E V EYL G L +F + AAEI GL FLHS +
Sbjct: 63 CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHS---KG 116
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
IV+ DLK NILLD++ KI DFG+C+ E+ L ++ G+ Y PE
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCK---ENML---GDAKTCTFCGTPDYIAPEILLG 170
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
D +SFG+++ ++L G+ P
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 65/209 (31%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 350 VGQGGFGCVYKGEMLGRT--VAIKMLYSHN--MQGQLEFQQ-EVRVLS-KLQHPHLVTLL 403
+G+G FG V E+ G AIK L +E E RVL+ +HP L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 404 GACP----EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSK 458
C E V EYL G L + + RAR AAEI GL FLH
Sbjct: 63 --CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD----EARARFYAAEIICGLQFLHK-- 114
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRL-VTEDTLYLPSFHRSTAPKGSFPYADPE 517
+ I++ DLK N+LLD + KI DFG+C+ + + +++ G+ Y PE
Sbjct: 115 -KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-------KASTFCGTPDYIAPE 166
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ D +SFG+++ ++L G+ P
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 16/195 (8%)
Query: 349 KVGQGGFGCVYKGEMLGRT--VAIKMLYSHNMQGQLE--FQQEVRVLSKLQHPHLVTLLG 404
++G+G FG V+ G + VA+K + L+ F QE R+L + HP++V L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 405 ACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
C + +V E + G F ++ L K+ ++ A+G+ +L S +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLT--FLRTEGPRLKVKELIQMVENAAAGMEYLES---KHC 115
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
+H DL +N L+ + KI DFG+ R ED +Y + P + PE G
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIP---VKWTAPEALNYG 171
Query: 523 VLTPKSDSYSFGLII 537
+ +SD +SFG+++
Sbjct: 172 RYSSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 40/213 (18%)
Query: 351 GQGGFGCVYKGEMLGRT------------VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH 398
GQG F +YKG + ++ V +K+L S + + L F + ++S+L H H
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHKH 62
Query: 399 LVTLLGAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
LV L G C + +V EY+ G L L R+ N L WK +A ++AS L +L
Sbjct: 63 LVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED- 119
Query: 458 KPEKIVHGDLKPQNILLDSE-------LSSKICDFGICR-LVTEDTLYLPSFHRSTAPKG 509
+K+VHG++ +NIL+ K+ D GI +++ +
Sbjct: 120 --KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI--------- 168
Query: 510 SFPYADPEYHRTGV--LTPKSDSYSFGLIILQL 540
P+ PE R G LT +D +SFG +L++
Sbjct: 169 --PWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 20/154 (12%)
Query: 349 KVGQGGFGCVYK--GEMLGRTVAIKMLYSHNMQGQLE--FQQEVRVLSKLQHPHLVTLLG 404
K+G+G +G V+K G+ VAIK ++ +E+R+L +L+HP+LV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI- 66
Query: 405 ACPEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
E + LV+EY + L + V L K +I + + F H
Sbjct: 67 ---EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK---KIIWQTLQAVNFCHKHN 120
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492
+H D+KP+NIL+ + K+CDFG R++T
Sbjct: 121 ---CIHRDVKPENILITKQGQIKLCDFGFARILT 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 343 NFSESFKVGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHP 397
+F+ +G+G FG V E G AIK+L + + + E RVL+ P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 398 HLVTLLGACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
+T L +C + +Y EY+ G L ++ V AAEI+ GL FL
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFL 117
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
H I++ DLK N++LDSE KI DFG+C+ D + +F G+ Y
Sbjct: 118 HR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC------GTPDYI 168
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE D +++G+++ ++L G+ P
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 47/167 (28%), Positives = 74/167 (44%), Gaps = 35/167 (20%)
Query: 349 KVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPHLVT 401
+G+G +G VYK + G+ AIK Q Q +E+ +L +L+H ++V+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 402 LLGACPEAW----SLVYEYLPNGSLQ---------DRLFRKSNVSPLLWKDRARIAAEIA 448
L+ E L+++Y + Q S V LLW +I
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW--------QIL 118
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLV 491
+G+ +LHS+ ++H DLKP NIL+ E KI D G+ RL
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 79/298 (26%), Positives = 122/298 (40%), Gaps = 63/298 (21%)
Query: 349 KVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQ---HPHLV 400
++G+G +G V+K L GR VA+K + + + +EV VL L+ HP++V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 401 TLLGACPEA-------WSLVYEYLPNGSLQDRLFR--KSNVSPLLWKDRARIAAEIASGL 451
L C + +LV+E++ + L L + + V KD + ++ GL
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD---MMFQLLRGL 123
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
FLHS ++VH DLKPQNIL+ S K+ DFG+ R+ + T+ +
Sbjct: 124 DFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-------LTSVVVTL 173
Query: 512 PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILD---- 567
Y PE D +S G I ++ R P+ R + +L ILD
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL-----FRGSSDVDQLGKILDVIGL 227
Query: 568 PLAGDWPTFVA--------------RRLV--------DLGLQCCELYGRERPDITPSL 603
P DWP VA + V DL L+C +R +L
Sbjct: 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 349 KVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G+G G C+ + + GR VA+KM+ Q + EV ++ QH ++V + +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 407 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
E W L+ E+L G+L D + S L + A + + LC+LHS + ++
Sbjct: 88 LVGEELWVLM-EFLQGGALTDIV---SQTR-LNEEQIATVCESVLQALCYLHS---QGVI 139
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 523
H D+K +ILL + K+ DFG C +++D +P + + G+ + PE
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKD---VP---KRKSLVGTPYWMAPEVISRTP 193
Query: 524 LTPKSDSYSFGLIILQLLTGRLP 546
+ D +S G+++++++ G P
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 66/243 (27%), Positives = 103/243 (42%), Gaps = 62/243 (25%)
Query: 332 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQ-GQLEFQQ 386
F+ DL+ + ++G+G FG V K ML G +A+K + S + Q
Sbjct: 1 FTAEDLK-------DLGEIGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLM 51
Query: 387 EVRVLSKLQH-PHLVTLLGA---------CPEA--------WSLVYEYLPNGSLQDRLFR 428
++ V+ + P++V GA C E + VYE L + + +
Sbjct: 52 DLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-KSVIPEEILG 110
Query: 429 KSNVSPLLWKDRARIAAEIASGLCFLHSSKPE-KIVHGDLKPQNILLDSELSSKICDFGI 487
K V+ + +A L+ K E KI+H D+KP NILLD + K+CDFGI
Sbjct: 111 KIAVATV----KA------------LNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGI 154
Query: 488 C-RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTP---KSDSYSFGLIILQLLTG 543
+LV S + T G PY PE +SD +S G+ + ++ TG
Sbjct: 155 SGQLVD-------SIAK-TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
Query: 544 RLP 546
+ P
Sbjct: 207 KFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 72/226 (31%), Positives = 98/226 (43%), Gaps = 52/226 (23%)
Query: 344 FSESFKVGQGGFGCVY--KGEMLGRTVAIK-MLYSHNMQGQLEFQ---QEVRVLSKLQHP 397
F++ ++G G FG VY + VAIK M YS Q ++Q +EVR L +L+HP
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 398 HLVTLLGAC----PEAWSLVYEYLPNGSLQDRL--FRKSNVSPLLWKDRARIAAEIASGL 451
+ + G C AW LV EY GS D L +K PL + A I GL
Sbjct: 76 NTIEYKG-CYLREHTAW-LVMEYCL-GSASDILEVHKK----PLQEVEIAAICHGALQGL 128
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
+LHS + +H D+K NILL + K+ DFG LV +P SF
Sbjct: 129 AYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLV--------------SPANSF 171
Query: 512 ---PY--------ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PY A E G K D +S G+ ++L + P
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDG----KVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 349 KVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G+G G C+ + GR VA+K + Q + EV ++ QHP++V + +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 407 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
E W +V E+L G+L D + + A + + L FLH+ + ++
Sbjct: 86 LVGDELW-VVMEFLEGGALTDIVTHTRMNEEQI----ATVCLAVLKALSFLHA---QGVI 137
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 523
H D+K +ILL S+ K+ DFG C V+++ +P R + G+ + PE
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKE---VP---RRKSLVGTPYWMAPEVISRLP 191
Query: 524 LTPKSDSYSFGLIILQLLTGRLP 546
+ D +S G+++++++ G P
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 24/205 (11%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQ---LEFQQEVRVL-SKLQHPHLVTLL 403
+ +G FG VY K G AIK+L +M + + E ++ + + P++ L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 404 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+ + LV EYL G L + P W + AE+ G+ LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWA--KQYIAEVVLGVEDLHQ---RG 117
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
I+H D+KP+N+L+D K+ DFG+ R E+ ++ G+ Y PE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV----------GTPDYLAPETILG 167
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
SD +S G +I + L G P
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 55/213 (25%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 343 NFSESFKVGQGGFGCVYK------GEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH 396
+F + ++G G G V+K G ++ R + I + ++ Q+ +E++VL +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKL-IHLEIKPAIRNQI--IRELQVLHECNS 62
Query: 397 PHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
P++V GA S+ E++ GSL D++ +K+ P + +++ + GL +L
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP--EQILGKVSIAVIKGLTYL 119
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
+ KI+H D+KP NIL++S K+CDFG+ + + + + G+ Y
Sbjct: 120 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--------ANSFVGTRSYM 169
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 547
PE + + +SD +S GL ++++ GR P+
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 78/254 (30%), Positives = 116/254 (45%), Gaps = 38/254 (14%)
Query: 343 NFSESFKV-GQGGFGCVY-----KGEMLGRTVAIKMLYSHNMQGQLEFQQEVR----VLS 392
NF E KV G G +G V+ G G+ A+K+L + + + + R VL
Sbjct: 1 NF-ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE 59
Query: 393 KL-QHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIA 448
+ Q P LVTL A L+ +Y+ G + L+++ N S +D R + EI
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS----EDEVRFYSGEII 115
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR-LVTEDTLYLPSFHRSTAP 507
L LH IV+ D+K +NILLDSE + DFG+ + ++E+ R+ +
Sbjct: 116 LALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK------ERTYSF 166
Query: 508 KGSFPYADPEYHRTGVLTPKS-DSYSFGLIILQLLTGRLPVGLAGE-------VRRAVSC 559
G+ Y PE R K+ D +S G++I +LLTG P L GE RR + C
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC 226
Query: 560 G-KLSSILDPLAGD 572
S + P A D
Sbjct: 227 DPPFPSFIGPEAQD 240
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 39/219 (17%)
Query: 341 TCNFSESFKVGQGGFG--CVYKGEMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQ 395
T + + VG G FG C + ++ G+ VAIK + +S + + + +E+++L L+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLR 67
Query: 396 HPHLVTL--LGACP-EAWSLVYEYLP---NGSLQDRLFRKSNVSPLLWKDRARIAAEIAS 449
H ++++L + P E V E L + L R K + L+ +I
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLY--------QILR 119
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 509
GL ++HS+ +VH DLKP NIL++ KICDFG+ R + T
Sbjct: 120 GLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR---------IQDPQMTGYVS 167
Query: 510 SFPYADPE----YHRTGVLTPKSDSYSFGLIILQLLTGR 544
+ Y PE + + V + D +S G I ++L G+
Sbjct: 168 TRYYRAPEIMLTWQKYDV---EVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLG 404
+G+GGFG C + G+ A K L ++ G+ E ++L K+ +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A +A LV + G L+ ++ N P ++RA AAEI GL LH E+
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHR---ER 122
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
IV+ DLKP+NILLD +I D G+ + +P G+ Y PE +
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGL-------AVEIPEGETIRGRVGTVGYMAPEVVKN 175
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
T D + G +I +++ G+ P
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-10
Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 42/231 (18%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
+G+GG G VY + R VA+K + S N + F +E ++ + L HP +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 404 GACPEAWSLVYEYLP----------------NGSLQDRLFRKSNVSPLLWKDRARIAAEI 447
C + VY +P SL L K++V L I +I
Sbjct: 69 SICSDG-DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL-----SIFHKI 122
Query: 448 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI---CRLVTEDTLYL------ 498
+ + ++HS + ++H DLKP NILL I D+G +L ED L +
Sbjct: 123 CATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 499 PSFHRSTAPK---GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ T P G+ Y PE + +D Y+ G+I+ Q+LT P
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLG 404
+G+GGFG C + G+ A K L ++ G+ E R+L K+ +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A +A LV + G L+ ++ N P + RA AAE+ GL L E+
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQR---ER 122
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
IV+ DLKP+NILLD +I D G+ + +P G+ Y PE
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGL-------AVQIPEGETVRGRVGTVGYMAPEVINN 175
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
T D + G +I +++ G+ P
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 405
+G+G FG +Y+ V K L + + + + E+ +LS LQHP+++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 406 CPEAWSLV--YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA--EIASGLCFLHSSKPEK 461
+ +L+ EY G+L D++ R+ L+++ + +I S + ++H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIHK---AG 121
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
I+H D+K NI L K+ DFGI +++ + + G+ Y PE +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV------VGTPYYMSPELCQG 175
Query: 522 GVLTPKSDSYSFGLIILQLLT 542
KSD ++ G ++ +LLT
Sbjct: 176 VKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 350 VGQGGFGCVYKGEMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSK-------LQHPHL 399
+G+G FG V +L R A + Y+ + + L+ ++E ++S+ ++HP L
Sbjct: 3 IGKGSFGKV----LLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 400 VTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHS 456
V L + A L V +Y+ G L L R+ + RAR AAEIAS L +LHS
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHS 114
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
IV+ DLKP+NILLDS+ + DFG+C+ E +F G+ Y P
Sbjct: 115 LN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC------GTPEYLAP 165
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E D + G ++ ++L G P
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 5e-10
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 36/214 (16%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM-QGQLE--FQQEVRVLSKLQHPHLVTLLG 404
+G GGFG V K + RT A+K + ++ + + E +L + HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 405 ACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPE 460
+ +Y EY G L L + L + AR A + +LH+
Sbjct: 61 TFKDKKY-IYMLMEYCLGGELWTILRDRG----LFDEYTARFYIACVVLAFEYLHN---R 112
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE--- 517
I++ DLKP+N+LLDS K+ DFG + L S ++ G+ Y PE
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAK-------KLKSGQKTWTFCGTPEYVAPEIIL 165
Query: 518 ---YHRTGVLTPKSDSYSFGLIILQLLTGRLPVG 548
Y + D +S G+++ +LLTGR P G
Sbjct: 166 NKGYDFS------VDYWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 22/174 (12%)
Query: 387 EVRVLSKLQH-PHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI 443
E +VL ++ P LVTL A L+ +Y+ G L L+++ + + + R+
Sbjct: 54 ERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT----ESEVRV 109
Query: 444 -AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502
AEI L LH I++ D+K +NILLDSE + DFG+ + +
Sbjct: 110 YIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE----- 161
Query: 503 RSTAPKGSFPYADPEYHRTGVLTPKSDS----YSFGLIILQLLTGRLPVGLAGE 552
R+ + G+ Y PE R G + D +S G++ +LLTG P + GE
Sbjct: 162 RAYSFCGTIEYMAPEVIRGG--SGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 66/249 (26%), Positives = 104/249 (41%), Gaps = 39/249 (15%)
Query: 315 NYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLY 374
N D F+ E E + L+ +F +G+G FG V L R + K +Y
Sbjct: 20 NIDNFLSRYEKAAEK----ITKLRMKAEDFDVIKVIGRGAFGEVQ----LVRHKSSKQVY 71
Query: 375 SHNMQGQLE---------FQQEVRVLSKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQ 423
+ + + E F +E +++ +V L A + L V EY+P G L
Sbjct: 72 AMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLV 131
Query: 424 DRLFRKSNVS-PLLWKDRARI-AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSK 481
+ + SN P W AR AE+ L +HS +H D+KP N+LLD K
Sbjct: 132 NLM---SNYDIPEKW---ARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLK 182
Query: 482 ICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT----GVLTPKSDSYSFGLII 537
+ DFG C + + + TA G+ Y PE ++ G + D +S G+ +
Sbjct: 183 LADFGTCMKMDANGM----VRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237
Query: 538 LQLLTGRLP 546
++L G P
Sbjct: 238 YEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 7e-10
Identities = 23/45 (51%), Positives = 27/45 (60%), Gaps = 1/45 (2%)
Query: 4 HGIQKLVMGAFPDNCMKVKM-GSRKASYAAKNAPMFCEIWFVNKG 47
HGI KLVMGA DN +K S AS K AP FC ++ V+KG
Sbjct: 102 HGITKLVMGASSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVSKG 146
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 43/177 (24%), Positives = 81/177 (45%), Gaps = 36/177 (20%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPHLVTLLG 404
K+GQG FG V+K + VA+K + N + +E+++L L+H ++V L+
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78
Query: 405 AC---PEAWS-------LVYEYLPN---GSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 451
C ++ LV+E+ + G L ++ + + + ++ + +GL
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS------EIKKVMKMLLNGL 132
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 508
++H +K I+H D+K NIL+ + K+ DFG+ R +F S K
Sbjct: 133 YYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR----------AFSLSKNSK 176
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 30/210 (14%)
Query: 350 VGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQGQLEFQ---QEVRVLS-KLQHPHLVTLL 403
+G+G FG V E+ G AIK+L + + E R+L+ +HP L T L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL-TAL 61
Query: 404 GAC---PEAWSLVYEYLPNGSL--QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSS 457
C + V EY+ G L Q + RK + R+R AAE+ L FLH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP------RSRFYAAEVTLALMFLHR- 114
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRL-VTEDTLYLPSFHRSTAPKGSFPYADP 516
+++ DLK NILLD+E K+ DFG+C+ + +T G+ Y P
Sbjct: 115 --HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT-------TTTFCGTPDYIAP 165
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E + P D ++ G+++ +++ G+ P
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 344 FSESFKVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPH 398
F + +G+GGFG C + G+ A K L ++ G+ E ++L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 399 LVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 455
+V L A +A LV + G L+ ++ N P ++RA AAEI GL LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLH 119
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
E V+ DLKP+NILLD +I D G+ + +P G+ Y
Sbjct: 120 R---ENTVYRDLKPENILLDDYGHIRISDLGL-------AVKIPEGESIRGRVGTVGYMA 169
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE T D + G +I +++ G+ P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 41/221 (18%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKL-QHPHLVTLLG 404
VG G +G VYKG + G+ AIK++ ++ G + E +QE+ +L K H ++ T G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 405 AC---------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
A + W LV E+ GS+ D L + + + L + A I EI GL LH
Sbjct: 71 AFIKKNPPGMDDQLW-LVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLH 128
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF---P 512
K++H D+K QN+LL K+ DFG+ R+ + +F P
Sbjct: 129 Q---HKVIHRDIKGQNVLLTENAEVKLVDFGVS----------AQLDRTVGRRNTFIGTP 175
Query: 513 Y-ADPEY-----HRTGVLTPKSDSYSFGLIILQLLTGRLPV 547
Y PE + KSD +S G+ +++ G P+
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 350 VGQGGFGCVYKGEMLGRT--VAIKMLYSHN--MQGQLEFQQ-EVRVLS-KLQHPHLVTLL 403
+G+G FG V E+ G+ A+K L + +E E RVL+ ++P L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 404 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPE 460
E V E+L G L + K L+ RA AAEI GL FLHS +
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFD--LY--RATFYAAEIVCGLQFLHS---K 115
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
I++ DLK N++LD + KI DFG+C+ + ++ + R++ G+ Y PE +
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCK----ENVFGDN--RASTFCGTPDYIAPEILQ 169
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLP 546
T D +SFG+++ ++L G+ P
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 46/164 (28%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 386 QEVRVLSKLQHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI 443
+E++VL + P++V GA S+ E++ GSL D++ +++ P + I
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVSI 110
Query: 444 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503
A + GL +L + +I+H D+KP NIL++S K+CDFG+ + +
Sbjct: 111 A--VLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-------- 158
Query: 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 547
+ + G+ Y PE + + +SD +S GL +++L GR P+
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 50/150 (33%), Positives = 75/150 (50%), Gaps = 18/150 (12%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGA- 405
VG G +G VYKG + G+ AIK++ + + E + E+ +L K H ++ T GA
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE-EIKLEINMLKKYSHHRNIATYYGAF 82
Query: 406 ---CP-----EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
P + W LV E+ GS+ D L + + + L A I EI GL LH+
Sbjct: 83 IKKSPPGHDDQLW-LVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICREILRGLAHLHA- 139
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGI 487
K++H D+K QN+LL K+ DFG+
Sbjct: 140 --HKVIHRDIKGQNVLLTENAEVKLVDFGV 167
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 60/264 (22%), Positives = 108/264 (40%), Gaps = 60/264 (22%)
Query: 350 VGQGGFGCVYKGE--MLGRTVAIKML----YSHNMQGQLEF----------QQEVRVLSK 393
+G+G +G V K + G+ VAIK + S+++ + +E++++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 394 LQHPHLVTLLGA-CPEAW-SLVYEYLPNGSLQDRLFRK-----SNVSPLLWKDRARIAAE 446
++H +++ L+ + +LV + + L+ + RK S V +L +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILL--------Q 127
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 506
I +GL LH +H DL P NI ++S+ KI DFG+ R T
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 507 PKG--------SFPYADPE-------YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 551
+ + Y PE YH D +S G I +LLTG+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFA------VDMWSVGCIFAELLTGKPLFPGEN 238
Query: 552 EVRRAVSCGKLSSIL-DPLAGDWP 574
E+ + G++ +L P +WP
Sbjct: 239 EIDQ---LGRIFELLGTPNEDNWP 259
|
Length = 335 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 344 FSESFKVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPH 398
F + +G+GGFG C + G+ A K L ++ G+ E ++L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 399 LVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 455
+V+L A +A LV + G L+ ++ + RA AAEI GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLH 119
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
E+IV+ DLKP+NILLD +I D G+ +++P G+ Y
Sbjct: 120 Q---ERIVYRDLKPENILLDDHGHIRISDLGL-------AVHVPEGQTIKGRVGTVGYMA 169
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE + T D ++ G ++ +++ G+ P
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLY----SHNMQGQLE-FQQEVRVLSKLQHPHLVTL 402
+GQG FG VY GR +A+K + S ++ + E+++L L H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 403 LGAC---PE-AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G E S+ E++P GS++D+L + L + +I G+ +LHS+
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEGVSYLHSNM 126
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
IVH D+K NIL DS + K+ DFG + + L T G+ + PE
Sbjct: 127 ---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT---GTPYWMSPEV 180
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
K+D +S G ++++LT + P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 23/150 (15%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
++G G FG VYK + G A K++ + + + ++ E+ +L+ HP++V LLGA
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 407 ---PEAWSLVYEYLPNGSLQ------DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
+ W ++ E+ P G++ DR + + I ++ L +LHS
Sbjct: 79 YWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV--------ICRQMLEALQYLHS- 128
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGI 487
KI+H DLK N+LL + K+ DFG+
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGV 156
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 10/157 (6%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA- 405
+VG G +G VYK L G A+K++ QQE+ ++ + +H ++V G+
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 406 -CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
E + EY GSLQD ++ + PL A + E GL +LHS +H
Sbjct: 76 LSREKLWICMEYCGGGSLQD-IYHVT--GPLSELQIAYVCRETLQGLAYLHSKGK---MH 129
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501
D+K NILL K+ DFG+ +T SF
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 67/272 (24%), Positives = 114/272 (41%), Gaps = 26/272 (9%)
Query: 350 VGQGGFGCVY-------KGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
+GQG FG VY E+ + V + + E+++L LQH +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 403 LGACPE----AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G + ++ EY+P GS++D+L ++ + + R +I G+ +LHS+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR---QILEGMSYLHSNM 126
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
IVH D+K NIL DS + K+ DFG + + + T G+ + PE
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT---GTPYWMSPEV 180
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA 578
K+D +S G ++++LT + P E + K+++ P P+ ++
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP---WAEYEAMAAIFKIAT--QPTNPQLPSHIS 235
Query: 579 RRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
D L C + R RP L QL
Sbjct: 236 EHARDF-LGCIFVEARHRPSAEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 13/147 (8%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL--L 403
K+G+G + V+KG ++ VA+K + H +EV +L L+H ++VTL +
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 404 GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA-EIASGLCFLHSSKPEKI 462
+LV+EYL + L+ L N L+ +I ++ GL + H KI
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKI 124
Query: 463 VHGDLKPQNILLDSELSSKICDFGICR 489
+H DLKPQN+L++ + K+ DFG+ R
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 46/143 (32%), Positives = 71/143 (49%), Gaps = 13/143 (9%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGAC- 406
G G FG VYK + G A K++ + +LE F E+ +LS+ +HP++V L A
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKII-QIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
+ W L+ E+ G+L D + + L + ++ L FLHS K++H
Sbjct: 73 YENKLWILI-EFCDGGAL-DSIMLELE-RGLTEPQIRYVCRQMLEALNFLHS---HKVIH 126
Query: 465 GDLKPQNILLDSELSSKICDFGI 487
DLK NILL + K+ DFG+
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGV 149
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 3e-09
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 61/227 (26%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYS--HNMQ-GQLEFQQEVRVLSKL-QHPHLVTL 402
K+G+G +G V+K VA+K ++ N Q F+ E+ L +L HP++V L
Sbjct: 14 KLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKL 72
Query: 403 LGACPEA----WSLVYEYLPN--------GSLQDRLFRKSNVSPLLWKDRARIAAEIASG 450
L LV+EY+ L+D + ++ + LL +A
Sbjct: 73 LNVIKAENDKDIYLVFEYMETDLHAVIRANILED-VHKRYIMYQLL---KA--------- 119
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS---------- 500
L ++HS ++H DLKP NILL+S+ K+ DFG+ R ++E +
Sbjct: 120 LKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 501 FHRSTAPK---GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
++R AP+ GS Y GV D +S G I+ ++L G+
Sbjct: 177 WYR--APEILLGSTRYT------KGV-----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 16/139 (11%)
Query: 350 VGQGGFGCVYKG---------EMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLV 400
+GQG F ++KG E+ V +K+L + F + ++S+L H HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 401 TLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G C + +V EY+ GSL L + N+ + WK +A ++A L FL
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLED-- 118
Query: 459 PEKIVHGDLKPQNILLDSE 477
+ + HG++ +N+LL E
Sbjct: 119 -KGLTHGNVCAKNVLLIRE 136
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 34/159 (21%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQ---------QEVRVLSKLQHP 397
K+G+G +G VYK + T+A+K + +LE + +E+ +L ++QH
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKI-------RLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 398 HLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAA---EIASGL 451
++V L + LV+EYL D +K + SP K+ I +I G+
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICR 489
+ HS +++H DLKPQN+L+D ++ K+ DFG+ R
Sbjct: 116 AYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLG 404
+G+GGFG C + + G+ A K L ++ G+ E +L K+ P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI---AAEIASGLCFLHSSKP 459
A LV + G L+ ++ + R+ +A+I G+ LHS
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERG----LEMERVIHYSAQITCGILHLHSMD- 115
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
IV+ D+KP+N+LLD + + ++ D G+ + L T G+ Y PE
Sbjct: 116 --IVYRDMKPENVLLDDQGNCRLSDLGL-------AVELKDGKTITQRAGTNGYMAPEIL 166
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ + D ++ G I +++ GR P
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 34/211 (16%)
Query: 349 KVGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQ--------QEVRVLSKLQHPH 398
+VGQGG+G V+ K + G VA+K M+ L F+ E +L+ +
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKR-----MKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 399 LVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 455
LV LL A E L EY+P G + L N +L +D AR AE+ + LH
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL----NNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
+H DLKP+N L+D+ K+ DFG+ + + + + GS Y
Sbjct: 119 ELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---------YANSVVGSPDYMA 166
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE R D +S G ++ + L G P
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
+G+G FG V + R A+K + ++ + E E VL+++ P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
+ PE LV ++ G L L R+ D +R A LC L + +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRF------DLSRARFYTAELLCALENLHKFNV 114
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
++ DLKP+NILLD + +CDFG+C+L +D ++ G+ Y PE
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDD------DKTNTFCGTPEYLAPELLLGH 168
Query: 523 VLTPKSDSYSFGLIILQLLTGRLP 546
T D ++ G+++ ++LTG P
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 49/203 (24%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 349 KVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G+G G C+ + G+ VA+K + Q + EV ++ QH ++V + +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 407 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
E W +V E+L G+L D + + + + A + + L LH+ + ++
Sbjct: 87 LVGDELW-VVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHA---QGVI 138
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 523
H D+K +ILL + K+ DFG C V+++ R + G+ + PE
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV------PRRKSLVGTPYWMAPELISRLP 192
Query: 524 LTPKSDSYSFGLIILQLLTGRLP 546
P+ D +S G+++++++ G P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 66/269 (24%), Positives = 118/269 (43%), Gaps = 26/269 (9%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHP 397
NF K+G+G F VY+ L G VA+K + ++ + + + +E+ +L +L HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 398 HLVTLLGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRA--RIAAEIASGLCF 453
+++ + E ++V E G L R+ + L ++ + ++ S L
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLS-RMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 513
+HS +++H D+KP N+ + + K+ D G+ R + T S G+ Y
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL------VGTPYY 172
Query: 514 ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS-CGKLSSI-LDPLAG 571
PE KSD +S G ++ ++ + P G+ S C K+ PL
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEQCDYPPLPS 230
Query: 572 DWPTFVARRLVDLGLQCCELYGRERPDIT 600
D + R+LV++ C +RPDIT
Sbjct: 231 DHYSEELRQLVNM---CINPDPEKRPDIT 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 66/277 (23%), Positives = 114/277 (41%), Gaps = 51/277 (18%)
Query: 350 VGQGGFGCVY---KGEMLGRTVAIKMLYSHNM---QGQLEFQQEVR--------VLSKLQ 395
+G G FGCVY K +A+K + HN + + E + + + +L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 396 HPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLF----RKSNVSP-LLWKDRARIAAEIA 448
HP++V E L V + + L + +K + +W I ++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN----IFVQMV 123
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 508
L +LH K ++IVH DL P NI+L + I DFG+ + ++ + T+
Sbjct: 124 LALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES-------KLTSVV 174
Query: 509 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP------VGLAGEVRRAVSCGKL 562
G+ Y+ PE + K+D ++FG I+ Q+ T + P + LA ++ AV
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV----- 229
Query: 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDI 599
+PL + + D+ C RPDI
Sbjct: 230 ---YEPLPEG---MYSEDVTDVITSCLTPDAEARPDI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLLG 404
VG+G FG V + + G A+K++ + Q F++E +LS P + L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 405 ACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A + + LV EY P G L L R + +D A+ AE+ + HS
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ---FDEDMAQFYLAELVLAI---HSVHQMG 122
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
VH D+KP+N+L+D K+ DFG +T + + P G+ Y PE T
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS-----KLPVGTPDYIAPEVLTT 177
Query: 522 ------GVLTPKSDSYSFGLIILQLLTGRLP 546
G + D +S G+I +++ GR P
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 59/221 (26%), Positives = 89/221 (40%), Gaps = 50/221 (22%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIK-MLYSHNMQGQLEFQQEVRVLSKLQH--PHLVTLLG 404
+G G G VYK G +A+K M + N + ++ V+ K H P++V G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK-SHDCPYIVKCYG 81
Query: 405 A---------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL- 454
C E S D+L ++ P+ ++ I L +L
Sbjct: 82 YFITDSDVFICMELMSTCL---------DKLLKRIQ-GPIPEDILGKMTVAIVKALHYLK 131
Query: 455 --HSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC-RLVTEDTLYLPSFHRSTAPKGSF 511
H ++H D+KP NILLD+ + K+CDFGI RLV T G
Sbjct: 132 EKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--------KTRSAGCA 178
Query: 512 PYADPEYHRTGVLTPK------SDSYSFGLIILQLLTGRLP 546
Y PE R P +D +S G+ +++L TG+ P
Sbjct: 179 AYMAPE--RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 350 VGQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLLG 404
+G+G FG V + + + A+K+L M + + F +E +++ P +V L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 405 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A + L V EY+P G L + L +V P W AR AE+ L +HS
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVN-LMSNYDV-PEKW---ARFYTAEVVLALDAIHSMG--- 162
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
+H D+KP N+LLD K+ DFG C + ++ + R G+ Y PE ++
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-----RCDTAVGTPDYISPEVLKS 217
Query: 522 ----GVLTPKSDSYSFGLIILQLLTGRLP 546
G + D +S G+ + ++L G P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 21/151 (13%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL--L 403
K+G+G + V+KG ++ VA+K + H +EV +L L+H ++VTL +
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 404 GACPEAWSLVYEYLPNGSLQ-----DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
++ +LV+EYL Q + NV L+ +I GL + H
Sbjct: 73 VHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLY--------QILRGLAYCHR-- 122
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICR 489
K++H DLKPQN+L++ K+ DFG+ R
Sbjct: 123 -RKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 7/110 (6%)
Query: 433 SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492
SPL +D + ++A G+ FL S K +H DL +NILL KICDFG+ R +
Sbjct: 169 SPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIY 225
Query: 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
+D P + R + + + PE V T +SD +SFG+++ ++ +
Sbjct: 226 KD----PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL--L 403
K+G+G + VYKG ++ VA+K + H +EV +L L+H ++VTL +
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 404 GACPEAWSLVYEYLPNGSLQ-----DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
++ +LV+EYL Q NV L+ ++ GL + H
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLF--------QLLRGLNYCHR-- 122
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICR 489
K++H DLKPQN+L++ K+ DFG+ R
Sbjct: 123 -RKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPH 398
F + ++G+G +G VY+ G VA+K + N + + +E+ +L L+HP+
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 399 LVTLL----GACPEAWSLVYEYLPN--GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLC 452
+V L G ++ LV EY SL D + +P + ++ GL
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLD-----NMPTPFSESQVKCLMLQLLRGLQ 122
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK-GSF 511
+LH I+H DLK N+LL + KI DFG+ R T LP+ + PK +
Sbjct: 123 YLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLAR-----TYGLPAKPMT--PKVVTL 172
Query: 512 PYADPEY------HRTGVLTPKSDSYSFGLIILQLLTGR 544
Y PE + T + D ++ G I+ +LL +
Sbjct: 173 WYRAPELLLGCTTYTTAI-----DMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 69/282 (24%), Positives = 120/282 (42%), Gaps = 31/282 (10%)
Query: 344 FSESFKVGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPH 398
F++ ++G G FG VY + VAIK + Q ++Q +EV+ L +++HP+
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 399 LVTLLGACPE---AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
+ G AW LV EY GS D L + + PL + A I GL +LH
Sbjct: 87 SIEYKGCYLREHTAW-LVMEYCL-GSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
S ++H D+K NILL K+ DFG + + ++ + + AP+ +
Sbjct: 143 S---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYW-MAPEVILAMDE 198
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPT 575
+Y K D +S G+ ++L + P+ + +S++ + PT
Sbjct: 199 GQY------DGKVDVWSLGITCIELAERKPPL---------FNMNAMSALYHIAQNESPT 243
Query: 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERP 617
+ D + ++ P P+ + L+ + V ERP
Sbjct: 244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKML-YSHNMQGQLE----FQQEVRVLSKLQHPHLVTL 402
+G+G FG VY GR +A+K + + + Q + + E+++L L+H +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 403 LGAC--PE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G PE S+ EY+P GS++D+L L R +I G+ +LHS+
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGVSYLHSNM 126
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
IVH D+K NIL DS + K+ DFG + + T+ + S + G+ + PE
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRI--QTICM-SGTGIKSVTGTPYWMSPEV 180
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
K+D +S ++++LT + P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 70/236 (29%), Positives = 99/236 (41%), Gaps = 38/236 (16%)
Query: 327 PESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF 384
P+ AE D FS+ ++G G FG VY + VAIK + Q ++
Sbjct: 2 PDVAELFFKDDPEKL--FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 385 Q---QEVRVLSKLQHPHLVTLLGACPE---AWSLVYEYLPNGSLQDRLFRKSNVSPLLWK 438
Q +EVR L KL+HP+ + G AW LV EY GS D L + + PL
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW-LVMEYCL-GSASDLL--EVHKKPLQEV 115
Query: 439 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498
+ A + GL +LHS ++H D+K NILL K+ DFG ++
Sbjct: 116 EIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------- 165
Query: 499 PSFHRSTAPKGSF---PY-ADPEY---HRTGVLTPKSDSYSFGLIILQLLTGRLPV 547
AP F PY PE G K D +S G+ ++L + P+
Sbjct: 166 -------APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 21/168 (12%)
Query: 346 ESFKV-GQGGFGCV--YKGEMLGRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHL 399
ES KV G+G FG V + + G A+K L M + Q+ + E +L++ +P +
Sbjct: 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWV 63
Query: 400 VTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
V L + L+ EYLP G + L +K + ++ R IA + + S
Sbjct: 64 VKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFT----EEETRFY--IAETILAIDSI 117
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505
+H D+KP N+LLD++ K+ DFG+C L HR+
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT-------GLKKSHRTE 158
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 12/158 (7%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
++G G +G VYK + G AIK++ + QQE+ ++ +H ++V G+
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 407 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
+ W + E+ GSLQD ++ + PL A ++ E GL +LHS +
Sbjct: 76 LRRDKLW-ICMEFCGGGSLQD-IYHVT--GPLSESQIAYVSRETLQGLYYLHSKGK---M 128
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501
H D+K NILL K+ DFG+ +T SF
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 22/162 (13%)
Query: 396 HPHLVTLLGACPEAWS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGL 451
HP LV L +C + S V E++ G L + R+ L ++ AR +AEI+ L
Sbjct: 55 HPFLVGL-HSCFQTESRLFFVIEFVSGGDLMFHMQRQRK----LPEEHARFYSAEISLAL 109
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDTLYLPSFHRSTAPKG 509
FLH I++ DLK N+LLD+E K+ D+G+C+ + DT ++ G
Sbjct: 110 NFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--------TSTFCG 158
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 551
+ Y PE R D ++ G+++ +++ GR P + G
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 35/110 (31%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 433 SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492
PL +D + ++A G+ FL S K +H DL +NILL KICDFG+ R +
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
+D P + R + + PE V T +SD +SFG+++ ++ +
Sbjct: 225 KD----PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 64/243 (26%), Positives = 105/243 (43%), Gaps = 27/243 (11%)
Query: 315 NYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCV--YKGEMLGRTVAIKM 372
N D F+ E + + LQ ++ +G+G FG V + + + A+K+
Sbjct: 20 NIDNFLNRYEKIVRK----IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKL 75
Query: 373 LYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLF 427
L M + + F +E +++ P +V L A + L V EY+P G L + L
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LM 134
Query: 428 RKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487
+V P W AE+ L +HS ++H D+KP N+LLD K+ DFG
Sbjct: 135 SNYDV-PEKWAKF--YTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT 188
Query: 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT----GVLTPKSDSYSFGLIILQLLTG 543
C + E + TA G+ Y PE ++ G + D +S G+ + ++L G
Sbjct: 189 CMKMDETGM----VRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
Query: 544 RLP 546
P
Sbjct: 244 DTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 4e-08
Identities = 48/154 (31%), Positives = 82/154 (53%), Gaps = 24/154 (15%)
Query: 349 KVGQGGFGCVYKG-EML-GRTVAIKML-YSHNMQG-QLEFQQEVRVLSKLQHPHLVTL-- 402
++ +G +G VY+ + G VA+K L +G + +E+ +L KLQHP++VT+
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 403 --LGACPEAWSLVYEYLPNG--SLQDRL---FRKSNVSPLLWKDRARIAAEIASGLCFLH 455
+G+ + +V EY+ + SL + + F +S V L+ ++ SG+ LH
Sbjct: 72 VVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM--------LQLLSGVAHLH 123
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+ I+H DLK N+LL++ KICDFG+ R
Sbjct: 124 DN---WILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 67/230 (29%), Positives = 96/230 (41%), Gaps = 74/230 (32%)
Query: 350 VGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQ---------QEVRVLSKLQHPH 398
VG G +G V GR VAIK L FQ +E+R+L + H +
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSR-------PFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 399 LVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSN-VSPLLWKDRARIAA------------ 445
++ LL + P SL+D F+ V+ L+ D I
Sbjct: 76 VIGLLDV----------FTPASSLED--FQDVYLVTHLMGADLNNIVKCQKLSDDHIQFL 123
Query: 446 --EIASGLCFLHSSKPEKIVHGDLKPQNILL--DSELSSKICDFGICRLVTEDTLYLPSF 501
+I GL ++HS+ I+H DLKP NI + D EL KI DFG+ R T+D +
Sbjct: 124 VYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCEL--KILDFGLARH-TDDEM----- 172
Query: 502 HRSTAPKGSFPYADPE-------YHRTGVLTPKSDSYSFGLIILQLLTGR 544
T + Y PE Y++T D +S G I+ +LLTG+
Sbjct: 173 ---TGYVATRWYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 22/209 (10%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLLG 404
+G+G FG V K + R A+K+L M + E F++E VL + TL
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 405 ACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
A + LV +Y G L L + + P +D AR IA + +HS
Sbjct: 69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLP---EDMARFY--IAEMVLAIHSIHQLHY 123
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT- 521
VH D+KP N+LLD ++ DFG C + +D +S+ G+ Y PE +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-----QSSVAVGTPDYISPEILQAM 178
Query: 522 ----GVLTPKSDSYSFGLIILQLLTGRLP 546
G P+ D +S G+ + ++L G P
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYS--HNMQGQLEFQQEVRVLSKLQHPHLV----T 401
+G+G +G C G VAIK + ++ +E+++L L+HP +V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 402 LLGACPEAWS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
+L + +V+E L L + +++P + ++ L ++H++
Sbjct: 68 MLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTP---EHHQFFLYQLLRALKYIHTAN 123
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED-------TLYLPS-FHRSTAPKGS 510
+ H DLKP+NIL +++ KICDFG+ R+ D T Y+ + ++R+ GS
Sbjct: 124 ---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 511 FPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
F TP D +S G I ++LTG+
Sbjct: 181 F---------FSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 41/152 (26%), Positives = 74/152 (48%), Gaps = 9/152 (5%)
Query: 343 NFSESFKVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQ-QEVRVLSKLQHPHL 399
NF + K+G+G + VYKG G VA+K ++ +G +E+ ++ +L+H ++
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 400 VTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
V L LV+EY+ + L+ + L ++ G+ F H +
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+ ++H DLKPQN+L++ K+ DFG+ R
Sbjct: 120 R---VLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 85/319 (26%), Positives = 125/319 (39%), Gaps = 62/319 (19%)
Query: 321 GLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVY--KGEMLGRTVAIKMLYSHNM 378
G+V+D PE A+ D F ++G G FG VY VA+K +
Sbjct: 3 GVVKD-PEIADLFYKDDPEEI--FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK 59
Query: 379 QGQLEFQ---QEVRVLSKLQHPHLVTLLGACPE---AWSLVYEYLPNGSLQDRLFRKSNV 432
Q ++Q +EV+ L +L+HP+ + G + AW LV EY GS D L + +
Sbjct: 60 QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW-LVMEYCL-GSASDLL--EVHK 115
Query: 433 SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492
PL + A I GL +LHS ++H D+K NILL K+ DFG +
Sbjct: 116 KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS 172
Query: 493 EDTLYLPSFHRSTAPKGSF---PY-ADPEY---HRTGVLTPKSDSYSFGLIILQLLTGRL 545
P SF PY PE G K D +S G+ ++L +
Sbjct: 173 --------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 218
Query: 546 PVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA-------RRLVDLGLQCCELYGRERPD 598
P+ + +S++ D PT + R VD LQ + P
Sbjct: 219 PL---------FNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQ-------KIPQ 262
Query: 599 ITPSLVKELEQLHVAEERP 617
P+ + L V +RP
Sbjct: 263 ERPASAELLRHDFVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 22/162 (13%)
Query: 396 HPHLVTLLGACPEAWS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGL 451
HP LV L +C + S V EY+ G L + R+ L ++ AR +AEI+ L
Sbjct: 55 HPFLVGL-HSCFQTESRLFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLAL 109
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDTLYLPSFHRSTAPKG 509
+LH I++ DLK N+LLDSE K+ D+G+C+ L DT ++ G
Sbjct: 110 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--------TSTFCG 158
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 551
+ Y PE R D ++ G+++ +++ GR P + G
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 67/281 (23%), Positives = 124/281 (44%), Gaps = 38/281 (13%)
Query: 350 VGQGGFGCVYKGEMLGR----TVAIK-MLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLL 403
+G+G FG V +G++ VA+K M + + ++E F E + + HP+++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 404 GACPE--------AWSLVYEYLPNGSLQD-RLFRKSNVSPLLWKDR--ARIAAEIASGLC 452
G C + + ++ ++ +G L L+ + P + + +IASG+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 512
+L S + +H DL +N +L+ ++ + DFG+ + + Y + K
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY----RQGRIAKMPVK 179
Query: 513 YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPV-GLA-GEVRRAVSCG-KLSSILDP 568
+ E V T KSD +SFG+ + ++ T G+ P G+ E+ + G +L D
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDC 239
Query: 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609
L G L L C L ++RP +L ELE+
Sbjct: 240 LDG---------LYSLMSSCWLLNPKDRPSFE-TLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYS--HNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 405
+G G FG V+ G+ VA+K + + N+ +E+++L +H ++++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 406 CPEAWSLVYE--YLPNGSLQDRLFRKSNVSPL-LWKDRARI-AAEIASGLCFLHSSKPEK 461
+E Y+ +Q L K VSP L D ++ +I GL +LHS+
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDL-HKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--- 123
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY--- 518
I+H D+KP N+L++S KICDFG+ R+ D S H T + Y PE
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD----ESKHM-TQEVVTQYYRAPEILMG 178
Query: 519 --HRTGVLTPKSDSYSFGLIILQLLTGRL 545
H T + D +S G I +LL R+
Sbjct: 179 SRHYTSAV----DIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 13/147 (8%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVTL--L 403
K+G+G + VYKG+ + G+ VA+K++ +G +E +L L+H ++V L +
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 404 GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA-EIASGLCFLHSSKPEKI 462
E +LV+EY+ Q + P + ++ ++ GL ++H I
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPGGLHP----ENVKLFLFQLLRGLSYIHQ---RYI 124
Query: 463 VHGDLKPQNILLDSELSSKICDFGICR 489
+H DLKPQN+L+ K+ DFG+ R
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 27/209 (12%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQH---PHLVT 401
+G+GGFG VY + G+ A+K L + QG+ E +LS + P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 402 LLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
+ A P+ + + + G L L + S K+ A EI GL +H+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSE---KEMRFYATEIILGLEHMHN--- 115
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGI-CRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
+V+ DLKP NILLD +I D G+ C S + A G+ Y PE
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDF---------SKKKPHASVGTHGYMAPEV 166
Query: 519 HRTGVLTPKS-DSYSFGLIILQLLTGRLP 546
+ G S D +S G ++ +LL G P
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 46/207 (22%), Positives = 80/207 (38%), Gaps = 19/207 (9%)
Query: 351 GQGGFGCVYKGEMLGRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 408
+ K + VA+K L S + + QQE+ +LQHP+++ + +
Sbjct: 11 EDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV 70
Query: 409 AWSL--VYEYLPNGSLQDRLFR--KSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
L V + GS +D L + L A I ++ + L ++HS + +H
Sbjct: 71 DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI---AFILKDVLNALDYIHS---KGFIH 124
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS---FPYADPEYHRT 521
+K +ILL + + + + H PK S P+ PE +
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF--PKSSVKNLPWLSPEVLQQ 182
Query: 522 GVL--TPKSDSYSFGLIILQLLTGRLP 546
+ KSD YS G+ +L G +P
Sbjct: 183 NLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 18/153 (11%)
Query: 352 QGGFGCVYKGEMLG------RTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLG 404
+G FG ++ G ++ V +K + H + Q+ QE +L L H +++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 405 AC---PEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
C E ++Y Y+ G+L Q RL +N L + +A +IA G+ +LH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
++H D+ +N ++D EL KI D + R
Sbjct: 136 ---RGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 45/209 (21%), Positives = 85/209 (40%), Gaps = 43/209 (20%)
Query: 358 VYKGEMLGRTVAIKML--YSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLG-------ACP 407
+YKG + V I+ + + ++ + E++ L ++ +++ + G P
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 408 EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS--SKPEKIVHG 465
SL+ EY G L++ L ++ + L +K + +A + GL L+ +KP +
Sbjct: 96 RL-SLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP----YK 147
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP--------E 517
+L + L+ KI G+ E L P F Y E
Sbjct: 148 NLTSVSFLVTENYKLKIICHGL-----EKILSSPPFKNVNF----MVYFSYKMLNDIFSE 198
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y T K D YS G+++ ++ TG++P
Sbjct: 199 Y------TIKDDIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 346 ESFKV-GQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHL 399
E KV G+G FG V K + G+ A+K+L M + E F++E VL +
Sbjct: 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWI 63
Query: 400 VTLLGACP--EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
L A LV +Y G L L + + P +D AR +A + + S
Sbjct: 64 TNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP---EDMARFY--LAEMVLAIDSV 118
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGIC-RLVTEDTLYLPSFHRSTAPKGSFPYADP 516
VH D+KP N+LLD ++ DFG C RL+ + T+ +S G+ Y P
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV------QSNVAVGTPDYISP 172
Query: 517 EYHR-----TGVLTPKSDSYSFGLIILQLLTGRLP 546
E + G P+ D +S G+ + ++L G P
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQH---PHLVT 401
+G+GGFG VY + G+ A+K L + QG+ E +LS + P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 402 LLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
+ A P+ S + + + G L L + S + AAEI GL +H+
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE---AEMRFYAAEIILGLEHMHN--- 115
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGI-CRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
+V+ DLKP NILLD +I D G+ C S + A G+ Y PE
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDF---------SKKKPHASVGTHGYMAPEV 166
Query: 519 HRTGVLTPKS-DSYSFGLIILQLLTGRLP 546
+ GV S D +S G ++ +LL G P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 48/209 (22%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 348 FKVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 405
K+G+G G C+ + G+ VA+K + Q + EV ++ H ++V + +
Sbjct: 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 406 C---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
E W +V E+L G+L D + + + + A + + L +LH+ + +
Sbjct: 88 YLVGDELW-VVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHN---QGV 139
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
+H D+K +ILL S+ K+ DFG C V+++ PK P +
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-----------PKRKSLVGTPYWMAPE 188
Query: 523 VLT-----PKSDSYSFGLIILQLLTGRLP 546
V++ + D +S G+++++++ G P
Sbjct: 189 VISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 44/146 (30%), Positives = 75/146 (51%), Gaps = 11/146 (7%)
Query: 350 VGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
+G+GGFG V +M G+ A K L ++ + ++ E R+L+K+ +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A LV + G L+ ++ +P + RA A+I SGL LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RR 117
Query: 462 IVHGDLKPQNILLDSELSSKICDFGI 487
I++ DLKP+N+LLD++ + +I D G+
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGL 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 22/209 (10%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLLG 404
+G+G FG V K + + A+K+L M + E F++E VL + + TL
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 405 ACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
A + LV +Y G L L + + P +D AR +A + + S
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP---EDMARFY--LAEMVIAIDSVHQLHY 123
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT- 521
VH D+KP NIL+D ++ DFG C + ED +S+ G+ Y PE +
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-----QSSVAVGTPDYISPEILQAM 178
Query: 522 ----GVLTPKSDSYSFGLIILQLLTGRLP 546
G P+ D +S G+ + ++L G P
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 35/167 (20%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQE------VRVLSKLQ----H 396
K+G+G +G VYK G+ VA+K + +LE +E +R +S LQ
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALK-------KTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 397 PHLVTLL--------GACPEAWSLVYEYLPNG--SLQDRLFRKSNVSPLLWKDRARIAAE 446
++V LL P + LV+EYL + D + PL K +
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLY-LVFEYLDSDLKKFMDS-NGRGPGRPLPAKTIKSFMYQ 118
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVT 492
+ G+ H ++H DLKPQN+L+D + KI D G+ R +
Sbjct: 119 LLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS 162
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 434 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493
L +D + ++A G+ FL S K +H DL +NILL KICDFG+ R + +
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
D P + R + + PE V T +SD +SFG+++ ++ +
Sbjct: 232 D----PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 55/225 (24%), Positives = 102/225 (45%), Gaps = 51/225 (22%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
+G G G V+ + VA+K + + Q +E++++ +L H ++V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66
Query: 408 EAWSLVYEYL-PNGS-LQDRLFRKSNVSPL-------------------LWKDRARI-AA 445
VYE L P+GS L + + + ++ + L ++ AR+
Sbjct: 67 -----VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMY 121
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRS 504
++ GL ++HS+ ++H DLKP N+ +++E L KI DFG+ R+V D Y + S
Sbjct: 122 QLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIV--DPHYSHKGYLS 176
Query: 505 TAPKGSFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGR 544
+ Y P +L+P + D ++ G I ++LTG+
Sbjct: 177 EGLVTKW-YRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 35/158 (22%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPHLVTL-- 402
K+G+G + VYKG ++ G+ VA+K + + +G F +E +L L+H ++VTL
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHD 70
Query: 403 LGACPEAWSLVYEYL-----------PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 451
+ + +LV+EYL G NV L+ ++ GL
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGG------LSMHNVRLFLF--------QLLRGL 116
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+ H +++H DLKPQN+L+ K+ DFG+ R
Sbjct: 117 AYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 32/147 (21%), Positives = 56/147 (38%), Gaps = 18/147 (12%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH-----PHLVTLL 403
+ G VY +K+ + + + + ++EV +L L P ++
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYVLKI--NPSREKGADREREVAILQLLARKGLPVPKVLASG 62
Query: 404 GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
+ ++ L+ E++ +L VS +D A AE+ L LH +
Sbjct: 63 ESDGWSY-LLMEWIEGETL-------DEVSEEEKEDIAEQLAEL---LAKLHQLPLLVLC 111
Query: 464 HGDLKPQNILLDSELSSKICDFGICRL 490
HGDL P NIL+D I D+
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 350 VGQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLE--FQQEVRVLSKLQHPHLVTLLGA 405
VG+G +G V + G+ IK L N + +QE ++LS+L+HP++V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY--- 64
Query: 406 CPEAWS-------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRA-RIAAEIASGLCFLHSS 457
E+W +V + G L +L K LL +++ +IA L +LH
Sbjct: 65 -RESWEGEDGLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQVVEWFVQIAMALQYLHE- 120
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
+ I+H DLK QN+ L K+ D GI R++ ++ G+ Y PE
Sbjct: 121 --KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN------QCDMASTLIGTPYYMSPE 172
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT 542
KSD ++ G + ++ T
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 349 KVGQGGFGCVY--KGEMLGRTVAIKMLYS-----HNMQGQLEFQQEVRVLSKLQHPHLVT 401
++G+G FG VY K + +K+L N ++ QE ++LSKL HP +V
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 402 LLGACPE--AWSLVYEYLPNGSLQDRLFR-KSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
+ E A+ ++ EY L +L K L ++ G+ ++H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-- 124
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
+I+H DLK +NI L + L KI DFG+ RL+ + S +T G+ Y PE
Sbjct: 125 -RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL------MGSCDLATTFTGTPYYMSPEA 176
Query: 519 HRTGVLTPKSDSYSFGLIILQL 540
+ KSD +S G I+ ++
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 26/160 (16%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKML--YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
+G+G +G V G VAIK + + H Q + E+++L + +H +++ +L
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHENIIGILD 70
Query: 405 ACP----EAWSLVY---EYLPNGSLQD--RLFRKSNVSPLLWKDRAR-IAAEIASGLCFL 454
E+++ VY E + D +L + ++S D + +I GL ++
Sbjct: 71 IIRPPSFESFNDVYIVQELMET----DLYKLIKTQHLS----NDHIQYFLYQILRGLKYI 122
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494
HS+ ++H DLKP N+LL++ KICDFG+ R+ +
Sbjct: 123 HSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 32/271 (11%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHP 397
NF K+G+G F VY+ L + VA+K + M Q +E+ +L +L HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 398 HLVTLLGACPE--AWSLVYEYLPNGSLQDRLF---RKSNVSP--LLWKDRARIAAEIASG 450
+++ L + E ++V E G L + ++ + P +WK ++ S
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWK----YFVQLCSA 118
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS 510
+ +HS +++H D+KP N+ + + K+ D G+ R + T S G+
Sbjct: 119 VEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL------VGT 169
Query: 511 FPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS-CGKLSSI-LDP 568
Y PE KSD +S G ++ ++ + P G+ S C K+ P
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLFSLCQKIEQCDYPP 227
Query: 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDI 599
L + + R LV + C +RPDI
Sbjct: 228 LPTEHYSEKLRELVSM---CIYPDPDQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 21/168 (12%)
Query: 385 QQEVRVLSKLQHPHLVTLLGACPEAWS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDRA 441
Q E V + + L +C + S LV EY+ G L + R+ L ++ A
Sbjct: 43 QTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK----LPEEHA 98
Query: 442 RI-AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDTLYL 498
R AAEI L FLH I++ DLK N+LLD++ K+ D+G+C+ L DT
Sbjct: 99 RFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--- 152
Query: 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
++ G+ Y PE R D ++ G+++ +++ GR P
Sbjct: 153 -----TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 40/144 (27%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
++G G FG VYK + G A K++ + + + ++ E+ +L+ HP++V LL A
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 407 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
W L+ E+ G++ + PL + + L +LH +K I+
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVMLELER--PLTEPQIRVVCKQTLEALNYLHENK---II 125
Query: 464 HGDLKPQNILLDSELSSKICDFGI 487
H DLK NIL + K+ DFG+
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGV 149
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 16/133 (12%)
Query: 415 EYLPNGSLQDRLFRKSNVSPLL-WKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNIL 473
+YLP+ + R N SP L + D + ++A+G+ FL S + VH DL +N+L
Sbjct: 215 QYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVL 271
Query: 474 LDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS----FPYADPEYHRTGVLTPKSD 529
+ KICDFG+ R + D+ Y+ KGS + PE + T SD
Sbjct: 272 ICEGKLVKICDFGLARDIMRDSNYI--------SKGSTFLPLKWMAPESIFNNLYTTLSD 323
Query: 530 SYSFGLIILQLLT 542
+SFG+++ ++ T
Sbjct: 324 VWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 49/201 (24%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 350 VGQGGFGCVYKG--EMLGRT---VAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
+G G FG + +G ++ + VAI L + + + F E L + H ++V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 404 GACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
G ++ V EY+ NG+L D RK L+ + +ASG+ +L
Sbjct: 73 GVITRGNTMMIVTEYMSNGAL-DSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG--- 127
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
VH L +L++S+L KI F + + +Y +S +A PE +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-----WAAPEAIQY 182
Query: 522 GVLTPKSDSYSFGLIILQLLT 542
+ SD +SFG+++ ++++
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 35/212 (16%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKML----YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
VG+G FG + + + A+K + S ++ ++E +L+K++HP++V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS---RKEAVLLAKMKHPNIVAFK 64
Query: 404 GACPEAWSL--VYEYLPNGSL-------QDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
+ L V EY G L + +LF + + L W ++ G+ +
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI--LQW------FVQMCLGVQHI 116
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
H ++++H D+K +NI L K+ DFG RL+T Y ++ G+ Y
Sbjct: 117 HE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY------VGTPYYV 167
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE KSD +S G I+ +L T + P
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 13/147 (8%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPHLVTL-- 402
K+G+G + VYKG + G+ VA+K++ +G + F +E +L L+H ++V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHD 70
Query: 403 LGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
+ E + V+EY+ Q + + P + ++ GL ++H + I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPY---NVRLFMFQLLRGLAYIHG---QHI 124
Query: 463 VHGDLKPQNILLDSELSSKICDFGICR 489
+H DLKPQN+L+ K+ DFG+ R
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 50/234 (21%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM--QGQ-LEFQQEVRVLSKLQHPHLVTLLG 404
+G+G FG V+ + + G+ A+K+L +M + Q + E +L+ P +V L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY- 67
Query: 405 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 455
+S LV EY+P G L + L RK + AR AE+ L +H
Sbjct: 68 -----YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE----ETARFYIAELVLALDSVH 118
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGIC--------RLVTEDTLYLPSF------ 501
+H D+KP NIL+D++ K+ DFG+C R + + F
Sbjct: 119 K---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 502 ---------HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
R+ + G+ Y PE R + D +S G+I+ ++L G P
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 343 NFSESFKV-GQGGFGCVY-----KGEMLGRTVAIKMLYSHNMQGQLEFQQEVR----VLS 392
NF E KV G G +G V+ G G+ A+K+L + + + + R VL
Sbjct: 1 NF-ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 393 KL-QHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIAS 449
+ Q P LVTL A L+ +Y+ G L L ++ ++ + EI
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE---QEVQIYSGEIVL 116
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 509
L LH I++ D+K +NILLDS + DFG+ + ED + R+ + G
Sbjct: 117 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-----ERAYSFCG 168
Query: 510 SFPYADPEYHRTGVL--TPKSDSYSFGLIILQLLTGRLPVGLAGE 552
+ Y P+ R G D +S G+++ +LLTG P + GE
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 20/157 (12%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYS--HNMQGQLEFQQEVRVLSKLQHPHLVTL--- 402
+G+G +G C K VAIK + + N +E+++L L H +++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 403 -LGACPEAWS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSS 457
EA++ +VYE L + L ++ R S L D + ++ GL ++HS+
Sbjct: 73 MPPPHREAFNDVYIVYE-LMDTDLH-QIIRSSQT---LSDDHCQYFLYQLLRGLKYIHSA 127
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494
++H DLKP N+LL++ KICDFG+ R +E
Sbjct: 128 N---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 32/215 (14%)
Query: 344 FSESFKVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQL---EFQQEVRVLSKLQHPH 398
+ + +VG G +G C G VAIK LY Q +L +E+R+L ++H +
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 399 LVTLLGACPEAWSL-----VYEYLP-NGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGL 451
++ LL SL Y +P G+ +L + +S +DR + + ++ GL
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS----EDRIQFLVYQMLKGL 131
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV-TEDTLYLPS-FHRSTAPKG 509
++H++ I+H DLKP N+ ++ + KI DFG+ R +E T Y+ + ++R AP+
Sbjct: 132 KYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYR--APEV 186
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
+ Y +T D +S G I+ ++LTG+
Sbjct: 187 ILNWM--HYTQT------VDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 45/214 (21%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSH-NMQGQLEFQQEVRVLSKLQ-HPHLVTL-- 402
K+G+G F V K + G+ AIK + H Q+ +E++ L +L HP+++ L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 403 --LGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
+LV+E L + +L + K PL K ++ L +H +
Sbjct: 66 VLFDRKTGRLALVFE-LMDMNLYE--LIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG-- 120
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
I H D+KP+NIL+ ++ K+ DFG C R K PY EY
Sbjct: 121 -IFHRDIKPENILIKDDI-LKLADFGSC--------------RGIYSKP--PYT--EYIS 160
Query: 521 T------------GVLTPKSDSYSFGLIILQLLT 542
T G PK D ++ G + ++L+
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 49/216 (22%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 350 VGQGGFGCVYKGEM-----LGRTVAIKMLYSH-NMQGQLE-FQQEVRVLSKLQHPHLVTL 402
+G+G FG V + ++ + VA+KML + +E F +E + + HP+++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 403 LGACPEAWS--------LVYEYLPNGSLQDRLFRK---SNVSPLLWKDRARIAAEIASGL 451
+G + + ++ ++ +G L L L + R +IASG+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
+L S + +H DL +N +L+ ++ + DFG+ + + Y + A K
Sbjct: 127 EYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYY----RQGCASKLPV 179
Query: 512 PYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
+ E V T SD ++FG+ + +++T G+ P
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 49/144 (34%), Positives = 67/144 (46%), Gaps = 25/144 (17%)
Query: 347 SFKV----GQGGFGCVY----KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQ 395
FK G+G G V+ KG G+ A+K+L M + + ++ E +L+ L
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGT--GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59
Query: 396 HPHLVTLLG--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSP--LLWKDRARI-AAEIASG 450
HP L TL LV +Y P G L FR P L ++ AR AAE+
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGEL----FRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 451 LCFLHSSKPEKIVHGDLKPQNILL 474
L +LH IV+ DLKP+NILL
Sbjct: 116 LEYLHL---LGIVYRDLKPENILL 136
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 22/152 (14%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKML-YSHNMQGQLEFQ-QEVRVLSKLQHPHLVTLLG 404
K+G+G +G V+K VA+K + + +G +E+ +L +L+H ++V L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 405 A--CPEAWSLVYEYLPNGSLQD--RLFRKSNVSPLLWKDRARIAA---EIASGLCFLHSS 457
+ +LV+EY QD + F N D + + ++ GL F HS
Sbjct: 67 VLHSDKKLTLVFEYCD----QDLKKYFDSCNGDI----DPEIVKSFMFQLLKGLAFCHS- 117
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
++H DLKPQN+L++ K+ DFG+ R
Sbjct: 118 --HNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 34/114 (29%), Positives = 61/114 (53%), Gaps = 8/114 (7%)
Query: 434 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493
PL D R ++++A G+ FL S + +H D+ +N+LL +KICDFG+ R +
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
D+ Y+ + K + PE V T +SD +S+G+++ ++ + G+ P
Sbjct: 265 DSNYVVKGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 36/211 (17%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
VG G +G C G VA+K L S Q + ++ E+R+L ++H +++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83
Query: 405 ACPEAWSL-----VY--EYLPNGSLQD----RLFRKSNVSPLLWKDRARIAAEIASGLCF 453
A SL VY +L L + + +V L++ +I GL +
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY--------QILRGLKY 135
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 513
+HS+ I+H DLKP N+ ++ + KI DFG+ R ++ + AP+ +
Sbjct: 136 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 192
Query: 514 ADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
Y++T D +S G I+ +LLTGR
Sbjct: 193 M--HYNQT------VDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 350 VGQGGFGCVYK--GEMLGRTVAIKMLYS-HNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGA 405
+G+G +G V+K + G A+K+L H++ ++E E +L L HP++V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE--AEYNILKALSDHPNVVKFYGM 83
Query: 406 C--------PEAWSLVYEYLPNGSLQDR----LFRKSNVSPLLWKDRARIAAEIASGLCF 453
+ W LV E GS+ D L R + + A I E GL
Sbjct: 84 YYKKDVKNGDQLW-LVLELCNGGSVTDLVKGFLKRGERMEEPII---AYILHEALMGLQH 139
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 513
LH +K +H D+K NILL +E K+ DFG+ +T + R G+ +
Sbjct: 140 LHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS------TRLRRNTSVGTPFW 190
Query: 514 ADPEY-----HRTGVLTPKSDSYSFGLIILQLLTGRLPVG 548
PE + D +S G+ ++L G P+
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 42/166 (25%), Positives = 77/166 (46%), Gaps = 32/166 (19%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPHLVTLLGA 405
+G+G +G VYK + G VA+K + N + +E+++L +L H ++V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 406 C------------PEAWSLVYEYLPN---GSLQDRL--FRKSNVSPLLWKDRARIAAEIA 448
A+ LV+EY+ + G L+ L F + ++ + ++
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM--------KQLL 126
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494
GL + H + +H D+K NILL+++ K+ DFG+ RL +
Sbjct: 127 EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505
++A G+ FL S + +H DL +NILL +KICDFG+ R + D+ Y+ +
Sbjct: 222 QVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 506 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
K + PE V T +SD +S+G+++ ++ +
Sbjct: 279 PVK----WMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 47/166 (28%), Positives = 73/166 (43%), Gaps = 33/166 (19%)
Query: 351 GQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVR--VLSKL-QHPHLVTLLGACP 407
G G C + G+ VAIK L S Q ++ R VL KL H +++ LL
Sbjct: 27 GAQGIVCAAYDTVTGQNVAIKKL-SRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV-- 83
Query: 408 EAWSLVYEYLPNGSLQDRLFRK---------SNVSPLLWK--DRARIAAEIASGLC---F 453
+ P SL++ F+ +N+ ++ D R++ + LC
Sbjct: 84 --------FTPQKSLEE--FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKH 133
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499
LHS+ I+H DLKP NI++ S+ + KI DFG+ R + P
Sbjct: 134 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 176
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 7/112 (6%)
Query: 368 VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWS--LVYEYLPNGSLQDR 425
V +K+L + L F + ++ ++ H H+V L G C +V E++ G L
Sbjct: 35 VILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLF 94
Query: 426 LFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE 477
+ RKS+V WK ++A ++AS L +L + +VHG++ +NILL E
Sbjct: 95 MHRKSDVLTTPWK--FKVAKQLASALSYLED---KDLVHGNVCTKNILLARE 141
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 19/151 (12%)
Query: 350 VGQGGFGCVYKGE--MLGRTVAIKM-----LYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
+ +G FG VY G + A+K+ + + NM Q++ +++ LSK P +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK--SPFIVHL 69
Query: 403 LGACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKP 459
+ A + LV EYL G ++ L ++ ++ A +E+A L +LH
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLL----HIYGYFDEEMAVKYISEVALALDYLHR--- 122
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRL 490
I+H DLKP N+L+ +E K+ DFG+ ++
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 66/247 (26%), Positives = 107/247 (43%), Gaps = 37/247 (14%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVL---SKLQHPHLVT 401
+G+G FG VY + + R A+K+L + + E E +L + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 402 LLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSK 458
L + LV +Y+ G L L ++ S +DRA+ AE+ L LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS----EDRAKFYIAELVLALEHLHKYD 116
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
IV+ DLKP+NILLD+ +CDFG+ + D +F G+ Y PE
Sbjct: 117 ---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC------GTTEYLAPE- 166
Query: 519 HRTGVL------TPKSDSYSFGLIILQLLTGRLP--VGLAGEVRRAVSCGKLSSILDPLA 570
VL T D +S G+++ ++ G P ++ R ++ GK+ + L+
Sbjct: 167 ----VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLS 222
Query: 571 GDWPTFV 577
+ FV
Sbjct: 223 DEGRQFV 229
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 25/196 (12%)
Query: 342 CNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHN--------MQGQL-EFQQEVRVLS 392
F + +G G FG V L R V K LY+ ++ Q+ + E +L+
Sbjct: 1 SMFVKIKTLGIGAFGEV----CLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILA 56
Query: 393 KLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG 450
+ + +V L + + +L V +Y+P G + L R + +D AR IA
Sbjct: 57 EADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG----IFPEDLARFY--IAEL 110
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC---RLVTEDTLYLPSFH-RSTA 506
C + S +H D+KP NIL+D + K+ DFG+C R + Y H R +
Sbjct: 111 TCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170
Query: 507 PKGSFPYADPEYHRTG 522
S + DP R G
Sbjct: 171 MDFSNEWGDPANCRCG 186
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 350 VGQGGFGCV----YKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTL 402
+G G FG V YK E VAIK + Q + E ++L+ + HP V L
Sbjct: 38 LGTGSFGRVILATYKNEDF-PPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNL 96
Query: 403 LGACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKP 459
G+ + LV E++ G L R++ P D AA+I +L S
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFP---NDVGCFYAAQIVLIFEYLQSLN- 151
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
IV+ DLKP+N+LLD + K+ DFG ++V T L G+ Y PE
Sbjct: 152 --IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC---------GTPEYIAPEIL 200
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLP 546
+D ++ G+ I ++L G P
Sbjct: 201 LNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 19/44 (43%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+I GL ++HS+ ++H DLKP N+L++++ KICDFG+ R
Sbjct: 113 QILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 4e-05
Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 396 HPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCF 453
+P+ + L + + L+ +Y+ +G L D L ++ +S K +I ++ L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVK---KIIRQLVEALND 124
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 512
LH I+H D+K +N+L D +CD+G+C+ T PS + G+
Sbjct: 125 LHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIGT---PSCYD-----GTLD 171
Query: 513 YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y PE + D ++ G++ +LLTG+ P
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 35/133 (26%), Positives = 58/133 (43%), Gaps = 16/133 (12%)
Query: 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNIL 473
Y+ + + L L D ++A G+ FL S + VH DL +N+L
Sbjct: 214 YKGSNDSEV-KNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVL 269
Query: 474 LDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS----FPYADPEYHRTGVLTPKSD 529
L KICDFG+ R + D+ Y+ KGS + PE + T SD
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYV--------SKGSTFLPVKWMAPESIFDNLYTTLSD 321
Query: 530 SYSFGLIILQLLT 542
+S+G+++ ++ +
Sbjct: 322 VWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 20/154 (12%)
Query: 346 ESFKV-GQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLEFQQ------EVRVLSKLQH 396
ES KV G+G FG V + + G A+K+L +M LE +Q E +L +
Sbjct: 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM---LEKEQVGHIRAERDILVEADS 60
Query: 397 PHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
+V + + + +L + E+LP G + L +K ++ IA + +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT------EEETQFYIAETVLAI 114
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488
S +H D+KP N+LLDS+ K+ DFG+C
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLC 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 6e-05
Identities = 44/161 (27%), Positives = 70/161 (43%), Gaps = 23/161 (14%)
Query: 351 GQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVR--VLSK-LQHPHLVTLLGACP 407
G G C +L R VAIK L S Q Q ++ R VL K + H ++++LL
Sbjct: 28 GAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV-- 84
Query: 408 EAWSLVYEYLPNGSLQD-------RLFRKSNVSPLLWK--DRARIAAEIASGLCFLHSSK 458
+ P SL++ +N+ ++ D R++ + LC +
Sbjct: 85 --------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499
I+H DLKP NI++ S+ + KI DFG+ R + P
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 46/169 (27%)
Query: 350 VGQGGFGCVYK--GEMLGRTVAIKMLYSHNMQGQLEFQQ----EVRVLSKLQHPHLVTLL 403
VG+G +G V K + VAIK + + E ++ E+++L L+ ++V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLKQENIVEL- 65
Query: 404 GACPEAWS------LVYEY-----------LPNGSLQDRLFRKSNVSPLLWKDRARIAAE 446
EA+ LV+EY +PNG +++ R+ I
Sbjct: 66 ---KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV-------------RSYIYQL 109
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495
I + +H IVH D+KP+N+L+ K+CDFG R ++E +
Sbjct: 110 IKA----IHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 42/145 (28%), Positives = 64/145 (44%), Gaps = 23/145 (15%)
Query: 438 KDRARIA---AEIASGLCFL------HSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488
K RA+ E +GL F+ H + ++H D+K NILL S K+ DFG
Sbjct: 131 KSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190
Query: 489 RL----VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
++ V++D G+ Y PE R + K+D +S G+++ +LLT +
Sbjct: 191 KMYAATVSDDV--------GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242
Query: 545 LPVGLAGEVRRAVSCGKLSSILDPL 569
P GE V L+ DPL
Sbjct: 243 RP--FDGENMEEVMHKTLAGRYDPL 265
|
Length = 496 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 36/219 (16%)
Query: 345 SESFK----VGQGGFGCVYKGEMLGRT--VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH 398
++S+K +G G FG VY+ + + VAIK + +Q +E+ ++ L H +
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHIN 120
Query: 399 LVTL----LGACPEA------WSLVYEYLPNG--SLQDRLFRKSNVSPLLWKDRARIAAE 446
++ L C + ++V E++P R ++ PL + +
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL--YSYQ 178
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRST 505
+ L ++HS + I H DLKPQN+L+D + K+CDFG + L + RS
Sbjct: 179 LCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK-------NLLAGQRSV 228
Query: 506 APKGSFPYADPEYHRTGV-LTPKSDSYSFGLIILQLLTG 543
+ S Y PE T D +S G II +++ G
Sbjct: 229 SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 26/76 (34%), Positives = 38/76 (50%), Gaps = 6/76 (7%)
Query: 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNI 472
V +Y+P G + L R + +D AR IA C + S +H D+KP NI
Sbjct: 79 VMDYIPGGDMMSLLIRLG----IFEEDLARFY--IAELTCAIESVHKMGFIHRDIKPDNI 132
Query: 473 LLDSELSSKICDFGIC 488
L+D + K+ DFG+C
Sbjct: 133 LIDRDGHIKLTDFGLC 148
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 350 VGQGGFGCVY---KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLL 403
+ G +G VY E R A+K + N+ + + QQ E +L+ ++P +V++
Sbjct: 9 ISNGAYGAVYLVRHKETRQR-FAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMF 67
Query: 404 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIA-AEIASGLCFLHSSKPE 460
+ +V EY+ G L N+ L D AR+ AE L +LH+
Sbjct: 68 CSFETKRHLCMVMEYVEGGDCATLL---KNIGALP-VDMARMYFAETVLALEYLHNYG-- 121
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDT-LYLPSFHRSTAP------KGSF 511
IVH DLKP N+L+ S K+ DFG+ + L++ T LY + T G+
Sbjct: 122 -IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180
Query: 512 PYADPEY-HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y PE R G P D ++ G+I+ + L G +P
Sbjct: 181 EYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 44/202 (21%)
Query: 368 VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC---PEAWSLVYEYLPNGSLQD 424
V +K+L + L F + ++S++ H HL + G C E +V E++ +G L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSEN-IMVEEFVEHGPLDV 105
Query: 425 RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICD 484
L ++ P+ WK +A ++AS L +L + +VHG++ +NILL
Sbjct: 106 CLRKEKGRVPVAWK--ITVAQQLASALSYLED---KNLVHGNVCAKNILLARL------- 153
Query: 485 FGICRLVTEDTLYLPSFHRSTAPKGSF------------PYADPEYHRTGV-LTPKSDSY 531
G+ E T F + + P SF P+ PE G L+ +D +
Sbjct: 154 -GLA----EGTS---PFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKW 205
Query: 532 SFGLIILQL-------LTGRLP 546
SFG +L++ L R P
Sbjct: 206 SFGTTLLEICFDGEVPLKERTP 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 20/154 (12%)
Query: 346 ESFKV-GQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLEFQQ------EVRVLSKLQH 396
ES KV G+G FG V + + G A+K+L +M LE +Q E +L +
Sbjct: 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM---LEKEQVAHIRAERDILVEADG 60
Query: 397 PHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
+V + + + +L + E+LP G + L +K +S IA + +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS------EEATQFYIAETVLAI 114
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488
+ +H D+KP N+LLD++ K+ DFG+C
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLC 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 28/135 (20%), Positives = 56/135 (41%), Gaps = 2/135 (1%)
Query: 175 KAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRK-EAEDALQTTIQDQE 233
+ EEL+ ++L +E E K++ E+ E + L +
Sbjct: 240 ELEELQEELKEAEEELEELTAELQELEEKLEELRLEV-SELEEEIEELQKELYALANEIS 298
Query: 234 KLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRR 293
+L+Q+K + + L R + L ++ +E + DE EL ++ + L++E + +
Sbjct: 299 RLEQQKQILRERLANLERQLEELEAQLEELESKLDELAEELAELEEKLEELKEELESLEA 358
Query: 294 QKVEAVRWLERWRSR 308
+ E LE SR
Sbjct: 359 ELEELEAELEELESR 373
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 45/215 (20%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQL---EFQQEVRVLSKLQHPHLVTLLG 404
VG G +G C + G VAIK L S Q ++ +E+ +L +QH +++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 405 ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA-------------EIASGL 451
A S QD V P + D +I ++ GL
Sbjct: 82 VFTSAVSG-------DEFQDFYL----VMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV-TEDTLYLPS-FHRSTAPKG 509
++HS+ I+H DLKP N+ ++ + KI DFG+ R E T Y+ + ++R AP+
Sbjct: 131 KYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYR--APEV 185
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
+ Y++T D +S G I+ ++LTG+
Sbjct: 186 ILNWM--HYNQT------VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 23/151 (15%)
Query: 351 GQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVR--VLSK-LQHPHLVTLLGACP 407
G G C +L R VAIK L S Q Q ++ R VL K + H +++ LL
Sbjct: 35 GAQGIVCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV-- 91
Query: 408 EAWSLVYEYLPNGSLQD-------RLFRKSNVSPLLWK--DRARIAAEIASGLCFLHSSK 458
+ P SL++ +N+ ++ D R++ + LC +
Sbjct: 92 --------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICR 489
I+H DLKP NI++ S+ + KI DFG+ R
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 32/217 (14%)
Query: 350 VGQGGFGCVYK--GEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGAC 406
+G+G +G VYK + G A+K+L + + E + E +L L HP++V G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 407 PEA--------WSLVYEYLPNGSLQDRLFRKSNVSPLLWK----DRARIAAEIASGLCFL 454
+A W LV E GS+ + V LL D A I+ + L L
Sbjct: 89 YKADKLVGGQLW-LVLELCNGGSVTEL------VKGLLICGQRLDEAMISYILYGALLGL 141
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
+I+H D+K NILL +E K+ DFG+ +T L R+T+ F A
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-----RRNTSVGTPFWMA 196
Query: 515 DP----EYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 547
E + D +S G+ ++L G P+
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 23/161 (14%)
Query: 351 GQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ---HPHLVTLLGACP 407
G G C +LG VA+K L S Q Q ++ R L L+ H ++++LL
Sbjct: 32 GAQGIVCAAFDTVLGINVAVKKL-SRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV-- 88
Query: 408 EAWSLVYEYLPNGSLQD-------RLFRKSNVSPLLWK--DRARIAAEIASGLCFLHSSK 458
+ P SL++ +N+ ++ D R++ + LC +
Sbjct: 89 --------FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 140
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499
I+H DLKP NI++ S+ + KI DFG+ R + + P
Sbjct: 141 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP 181
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 16/46 (34%), Positives = 30/46 (65%), Gaps = 3/46 (6%)
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491
++ GL ++HS+ ++H DLKP N+L++ + +I DFG+ R +
Sbjct: 115 QLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 5e-04
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 45/205 (21%)
Query: 387 EVRVLSKLQHPHLVT----LLGACPEAWSLVYEYLPNGSLQD------RLFRKSNVSPLL 436
EV V+ +L+H ++V L + ++ E+ G L ++F K ++
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 437 WKDRARIAAEIASGLCFLHSSKP----EKIVHGDLKPQNILLDSELS------------- 479
I ++ L + H+ K E+++H DLKPQNI L + +
Sbjct: 122 -----DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176
Query: 480 ----SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE--YHRTGVLTPKSDSYSF 533
+KI DFG+ + + +++ + + G+ Y PE H T KSD ++
Sbjct: 177 GRPIAKIGDFGLSKNIGIESM-------AHSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229
Query: 534 GLIILQLLTGRLPVGLAGEVRRAVS 558
G II +L +G+ P A + +S
Sbjct: 230 GCIIYELCSGKTPFHKANNFSQLIS 254
|
Length = 1021 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 46/221 (20%), Positives = 89/221 (40%), Gaps = 32/221 (14%)
Query: 350 VGQGGFGCVYK-----GEMLGRTVAIKMLYSHNMQGQLEF-----QQEVRVLSKLQHPHL 399
+G GGFGCVY+ + K+ N +E ++ ++ ++ H
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHN 79
Query: 400 VTLLGACPEAW--------SLVYEYLPNGSLQDRLFRKSN--VSPLLWKDR---ARIAAE 446
+ LG P+ + + Y ++ L ++L + + K++ I +
Sbjct: 80 IDHLG-IPKYYGCGSFKRCRMYYRFI----LLEKLVENTKEIFKRIKCKNKKLIKNIMKD 134
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 506
+ + L ++H I HGD+KP+NI++D I D+GI ++
Sbjct: 135 MLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKD 191
Query: 507 -PKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+G+ YA + H +T + D S G +L+ +LP
Sbjct: 192 LHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 15/153 (9%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQL-EFQQEVRVLSKLQHP 397
+F +G+G FG V + G+ A+K L M + QL + E VL++ P
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 398 HLVTLLGACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFL 454
+V+L + +A L+ E+LP G L L + S +D R AE + +
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFS----EDVTRFYMAECVLAIEAV 117
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487
H +H D+KP NIL+D K+ DFG+
Sbjct: 118 HKLG---FIHRDIKPDNILIDRGGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-04
Identities = 35/173 (20%), Positives = 73/173 (42%), Gaps = 16/173 (9%)
Query: 148 SEKRESTDSDSKVEEDPLYVQHREVSIKA--EELRNSAFAEFLRRKKLESEAMEAIGKVK 205
E E + ++EE+ ++ +K EEL A ++LE E EA ++
Sbjct: 751 EELEELQERLEELEEELESLEEALAKLKEEIEELEEKRQALQEELEELEEELEEAERRLD 810
Query: 206 AFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQEANR 265
A E R+ E ++ ++ E+L+++ + +EL + + L +E
Sbjct: 811 ALERELESLEQRRERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEA 870
Query: 266 R--------------RDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLER 304
++E EL+ +++ +A L++E +++R + E LER
Sbjct: 871 EKEELEDELKELEEEKEELEEELRELESELAELKEEIEKLRERLEELEAKLER 923
|
Length = 1163 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 346 ESFKVGQGGFGCVYKGEMLG----RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
E KVG+G +G VYK + R A+K + + + +E+ +L +L+HP++++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVIS 62
Query: 402 LLG-----ACPEAWSLVYEYLPNGSLQDRLFR---KSNVSPLLWKDRARIAA---EIASG 450
L A + W L+++Y + F K+N P+ R + + +I G
Sbjct: 63 LQKVFLSHADRKVW-LLFDYAEHDLWHIIKFHRASKANKKPVQLP-RGMVKSLLYQILDG 120
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFHRSTA 506
+ +LH++ ++H DLKP NIL+ E KI D G RL L
Sbjct: 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 507 PKGSFPYADPEY-----HRTGVLTPKSDSYSFGLIILQLLT 542
+F Y PE H T + D ++ G I +LLT
Sbjct: 178 ---TFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 34/157 (21%), Positives = 62/157 (39%), Gaps = 15/157 (9%)
Query: 387 EVRVLSKLQHPHLVTLLG--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIA 444
E +L + HP ++ + +V LP+ S + PL I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 445 AEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRS 504
+I GL +LH+ ++I+H D+K +NI ++ I D G + +L
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL------ 214
Query: 505 TAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLL 541
G+ PE K+D +S G+++ ++L
Sbjct: 215 -GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 43/150 (28%), Positives = 61/150 (40%), Gaps = 17/150 (11%)
Query: 397 PHLVTLLG--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
P++V L ++ LV ++ G L + + N+ K R AAE+ L L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK---RWAAEMVVALDAL 101
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
H E IV DL P NILLD ++ F V ED+ + Y
Sbjct: 102 HR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEV-EDSCDGEAVENM--------YC 149
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
PE T D +S G I+ +LLTG+
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 64/247 (25%), Positives = 87/247 (35%), Gaps = 68/247 (27%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIK---MLYSHNMQGQLEFQQEVRV-------LSKLQHPH 398
K+G+G FG VYK ++ + + +L G +E RV + +
Sbjct: 139 KLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGF 198
Query: 399 LVTLLG-ACPEAWSLVYEYLPNGSLQDRLFRKS---NVSPLLWKDR-------------- 440
L + E W LV+ Y +L D + K NV P L
Sbjct: 199 LEPVSSKKEDEYW-LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKII 257
Query: 441 ARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLP 499
I +I L LHS+ IVH D+KPQNI+ S KI D G + Y+P
Sbjct: 258 QTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP 314
Query: 500 SFHRSTAPKGSF---P-YADPEYHRTGVLTPKS----------------------DSYSF 533
F P YA PE + TP + D YS
Sbjct: 315 K---------EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365
Query: 534 GLIILQL 540
GLI LQ+
Sbjct: 366 GLIFLQM 372
|
Length = 566 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 44/215 (20%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
VG G +G C L + VA+K L S Q + ++ E+R+L ++H +++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKL-SRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 405 ACPEAWSLVYEYLPNGSLQDRLFRKSN-VSPLLWKDRARIAA--------------EIAS 449
+ P S+++ F + V+ L+ D I ++
Sbjct: 82 V----------FTPATSIEN--FNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR 129
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 509
GL ++HS+ I+H DLKP N+ ++ + +I DFG+ R ++ + AP+
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEI 186
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
+ Y++T D +S G I+ +LL G+
Sbjct: 187 MLNWM--HYNQT------VDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 20/86 (23%), Positives = 38/86 (44%)
Query: 219 KEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQ 278
+E + L+ ++ ++ ++E +T EL + L E +E EL +
Sbjct: 235 EELREELEELQEELKEAEEELEELTAELQELEEKLEELRLEVSELEEEIEELQKELYALA 294
Query: 279 ASIATLQQEKQRIRRQKVEAVRWLER 304
I+ L+Q+KQ +R + R LE
Sbjct: 295 NEISRLEQQKQILRERLANLERQLEE 320
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|222135 pfam13445, zf-RING_LisH, RING-type zinc-finger, LisH dimerisation motif | Back alignment and domain information |
|---|
Score = 36.5 bits (85), Expect = 0.002
Identities = 15/50 (30%), Positives = 23/50 (46%), Gaps = 4/50 (8%)
Query: 612 VAEERPVPSFFLCPILQEIMHD----PQVAADGFTYEGKAIRDWLENGRE 657
+ S F+CPI +E+M D P + G Y KA+ +NG +
Sbjct: 1 LPYAHHFHSIFVCPISKEVMTDEENPPVMLPCGHVYSRKALEKLAKNGGK 50
|
This zinc-finger is the dimerisation motif for LisH proteins, and is also a typical RING-type of plant ubiquitin ligases. Length = 55 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 36/220 (16%)
Query: 346 ESFKVGQGGFGCVYKGEMLG----RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
E KVG+G +G VYK + + A+K + + + +E+ +L +L+HP+++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIA 62
Query: 402 L----LGACPEAWSLVYEYLPNGSLQDRLFR---KSNVSPLLWKDRARIAA---EIASGL 451
L L L+++Y + F K+N P+ R+ + + +I G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLP-RSMVKSLLYQILDGI 121
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFHRSTAP 507
+LH++ ++H DLKP NIL+ E KI D G RL L
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV- 177
Query: 508 KGSFPYADPEY-----HRTGVLTPKSDSYSFGLIILQLLT 542
+F Y PE H T + D ++ G I +LLT
Sbjct: 178 --TFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|100796 PRK01156, PRK01156, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 16/119 (13%), Positives = 48/119 (40%), Gaps = 4/119 (3%)
Query: 175 KAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEK 234
K L+ + +++++K + I +++ +E Y K E + + +
Sbjct: 330 KLSVLQ-KDYNDYIKKKSRYDDLNNQILELEGYEMDY---NSYLKSIESLKKKIEEYSKN 385
Query: 235 LKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRR 293
+++ AF+++ L + + E N + + + ++ + I L++ + R
Sbjct: 386 IERMSAFISEILKIQEIDPDAIKKELNEINVKLQDISSKVSSLNQRIRALRENLDELSR 444
|
Length = 895 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 32/159 (20%), Positives = 62/159 (38%), Gaps = 5/159 (3%)
Query: 138 RSSSAGSGYMSEKRESTDSDSKVEE-----DPLYVQHREVSIKAEELRNSAFAEFLRRKK 192
+ + + E S++EE + L + E+ + EEL + K
Sbjct: 717 QLEELKRELAALEEELEQLQSRLEELEEELEELEEELEELQERLEELEEELESLEEALAK 776
Query: 193 LESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRN 252
L+ E E K +A + +EAE L ++ E L+Q + + QE+
Sbjct: 777 LKEEIEELEEKRQALQEELEELEEELEEAERRLDALERELESLEQRRERLEQEIEELEEE 836
Query: 253 VALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRI 291
+ L + E +E EL+ ++ + L+ EK+ +
Sbjct: 837 IEELEEKLDELEEELEELEKELEELKEELEELEAEKEEL 875
|
Length = 1163 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 30/137 (21%), Positives = 57/137 (41%), Gaps = 16/137 (11%)
Query: 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNI 472
+Y ++ + + + PLL + R I ++ + ++H +K++H D+K +NI
Sbjct: 249 LYSFMYDEAFDWK------DRPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENI 298
Query: 473 LLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYS 532
L+ + + DFG T G+ PE +D +S
Sbjct: 299 FLNCDGKIVLGDFG-----TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWS 353
Query: 533 FGLIILQLLTGRL-PVG 548
GLI+L +L+ P+G
Sbjct: 354 CGLILLDMLSHDFCPIG 370
|
Length = 501 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 33/128 (25%), Positives = 51/128 (39%), Gaps = 27/128 (21%)
Query: 434 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS------------- 480
P + A+I + L + H+ ++H DLKP+NIL+++ +
Sbjct: 227 PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284
Query: 481 ---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLII 537
+ICD G C H TA + Y PE +D +S G II
Sbjct: 285 CRVRICDLGGC---------CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII 335
Query: 538 LQLLTGRL 545
+L TG+L
Sbjct: 336 YELYTGKL 343
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 688 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| PF04564 | 73 | U-box: U-box domain; InterPro: IPR003613 Quality c | 99.31 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.16 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.04 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.96 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.71 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.66 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.53 | |
| smart00504 | 63 | Ubox Modified RING finger domain. Modified RING fi | 98.49 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.48 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.43 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.41 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.41 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.27 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.26 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.24 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.22 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.18 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.1 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.97 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.95 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.93 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.88 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.8 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.8 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.72 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.62 | |
| KOG4642 | 284 | consensus Chaperone-dependent E3 ubiquitin protein | 97.61 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.57 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.54 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.5 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.47 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.45 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.3 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.21 | |
| PLN02236 | 344 | choline kinase | 97.11 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.03 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.92 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.81 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.78 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.67 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.67 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.51 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.41 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.4 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.35 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.34 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.29 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.03 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.96 | |
| KOG1029 | 1118 | consensus Endocytic adaptor protein intersectin [S | 95.6 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.42 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.4 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.13 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.04 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=453.17 Aligned_cols=275 Identities=47% Similarity=0.785 Sum_probs=241.5
Q ss_pred CCcccCHHHHHHHhcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEeccc
Q 005616 328 ESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406 (688)
Q Consensus 328 ~~~~~~~~el~~at~~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~ 406 (688)
....|++.+|..||++|+..+.||+||||.||+|.+. |..||||++.........+|.+|+.+|.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 4677999999999999999999999999999999998 489999988766543245599999999999999999999999
Q ss_pred CC--C-ceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEe
Q 005616 407 PE--A-WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKIC 483 (688)
Q Consensus 407 ~~--~-~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~ 483 (688)
.+ . .+||||||++|+|.++|+..... +++|..|++|+.++|+||+|||..++++||||||||+|||||.++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 53 2 79999999999999999987654 89999999999999999999999987899999999999999999999999
Q ss_pred ecCccccccC-CCCcCCCccccCCC-CCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCC---------ChhH
Q 005616 484 DFGICRLVTE-DTLYLPSFHRSTAP-KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVG---------LAGE 552 (688)
Q Consensus 484 DFGla~~~~~-~~~~~~~~~~~~~~-~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~---------~~~~ 552 (688)
|||+|+..+. .... ... .||.+|+|||++..+.++.|+|||||||+|+||+||+.|.. ...|
T Consensus 220 DFGLa~~~~~~~~~~-------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w 292 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSV-------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW 292 (361)
T ss_pred CccCcccCCccccce-------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence 9999977654 2211 111 89999999999999999999999999999999999998875 2445
Q ss_pred HHHHhhcCccccccCCCC--CCCCH-HHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhh
Q 005616 553 VRRAVSCGKLSSILDPLA--GDWPT-FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 553 ~~~~i~~~~l~~~ldp~~--~~~~~-~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~ 611 (688)
+...+..+.+.+++||.. +.++. .....+..++.+|++.+|.+||+|. +|++.|+.+.
T Consensus 293 ~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~-~Vv~~L~~~~ 353 (361)
T KOG1187|consen 293 AKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMS-QVVKELEGIL 353 (361)
T ss_pred HHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHH-HHHHHHHhhc
Confidence 667888889999999985 45664 5788899999999999999999999 6788886543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=399.47 Aligned_cols=248 Identities=37% Similarity=0.600 Sum_probs=209.9
Q ss_pred eeeeccCceEEEEEEECCeE-EEEEEEecCCccc--hHHHHHHHHHHHcCCCCceeeEecccCCC---ceeEEeeCCCCc
Q 005616 348 FKVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGACPEA---WSLVYEYLPNGS 421 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~g~~-VAIK~l~~~~~~~--~~~f~~E~~iL~~l~HpnIV~l~g~~~~~---~~LV~E~~~~gs 421 (688)
..||.|+||+||+|.+.|.. ||||++....... ...|.+|+.+|.+++|||||+++|+|.+. .+||||||++|+
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 45999999999999999988 9999998754433 45899999999999999999999999654 689999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-ceEEeecCccccccCCCCcCCC
Q 005616 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-~~KL~DFGla~~~~~~~~~~~~ 500 (688)
|..+|... ....+++..++.|+.+||+||.|||+.++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 127 L~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~----- 198 (362)
T KOG0192|consen 127 LSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK----- 198 (362)
T ss_pred HHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-----
Confidence 99999885 33679999999999999999999999774 99999999999999998 99999999998876432
Q ss_pred ccccCCCCCCCCCCChhhhc--cCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCccccccCCCCCCCCHH
Q 005616 501 FHRSTAPKGSFPYADPEYHR--TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~--~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~ldp~~~~~~~~ 576 (688)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||.....+ ...+..+.. ....|..
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~-------Rp~~p~~ 270 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL-------RPPIPKE 270 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC-------CCCCCcc
Confidence 1234578999999999999 569999999999999999999999999866542 222222211 1123334
Q ss_pred HHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhh
Q 005616 577 VARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~ 612 (688)
+...+..|+.+||+.||..||++. +++..|+.+..
T Consensus 271 ~~~~l~~l~~~CW~~dp~~RP~f~-ei~~~l~~~~~ 305 (362)
T KOG0192|consen 271 CPPHLSSLMERCWLVDPSRRPSFL-EIVSRLESIMS 305 (362)
T ss_pred CCHHHHHHHHHhCCCCCCcCCCHH-HHHHHHHHHHH
Confidence 677899999999999999999999 88888887754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=391.19 Aligned_cols=246 Identities=26% Similarity=0.399 Sum_probs=214.7
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
..|...+.||+|||+.||.++.. |..||+|++.+... ...+.+.+|++|.+.|+|||||+++++|++ +.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 56889999999999999999883 99999999987544 345568999999999999999999999976 489999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
|+|++++|..++.+. .++++.++..++.||+.||.|||+.+ |||||||..|+||+++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999998744 57999999999999999999999976 999999999999999999999999999998754
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCCh--hHHHHHhhcCccccccCCCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA--GEVRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~--~~~~~~i~~~~l~~~ldp~~~~ 572 (688)
. .+..+.+|||.|+|||++....++..+||||+|||||.||+|+|||... .+....+..... .
T Consensus 172 ~------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y---------~ 236 (592)
T KOG0575|consen 172 G------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY---------S 236 (592)
T ss_pred c------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc---------c
Confidence 3 2457889999999999999999999999999999999999999999743 445555555433 3
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
.|...+....+||.++|+.||.+|||+.+.+.+.+=
T Consensus 237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 455677889999999999999999999976665553
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=374.08 Aligned_cols=250 Identities=30% Similarity=0.433 Sum_probs=205.8
Q ss_pred cCHHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccC-
Q 005616 332 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACP- 407 (688)
Q Consensus 332 ~~~~el~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~- 407 (688)
+++.||+. ...||+|..|+||++++. +..+|+|++.... ...+.++.+|++++...+|||||.+||+|.
T Consensus 76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 44555544 467999999999999997 8899999995543 345668999999999999999999999993
Q ss_pred -C-CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeec
Q 005616 408 -E-AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 408 -~-~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DF 485 (688)
. ..+|+||||++|||++++... +.+++....+|+.+|++||.|||.. ..||||||||+|||++..|.+|||||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccc
Confidence 3 378999999999999999765 3588999999999999999999963 24999999999999999999999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCCh----hHHHHHhhcCc
Q 005616 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA----GEVRRAVSCGK 561 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~----~~~~~~i~~~~ 561 (688)
|.++.+.+.. ..+.+||..|||||.+.+..|+.++||||||++++|+.+|+.||... ......
T Consensus 224 GVS~~lvnS~--------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L----- 290 (364)
T KOG0581|consen 224 GVSGILVNSI--------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL----- 290 (364)
T ss_pred cccHHhhhhh--------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH-----
Confidence 9999886542 35778999999999999999999999999999999999999999754 111111
Q ss_pred cccccCCCCCCCCHH-HHHHHHHHHHHcccCCCCCCCCCcHHHHHH
Q 005616 562 LSSILDPLAGDWPTF-VARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 562 l~~~ldp~~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~ 606 (688)
+..+++......|.. +++++..++..||++||.+||++.+.+.+.
T Consensus 291 l~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 291 LCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred HHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 122233223344544 788999999999999999999998555433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=361.43 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=211.6
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc--hHHHHHHHHHHHcCCCCceeeEecc-cCC---CceeEE
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGA-CPE---AWSLVY 414 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~--~~~f~~E~~iL~~l~HpnIV~l~g~-~~~---~~~LV~ 414 (688)
+|.+.++||+|.||+||+++.. |..||.|.++...+.. ......|+.+|++|+|||||++|++ |.+ -.+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 4666678999999999999775 8999999998665543 4468899999999999999999994 432 278999
Q ss_pred eeCCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCC-ceEeCCCCCCceeeCCCCceEEeecCcccccc
Q 005616 415 EYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPE-KIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~ 492 (688)
|||..|+|..++...+ ....+++..+++++.|++.||..+|+.-+. -|+||||||.||+|+.+|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999987643 346789999999999999999999995432 39999999999999999999999999999987
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--HHHHHhhcCccccccCCCC
Q 005616 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~i~~~~l~~~ldp~~ 570 (688)
.... .....+|||.||+||.+...+|++||||||+||++|||+.-++||.+.. .....+..|.+..+
T Consensus 180 s~~t------fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~----- 248 (375)
T KOG0591|consen 180 SKTT------FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPL----- 248 (375)
T ss_pred chhH------HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCC-----
Confidence 6553 3467899999999999999999999999999999999999999997653 34455666654322
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
+...++..|..||..|+..||..||+....+.+...
T Consensus 249 --p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 249 --PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 125788999999999999999999997645544443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=370.96 Aligned_cols=246 Identities=25% Similarity=0.346 Sum_probs=204.1
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-------chHHHHHHHHHHHcCCCCceeeEecccC--C
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-------GQLEFQQEVRVLSKLQHPHLVTLLGACP--E 408 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~-------~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~ 408 (688)
..+.|...+.||+|+||.|-+|... |+.||||++++.... ....+.+|++||++|+|||||+++++|. +
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3456777899999999999999775 999999999765332 2234679999999999999999999994 4
Q ss_pred CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC---CceEEeec
Q 005616 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE---LSSKICDF 485 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~---~~~KL~DF 485 (688)
..||||||+.||.|.+.+..++ .+.+..-..++.|++.|+.|||+.| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 5799999999999999997764 3555667889999999999999976 9999999999999766 78999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCC--C-CcchHhHHHHHHHHHHhCCCCCCChh---HHHHHhhc
Q 005616 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL--T-PKSDSYSFGLIILQLLTGRLPVGLAG---EVRRAVSC 559 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~--s-~ksDVwSfGviL~ELltG~~Pf~~~~---~~~~~i~~ 559 (688)
|+|+...... .+.+.+|||.|.|||++.+..+ . .++|+||+||+||-+|+|.+||.... .....+..
T Consensus 324 GlAK~~g~~s-------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~ 396 (475)
T KOG0615|consen 324 GLAKVSGEGS-------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK 396 (475)
T ss_pred chhhccccce-------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc
Confidence 9999987443 4578899999999999977643 3 48899999999999999999997332 26677777
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 560 ~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
|++... ......++.+..+||.+||..||+.||++.+++
T Consensus 397 G~y~f~-----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL 435 (475)
T KOG0615|consen 397 GRYAFG-----PLQWDRISEEALDLINWMLVVDPENRPSADEAL 435 (475)
T ss_pred Cccccc-----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence 776432 122346788999999999999999999998444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=365.48 Aligned_cols=244 Identities=31% Similarity=0.439 Sum_probs=197.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecC--CccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEE
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSH--NMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 414 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~--~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~ 414 (688)
..+|.....||.|+||+||+|++. +..||||.+... ....++-+..|+.+|+.++|||||.|++++. +..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888889999999999999986 889999999776 3445666889999999999999999999984 4589999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC------CceEEeecCcc
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE------LSSKICDFGIC 488 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~------~~~KL~DFGla 488 (688)
|||.||+|.+++...+ .+++..+..++.|||.||++||+.+ ||||||||.||||+.+ -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999998765 5888999999999999999999976 9999999999999865 45899999999
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--HHHHHhhcCcccccc
Q 005616 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSIL 566 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~i~~~~l~~~l 566 (688)
+.+.... ...+.+|+|-|||||++....|+.|+|+||+|+|||+|++|++||.... +....++.+.-.-
T Consensus 163 R~L~~~~-------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~-- 233 (429)
T KOG0595|consen 163 RFLQPGS-------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV-- 233 (429)
T ss_pred hhCCchh-------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc--
Confidence 9988654 2357789999999999999999999999999999999999999997333 3333444432211
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 567 dp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
...+...+..+.+|+...+..+|.+|-+..+-+
T Consensus 234 ----~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 234 ----PVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred ----CchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 122223334455666666666666666655333
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=368.75 Aligned_cols=247 Identities=23% Similarity=0.279 Sum_probs=199.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
.++|.....||+|+||.||+++-+ |..+|+|++++..+. ....+..|.++|....+|+||+||..|++ .+|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 356788889999999999999775 899999999988764 34568899999999999999999999965 58999
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
|||++||++..+|.+.+ .|+...+..++.+++.|+..||..| ||||||||+|+|||..|++||+||||+.-+..
T Consensus 220 MEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999998765 6888999999999999999999977 99999999999999999999999999964322
Q ss_pred CCC-----------------cCCCcc------------------------ccCCCCCCCCCCChhhhccCCCCCcchHhH
Q 005616 494 DTL-----------------YLPSFH------------------------RSTAPKGSFPYADPEYHRTGVLTPKSDSYS 532 (688)
Q Consensus 494 ~~~-----------------~~~~~~------------------------~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwS 532 (688)
... ..+.+. .....+|||.|||||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 000 000000 112468999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCChh--HHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCC
Q 005616 533 FGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDI 599 (688)
Q Consensus 533 fGviL~ELltG~~Pf~~~~--~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 599 (688)
||||+||||.|.+||.... ..+..+...+..-. -| -....+.+..+||.+||. ||..|-..
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-fP----~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-FP----EEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-CC----CcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 9999999999999997543 34444333221110 01 111234789999999999 99999983
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=375.83 Aligned_cols=250 Identities=32% Similarity=0.515 Sum_probs=211.9
Q ss_pred cccceeeeccCceEEEEEEECCe-EEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCC
Q 005616 344 FSESFKVGQGGFGCVYKGEMLGR-TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~g~-~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
+...+.||+|-||.||.|.+++. .||+|.++...+ ....|.+|+.+|.+|+|+|||+++|+|.. ..+||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 34457799999999999999976 899999987643 34578899999999999999999999954 479999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCC
Q 005616 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~ 500 (688)
+|.++|... ....+...+.+.++.|||+|++||++.+ +|||||...||||+++..+||+|||+|+...++...
T Consensus 287 sLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~--- 359 (468)
T KOG0197|consen 287 SLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT--- 359 (468)
T ss_pred cHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee---
Confidence 999999873 3356888999999999999999999976 999999999999999999999999999955544321
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCccccccCCCCCCCCHHH
Q 005616 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l~~~ldp~~~~~~~~~ 577 (688)
......-...|.|||.+..+.++.|||||||||+||||+| |+.||.... ++...+..|... ..|..+
T Consensus 360 --~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl--------p~P~~C 429 (468)
T KOG0197|consen 360 --ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL--------PRPEGC 429 (468)
T ss_pred --ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC--------CCCCCC
Confidence 2233344567999999999999999999999999999999 999987544 466667766432 346667
Q ss_pred HHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhh
Q 005616 578 ARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 578 ~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~ 612 (688)
+..+.+|+..||+.+|++|||+. .+...|+.+..
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~-~L~~~l~~~~~ 463 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFE-TLREVLEDFFT 463 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHH-HHHHHHHHhhh
Confidence 88999999999999999999998 88888877643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=359.34 Aligned_cols=238 Identities=29% Similarity=0.393 Sum_probs=204.2
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
..+|...+.||+|+||.||.++.. ++.+|+|++++.... ......+|..||..++||+||+++..|++ .+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467899999999999999999775 889999999877553 34568899999999999999999999965 59999
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
++|+.||.|..+|.+.+ .+++..+.-++.+|+.||.|||+.+ ||||||||+|||||.+|+++|+|||+|+..-.
T Consensus 104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999998765 4677888899999999999999966 99999999999999999999999999996544
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--HHHHHhhcCccccccCCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~i~~~~l~~~ldp~~~ 571 (688)
... .+...+||+.|||||++.+.+|+..+|+|||||++|||++|.+||...+ .+...+..+++.
T Consensus 178 ~~~------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~-------- 243 (357)
T KOG0598|consen 178 DGD------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP-------- 243 (357)
T ss_pred CCC------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC--------
Confidence 332 3456899999999999999999999999999999999999999997544 455556555522
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCC
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs 598 (688)
..|...+....+|+...|..||.+|-.
T Consensus 244 ~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 223345678899999999999999974
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=345.16 Aligned_cols=257 Identities=18% Similarity=0.261 Sum_probs=208.9
Q ss_pred CCcccCHHHHHHHhcCcccceeeeccCceEEEEEEECCeEEEEEEEecCCccc---hHHHHHHHHHHHcCCCCceeeEec
Q 005616 328 ESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHPHLVTLLG 404 (688)
Q Consensus 328 ~~~~~~~~el~~at~~f~~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~---~~~f~~E~~iL~~l~HpnIV~l~g 404 (688)
....++.++| ++.....||+|++|.||+|.+.|..||||++....... ...|.+|+.+|.+++|||||+++|
T Consensus 11 ~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 11 DIKCIESDDI-----DKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred cceecCHHHc-----CCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 3455666776 33334689999999999999999999999997654433 356889999999999999999999
Q ss_pred ccCC------CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC
Q 005616 405 ACPE------AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL 478 (688)
Q Consensus 405 ~~~~------~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~ 478 (688)
+|.+ ..++||||+++|+|.+++... ..++|...+.++.+++.||.|||... +++||||||+|||++.++
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~ 160 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENY 160 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCC
Confidence 9854 367999999999999999764 35889999999999999999999842 378999999999999999
Q ss_pred ceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc--CCCCCcchHhHHHHHHHHHHhCCCCCCChh--HHH
Q 005616 479 SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVR 554 (688)
Q Consensus 479 ~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~ 554 (688)
.+||+|||+++...... ....||..|+|||++.+ ..++.++|||||||++|||++|+.||.... .+.
T Consensus 161 ~~kl~dfg~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~ 231 (283)
T PHA02988 161 KLKIICHGLEKILSSPP---------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY 231 (283)
T ss_pred cEEEcccchHhhhcccc---------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999998764322 23468899999999876 689999999999999999999999997543 233
Q ss_pred HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhh
Q 005616 555 RAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 555 ~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~ 611 (688)
..+..+.... ..+...+..+.+|+.+||+.||.+||++. ++++.|+.+.
T Consensus 232 ~~i~~~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~Rps~~-ell~~l~~~~ 280 (283)
T PHA02988 232 DLIINKNNSL-------KLPLDCPLEIKCIVEACTSHDSIKRPNIK-EILYNLSLYK 280 (283)
T ss_pred HHHHhcCCCC-------CCCCcCcHHHHHHHHHHhcCCcccCcCHH-HHHHHHHHHH
Confidence 3332222111 12334567899999999999999999999 8888888764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=360.28 Aligned_cols=248 Identities=28% Similarity=0.363 Sum_probs=207.8
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcC-CCCceeeEecccCC--Cce
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWS 411 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~ 411 (688)
..++|.+++.||.|+|++||+++.. ++.||||++.+...- ...-+..|-.+|.+| .||.||+||..|++ .+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3467899999999999999999886 899999999765432 233477899999999 89999999999966 489
Q ss_pred eEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccc
Q 005616 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~ 491 (688)
+|+||+++|+|.++|.+.+ .|++.....++.+|+.||+|||+.| ||||||||+|||||.+|++||+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999998764 5778888999999999999999977 999999999999999999999999999998
Q ss_pred cCCCCc-----CCCccc--cCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCcccc
Q 005616 492 TEDTLY-----LPSFHR--STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSS 564 (688)
Q Consensus 492 ~~~~~~-----~~~~~~--~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~ 564 (688)
+..... .+.... ....+||..|++||++..+..++.+|+|+||||||+|+.|++||....+....-. +.
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk---I~- 300 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK---IQ- 300 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH---HH-
Confidence 754332 111111 2568999999999999999999999999999999999999999987665322111 11
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 565 ~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
...-+||...++.+.+|+.+.|..||.+|++..
T Consensus 301 ---~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~ 333 (604)
T KOG0592|consen 301 ---ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQ 333 (604)
T ss_pred ---HhcccCCCCCCHHHHHHHHHHHccCccccccHH
Confidence 112356777778999999999999999999996
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=354.80 Aligned_cols=256 Identities=29% Similarity=0.454 Sum_probs=204.3
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcC-CCCceeeEecccCC--
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE-- 408 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~-- 408 (688)
..++|...+.||.|+||.||+|.+. +..||||++..... .....+.+|+.++..+ +|||||+++|+|..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3467888999999999999999752 46799999975432 2345689999999999 89999999998843
Q ss_pred -CceeEEeeCCCCcHHHHhcccCC--------------------------------------------------------
Q 005616 409 -AWSLVYEYLPNGSLQDRLFRKSN-------------------------------------------------------- 431 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 431 (688)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 36899999999999999865321
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCccccCCCC
Q 005616 432 ---VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 508 (688)
Q Consensus 432 ---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~ 508 (688)
..++++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........ .......
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~----~~~~~~~ 237 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----VRKGSAR 237 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcch----hcccCCC
Confidence 135888999999999999999999965 999999999999999999999999999876433211 1123445
Q ss_pred CCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh---HHHHHhhcCccccccCCCCCCCCHHHHHHHHHH
Q 005616 509 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG---EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDL 584 (688)
Q Consensus 509 Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~---~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~L 584 (688)
+++.|+|||++.+..++.++|||||||+||||++ |..||.... .+...+..+... ..+...+..+.+|
T Consensus 238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~l 309 (338)
T cd05102 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM--------RAPENATPEIYRI 309 (338)
T ss_pred CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC--------CCCCCCCHHHHHH
Confidence 6789999999999999999999999999999997 999997532 222333333211 1223445689999
Q ss_pred HHHcccCCCCCCCCCcHHHHHHHHHhh
Q 005616 585 GLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 585 i~~Cl~~dP~~RPs~~e~l~~~Le~l~ 611 (688)
+.+||+.||.+||++. +|++.|+.+.
T Consensus 310 i~~cl~~dp~~RPs~~-el~~~l~~~~ 335 (338)
T cd05102 310 MLACWQGDPKERPTFS-ALVEILGDLL 335 (338)
T ss_pred HHHHccCChhhCcCHH-HHHHHHHHHH
Confidence 9999999999999998 8888888753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=334.62 Aligned_cols=230 Identities=29% Similarity=0.410 Sum_probs=204.1
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
+|.....||.|+||.|.+++.. |..+|+|++.+.... ..+...+|..+|+.+.||++++|++.|.+ ..+||||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 4667789999999999999886 888999999877543 34457899999999999999999999865 4889999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|++||.|..+|.+.+ .++.+.+..++.+|+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+.+...
T Consensus 125 yv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred ccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999999998765 5788999999999999999999977 999999999999999999999999999998754
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--HHHHHhhcCccccccCCCCCCC
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~i~~~~l~~~ldp~~~~~ 573 (688)
+.+.+|||.|+|||++...+|+.++|+|||||++|||+.|.+||.... .+...+..|++ .+
T Consensus 198 --------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v---------~f 260 (355)
T KOG0616|consen 198 --------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV---------KF 260 (355)
T ss_pred --------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc---------cC
Confidence 356799999999999999999999999999999999999999997544 45566666655 56
Q ss_pred CHHHHHHHHHHHHHcccCCCCCC
Q 005616 574 PTFVARRLVDLGLQCCELYGRER 596 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~R 596 (688)
|..++..+.+|+...|+.|-..|
T Consensus 261 P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 261 PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CcccCHHHHHHHHHHHhhhhHhh
Confidence 77888899999999999999888
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.99 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=206.7
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEeccc--CC--CceeEE
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PE--AWSLVY 414 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~--~~--~~~LV~ 414 (688)
..++...+.||+|+||.||++... |...|||.+..........+.+|+.+|.+++|||||+++|.. .+ .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345777789999999999999886 799999998766433356689999999999999999999973 44 488999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC-CCceEEeecCccccccC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFGICRLVTE 493 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-~~~~KL~DFGla~~~~~ 493 (688)
||+++|+|.+++.+.+. .|++..+..+..||+.||.|||+.+ ||||||||+||||+. +|.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999987764 6899999999999999999999855 999999999999999 79999999999988764
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCCh-hHHHHHhhcCccccccCCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLA-GEVRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~-~~~~~~i~~~~l~~~ldp~~~ 571 (688)
... .........||+.|||||++..+ ...+++|||||||+++||+||++||... ......+..+.-. ...
T Consensus 171 ~~~---~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-----~~P 242 (313)
T KOG0198|consen 171 KGT---KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-----SLP 242 (313)
T ss_pred ccc---cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-----CCC
Confidence 111 11123567899999999999864 3446999999999999999999999762 2222222222111 122
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHH
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~ 609 (688)
.+|...+....+++.+|+..+|..|||+.+.+.+.+..
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 56667888999999999999999999999666555443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=357.06 Aligned_cols=247 Identities=27% Similarity=0.426 Sum_probs=210.6
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEeccc--CCCceeEEeeCC
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLP 418 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~LV~E~~~ 418 (688)
.|....+||+|+.|.||.+... +..||||++........+-+.+|+.+|+..+|+|||.++..| .+.+++|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 3555578999999999999775 788999999888777777899999999999999999999887 566999999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
||+|.+.+... .+++.++..|+.+++.||.|||..+ |||||||.+||||+.+|.+||+|||+|..+.....
T Consensus 354 ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 354 GGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred CCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 99999998653 4889999999999999999999966 99999999999999999999999999998875542
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH--HhhcCccccccCCCCCCCCHH
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~i~~~~l~~~ldp~~~~~~~~ 576 (688)
+....+|||.|||||+.....|++|+||||||++++||+-|.+||-....+.. .+.......+ ..+..
T Consensus 425 ----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~l------k~~~k 494 (550)
T KOG0578|consen 425 ----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKL------KNPEK 494 (550)
T ss_pred ----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCc------CCccc
Confidence 45778999999999999999999999999999999999999999965443322 2222222221 34556
Q ss_pred HHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 577 VARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
++..|.+++.+||+.|+.+||++.+.|.+.+-
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEHPFL 526 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence 78899999999999999999999966554443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=355.20 Aligned_cols=263 Identities=30% Similarity=0.507 Sum_probs=210.1
Q ss_pred CHHHHHHHhcCcccceeeeccCceEEEEEEECCeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccCC-C
Q 005616 333 SLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE-A 409 (688)
Q Consensus 333 ~~~el~~at~~f~~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~ 409 (688)
+..+.....+.+.....||+|.||+||+|.|.| .||||+++..... ..+.|++|+.+|++-+|.||+-++|||-. .
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 334444455556677889999999999999987 5899999877654 34579999999999999999999999954 5
Q ss_pred ceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccc
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~ 489 (688)
..||.-+|.|.+|..+|+-.. ..|.....+.|+.|||.|+.|||..+ |||||||..||||.+++.|||+|||++.
T Consensus 462 ~AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 462 LAIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred eeeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 689999999999999998765 46888999999999999999999954 9999999999999999999999999997
Q ss_pred cccCCCCcCCCccccCCCCCCCCCCChhhhcc---CCCCCcchHhHHHHHHHHHHhCCCCCCCh--hHHHHHhhcCcccc
Q 005616 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT---GVLTPKSDSYSFGLIILQLLTGRLPVGLA--GEVRRAVSCGKLSS 564 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSfGviL~ELltG~~Pf~~~--~~~~~~i~~~~l~~ 564 (688)
...... ..+......|...|||||+++- .+|++.+||||||+|+|||+||..||... +.+.-++..|.+..
T Consensus 537 vk~~w~----g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~p 612 (678)
T KOG0193|consen 537 VKTRWS----GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMP 612 (678)
T ss_pred eeeeec----cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCc
Confidence 654332 1123345678889999998863 47999999999999999999999999722 22333344443221
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 565 ~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
|. ......++..+.+|+..||..++++||.+. .|+..|+.+
T Consensus 613 --d~--s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~-~il~~l~~l 653 (678)
T KOG0193|consen 613 --DL--SKIRSNCPKAMKRLLSDCWKFDREERPLFP-QLLSKLEEL 653 (678)
T ss_pred --cc--hhhhccCHHHHHHHHHHHHhcCcccCccHH-HHHHHHHHh
Confidence 11 122234567899999999999999999999 555555544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=330.03 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=198.9
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
.|+...++|+|+||+||+++.+ |+.||||++...... -.+-..+|+++|++++|||+|.|+.+|. ..++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4667789999999999999886 899999999765432 2345789999999999999999999994 458999999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
|+..-|.++- +.. ..++...+.+++.|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+.+.....
T Consensus 83 ~dhTvL~eLe-~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 83 CDHTVLHELE-RYP--NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred cchHHHHHHH-hcc--CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 9876665543 332 35788899999999999999999977 99999999999999999999999999999874321
Q ss_pred cCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhc----Ccc---------
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----GKL--------- 562 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~----~~l--------- 562 (688)
..+..+.|..|.|||.+.+ ..|+..+||||+||++.||++|.+.|.+..++.+.... |.+
T Consensus 157 ------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 157 ------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred ------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 2467789999999998877 68999999999999999999999999877766544211 211
Q ss_pred ----------ccccCC--CCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 563 ----------SSILDP--LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 563 ----------~~~ldp--~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.+.-++ ....+| ..+.-+++|+..||+.||++|++-.+.+
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHh
Confidence 111111 011122 3455789999999999999999988544
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=337.76 Aligned_cols=242 Identities=25% Similarity=0.337 Sum_probs=195.5
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
.|...+.||+|+||.||+|... |..||||.+..... .....+.+|+.++..++|+||++++++|.+ ..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677889999999999999875 88999999875432 233457899999999999999999998843 5789999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|+++|+|..++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999988865432 35899999999999999999999965 9999999999999999999999999998754322
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCccccccCCCCCCC
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~ldp~~~~~ 573 (688)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+... +......+
T Consensus 157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~ 224 (285)
T cd05631 157 -------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR-----VKEDQEEY 224 (285)
T ss_pred -------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH-----hhcccccC
Confidence 123457999999999999999999999999999999999999999753321 1111100 00111233
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
+...+..+.+|+.+||+.||.+||+..
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCR 251 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCC
Confidence 445667899999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=354.43 Aligned_cols=233 Identities=28% Similarity=0.462 Sum_probs=197.4
Q ss_pred cceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCcHH
Q 005616 346 ESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQ 423 (688)
Q Consensus 346 ~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL~ 423 (688)
+...||.|+-|-||+|++.+..||||+++.-. ..+++-|++|+|||||.+.|+|.. .+|||||||..|.|.
T Consensus 128 ELeWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 34789999999999999999999999875322 347888999999999999999965 378999999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCccc
Q 005616 424 DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503 (688)
Q Consensus 424 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~ 503 (688)
..|.... +++-.....|..+||.|+.|||.+. |||||||.-||||..+..+||+|||.++...... .
T Consensus 201 ~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S-------T 267 (904)
T KOG4721|consen 201 EVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS-------T 267 (904)
T ss_pred HHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh-------h
Confidence 9997654 4666788899999999999999977 9999999999999999999999999999876543 2
Q ss_pred cCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHHHHHHHHH
Q 005616 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVD 583 (688)
Q Consensus 504 ~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~ 583 (688)
...++||..|||||++.+.+.+.|+|||||||||||||||..||...+...-.|..|. ..+ .-..|..+++.|.-
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs--NsL---~LpvPstcP~Gfkl 342 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS--NSL---HLPVPSTCPDGFKL 342 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccC--Ccc---cccCcccCchHHHH
Confidence 4567899999999999999999999999999999999999999987665322222222 111 12445667789999
Q ss_pred HHHHcccCCCCCCCCCcHHH
Q 005616 584 LGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 584 Li~~Cl~~dP~~RPs~~e~l 603 (688)
|+.+||+-.|..||++++.+
T Consensus 343 L~Kqcw~sKpRNRPSFrqil 362 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQIL 362 (904)
T ss_pred HHHHHHhcCCCCCccHHHHH
Confidence 99999999999999999544
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=338.68 Aligned_cols=258 Identities=28% Similarity=0.409 Sum_probs=197.6
Q ss_pred cCcccceeeeccCceEEEEEEEC------------------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML------------------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTL 402 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~------------------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l 402 (688)
++|...+.||+|+||.||+|.+. +..||||.+..... .....|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 56788899999999999999753 34699999876533 334579999999999999999999
Q ss_pred ecccC--CCceeEEeeCCCCcHHHHhcccC----------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEe
Q 005616 403 LGACP--EAWSLVYEYLPNGSLQDRLFRKS----------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464 (688)
Q Consensus 403 ~g~~~--~~~~LV~E~~~~gsL~~~L~~~~----------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiH 464 (688)
+++|. +..++||||+++|+|.+++.... ....++|..++.++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 99985 35889999999999999885432 1235788999999999999999999966 999
Q ss_pred CCCCCCceeeCCCCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh--
Q 005616 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-- 542 (688)
Q Consensus 465 rDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-- 542 (688)
|||||+|||++.++.+||+|||+++........ .......++..|+|||++..+.++.++|||||||++|||++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYY----RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCcee----EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 999999999999999999999999865433211 11234456889999999998999999999999999999987
Q ss_pred CCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 543 GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 543 G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
|..||..... +...+... +...........+..++..+.+|+.+||+.+|.+||++. +|.+.|+
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~-~i~~~l~ 303 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEF-FRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFS-DIHAFLT 303 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHH-hhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHH-HHHHHHh
Confidence 5677764322 11111100 000000000112233456899999999999999999998 6766664
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=347.46 Aligned_cols=243 Identities=28% Similarity=0.426 Sum_probs=203.9
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecC----Cc-cchHHHHHHHHHHHcCC-CCceeeEeccc--CC
Q 005616 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSH----NM-QGQLEFQQEVRVLSKLQ-HPHLVTLLGAC--PE 408 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~----~~-~~~~~f~~E~~iL~~l~-HpnIV~l~g~~--~~ 408 (688)
...++|...+.||+|+||.||.|... |..||||++... .. .....+.+|+.+++.++ ||||++++.++ ..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 44578999999999999999999875 899999977654 11 23445778999999998 99999999998 44
Q ss_pred CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC-CceEEeecCc
Q 005616 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGI 487 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~-~~~KL~DFGl 487 (688)
..++||||+.||+|.+++... .++.+.....++.|++.|+.|||+.+ |+||||||+|||||.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 689999999999999999873 45778999999999999999999976 9999999999999999 9999999999
Q ss_pred ccccc-CCCCcCCCccccCCCCCCCCCCChhhhccCC-CC-CcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCcc
Q 005616 488 CRLVT-EDTLYLPSFHRSTAPKGSFPYADPEYHRTGV-LT-PKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKL 562 (688)
Q Consensus 488 a~~~~-~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s-~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l 562 (688)
+.... .+. .....+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||..... ....+..+.+
T Consensus 168 s~~~~~~~~-------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~ 240 (370)
T KOG0583|consen 168 SAISPGEDG-------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF 240 (370)
T ss_pred ccccCCCCC-------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc
Confidence 99874 222 346789999999999999877 85 799999999999999999999986432 2222333322
Q ss_pred ccccCCCCCCCCHHH-HHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 563 SSILDPLAGDWPTFV-ARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 563 ~~~ldp~~~~~~~~~-~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.+|..+ +..+..|+.+||..||..|+++.+.+
T Consensus 241 ---------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 241 ---------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ---------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 344445 88999999999999999999998444
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=344.57 Aligned_cols=246 Identities=29% Similarity=0.393 Sum_probs=209.1
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
++|.+...||+|+||.||||+.+ .+.||||.+.+.... ....+.+|++|++.++|||||.++++|+. ..++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778889999999999999876 678999999766543 34568999999999999999999999965 5889999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|+.| +|..+|.... .++++.+..|+.+++.||.|||++. |+|||+||.||||+.+|.+|+||||+|+.+..+.
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 9999997654 5889999999999999999999976 9999999999999999999999999999887654
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCH
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~ 575 (688)
. ..+...|||.|||||+..+..|+..+|.||+|||+|||.+|++||... .+...+.. +-.....||.
T Consensus 155 ~------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-si~~Lv~~------I~~d~v~~p~ 221 (808)
T KOG0597|consen 155 S------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-SITQLVKS------ILKDPVKPPS 221 (808)
T ss_pred e------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-HHHHHHHH------HhcCCCCCcc
Confidence 3 346788999999999999999999999999999999999999999532 22222211 1111235677
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
..+..+..++...|..||..|.+-.+.+-+.+
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF 253 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPF 253 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence 88999999999999999999999886665555
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=336.26 Aligned_cols=233 Identities=27% Similarity=0.360 Sum_probs=196.0
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||+|... |..||||++..... .....+.+|+.++..++||||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999986 88999999975432 234568899999999999999999998854 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999986543 5788999999999999999999966 999999999999999999999999999876432
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~ 572 (688)
. ....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... +...+..+.. .
T Consensus 155 ~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~---------~ 216 (291)
T cd05612 155 T---------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL---------E 216 (291)
T ss_pred c---------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc---------C
Confidence 1 345699999999999999999999999999999999999999975432 2333333321 2
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCC
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs 598 (688)
++...+..+.+|+.+||+.||.+||+
T Consensus 217 ~~~~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 217 FPRHLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHccC
Confidence 34445678999999999999999996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.58 Aligned_cols=262 Identities=22% Similarity=0.297 Sum_probs=211.0
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccch-HHHHHHHHHHHcCCCCceeeEeccc--CCCceeEE
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVY 414 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~-~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~LV~ 414 (688)
..++|.....||.|..++||+|+.. +..||||++........ ..+.+|+..++.++|||||+++..| .+.+++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 3578999999999999999999885 89999999987765544 7799999999999999999999988 45689999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
.||.+||+.+++...-. ..+++..+..|+.++++||.|||.+| .||||||+.||||+.+|.+||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999976543 34889999999999999999999977 999999999999999999999999998877654
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhcc--CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHh--hcCccccccCC-C
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV--SCGKLSSILDP-L 569 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i--~~~~l~~~ldp-~ 569 (688)
... ........+||+.|||||++.. ..|+.|+||||||++.+||.+|..||.....+...+ ..+.....+-. .
T Consensus 180 G~R--~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~ 257 (516)
T KOG0582|consen 180 GDR--QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGL 257 (516)
T ss_pred Cce--eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccC
Confidence 421 1112267799999999999543 479999999999999999999999998655443322 22322221100 1
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
..+....+...+.+++..||+.||.+|||+.+.+.+.+
T Consensus 258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~F 295 (516)
T KOG0582|consen 258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAF 295 (516)
T ss_pred ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHH
Confidence 11223345668999999999999999999996655444
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=365.47 Aligned_cols=254 Identities=30% Similarity=0.510 Sum_probs=216.8
Q ss_pred cCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--Cce
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWS 411 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~ 411 (688)
.+......||+|.||+||+|+.. ...||||.++..... .+.+|++|+.+++.|+|||||+|+|+|.+ ..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34455577999999999999875 246999999987765 77899999999999999999999999954 489
Q ss_pred eEEeeCCCCcHHHHhcccCC-----------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCce
Q 005616 412 LVYEYLPNGSLQDRLFRKSN-----------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~-----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~ 480 (688)
+|+|||..|+|..+|..... ..+|+..+.+.|+.|||.|+.||-+.+ +|||||-..|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 99999999999999975321 234899999999999999999999977 9999999999999999999
Q ss_pred EEeecCccccccCCCCcCCCccccC-CCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCCh--hHHHHH
Q 005616 481 KICDFGICRLVTEDTLYLPSFHRST-APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLA--GEVRRA 556 (688)
Q Consensus 481 KL~DFGla~~~~~~~~~~~~~~~~~-~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~--~~~~~~ 556 (688)
||+|||+++.+-..+.+ +.. ...-...||+||.+..++||++||||||||+|||+++ |+.||... .++...
T Consensus 643 KIsDfGLsRdiYssDYY-----k~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYY-----KVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred Eecccccchhhhhhhhh-----cccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 99999999876544322 211 3334578999999999999999999999999999999 99998643 467888
Q ss_pred hhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhh
Q 005616 557 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 557 i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~ 612 (688)
+..|++. ..|..++..+..|+..||+.+|.+||++. +|-..|+....
T Consensus 718 i~~g~lL--------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~-eI~~~L~~~~~ 764 (774)
T KOG1026|consen 718 IRAGQLL--------SCPENCPTEVYSLMLECWNENPKRRPSFK-EIHSRLQAWAQ 764 (774)
T ss_pred HHcCCcc--------cCCCCCCHHHHHHHHHHhhcCcccCCCHH-HHHHHHHHHHh
Confidence 8888774 34667788999999999999999999999 89889887754
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.59 Aligned_cols=234 Identities=24% Similarity=0.369 Sum_probs=196.8
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||+|++. +..||||++..... .....+.+|+.++.+++||||+++++++.+ ..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888999999999999999986 78999999975432 334568899999999999999999999844 578999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999987543 5788899999999999999999966 999999999999999999999999999876432
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~ 572 (688)
. ....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....+..+.+ .
T Consensus 172 ~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~---------~ 233 (329)
T PTZ00263 172 T---------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL---------K 233 (329)
T ss_pred c---------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc---------C
Confidence 2 235799999999999999999999999999999999999999965433 2333333322 2
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCC
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDI 599 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 599 (688)
+|..++..+.+|+.+||+.||.+||+.
T Consensus 234 ~p~~~~~~~~~li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 234 FPNWFDGRARDLVKGLLQTDHTKRLGT 260 (329)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 233355678999999999999999985
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=349.55 Aligned_cols=239 Identities=26% Similarity=0.380 Sum_probs=203.7
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcC-CCCceeeEecccC--CCc
Q 005616 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACP--EAW 410 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~--~~~ 410 (688)
..-.+|....+||+|+||+|+++.+. +..+|||++++... .+.+....|..|+... +||.++.|+.+|+ +..
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34468999999999999999999987 67899999998865 3455678899988887 5999999999995 468
Q ss_pred eeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
++||||+.||++..+.. ...+++..+.-++..|+.||.|||.++ |||||||.+|||||.+|++||+|||+++.
T Consensus 445 ~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 99999999999443332 245888999999999999999999976 99999999999999999999999999997
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCC
Q 005616 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDP 568 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp 568 (688)
..... ..+.+.+|||.|||||++.+..|+..+|+|||||+|||||+|..||.+.++ +...+...
T Consensus 518 ~m~~g------~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-------- 583 (694)
T KOG0694|consen 518 GMGQG------DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-------- 583 (694)
T ss_pred cCCCC------CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------
Confidence 65332 145788999999999999999999999999999999999999999986554 33333322
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCC
Q 005616 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDI 599 (688)
Q Consensus 569 ~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 599 (688)
..-+|..++.+.+.++.++|..+|.+|-.+
T Consensus 584 -~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 -EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 124677889999999999999999999988
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=326.31 Aligned_cols=250 Identities=25% Similarity=0.365 Sum_probs=200.9
Q ss_pred cCcccceeeeccCceEEEEEEEC-----CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~-----g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
++|...+.||+|+||.||+|.+. +..||+|.++.... .....|.+|+.++..++||||++++|++.. ..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888899999999999999764 56899999976533 234568999999999999999999999844 58899
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
|||+++|+|.+++.... ..+++..++.++.+++.||.|||+.+ ++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999987543 46899999999999999999999965 99999999999999999999999998765432
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~ 570 (688)
.... ......++..|+|||++.+..++.++|||||||++||+++ |..||..... ....+..+...
T Consensus 160 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------- 227 (266)
T cd05064 160 EAIY-----TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------- 227 (266)
T ss_pred cchh-----cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-------
Confidence 2111 1123345678999999999999999999999999999775 9999964432 22333332211
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
..+..++..+.+++.+||+.+|.+||++. +|.+.|..+
T Consensus 228 -~~~~~~~~~~~~li~~c~~~~p~~RP~~~-~i~~~l~~~ 265 (266)
T cd05064 228 -PAPRNCPNLLHQLMLDCWQKERGERPRFS-QIHSILSKM 265 (266)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCCCHH-HHHHHHHhh
Confidence 12334566899999999999999999998 777777653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=344.28 Aligned_cols=253 Identities=29% Similarity=0.420 Sum_probs=200.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcC-CCCceeeEecccCC--C
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--A 409 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~ 409 (688)
.++|...+.||+|+||.||+|.+. +..||||+++.... .....+.+|+.+|..+ +|||||+++|+|.+ .
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 457888999999999999999742 45799999975432 3345688999999999 89999999999954 4
Q ss_pred ceeEEeeCCCCcHHHHhcccCC----------------------------------------------------------
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSN---------------------------------------------------------- 431 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~---------------------------------------------------------- 431 (688)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 7899999999999998864321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 432 --------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 432 --------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
...++|..++.|+.+|+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 125789999999999999999999965 999999999999999999999999999876543211
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh---HHHHHhhcCccccccCCCCCCC
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG---EVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~---~~~~~i~~~~l~~~ldp~~~~~ 573 (688)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.... .....+..+... ..
T Consensus 271 ----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--------~~ 338 (375)
T cd05104 271 ----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM--------LS 338 (375)
T ss_pred ----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC--------CC
Confidence 11223345678999999999999999999999999999998 889986432 233333333211 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHH
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~ 609 (688)
+...+..+.+|+.+||+.||.+||++. +|++.|+.
T Consensus 339 ~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~~l~~ 373 (375)
T cd05104 339 PECAPSEMYDIMKSCWDADPLKRPTFK-QIVQLIEQ 373 (375)
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHH-HHHHHHHh
Confidence 222356899999999999999999999 77777764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=335.30 Aligned_cols=230 Identities=25% Similarity=0.329 Sum_probs=190.1
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEEecCC---ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCcH
Q 005616 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 422 (688)
Q Consensus 350 LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~---~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL 422 (688)
||+|+||.||+|... +..||+|++.... ......+.+|+.++.+++||||++++++|.+ ..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999886 7889999997542 2334568899999999999999999998854 58899999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCcc
Q 005616 423 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502 (688)
Q Consensus 423 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~ 502 (688)
.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~------ 148 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD------ 148 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC------
Confidence 9998754 35789999999999999999999966 99999999999999999999999999986432221
Q ss_pred ccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHHHH
Q 005616 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARR 580 (688)
Q Consensus 503 ~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~~~ 580 (688)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+. ..++...+..
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 219 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP---------LRFPDGFDRD 219 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC---------CCCCCcCCHH
Confidence 22456799999999999999999999999999999999999999964332 222222211 1234455678
Q ss_pred HHHHHHHcccCCCCCCCCCc
Q 005616 581 LVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 581 l~~Li~~Cl~~dP~~RPs~~ 600 (688)
+.+|+.+||..||.+||++.
T Consensus 220 ~~~li~~~L~~dp~~R~~~~ 239 (312)
T cd05585 220 AKDLLIGLLSRDPTRRLGYN 239 (312)
T ss_pred HHHHHHHHcCCCHHHcCCCC
Confidence 99999999999999999875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.98 Aligned_cols=244 Identities=29% Similarity=0.448 Sum_probs=210.4
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
+-|..++.||.|+.|.|..|++. |+.+|||++.+... .....+.+|+-||+.+.|||+++||+++.+ .+|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45677889999999999999885 99999999976632 234568899999999999999999999965 589999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|-|.++|..++ ++++.+..+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|..-..+
T Consensus 92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999998775 5888999999999999999999987 999999999999999999999999999987665
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCC-CCcchHhHHHHHHHHHHhCCCCCCCh--hHHHHHhhcCccccccCCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVL-TPKSDSYSFGLIILQLLTGRLPVGLA--GEVRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSfGviL~ELltG~~Pf~~~--~~~~~~i~~~~l~~~ldp~~~ 571 (688)
.. -.+-+|.|.|.|||++.+.+| +.++||||+|||||.||||+.||+.. ..+...+..|.+
T Consensus 166 kl-------LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f--------- 229 (786)
T KOG0588|consen 166 KL-------LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF--------- 229 (786)
T ss_pred cc-------ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc---------
Confidence 43 246689999999999999988 57999999999999999999999732 223444555654
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
+.|.+++.+..+|+.+|+..||..|.|+.+.+.+.+
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 456778889999999999999999999996665554
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.42 Aligned_cols=253 Identities=26% Similarity=0.370 Sum_probs=202.1
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccCC----CceeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV 413 (688)
+.|..+.+||+|.||.||+++.. |+.||+|++...... ...-..+|+.||++|+|||||+|.+...+ ..|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 45677789999999999999986 889999999887643 33456799999999999999999998733 48999
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
+|||+. +|..++.... -.|+..++..++.|++.||.|+|+.+ |+|||||.+|||||++|.+||+|||+|+++..
T Consensus 197 FeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999965 7777775533 35888999999999999999999966 99999999999999999999999999998865
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhc----C--------
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----G-------- 560 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~----~-------- 560 (688)
.... ..+..+-|..|.|||++.+. .|++++|+||.||||.||++|++.|.+..++.+.-.. |
T Consensus 271 ~~~~-----~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 271 SGSA-----PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred CCCc-----ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 5422 35778899999999988765 7999999999999999999999999877665443211 1
Q ss_pred --ccc--cccCCCCCCCCH-------HHHHHHHHHHHHcccCCCCCCCCCcHHHHHH
Q 005616 561 --KLS--SILDPLAGDWPT-------FVARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 561 --~l~--~~ldp~~~~~~~-------~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~ 606 (688)
++. ..+.| ...+.. ..+...++|+..+|..||.+|.|+.+.+...
T Consensus 346 ~~kLP~~~~~kp-~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se 401 (560)
T KOG0600|consen 346 VSKLPHATIFKP-QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSE 401 (560)
T ss_pred cccCCcccccCC-CCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCc
Confidence 111 11111 011111 2345788999999999999999998655443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=335.75 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=198.5
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEe
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYE 415 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E 415 (688)
.++|.....||+|+||.||+++.. |..||+|.+..... .....+.+|+.+|..++||||+++++++. +..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367889999999999999999986 78899999876532 23456999999999999999999999984 34889999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|+++|+|.+++.... .+++..+..++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999999986543 5788999999999999999999853 49999999999999999999999999987654322
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCcc------cc---
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKL------SS--- 564 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l------~~--- 564 (688)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... +...+..... ..
T Consensus 159 --------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 159 --------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred --------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccC
Confidence 2345799999999999999999999999999999999999999964332 1111110000 00
Q ss_pred -----------------------------ccCCCCCCC-CHHHHHHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 565 -----------------------------ILDPLAGDW-PTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 565 -----------------------------~ldp~~~~~-~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
++....... ...++..+.+|+.+||+.||++|||+.+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 1135678999999999999999999995443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=333.48 Aligned_cols=253 Identities=26% Similarity=0.433 Sum_probs=201.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--Ce----EEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC-CceeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GR----TVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~----~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV 413 (688)
.+|...+.||+|+||.||+|.+. |. .||||++..... .....|.+|+.++..++||||++++|+|.. ..++|
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 46888899999999999999873 33 489999875433 345678999999999999999999999854 57899
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
++|+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 87 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999999987643 35789999999999999999999965 99999999999999999999999999987654
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCccccccCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l~~~ldp~~ 570 (688)
..... ......++..|+|||++.+..++.++|||||||++|||++ |..||.... .+...+..+...
T Consensus 162 ~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------- 230 (316)
T cd05108 162 DEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL------- 230 (316)
T ss_pred CCcce----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCC-------
Confidence 32211 1123345678999999999999999999999999999998 999997533 222222222111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhh
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~ 612 (688)
..+..++..+.+++.+||..+|.+||++. +++..|..+..
T Consensus 231 -~~~~~~~~~~~~li~~cl~~~p~~Rps~~-~l~~~l~~~~~ 270 (316)
T cd05108 231 -PQPPICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMAR 270 (316)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCcCHH-HHHHHHHHHHc
Confidence 11223446789999999999999999999 66666766643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=338.07 Aligned_cols=229 Identities=26% Similarity=0.331 Sum_probs=189.5
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCc
Q 005616 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gs 421 (688)
.||+|+||.||++... |..||||++..... .....+.+|+.++..++||||++++++|.+ ..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 6999999999999875 88999999976432 233467889999999999999999998844 4789999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCc
Q 005616 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~ 501 (688)
|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 82 L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~------ 149 (323)
T cd05571 82 LFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG------ 149 (323)
T ss_pred HHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC------
Confidence 99988654 35789999999999999999999966 9999999999999999999999999987543221
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHHH
Q 005616 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVAR 579 (688)
Q Consensus 502 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~~ 579 (688)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..+. ..++...+.
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~---------~~~p~~~~~ 220 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------IRFPRTLSP 220 (323)
T ss_pred CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---------CCCCCCCCH
Confidence 112345799999999999999999999999999999999999999965432 222222221 133445667
Q ss_pred HHHHHHHHcccCCCCCCCC
Q 005616 580 RLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 580 ~l~~Li~~Cl~~dP~~RPs 598 (688)
.+.+|+.+||+.||.+||+
T Consensus 221 ~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HHHHHHHHHccCCHHHcCC
Confidence 8999999999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=338.23 Aligned_cols=245 Identities=25% Similarity=0.295 Sum_probs=198.8
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|.....||+|+||.||+|.+. +..||||++..... .....+.+|+.++..++||||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46888999999999999999986 78999999976432 234568899999999999999999999854 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 999999999999654 35788999999999999999999966 99999999999999999999999999986543
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCcccccc-CCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSIL-DPLAG 571 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~l-dp~~~ 571 (688)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... ....+.... ..+ .|...
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~ 223 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK--ETLQRPVYD 223 (333)
T ss_pred --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc--ccccCCCCC
Confidence 12456799999999999999999999999999999999999999975432 222222111 111 11111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
......+..+.+|+.+||..+|.+||++.+.+
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll 255 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIK 255 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHH
Confidence 11123567899999999999999999988444
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=327.22 Aligned_cols=249 Identities=22% Similarity=0.274 Sum_probs=195.0
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
++|...+.||+|+||.||+|++. +..||||++..... .....+.+|+.++..++||||++++++|.+ ..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999986 78899999976532 234568899999999999999999999854 4789999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|++++++..+.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99998877654322 45889999999999999999999966 9999999999999999999999999998764322
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhh----cCc----------
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGK---------- 561 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~----~~~---------- 561 (688)
.. ......||+.|+|||++.+..++.++|||||||++|||++|++||........... .+.
T Consensus 155 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 155 NA-----NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred cc-----cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 11 12345789999999999998999999999999999999999999975432211110 000
Q ss_pred ----cccccCCCC-------CCCCHHHHHHHHHHHHHcccCCCCCCCCCcH
Q 005616 562 ----LSSILDPLA-------GDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 562 ----l~~~ldp~~-------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
......+.. ..+....+..+.+|+.+||+.||.+|||+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~ 280 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQ 280 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHH
Confidence 000000000 0111234567999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.06 Aligned_cols=249 Identities=28% Similarity=0.452 Sum_probs=202.1
Q ss_pred cCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 418 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~ 418 (688)
++|...++||+|+||.||+|... +..||+|.+..... ....+.+|+.++..++||||+++++++.+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 56888899999999999999876 67799998865432 35678999999999999999999988744 4789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
+|+|.+++.... ...+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05072 85 KGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT- 159 (261)
T ss_pred CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence 999999986543 245789999999999999999999965 999999999999999999999999999876543211
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCccccccCCCCCCCCH
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l~~~ldp~~~~~~~ 575 (688)
......++..|+|||++....+++++|||||||++|+|+| |..||.... .....+..+... + ...
T Consensus 160 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----~----~~~ 227 (261)
T cd05072 160 ----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM----P----RME 227 (261)
T ss_pred ----ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC----C----CCC
Confidence 1223446778999999998899999999999999999998 999996432 223333222111 1 112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHH
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~ 609 (688)
.++..+.+++.+||..+|++||++. ++.+.|+.
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~ 260 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTFD-YLQSVLDD 260 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHH-HHHHHHhc
Confidence 3456789999999999999999998 88888875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=343.01 Aligned_cols=254 Identities=28% Similarity=0.453 Sum_probs=201.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcC-CCCceeeEecccCC--C
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--A 409 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~ 409 (688)
.++|...+.||+|+||.||+|... +..||||++..... .....+.+|+.+++.+ +|||||+++|+|.+ .
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457888999999999999999753 24799999976543 2345688999999999 89999999999854 4
Q ss_pred ceeEEeeCCCCcHHHHhcccC-----------------------------------------------------------
Q 005616 410 WSLVYEYLPNGSLQDRLFRKS----------------------------------------------------------- 430 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~----------------------------------------------------------- 430 (688)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 789999999999999885421
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCcc
Q 005616 431 --------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502 (688)
Q Consensus 431 --------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~ 502 (688)
...++++..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........ .
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~----~ 269 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY----V 269 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce----e
Confidence 1135788999999999999999999965 999999999999999999999999999876433211 1
Q ss_pred ccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH---HHHHhhcCccccccCCCCCCCCHHHH
Q 005616 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE---VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 503 ~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~---~~~~i~~~~l~~~ldp~~~~~~~~~~ 578 (688)
......++..|+|||++....++.++|||||||++|+|++ |+.||..... ....+..+. . ...+...+
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~-----~---~~~~~~~~ 341 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY-----Q---MSRPDFAP 341 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc-----C---ccCCCCCC
Confidence 1223345678999999998999999999999999999997 9999964332 222222221 0 11122345
Q ss_pred HHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 579 RRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 579 ~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
..+.+++.+||+.||.+||++. +|++.|+.+
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~-~l~~~l~~~ 372 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFS-QISQLIQRQ 372 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHH-HHHHHHHHH
Confidence 6899999999999999999999 888888765
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.88 Aligned_cols=251 Identities=33% Similarity=0.520 Sum_probs=202.8
Q ss_pred CcccceeeeccCceEEEEEEECC-------eEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005616 343 NFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~g-------~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
+|...+.||+|+||.||+|...+ ..||+|.+..... .....|.+|+.++..++||||+++++++.+ ..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 57778899999999999998752 5699999875443 234568999999999999999999999854 4789
Q ss_pred EEeeCCCCcHHHHhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCc
Q 005616 413 VYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 479 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~ 479 (688)
+|||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 9999999999999875421 145889999999999999999999966 999999999999999999
Q ss_pred eEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHH
Q 005616 480 SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRA 556 (688)
Q Consensus 480 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~ 556 (688)
+||+|||++......... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.... .+...
T Consensus 163 ~~L~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 163 VKISDFGLSRDIYSADYY----RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred EEECCCcceeeccccccc----cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999865432211 12234567889999999998999999999999999999998 999986432 33333
Q ss_pred hhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHH
Q 005616 557 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 557 i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~ 609 (688)
+..+... ..+..++..+.+|+.+||+.||.+||++. +|.+.|+.
T Consensus 239 i~~~~~~--------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~-~i~~~l~~ 282 (283)
T cd05048 239 IRSRQLL--------PCPEDCPARVYALMIECWNEIPARRPRFK-DIHTRLRS 282 (283)
T ss_pred HHcCCcC--------CCcccCCHHHHHHHHHHccCChhhCcCHH-HHHHHHhc
Confidence 3333221 22345667899999999999999999999 77777653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=338.23 Aligned_cols=255 Identities=25% Similarity=0.319 Sum_probs=205.8
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc-hHHHHHHHHHHHcCC-CCceeeEecccCC---Ccee
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG-QLEFQQEVRVLSKLQ-HPHLVTLLGACPE---AWSL 412 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~-~~~f~~E~~iL~~l~-HpnIV~l~g~~~~---~~~L 412 (688)
..++|...++||.|.||.||+|+.. |..||||.++..-..- ...-.+|++.|.+|+ |||||+|..++.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4467888999999999999999875 8899999987654332 223468999999998 9999999999844 4789
Q ss_pred EEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccccc
Q 005616 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~ 492 (688)
|||||+ .+|.+++..+ ...+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+.+.
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999994 6899988776 368999999999999999999999977 9999999999999999999999999999886
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhh-ccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCc----------
Q 005616 493 EDTLYLPSFHRSTAPKGSFPYADPEYH-RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGK---------- 561 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~-~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~---------- 561 (688)
... ..+..+.|..|.|||++ +.+.|+.+.|+||+|||++|+.+-++.|.+..++.+.+..-.
T Consensus 162 Skp-------PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 162 SKP-------PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred cCC-------CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 544 34678899999999976 667899999999999999999999999987776654432110
Q ss_pred -----cccccCCC--------CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 562 -----LSSILDPL--------AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 562 -----l~~~ldp~--------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
+...+... ....-+..+.++.+|+.+||.+||.+|||+.+.+...+
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 11111110 11111236778999999999999999999996554433
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=319.25 Aligned_cols=246 Identities=26% Similarity=0.458 Sum_probs=198.0
Q ss_pred cCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 418 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~ 418 (688)
++|...+.||+|+||.||+|.+. +..+|+|.+.... .....|.+|+.++.+++||||++++++|.+ ..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 45777889999999999999887 5689999886443 335678999999999999999999999854 4789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
+|+|.+++.... ..++|..+..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999999886543 35889999999999999999999966 999999999999999999999999998865432211
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCCCCH
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~ 575 (688)
......++..|+|||++.+..++.++||||||+++|+|++ |+.||..... ....+..+... ..+.
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--------~~~~ 224 (256)
T cd05114 157 ----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL--------YRPK 224 (256)
T ss_pred ----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC--------CCCC
Confidence 1223346678999999988899999999999999999999 8999965432 22333333211 1122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
..+..+.+|+.+||+.+|.+||++. +++..|
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~-~l~~~l 255 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFA-ELLRAI 255 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHH-HHHHhh
Confidence 2346789999999999999999998 565543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=350.51 Aligned_cols=248 Identities=21% Similarity=0.251 Sum_probs=202.2
Q ss_pred CcccceeeeccCceEEEEEEEC---CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeC
Q 005616 343 NFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~---g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
.|...+.||+|+||.||++... +..||+|.+..........+.+|+.+|+.++|||||+++++|. +..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999764 5678999876555555556889999999999999999999984 4589999999
Q ss_pred CCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 418 PNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 418 ~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
++|+|.+++... ....++++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988643 23356889999999999999999999965 99999999999999999999999999987654321
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~ 574 (688)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... +...+..+... ..+
T Consensus 225 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~--------~~~ 292 (478)
T PTZ00267 225 L----DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD--------PFP 292 (478)
T ss_pred c----ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------CCC
Confidence 1 123456799999999999999999999999999999999999999975432 22223223221 123
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCCcHHHHH
Q 005616 575 TFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 575 ~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~ 605 (688)
..++..+.+|+.+||..||..||++.+.+.+
T Consensus 293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 3455789999999999999999999865543
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=319.91 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=202.4
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
.+|...+.||.|+||.||+|.+. +..||+|.+.... .....+.+|+.++..++||||++++++|.. ..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35777889999999999999885 7889999987543 345678999999999999999999999843 478999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++++|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999986543 245899999999999999999999965 999999999999999999999999999876543211
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCCCC
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~ 574 (688)
......++..|+|||++.+..++.++|||||||++|||++ |..||..... ....+..+. ....+
T Consensus 161 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--------~~~~~ 227 (263)
T cd05052 161 -----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY--------RMERP 227 (263)
T ss_pred -----ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--------CCCCC
Confidence 1122334678999999999999999999999999999998 9999864332 222222221 11223
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 575 ~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
...+..+.+++.+||+.+|.+||++. ++.+.|+.+
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~-~l~~~l~~~ 262 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFA-EIHQAFETM 262 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHH-HHHHHHHhh
Confidence 34567899999999999999999999 788887754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=334.35 Aligned_cols=229 Identities=26% Similarity=0.334 Sum_probs=188.4
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCc
Q 005616 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gs 421 (688)
.||+|+||.||++... |..||+|++..... .....+.+|+.++..++||||++++++|.. ..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 6999999999999875 78999999976432 234467889999999999999999998843 5889999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCc
Q 005616 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~ 501 (688)
|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~----- 150 (323)
T cd05595 82 LFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-----
Confidence 998886543 5789999999999999999999966 99999999999999999999999999875432211
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHHH
Q 005616 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVAR 579 (688)
Q Consensus 502 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~~ 579 (688)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..+. ..+|...+.
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~---------~~~p~~~~~ 220 (323)
T cd05595 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------IRFPRTLSP 220 (323)
T ss_pred -ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------CCCCCCCCH
Confidence 12345799999999999999999999999999999999999999965432 222222111 123445567
Q ss_pred HHHHHHHHcccCCCCCCCC
Q 005616 580 RLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 580 ~l~~Li~~Cl~~dP~~RPs 598 (688)
.+.+|+.+||+.||.+||+
T Consensus 221 ~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HHHHHHHHHccCCHHHhCC
Confidence 8999999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=318.59 Aligned_cols=250 Identities=28% Similarity=0.448 Sum_probs=202.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeC
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
.++|...+.||+|+||.||+|.+. +..||||.++... .....|.+|+.++.+++||||+++++++.. ..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 456888899999999999999876 6789999987544 345679999999999999999999998854 478999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999987644 346899999999999999999999965 999999999999999999999999999877532211
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCCCC
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~ 574 (688)
......++..|+|||++.+..++.++||||||+++|+|+| |+.||..... ....+..+.. ...+
T Consensus 160 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------~~~~ 226 (261)
T cd05068 160 -----AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR--------MPCP 226 (261)
T ss_pred -----ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------CCCC
Confidence 1112233468999999999999999999999999999999 9999965432 2222222111 0122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHH
Q 005616 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 575 ~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~ 609 (688)
...+..+.+++.+||+.+|.+||++. .+...|+.
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~-~l~~~l~~ 260 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFE-TLQWKLED 260 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHH-HHHHHHhc
Confidence 23456899999999999999999999 78777764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.39 Aligned_cols=229 Identities=27% Similarity=0.331 Sum_probs=188.8
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCc
Q 005616 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gs 421 (688)
.||+|+||.||++... |..||||++..... .....+.+|+.++..++||||+++++++.+ ..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 6999999999999875 78999999976432 234568899999999999999999998844 4789999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCc
Q 005616 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~ 501 (688)
|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 82 L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~----- 150 (328)
T cd05593 82 LFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA----- 150 (328)
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-----
Confidence 99888654 35889999999999999999999966 99999999999999999999999999876432211
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHHH
Q 005616 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVAR 579 (688)
Q Consensus 502 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~~ 579 (688)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+. ..+|...+.
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~---------~~~p~~~~~ 220 (328)
T cd05593 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED---------IKFPRTLSA 220 (328)
T ss_pred -ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC---------ccCCCCCCH
Confidence 12345799999999999999999999999999999999999999965432 212221111 123445567
Q ss_pred HHHHHHHHcccCCCCCCCC
Q 005616 580 RLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 580 ~l~~Li~~Cl~~dP~~RPs 598 (688)
.+.+|+.+||+.||.+||+
T Consensus 221 ~~~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLG 239 (328)
T ss_pred HHHHHHHHHcCCCHHHcCC
Confidence 8999999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.67 Aligned_cols=249 Identities=26% Similarity=0.375 Sum_probs=191.1
Q ss_pred CcccceeeeccCceEEEEEEEC---CeEEEEEEEecCCcc--chHHHHHHHHHHHcC---CCCceeeEecccC-------
Q 005616 343 NFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKL---QHPHLVTLLGACP------- 407 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~---g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l---~HpnIV~l~g~~~------- 407 (688)
+|...+.||+|+||.||+|+.. |..||||++...... ....+.+|+.++..+ +||||++++++|.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6888899999999999999873 678999998754332 234566788777766 6999999999873
Q ss_pred CCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCc
Q 005616 408 EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 408 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGl 487 (688)
...++||||++ ++|.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 23789999996 689888865432 35899999999999999999999966 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH--HhhcC-----
Q 005616 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSCG----- 560 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~i~~~----- 560 (688)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|++||........ .+...
T Consensus 157 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~ 229 (290)
T cd07862 157 ARIYSFQM-------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 229 (290)
T ss_pred eEeccCCc-------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence 98764332 22455799999999999988999999999999999999999999975433211 11100
Q ss_pred --cc-------ccccCCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 561 --KL-------SSILDPLAG----DWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 561 --~l-------~~~ldp~~~----~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.. ...+.+... ...+..+..+.+|+.+||+.||++||++.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 00 000000000 01123456788999999999999999998443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=337.15 Aligned_cols=233 Identities=25% Similarity=0.305 Sum_probs=194.4
Q ss_pred cCcccceeeeccCceEEEEEEEC---CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~---g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
++|.....||+|+||.||+|.+. +..||+|++..... .....+.+|+.++..++|||||+++++|.+ ..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 46888999999999999999865 35799999865432 334568899999999999999999999854 47899
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999987543 5788999999999999999999966 99999999999999999999999999987543
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~ 571 (688)
. .....||+.|+|||++.+..++.++|||||||++|||++|..||..... ....+..+..
T Consensus 184 ~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~--------- 245 (340)
T PTZ00426 184 R---------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII--------- 245 (340)
T ss_pred C---------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---------
Confidence 2 1345799999999999999999999999999999999999999975543 2233333221
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCC
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs 598 (688)
.+|...+..+.+++.+||+.||.+|++
T Consensus 246 ~~p~~~~~~~~~li~~~l~~dp~~R~~ 272 (340)
T PTZ00426 246 YFPKFLDNNCKHLMKKLLSHDLTKRYG 272 (340)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHcCC
Confidence 233345567899999999999999974
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=324.14 Aligned_cols=255 Identities=29% Similarity=0.470 Sum_probs=207.1
Q ss_pred cCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
.+|.....||+|+||.||+|... +..|++|.+..........|.+|+.++++++||||+++++++.+ ..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999753 35689999876665566779999999999999999999999854 4789
Q ss_pred EEeeCCCCcHHHHhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCc
Q 005616 413 VYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 479 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~ 479 (688)
||||+++++|.+++..... ...++|..++.++.+|+.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999865421 234899999999999999999999966 999999999999999999
Q ss_pred eEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHH
Q 005616 480 SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRA 556 (688)
Q Consensus 480 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~ 556 (688)
++|+|||++......... .......|+..|+|||++.+..++.++|||||||++|||+| |..||.... .....
T Consensus 162 ~~l~dfg~a~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred EEECCCCcccccCCCcee----ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999765432211 12234557889999999999999999999999999999999 999985433 23333
Q ss_pred hhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhh
Q 005616 557 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 557 i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~ 612 (688)
+..+.... .+...+..+.+|+.+||+.+|.+||++. ++.+.|+.+..
T Consensus 238 ~~~~~~~~--------~~~~~~~~~~~li~~~l~~~P~~Rpt~~-~v~~~l~~~~~ 284 (291)
T cd05094 238 ITQGRVLE--------RPRVCPKEVYDIMLGCWQREPQQRLNIK-EIYKILHALGK 284 (291)
T ss_pred HhCCCCCC--------CCccCCHHHHHHHHHHcccChhhCcCHH-HHHHHHHHHHh
Confidence 33332221 1223456799999999999999999999 89999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=331.81 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=191.3
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC-------Cce
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------AWS 411 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------~~~ 411 (688)
+|...+.||+|+||.||+|... |..||||++.... ......+.+|+.+++.++||||+++++++.. ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999875 7899999987432 2334568899999999999999999998721 268
Q ss_pred eEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccc
Q 005616 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~ 491 (688)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 6888888654 35889999999999999999999966 999999999999999999999999999865
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhcc--CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH--------------
Q 005616 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR-------------- 555 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~-------------- 555 (688)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|+||++||........
T Consensus 154 ~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 154 FNDTPT---AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred ccccCc---cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 332211 011234679999999999876 6789999999999999999999999964332110
Q ss_pred ---HhhcCccccccC----CCCCCC---CHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 556 ---AVSCGKLSSILD----PLAGDW---PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 556 ---~i~~~~l~~~ld----p~~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.+........+. .....+ -+..+..+.+|+.+||+.||.+||++.+.+
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l 288 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHh
Confidence 011110000000 000000 012345788999999999999999998544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=325.44 Aligned_cols=245 Identities=37% Similarity=0.625 Sum_probs=192.5
Q ss_pred cceeeeccCceEEEEEEEC------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEee
Q 005616 346 ESFKVGQGGFGCVYKGEML------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 346 ~~~~LG~G~~G~Vy~g~~~------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
....||.|.||.||+|.+. +..|+||.++.... .....|.+|+.++.+++||||++++|+|. +..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3468999999999999987 67899999965433 34678999999999999999999999995 347899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++|+|.++|.... ...+++..++.|+.||+.||.|||+.+ |+|+||+++|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999998762 246899999999999999999999966 99999999999999999999999999987732221
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCccccccCCCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l~~~ldp~~~~~ 573 (688)
. .......+...|+|||.+....++.++||||||+++|||++ |+.||.... .+...+..+... ..
T Consensus 159 ~----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~--------~~ 226 (259)
T PF07714_consen 159 Y----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRL--------PI 226 (259)
T ss_dssp E----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEET--------TS
T ss_pred c----ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ee
Confidence 1 12344557788999999999999999999999999999999 789986433 233334333321 22
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
+..++..+.+++..||..+|.+||++. ++++.|
T Consensus 227 ~~~~~~~~~~li~~C~~~~p~~RPs~~-~i~~~L 259 (259)
T PF07714_consen 227 PDNCPKDIYSLIQQCWSHDPEKRPSFQ-EILQEL 259 (259)
T ss_dssp BTTSBHHHHHHHHHHT-SSGGGS--HH-HHHHHH
T ss_pred ccchhHHHHHHHHHHcCCChhhCcCHH-HHHhcC
Confidence 334566789999999999999999998 665554
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=322.46 Aligned_cols=253 Identities=29% Similarity=0.463 Sum_probs=200.8
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--C
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--A 409 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~ 409 (688)
++++|+..+.||+|+||.||+|.+. +..||||++..... .....|.+|+.++..++||||+++++++.+ .
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5678999999999999999999764 35799999865432 334568999999999999999999999854 4
Q ss_pred ceeEEeeCCCCcHHHHhcccCC-------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEE
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSN-------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI 482 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL 482 (688)
.++||||+++|+|.+++..... ...+++..++.++.+++.||.|||+.+ ++|+||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 7899999999999999865321 234688999999999999999999965 999999999999999999999
Q ss_pred eecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhc
Q 005616 483 CDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSC 559 (688)
Q Consensus 483 ~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~ 559 (688)
+|||++......... .......+++.|+|||++.++.++.++|||||||++|||++ |..||..... ....+..
T Consensus 161 ~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 161 GDFGMTRDIYETDYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred CCCCCccccCCccee----ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999998865433211 11223456788999999999999999999999999999999 7889864432 2222222
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 560 ~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
+... ..+...+..+.+++.+||+.+|.+||++. +++..|+
T Consensus 237 ~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~-e~l~~l~ 276 (277)
T cd05062 237 GGLL--------DKPDNCPDMLFELMRMCWQYNPKMRPSFL-EIISSIK 276 (277)
T ss_pred CCcC--------CCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHhh
Confidence 2221 12233456799999999999999999998 6665554
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=331.63 Aligned_cols=242 Identities=26% Similarity=0.366 Sum_probs=193.2
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHH---HcCCCCceeeEecccCC--CceeE
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVL---SKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL---~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
|...+.||+|+||.||+|.+. |..||||++..... .....+.+|+.++ ..++||||+++++++.+ ..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999886 78999999975432 2234566776665 56689999999999844 58899
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
|||+++|+|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999988754 35899999999999999999999966 99999999999999999999999999875432
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~ 571 (688)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+..
T Consensus 154 ~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~--------- 218 (324)
T cd05589 154 FG------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV--------- 218 (324)
T ss_pred CC------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 21 122456799999999999999999999999999999999999999975432 2222222211
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
.++...+..+.+++.+||+.||.+||++.+..+..+
T Consensus 219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l 254 (324)
T cd05589 219 RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDV 254 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHH
Confidence 233345678899999999999999998764433333
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.85 Aligned_cols=242 Identities=25% Similarity=0.317 Sum_probs=196.0
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
+|...+.||+|+||.||++... +..||||++...... ....+.+|+.++..++||||+++++++.. ..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999875 789999999754332 23457889999999999999999998854 5889999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999988865432 46899999999999999999999966 9999999999999999999999999998754322
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHH--HHhhcCccccccCCCCCCC
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~i~~~~l~~~ldp~~~~~ 573 (688)
......|++.|+|||++.+..++.++|||||||++|+|++|..||....... ..+.. .+......+
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~-----~~~~~~~~~ 224 (285)
T cd05605 157 -------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER-----RVKEDQEEY 224 (285)
T ss_pred -------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH-----Hhhhccccc
Confidence 1234578999999999998999999999999999999999999997543211 11110 011112234
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
+..++..+.+|+.+||+.||.+||+..
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCR 251 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCC
Confidence 445677899999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=363.52 Aligned_cols=251 Identities=31% Similarity=0.538 Sum_probs=208.0
Q ss_pred CcccceeeeccCceEEEEEEEC---Ce----EEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML---GR----TVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~---g~----~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
+......||+|.||.||.|... |. .||||.++... .+...+|.+|..+|++++|||||+++|+|.+ ..+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 3455678999999999999885 33 39999997764 4566789999999999999999999999954 4789
Q ss_pred EEeeCCCCcHHHHhcccC----CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcc
Q 005616 413 VYEYLPNGSLQDRLFRKS----NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla 488 (688)
++|||.+|+|..+|.+.. ....|+..+.+.++.+||+|+.||++.+ +|||||...|+||+....+||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999998762 2356899999999999999999999966 999999999999999999999999999
Q ss_pred ccccCCCCcCCCccccCCC-CCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHh-hcCccc
Q 005616 489 RLVTEDTLYLPSFHRSTAP-KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAV-SCGKLS 563 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~-~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i-~~~~l~ 563 (688)
+.+-....+ ..... .-...|||||.+..+.++.|+|||||||+|||++| |..||....+ +...+ ..|.+
T Consensus 850 rDiy~~~yy-----r~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL- 923 (1025)
T KOG1095|consen 850 RDIYDKDYY-----RKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL- 923 (1025)
T ss_pred Hhhhhchhe-----eccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc-
Confidence 955443322 11222 23357999999999999999999999999999999 9999986654 33323 33422
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhh
Q 005616 564 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 564 ~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~ 611 (688)
+.|..++..+.+|+.+||+.+|++||+++ .|++.+..+.
T Consensus 924 --------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~-~i~~q~~~i~ 962 (1025)
T KOG1095|consen 924 --------DPPSYCPEKLYQLMLQCWKHDPEDRPSFR-TIVEQDPAIS 962 (1025)
T ss_pred --------CCCCCCChHHHHHHHHHccCChhhCccHH-HHHhhhhhhh
Confidence 34567788999999999999999999999 7777776654
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.35 Aligned_cols=251 Identities=30% Similarity=0.528 Sum_probs=207.7
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
...+|...+.||.|+||.||+|... +..||+|++..........+..|+.++..++||||+++++++.+ ..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3457888899999999999999987 68899999987766567789999999999999999999999844 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++|+|.+++..... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999976532 46899999999999999999999966 99999999999999999999999999987654321
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCccccccCCCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l~~~ldp~~~~~ 573 (688)
......++..|+|||++....++.++||||||+++|+|++ |+.||.... .....+..+. ....
T Consensus 160 ------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~ 225 (261)
T cd05148 160 ------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY--------RMPC 225 (261)
T ss_pred ------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC--------cCCC
Confidence 1224456778999999998899999999999999999998 899996433 2222222211 1122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHH
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~ 609 (688)
+...+..+.+++.+||+.+|.+||++. ++.+.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~-~l~~~L~~ 260 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFK-ALREELDN 260 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHhc
Confidence 334567899999999999999999999 88888875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.00 Aligned_cols=238 Identities=23% Similarity=0.338 Sum_probs=191.0
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCcH
Q 005616 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 422 (688)
Q Consensus 350 LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL 422 (688)
||+|+||+||++... |..||+|.+...... ....+..|+.++..++||||+++++++.. ..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 789999998754332 23467889999999999999999998844 47899999999999
Q ss_pred HHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCc
Q 005616 423 QDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 423 ~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~ 501 (688)
..++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~----- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS----- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-----
Confidence 98875432 2356899999999999999999999965 99999999999999999999999999987654321
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCccccccCCCCCCCCHHHHH
Q 005616 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTFVAR 579 (688)
Q Consensus 502 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~ldp~~~~~~~~~~~ 579 (688)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+.... +.. ...++..++.
T Consensus 153 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~ 226 (280)
T cd05608 153 -KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI----LND-SVTYPDKFSP 226 (280)
T ss_pred -cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh----ccc-CCCCcccCCH
Confidence 123457999999999999999999999999999999999999999643211 11111110 110 1133445677
Q ss_pred HHHHHHHHcccCCCCCCCCCcH
Q 005616 580 RLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 580 ~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
.+.+++.+||+.||.+||++.+
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~ 248 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRD 248 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCC
Confidence 8999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.83 Aligned_cols=248 Identities=26% Similarity=0.336 Sum_probs=205.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEee
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
..|.....||+|.||.||+|.+. ++.||||++...... ..+++++|+.+|+.++++||.++||.+. ..+.++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34666678999999999999986 889999999876554 4567999999999999999999999884 457899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
|.||++.+.|.... .+.+..+.-|+.++..||.|||..+ .+|||||+.||||..+|.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999986543 3466778889999999999999966 99999999999999999999999999998876542
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHH
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~ 576 (688)
+....+|||.|||||++....|+.|+||||||++.+||.+|.+|+.....+...+ .+...........
T Consensus 167 ------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------lIpk~~PP~L~~~ 234 (467)
T KOG0201|consen 167 ------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------LIPKSAPPRLDGD 234 (467)
T ss_pred ------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------eccCCCCCccccc
Confidence 3478899999999999998899999999999999999999999997555422111 1111112233336
Q ss_pred HHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 577 VARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
+++.+.+++..||+.||+.||++.+.+.+.+
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~F 265 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLKHKF 265 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhhHH
Confidence 6788999999999999999999996665544
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=331.08 Aligned_cols=238 Identities=26% Similarity=0.335 Sum_probs=193.2
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC---ccchHHHHHHHHHHHcCCCC-ceeeEecccC--CCceeEE
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHP-HLVTLLGACP--EAWSLVY 414 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~---~~~~~~f~~E~~iL~~l~Hp-nIV~l~g~~~--~~~~LV~ 414 (688)
+|...+.||+|+||.||+|... +..||||++.... ......+..|..++..+.|+ +|+++++++. +..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999886 6789999997542 23345688899999999765 5788888874 4588999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999988654 35788999999999999999999965 999999999999999999999999998753221
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~ 572 (688)
.. ......||+.|+|||++.+..++.++|||||||++|+|+||+.||..... ....+..+. ..
T Consensus 155 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~---------~~ 219 (324)
T cd05587 155 GK------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN---------VS 219 (324)
T ss_pred CC------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------CC
Confidence 11 12345799999999999999999999999999999999999999975443 222222221 12
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCcH
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
++...+..+.+|+.+||..||.+||+...
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 248 (324)
T cd05587 220 YPKSLSKEAVSICKGLLTKHPAKRLGCGP 248 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCC
Confidence 33445678899999999999999999753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=329.86 Aligned_cols=234 Identities=27% Similarity=0.369 Sum_probs=188.9
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeEEeeCCCC
Q 005616 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||+|... +..||||+++.... .....+..|..++..+ +||||+++++++.. ..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999886 67899999976422 2334566677777654 89999999998843 478999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCC
Q 005616 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~ 500 (688)
+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~----- 150 (316)
T cd05592 82 DLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----- 150 (316)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-----
Confidence 9999886543 5788999999999999999999966 9999999999999999999999999997653322
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHH
Q 005616 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~ 578 (688)
.......||+.|+|||++.+..++.++|||||||++|||++|..||..... +...+... ...++...+
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~---------~~~~~~~~~ 220 (316)
T cd05592 151 -GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND---------RPHFPRWIS 220 (316)
T ss_pred -CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------CCCCCCCCC
Confidence 122455799999999999999999999999999999999999999975443 22222111 112334456
Q ss_pred HHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 579 RRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 579 ~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
..+.+|+.+||+.||.+||++.+.+
T Consensus 221 ~~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 221 KEAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHH
Confidence 7889999999999999999986444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=307.97 Aligned_cols=249 Identities=26% Similarity=0.374 Sum_probs=200.7
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc--hHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~--~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|...++||+|.||.||+|++. |+.||||+++.....+ .....+|++.|+.++|||||.|+++|.+ +..||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 5667789999999999999986 8999999998764432 2357899999999999999999999965 58899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
|+ .+|...+.... ..++-.++..++.++++||+|||... |+||||||.|+|++.+|.+||+|||+|+.+.....
T Consensus 83 m~-tdLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 83 MP-TDLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-ccHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 95 58999887655 56888999999999999999999976 99999999999999999999999999999875542
Q ss_pred cCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhc----C--------ccc
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----G--------KLS 563 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~----~--------~l~ 563 (688)
. .+..+-|..|.|||.+.+ ..|+..+|+||.|||+.||+-|.+-|.+..++.+.... | .+.
T Consensus 157 ~------~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 157 I------QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred c------cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 2 233478999999997765 57999999999999999999999988777665543211 0 111
Q ss_pred cccC---------CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 564 SILD---------PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 ~~ld---------p~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.+.| +.....-+..+..+.+|+..++..||.+|+++.+.+
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL 279 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQAL 279 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHh
Confidence 1111 111112223566789999999999999999998544
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=329.98 Aligned_cols=237 Identities=27% Similarity=0.342 Sum_probs=193.9
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeEE
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV~ 414 (688)
+|.....||+|+||.||+|... +..||||++..... .....+..|..++..+ +||+|+++++++.+ ..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5778899999999999999886 67899999976432 2334567788888877 58999999998844 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999886543 5788999999999999999999965 999999999999999999999999999764322
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~ 572 (688)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ....+..+. ..
T Consensus 155 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---------~~ 219 (323)
T cd05616 155 GV------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------VA 219 (323)
T ss_pred CC------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CC
Confidence 21 12456799999999999999999999999999999999999999975442 222232221 12
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
+|...+..+.+|+.+||+.+|.+|++..
T Consensus 220 ~p~~~s~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05616 220 YPKSMSKEAVAICKGLMTKHPGKRLGCG 247 (323)
T ss_pred CCCcCCHHHHHHHHHHcccCHHhcCCCC
Confidence 3445567899999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=317.58 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=202.4
Q ss_pred cCcccceeeeccCceEEEEEEEC-----CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~-----g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
++|...+.||+|+||.||+|.+. ...||||.+...... ....|.+|+.++..++||||+++++++.+ ..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56888899999999999999885 347999998755433 34578999999999999999999998844 47899
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
|||+++++|.+++.... ..+++..++.++.+++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999987643 36899999999999999999999966 99999999999999999999999999998752
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCccccccCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l~~~ldp~~ 570 (688)
.... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.... .....+..+...
T Consensus 159 ~~~~----~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------- 227 (266)
T cd05033 159 SEAT----YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL------- 227 (266)
T ss_pred cccc----eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 2211 11223345678999999999999999999999999999998 999985433 222333222111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
..+...+..+.+|+.+||+.+|.+||++. ++++.|+.+
T Consensus 228 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~-ei~~~l~~~ 265 (266)
T cd05033 228 -PPPMDCPSALYQLMLDCWQKDRNERPTFS-QIVSTLDKM 265 (266)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHhh
Confidence 11223456789999999999999999999 787777754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=324.71 Aligned_cols=239 Identities=26% Similarity=0.410 Sum_probs=207.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchH---HHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL---EFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~---~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
..+|.+.+.||+|.||.|-++... |+.||||.+++....+.. .+.+|++||+.|+||||+.+|.+|.+ ...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 467888899999999999999774 999999999888765544 58899999999999999999999964 58899
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
|||..+|.|.+++...+ .|++.+...++.||..|+.|+|.++ ++|||||.+|||||.|+++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999998765 5889999999999999999999976 99999999999999999999999999998876
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCC-CCcchHhHHHHHHHHHHhCCCCCCChh--HHHHHhhcCccccccCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVL-TPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~i~~~~l~~~ldp~~ 570 (688)
... -.+++|+|.|.+||+..+.+| ++.+|-|||||+||.|+.|..||.+.+ .+...+..|.+.+.-
T Consensus 206 ~kf-------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---- 274 (668)
T KOG0611|consen 206 KKF-------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---- 274 (668)
T ss_pred ccH-------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC----
Confidence 553 357799999999999999988 589999999999999999999998765 345566667665432
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
.+....-||.+||-.||++|.|+.+.
T Consensus 275 ------~PSdA~gLIRwmLmVNP~RRATieDi 300 (668)
T KOG0611|consen 275 ------TPSDASGLIRWMLMVNPERRATIEDI 300 (668)
T ss_pred ------CCchHHHHHHHHHhcCcccchhHHHH
Confidence 23356679999999999999998743
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=339.74 Aligned_cols=255 Identities=26% Similarity=0.406 Sum_probs=204.2
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCcc-chHHHHHHHHHHHcCC-CCceeeEecccCC--
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQ-HPHLVTLLGACPE-- 408 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~-- 408 (688)
..++|.+.+.||+|+||.||+|.+. +..||||++...... ....|.+|+.+|.++. |||||+++|+|.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3578889999999999999999864 246999999754332 3456999999999996 9999999999954
Q ss_pred CceeEEeeCCCCcHHHHhcccCC---------------------------------------------------------
Q 005616 409 AWSLVYEYLPNGSLQDRLFRKSN--------------------------------------------------------- 431 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~--------------------------------------------------------- 431 (688)
..+||||||++|+|.++|.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 48999999999999998864310
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeC
Q 005616 432 ------------------------------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD 475 (688)
Q Consensus 432 ------------------------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd 475 (688)
...+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 134788999999999999999999966 99999999999999
Q ss_pred CCCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh---
Q 005616 476 SELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--- 551 (688)
Q Consensus 476 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--- 551 (688)
.++.+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNY----VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred CCCEEEEEeCCcceeccccccc----cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 9999999999999876433211 11234457788999999999999999999999999999997 999986432
Q ss_pred HHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 552 EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 552 ~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
.....+..+.. ...+...+..+.+|+.+||+.+|++||++. .|.+.|+.+
T Consensus 348 ~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-~l~~~l~~l 397 (400)
T cd05105 348 TFYNKIKSGYR--------MAKPDHATQEVYDIMVKCWNSEPEKRPSFL-HLSDIVESL 397 (400)
T ss_pred HHHHHHhcCCC--------CCCCccCCHHHHHHHHHHCccCHhHCcCHH-HHHHHHHHH
Confidence 22222322211 112334567899999999999999999998 788888875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=319.80 Aligned_cols=252 Identities=26% Similarity=0.397 Sum_probs=199.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--Ce----EEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC-CceeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GR----TVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~----~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV 413 (688)
.+|...+.||.|+||.||+|.+. |. .|++|.+..... ....++..|+.++..++||||++++|++.+ ..+++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 35677789999999999999884 44 477887754322 223567888889999999999999999854 46799
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
+||+++|+|.+++.... ..++|..+..|+.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 87 TQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 99999999999997543 46899999999999999999999965 99999999999999999999999999987643
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~ 570 (688)
.... .......++..|+|||++.++.++.++|||||||++|||++ |..||..... ....+..+....
T Consensus 162 ~~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------ 231 (279)
T cd05111 162 DDKK----YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLA------ 231 (279)
T ss_pred CCcc----cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC------
Confidence 3211 11234557789999999998999999999999999999998 9999965432 233333332211
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhh
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~ 611 (688)
.+......+..++.+||..+|..||++. ++.+.|..+.
T Consensus 232 --~~~~~~~~~~~li~~c~~~~p~~Rps~~-el~~~l~~~~ 269 (279)
T cd05111 232 --QPQICTIDVYMVMVKCWMIDENVRPTFK-ELANEFTRMA 269 (279)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHHHH
Confidence 1112345678899999999999999998 7777777754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=321.70 Aligned_cols=255 Identities=28% Similarity=0.449 Sum_probs=206.3
Q ss_pred cCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCcee
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSL 412 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~L 412 (688)
++|...+.||.|+||.||++... +..||+|.+..........+.+|+.++.+++||||++++++|. +..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888899999999999999752 3568999987665555667999999999999999999999985 35889
Q ss_pred EEeeCCCCcHHHHhcccC----------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEE
Q 005616 413 VYEYLPNGSLQDRLFRKS----------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI 482 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL 482 (688)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 1235899999999999999999999965 999999999999999999999
Q ss_pred eecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhc
Q 005616 483 CDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSC 559 (688)
Q Consensus 483 ~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~ 559 (688)
+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|++ |.+||.... .....+..
T Consensus 162 ~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 162 GDFGMSRDVYSTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred ccCCccccccCCcee----ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999865432211 11233456788999999999999999999999999999998 999986433 23334444
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhh
Q 005616 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 560 ~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~ 612 (688)
+.... .+...+..+.+|+.+||+.||.+||++. ++...|+.+..
T Consensus 238 ~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~-~v~~~l~~~~~ 281 (288)
T cd05093 238 GRVLQ--------RPRTCPKEVYDLMLGCWQREPHMRLNIK-EIHSLLQNLAK 281 (288)
T ss_pred CCcCC--------CCCCCCHHHHHHHHHHccCChhhCCCHH-HHHHHHHHHHH
Confidence 43221 1122345799999999999999999999 78888888754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=348.20 Aligned_cols=256 Identities=21% Similarity=0.283 Sum_probs=206.5
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC-
Q 005616 334 LADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE- 408 (688)
Q Consensus 334 ~~el~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~- 408 (688)
..++....++|...+.||+|+||.||+|... |..||||++..... .....+.+|+.++..++|+||+++++.+..
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 3455566789999999999999999999874 88999999976543 334568899999999999999999876621
Q ss_pred ---------CceeEEeeCCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC
Q 005616 409 ---------AWSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL 478 (688)
Q Consensus 409 ---------~~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~ 478 (688)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||||+.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNG 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCC
Confidence 1568999999999999986542 3356899999999999999999999965 99999999999999999
Q ss_pred ceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHH
Q 005616 479 SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRA 556 (688)
Q Consensus 479 ~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~ 556 (688)
.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... +...
T Consensus 181 ~vkL~DFGls~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~ 256 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSD----DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256 (496)
T ss_pred CEEEEecccCeeccccccc----cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9999999999876432211 123456799999999999999999999999999999999999999975432 2222
Q ss_pred hhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 557 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 557 i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
+..+.. + ..+...+..+.+|+.+||+.||.+||++.+.+.
T Consensus 257 ~~~~~~----~----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 257 TLAGRY----D----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred HhcCCC----C----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 222221 1 223345678999999999999999999995543
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.72 Aligned_cols=249 Identities=25% Similarity=0.336 Sum_probs=198.1
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||+|... |..||||++..... .....+..|+.++..++||||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999987 89999999976432 334568899999999999999999999854 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999765 45889999999999999999999965 999999999999999999999999999876543
Q ss_pred CCc-----------------------CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh
Q 005616 495 TLY-----------------------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 551 (688)
Q Consensus 495 ~~~-----------------------~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~ 551 (688)
... ...........||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 200 000012235679999999999999999999999999999999999999997554
Q ss_pred HHH--HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-CcHH
Q 005616 552 EVR--RAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPD-ITPS 602 (688)
Q Consensus 552 ~~~--~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs-~~e~ 602 (688)
... ..+.... ....-|.. ...+..+.+|+.+|+. +|.+||+ +.+.
T Consensus 235 ~~~~~~~i~~~~-~~~~~p~~----~~~~~~~~~li~~ll~-dp~~R~~s~~~l 282 (350)
T cd05573 235 LQETYNKIINWK-ESLRFPPD----PPVSPEAIDLICRLLC-DPEDRLGSFEEI 282 (350)
T ss_pred HHHHHHHHhccC-CcccCCCC----CCCCHHHHHHHHHHcc-ChhhcCCCHHHH
Confidence 321 1221100 00000111 1146789999999997 9999999 6633
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=315.67 Aligned_cols=249 Identities=32% Similarity=0.466 Sum_probs=201.3
Q ss_pred cCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEeeCCC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPN 419 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~~ 419 (688)
++|.+.+.||+|+||.||+|... +..||+|.+..... ....|.+|+.++++++|||++++++++.+ ..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCC
Confidence 46778889999999999999876 67899999876443 34679999999999999999999998844 57899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC
Q 005616 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
++|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 158 (260)
T cd05070 85 GSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-- 158 (260)
T ss_pred CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc--
Confidence 99999986543 245899999999999999999999966 999999999999999999999999999876443211
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCCCCHH
Q 005616 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~ 576 (688)
......++..|+|||++.+..++.++||||||+++|+|++ |.+||..... ....+..+. ....+..
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 227 (260)
T cd05070 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY--------RMPCPQD 227 (260)
T ss_pred ---cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------CCCCCCc
Confidence 1123345678999999988899999999999999999999 8999865332 222222111 1122334
Q ss_pred HHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHH
Q 005616 577 VARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~ 609 (688)
.+..+.+|+.+||..+|.+|||+. .+...|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rpt~~-~l~~~l~~ 259 (260)
T cd05070 228 CPISLHELMLQCWKKDPEERPTFE-YLQSFLED 259 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHH-HHHHHHhc
Confidence 566899999999999999999998 77777663
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=315.29 Aligned_cols=244 Identities=28% Similarity=0.439 Sum_probs=200.0
Q ss_pred cCcccceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC---CCceeEEeeCC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP---EAWSLVYEYLP 418 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~---~~~~LV~E~~~ 418 (688)
.+|...+.||+|+||.||+|...|..||+|.+.... ....|.+|+.++++++|+|++++++++. +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 367788999999999999999999999999986433 3457899999999999999999999752 34789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
+++|.+++..... ..+++..++.++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 84 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999875432 45889999999999999999999965 9999999999999999999999999987654321
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCccccccCCCCCCCCH
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l~~~ldp~~~~~~~ 575 (688)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||.... .+...+..+.. ...+.
T Consensus 157 ------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 222 (256)
T cd05082 157 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------MDAPD 222 (256)
T ss_pred ------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------CCCCC
Confidence 23345678999999999999999999999999999998 999986432 22233322211 12233
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHH
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~ 609 (688)
..+..+.+++.+||+.+|++||++. ++.+.|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~-~l~~~l~~ 255 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFL-QLREQLEH 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHH-HHHHHHhc
Confidence 4567899999999999999999999 77777764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=325.44 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=191.7
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
.++|...+.||.|+||.||+|... +..||||++..... .....+.+|+.+++.++||||+++++++.+ ..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999985 78999999875543 233467889999999999999999999844 5789999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 57777765433 45788999999999999999999966 9999999999999999999999999987543222
Q ss_pred CcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhc-----Cccc------
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC-----GKLS------ 563 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~-----~~l~------ 563 (688)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....+....+.. +...
T Consensus 158 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 158 H------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred c------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence 1 1234568999999998865 45889999999999999999999999754332211100 0000
Q ss_pred --c--ccCCCC-C-CCCH---------HHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 564 --S--ILDPLA-G-DWPT---------FVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 --~--~ldp~~-~-~~~~---------~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
. ..++.. . ..+. ..+..+.+|+.+||+.||.+|||+.+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 0 000000 0 0000 1235688999999999999999988433
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=320.01 Aligned_cols=251 Identities=29% Similarity=0.469 Sum_probs=201.9
Q ss_pred cCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--Cce
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWS 411 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~ 411 (688)
.+|...+.||+|+||.||+|... +..||||.+...... ....|.+|+.++..++||||+++++++.. ..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45777889999999999999763 367999999765444 45679999999999999999999999854 588
Q ss_pred eEEeeCCCCcHHHHhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCce
Q 005616 412 LVYEYLPNGSLQDRLFRKS-----------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~-----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~ 480 (688)
+||||+++|+|.+++.... ....+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999997542 1245789999999999999999999965 9999999999999999999
Q ss_pred EEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHh
Q 005616 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAV 557 (688)
Q Consensus 481 KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i 557 (688)
||+|||++......... .......+++.|+|||++.+..+++++|||||||++|||++ |..||.... .....+
T Consensus 162 kl~d~g~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred EECCcccceecccCcce----ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999765332211 11234456789999999999999999999999999999998 999986433 222333
Q ss_pred hcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 558 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 558 ~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
..+.... .+...+..+.+++.+||+.||.+||++. ++++.|+
T Consensus 238 ~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~-eil~~l~ 279 (280)
T cd05049 238 TQGRLLQ--------RPRTCPSEVYDIMLGCWKRDPQQRINIK-DIHERLQ 279 (280)
T ss_pred HcCCcCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHH-HHHHHhh
Confidence 3332221 1223456899999999999999999998 6766654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=315.35 Aligned_cols=243 Identities=28% Similarity=0.467 Sum_probs=196.7
Q ss_pred eeeccCceEEEEEEEC----CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEeeCCCCc
Q 005616 349 KVGQGGFGCVYKGEML----GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~----g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~~gs 421 (688)
.||+|+||.||+|.+. +..||+|++..... .....|.+|+.++..++||||++++|++.+ ..++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 5899999999999763 67899999865433 234578999999999999999999999854 5789999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCc
Q 005616 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~ 501 (688)
|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..........
T Consensus 82 L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~--- 152 (257)
T cd05116 82 LNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY--- 152 (257)
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCee---
Confidence 99998654 35789999999999999999999965 9999999999999999999999999998765432110
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCccccccCCCCCCCCHHHH
Q 005616 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 502 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l~~~ldp~~~~~~~~~~ 578 (688)
.......++..|+|||.+....++.++|||||||++|||++ |..||.... .+...+..+... ..+...+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~--------~~~~~~~ 224 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM--------ECPQRCP 224 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC--------CCCCCCC
Confidence 11123345678999999988889999999999999999998 999997432 233334333221 2333456
Q ss_pred HHHHHHHHHcccCCCCCCCCCcHHHHHHHHH
Q 005616 579 RRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 579 ~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~ 609 (688)
..+.+|+.+||+.||.+||++. .|.+.|+.
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~-~i~~~l~~ 254 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFA-VVELRLRN 254 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHH-HHHHHHhc
Confidence 7899999999999999999998 78777764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=329.08 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=198.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
.++|...+.||.|+||.||++.+. +..||+|.+..... .....+.+|+.++..++|||||+++++|.+ ..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367889999999999999999986 78899998876432 234568999999999999999999999843 5889999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|+++|+|.+++... ..+++..+..++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 99999999998654 35788999999999999999999743 49999999999999999999999999987654321
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhh---cCccccc-----
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVS---CGKLSSI----- 565 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~---~~~l~~~----- 565 (688)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||..... ....+. .+.....
T Consensus 159 --------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 159 --------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred --------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 2345689999999999988999999999999999999999999964332 111110 0000000
Q ss_pred ----------cCC------------------CCCCCC-HHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 566 ----------LDP------------------LAGDWP-TFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 566 ----------ldp------------------~~~~~~-~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
..| .....+ ..++..+.+|+.+||+.||.+||++.+.+.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 000 000000 113467899999999999999999996554443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=323.93 Aligned_cols=250 Identities=24% Similarity=0.305 Sum_probs=192.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
.+|...+.||.|+||.||+|... +..||+|++..... .....+.+|+.++..++||||+++++++.. ..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999886 78999999875433 234467899999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++ +|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 985 8888876543 35788999999999999999999965 99999999999999999999999999976543221
Q ss_pred cCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH---Hhh-cC-----------
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVS-CG----------- 560 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~---~i~-~~----------- 560 (688)
......||+.|+|||++.+ ..++.++|||||||++|+|+||++||........ ... .+
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred ------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 1234568999999998865 5689999999999999999999999964332110 000 00
Q ss_pred ---ccccccCCCC-----CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 561 ---KLSSILDPLA-----GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 561 ---~l~~~ldp~~-----~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.+...+.+.. .......+..+.+|+.+||+.||.+|||+.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 0000000100 000112356789999999999999999998443
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=320.24 Aligned_cols=251 Identities=30% Similarity=0.444 Sum_probs=199.6
Q ss_pred cCcccceeeeccCceEEEEEEE------CCeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC--CCcee
Q 005616 342 CNFSESFKVGQGGFGCVYKGEM------LGRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSL 412 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~------~g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~L 412 (688)
.+|+....||+|+||.||+|.+ .+..||+|.+..... .....|.+|+.+++.++||||+++++++. +..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3567778999999999999985 257899999875433 33457899999999999999999999974 45789
Q ss_pred EEeeCCCCcHHHHhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC
Q 005616 413 VYEYLPNGSLQDRLFRKSN--------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL 478 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~ 478 (688)
||||+++|+|.+++..... ...+++..++.++.+++.||.|||+.+ |+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853321 235789999999999999999999965 99999999999999999
Q ss_pred ceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHH
Q 005616 479 SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRR 555 (688)
Q Consensus 479 ~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~ 555 (688)
.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.... .+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYY----RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred cEEeccccccccccCCcce----ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999876433211 11233446778999999988899999999999999999998 999986433 2333
Q ss_pred HhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 556 AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 556 ~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
.+..+... ..+..++..+.+++.+||+.||.+||++. .|.+.|.
T Consensus 238 ~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~-~i~~~l~ 281 (283)
T cd05090 238 MVRKRQLL--------PCSEDCPPRMYSLMTECWQEGPSRRPRFK-DIHTRLR 281 (283)
T ss_pred HHHcCCcC--------CCCCCCCHHHHHHHHHHcccCcccCcCHH-HHHHHhh
Confidence 33332221 12233456889999999999999999998 6766654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=307.27 Aligned_cols=241 Identities=25% Similarity=0.385 Sum_probs=204.8
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|..++.||+|-||.||.|+.+ +..||+|++.+... ....++.+|++|-+.|+||||+++||+|.+ ..||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 46788899999999999999987 67899999977643 334578999999999999999999999966 489999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||.++|+|...|..... ..++......++.|+|.||.|+|..+ ||||||||+|+|++..|.+||+|||.+..-+.+
T Consensus 102 Eya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~ 177 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSN 177 (281)
T ss_pred EecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence 99999999999975432 45777888999999999999999955 999999999999999999999999999876532
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--HHHHHhhcCccccccCCCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~i~~~~l~~~ldp~~~~ 572 (688)
+....+||..|.+||...+..++..+|+|++|++.||++.|.+||.... +....+..-++ .
T Consensus 178 --------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~---------~ 240 (281)
T KOG0580|consen 178 --------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL---------K 240 (281)
T ss_pred --------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc---------c
Confidence 3567899999999999999999999999999999999999999997443 33333333222 3
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
+|..++....+||.+|+..+|.+|....+.+
T Consensus 241 ~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~ 271 (281)
T KOG0580|consen 241 FPSTISGGAADLISRLLVKNPIERLALTEVM 271 (281)
T ss_pred CCcccChhHHHHHHHHhccCccccccHHHHh
Confidence 4567788999999999999999999887443
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=336.25 Aligned_cols=245 Identities=24% Similarity=0.322 Sum_probs=192.6
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||+|+.. |..||||++..... .....+.+|+.++..++||||++++++|.+ ..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47888999999999999999886 78999999975432 233457899999999999999999999854 488999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999987543 5889999999999999999999966 999999999999999999999999999765322
Q ss_pred CCcCC--------------------------------CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh
Q 005616 495 TLYLP--------------------------------SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542 (688)
Q Consensus 495 ~~~~~--------------------------------~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt 542 (688)
..... ........+||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 11000 0001123569999999999999999999999999999999999
Q ss_pred CCCCCCChhHHH--HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 005616 543 GRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 543 G~~Pf~~~~~~~--~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs 598 (688)
|..||....... ..+..... ...-+. ....+..+.+|+.+|+. +|.+|++
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~----~~~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKE-TLQFPD----EVPLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCC-ccCCCC----CCCCCHHHHHHHHHHcc-CHhhcCC
Confidence 999997544322 12211110 000011 11235678899999996 9999998
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=319.87 Aligned_cols=260 Identities=27% Similarity=0.401 Sum_probs=200.4
Q ss_pred cCcccceeeeccCceEEEEEEE------CCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC----CCce
Q 005616 342 CNFSESFKVGQGGFGCVYKGEM------LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP----EAWS 411 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~------~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~----~~~~ 411 (688)
.+|.....||+|+||.||+|.. .+..||||.+..........|.+|+.++..++||||+++++++. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677889999999999999975 26789999987766555678999999999999999999999762 2478
Q ss_pred eEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccc
Q 005616 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~ 491 (688)
+||||+++|+|.+++.... ..+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999999986543 35899999999999999999999966 999999999999999999999999999876
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH-HHHhhcCcc--------
Q 005616 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV-RRAVSCGKL-------- 562 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~-~~~i~~~~l-------- 562 (688)
....... .......++..|+|||++.+..++.++|||||||++|||++|..|+...... ...+.....
T Consensus 159 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 159 PQDKEYY---KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred cCCCcce---eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 5432110 0112223455699999999889999999999999999999998776432211 111111100
Q ss_pred ccccCC-CCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 563 SSILDP-LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 563 ~~~ldp-~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
.+.+.. .....+...+..+.+|+.+||..+|.+|||+. +|+..|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~-ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS-ELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHH-HHHHHHHhc
Confidence 000100 00111223456899999999999999999999 788777754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=330.07 Aligned_cols=231 Identities=27% Similarity=0.406 Sum_probs=188.6
Q ss_pred eeeeccCceEEEEEEE-----CCeEEEEEEEecCCc----cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 348 FKVGQGGFGCVYKGEM-----LGRTVAIKMLYSHNM----QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~-----~g~~VAIK~l~~~~~----~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+.||+|+||.||++.. .+..||||++..... .....+.+|+.+|..++||||++++++|.. ..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 367899999975422 233457899999999999999999998854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999986543 5778889999999999999999966 99999999999999999999999999875432221
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCccccccCCCCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~ldp~~~~~~ 574 (688)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+..+.. ..+
T Consensus 156 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~---------~~~ 220 (323)
T cd05584 156 ------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL---------NLP 220 (323)
T ss_pred ------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------CCC
Confidence 123457999999999999989999999999999999999999999754432 222222221 233
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCC
Q 005616 575 TFVARRLVDLGLQCCELYGRERPDI 599 (688)
Q Consensus 575 ~~~~~~l~~Li~~Cl~~dP~~RPs~ 599 (688)
...+..+.+|+.+||+.+|.+||+.
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~ 245 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGA 245 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCC
Confidence 4456789999999999999999953
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=327.10 Aligned_cols=252 Identities=25% Similarity=0.318 Sum_probs=198.2
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--------------cchHHHHHHHHHHHcCCCCceeeE
Q 005616 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--------------QGQLEFQQEVRVLSKLQHPHLVTL 402 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--------------~~~~~f~~E~~iL~~l~HpnIV~l 402 (688)
..-|.|.....||+|.||.|-+|+.. ++.||||++.+... ...+.+.+|+.||++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34588999999999999999999886 88999999965422 123578899999999999999999
Q ss_pred ecccC----CCceeEEeeCCCCcHHHHhcccCCCCC-CCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC
Q 005616 403 LGACP----EAWSLVYEYLPNGSLQDRLFRKSNVSP-LLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE 477 (688)
Q Consensus 403 ~g~~~----~~~~LV~E~~~~gsL~~~L~~~~~~~~-l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~ 477 (688)
+.+.. +..|||+|||..|.+...- ...+ |+..++.+++.+++.||.|||..+ ||||||||+|+||+.+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 99874 4589999999998875432 2233 899999999999999999999966 9999999999999999
Q ss_pred CceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCC----CCCcchHhHHHHHHHHHHhCCCCCCChhHH
Q 005616 478 LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV----LTPKSDSYSFGLIILQLLTGRLPVGLAGEV 553 (688)
Q Consensus 478 ~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~----~s~ksDVwSfGviL~ELltG~~Pf~~~~~~ 553 (688)
|++||+|||.+.....+.... ....-...+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||......
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~-~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEG-SDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CcEEeeccceeeecccCCccc-cHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 999999999998774432211 111123478999999999887643 357899999999999999999999754432
Q ss_pred H--HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHH
Q 005616 554 R--RAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 554 ~--~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~ 605 (688)
. ..+... |..-...++....+.+||.++|.+||..|.++.+..++
T Consensus 326 ~l~~KIvn~-------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 326 ELFDKIVND-------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred HHHHHHhcC-------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 2 222221 22112222467899999999999999999999844433
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.78 Aligned_cols=251 Identities=34% Similarity=0.453 Sum_probs=202.5
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC-CCceeEEeeCC
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLVYEYLP 418 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~-~~~~LV~E~~~ 418 (688)
.++|...++||+|+||.||+|.+. +..||||.+..... ....|.+|+.++..++||||+++++++. +..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCC
Confidence 356888999999999999999886 45799999875332 3467899999999999999999999874 45789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
+|+|.+++.... ...+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 999999997542 245789999999999999999999966 999999999999999999999999999876543211
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCCCCH
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~ 575 (688)
......++..|+|||+..+..++.++||||||+++|+|+| |..||..... ....+..+.. ...+.
T Consensus 159 ----~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 226 (262)
T cd05071 159 ----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------MPCPP 226 (262)
T ss_pred ----cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC--------CCCcc
Confidence 1123456778999999998999999999999999999999 8888864332 2222222110 11223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
..+..+.+|+.+|++.+|.+||++. ++...|+..
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~-~~~~~l~~~ 260 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFE-YLQAFLEDY 260 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHH-HHHHHHHHh
Confidence 4567889999999999999999998 788877753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=348.47 Aligned_cols=259 Identities=23% Similarity=0.319 Sum_probs=208.3
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCC-CCceeeEeccc-----CC--
Q 005616 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGAC-----PE-- 408 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~-----~~-- 408 (688)
....++.+.+.|.+|||+.||.+++. |..||+|++...+......+.+|+.+|++|+ |+|||.+++.. .+
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 34567788899999999999999997 4899999998888788888999999999997 99999999943 11
Q ss_pred --CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecC
Q 005616 409 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 409 --~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFG 486 (688)
..+|.||||.||+|-+++..+.... |++.++++|+.++|+|+.+||... .||||||||-+||||+.+|+.||||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 2578999999999999998765433 999999999999999999999988 689999999999999999999999999
Q ss_pred ccccccCCCCcCC---CccccCCCCCCCCCCChhhh---ccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcC
Q 005616 487 ICRLVTEDTLYLP---SFHRSTAPKGSFPYADPEYH---RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCG 560 (688)
Q Consensus 487 la~~~~~~~~~~~---~~~~~~~~~Gt~~Y~APE~~---~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~ 560 (688)
.|........... .....-...-|+.|.|||.+ .+...+.|+|||||||+||-|+....||+..+. -+|..|
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--laIlng 269 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--LAILNG 269 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--eeEEec
Confidence 9875433221000 00001123468999999965 677899999999999999999999999986543 234444
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 561 KLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 561 ~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
++.- .-.+.++..|.+||..||+.||.+||++.+.+...++
T Consensus 270 ~Y~~-------P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 270 NYSF-------PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred cccC-------CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 4322 1123688999999999999999999999954444333
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=316.36 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=197.4
Q ss_pred ccceeeeccCceEEEEEEEC--C--eEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC--------Cc
Q 005616 345 SESFKVGQGGFGCVYKGEML--G--RTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--------AW 410 (688)
Q Consensus 345 ~~~~~LG~G~~G~Vy~g~~~--g--~~VAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--------~~ 410 (688)
.....||+|+||.||+|.+. + ..||+|.++... ......|..|+.++..++||||++++++|.. ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45678999999999999886 3 269999887543 2334578999999999999999999997621 25
Q ss_pred eeEEeeCCCCcHHHHhccc---CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCc
Q 005616 411 SLVYEYLPNGSLQDRLFRK---SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~---~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGl 487 (688)
++||||+.+|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 7999999999999887432 12345899999999999999999999965 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCcccc
Q 005616 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSS 564 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l~~ 564 (688)
++........ .......+++.|+|||++.+..+++++|||||||++|||++ |..||.... .....+..+...
T Consensus 159 ~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~- 233 (272)
T cd05075 159 SKKIYNGDYY----RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL- 233 (272)
T ss_pred ccccCcccce----ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence 9876543211 11223346778999999999999999999999999999999 889986433 233334333221
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 565 ~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
..+...+..+.+++.+||+.+|.+||++. +|++.|+.+
T Consensus 234 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~l~~~l~~~ 271 (272)
T cd05075 234 -------KQPPDCLDGLYSLMSSCWLLNPKDRPSFE-TLRCELEKA 271 (272)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHhh
Confidence 11223456789999999999999999998 777777653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.41 Aligned_cols=253 Identities=27% Similarity=0.424 Sum_probs=202.7
Q ss_pred cCcccceeeeccCceEEEEEEEC--Ce----EEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC-CceeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GR----TVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~----~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV 413 (688)
.+|...+.||.|+||.||+|.+. |. .||+|++..... .....+.+|+.++..+.||||++++++|.. ..+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 56788899999999999999864 43 589999875543 334578899999999999999999999854 57899
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
|+|+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 87 TQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 99999999999986543 46889999999999999999999965 99999999999999999999999999987753
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCccccccCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l~~~ldp~~ 570 (688)
.... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.... .....+..+...
T Consensus 162 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------- 230 (279)
T cd05109 162 DETE----YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL------- 230 (279)
T ss_pred ccce----eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-------
Confidence 3211 11223345778999999998899999999999999999998 999986433 233333332211
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhh
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~ 612 (688)
..+...+..+.+++.+||+.||..||++. ++.+.|+.+..
T Consensus 231 -~~~~~~~~~~~~li~~~l~~dp~~Rp~~~-~l~~~l~~~~~ 270 (279)
T cd05109 231 -PQPPICTIDVYMIMVKCWMIDSECRPRFR-ELVDEFSRMAR 270 (279)
T ss_pred -CCCccCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHhhc
Confidence 11223456889999999999999999999 67777776643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=315.29 Aligned_cols=246 Identities=27% Similarity=0.472 Sum_probs=198.0
Q ss_pred cCcccceeeeccCceEEEEEEECC-eEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEMLG-RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 418 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~g-~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~ 418 (688)
.+|.....||+|+||.||+|.+.+ ..||||.+.... .....|.+|+.++.+++||||++++++|.+ ..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 357778899999999999998874 469999987543 335679999999999999999999999854 4789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
+|+|.+++.... ..+++..++.++.+|+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-- 155 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce--
Confidence 999999986543 26899999999999999999999965 99999999999999999999999999886643321
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCCCCH
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~ 575 (688)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||..... +...+..+... ..+.
T Consensus 156 ---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 224 (256)
T cd05113 156 ---TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL--------YRPH 224 (256)
T ss_pred ---eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC--------CCCC
Confidence 11223346678999999998899999999999999999999 9999864432 22333332211 1122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
..+..+.+++.+||+.+|.+||++. +|+..|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~-~ll~~~ 255 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQ-QLLSSI 255 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHH-HHHHhh
Confidence 2357899999999999999999998 555443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=329.52 Aligned_cols=238 Identities=29% Similarity=0.387 Sum_probs=191.0
Q ss_pred CcccceeeeccCceEEEEEEE-----CCeEEEEEEEecCCc----cchHHHHHHHHHHHcC-CCCceeeEecccCC--Cc
Q 005616 343 NFSESFKVGQGGFGCVYKGEM-----LGRTVAIKMLYSHNM----QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AW 410 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~-----~g~~VAIK~l~~~~~----~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~ 410 (688)
+|...+.||+|+||.||+++. .+..||+|++..... .....+..|+.++..+ +||||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 578889999999999999876 378899999975422 2334688899999999 59999999998854 47
Q ss_pred eeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 89999999999999986543 5788999999999999999999966 99999999999999999999999999986
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChh------HHHHHhhcCccc
Q 005616 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAG------EVRRAVSCGKLS 563 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~------~~~~~i~~~~l~ 563 (688)
....... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||.... .+...+...
T Consensus 155 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--- 226 (332)
T cd05614 155 FLSEEKE-----RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC--- 226 (332)
T ss_pred ccccCCC-----ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC---
Confidence 5432211 12345799999999998765 47899999999999999999999996322 111111111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 564 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 564 ~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
....+...+..+.+|+.+||+.||.+||++.
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 257 (332)
T cd05614 227 ------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAG 257 (332)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 1123334567889999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.01 Aligned_cols=251 Identities=24% Similarity=0.401 Sum_probs=199.8
Q ss_pred cccceeeeccCceEEEEEEEC-----CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--------
Q 005616 344 FSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------- 408 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~-----g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------- 408 (688)
|...+.||+|+||.||+|.+. +..||||+++.... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456688999999999999874 36799999876433 234578999999999999999999998732
Q ss_pred CceeEEeeCCCCcHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeec
Q 005616 409 AWSLVYEYLPNGSLQDRLFRKS---NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DF 485 (688)
..++||||+++|+|..++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 2589999999999999885532 2246899999999999999999999965 999999999999999999999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCcc
Q 005616 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKL 562 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l 562 (688)
|+++......... ......++..|+|||++.+..++.++|||||||++|||++ |.+||..... ....+..+..
T Consensus 158 g~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05035 158 GLSKKIYSGDYYR----QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233 (273)
T ss_pred cceeecccccccc----ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9998765433211 1223345678999999988899999999999999999999 8899865433 2223322221
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 563 ~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
. ..+..++..+.+++.+||+.||.+||++. ++.+.|+.+
T Consensus 234 ~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-e~~~~l~~~ 272 (273)
T cd05035 234 L--------KQPEDCLDELYDLMYSCWRADPKDRPTFT-KLREVLENI 272 (273)
T ss_pred C--------CCCcCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHhh
Confidence 1 22334567899999999999999999998 788877754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.97 Aligned_cols=253 Identities=28% Similarity=0.440 Sum_probs=201.4
Q ss_pred CcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC--CCcee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSL 412 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~L 412 (688)
+|.....||+|+||.||+|... ...|++|.+..... .....+.+|+.++..++||||++++++|. +..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677789999999999999864 25689998875543 23456899999999999999999999984 35889
Q ss_pred EEeeCCCCcHHHHhcccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCc
Q 005616 413 VYEYLPNGSLQDRLFRKS---------------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQN 471 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~N 471 (688)
||||+.+|+|.+++.... ...++++..++.++.+++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999886421 1245889999999999999999999865 9999999999
Q ss_pred eeeCCCCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCCh
Q 005616 472 ILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLA 550 (688)
Q Consensus 472 ILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~ 550 (688)
||++.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSY----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEEcCCCcEEeccccccccccCccch----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999865433211 11233456778999999988899999999999999999999 99999643
Q ss_pred h--HHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhh
Q 005616 551 G--EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 551 ~--~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~ 611 (688)
. .+...+..+.. ...+...+..+.+++.+||+.+|.+||++. +++..|+.+.
T Consensus 234 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~-~i~~~l~~~~ 287 (290)
T cd05045 234 APERLFNLLKTGYR--------MERPENCSEEMYNLMLTCWKQEPDKRPTFA-DISKELEKMM 287 (290)
T ss_pred CHHHHHHHHhCCCC--------CCCCCCCCHHHHHHHHHHccCCcccCCCHH-HHHHHHHHHH
Confidence 3 22333322211 112234456899999999999999999999 8888888764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.16 Aligned_cols=244 Identities=27% Similarity=0.457 Sum_probs=196.3
Q ss_pred eeccCceEEEEEEEC----CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEeeCCCCcHH
Q 005616 350 VGQGGFGCVYKGEML----GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPNGSLQ 423 (688)
Q Consensus 350 LG~G~~G~Vy~g~~~----g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~~gsL~ 423 (688)
||+|+||.||+|.+. +..||+|++...... ....|.+|+.++..++||||++++++|.. ..++||||+++|+|.
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L~ 82 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLN 82 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCHH
Confidence 899999999999774 456999998765432 34569999999999999999999999854 478999999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCccc
Q 005616 424 DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503 (688)
Q Consensus 424 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~ 503 (688)
+++.... ..+++..++.++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......... ..
T Consensus 83 ~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~ 154 (257)
T cd05115 83 KFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY---KA 154 (257)
T ss_pred HHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccce---ec
Confidence 9986533 46899999999999999999999965 9999999999999999999999999998654332111 11
Q ss_pred cCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCccccccCCCCCCCCHHHHHH
Q 005616 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTFVARR 580 (688)
Q Consensus 504 ~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l~~~ldp~~~~~~~~~~~~ 580 (688)
.....+++.|+|||++....++.++|||||||++|+|++ |..||.... .+...+..+... ..+...+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 226 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL--------DCPAECPPE 226 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC--------CCCCCCCHH
Confidence 122334678999999988889999999999999999996 999996433 233333333221 233345678
Q ss_pred HHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 581 LVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 581 l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
+.+++.+||..+|++||++. .|.+.|+.+
T Consensus 227 l~~li~~c~~~~~~~Rp~~~-~i~~~l~~~ 255 (257)
T cd05115 227 MYALMKDCWIYKWEDRPNFA-KVEERMRTY 255 (257)
T ss_pred HHHHHHHHcCCChhhCcCHH-HHHHHHhhh
Confidence 99999999999999999999 777777653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=330.71 Aligned_cols=253 Identities=30% Similarity=0.483 Sum_probs=201.1
Q ss_pred cCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCcc-chHHHHHHHHHHHcC-CCCceeeEecccCC---C
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACPE---A 409 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~---~ 409 (688)
++|.+.+.||.|+||.||+|... ++.||+|++...... ....+..|+.++.++ +||||++++++|.. .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888899999999999999753 367999998754322 334678899999999 89999999998842 4
Q ss_pred ceeEEeeCCCCcHHHHhcccCC----------------------------------------------------------
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSN---------------------------------------------------------- 431 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~---------------------------------------------------------- 431 (688)
.+++|||+++|+|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 6799999999999998854321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCccccCCCCCCC
Q 005616 432 VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511 (688)
Q Consensus 432 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~ 511 (688)
..+++|..+..++.+|+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...... .......++.
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~----~~~~~~~~~~ 239 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----VRKGDARLPL 239 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcch----hhccCCCCCc
Confidence 136899999999999999999999965 999999999999999999999999999876433211 1223445678
Q ss_pred CCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh---HHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHH
Q 005616 512 PYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG---EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQ 587 (688)
Q Consensus 512 ~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~---~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~ 587 (688)
.|+|||++.+..++.++|||||||+||||++ |..||.... .....+..+... ..+......+.+++.+
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM--------RAPEYATPEIYSIMLD 311 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC--------CCCccCCHHHHHHHHH
Confidence 8999999999999999999999999999998 999996422 222223222211 1122345679999999
Q ss_pred cccCCCCCCCCCcHHHHHHHHHh
Q 005616 588 CCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 588 Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
||+.+|.+||++. +|++.|+.+
T Consensus 312 cl~~~p~~RPs~~-ell~~l~~~ 333 (337)
T cd05054 312 CWHNNPEDRPTFS-ELVEILGDL 333 (337)
T ss_pred HccCChhhCcCHH-HHHHHHHHH
Confidence 9999999999999 788888765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.49 Aligned_cols=239 Identities=29% Similarity=0.401 Sum_probs=194.5
Q ss_pred eeeeccCceEEEEEEE-----CCeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCC
Q 005616 348 FKVGQGGFGCVYKGEM-----LGRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 418 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~-----~g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~ 418 (688)
+.||+|+||.||++.. .|..||+|++..... .....+..|+.+|.+++||||++++++|.+ ..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 378999999976432 234457889999999999999999999854 4789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
+|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 99999998654 35889999999999999999999966 99999999999999999999999999886543321
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCccccccCCCCCCCCHH
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~ldp~~~~~~~~ 576 (688)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+..+.. ..|..
T Consensus 154 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~---------~~p~~ 220 (318)
T cd05582 154 ----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL---------GMPQF 220 (318)
T ss_pred ----ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC---------CCCCC
Confidence 223467999999999999889999999999999999999999999754432 222222211 23344
Q ss_pred HHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 577 VARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
.+..+.+|+.+||+.||.+||++.++++..+
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~ 251 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGPDGVEEI 251 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHH
Confidence 5678899999999999999999875444333
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.81 Aligned_cols=239 Identities=26% Similarity=0.338 Sum_probs=190.5
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHH-HHHcCCCCceeeEecccCC--CceeEEeeCCCC
Q 005616 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVR-VLSKLQHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~-iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||+|... |..||||++..... .....+..|.. ++..++||||+++++++.+ ..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 6999999999999985 88999999975432 22334555555 4678999999999998844 578999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCC
Q 005616 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~ 500 (688)
+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~----- 150 (323)
T cd05575 82 ELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS----- 150 (323)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-----
Confidence 999988654 35788999999999999999999966 9999999999999999999999999987543221
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHH
Q 005616 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~ 578 (688)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....+..+.. ..+...+
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------~~~~~~~ 220 (323)
T cd05575 151 -KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL---------RLKPNIS 220 (323)
T ss_pred -CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC---------CCCCCCC
Confidence 122455799999999999999999999999999999999999999975432 2222222211 1222346
Q ss_pred HHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 579 RRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 579 ~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
..+.+|+.+||+.||.+||++.+.+.+.++
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~il~ 250 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAKDDFLEIKN 250 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCCCCHHHHHc
Confidence 789999999999999999999755544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.00 Aligned_cols=245 Identities=28% Similarity=0.480 Sum_probs=203.3
Q ss_pred cCcccceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeCCC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPN 419 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~ 419 (688)
++|.....||.|+||.||+|...|+.||||.+..... ....+.+|+.++..++|+||+++++++. +..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 4677889999999999999999999999999976654 5667999999999999999999999985 458899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC
Q 005616 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 85 GSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence 999999865542 36899999999999999999999966 9999999999999999999999999998764322
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCccccccCCCCCCCCHH
Q 005616 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l~~~ldp~~~~~~~~ 576 (688)
....++..|+|||++..+.++.++||||||+++|+|++ |..||.... .....+..+... ..+..
T Consensus 157 -----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~ 223 (256)
T cd05039 157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM--------EAPEG 223 (256)
T ss_pred -----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--------CCccC
Confidence 12345678999999998899999999999999999997 999986443 222222222111 12233
Q ss_pred HHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHH
Q 005616 577 VARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~ 609 (688)
.+..+.+++.+||..+|.+||++. ++...|+.
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rp~~~-~l~~~l~~ 255 (256)
T cd05039 224 CPPEVYKVMKDCWELDPAKRPTFK-QLREQLAL 255 (256)
T ss_pred CCHHHHHHHHHHhccChhhCcCHH-HHHHHHhc
Confidence 457899999999999999999998 77777764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.68 Aligned_cols=250 Identities=31% Similarity=0.468 Sum_probs=203.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEeeCC
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLP 418 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~ 418 (688)
.++|...++||+|+||.||+|... +..||+|.+..... ....|.+|+.++++++||||+++++++.. ..++||||+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCC
Confidence 356888899999999999999886 78899999875443 35679999999999999999999998744 5789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
+|+|.+++..... ..+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05067 84 NGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc--
Confidence 9999999865432 46899999999999999999999966 99999999999999999999999999977653221
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCCCCH
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~ 575 (688)
.......++..|+|||++....++.++||||||+++|+|++ |++||..... ....+..+... ..+.
T Consensus 158 ---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 226 (260)
T cd05067 158 ---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM--------PRPD 226 (260)
T ss_pred ---ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--------CCCC
Confidence 11223456788999999999999999999999999999999 9999964432 22222222111 1122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHH
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~ 609 (688)
..+..+.+++.+||..+|++||++. .+...|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~-~l~~~l~~ 259 (260)
T cd05067 227 NCPEELYELMRLCWKEKPEERPTFE-YLRSVLED 259 (260)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHH-HHHHHhhc
Confidence 3456799999999999999999998 77777764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=313.04 Aligned_cols=242 Identities=26% Similarity=0.450 Sum_probs=192.7
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCcHH
Q 005616 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQ 423 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL~ 423 (688)
.||+|+||.||+|.+. +..||+|.+..... .....|.+|+.++..++||||++++++|.. ..++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 5999999999999884 88899998765432 334569999999999999999999999844 478999999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCccc
Q 005616 424 DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503 (688)
Q Consensus 424 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~ 503 (688)
+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......... .
T Consensus 82 ~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~----~ 152 (252)
T cd05084 82 TFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS----T 152 (252)
T ss_pred HHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccc----c
Confidence 9986543 45889999999999999999999966 9999999999999999999999999987654322110 0
Q ss_pred cCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHHHH
Q 005616 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARR 580 (688)
Q Consensus 504 ~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~~~ 580 (688)
.....++..|+|||++.++.++.++|||||||++|+|++ |..||..... ....+..+. ....+...+..
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 224 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV--------RLPCPELCPDA 224 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC--------CCCCcccCCHH
Confidence 112233567999999999999999999999999999998 8899864332 222222211 11223345678
Q ss_pred HHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 581 LVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 581 l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
+.+|+.+||+.+|.+||++. ++.+.|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~-~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFS-TVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHH-HHHHHHh
Confidence 99999999999999999999 6766664
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=327.59 Aligned_cols=231 Identities=27% Similarity=0.371 Sum_probs=189.7
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCC---ccchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeEEeeCCCC
Q 005616 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~---~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||+|... +..||||++.... ......+..|..++..+ +||||+++++++.+ ..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 6999999999999886 7889999997542 23345677888898877 69999999999854 478999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCC
Q 005616 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~ 500 (688)
+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---- 151 (320)
T cd05590 82 DLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---- 151 (320)
T ss_pred hHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC----
Confidence 9999886543 5788999999999999999999966 99999999999999999999999999876432211
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHH
Q 005616 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~ 578 (688)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... +...+..+.. ..+...+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~---------~~~~~~~ 220 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV---------VYPTWLS 220 (320)
T ss_pred --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC---------CCCCCCC
Confidence 12345799999999999999999999999999999999999999975442 2233322221 2233456
Q ss_pred HHHHHHHHHcccCCCCCCCCCc
Q 005616 579 RRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 579 ~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
..+.+|+.+||+.||.+||++.
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 221 QDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred HHHHHHHHHHcccCHHHCCCCC
Confidence 7889999999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=331.64 Aligned_cols=230 Identities=26% Similarity=0.331 Sum_probs=187.5
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCc
Q 005616 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gs 421 (688)
.||+|+||.||++... |..||+|++..... .....+.+|+.++..++||||+++++++.+ ..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 6999999999999875 88999999976432 234567889999999999999999998844 4789999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCc
Q 005616 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~ 501 (688)
|..++... ..+++..+..++.||+.||.|||+. .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~----- 151 (325)
T cd05594 82 LFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA----- 151 (325)
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-----
Confidence 99888654 3588999999999999999999973 2499999999999999999999999999875432221
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHHH
Q 005616 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVAR 579 (688)
Q Consensus 502 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~~ 579 (688)
......||+.|+|||++.+..++.++|||||||++|+|+||..||..... ....+..+. ..++...+.
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~---------~~~p~~~~~ 221 (325)
T cd05594 152 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------IRFPRTLSP 221 (325)
T ss_pred -ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC---------CCCCCCCCH
Confidence 12345799999999999999999999999999999999999999965432 222222211 123334567
Q ss_pred HHHHHHHHcccCCCCCCCC
Q 005616 580 RLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 580 ~l~~Li~~Cl~~dP~~RPs 598 (688)
.+.+|+.+||+.||.+|++
T Consensus 222 ~~~~li~~~L~~dP~~R~~ 240 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLG 240 (325)
T ss_pred HHHHHHHHHhhcCHHHhCC
Confidence 8999999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.98 Aligned_cols=253 Identities=29% Similarity=0.478 Sum_probs=206.4
Q ss_pred CcccceeeeccCceEEEEEEEC---C--eE-EEEEEEecCC---ccchHHHHHHHHHHHcCCCCceeeEecccC--CCce
Q 005616 343 NFSESFKVGQGGFGCVYKGEML---G--RT-VAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWS 411 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~---g--~~-VAIK~l~~~~---~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~ 411 (688)
+....++||+|+||.||+|.+. + .. ||||..+... .....+|.+|++++++++|||||++||++. +..+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 3444589999999999999885 2 23 8999988533 455678999999999999999999999984 4589
Q ss_pred eEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccc
Q 005616 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~ 491 (688)
||||+|+||+|.++|.+... .++..+++.++.++|.||+|||+.+ +|||||-..|+|++.++.+||+|||+++..
T Consensus 238 ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999999987653 6899999999999999999999966 999999999999999999999999998765
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHh-hcCccccccC
Q 005616 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAV-SCGKLSSILD 567 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i-~~~~l~~~ld 567 (688)
..-.. ......-...|+|||.+..+.|++++|||||||++||+++ |..||..... +...+ ..+...
T Consensus 313 ~~~~~------~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~---- 382 (474)
T KOG0194|consen 313 SQYVM------KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM---- 382 (474)
T ss_pred cceee------ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC----
Confidence 41110 0112245678999999999999999999999999999999 8889976553 44444 223221
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhhccC
Q 005616 568 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 615 (688)
Q Consensus 568 p~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~~~~ 615 (688)
..|...+..+..++.+||..+|++||+|. .+.+.|+.+.....
T Consensus 383 ----~~~~~~p~~~~~~~~~c~~~~p~~R~tm~-~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 383 ----PIPSKTPKELAKVMKQCWKKDPEDRPTMS-TIKKKLEALEKKKE 425 (474)
T ss_pred ----CCCCCCHHHHHHHHHHhccCChhhccCHH-HHHHHHHHHHhccc
Confidence 23335567888999999999999999999 88888888765433
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=327.14 Aligned_cols=244 Identities=25% Similarity=0.349 Sum_probs=195.6
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCC-CCceeeEecccC--CCceeEE
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQ-HPHLVTLLGACP--EAWSLVY 414 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~--~~~~LV~ 414 (688)
+|...+.||+|+||.||+|... |..||||++..... .....+..|..++..+. |++|+++++++. +..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999886 78999999975422 23446788999998885 567788888874 3588999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 999999999988654 35889999999999999999999965 999999999999999999999999998764322
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~ 572 (688)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....+..+. ..
T Consensus 155 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~---------~~ 219 (323)
T cd05615 155 GV------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN---------VS 219 (323)
T ss_pred Cc------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CC
Confidence 21 12345699999999999999999999999999999999999999975432 222222221 12
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
+|...+..+.+|+.+||+.+|.+|++..+...+.+
T Consensus 220 ~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i 254 (323)
T cd05615 220 YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDI 254 (323)
T ss_pred CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHH
Confidence 34445678899999999999999999764443333
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.98 Aligned_cols=245 Identities=28% Similarity=0.469 Sum_probs=195.9
Q ss_pred CcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCC
Q 005616 343 NFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPN 419 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~ 419 (688)
+|...+.||+|+||.||+|.+. +..+|+|++..... ....|.+|+.++..++||||+++++++.+ ..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4677788999999999999886 45799999864432 34568899999999999999999998854 47899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC
Q 005616 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
++|.+++.... ..+++..++.++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-- 156 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-- 156 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc--
Confidence 99999987543 36899999999999999999999966 999999999999999999999999999866432211
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCCCCHH
Q 005616 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~ 576 (688)
......++..|+|||++.+..++.++||||||+++|+|++ |..||..... ....+..+.. ...+..
T Consensus 157 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~ 225 (256)
T cd05059 157 ---SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR--------LYRPKL 225 (256)
T ss_pred ---ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc--------CCCCCC
Confidence 1122334568999999999999999999999999999999 8999864432 2222222211 112233
Q ss_pred HHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 577 VARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
.+..+.+|+.+||..+|++||++. +++..|
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~-~~l~~l 255 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFK-KLLSQL 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHH-HHHHHh
Confidence 567899999999999999999998 555443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=335.23 Aligned_cols=240 Identities=25% Similarity=0.411 Sum_probs=187.1
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeC
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
+|...+.||+|+||.||+|.+. |+.||||++...... ....|.+|+.++..++|+||+++++++.+ ..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4556678999999999999886 789999999654332 34568999999999999999999999854 478999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++|+|.+.. .+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 999986532 3456778899999999999999966 99999999999999999999999999987643221
Q ss_pred CCCccccCCCCCCCCCCChhhhcc-----CCCCCcchHhHHHHHHHHHHhCCCCCCChh--HHHHHhhcCccccccCCCC
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRT-----GVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~i~~~~l~~~ldp~~ 570 (688)
......||..|+|||++.. ...+.++|||||||++|||++|+.||.... ........... ...
T Consensus 224 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-----~~~ 293 (353)
T PLN00034 224 -----PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM-----SQP 293 (353)
T ss_pred -----cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc-----cCC
Confidence 1234579999999998743 234579999999999999999999996322 11111110000 001
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
...+..++..+.+|+.+||+.||.+||++.+.+
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell 326 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLL 326 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 122334567899999999999999999998443
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.07 Aligned_cols=253 Identities=22% Similarity=0.334 Sum_probs=203.8
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~ 414 (688)
++|...+.||.|+||.||+|+.. +..||||.+..... .....|.+|+.+++.++||||+++++++. +..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888899999999999999874 88999998865332 23346889999999999999999999884 4578999
Q ss_pred eeCCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 415 EYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
||+++|+|.+++.... ....+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998886432 2345788999999999999999999965 99999999999999999999999999887654
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh----HHHHHhhcCccccccCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG----EVRRAVSCGKLSSILDPL 569 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~----~~~~~i~~~~l~~~ldp~ 569 (688)
... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.... .....+..+....
T Consensus 159 ~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 227 (267)
T cd08228 159 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP----- 227 (267)
T ss_pred hhH------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC-----
Confidence 321 1234568899999999988889999999999999999999999985332 1222222111110
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhh
Q 005616 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~ 611 (688)
..+...+..+.+++.+||+.+|.+||++. ++++.|+.+.
T Consensus 228 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~-~vl~~~~~~~ 266 (267)
T cd08228 228 --LPTEHYSEKLRELVSMCIYPDPDQRPDIG-YVHQIAKQMH 266 (267)
T ss_pred --CChhhcCHHHHHHHHHHCCCCcccCcCHH-HHHHHHHHhc
Confidence 11224557899999999999999999999 8888888763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=335.02 Aligned_cols=254 Identities=21% Similarity=0.245 Sum_probs=192.9
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
.|...+.||+|+||+||+|... +..||||++..... .....+.+|+.++..++|||||+++++|.+ ..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999885 78999999976532 234568899999999999999999999854 4789999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|+++|+|.+++.... .+++..+..++.||+.||.|||..+ |+||||||+||||+.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987543 5788899999999999999999966 9999999999999999999999999986432110
Q ss_pred Cc-----------------------------------------CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHH
Q 005616 496 LY-----------------------------------------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFG 534 (688)
Q Consensus 496 ~~-----------------------------------------~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfG 534 (688)
.. ...........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 00 0000011245799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHH--cccCCCCCCCCCcHHHHH
Q 005616 535 LIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQ--CCELYGRERPDITPSLVK 605 (688)
Q Consensus 535 viL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~--Cl~~dP~~RPs~~e~l~~ 605 (688)
|++|||+||..||..................+ ........+..+.+|+.+ |+..+|..||++.+.+.+
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTL---HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---CCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999999997544322111110000000 001111245677888877 556677779998855443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.01 Aligned_cols=246 Identities=22% Similarity=0.296 Sum_probs=209.5
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc--hHHHHHHHHHHHcCCCCceeeEecccCC--C-ceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGACPE--A-WSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~--~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~-~~LV~ 414 (688)
++|...++||+|+||.++.++.+ ++.|++|.+....... .....+|+.++++++|||||.+++.|.+ . .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888899999999999988776 7889999997765443 3357899999999999999999999954 3 68999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
+||+||+|.+.+.+.. ...++.+.++.|+.|++.|+.|||+.+ |+|||||+.|||++.++.+||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998776 356899999999999999999999755 999999999999999999999999999999876
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~ 572 (688)
.. .....+||+.||.||++.+.+|+.|+|||||||++|||++-+++|...+. ....+..+. +. .
T Consensus 160 ~~------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~----~~----P 225 (426)
T KOG0589|consen 160 DS------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL----YS----P 225 (426)
T ss_pred hh------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc----CC----C
Confidence 52 23578999999999999999999999999999999999999999975543 222222222 22 3
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHH
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~ 605 (688)
.|..++..+..|+..|+..+|..||++.+.+.+
T Consensus 226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 455677899999999999999999999966654
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=316.58 Aligned_cols=239 Identities=23% Similarity=0.328 Sum_probs=189.1
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCcH
Q 005616 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 422 (688)
Q Consensus 350 LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL 422 (688)
||+|+||.||++... |..||+|.+...... ....+..|+.++.+++||||+++++++.+ ..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 889999998653322 23346679999999999999999998854 47899999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCcc
Q 005616 423 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502 (688)
Q Consensus 423 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~ 502 (688)
.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~------- 149 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK------- 149 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-------
Confidence 988865432 45889999999999999999999965 9999999999999999999999999998765332
Q ss_pred ccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHHHH
Q 005616 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARR 580 (688)
Q Consensus 503 ~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~~~ 580 (688)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+....+...+.. ....++..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 225 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF----EHQNFTEE 225 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc----ccccCCHH
Confidence 12345689999999999998999999999999999999999999964321 1111111111111110 11234667
Q ss_pred HHHHHHHcccCCCCCCCCCcHHH
Q 005616 581 LVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 581 l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
+.+|+.+||+.||.+||++.+.+
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHHHhccCHhhCCCCccch
Confidence 89999999999999999998544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=355.15 Aligned_cols=264 Identities=22% Similarity=0.254 Sum_probs=205.5
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...++||+|+||.||+|.+. |+.||||++...... ....|.+|+.+++.++||||+++++++.+ ..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999885 789999999754322 24568999999999999999999999854 478999
Q ss_pred eeCCCCcHHHHhcccC--------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecC
Q 005616 415 EYLPNGSLQDRLFRKS--------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFG 486 (688)
||++||+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 1234677889999999999999999965 9999999999999999999999999
Q ss_pred ccccccCCCCc------------CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHH
Q 005616 487 ICRLVTEDTLY------------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR 554 (688)
Q Consensus 487 la~~~~~~~~~------------~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~ 554 (688)
+++........ ...........||+.|+|||++.+..++.++|||||||++|||+||..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99876221100 001111234579999999999999999999999999999999999999996533211
Q ss_pred HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhh
Q 005616 555 RAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 555 ~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~ 612 (688)
... ...+ .++.........+..+.+++.+|+..||++||+..+++.+.|+....
T Consensus 239 i~~-~~~i---~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISY-RDVI---LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhh-hhhc---cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111 1111 11111011123456789999999999999999988899988887643
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=328.65 Aligned_cols=232 Identities=24% Similarity=0.310 Sum_probs=187.9
Q ss_pred eeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcC-CCCceeeEecccC--CCceeEEeeCCC
Q 005616 348 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACP--EAWSLVYEYLPN 419 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~--~~~~LV~E~~~~ 419 (688)
+.||+|+||.||+|... +..||+|++..... .....+..|+.++.++ +||||+++++++. +..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999886 78899999976432 2334577899998877 8999999999884 358899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC
Q 005616 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
|+|..++... ..+++..+..++.+|+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--- 151 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--- 151 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---
Confidence 9999888654 35889999999999999999999966 99999999999999999999999999875432211
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh-----------HHHHHhhcCccccccCC
Q 005616 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG-----------EVRRAVSCGKLSSILDP 568 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~-----------~~~~~i~~~~l~~~ldp 568 (688)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .+...+..+
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-------- 220 (329)
T cd05618 152 ---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-------- 220 (329)
T ss_pred ---ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--------
Confidence 1234579999999999999999999999999999999999999995211 111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 569 ~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
....|...+..+.+|+.+||+.||.+||+..
T Consensus 221 -~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~ 251 (329)
T cd05618 221 -QIRIPRSLSVKAASVLKSFLNKDPKERLGCH 251 (329)
T ss_pred -CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCC
Confidence 1123445567889999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=311.78 Aligned_cols=249 Identities=31% Similarity=0.434 Sum_probs=200.7
Q ss_pred cCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEeeCCC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPN 419 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~~ 419 (688)
++|.....||.|+||.||+|.+. +..||+|.+.... .....|.+|+.+++.++|||++++++++.. ..++||||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 45778889999999999999887 4579999886543 234578999999999999999999998854 47899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC
Q 005616 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
|+|.+++.... ...++|..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-- 158 (260)
T cd05069 85 GSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-- 158 (260)
T ss_pred CCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc--
Confidence 99999997543 245789999999999999999999965 999999999999999999999999999876433211
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCCCCHH
Q 005616 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~ 576 (688)
......++..|+|||+..+..++.++|||||||++|+|+| |..||..... ....+..+.. ...+..
T Consensus 159 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~ 227 (260)
T cd05069 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR--------MPCPQG 227 (260)
T ss_pred ---ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------CCCCcc
Confidence 1123346788999999998999999999999999999999 8999965332 2222222110 112334
Q ss_pred HHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHH
Q 005616 577 VARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~ 609 (688)
.+..+.+++.+||..||.+||++. .+.+.|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~ 259 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFE-YIQSFLED 259 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHH-HHHHHHhc
Confidence 567899999999999999999998 77777764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=325.81 Aligned_cols=234 Identities=29% Similarity=0.374 Sum_probs=189.1
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCC---ccchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeEEeeCCCC
Q 005616 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~---~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||+|.+. +..||||+++... ......+..|..++..+ +||||+++++++.+ ..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 6999999999999986 6789999997642 22344567788888764 89999999999844 478999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCC
Q 005616 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~ 500 (688)
+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 151 (316)
T cd05619 82 DLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---- 151 (316)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC----
Confidence 999998654 35788999999999999999999966 99999999999999999999999999875422111
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHH
Q 005616 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~ 578 (688)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... ....+..+. ..++...+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~---------~~~~~~~~ 220 (316)
T cd05619 152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN---------PCYPRWLT 220 (316)
T ss_pred --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CCCCccCC
Confidence 12345799999999999999999999999999999999999999965432 222222211 11233456
Q ss_pred HHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 579 RRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 579 ~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
..+.+|+.+||+.||.+||++.+++
T Consensus 221 ~~~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 221 REAKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred HHHHHHHHHHhccCHhhcCCChHHH
Confidence 6789999999999999999997444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=331.90 Aligned_cols=246 Identities=25% Similarity=0.297 Sum_probs=196.4
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|.....||+|+||.||++... |..||||+++.... .....+.+|+.++..++||||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999885 88999999976432 234568899999999999999999998854 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999997653 36889999999999999999999966 999999999999999999999999999876543
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhc------cCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHH--HHhhcCcccccc
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHR------TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSIL 566 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~------~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~i~~~~l~~~l 566 (688)
... ......||+.|+|||++. ...++.++|||||||++|+|++|..||....... ..+.... ..+
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~ 228 (330)
T cd05601 156 KMV-----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ--RFL 228 (330)
T ss_pred Cce-----eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC--Ccc
Confidence 211 123457999999999986 4568899999999999999999999996543321 2221111 111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 567 dp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
. .......+..+.+|+..|+. +|.+||++.+.+
T Consensus 229 ~---~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~ 261 (330)
T cd05601 229 K---FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLC 261 (330)
T ss_pred C---CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence 0 01111345678999999998 999999998443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.45 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=198.3
Q ss_pred ccceeeeccCceEEEEEEE------CCeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC----CceeE
Q 005616 345 SESFKVGQGGFGCVYKGEM------LGRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLV 413 (688)
Q Consensus 345 ~~~~~LG~G~~G~Vy~g~~------~g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV 413 (688)
.....||+|+||+||++.. .+..||+|.+..... .....|.+|+.+|+.++||||++++++|.. ..++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7788999999999988753 267899999876533 345678899999999999999999998742 36899
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
|||+++|+|.+++... .+++..++.++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999998653 4899999999999999999999965 99999999999999999999999999987654
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH-HHHHhh--c-----Cccccc
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE-VRRAVS--C-----GKLSSI 565 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~-~~~~i~--~-----~~l~~~ 565 (688)
..... .......++..|+|||++....++.++||||||+++|+|+||..||..... ...... . ..+...
T Consensus 160 ~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 160 GHEYY---RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cchhh---ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 32110 011233456779999999888999999999999999999999999864322 111110 0 001111
Q ss_pred cCCC-CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 566 LDPL-AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 566 ldp~-~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
++.. ....+...+..+.+++.+||+.+|.+||++. .++..|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~-~i~~~l~~~ 281 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR-SLIPILKEM 281 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHH-HHHHHHHHh
Confidence 1111 1112334567899999999999999999999 788888765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.16 Aligned_cols=245 Identities=29% Similarity=0.510 Sum_probs=198.2
Q ss_pred eeeeccCceEEEEEEEC--C---eEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEeeCCCC
Q 005616 348 FKVGQGGFGCVYKGEML--G---RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPNG 420 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~--g---~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~~g 420 (688)
+.||+|+||.||+|.+. + ..||+|.+...... ....+.+|+.+++.+.|||||++++++.. ..++||||+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 36999999999999874 2 67999998766543 45579999999999999999999998854 578999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCC
Q 005616 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~ 500 (688)
+|.+++.... .+++..++.++.|++.||.|||..+ |+|+||||+|||++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~-- 152 (257)
T cd05060 81 PLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY-- 152 (257)
T ss_pred cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc--
Confidence 9999997643 5789999999999999999999966 9999999999999999999999999998765433211
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHH
Q 005616 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~ 577 (688)
.......++..|+|||.+.+..++.++|||||||++|+|++ |.+||..... +...+..+... ..+...
T Consensus 153 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~ 223 (257)
T cd05060 153 -RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL--------PRPEEC 223 (257)
T ss_pred -ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC--------CCCCCC
Confidence 11122334568999999999999999999999999999998 9999965432 22333332211 223344
Q ss_pred HHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 578 ARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 578 ~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
+..+.+++.+||..+|.+||++. +|.+.|+.+
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~-~l~~~l~~~ 255 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFS-ELESTFRRD 255 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHH-HHHHHHHhc
Confidence 56899999999999999999999 788888754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.12 Aligned_cols=259 Identities=27% Similarity=0.393 Sum_probs=201.1
Q ss_pred hcCcccceeeeccCceEEEEEEECC------------------eEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceee
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEMLG------------------RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVT 401 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~g------------------~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~ 401 (688)
..+|.....||+|+||.||+|...+ ..||+|.+..... .....|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568888999999999999987642 4589999876543 34567899999999999999999
Q ss_pred EecccCC--CceeEEeeCCCCcHHHHhcccC--------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCc
Q 005616 402 LLGACPE--AWSLVYEYLPNGSLQDRLFRKS--------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQN 471 (688)
Q Consensus 402 l~g~~~~--~~~LV~E~~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~N 471 (688)
++++|.. ..++||||+++++|.+++.... ....+++..++.++.+++.||.|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999854 5889999999999999987643 1236899999999999999999999965 9999999999
Q ss_pred eeeCCCCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh--CCCCCCC
Q 005616 472 ILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT--GRLPVGL 549 (688)
Q Consensus 472 ILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt--G~~Pf~~ 549 (688)
|+++.++.++|+|||++......... .......+++.|+|||++....++.++|||||||++|||++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYY----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCCCceEEccccceeecccCcce----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999865433211 12234567889999999998899999999999999999998 7788864
Q ss_pred hhH--HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 550 AGE--VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 550 ~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
... +........ ...-.......+..++..+.+|+.+||+.||.+||++. +|...|+
T Consensus 237 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~-el~~~L~ 295 (296)
T cd05051 237 LTDQQVIENAGHFF-RDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFR-EIHLFLQ 295 (296)
T ss_pred cChHHHHHHHHhcc-ccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHH-HHHHHhc
Confidence 332 222211110 00000001112333457899999999999999999999 6666654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=326.23 Aligned_cols=235 Identities=27% Similarity=0.371 Sum_probs=189.5
Q ss_pred eeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeEEeeCCC
Q 005616 348 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPN 419 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV~E~~~~ 419 (688)
+.||+|+||.||+|.+. |..||||+++.... .....+..|..++..+ +||||+++++++.+ ..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999986 78999999976422 2344567788888765 89999999999854 47899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC
Q 005616 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 150 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---- 150 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC----
Confidence 9999988654 35788999999999999999999966 9999999999999999999999999987532211
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHH
Q 005616 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~ 577 (688)
.......||+.|+|||++.+..++.++|||||||++|||++|..||..... ....+..+. ...+...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~---------~~~~~~~ 219 (316)
T cd05620 151 --NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT---------PHYPRWI 219 (316)
T ss_pred --CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CCCCCCC
Confidence 122456799999999999999999999999999999999999999975432 222222111 1223335
Q ss_pred HHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 578 ARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 578 ~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
+..+.+|+.+||+.||.+||++.+++
T Consensus 220 ~~~~~~li~~~l~~dP~~R~~~~~~~ 245 (316)
T cd05620 220 TKESKDILEKLFERDPTRRLGVVGNI 245 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHH
Confidence 66889999999999999999986444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.59 Aligned_cols=252 Identities=26% Similarity=0.380 Sum_probs=200.7
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--Cce
Q 005616 336 DLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWS 411 (688)
Q Consensus 336 el~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~ 411 (688)
|++.+++++.....||+|+||.||+|.+. +..||+|.+..........+.+|+.++..++||||+++++++.. ..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34567788888899999999999999875 67899999887666666789999999999999999999999854 478
Q ss_pred eEEeeCCCCcHHHHhcccCCCCCC--CHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC-CCceEEeecCcc
Q 005616 412 LVYEYLPNGSLQDRLFRKSNVSPL--LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFGIC 488 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l--~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-~~~~KL~DFGla 488 (688)
+|+||+++++|.+++.... ..+ ++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++
T Consensus 82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEEecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 9999999999999987543 234 78889999999999999999865 999999999999986 679999999998
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhccCC--CCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH-hhcCccccc
Q 005616 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV--LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA-VSCGKLSSI 565 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~--~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~-i~~~~l~~~ 565 (688)
........ ......|++.|+|||++.... ++.++||||||+++|+|++|..||......... ...+.
T Consensus 157 ~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~---- 226 (268)
T cd06624 157 KRLAGINP------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM---- 226 (268)
T ss_pred eecccCCC------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh----
Confidence 76543221 122345899999999986643 789999999999999999999999643321111 11110
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 566 ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.......+......+.+++.+||+.+|.+||++.+.+
T Consensus 227 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 263 (268)
T cd06624 227 -FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLL 263 (268)
T ss_pred -hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHH
Confidence 0111234445667899999999999999999998443
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=316.56 Aligned_cols=249 Identities=26% Similarity=0.353 Sum_probs=197.6
Q ss_pred HHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccCC------
Q 005616 338 QTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE------ 408 (688)
Q Consensus 338 ~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~------ 408 (688)
+.+++.|...+.||.|+||.||+|... +..||+|.+.... .....+.+|+.++.++ +||||++++++|..
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 356788999999999999999999885 7889999986543 3456788999999999 79999999998842
Q ss_pred --CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecC
Q 005616 409 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 409 --~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFG 486 (688)
..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence 3679999999999999987543 246889999999999999999999965 9999999999999999999999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhc-----cCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCc
Q 005616 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGK 561 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~ 561 (688)
++....... .......|++.|+|||++. ...++.++|||||||++|||++|..||..............
T Consensus 157 ~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~ 230 (272)
T cd06637 157 VSAQLDRTV------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 230 (272)
T ss_pred Cceeccccc------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc
Confidence 998654322 1234567899999999885 34688899999999999999999999964433222211110
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 562 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 562 l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
. +.....+...+..+.+|+.+||..+|.+||++.+.
T Consensus 231 ~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 266 (272)
T cd06637 231 N-----PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266 (272)
T ss_pred C-----CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 0 00001112345678999999999999999998843
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=318.87 Aligned_cols=251 Identities=28% Similarity=0.433 Sum_probs=199.2
Q ss_pred CcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
+|...+.||.|+||.||+|.+. +..||||++...... ....|.+|+.++..++||||+++++++.+ ..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3566678999999999999874 367999999755432 23568899999999999999999999854 5789
Q ss_pred EEeeCCCCcHHHHhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCc
Q 005616 413 VYEYLPNGSLQDRLFRKS-------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 479 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~ 479 (688)
++||+.+++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 1235889999999999999999999966 999999999999999999
Q ss_pred eEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHH
Q 005616 480 SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRA 556 (688)
Q Consensus 480 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~ 556 (688)
+||+|||+++........ .......+++.|+|||++.++.++.++|||||||++|||++ |..||.... .+...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 163 VKISDLGLFREVYAADYY----KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred eEecccccccccccchhe----eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999998866433211 11234456789999999988899999999999999999998 888886432 23333
Q ss_pred hhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHH
Q 005616 557 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 557 i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~ 609 (688)
+..+... ..+..++..+.+|+..||+.+|.+||++. +|...|+.
T Consensus 239 i~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~RP~~~-~i~~~l~~ 282 (283)
T cd05091 239 IRNRQVL--------PCPDDCPAWVYTLMLECWNEFPSRRPRFK-DIHSRLRT 282 (283)
T ss_pred HHcCCcC--------CCCCCCCHHHHHHHHHHhCCCcccCCCHH-HHHHHhhC
Confidence 3333221 22334566789999999999999999998 77766653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=330.84 Aligned_cols=231 Identities=24% Similarity=0.325 Sum_probs=188.2
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeEEeeCCCC
Q 005616 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||+|... +..||||+++.... .....+..|..++..+ +||||++++++|.+ ..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 6999999999999886 78999999986432 2334588999999998 79999999999854 478999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCC
Q 005616 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~ 500 (688)
+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----- 150 (329)
T cd05588 82 DLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG----- 150 (329)
T ss_pred CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-----
Confidence 999888654 35899999999999999999999966 9999999999999999999999999987532211
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh-----------HHHHHhhcCccccccCCC
Q 005616 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG-----------EVRRAVSCGKLSSILDPL 569 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~-----------~~~~~i~~~~l~~~ldp~ 569 (688)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .....+..+.
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-------- 221 (329)
T cd05588 151 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-------- 221 (329)
T ss_pred -CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------
Confidence 12234579999999999999999999999999999999999999995321 1111121111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 570 AGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
...|...+..+.+|+.+||+.||.+||+..
T Consensus 222 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 251 (329)
T cd05588 222 -IRIPRSLSVKASSVLKGFLNKDPKERLGCH 251 (329)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 123334567899999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=326.66 Aligned_cols=231 Identities=25% Similarity=0.367 Sum_probs=188.6
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeEEeeCCCC
Q 005616 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||+|... +..||||++..... .....+..|..++..+ +||||++++++|.+ ..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 5999999999999886 67899999976432 2344577899999876 79999999999854 478999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCC
Q 005616 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~ 500 (688)
+|...+.... .+++..+..++.+|+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---- 151 (321)
T cd05591 82 DLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---- 151 (321)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc----
Confidence 9998886543 5788999999999999999999966 99999999999999999999999999876432221
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHH
Q 005616 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~ 578 (688)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+.. .+|...+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~---------~~p~~~~ 220 (321)
T cd05591 152 --TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV---------LYPVWLS 220 (321)
T ss_pred --cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------CCCCCCC
Confidence 12345799999999999999999999999999999999999999975443 2222322221 1233345
Q ss_pred HHHHHHHHHcccCCCCCCCCCc
Q 005616 579 RRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 579 ~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
..+.+|+.+||+.||.+||+..
T Consensus 221 ~~~~~ll~~~L~~dp~~R~~~~ 242 (321)
T cd05591 221 KEAVSILKAFMTKNPNKRLGCV 242 (321)
T ss_pred HHHHHHHHHHhccCHHHcCCCC
Confidence 7889999999999999999643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=310.20 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=204.5
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||.|+||.||+|... |..||+|.++.... .....+.+|+.++++++|+||+++++++.+ ..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999886 88999999864332 235578999999999999999999999854 478999
Q ss_pred eeCCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 415 EYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
||+++|+|..++.... ....+++..++.++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886532 2345899999999999999999999966 99999999999999999999999999886643
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH----HHHHhhcCccccccCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE----VRRAVSCGKLSSILDPL 569 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~----~~~~i~~~~l~~~ldp~ 569 (688)
... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+...
T Consensus 159 ~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 226 (267)
T cd08224 159 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP------ 226 (267)
T ss_pred CCc------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC------
Confidence 321 12345688999999999988999999999999999999999999854321 11112222111
Q ss_pred CCCCCH-HHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 570 AGDWPT-FVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 570 ~~~~~~-~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
..+. ..+..+.+++.+||..+|.+||++. .|+..|+.+
T Consensus 227 --~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~-~il~~~~~~ 265 (267)
T cd08224 227 --PLPADHYSEELRDLVSRCINPDPEKRPDIS-YVLQVAKEM 265 (267)
T ss_pred --CCChhhcCHHHHHHHHHHcCCCcccCCCHH-HHHHHHHHh
Confidence 1122 4566899999999999999999998 788888765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=322.55 Aligned_cols=239 Identities=27% Similarity=0.337 Sum_probs=189.7
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHH-HHHcCCCCceeeEecccCC--CceeEEeeCCCC
Q 005616 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVR-VLSKLQHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~-iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||+|+.. |..||+|++..... .....+..|.. ++..++||||++++++|.+ ..++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999985 78999999975432 22334555654 5788999999999998844 588999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCC
Q 005616 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~ 500 (688)
+|...+... ..++...+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.......
T Consensus 82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---- 151 (321)
T cd05603 82 ELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---- 151 (321)
T ss_pred CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC----
Confidence 999888653 35778889999999999999999965 99999999999999999999999999875422211
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHH
Q 005616 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~ 578 (688)
......||+.|+|||++.+..++.++|||||||++|||++|..||...+. ....+..+. ...+....
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---------~~~~~~~~ 220 (321)
T cd05603 152 --TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP---------LQLPGGKT 220 (321)
T ss_pred --ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC---------CCCCCCCC
Confidence 12345799999999999999999999999999999999999999965432 222222221 12333456
Q ss_pred HHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 579 RRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 579 ~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
..+.+++.+||+.||.+||+....+.+.++
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~ 250 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAKADFLEIKN 250 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCCCCHHHHhC
Confidence 689999999999999999998755554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.48 Aligned_cols=251 Identities=27% Similarity=0.434 Sum_probs=200.4
Q ss_pred cCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
.+|....+||+|+||.||++... +..||+|.+..........|.+|+.++..++||||+++++++.+ ..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677789999999999999642 56799999876665666789999999999999999999999854 4789
Q ss_pred EEeeCCCCcHHHHhcccCC------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCce
Q 005616 413 VYEYLPNGSLQDRLFRKSN------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~ 480 (688)
||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999875431 135889999999999999999999966 9999999999999999999
Q ss_pred EEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHh
Q 005616 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAV 557 (688)
Q Consensus 481 KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i 557 (688)
||+|||++......... .......+++.|+|||++.+..++.++|||||||++|||++ |.+||..... ....+
T Consensus 162 kL~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYY----RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred EECCCCceeEcCCCcee----ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 99999999765432211 11233446788999999999999999999999999999998 9999854332 22222
Q ss_pred hcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 558 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 558 ~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
..+... ..+..++..+.+|+.+||+.||.+||++. +|.+.|+
T Consensus 238 ~~~~~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~-~l~~~l~ 279 (280)
T cd05092 238 TQGREL--------ERPRTCPPEVYAIMQGCWQREPQQRMVIK-DIHSRLQ 279 (280)
T ss_pred HcCccC--------CCCCCCCHHHHHHHHHHccCChhhCCCHH-HHHHHHh
Confidence 222111 11223456789999999999999999999 6766654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.61 Aligned_cols=256 Identities=28% Similarity=0.458 Sum_probs=204.0
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcC-CCCceeeEecccCC-
Q 005616 339 TATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE- 408 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~- 408 (688)
...++|...+.||+|+||.||+|... ...||+|.+..... .....+.+|+.++.++ +||||++++++|..
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34467888899999999999999874 25799999875432 3345688999999999 89999999999854
Q ss_pred -CceeEEeeCCCCcHHHHhccc-------------CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee
Q 005616 409 -AWSLVYEYLPNGSLQDRLFRK-------------SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 474 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL 474 (688)
..++||||+++|+|..++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 478999999999999998643 22356899999999999999999999865 9999999999999
Q ss_pred CCCCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--
Q 005616 475 DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG-- 551 (688)
Q Consensus 475 d~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~-- 551 (688)
+.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYY----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred cCCCeEEeCccccccccccccce----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 99999999999999876543211 11223345678999999998999999999999999999998 999986433
Q ss_pred HHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 552 EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 552 ~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
.....+..+... ..+...+..+.+|+.+||..||.+|||+. ++++.|+.+
T Consensus 242 ~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~-eil~~l~~~ 291 (293)
T cd05053 242 ELFKLLKEGYRM--------EKPQNCTQELYHLMRDCWHEVPSQRPTFK-QLVEDLDRM 291 (293)
T ss_pred HHHHHHHcCCcC--------CCCCCCCHHHHHHHHHHcccCcccCcCHH-HHHHHHHHh
Confidence 233333322211 22334456899999999999999999998 777777754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=315.21 Aligned_cols=252 Identities=30% Similarity=0.475 Sum_probs=201.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--Cc
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AW 410 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~ 410 (688)
.++|.....||.|+||.||+|... +..||+|.+..... .....|.+|+.++..++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357888899999999999999875 26799999865532 334578899999999999999999999854 48
Q ss_pred eeEEeeCCCCcHHHHhcccCC-------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEe
Q 005616 411 SLVYEYLPNGSLQDRLFRKSN-------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKIC 483 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~ 483 (688)
++||||+++|+|.+++..... ...++|..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 899999999999999865321 234789999999999999999999965 9999999999999999999999
Q ss_pred ecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcC
Q 005616 484 DFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCG 560 (688)
Q Consensus 484 DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~ 560 (688)
|||+++........ .......++..|+|||.+.++.++.++|||||||++|||+| |..||.... .....+..+
T Consensus 162 dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05032 162 DFGMTRDIYETDYY----RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237 (277)
T ss_pred CcccchhhccCccc----ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence 99999876543321 12234457889999999998899999999999999999998 999986433 233333322
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 561 KLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 561 ~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
... ..+...+..+.+++.+||+.+|.+|||+. ++...|+
T Consensus 238 ~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~l~~~l~ 276 (277)
T cd05032 238 GHL--------DLPENCPDKLLELMRMCWQYNPKMRPTFL-EIVSSLK 276 (277)
T ss_pred CCC--------CCCCCCCHHHHHHHHHHcCCChhhCCCHH-HHHHHhc
Confidence 221 12233467899999999999999999998 6666554
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=306.44 Aligned_cols=263 Identities=23% Similarity=0.295 Sum_probs=210.2
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC-------CC
Q 005616 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP-------EA 409 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~-------~~ 409 (688)
...++|.+.+.||.|||+.||.++.- +..+|+|++......+.+...+|++..++++|||++++++++. +.
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 44578999999999999999999854 7889999998888888889999999999999999999999872 23
Q ss_pred ceeEEeeCCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcc
Q 005616 410 WSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla 488 (688)
.||+++|...|+|.+.+.... ....+++.+++.|+.+|++||.+||... .+++||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 799999999999999998764 3457899999999999999999999988 48999999999999999999999999998
Q ss_pred ccccCCCCc---CCCccccCCCCCCCCCCChhhhc---cCCCCCcchHhHHHHHHHHHHhCCCCCCChhH----HHHHhh
Q 005616 489 RLVTEDTLY---LPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE----VRRAVS 558 (688)
Q Consensus 489 ~~~~~~~~~---~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~----~~~~i~ 558 (688)
....-.... ....+.......|..|.|||.+. +...+.++|||||||+||+|+.|..||...-. +.-++.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ 256 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence 865422111 01112223445788999999874 45678999999999999999999999963221 111222
Q ss_pred cCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 559 CGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 559 ~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
.+.+.- | -...+++.+.+|+.+|++.||.+||++. +|+..++.+
T Consensus 257 n~q~s~---P----~~~~yse~l~~lik~mlqvdP~qRP~i~-~ll~~~d~L 300 (302)
T KOG2345|consen 257 NAQISI---P----NSSRYSEALHQLIKSMLQVDPNQRPTIP-ELLSKLDDL 300 (302)
T ss_pred cccccc---C----CCCCccHHHHHHHHHHhcCCcccCCCHH-HHHHHHHhh
Confidence 222211 1 1122788999999999999999999999 666555543
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=312.55 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=200.7
Q ss_pred hcCcccceeeeccCceEEEEEEEC--C---eEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--G---RTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g---~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
+++|...+.||+|+||.||+|.+. + ..||||.+.... ......+.+|+.++..++||||+++++++.+ ..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999874 3 369999986553 2334578999999999999999999999854 4789
Q ss_pred EEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccccc
Q 005616 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~ 492 (688)
||||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999986543 46899999999999999999999966 9999999999999999999999999998664
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCccccccCCC
Q 005616 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPL 569 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l~~~ldp~ 569 (688)
...... ........++.|+|||++....++.++|||||||++|||++ |..||.... .....+..+.. .
T Consensus 159 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~----~-- 229 (268)
T cd05063 159 DDPEGT---YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR----L-- 229 (268)
T ss_pred cccccc---eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC----C--
Confidence 322110 11122234567999999998899999999999999999998 999985432 22333322210 1
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
..+...+..+.+++.+||+.+|.+||++. ++...|+.+
T Consensus 230 --~~~~~~~~~~~~li~~c~~~~p~~Rp~~~-~i~~~l~~~ 267 (268)
T cd05063 230 --PAPMDCPSAVYQLMLQCWQQDRARRPRFV-DIVNLLDKL 267 (268)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHhh
Confidence 11223456789999999999999999999 787777654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=309.25 Aligned_cols=242 Identities=29% Similarity=0.397 Sum_probs=199.7
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|...+.||+|+||.||+|... +..|++|.+..... .....+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999885 78999999875432 345678999999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++++|.+++.... ...+++..++.++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999987642 256899999999999999999999865 99999999999999999999999999987654321
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCccccccCCCCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~ldp~~~~~~ 574 (688)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+..+... ..+
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~ 222 (256)
T cd08529 157 ------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP--------PVS 222 (256)
T ss_pred ------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------CCc
Confidence 123456889999999999999999999999999999999999999755432 1222222211 222
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 575 TFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 575 ~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
..++..+.+++.+||+.+|++||++.+.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l 250 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQL 250 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHH
Confidence 2456789999999999999999999843
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.65 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=198.9
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--C
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--A 409 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~ 409 (688)
.+++|...+.||+|+||.||+|.+. +..||+|.+..... .....|.+|+.+++.++||||+++++++.+ .
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567889999999999999999885 36789998865433 334569999999999999999999998743 5
Q ss_pred ceeEEeeCCCCcHHHHhcccCC----CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC---ceEE
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSN----VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL---SSKI 482 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~---~~KL 482 (688)
.++||||+++++|.+++..... ...++|..++.++.+|+.||.|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 7899999999999999876532 235899999999999999999999966 99999999999998765 5999
Q ss_pred eecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhc
Q 005616 483 CDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSC 559 (688)
Q Consensus 483 ~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~ 559 (688)
+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.... .....+..
T Consensus 161 ~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 161 ADFGMARDIYRASYY----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred ccCccccccCCccce----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999876432211 01122334568999999999999999999999999999997 999996433 22222222
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 560 ~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
+. ...++..++..+.+++.+||+.+|++||++. +|++.|+
T Consensus 237 ~~--------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~-~vl~~l~ 276 (277)
T cd05036 237 GG--------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFA-TILERIQ 276 (277)
T ss_pred CC--------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHhh
Confidence 11 1123344567899999999999999999999 5655543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=335.53 Aligned_cols=245 Identities=22% Similarity=0.291 Sum_probs=189.1
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||+++.. +..||||++..... .....+.+|+.+|..++||||+++++.|.+ ..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999886 78999999865422 234568899999999999999999999854 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999986543 5788889999999999999999966 999999999999999999999999998543210
Q ss_pred CCc-------------------------------------CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHH
Q 005616 495 TLY-------------------------------------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLII 537 (688)
Q Consensus 495 ~~~-------------------------------------~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL 537 (688)
... ...........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 000 0000011245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCChhHHHH--HhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 005616 538 LQLLTGRLPVGLAGEVRR--AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 538 ~ELltG~~Pf~~~~~~~~--~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs 598 (688)
|||++|+.||........ .+..... ....+ .....+..+.+++.+|+ .+|.+|+.
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~----~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWET-TLHIP----SQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccCc-cccCC----CCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 999999999975543221 1211111 00011 11134557788888876 59999994
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=313.00 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=202.8
Q ss_pred cCcccceeeeccCceEEEEEEECC-----eEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC-CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEMLG-----RTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~g-----~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~ 414 (688)
++|.....||.|+||.||+|.+.+ ..||||...... ......|.+|+.++..++||||++++++|.+ ..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 457788899999999999998752 368999887654 3445679999999999999999999998854 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... ..+++..++.++.+++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 86 ELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 9999999999996543 35899999999999999999999966 999999999999999999999999999876543
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhHH--HHHhhcCccccccCCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV--RRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~~--~~~i~~~~l~~~ldp~~~ 571 (688)
... ......++..|+|||++....++.++||||||+++|||++ |..||...... ...+..+...
T Consensus 161 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-------- 227 (270)
T cd05056 161 SYY-----KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL-------- 227 (270)
T ss_pred cce-----ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC--------
Confidence 211 1223345678999999988899999999999999999996 99999654432 2222222111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhh
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~ 612 (688)
..+...+..+.+++.+|+..+|.+||++. ++...|+.+..
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~-~~~~~l~~~~~ 267 (270)
T cd05056 228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFT-ELKAQLSDILQ 267 (270)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHh
Confidence 12233456899999999999999999998 78888877643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.51 Aligned_cols=255 Identities=24% Similarity=0.321 Sum_probs=204.2
Q ss_pred hcCcccceeeeccCceEEEEEEEC------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC---CCc
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP---EAW 410 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~---~~~ 410 (688)
.++|.....||+|+||.||+|.+. +..|++|++..... .....+.+|+.++..++||||+++++++. ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 467888899999999999999875 37799998875432 33456889999999999999999999874 347
Q ss_pred eeEEeeCCCCcHHHHhcccCCC-----CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeec
Q 005616 411 SLVYEYLPNGSLQDRLFRKSNV-----SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~-----~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DF 485 (688)
+++++|+++|+|.+++...... ..+++..++.++.+++.||.|||+.+ |+|+||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998764322 56899999999999999999999865 999999999999999999999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCcc
Q 005616 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKL 562 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l 562 (688)
|+++.+....... ......++..|+|||++.+..++.++|||||||++||+++ |+.||..... +...+..+..
T Consensus 162 g~~~~~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 237 (280)
T cd05043 162 ALSRDLFPMDYHC----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR 237 (280)
T ss_pred CCcccccCCceEE----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC
Confidence 9998664332110 1123356778999999998899999999999999999999 9999975432 2222222211
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhh
Q 005616 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 563 ~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~ 611 (688)
...+..++..+.+++.+||..+|++||++. +++..|+.+.
T Consensus 238 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~~~~~l~~~~ 277 (280)
T cd05043 238 --------LAQPINCPDELFAVMACCWALDPEERPSFS-QLVQCLTDFH 277 (280)
T ss_pred --------CCCCCcCCHHHHHHHHHHcCCChhhCCCHH-HHHHHHHHHH
Confidence 011223456789999999999999999998 7888888764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.89 Aligned_cols=231 Identities=26% Similarity=0.356 Sum_probs=189.4
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCC---ccchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeEEeeCCCC
Q 005616 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~---~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||+|.+. +..||||++.... ......+..|..++..+ +||||+++++++.+ ..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999886 6789999997643 23345677899999888 79999999998843 588999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCC
Q 005616 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~ 500 (688)
+|..++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 151 (318)
T cd05570 82 DLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---- 151 (318)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC----
Confidence 9998886543 5899999999999999999999966 99999999999999999999999999875322211
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHH
Q 005616 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~ 578 (688)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... +...+..+.. .++...+
T Consensus 152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~---------~~~~~~~ 220 (318)
T cd05570 152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV---------RYPRWLS 220 (318)
T ss_pred --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC---------CCCCcCC
Confidence 12345699999999999999999999999999999999999999975432 2222222211 2233456
Q ss_pred HHHHHHHHHcccCCCCCCCCCc
Q 005616 579 RRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 579 ~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
..+.+|+.+||+.||.+||++.
T Consensus 221 ~~~~~li~~~l~~dP~~R~s~~ 242 (318)
T cd05570 221 KEAKSILKSFLTKNPEKRLGCL 242 (318)
T ss_pred HHHHHHHHHHccCCHHHcCCCC
Confidence 7899999999999999999993
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=342.00 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=190.6
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC---------
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--------- 408 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--------- 408 (688)
...+|...+.||+|+||.||+|... +..||||++.... ....+|+.+|+.++|||||++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999885 7899999885432 234579999999999999999887521
Q ss_pred -CceeEEeeCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-ceEEeec
Q 005616 409 -AWSLVYEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDF 485 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-~~KL~DF 485 (688)
..++||||+++ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 14589999985 566655432 23356899999999999999999999966 99999999999999664 7999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH---Hhh-cC
Q 005616 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVS-CG 560 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~---~i~-~~ 560 (688)
|+|+.+.... ......||+.|+|||++.+ ..++.++|||||||+||||++|.+||........ .+. .|
T Consensus 216 Gla~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 288 (440)
T PTZ00036 216 GSAKNLLAGQ-------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG 288 (440)
T ss_pred ccchhccCCC-------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9998765332 1234578999999998865 4699999999999999999999999975432211 111 00
Q ss_pred c------------cccccCCC------CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 561 K------------LSSILDPL------AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 561 ~------------l~~~ldp~------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
. +..+--+. ...+|...+..+.+|+.+||..||.+|||+.+.+.+.+
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 0 00000000 01122234568999999999999999999996665544
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=317.05 Aligned_cols=243 Identities=24% Similarity=0.313 Sum_probs=194.9
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
|...+.||.|+||+||+|.+. ++.||+|.+...... ....+.+|+.++..++|+||+++++++.. ..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667788999999999999886 789999998765432 23457889999999999999999988743 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999988865432 46899999999999999999999965 9999999999999999999999999987654322
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHH--HHhhcCccccccCCCCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~i~~~~l~~~ldp~~~~~~ 574 (688)
......|+..|+|||++.+..++.++|||||||++|+|++|..||....... ..+. ..+... ...++
T Consensus 157 ------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~-~~~~~~----~~~~~ 225 (285)
T cd05632 157 ------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD-RRVLET----EEVYS 225 (285)
T ss_pred ------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-Hhhhcc----ccccC
Confidence 1234579999999999998999999999999999999999999997543211 1111 111110 11233
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 575 TFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 575 ~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
...+..+.+|+..||+.||.+||++.+.
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~ 253 (285)
T cd05632 226 AKFSEEAKSICKMLLTKDPKQRLGCQEE 253 (285)
T ss_pred ccCCHHHHHHHHHHccCCHhHcCCCccc
Confidence 3456678999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=311.84 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=202.7
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~ 414 (688)
++|...+.||.|+||.||+|... +..||||.+..... .....|.+|+.++..++||||++++++|. +..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 36777889999999999999874 88999998865432 23457889999999999999999999884 3578999
Q ss_pred eeCCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 415 EYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
||+++++|.+++.... ....+++..++.++.+|+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886432 2346899999999999999999999966 99999999999999999999999999887653
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH-HHHHhhcCccccccCCCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE-VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~-~~~~i~~~~l~~~ldp~~~~ 572 (688)
... ......|+..|+|||++.+..++.++||||||+++|+|++|..||..... ...... .+.....+. .
T Consensus 159 ~~~------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~--~ 228 (267)
T cd08229 159 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK--KIEQCDYPP--L 228 (267)
T ss_pred CCc------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh--hhhcCCCCC--C
Confidence 321 12344689999999999988999999999999999999999999853321 111110 011100010 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
.+...+..+.+++.+||+.+|.+|||+. +|.+.+..+
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~i~~~~~~~ 265 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDIT-YVYDVAKRM 265 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCHH-HHHHHHhhh
Confidence 1224567899999999999999999999 788877765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.43 Aligned_cols=258 Identities=25% Similarity=0.405 Sum_probs=196.5
Q ss_pred cCcccceeeeccCceEEEEEEECC----------------eEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEec
Q 005616 342 CNFSESFKVGQGGFGCVYKGEMLG----------------RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLG 404 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~g----------------~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g 404 (688)
++|...+.||+|+||.||++...+ ..||||.+..... .....|.+|++++.+++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999987642 2489999876432 23456999999999999999999999
Q ss_pred ccC--CCceeEEeeCCCCcHHHHhcccC---------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCcee
Q 005616 405 ACP--EAWSLVYEYLPNGSLQDRLFRKS---------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNIL 473 (688)
Q Consensus 405 ~~~--~~~~LV~E~~~~gsL~~~L~~~~---------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NIL 473 (688)
++. +..++||||+++++|.+++.... ....++|..++.++.+++.||.|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 984 35889999999999999986432 1134789999999999999999999966 999999999999
Q ss_pred eCCCCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh--CCCCCCChh
Q 005616 474 LDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT--GRLPVGLAG 551 (688)
Q Consensus 474 Ld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt--G~~Pf~~~~ 551 (688)
++.++.+||+|||++......... .......++..|+|||++..+.++.++|||||||++|+|++ |..||....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYY----RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EcCCCcEEecccccccccccCcce----eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999999865432211 11233456788999999998999999999999999999998 667876432
Q ss_pred H--HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 552 E--VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 552 ~--~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
. +...+.. .............+...+..+.+|+.+||+.+|.+||++. +|.+.|+
T Consensus 238 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~-~i~~~l~ 294 (295)
T cd05097 238 DEQVIENTGE-FFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFN-KIHHFLR 294 (295)
T ss_pred hHHHHHHHHH-hhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHh
Confidence 2 1111100 0000000000111223456899999999999999999998 7777664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=328.13 Aligned_cols=251 Identities=21% Similarity=0.249 Sum_probs=193.0
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC-------
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE------- 408 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~------- 408 (688)
..++|...+.||+|+||.||++... |..||||++.... ......+.+|+.++..++||||+++++++..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999875 8899999986542 2334568899999999999999999998732
Q ss_pred -CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCc
Q 005616 409 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGl 487 (688)
..++||||+.++ |...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 258999999764 555543 24778889999999999999999966 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH---h-------
Q 005616 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---V------- 557 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---i------- 557 (688)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..... +
T Consensus 170 a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 170 ARTACTNF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred ccccccCc-------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 97653322 123457899999999999999999999999999999999999999754321100 0
Q ss_pred ---------------hc-Cccc-----cc----cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHH
Q 005616 558 ---------------SC-GKLS-----SI----LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 558 ---------------~~-~~l~-----~~----ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~ 606 (688)
.. .... +. ..+............+.+|+.+||..||.+|||+.+.+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00 0000 00 00000011112346789999999999999999999655443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=327.84 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=189.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||+||++... +..||||++..... .....+.+|+.++..++||||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999885 78999999975432 223468889999999999999999999855 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999999764 35889999999999999999999966 999999999999999999999999999865421
Q ss_pred CCcC---------C--------------------CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCC
Q 005616 495 TLYL---------P--------------------SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL 545 (688)
Q Consensus 495 ~~~~---------~--------------------~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~ 545 (688)
.... + ........+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 1000 0 0001134579999999999999999999999999999999999999
Q ss_pred CCCChhH--HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccc--CCCCCCCCCcH
Q 005616 546 PVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCE--LYGRERPDITP 601 (688)
Q Consensus 546 Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~--~dP~~RPs~~e 601 (688)
||..... ....+......-.+ |. . ...+..+.+|+.+++. .++..||++.+
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~-p~--~--~~~s~~~~~li~~l~~~~~~r~~r~~~~e 289 (363)
T cd05628 235 PFCSETPQETYKKVMNWKETLIF-PP--E--VPISEKAKDLILRFCCEWEHRIGAPGVEE 289 (363)
T ss_pred CCCCCCHHHHHHHHHcCcCcccC-CC--c--CCCCHHHHHHHHHHcCChhhcCCCCCHHH
Confidence 9975432 22223221111111 11 1 1134567777777443 23345677763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=327.02 Aligned_cols=239 Identities=27% Similarity=0.331 Sum_probs=190.2
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHH-HHHcCCCCceeeEecccC--CCceeEEeeCCCC
Q 005616 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVR-VLSKLQHPHLVTLLGACP--EAWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~-iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~g 420 (688)
.||+|+||.||+|... |..||||++..... .....+..|.. +++.++||||+++++++. +..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 5999999999999885 88999999975422 23345566655 467789999999999884 4588999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCC
Q 005616 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~ 500 (688)
+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~----- 150 (325)
T cd05604 82 ELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS----- 150 (325)
T ss_pred CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-----
Confidence 999888654 35889999999999999999999966 9999999999999999999999999987543221
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHH
Q 005616 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~ 578 (688)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||..... +...+..+.+ ..++..+
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~---------~~~~~~~ 220 (325)
T cd05604 151 -DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL---------VLRPGAS 220 (325)
T ss_pred -CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc---------cCCCCCC
Confidence 122455799999999999999999999999999999999999999975432 2222222211 1122345
Q ss_pred HHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 579 RRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 579 ~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
..+.+++.+|++.+|.+||++.+.+.+.++
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAKEDFLEIQE 250 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCCCCHHHHhc
Confidence 678899999999999999999855544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=313.16 Aligned_cols=247 Identities=25% Similarity=0.311 Sum_probs=195.6
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEee
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
.++|...+.||+|+||.||+|... +..||+|++..........+.+|+.++..++||||+++++++. +..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 357888999999999999999974 7889999997665555567889999999999999999999884 357899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++++|.+++... .++++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999988643 35789999999999999999999965 99999999999999999999999999987643221
Q ss_pred cCCCccccCCCCCCCCCCChhhhc---cCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~ 573 (688)
......|++.|+|||++. ...++.++|||||||++|||++|+.||.............. ..+.+.....
T Consensus 162 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~ 233 (267)
T cd06646 162 ------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK--SNFQPPKLKD 233 (267)
T ss_pred ------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec--CCCCCCCCcc
Confidence 123456889999999874 44578899999999999999999999854332211111000 0011111111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCCcH
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
...++..+.+|+.+||..+|.+||++.+
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 261 (267)
T cd06646 234 KTKWSSTFHNFVKISLTKNPKKRPTAER 261 (267)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHH
Confidence 2234568999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.45 Aligned_cols=256 Identities=27% Similarity=0.444 Sum_probs=203.5
Q ss_pred hcCcccceeeeccCceEEEEEEEC---------CeEEEEEEEecCC-ccchHHHHHHHHHHHcC-CCCceeeEecccCC-
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML---------GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~---------g~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~- 408 (688)
.++|.+.+.||+|+||.||++... +..||+|.+.... ......+..|+.++..+ +||||++++++|.+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357899999999999999999763 2469999997643 23345688999999999 79999999999854
Q ss_pred -CceeEEeeCCCCcHHHHhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee
Q 005616 409 -AWSLVYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 474 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL 474 (688)
..++||||+++|+|.+++..... ...++|..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 47899999999999999976431 135899999999999999999999865 9999999999999
Q ss_pred CCCCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--
Q 005616 475 DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG-- 551 (688)
Q Consensus 475 d~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~-- 551 (688)
+.++.+||+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred cCCCcEEECCCcccccccccchh----hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999998766432211 11122335578999999998999999999999999999998 888986433
Q ss_pred HHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhh
Q 005616 552 EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 552 ~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~ 612 (688)
.+...+..+... +.+...+..+.+|+.+||..+|.+||++. ++++.|+.+..
T Consensus 250 ~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~-evl~~l~~~~~ 301 (307)
T cd05098 250 ELFKLLKEGHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRILA 301 (307)
T ss_pred HHHHHHHcCCCC--------CCCCcCCHHHHHHHHHHcccChhhCcCHH-HHHHHHHHHHH
Confidence 222333322211 22334567899999999999999999999 78888887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.17 Aligned_cols=246 Identities=21% Similarity=0.270 Sum_probs=188.9
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
.|...+.||+|+||.||+|+.. +..||||++..... .....+.+|+.+++.++|||||+++++|.+ ..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999885 78899999975432 233468899999999999999999999854 4789999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999998654 35788889999999999999999966 9999999999999999999999999985432100
Q ss_pred Cc-----------------------------------------CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHH
Q 005616 496 LY-----------------------------------------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFG 534 (688)
Q Consensus 496 ~~-----------------------------------------~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfG 534 (688)
.. ...........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00 0000011235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 005616 535 LIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 535 viL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs 598 (688)
|+||||++|++||..................+ ........+..+.+++.+|+ .+|.+|++
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~p~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSL---HIPPQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc---CCCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 99999999999997554322221111100000 00111234567778887776 49999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=317.71 Aligned_cols=252 Identities=29% Similarity=0.449 Sum_probs=198.0
Q ss_pred cCcccceeeeccCceEEEEEEEC--C--eEEEEEEEecCC-ccchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--G--RTVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g--~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV 413 (688)
++|.....||.|+||.||+|.+. + ..+++|.++... ......|.+|+.++.++ +||||+++++++.+ ..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46888899999999999999875 3 347888887432 23345689999999999 79999999999854 47899
Q ss_pred EeeCCCCcHHHHhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCce
Q 005616 414 YEYLPNGSLQDRLFRKS-------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~ 480 (688)
|||+++|+|.+++.... ....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986532 1235889999999999999999999965 9999999999999999999
Q ss_pred EEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHh
Q 005616 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAV 557 (688)
Q Consensus 481 KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i 557 (688)
||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |..||.... .....+
T Consensus 159 kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~ 231 (297)
T cd05089 159 KIADFGLSRGEEVYV-------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231 (297)
T ss_pred EECCcCCCcccccee-------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999986432111 1122233567999999998899999999999999999997 999996433 222222
Q ss_pred hcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhh
Q 005616 558 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 558 ~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~ 612 (688)
..+. ....+..++..+.+|+.+||+.+|.+||++. ++++.|+.+..
T Consensus 232 ~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~~~~ 277 (297)
T cd05089 232 PQGY--------RMEKPRNCDDEVYELMRQCWRDRPYERPPFA-QISVQLSRMLE 277 (297)
T ss_pred hcCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHH
Confidence 2221 1112233556889999999999999999999 67777776654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.83 Aligned_cols=239 Identities=26% Similarity=0.325 Sum_probs=189.6
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHH-HHHcCCCCceeeEecccC--CCceeEEeeCCCC
Q 005616 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVR-VLSKLQHPHLVTLLGACP--EAWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~-iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~g 420 (688)
.||+|+||.||+|+.. +..||+|++..... .....+..|.. ++..++||||+++++++. +..++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 6999999999999886 67899999975432 22234444544 567889999999999884 3578999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCC
Q 005616 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~ 500 (688)
+|.+++.... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---- 151 (325)
T cd05602 82 ELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---- 151 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC----
Confidence 9999886543 4677888899999999999999966 99999999999999999999999999975432211
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCccccccCCCCCCCCHHHH
Q 005616 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~ldp~~~~~~~~~~ 578 (688)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ...+..+.. ..+...+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~---------~~~~~~~ 220 (325)
T cd05602 152 --TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL---------QLKPNIT 220 (325)
T ss_pred --CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc---------CCCCCCC
Confidence 224567999999999999999999999999999999999999999754332 222222111 2223456
Q ss_pred HHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 579 RRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 579 ~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
..+.+++.+||+.||.+||++.+.+.+.++
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 789999999999999999999866555544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=329.16 Aligned_cols=231 Identities=23% Similarity=0.309 Sum_probs=188.3
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcC-CCCceeeEecccC--CCceeEEeeCCCC
Q 005616 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACP--EAWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~--~~~~LV~E~~~~g 420 (688)
.||+|+||.||+|... +..||||++..... .....+.+|+.++.++ +||||+++++++. +..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 6999999999999886 78899999986532 2334588999999888 6999999999884 3578999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCC
Q 005616 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~ 500 (688)
+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---- 151 (327)
T cd05617 82 DLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---- 151 (327)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC----
Confidence 999888654 35899999999999999999999966 99999999999999999999999999875322111
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh---------HHHHHhhcCccccccCCCCC
Q 005616 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG---------EVRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~---------~~~~~i~~~~l~~~ldp~~~ 571 (688)
......||+.|+|||++.+..++.++|||||||+||+|++|..||.... .....+... ..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~~ 220 (327)
T cd05617 152 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK---------PI 220 (327)
T ss_pred --ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC---------CC
Confidence 1234679999999999999999999999999999999999999995321 111222111 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
..|...+..+.+++.+||+.||.+||++.
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 23444567889999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=317.84 Aligned_cols=246 Identities=25% Similarity=0.383 Sum_probs=200.6
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
.+|.....||.|+||.||+|... +..||+|.+..........+.+|+.++..++||||+++++.|. ...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888899999999999999874 7899999998766666677999999999999999999999884 3588999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 99999998854 34789999999999999999999966 99999999999999999999999999886543221
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHHH
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~~ 577 (688)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||................ .+ ....+...
T Consensus 172 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~---~~-~~~~~~~~ 242 (296)
T cd06654 172 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG---TP-ELQNPEKL 242 (296)
T ss_pred -----ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC---CC-CCCCcccc
Confidence 1234568999999999998889999999999999999999999996544322111110000 00 11123345
Q ss_pred HHHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 578 ARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 578 ~~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
+..+.+|+.+||..+|.+||++.+.+.
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 678999999999999999999985444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=333.38 Aligned_cols=248 Identities=22% Similarity=0.255 Sum_probs=190.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||.|+||.||++... |..||||++..... .....+.+|+.++..++|||||+++++|.+ ..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999885 88999999865432 233568899999999999999999999854 488999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999998654 35788999999999999999999966 999999999999999999999999999643211
Q ss_pred CCc------------CCC-----------------------------ccccCCCCCCCCCCChhhhccCCCCCcchHhHH
Q 005616 495 TLY------------LPS-----------------------------FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSF 533 (688)
Q Consensus 495 ~~~------------~~~-----------------------------~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSf 533 (688)
... ... ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 000 000113579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCChhHH--HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC---CCcH
Q 005616 534 GLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERP---DITP 601 (688)
Q Consensus 534 GviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP---s~~e 601 (688)
||++|||++|.+||...... ...+.... ..+. . ......+..+.+|+.+|+. +|.+|+ ++.+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~--~-p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWR--ETLY--F-PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccC--CccC--C-CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 99999999999999654322 12221110 0000 0 0011245678899999997 777765 6653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=332.27 Aligned_cols=244 Identities=19% Similarity=0.239 Sum_probs=188.6
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
++|...+.||+|+||.||++.+. +..||||... ...+.+|+.++++++|||||+++++|. ...++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 67999999999999999999886 7899999753 234778999999999999999999884 3478999998
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
. ++|..++... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 166 ~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 166 K-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred C-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 5 6888877554 35789999999999999999999965 99999999999999999999999999975432211
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh----------HHHHHhh-cCcc----
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG----------EVRRAVS-CGKL---- 562 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~----------~~~~~i~-~~~l---- 562 (688)
.......||+.|+|||++.+..+++++|||||||++|||++|+.||.... .+...+. .|..
T Consensus 238 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 238 ----NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred ----cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 12235679999999999999999999999999999999999998864211 0100100 0000
Q ss_pred --------ccc---------cCCC-CCCCC--HHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 563 --------SSI---------LDPL-AGDWP--TFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 563 --------~~~---------ldp~-~~~~~--~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
... ..+. ...+. ...+..+.+|+.+||+.||.+|||+.+.+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL 374 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence 000 0000 00011 12456799999999999999999998444
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=307.07 Aligned_cols=240 Identities=28% Similarity=0.463 Sum_probs=192.9
Q ss_pred eeeccCceEEEEEEEC-CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCcHHH
Q 005616 349 KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQD 424 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL~~ 424 (688)
+||.|+||.||+|... +..||+|.+...... ....|.+|+.++..++||||++++++|.+ ..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 6999999999999876 778999998765432 23468899999999999999999999854 5889999999999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCcccc
Q 005616 425 RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRS 504 (688)
Q Consensus 425 ~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~ 504 (688)
++.... ..+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++......... ..
T Consensus 82 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-----~~ 151 (250)
T cd05085 82 FLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-----SS 151 (250)
T ss_pred HHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-----cC
Confidence 886543 35789999999999999999999965 999999999999999999999999998765432211 11
Q ss_pred CCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHHHHH
Q 005616 505 TAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARRL 581 (688)
Q Consensus 505 ~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~~~l 581 (688)
....+++.|+|||++.++.++.++||||||+++|++++ |..||..... ....+..+.. ...+...+..+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 223 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR--------MSCPQKCPDDV 223 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC--------CCCCCCCCHHH
Confidence 22345678999999999999999999999999999998 9999964432 2222222211 11223356789
Q ss_pred HHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 582 VDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 582 ~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
.+++.+||..+|.+||++. ++.+.|
T Consensus 224 ~~li~~~l~~~p~~Rp~~~-~l~~~l 248 (250)
T cd05085 224 YKVMQRCWDYKPENRPKFS-ELQKEL 248 (250)
T ss_pred HHHHHHHcccCcccCCCHH-HHHHHh
Confidence 9999999999999999998 666555
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=317.31 Aligned_cols=253 Identities=28% Similarity=0.465 Sum_probs=200.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--Ce----EEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC-CceeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GR----TVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~----~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV 413 (688)
++|...+.||+|+||.||+|.+. |. .||+|.+..... .....+.+|+.++..++||||++++|+|.. ..+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 45677789999999999999874 43 579998865433 223468899999999999999999999854 46799
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
++|+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 87 TQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred ehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 99999999999986543 35789999999999999999999965 99999999999999999999999999987653
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCCh--hHHHHHhhcCccccccCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLA--GEVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~--~~~~~~i~~~~l~~~ldp~~ 570 (688)
.... .......++..|+|||++.+..++.++|||||||++|||++ |..||... ......+..+...
T Consensus 162 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------- 230 (303)
T cd05110 162 DEKE----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL------- 230 (303)
T ss_pred cccc----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC-------
Confidence 3211 11223456788999999998999999999999999999997 99998643 2333333332211
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhh
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~ 612 (688)
..+...+..+.+++..||..+|.+||++. +++..|+.+..
T Consensus 231 -~~~~~~~~~~~~li~~c~~~~p~~Rp~~~-~l~~~l~~~~~ 270 (303)
T cd05110 231 -PQPPICTIDVYMVMVKCWMIDADSRPKFK-ELAAEFSRMAR 270 (303)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHh
Confidence 11122345789999999999999999998 67788887643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=318.51 Aligned_cols=256 Identities=27% Similarity=0.446 Sum_probs=204.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC---------CeEEEEEEEecCC-ccchHHHHHHHHHHHcC-CCCceeeEecccCC-
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML---------GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~---------g~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~- 408 (688)
..+|.....||+|+||.||+|+.. +..||+|.+.... ......+.+|+.++..+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467888899999999999999752 3479999987543 23445789999999999 89999999999854
Q ss_pred -CceeEEeeCCCCcHHHHhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee
Q 005616 409 -AWSLVYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 474 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL 474 (688)
..++||||+++|+|.+++..... ...++|..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 47899999999999999976421 235789999999999999999999966 9999999999999
Q ss_pred CCCCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--
Q 005616 475 DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG-- 551 (688)
Q Consensus 475 d~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~-- 551 (688)
+.++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred cCCCcEEECCCccceeccccccc----ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999876543211 11233456788999999998899999999999999999998 788886432
Q ss_pred HHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhh
Q 005616 552 EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 552 ~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~ 612 (688)
.+...+..+... ..+...+..+.+|+.+||+.+|.+||++. ++++.|+.+..
T Consensus 247 ~~~~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rps~~-e~l~~l~~~~~ 298 (304)
T cd05101 247 ELFKLLKEGHRM--------DKPANCTNELYMMMRDCWHAIPSHRPTFK-QLVEDLDRILT 298 (304)
T ss_pred HHHHHHHcCCcC--------CCCCCCCHHHHHHHHHHcccChhhCCCHH-HHHHHHHHHHH
Confidence 233333332211 12234567899999999999999999998 78888887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.05 Aligned_cols=244 Identities=24% Similarity=0.313 Sum_probs=194.8
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
..++|...+.||+|+||.||+++.. +..||||++..... .....+.+|+.++..++||||+++++++.+ ..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568899999999999999999886 78999999975322 233457899999999999999999998854 4789
Q ss_pred EEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccccc
Q 005616 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~ 492 (688)
||||+++|+|.+++... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999988543 4677888999999999999999965 9999999999999999999999999998764
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhhccC----CCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCcccccc
Q 005616 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTG----VLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSIL 566 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~----~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~l 566 (688)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ...+..+...
T Consensus 194 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--- 265 (370)
T cd05596 194 ANGM-----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS--- 265 (370)
T ss_pred CCCc-----ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc---
Confidence 3221 112356799999999988653 4889999999999999999999999754432 2222221110
Q ss_pred CCCCCCCCH--HHHHHHHHHHHHcccCCCCC--CCCCcHH
Q 005616 567 DPLAGDWPT--FVARRLVDLGLQCCELYGRE--RPDITPS 602 (688)
Q Consensus 567 dp~~~~~~~--~~~~~l~~Li~~Cl~~dP~~--RPs~~e~ 602 (688)
..++. ..+..+.+|+.+||..+|.+ ||++.+.
T Consensus 266 ----~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~el 301 (370)
T cd05596 266 ----LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEI 301 (370)
T ss_pred ----CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHH
Confidence 01111 34678999999999999987 9998743
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=309.19 Aligned_cols=247 Identities=26% Similarity=0.429 Sum_probs=196.7
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc---------hHHHHHHHHHHHcCCCCceeeEecccC--CC
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---------QLEFQQEVRVLSKLQHPHLVTLLGACP--EA 409 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~---------~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~ 409 (688)
+|.....||.|+||.||+|... +..||+|.+....... ...+.+|+.++.+++||||+++++++. +.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3666789999999999999874 7889999886543322 245889999999999999999999984 35
Q ss_pred ceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccc
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~ 489 (688)
.++||||+++++|.+++... ..+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 78999999999999999654 35788999999999999999999966 9999999999999999999999999998
Q ss_pred cccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCC
Q 005616 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPL 569 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~ 569 (688)
...................|+..|+|||++.+..++.++|||||||++|+|++|+.||.............. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~~ 228 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------NA 228 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc------cC
Confidence 775322111111112234688999999999988999999999999999999999999976544322221111 01
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcH
Q 005616 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
....+...+..+.+++.+||+.+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06628 229 SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAE 260 (267)
T ss_pred CCcCCcccCHHHHHHHHHHccCCchhCcCHHH
Confidence 11233345678999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=306.91 Aligned_cols=243 Identities=37% Similarity=0.596 Sum_probs=200.3
Q ss_pred eeeccCceEEEEEEEC-----CeEEEEEEEecCCccc-hHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCC
Q 005616 349 KVGQGGFGCVYKGEML-----GRTVAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~-----g~~VAIK~l~~~~~~~-~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||+|... +..|++|.+....... ...+.+|+.++..++|+||+++++++.+ ..++||||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 6999999999999886 6789999998765443 5679999999999999999999999854 478999999999
Q ss_pred cHHHHhcccCC------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 421 SLQDRLFRKSN------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 421 sL~~~L~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
+|.+++..... ...+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||.+......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999977521 257899999999999999999999965 999999999999999999999999999887654
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~ 571 (688)
.. ........+++.|+|||.+....++.++||||||+++|+|++ |..||..... +...+..+. ..
T Consensus 159 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~~ 226 (262)
T cd00192 159 DY----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--------RL 226 (262)
T ss_pred cc----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------CC
Confidence 32 112345568899999999988899999999999999999999 6999975432 223333221 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
..+..++..+.+++.+||..+|.+||++. +++..|
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~l~~~l 261 (262)
T cd00192 227 PKPEYCPDELYELMLSCWQLDPEDRPTFS-ELVERL 261 (262)
T ss_pred CCCccCChHHHHHHHHHccCCcccCcCHH-HHHHhh
Confidence 23344567899999999999999999998 565544
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=309.55 Aligned_cols=243 Identities=28% Similarity=0.447 Sum_probs=198.5
Q ss_pred cCcccceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC-CCceeEEeeCCCC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLVYEYLPNG 420 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~-~~~~LV~E~~~~g 420 (688)
++|...+.||+|+||.||+|...+..||+|.+.... ....+.+|+.++..++||||+++++++. +..++||||++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCC
Confidence 457788999999999999999889999999986532 3457899999999999999999999884 4588999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCC
Q 005616 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~ 500 (688)
+|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 84 NLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred CHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 99999876432 45789999999999999999999965 9999999999999999999999999987643221
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHH
Q 005616 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~ 577 (688)
.....+..|+|||++.++.++.++|||||||++|+|++ |..||..... ....+..+... ..+..+
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~ 222 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--------EPPEGC 222 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC--------CCCCcC
Confidence 12334578999999998899999999999999999998 9999864432 23333332111 112234
Q ss_pred HHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 578 ARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 578 ~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
+..+.+++.+||+.+|..||++. +|...|+
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~-~l~~~l~ 252 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFH-KLREKLE 252 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHH-HHHHHHc
Confidence 56889999999999999999998 6666554
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=314.42 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=189.9
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcC---CCCceeeEecccCC-------
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKL---QHPHLVTLLGACPE------- 408 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l---~HpnIV~l~g~~~~------- 408 (688)
+|...+.||+|+||.||+|... |..||+|.+...... ....+.+|+.++..+ +||||++++++|..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999886 788999998754322 233566788777765 69999999998742
Q ss_pred CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcc
Q 005616 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla 488 (688)
..++||||+.+ +|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 26899999985 88888765432 45899999999999999999999966 999999999999999999999999999
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH---Hhhc-C----
Q 005616 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSC-G---- 560 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~---~i~~-~---- 560 (688)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||........ .... +
T Consensus 156 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 156 RIYSCQM-------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 228 (288)
T ss_pred ccccCcc-------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence 8764322 12345689999999999999999999999999999999999999964432211 1100 0
Q ss_pred -cccc-------ccCCCC----CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 561 -KLSS-------ILDPLA----GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 561 -~l~~-------~ldp~~----~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.... .+.+.. ....+..+..+.+|+.+||+.||.+||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l 283 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 0000 000000 011123456789999999999999999988433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=318.89 Aligned_cols=251 Identities=28% Similarity=0.427 Sum_probs=195.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--Ce--EEEEEEEecCC-ccchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GR--TVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~--~VAIK~l~~~~-~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV 413 (688)
++|...+.||+|+||.||+|.+. +. .+|+|.+.... ......|.+|+.++.++ +||||++++++|.+ ..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56788899999999999999875 44 46777776432 23345788999999999 89999999999854 48899
Q ss_pred EeeCCCCcHHHHhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCce
Q 005616 414 YEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~ 480 (688)
|||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999975431 235889999999999999999999965 9999999999999999999
Q ss_pred EEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHh
Q 005616 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAV 557 (688)
Q Consensus 481 KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i 557 (688)
||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||..... ....+
T Consensus 164 kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 164 KIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred EeCccccCcccchhh-------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 999999986432111 1122335678999999988889999999999999999998 9999964332 11212
Q ss_pred hcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhh
Q 005616 558 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 558 ~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~ 611 (688)
..+. ....+...+..+.+|+.+||+.+|.+||++. +++..|+.+.
T Consensus 237 ~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~il~~l~~~~ 281 (303)
T cd05088 237 PQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRML 281 (303)
T ss_pred hcCC--------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHH
Confidence 1110 1112223456789999999999999999999 6666666553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=314.26 Aligned_cols=252 Identities=29% Similarity=0.477 Sum_probs=201.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--Cc
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AW 410 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~ 410 (688)
.++|.....||.|+||.||+|... +..||+|++..... .....|.+|+.+++.++||||++++++|.+ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999863 57899999875433 334569999999999999999999999854 47
Q ss_pred eeEEeeCCCCcHHHHhcccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCc
Q 005616 411 SLVYEYLPNGSLQDRLFRKS-------------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQN 471 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~-------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~N 471 (688)
++||||+++|+|.+++.... ....+++..++.++.+++.||.|||..+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 89999999999999986432 1235789999999999999999999965 9999999999
Q ss_pred eeeCCCCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCCh
Q 005616 472 ILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLA 550 (688)
Q Consensus 472 ILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~ 550 (688)
||++.++.++|+|||++......... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYY----KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred eEecCCCceEECccccceecccCccc----cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999998765432211 11123345678999999998999999999999999999998 88888532
Q ss_pred --hHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 551 --GEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 551 --~~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
......+..+... ..+...+..+.+|+.+||+.+|.+||++. ++.+.|+
T Consensus 237 ~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~-el~~~l~ 287 (288)
T cd05050 237 AHEEVIYYVRDGNVL--------SCPDNCPLELYNLMRLCWSKLPSDRPSFA-SINRILQ 287 (288)
T ss_pred CHHHHHHHHhcCCCC--------CCCCCCCHHHHHHHHHHcccCcccCCCHH-HHHHHhh
Confidence 2333333333322 12233457899999999999999999999 7777765
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=313.88 Aligned_cols=258 Identities=24% Similarity=0.333 Sum_probs=203.1
Q ss_pred cCHHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccC-
Q 005616 332 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACP- 407 (688)
Q Consensus 332 ~~~~el~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~- 407 (688)
+.++.+..++++|.....||+|+||.||+|... +..||+|++.... .....+.+|+.++..+ +||||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 556778888999999999999999999999885 7899999886432 2235688999999999 6999999999872
Q ss_pred ------CCceeEEeeCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCce
Q 005616 408 ------EAWSLVYEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 408 ------~~~~LV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~ 480 (688)
+..++||||+++++|.+++... .....+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 2378999999999999987643 22346889999999999999999999965 9999999999999999999
Q ss_pred EEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhc-----cCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH
Q 005616 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR 555 (688)
Q Consensus 481 KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~ 555 (688)
||+|||++........ ......|++.|+|||++. +..++.++|||||||++|+|++|+.||........
T Consensus 164 kl~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~ 237 (286)
T cd06638 164 KLVDFGVSAQLTSTRL------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237 (286)
T ss_pred EEccCCceeecccCCC------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence 9999999887643221 223456999999999875 34578999999999999999999999875543322
Q ss_pred HhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 556 AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 556 ~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
........ .+.. ..+...+..+.+|+.+||+.||++||++.+.+
T Consensus 238 ~~~~~~~~---~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 281 (286)
T cd06638 238 LFKIPRNP---PPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281 (286)
T ss_pred HhhccccC---CCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 22111110 0000 11222456799999999999999999998443
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=310.78 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=200.3
Q ss_pred cCcccceeeeccCceEEEEEEEC-----CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~-----g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV 413 (688)
.+|...+.||+|+||.||+|.+. +..||+|.+..... .....|.+|+.++..++||||+++++++. +..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999873 33799999865432 23457899999999999999999999984 347899
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
|||+++++|.+++.... ..+++..++.++.+++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999997543 45899999999999999999999966 99999999999999999999999999987654
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCccccccCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l~~~ldp~~ 570 (688)
..... .......++..|+|||++.+..++.++||||||+++|++++ |..||.... .....+..+..
T Consensus 159 ~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-------- 227 (267)
T cd05066 159 DPEAA---YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-------- 227 (267)
T ss_pred cccee---eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc--------
Confidence 32110 11122334678999999998899999999999999999887 999986433 22222322211
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
...+...+..+.+++.+|++.+|.+||++. ++++.|+.+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~~ 266 (267)
T cd05066 228 LPAPMDCPAALHQLMLDCWQKDRNERPKFE-QIVSILDKL 266 (267)
T ss_pred CCCCCCCCHHHHHHHHHHcccCchhCCCHH-HHHHHHHhh
Confidence 011223456789999999999999999999 777777653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=307.97 Aligned_cols=247 Identities=25% Similarity=0.343 Sum_probs=197.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-----chHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-----GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~-----~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
++|...+.||.|++|.||+|... +..||+|.+...... ....+.+|+.++.+++||||+++++++.+ ..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999874 789999998754321 23468899999999999999999999854 5889
Q ss_pred EEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccccc
Q 005616 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~ 492 (688)
||||+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999988654 35788999999999999999999966 9999999999999999999999999997654
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCC
Q 005616 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~ 572 (688)
...... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.............. .+....
T Consensus 156 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-----~~~~~~ 227 (263)
T cd06625 156 TICSSG---TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT-----QPTNPQ 227 (263)
T ss_pred cccccc---ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-----cCCCCC
Confidence 322110 011345688999999999998999999999999999999999999965433222111110 011123
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
.+......+.+++.+||..+|.+||++.+.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 257 (263)
T cd06625 228 LPSHVSPDARNFLRRTFVENAKKRPSAEEL 257 (263)
T ss_pred CCccCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 344566789999999999999999998843
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=308.46 Aligned_cols=246 Identities=28% Similarity=0.488 Sum_probs=191.2
Q ss_pred eeeccCceEEEEEEEC-----CeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccC--C-CceeEEeeCCC
Q 005616 349 KVGQGGFGCVYKGEML-----GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACP--E-AWSLVYEYLPN 419 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~-----g~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~-~~~LV~E~~~~ 419 (688)
.||+|+||.||+|.+. +..||||.+.... ......+.+|+.+++.++||||++++++|. + ..++||||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 5899999999999863 3579999985432 234567889999999999999999999763 2 37899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC
Q 005616 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
|+|.+++.... ..+++..++.++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 82 GDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 99999987543 34678888999999999999999965 99999999999999999999999999986543221110
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhC-CCCCCChhH--HHHHhhcCccccccCCCCCCCCHH
Q 005616 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG-RLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG-~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~ 576 (688)
.......+++.|+|||++.+..++.++|||||||++|||++| .+||..... ....+..+.. ...+..
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~ 226 (262)
T cd05058 157 --HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR--------LLQPEY 226 (262)
T ss_pred --cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--------CCCCCc
Confidence 112234567889999999888999999999999999999995 566653322 2222222211 111223
Q ss_pred HHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 577 VARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
.+..+.+++.+||+.+|++||++. +++..|+.+
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~~-~il~~l~~~ 259 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTFS-ELVSRIEQI 259 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHH-HHHHHHHHH
Confidence 456799999999999999999998 787777765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=313.30 Aligned_cols=241 Identities=23% Similarity=0.339 Sum_probs=194.2
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeCCC
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPN 419 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~ 419 (688)
|.....||.|+||.||+|... +..+++|.+..........+.+|+.++..++||||++++++|. +..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456678999999999999986 6788999987665555667899999999999999999999884 357899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC
Q 005616 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
++|..++.... .++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---- 157 (282)
T cd06643 87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 157 (282)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc----
Confidence 99999876533 46899999999999999999999966 9999999999999999999999999987654322
Q ss_pred CccccCCCCCCCCCCChhhhc-----cCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhh--cCccccccCCCCCC
Q 005616 500 SFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS--CGKLSSILDPLAGD 572 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~--~~~l~~~ldp~~~~ 572 (688)
.......|++.|+|||++. +..++.++|||||||++|+|++|++||........... .+..... .
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------~ 229 (282)
T cd06643 158 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL------A 229 (282)
T ss_pred --cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC------C
Confidence 1223456899999999873 44578899999999999999999999975443222111 1111111 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCcH
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
.+..++..+.+|+.+||+.+|.+||++.+
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQ 258 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 22334568999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=311.10 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=198.1
Q ss_pred CcccceeeeccCceEEEEEEEC--C---eEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--G---RTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g---~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
+|...+.||+|+||.||+|.+. + ..||||.+.... ......|..|+.++..++||||+++++++.+ ..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4677889999999999999875 3 369999987543 2345679999999999999999999999854 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999986543 45899999999999999999999965 999999999999999999999999998866443
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~ 571 (688)
... +.........++..|+|||++.+..++.++|||||||++|||++ |..||..... +...+.... . .
T Consensus 160 ~~~-~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~--~------~ 230 (269)
T cd05065 160 TSD-PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY--R------L 230 (269)
T ss_pred ccc-cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--c------C
Confidence 211 01111111122457999999999999999999999999999887 9999864332 222222111 0 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
..+...+..+.+++.+||..+|.+||++. .+...|+.+
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~~ 268 (269)
T cd05065 231 PPPMDCPTALHQLMLDCWQKDRNARPKFG-QIVSTLDKM 268 (269)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHhh
Confidence 11223456789999999999999999998 777777653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=314.95 Aligned_cols=255 Identities=28% Similarity=0.453 Sum_probs=201.1
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--C
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--A 409 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~ 409 (688)
.+++|.+.+.||+|+||.||+|... +..||+|.+..... .....+.+|+.++..++||||+++++++.+ .
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4568889999999999999999653 35799998865432 234468899999999999999999998843 5
Q ss_pred ceeEEeeCCCCcHHHHhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEE
Q 005616 410 WSLVYEYLPNGSLQDRLFRKS-------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI 482 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL 482 (688)
.++||||+++|+|.+++.... ....+++..++.++.+++.||.|||+.+ |+||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 799999999999999996532 1245678889999999999999999965 999999999999999999999
Q ss_pred eecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhc
Q 005616 483 CDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSC 559 (688)
Q Consensus 483 ~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~ 559 (688)
+|||+++........ .......++..|+|||.+.++.++.++|||||||++|||++ |..||..... +...+..
T Consensus 161 ~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (288)
T cd05061 161 GDFGMTRDIYETDYY----RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236 (288)
T ss_pred CcCCccccccccccc----cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999865432211 11223345778999999999999999999999999999999 7889864332 2222222
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 560 ~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
+... ..+...+..+.+++.+||+.+|.+||++. ++++.|+..
T Consensus 237 ~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~ll~~l~~~ 278 (288)
T cd05061 237 GGYL--------DQPDNCPERVTDLMRMCWQFNPKMRPTFL-EIVNLLKDD 278 (288)
T ss_pred CCCC--------CCCCCCCHHHHHHHHHHcCCChhHCcCHH-HHHHHHHhh
Confidence 2221 12223456899999999999999999998 677776654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=330.54 Aligned_cols=258 Identities=28% Similarity=0.433 Sum_probs=203.8
Q ss_pred HHHHhcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCccc-hHHHHHHHHHHHcCC-CCceeeEecccC
Q 005616 337 LQTATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQG-QLEFQQEVRVLSKLQ-HPHLVTLLGACP 407 (688)
Q Consensus 337 l~~at~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~~~-~~~f~~E~~iL~~l~-HpnIV~l~g~~~ 407 (688)
.....++|...+.||+|+||.||+|++. +..||||+++...... ...+.+|+.+|.++. |||||+++|+|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3344456778899999999999999864 3579999997653332 346889999999997 999999999995
Q ss_pred C--CceeEEeeCCCCcHHHHhcccCC------------------------------------------------------
Q 005616 408 E--AWSLVYEYLPNGSLQDRLFRKSN------------------------------------------------------ 431 (688)
Q Consensus 408 ~--~~~LV~E~~~~gsL~~~L~~~~~------------------------------------------------------ 431 (688)
. ..++||||+++|+|.+++.....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 4 47899999999999999865321
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCC
Q 005616 432 -----------------------------------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQ 470 (688)
Q Consensus 432 -----------------------------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~ 470 (688)
...++|..++.|+.+|+.||.|||+.+ |+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 124788889999999999999999855 999999999
Q ss_pred ceeeCCCCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCC
Q 005616 471 NILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGL 549 (688)
Q Consensus 471 NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~ 549 (688)
|||++.++.+||+|||+++........ .......++..|+|||++....++.++|||||||++|||++ |..||..
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNY----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred eEEEeCCCEEEEEecCcceeccccccc----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999865432211 11223457889999999998899999999999999999998 8999864
Q ss_pred hhH---HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 550 AGE---VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 550 ~~~---~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
... ....+..+.. ...+...+..+.+|+.+||..+|..||++. +|++.|+.+
T Consensus 345 ~~~~~~~~~~~~~~~~--------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~-ell~~L~~~ 399 (401)
T cd05107 345 LPMNEQFYNAIKRGYR--------MAKPAHASDEIYEIMQKCWEEKFEIRPDFS-QLVHLVGDL 399 (401)
T ss_pred CCchHHHHHHHHcCCC--------CCCCCCCCHHHHHHHHHHcCCChhHCcCHH-HHHHHHHHH
Confidence 322 2222222211 112333467899999999999999999999 788888765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=326.26 Aligned_cols=250 Identities=22% Similarity=0.250 Sum_probs=193.0
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC------
Q 005616 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE------ 408 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~------ 408 (688)
...++|...+.||+|+||.||++... +..||||++..... .....+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999875 88999999875432 234568899999999999999999998732
Q ss_pred --CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecC
Q 005616 409 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 409 --~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFG 486 (688)
..++||||+++ +|...+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 25899999976 5655553 24788899999999999999999966 9999999999999999999999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH---hh-----
Q 005616 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VS----- 558 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---i~----- 558 (688)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... +.
T Consensus 165 ~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (355)
T cd07874 165 LARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_pred ccccCCCcc-------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 998654322 123457899999999999999999999999999999999999999654321110 00
Q ss_pred -----------------c-Ccccccc------C---CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 559 -----------------C-GKLSSIL------D---PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 559 -----------------~-~~l~~~l------d---p~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
. ....... + +.....+......+.+|+.+||+.||.+|||+.+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 0 0000000 0 0001112223567899999999999999999985544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=318.62 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=192.0
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEee
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
++|...+.||+|+||.||+|... +..||||.+...... ....+.+|+.++.+++||||+++++++. +..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888999999999999999875 788999998755432 3346788999999999999999999984 458899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++ +|..++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 7877775543 35788999999999999999999965 99999999999999999999999999976543221
Q ss_pred cCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHH--HHh-h-cCc-----cccc-
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAV-S-CGK-----LSSI- 565 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~i-~-~~~-----l~~~- 565 (688)
......+|+.|+|||++.+ ..++.++|||||||++|+|+||++||....... ..+ . .+. ...+
T Consensus 160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 160 ------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred ------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 1234568999999998865 568999999999999999999999996433211 000 0 000 0000
Q ss_pred -------cC-CCC-----CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 566 -------LD-PLA-----GDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 566 -------ld-p~~-----~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
.+ +.. .......+..+.+|+.+||+.||.+|||+.+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00 000 0011234567899999999999999999985443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=355.06 Aligned_cols=254 Identities=23% Similarity=0.312 Sum_probs=199.0
Q ss_pred HHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccC----CC
Q 005616 338 QTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP----EA 409 (688)
Q Consensus 338 ~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~----~~ 409 (688)
....++|.+...||.|+||.||++.+. +..||+|++..... .....|..|+.+|..|+|||||+++++|. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344578999999999999999999986 67899999876533 23456899999999999999999999873 23
Q ss_pred ceeEEeeCCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCC----CceEeCCCCCCceeeCC--------
Q 005616 410 WSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKP----EKIVHGDLKPQNILLDS-------- 476 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~----~~IiHrDIKp~NILLd~-------- 476 (688)
++|||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.++ ++||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 789999999999999987532 23568999999999999999999998652 45999999999999964
Q ss_pred ---------CCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc--CCCCCcchHhHHHHHHHHHHhCCC
Q 005616 477 ---------ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRL 545 (688)
Q Consensus 477 ---------~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSfGviL~ELltG~~ 545 (688)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..+++++||||||||||+|+||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES-------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc-------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 3458999999998764332 1234579999999998854 458999999999999999999999
Q ss_pred CCCChhHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 546 PVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 546 Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
||.........+..-. ...... ....+..+.+||..||..+|.+||++.+.+.
T Consensus 242 PF~~~~~~~qli~~lk--~~p~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 242 PFHKANNFSQLISELK--RGPDLP----IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCcCCcHHHHHHHHh--cCCCCC----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9975443322221100 000000 1123567999999999999999999986553
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=305.71 Aligned_cols=245 Identities=27% Similarity=0.359 Sum_probs=200.4
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
++|.....||.|+||.||+|... +..|++|.+..... ...+.+|+.+++.++||||+++++++.+ ..++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 57888899999999999999986 68899999875433 6689999999999999999999999854 478999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++++|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999999986533 46899999999999999999999966 99999999999999999999999999987654321
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHHH
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~~ 577 (688)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||............... .+.....+...
T Consensus 155 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 225 (256)
T cd06612 155 -----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK----PPPTLSDPEKW 225 (256)
T ss_pred -----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC----CCCCCCchhhc
Confidence 123455889999999999989999999999999999999999999754433222111110 00011223345
Q ss_pred HHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 578 ARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 578 ~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
...+.+++.+||+.+|.+||++.+.+
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il 251 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLL 251 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHh
Confidence 67899999999999999999998433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=329.84 Aligned_cols=244 Identities=23% Similarity=0.330 Sum_probs=191.7
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--Cce
Q 005616 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWS 411 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~ 411 (688)
...++|...+.||+|+||.||++... +..||+|++..... .....+.+|+.++..++||||+++++++.+ ..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34568999999999999999999986 78899999865322 233458899999999999999999999854 478
Q ss_pred eEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccc
Q 005616 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~ 491 (688)
+||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 999999999999988543 4788899999999999999999966 999999999999999999999999999876
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccC----CCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCccccc
Q 005616 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTG----VLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSI 565 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~----~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~ 565 (688)
..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ...+.....
T Consensus 193 ~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~--- 264 (370)
T cd05621 193 DETGM-----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN--- 264 (370)
T ss_pred ccCCc-----eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc---
Confidence 43221 122456799999999998654 3789999999999999999999999754432 122221111
Q ss_pred cCCCCCCCC--HHHHHHHHHHHHHcccCCCCC--CCCCcH
Q 005616 566 LDPLAGDWP--TFVARRLVDLGLQCCELYGRE--RPDITP 601 (688)
Q Consensus 566 ldp~~~~~~--~~~~~~l~~Li~~Cl~~dP~~--RPs~~e 601 (688)
...+| ...+..+.+++..|+..++.. ||++.+
T Consensus 265 ----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e 300 (370)
T cd05621 265 ----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEE 300 (370)
T ss_pred ----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHH
Confidence 01112 134667889999999754433 777763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=320.58 Aligned_cols=246 Identities=26% Similarity=0.294 Sum_probs=188.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||++... +..||||++..... .....|.+|+.++..++||||++++++|.+ ..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999886 78999999975322 233458899999999999999999999854 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999986533 35788999999999999999999966 999999999999999999999999998765433
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhcc-----CCCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCccccccC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRT-----GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILD 567 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~ld 567 (688)
... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||...... ...+........+.
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 230 (331)
T cd05597 156 GTV-----QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP 230 (331)
T ss_pred CCc-----cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCC
Confidence 211 1233569999999999863 45788999999999999999999999654322 12221111000011
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccC--CCCCCCCCcH
Q 005616 568 PLAGDWPTFVARRLVDLGLQCCEL--YGRERPDITP 601 (688)
Q Consensus 568 p~~~~~~~~~~~~l~~Li~~Cl~~--dP~~RPs~~e 601 (688)
+ .....+..+.+|+.+|+.. ++..||++.+
T Consensus 231 ~----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~ 262 (331)
T cd05597 231 P----DVTDVSEEAKDLIRRLICSPETRLGRNGLQD 262 (331)
T ss_pred C----ccCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 1 1112456788888887754 3333667663
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=327.90 Aligned_cols=251 Identities=23% Similarity=0.315 Sum_probs=191.6
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC-------Cce
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------AWS 411 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------~~~ 411 (688)
+|+..+.||+|+||.||+|... |..||||++.... ......+.+|+.++..++||||+++++++.. ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999874 8999999986532 2334578899999999999999999998843 468
Q ss_pred eEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccc
Q 005616 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~ 491 (688)
+||||+. ++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 5777776543 35889999999999999999999966 999999999999999999999999999875
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH--hh----cCcc--
Q 005616 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VS----CGKL-- 562 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--i~----~~~l-- 562 (688)
...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......... +. ....
T Consensus 154 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 154 EPDESK-----HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred ccCccc-----cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 432211 12345689999999998764 5799999999999999999999999644321110 00 0000
Q ss_pred -------------ccccCCC----CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHH
Q 005616 563 -------------SSILDPL----AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 563 -------------~~~ldp~----~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~ 605 (688)
.....+. ........+..+.+|+.+||+.||.+|||+.+.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000 001112235678999999999999999999855443
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=315.26 Aligned_cols=259 Identities=26% Similarity=0.404 Sum_probs=196.5
Q ss_pred cCcccceeeeccCceEEEEEEEC------------------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML------------------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTL 402 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~------------------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l 402 (688)
++|...+.||+|+||.||++... +..||+|++..... .....|.+|+.++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888899999999999998542 23689999875533 344679999999999999999999
Q ss_pred ecccC--CCceeEEeeCCCCcHHHHhcccCC--------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCce
Q 005616 403 LGACP--EAWSLVYEYLPNGSLQDRLFRKSN--------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNI 472 (688)
Q Consensus 403 ~g~~~--~~~~LV~E~~~~gsL~~~L~~~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NI 472 (688)
++++. +..++||||+++|+|.+++..... ...+++..++.++.+++.||.|||+.+ |+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99984 458899999999999999876431 134788999999999999999999966 99999999999
Q ss_pred eeCCCCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh--CCCCCCCh
Q 005616 473 LLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT--GRLPVGLA 550 (688)
Q Consensus 473 LLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt--G~~Pf~~~ 550 (688)
|++.++.++|+|||++..+...... .......+++.|++||+...+.++.++|||||||++|||++ |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYY----RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcce----eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999865432211 11123345678999999888899999999999999999998 77888643
Q ss_pred hHHHHHhhcCccc-cccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 551 GEVRRAVSCGKLS-SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 551 ~~~~~~i~~~~l~-~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
.........+... ..........+..++..+.+|+.+||+.||.+||++. +|.+.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~-~i~~~l~ 295 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQ-EIHATLL 295 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHH-HHHHHHh
Confidence 2211110000000 0000000011223457899999999999999999999 6766664
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=316.88 Aligned_cols=240 Identities=25% Similarity=0.346 Sum_probs=192.3
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc---hHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEee
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~---~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
|...+.||+|+||.||++... +..||||.+....... ...+.+|+.++..++|+||+++++.+. +..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999886 7899999987653322 345778999999999999999999884 347899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 999999998865432 45889999999999999999999965 9999999999999999999999999987654322
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCccccccCCCCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~ldp~~~~~~ 574 (688)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .... ...++.....++
T Consensus 157 ------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~ 225 (285)
T cd05630 157 ------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-----ERLVKEVQEEYS 225 (285)
T ss_pred ------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH-----HhhhhhhhhhcC
Confidence 113457999999999999999999999999999999999999999743211 0000 001111111223
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCC
Q 005616 575 TFVARRLVDLGLQCCELYGRERPDI 599 (688)
Q Consensus 575 ~~~~~~l~~Li~~Cl~~dP~~RPs~ 599 (688)
...+..+.+|+.+||+.||.+||++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~R~s~ 250 (285)
T cd05630 226 EKFSPDARSLCKMLLCKDPKERLGC 250 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHccCC
Confidence 3455678999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=309.79 Aligned_cols=234 Identities=25% Similarity=0.394 Sum_probs=184.1
Q ss_pred eeeccCceEEEEEEEC--------------CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005616 349 KVGQGGFGCVYKGEML--------------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--------------g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
.||+|+||.||+|.+. ...|++|.+..........|..|+.++..++||||++++++|.. ..++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 5899999999999753 23589998876555555678899999999999999999999854 4789
Q ss_pred EEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCc-------eEEeec
Q 005616 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS-------SKICDF 485 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~-------~KL~DF 485 (688)
||||+++|+|..++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++. ++++||
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999998886543 45899999999999999999999965 999999999999987664 899999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhc-cCCCCCcchHhHHHHHHHHHH-hCCCCCCChhHHHH-HhhcCcc
Q 005616 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR-TGVLTPKSDSYSFGLIILQLL-TGRLPVGLAGEVRR-AVSCGKL 562 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-~~~~s~ksDVwSfGviL~ELl-tG~~Pf~~~~~~~~-~i~~~~l 562 (688)
|++...... ....|+..|+|||++. +..++.++|||||||++|||+ +|..||........ ....+..
T Consensus 157 g~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 226 (262)
T cd05077 157 GIPITVLSR----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC 226 (262)
T ss_pred CCCccccCc----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCc
Confidence 998655321 2345788999999886 567899999999999999998 58888864332111 1111111
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 563 ~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
.. .......+.+|+.+||+.||.+||++. +|++.|
T Consensus 227 -~~--------~~~~~~~~~~li~~cl~~dp~~Rp~~~-~il~~~ 261 (262)
T cd05077 227 -ML--------VTPSCKELADLMTHCMNYDPNQRPFFR-AIMRDI 261 (262)
T ss_pred -cC--------CCCChHHHHHHHHHHcCCChhhCcCHH-HHHHhc
Confidence 00 111245789999999999999999998 555443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.73 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=204.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
.+|.....||.|+||.||+|... |..||||.+..........+.+|+.+++.++||||++++++|. +..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46888999999999999999864 8899999997766556677899999999999999999999984 3588999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++++|..++.. ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999998854 34789999999999999999999966 99999999999999999999999999887644321
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHh--hcCccccccCCCCCCCCH
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV--SCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i--~~~~l~~~ldp~~~~~~~ 575 (688)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.......... ....... ...+.
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~------~~~~~ 239 (296)
T cd06655 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE------LQNPE 239 (296)
T ss_pred -----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc------cCCcc
Confidence 1234568999999999998899999999999999999999999997654432221 1111111 11233
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHH
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~ 609 (688)
.++..+.+++.+||..+|.+||++.+.+.+.+-.
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~ 273 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence 4556789999999999999999999666555543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=323.10 Aligned_cols=254 Identities=29% Similarity=0.455 Sum_probs=199.4
Q ss_pred cCcccceeeeccCceEEEEEEE-------CCeEEEEEEEecCCcc-chHHHHHHHHHHHcC-CCCceeeEecccCC---C
Q 005616 342 CNFSESFKVGQGGFGCVYKGEM-------LGRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACPE---A 409 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~-------~g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~---~ 409 (688)
++|...+.||+|+||.||+|.+ .++.||||+++..... ....+.+|+.++.++ +|||||+++++|.. .
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4688889999999999999974 2578999999764332 344688999999999 68999999998843 3
Q ss_pred ceeEEeeCCCCcHHHHhcccCC----------------------------------------------------------
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSN---------------------------------------------------------- 431 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~---------------------------------------------------------- 431 (688)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 6899999999999999864321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCccccC
Q 005616 432 ------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505 (688)
Q Consensus 432 ------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~~ 505 (688)
...++|..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~ 239 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----VRKG 239 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcch----hhcC
Confidence 124788999999999999999999965 999999999999999999999999999876432211 1122
Q ss_pred CCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh---HHHHHhhcCccccccCCCCCCCCHHHHHHH
Q 005616 506 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG---EVRRAVSCGKLSSILDPLAGDWPTFVARRL 581 (688)
Q Consensus 506 ~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~---~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l 581 (688)
...+++.|+|||++.+..++.++||||||+++|+|++ |..||.... .....+..+... ..+...+..+
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 311 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--------RAPDYTTPEM 311 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC--------CCCCCCCHHH
Confidence 3446778999999988899999999999999999997 999986432 222222222211 1112234578
Q ss_pred HHHHHHcccCCCCCCCCCcHHHHHHHHHhh
Q 005616 582 VDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 582 ~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~ 611 (688)
.+++.+||+.+|.+||++. +|++.|+.+.
T Consensus 312 ~~~~~~cl~~~p~~Rps~~-eil~~l~~~~ 340 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFS-ELVEHLGNLL 340 (343)
T ss_pred HHHHHHHccCChhhCcCHH-HHHHHHHHHH
Confidence 9999999999999999999 7777777653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=311.93 Aligned_cols=249 Identities=23% Similarity=0.283 Sum_probs=192.2
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|...+.||.|+||.||+|... +..||||.+..... .....+.+|+.++..++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999885 78999999865432 234568899999999999999999999853 57899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+. ++|.+++........+++..+..++.||+.||.|||+.+ |+|+||||+|||++.+|.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 688888865544457899999999999999999999965 99999999999999999999999999976543221
Q ss_pred cCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhc----Ccc---------
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----GKL--------- 562 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~----~~l--------- 562 (688)
......+++.|+|||++.+. .++.++|||||||++|+|+||++||............ +..
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 157 ------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred ------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 12334678999999988654 5789999999999999999999999754332111100 000
Q ss_pred -----ccccC----CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcH
Q 005616 563 -----SSILD----PLAGDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 563 -----~~~ld----p~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
...++ ..........+..+.+|+.+||+.||.+|||+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ 278 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK 278 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 00000 0000011124567889999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=338.18 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=188.6
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCC------CceeeEeccc
Q 005616 335 ADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH------PHLVTLLGAC 406 (688)
Q Consensus 335 ~el~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~H------pnIV~l~g~~ 406 (688)
+++...+++|...+.||+|+||+||+|.+. +..||||+++... .....+..|+.++..++| +++++++++|
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344456789999999999999999999885 7889999996432 223345667777777654 4588888887
Q ss_pred CC---CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-----
Q 005616 407 PE---AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL----- 478 (688)
Q Consensus 407 ~~---~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~----- 478 (688)
.. ..++||+++ +++|.+++... ..+++..+..|+.||+.||.|||+.. +||||||||+||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccc
Confidence 43 377899888 77888887654 35899999999999999999999731 399999999999998765
Q ss_pred -----------ceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCC
Q 005616 479 -----------SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 547 (688)
Q Consensus 479 -----------~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf 547 (688)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||+||||++|++||
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~---------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH---------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc---------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 499999998754322 224568999999999999999999999999999999999999999
Q ss_pred CChhHHHHH--hh--cCccc-----------------------cccCCC-----C--CCC-CHHHHHHHHHHHHHcccCC
Q 005616 548 GLAGEVRRA--VS--CGKLS-----------------------SILDPL-----A--GDW-PTFVARRLVDLGLQCCELY 592 (688)
Q Consensus 548 ~~~~~~~~~--i~--~~~l~-----------------------~~ldp~-----~--~~~-~~~~~~~l~~Li~~Cl~~d 592 (688)
......... +. .|.+. ...++. . ... .......+.+|+.+||+.|
T Consensus 346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 425 (467)
T PTZ00284 346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD 425 (467)
T ss_pred CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence 754432111 00 01000 000000 0 000 0012356789999999999
Q ss_pred CCCCCCCcHHHH
Q 005616 593 GRERPDITPSLV 604 (688)
Q Consensus 593 P~~RPs~~e~l~ 604 (688)
|.+|||+.+.+.
T Consensus 426 P~~R~ta~e~L~ 437 (467)
T PTZ00284 426 RQKRLNARQMTT 437 (467)
T ss_pred hhhCCCHHHHhc
Confidence 999999995553
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=325.28 Aligned_cols=248 Identities=23% Similarity=0.265 Sum_probs=192.0
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC-------
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE------- 408 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~------- 408 (688)
..++|...+.||+|+||.||++... +..||||++.... ......+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999875 7889999987543 2334568899999999999999999988732
Q ss_pred -CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCc
Q 005616 409 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGl 487 (688)
..++||||+++ +|...+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 25899999975 5666653 24788999999999999999999965 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH--Hhhc--C---
Q 005616 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSC--G--- 560 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~i~~--~--- 560 (688)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.... .+.. +
T Consensus 173 a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 173 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred ccccCCCC-------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 98654322 12345789999999999999999999999999999999999999965432111 0000 0
Q ss_pred -------------------cc---------ccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 561 -------------------KL---------SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 561 -------------------~l---------~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.. ...+-+............+.+|+.+||+.||.+|||+.+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L 316 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 00 00000000111112345789999999999999999998544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.40 Aligned_cols=250 Identities=34% Similarity=0.505 Sum_probs=202.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeC
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
.++|...+.||.|+||.||+|.+. +..||||.+..... ....+.+|+.++++++||||+++++++.. ..++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 467888899999999999999876 57799999875443 45679999999999999999999999854 588999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++++|.+++..... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (261)
T cd05034 84 SKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY- 158 (261)
T ss_pred CCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence 99999999976432 45899999999999999999999966 99999999999999999999999999987653221
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCCCC
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~ 574 (688)
.......++..|+|||.+.+..+++++||||||+++|+|++ |+.||..... ....+..+. . ...+
T Consensus 159 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-~-------~~~~ 226 (261)
T cd05034 159 ----TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY-R-------MPRP 226 (261)
T ss_pred ----hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C-------CCCC
Confidence 11123335678999999998899999999999999999999 9999965332 222222111 0 0112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHH
Q 005616 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 575 ~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~ 609 (688)
...+..+.+++.+|+..+|.+||++. ++...|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~-~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFE-YLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHH-HHHHHHhc
Confidence 23356899999999999999999998 77777764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=306.99 Aligned_cols=244 Identities=30% Similarity=0.455 Sum_probs=196.5
Q ss_pred eeeccCceEEEEEEEC---C--eEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEeeCCCCc
Q 005616 349 KVGQGGFGCVYKGEML---G--RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~---g--~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~~gs 421 (688)
.||+|++|.||+|.+. + ..||||.+..... .....|.+|+.++++++||||+++++++.+ ..++||||+++|+
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~ 81 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGS 81 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCCc
Confidence 5899999999999874 2 3699999987766 456679999999999999999999998754 4789999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCc
Q 005616 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~ 501 (688)
|.+++..... ..++|..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---~ 154 (257)
T cd05040 82 LLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH---Y 154 (257)
T ss_pred HHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc---e
Confidence 9999976543 56899999999999999999999965 999999999999999999999999999877543211 1
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHH
Q 005616 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 502 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~ 578 (688)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ....+... . .....+...+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~------~~~~~~~~~~ 227 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE-G------ERLERPEACP 227 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-C------CcCCCCccCC
Confidence 11224567889999999999999999999999999999999 9999964332 22222110 0 0111223345
Q ss_pred HHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 579 RRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 579 ~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
..+.+++.+||+.+|.+||++. +++..|
T Consensus 228 ~~~~~li~~~l~~~p~~Rps~~-~~~~~l 255 (257)
T cd05040 228 QDIYNVMLQCWAHNPADRPTFA-ALREFL 255 (257)
T ss_pred HHHHHHHHHHCCCCcccCCCHH-HHHHHh
Confidence 6899999999999999999998 565554
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.96 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=196.9
Q ss_pred CcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCc------cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005616 343 NFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNM------QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~------~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
+|.....||.|+||.||+|... |..+|||.+..... .....+.+|+.+++.++|+||++++++|.+ ..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 3667789999999999999875 78899999865432 122458899999999999999999999854 47899
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999996543 5788999999999999999999966 99999999999999999999999999986542
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~ 573 (688)
...............|+..|+|||++.+..++.++|||||||++|+|++|..||..................+ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~ 230 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM----PRL 230 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC----CCC
Confidence 2111111112234568999999999999999999999999999999999999997544332222111111111 122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
+..++..+.+++.+||+.+|.+||++.+.
T Consensus 231 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 259 (265)
T cd06631 231 PDSFSAAAIDFVTSCLTRDQHERPSALQL 259 (265)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 33456788999999999999999999843
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=316.23 Aligned_cols=253 Identities=27% Similarity=0.414 Sum_probs=201.5
Q ss_pred hcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcC-CCCceeeEecccCC--C
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--A 409 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~ 409 (688)
.++|...+.||+|+||.||+|... +..||||+++.... .....+.+|+.+++++ +||||++++++|.. .
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357899999999999999999752 45799999875533 2345689999999999 79999999999843 4
Q ss_pred ceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccc
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~ 489 (688)
.++||||+++|+|.+++..... ..+++..+..++.+++.||.|||+.+ |+|+||||+|||++.++.++|+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 7899999999999999875432 34899999999999999999999965 9999999999999999999999999998
Q ss_pred cccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH---HHHHhhcCccccc
Q 005616 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE---VRRAVSCGKLSSI 565 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~---~~~~i~~~~l~~~ 565 (688)
........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ....+..+..
T Consensus 190 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~--- 262 (302)
T cd05055 190 DIMNDSNY----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR--- 262 (302)
T ss_pred cccCCCce----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc---
Confidence 66443211 11223456788999999999999999999999999999998 9999864332 2222222211
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 566 ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
...+...+..+.+++.+||+.+|++||++. +++..|+.+
T Consensus 263 -----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~-ell~~l~~~ 301 (302)
T cd05055 263 -----MAQPEHAPAEIYDIMKTCWDADPLKRPTFK-QIVQLIGKQ 301 (302)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHHhh
Confidence 011223456899999999999999999999 777777653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.09 Aligned_cols=246 Identities=26% Similarity=0.343 Sum_probs=201.0
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
++|.....||.|+||.||+|... +..+++|.+..........+.+|+.+++.++||||+++++++. +..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999885 6889999998766556678999999999999999999999884 3578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 83 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 83 GGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence 9999999886542 35889999999999999999999966 9999999999999999999999999998764322
Q ss_pred CCCccccCCCCCCCCCCChhhhccC---CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHh--hcCccccccCCCCCC
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTG---VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV--SCGKLSSILDPLAGD 572 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~---~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i--~~~~l~~~ldp~~~~ 572 (688)
.......|+..|+|||++.+. .++.++|||||||++|+|+||++||.......... ....+ .+....
T Consensus 156 ----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~ 227 (262)
T cd06613 156 ----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF----PPPKLK 227 (262)
T ss_pred ----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC----CCcccc
Confidence 122345688999999998776 88999999999999999999999997544322221 11111 111112
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
.+...+..+.+++.+||..+|.+||++.+.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 257 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKL 257 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHH
Confidence 233456789999999999999999999843
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=313.92 Aligned_cols=246 Identities=27% Similarity=0.386 Sum_probs=196.2
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeC
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
+|...+.||.|+||.||++... |..||+|.+.... ......+.+|+.++.+++||||+++++++. ...++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5777889999999999999986 8899999887542 233457899999999999999999999884 4578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++++|..++........+++..+..++.+++.||.|||+.. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 99999998876433346899999999999999999999742 49999999999999999999999999987654322
Q ss_pred CCCccccCCCCCCCCCCChhhhccC------CCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCC
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTG------VLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPL 569 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~------~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~ 569 (688)
.....|++.|+|||++.+. .++.++|||||||++|+|++|+.||..... ....+. .+.+..
T Consensus 158 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-----~~~~~~ 226 (286)
T cd06622 158 ------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS-----AIVDGD 226 (286)
T ss_pred ------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH-----HHhhcC
Confidence 2344688999999988554 358899999999999999999999964322 111111 111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
....+..++..+.+|+.+||+.+|.+||++.+.+
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~ 260 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence 1233445778899999999999999999998433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.74 Aligned_cols=250 Identities=28% Similarity=0.439 Sum_probs=201.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEeeCC
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLP 418 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~ 418 (688)
..+|...+.||+|+||.||+|.+. +..||+|.+.... .....|.+|+.+++.++|+||+++++++.+ ..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCC
Confidence 357888899999999999999875 6779999886543 234578999999999999999999998754 4689999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
+|+|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 158 (260)
T cd05073 84 KGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-
Confidence 999999997643 245789999999999999999999865 999999999999999999999999999876433211
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCCCCH
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~ 575 (688)
......++..|+|||++..+.++.++|||||||++|+++| |..||..... ....+..+... ..+.
T Consensus 159 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 226 (260)
T cd05073 159 ----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM--------PRPE 226 (260)
T ss_pred ----cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC--------CCcc
Confidence 1223346678999999998899999999999999999999 9999975432 23333222111 1122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHH
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~ 609 (688)
..+..+.+++.+||+.+|.+||++. ++...|+.
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~-~l~~~L~~ 259 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFE-YIQSVLDD 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHH-HHHHHHhc
Confidence 3456799999999999999999998 78877764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=327.20 Aligned_cols=247 Identities=23% Similarity=0.348 Sum_probs=192.0
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||++... +..||||++..... .....+.+|+.++..++||||+++++++.+ ..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999885 78999999975432 234568889999999999999999999854 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||||+.+|.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999998654 35788999999999999999999966 999999999999999999999999998755321
Q ss_pred CCcC-----------------------------CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCC
Q 005616 495 TLYL-----------------------------PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL 545 (688)
Q Consensus 495 ~~~~-----------------------------~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~ 545 (688)
.... ..........||+.|+|||++.+..++.++|||||||++|||++|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 1000 00001124579999999999999999999999999999999999999
Q ss_pred CCCChhH--HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 546 PVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 546 Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
||..... ....+........+.+ . ...+..+.+|+.+|+. ||.+|++..
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~---~--~~~s~~~~~li~~l~~-~p~~R~~~~ 285 (360)
T cd05627 235 PFCSETPQETYRKVMNWKETLVFPP---E--VPISEKAKDLILRFCT-DSENRIGSN 285 (360)
T ss_pred CCCCCCHHHHHHHHHcCCCceecCC---C--CCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence 9965432 2222222111000111 0 1135678888888774 999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=313.55 Aligned_cols=241 Identities=26% Similarity=0.383 Sum_probs=189.3
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeC
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
+|...+.||+|+||.||+|.+. +..||||++.... ......|.+|+.++.+++||||++++++|. +..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5777889999999999999875 7889999987553 233456899999999999999999999984 4578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++++|..+. .+++..+..++.+++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999997542 4678889999999999999999966 9999999999999999999999999998654322
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHh-hcCccccccCCCCCCC-CH
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV-SCGKLSSILDPLAGDW-PT 575 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i-~~~~l~~~ldp~~~~~-~~ 575 (688)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||.......... ..+....+.++..... ..
T Consensus 150 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (279)
T cd06619 150 ------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG 223 (279)
T ss_pred ------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCC
Confidence 234578999999999999899999999999999999999999996322100000 0000000001100111 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCCcH
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
..+..+.+++.+||+.+|.+||++.+
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~e 249 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPEN 249 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHH
Confidence 24567899999999999999999884
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=312.29 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=198.3
Q ss_pred cCcccceeeeccCceEEEEEEE------CCeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC----Cc
Q 005616 342 CNFSESFKVGQGGFGCVYKGEM------LGRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AW 410 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~------~g~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~ 410 (688)
..|...+.||+|+||.||++.+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467788999999999999975 26789999987553 2334579999999999999999999998843 37
Q ss_pred eeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
++||||+++++|.+++.... ..++|..++.++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 89999999999999986543 35899999999999999999999965 99999999999999999999999999987
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH-----------------
Q 005616 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV----------------- 553 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~----------------- 553 (688)
........ .......|+..|+|||++.+..++.++|||||||++|+|+|++.|+......
T Consensus 159 ~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 159 IETDKEYY---TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred cccCccce---eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 65432210 1123455777899999998889999999999999999999987765321110
Q ss_pred HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 554 RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 554 ~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
...+..+. ....+..++..+.+|+.+||+.+|.+||++. +++..|+.+
T Consensus 236 ~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGK--------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQ-NLIEGFEAI 283 (284)
T ss_pred HHHHHcCc--------cCCCCCCCCHHHHHHHHHHccCCcccCcCHH-HHHHHHHhh
Confidence 00111111 0111233567899999999999999999998 777777653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=306.77 Aligned_cols=242 Identities=23% Similarity=0.309 Sum_probs=197.7
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeC
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
+|...+.||.|+||.||++... +..||+|.+.... ......+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4777899999999999999886 7889999986543 3345578899999999999999999999854 488999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++|+|.+++.... ...+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 9999999886432 245788999999999999999999966 99999999999999999999999999976643221
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCH
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~ 575 (688)
......|++.|+|||++.+..++.++||||||+++|+|++|..||..... ....+..+... ..+.
T Consensus 156 -----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 222 (255)
T cd08219 156 -----YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK--------PLPS 222 (255)
T ss_pred -----ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC--------CCCc
Confidence 12345689999999999988999999999999999999999999975442 22222222221 1223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
..+..+.+|+.+||+.||.+||++.+.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~i 249 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTI 249 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHH
Confidence 455678999999999999999999843
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=313.33 Aligned_cols=244 Identities=23% Similarity=0.318 Sum_probs=196.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
++|...+.||.|+||.||+|... +..|++|.+..........+.+|+.+++.++||||++++++|. ...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888899999999999999885 7889999998766566677999999999999999999999873 4588999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++++|..++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 9999988876543 35899999999999999999999965 9999999999999999999999999987543221
Q ss_pred CCCccccCCCCCCCCCCChhhhc-----cCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH--hhcCccccccCCCC
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPLA 570 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--i~~~~l~~~ldp~~ 570 (688)
.......|++.|+|||++. ...++.++|||||||++|+|++|.+||......... +..+....
T Consensus 165 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------ 234 (292)
T cd06644 165 ----QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT------ 234 (292)
T ss_pred ----cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc------
Confidence 1223456889999999874 345788999999999999999999999654332211 11111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
...+...+..+.+++.+||..+|++||++.+.
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 266 (292)
T cd06644 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQL 266 (292)
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 11223455678999999999999999998743
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.56 Aligned_cols=243 Identities=29% Similarity=0.454 Sum_probs=191.0
Q ss_pred eeeccCceEEEEEEEC--Ce--EEEEEEEecCC-ccchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeEEeeCCCC
Q 005616 349 KVGQGGFGCVYKGEML--GR--TVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~--~VAIK~l~~~~-~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||+|.+. +. .+++|.++... ......+.+|+.++.++ +||||++++++|.. ..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 5899999999999885 33 47888887543 23445788999999999 89999999999854 478999999999
Q ss_pred cHHHHhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCc
Q 005616 421 SLQDRLFRKS-------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 421 sL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGl 487 (688)
+|.+++.... ....+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCC
Confidence 9999986542 1235789999999999999999999965 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCcccc
Q 005616 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSS 564 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~ 564 (688)
+....... .......+..|+|||++....++.++|||||||++|||++ |..||..... ....+..+..
T Consensus 159 ~~~~~~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-- 229 (270)
T cd05047 159 SRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-- 229 (270)
T ss_pred ccccchhh-------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC--
Confidence 86332111 1122334678999999988899999999999999999997 9999964322 2222222111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 565 ~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
...+...+..+.+|+.+||..+|.+||++. +++..|+.+
T Consensus 230 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~il~~l~~~ 268 (270)
T cd05047 230 ------LEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRM 268 (270)
T ss_pred ------CCCCCcCCHHHHHHHHHHcccChhhCCCHH-HHHHHHHHh
Confidence 112223456789999999999999999999 777777654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=315.60 Aligned_cols=245 Identities=26% Similarity=0.366 Sum_probs=200.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
++|...+.||.|+||.||+|... +..||||.+..........+.+|+.+++.++||||++++++|.. ..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 67888899999999999999874 88999999987666666778999999999999999999999844 588999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++++|.+++.. ..+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence 99999999854 34788999999999999999999965 99999999999999999999999999876543321
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHHH
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~~ 577 (688)
......|++.|+|||.+.+..++.++|||||||++|+|++|..||............... .......+...
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~ 241 (297)
T cd06656 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN----GTPELQNPERL 241 (297)
T ss_pred -----CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC----CCCCCCCcccc
Confidence 123456889999999999989999999999999999999999999654432211111100 00011223345
Q ss_pred HHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 578 ARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 578 ~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
+..+.+|+.+||..+|.+||++.+.+
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il 267 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELL 267 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHh
Confidence 66789999999999999999998444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=312.76 Aligned_cols=246 Identities=24% Similarity=0.314 Sum_probs=199.5
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
.++|...+.||.|+||.||+|.+. +..||+|.+..........|.+|+.++++++||||+++++++.. ..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888899999999999999885 78899999987666666789999999999999999999999844 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999999986543 35899999999999999999999966 99999999999999999999999999876543221
Q ss_pred cCCCccccCCCCCCCCCCChhhhc-----cCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH--hhcCccccccCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPL 569 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--i~~~~l~~~ldp~ 569 (688)
......|++.|+|||++. +..++.++||||||+++|+|++|+.||......... +..+....
T Consensus 159 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----- 227 (280)
T cd06611 159 ------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT----- 227 (280)
T ss_pred ------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCC-----
Confidence 223456899999999874 345788999999999999999999999755432221 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
...+...+..+.+++.+||+.+|.+||++.+.+
T Consensus 228 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (280)
T cd06611 228 -LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260 (280)
T ss_pred -cCCcccCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 112334556889999999999999999998444
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.01 Aligned_cols=247 Identities=27% Similarity=0.382 Sum_probs=187.5
Q ss_pred eeeccCceEEEEEEEC----CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCc
Q 005616 349 KVGQGGFGCVYKGEML----GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~----g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gs 421 (688)
.||+|+||.||+|... +..+|+|.+..... .....|.+|+.++..++||||++++|+|.+ ..++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5899999999999864 35799998876543 334578899999999999999999999854 4789999999999
Q ss_pred HHHHhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC
Q 005616 422 LQDRLFRKS--NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 422 L~~~L~~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
|.+++.... ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~-- 156 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY-- 156 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence 999987543 2234677888899999999999999966 999999999999999999999999998765432211
Q ss_pred CccccCCCCCCCCCCChhhhccC-------CCCCcchHhHHHHHHHHHHh-CCCCCCChhHHH--HHhhcCccccccCCC
Q 005616 500 SFHRSTAPKGSFPYADPEYHRTG-------VLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVR--RAVSCGKLSSILDPL 569 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~~~-------~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~~~--~~i~~~~l~~~ldp~ 569 (688)
.......|+..|+|||++... .++.++||||||+++|||++ |..||....... .....+......++.
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 157 --VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred --ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 112345678899999987532 35889999999999999996 999996543221 111111111111221
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
.....+..+.+++..|+ .+|.+||++. +|+..|
T Consensus 235 ---~~~~~~~~~~~l~~~c~-~~P~~Rpt~~-~l~~~l 267 (269)
T cd05087 235 ---LKLPLSDRWYEVMQFCW-LQPEQRPSAE-EVHLLL 267 (269)
T ss_pred ---cCCCCChHHHHHHHHHh-cCcccCCCHH-HHHHHh
Confidence 12223456888999998 6899999999 666554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.80 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=202.7
Q ss_pred cCcccceeeeccCceEEEEEEEC---------CeEEEEEEEecCCc-cchHHHHHHHHHHHcC-CCCceeeEecccCC--
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML---------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE-- 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~---------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~-- 408 (688)
.+|...+.||+|+||.||+|+.. ...||+|.+..... .....+.+|+.++..+ +||||++++++|.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56778899999999999999752 35699999875432 3345688999999999 69999999999854
Q ss_pred CceeEEeeCCCCcHHHHhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeC
Q 005616 409 AWSLVYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD 475 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd 475 (688)
..++||||+++|+|.+++..... ...++|..+..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 47899999999999999965321 245899999999999999999999965 99999999999999
Q ss_pred CCCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--H
Q 005616 476 SELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--E 552 (688)
Q Consensus 476 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~ 552 (688)
.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||.... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYY----KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred CCCcEEEccccccccccccccc----cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999876532211 11122335568999999999999999999999999999999 889986432 2
Q ss_pred HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhh
Q 005616 553 VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 553 ~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~ 612 (688)
+...+..+... ..+..++..+.+|+.+||..+|.+||++. +++..|+.+..
T Consensus 245 ~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~ll~~l~~~~~ 295 (314)
T cd05099 245 LFKLLREGHRM--------DKPSNCTHELYMLMRECWHAVPTQRPTFK-QLVEALDKVLA 295 (314)
T ss_pred HHHHHHcCCCC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHHHHH
Confidence 33333333211 12334456888999999999999999998 78888887754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=339.44 Aligned_cols=250 Identities=28% Similarity=0.441 Sum_probs=212.9
Q ss_pred ccceeeeccCceEEEEEEEC--C---eEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 345 SESFKVGQGGFGCVYKGEML--G---RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 345 ~~~~~LG~G~~G~Vy~g~~~--g---~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
.+.++||.|.||.||+|+++ | ..||||.++..... .+.+|..|+.||.++.||||++|-|+... ..+||.||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 45688999999999999986 4 46999999987654 45579999999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
|+||+|+.+|..+. ..+++-+..-++.+||.|+.||-+++ +|||||...|||++.+..+|++|||+++.+.++..
T Consensus 712 MENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 712 MENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 99999999998876 45889999999999999999999987 99999999999999999999999999998865541
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCCh--hHHHHHhhcCccccccCCCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLA--GEVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~--~~~~~~i~~~~l~~~ldp~~~~~ 573 (688)
....+....-...|.|||.+...++|.++|||||||+|||.++ |..||... .++..++..|--. .-
T Consensus 787 ---~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRL--------Pp 855 (996)
T KOG0196|consen 787 ---AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRL--------PP 855 (996)
T ss_pred ---ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCC--------CC
Confidence 2223334444678999999999999999999999999999888 99998533 3567777766321 33
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhh
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~ 611 (688)
|.+++..|.+|++.||++|..+||.+. .|+..|+.+-
T Consensus 856 PmDCP~aL~qLMldCWqkdR~~RP~F~-qiV~~lDklI 892 (996)
T KOG0196|consen 856 PMDCPAALYQLMLDCWQKDRNRRPKFA-QIVSTLDKLI 892 (996)
T ss_pred CCCCcHHHHHHHHHHHHHHhhcCCCHH-HHHHHHHHHh
Confidence 556778999999999999999999999 7888888874
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.06 Aligned_cols=241 Identities=27% Similarity=0.342 Sum_probs=197.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
++|.....||.|+||.||+|... +..||+|.+.... ......+.+|+.+++.++||||+++++++.+ ..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778889999999999999885 7899999987654 3344578899999999999999999998854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++++|.+++... ++++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999998653 6899999999999999999999965 99999999999999999999999999988764321
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHH--HHhhcCccccccCCCCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~i~~~~l~~~ldp~~~~~~ 574 (688)
......|++.|+|||++.+..++.++|||||||++|+|+||..||....... ..+..+.. + ..+
T Consensus 154 ------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-----~---~~~ 219 (274)
T cd06609 154 ------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP-----P---SLE 219 (274)
T ss_pred ------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC-----C---CCc
Confidence 2244578899999999999889999999999999999999999997543221 11111111 1 111
Q ss_pred HH-HHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 575 TF-VARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 575 ~~-~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.. ++..+.+++.+||..+|++||++.+.+
T Consensus 220 ~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il 249 (274)
T cd06609 220 GNKFSKPFKDFVSLCLNKDPKERPSAKELL 249 (274)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence 11 556799999999999999999998433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=308.26 Aligned_cols=244 Identities=23% Similarity=0.315 Sum_probs=194.7
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
++|...+.||+|+||.||+|... +..||+|.++.........+.+|+.++..++||||+++++++. +..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46778889999999999999885 7899999997765555567889999999999999999999884 4588999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 999999988654 35889999999999999999999976 9999999999999999999999999987664322
Q ss_pred CCCccccCCCCCCCCCCChhhhc---cCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH--hhcCccccccCCCCCC
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPLAGD 572 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--i~~~~l~~~ldp~~~~ 572 (688)
.......|++.|+|||++. ...++.++|||||||++|+|++|..||......... ....... +....
T Consensus 161 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~----~~~~~ 232 (267)
T cd06645 161 ----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ----PPKLK 232 (267)
T ss_pred ----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC----CCccc
Confidence 1224457899999999874 456889999999999999999999998543321111 1111111 10000
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCcH
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
....++..+.+++.+||..+|.+||++.+
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 261 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEK 261 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 11123457899999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=311.87 Aligned_cols=259 Identities=28% Similarity=0.444 Sum_probs=201.2
Q ss_pred CcccceeeeccCceEEEEEEEC------CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC----Cce
Q 005616 343 NFSESFKVGQGGFGCVYKGEML------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWS 411 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~------g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~ 411 (688)
.|...+.||+|+||.||+|.+. +..||||++...... ....|.+|+.+++.++||||+++++++.. ..+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4666789999999999999864 578999999766543 45679999999999999999999998854 478
Q ss_pred eEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccc
Q 005616 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~ 491 (688)
+||||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 85 lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 9999999999999997643 35899999999999999999999965 999999999999999999999999999887
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH-hh-------cCccc
Q 005616 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA-VS-------CGKLS 563 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~-i~-------~~~l~ 563 (688)
....... .......++..|++||++.+..++.++||||||+++|||+||..|+......... .. ...+.
T Consensus 160 ~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 160 PEDKDYY---YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred ccCCcce---eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 6332211 1122334566799999999889999999999999999999999997532211000 00 00000
Q ss_pred cccCC-CCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 564 SILDP-LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 564 ~~ldp-~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
..+.. .....+..++..+.+|+.+||+.+|.+||++. +|+.+|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~-ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFA-DLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHH-HHHHHHhhc
Confidence 00000 00111223456899999999999999999999 788888764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.78 Aligned_cols=244 Identities=27% Similarity=0.444 Sum_probs=194.2
Q ss_pred eeeccCceEEEEEEECC--------eEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeC
Q 005616 349 KVGQGGFGCVYKGEMLG--------RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~g--------~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
.||.|+||.||+|+... ..||||.+..... .....|.+|+.+++.++||||++++++|.. ..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 59999999999998742 5799998865432 345678999999999999999999998843 478999999
Q ss_pred CCCcHHHHhcccC----CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-----ceEEeecCcc
Q 005616 418 PNGSLQDRLFRKS----NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-----SSKICDFGIC 488 (688)
Q Consensus 418 ~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-----~~KL~DFGla 488 (688)
++++|.+++.... ....++|..++.++.+++.||.|||+.+ ++|+||||+||+++.++ .++|+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999987532 2235789999999999999999999865 99999999999999887 8999999999
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhHH--HHHhhcCccccc
Q 005616 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV--RRAVSCGKLSSI 565 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~~--~~~i~~~~l~~~ 565 (688)
......... .......++..|+|||++.++.++.++|||||||++|+|+| |..||...... ...+..+.
T Consensus 159 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---- 230 (269)
T cd05044 159 RDIYKSDYY----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG---- 230 (269)
T ss_pred ccccccccc----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC----
Confidence 866433211 11223456788999999999999999999999999999998 99998644322 22222211
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 566 ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
....+...+..+.+++.+||..+|.+||++. ++.+.|+
T Consensus 231 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~ 268 (269)
T cd05044 231 ----RLQKPENCPDKIYQLMTNCWAQDPSERPTFD-RIQEILQ 268 (269)
T ss_pred ----ccCCcccchHHHHHHHHHHcCCCcccCCCHH-HHHHHHh
Confidence 1122334567899999999999999999999 6776664
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=302.38 Aligned_cols=243 Identities=24% Similarity=0.311 Sum_probs=198.5
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC---CceeEEe
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE---AWSLVYE 415 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~---~~~LV~E 415 (688)
+|...+.||.|++|.||++... +..||+|.+..... .....+.+|+.++++++|||++++++.+.. ..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999875 78899999875433 334568899999999999999999988742 2679999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|+++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999987543 245899999999999999999999966 9999999999999999999999999998764322
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCC
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~ 573 (688)
. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ....+..+.+. ..
T Consensus 157 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~--------~~ 222 (257)
T cd08223 157 D------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP--------PM 222 (257)
T ss_pred C------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--------CC
Confidence 1 22345689999999999999999999999999999999999999975432 11222222221 22
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
+...+..+.+++.+||+.+|.+||++.+.+
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 252 (257)
T cd08223 223 PKDYSPELGELIATMLSKRPEKRPSVKSIL 252 (257)
T ss_pred ccccCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 334667899999999999999999988433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=322.67 Aligned_cols=247 Identities=21% Similarity=0.289 Sum_probs=190.8
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC------
Q 005616 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE------ 408 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~------ 408 (688)
...++|.....||.|+||.||+|... +..||||.+..... .....+.+|+.+|..++||||++++++|..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 44578999999999999999999875 78899999865432 234567899999999999999999988732
Q ss_pred --CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecC
Q 005616 409 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 409 --~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFG 486 (688)
..+++++++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 257899987 7899887743 35889999999999999999999966 9999999999999999999999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH--h-h-cCc
Q 005616 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--V-S-CGK 561 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--i-~-~~~ 561 (688)
++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... + . .+.
T Consensus 164 ~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07878 164 LARQADDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT 234 (343)
T ss_pred cceecCCC---------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99865432 234578999999999876 57899999999999999999999999643321110 0 0 000
Q ss_pred -------------cccccCCCCCCCC--------HHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 562 -------------LSSILDPLAGDWP--------TFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 562 -------------l~~~ldp~~~~~~--------~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
....+.. ....+ ......+.+|+.+||+.||.+|||+.+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell 296 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296 (343)
T ss_pred CCHHHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0000000 00000 01234578999999999999999998544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.99 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=201.5
Q ss_pred cCHHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccC-
Q 005616 332 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACP- 407 (688)
Q Consensus 332 ~~~~el~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~- 407 (688)
.++.++..+.+.|.....||.|+||.||+|.+. +..||+|++.... .....+..|+.++.++ +||||++++++|.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 466777788899999999999999999999985 7889999986543 2345688999999999 7999999999983
Q ss_pred -------CCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCce
Q 005616 408 -------EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 408 -------~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~ 480 (688)
+..++||||+++|+|.+++..... ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 236899999999999998865432 45788889999999999999999966 9999999999999999999
Q ss_pred EEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhc-----cCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH
Q 005616 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR 555 (688)
Q Consensus 481 KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~ 555 (688)
+|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|+|++|..||........
T Consensus 161 ~l~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 234 (282)
T cd06636 161 KLVDFGVSAQLDRTVG------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234 (282)
T ss_pred EEeeCcchhhhhcccc------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence 9999999876543211 123457899999999875 35688899999999999999999999965433222
Q ss_pred HhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcH
Q 005616 556 AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 556 ~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
...... ...+. .....++..+.+|+.+||+.||.+||++.+
T Consensus 235 ~~~~~~---~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~e 275 (282)
T cd06636 235 LFLIPR---NPPPK--LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQ 275 (282)
T ss_pred hhhHhh---CCCCC--CcccccCHHHHHHHHHHhCCChhhCcCHHH
Confidence 211111 00010 111234568999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.58 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=194.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEee
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
++|...+.||+|+||.||++... +..||+|.+..... .....+.+|+.++.+++||||++++++|. +..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999886 77899998875432 23456889999999999999999999984 458899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++++|.+++... ..+++..+..++.+++.||.|||+.. +|+|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 9999999998654 45788999999999999999999842 49999999999999999999999999987653321
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCccccccC-------
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILD------- 567 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~ld------- 567 (688)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...... ...+.. .......
T Consensus 155 -------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 226 (308)
T cd06615 155 -------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR-PVSEGEAKESHRPV 226 (308)
T ss_pred -------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcC-ccccccccCCcccc
Confidence 23457899999999998888999999999999999999999998533211 111100 0000000
Q ss_pred ----------------------CCCCCCC-HHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 568 ----------------------PLAGDWP-TFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 568 ----------------------p~~~~~~-~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
......+ ..++..+.+|+.+||..+|++||++.+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 285 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 0000000 12456799999999999999999988433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=325.33 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=193.7
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC
Q 005616 334 LADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE 408 (688)
Q Consensus 334 ~~el~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~ 408 (688)
+.++....++|...+.||+|+||.||++... +..||+|++..... .....+.+|+.++..++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3444556689999999999999999999886 78899999865322 233457899999999999999999999854
Q ss_pred --CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecC
Q 005616 409 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 409 --~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFG 486 (688)
..++||||+++|+|.+++... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 478999999999999988543 4678889999999999999999966 9999999999999999999999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhccC----CCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcC
Q 005616 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG----VLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCG 560 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~----~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~ 560 (688)
++........ .......||+.|+|||++... .++.++|||||||++|||++|..||...... ...+...
T Consensus 188 ~a~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 262 (371)
T cd05622 188 TCMKMNKEGM-----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 262 (371)
T ss_pred ceeEcCcCCc-----ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 9987653321 122456799999999998653 3789999999999999999999999754432 2222211
Q ss_pred c-cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCC---CCCCc
Q 005616 561 K-LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRE---RPDIT 600 (688)
Q Consensus 561 ~-l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~---RPs~~ 600 (688)
. .... ..+...+..+.+|+..|+. +|.. ||++.
T Consensus 263 ~~~~~~------~~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ 299 (371)
T cd05622 263 KNSLTF------PDDNDISKEAKNLICAFLT-DREVRLGRNGVE 299 (371)
T ss_pred CCcccC------CCcCCCCHHHHHHHHHHcC-ChhhhcCCCCHH
Confidence 1 1110 1112356788999999998 5555 45554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.80 Aligned_cols=243 Identities=27% Similarity=0.384 Sum_probs=196.5
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeC
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
.|...+.||.|+||.||+|.+. +..||+|.+..... .....+.+|+.++++++||||++++++|.. ..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556678999999999999875 78899999875443 334568999999999999999999999854 488999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 99999998853 35789999999999999999999965 99999999999999999999999999877643221
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHH--HHhhcCccccccCCCCCCCCH
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~i~~~~l~~~ldp~~~~~~~ 575 (688)
......|+..|+|||++.+..++.++|||||||++|||++|..||....... ..+..+. ....+.
T Consensus 157 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 223 (277)
T cd06642 157 -----KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS--------PPTLEG 223 (277)
T ss_pred -----hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC--------CCCCCc
Confidence 1233468899999999999899999999999999999999999986433211 1111111 112233
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCCcHHHHHH
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~ 606 (688)
..+..+.+++.+||+.+|.+||++.+.+.+.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 4567899999999999999999999655443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=316.74 Aligned_cols=256 Identities=27% Similarity=0.453 Sum_probs=202.9
Q ss_pred cCcccceeeeccCceEEEEEEEC---------CeEEEEEEEecCCc-cchHHHHHHHHHHHcC-CCCceeeEecccCC--
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML---------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE-- 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~---------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~-- 408 (688)
.+|.+.+.||+|+||.||++... +..||+|.+..... .....+.+|+.++.++ +||||++++++|.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888899999999999999753 23689998875432 2345789999999999 79999999999854
Q ss_pred CceeEEeeCCCCcHHHHhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeC
Q 005616 409 AWSLVYEYLPNGSLQDRLFRKS-------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD 475 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd 475 (688)
..++||||+++|+|.+++.... ....++|..++.++.|++.||.|||..+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 4789999999999999987532 1235889999999999999999999965 99999999999999
Q ss_pred CCCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--H
Q 005616 476 SELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--E 552 (688)
Q Consensus 476 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~ 552 (688)
.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred CCCcEEECCcccceeccccccc----ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999866432211 11223345678999999999999999999999999999998 888886433 2
Q ss_pred HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhhc
Q 005616 553 VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVA 613 (688)
Q Consensus 553 ~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~~ 613 (688)
....+..+... +.+...+..+.+|+.+||+.+|.+||++. +++..|+.+...
T Consensus 245 ~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~-ell~~l~~~~~~ 296 (334)
T cd05100 245 LFKLLKEGHRM--------DKPANCTHELYMIMRECWHAVPSQRPTFK-QLVEDLDRVLTV 296 (334)
T ss_pred HHHHHHcCCCC--------CCCCCCCHHHHHHHHHHcccChhhCcCHH-HHHHHHHHHhhh
Confidence 33333322211 12233456899999999999999999998 788888877543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=307.19 Aligned_cols=252 Identities=27% Similarity=0.448 Sum_probs=202.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--C----eEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC-CCceeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--G----RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g----~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~-~~~~LV 413 (688)
.+|...+.||+|+||.||+|.+. | ..||+|.+..... .....+.+|+.++..++||||++++++|. ...++|
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 45777789999999999999874 3 2589998876543 33457899999999999999999999985 457899
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 87 TQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 99999999999987643 35899999999999999999999965 99999999999999999999999999987654
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCccccccCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l~~~ldp~~ 570 (688)
..... ......++..|+|||.+....++.++||||||+++|||++ |..||.... .+...+..+...
T Consensus 162 ~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------- 230 (279)
T cd05057 162 DEKEY----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL------- 230 (279)
T ss_pred cccce----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC-------
Confidence 32111 1122334678999999988899999999999999999999 999997533 233333332211
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhh
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~ 611 (688)
..+...+..+.+++.+||..+|..||++. .+...|+.+.
T Consensus 231 -~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~-~l~~~l~~~~ 269 (279)
T cd05057 231 -PQPPICTIDVYMVLVKCWMIDAESRPTFK-ELINEFSKMA 269 (279)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCCCHH-HHHHHHHHHH
Confidence 11222345789999999999999999999 7888888764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=322.15 Aligned_cols=246 Identities=29% Similarity=0.438 Sum_probs=210.8
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc---hHHHHHHHHHHHcCC-CCceeeEecccCC--Cce
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQ-HPHLVTLLGACPE--AWS 411 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~---~~~f~~E~~iL~~l~-HpnIV~l~g~~~~--~~~ 411 (688)
....|.....||.|.||.||+++.. |..+|+|++.+....+ ...+.+|+.+|.++. |||||.++++|.+ ..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4467888899999999999999886 8899999998876644 357999999999998 9999999999965 479
Q ss_pred eEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC----CceEEeecCc
Q 005616 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE----LSSKICDFGI 487 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~----~~~KL~DFGl 487 (688)
+|||++.||.|.+.+... .+++.++..++.+++.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999876 2899999999999999999999966 9999999999999643 5799999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--HHHHHhhcCccccc
Q 005616 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSI 565 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~i~~~~l~~~ 565 (688)
+....... .....+||+.|+|||++....|+..+||||+||++|.|++|.+||.... .....+..+++
T Consensus 186 a~~~~~~~-------~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~--- 255 (382)
T KOG0032|consen 186 AKFIKPGE-------RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF--- 255 (382)
T ss_pred ceEccCCc-------eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC---
Confidence 99887632 3467899999999999999999999999999999999999999997665 34445556655
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 566 ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
+.....|+ .++..+.+++..|+..||..|+++.+.+.
T Consensus 256 -~f~~~~w~-~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 -DFTSEPWD-DISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -CCCCCCcc-ccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 22233444 56889999999999999999999985443
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.54 Aligned_cols=247 Identities=28% Similarity=0.396 Sum_probs=186.0
Q ss_pred eeeccCceEEEEEEEC----CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCc
Q 005616 349 KVGQGGFGCVYKGEML----GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~----g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gs 421 (688)
.||+|+||.||+|... ...+|+|.+..... .....|.+|+.+++.++||||++++|+|.+ ..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5899999999999753 35688888764432 234568899999999999999999999854 4889999999999
Q ss_pred HHHHhcccCC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC
Q 005616 422 LQDRLFRKSN--VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 422 L~~~L~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
|.+++..... ....++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 156 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY-- 156 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe--
Confidence 9999976532 233567888999999999999999966 999999999999999999999999998764332211
Q ss_pred CccccCCCCCCCCCCChhhhcc-------CCCCCcchHhHHHHHHHHHHh-CCCCCCChhHH--HHHhhcCccccccCCC
Q 005616 500 SFHRSTAPKGSFPYADPEYHRT-------GVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV--RRAVSCGKLSSILDPL 569 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~~-------~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~~--~~~i~~~~l~~~ldp~ 569 (688)
.......+++.|+|||++.. ..++.++|||||||++|||++ |..||...... ...........+.++
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~- 233 (269)
T cd05042 157 --ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP- 233 (269)
T ss_pred --eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC-
Confidence 11233456788999998743 456889999999999999999 78888654321 111111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
..+...+..+.+++..|+ .||++||++. +|.+.|
T Consensus 234 --~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~-~v~~~l 267 (269)
T cd05042 234 --QLDLKYSDRWYEVMQFCW-LDPETRPTAE-EVHELL 267 (269)
T ss_pred --cccccCCHHHHHHHHHHh-cCcccccCHH-HHHHHh
Confidence 233345567788888898 5999999998 666554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=319.05 Aligned_cols=245 Identities=25% Similarity=0.296 Sum_probs=189.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||++... +..||+|++..... .....|..|+.++..++|+||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999986 67899999865322 223358889999999999999999998844 588999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999997643 35889999999999999999999966 999999999999999999999999999765432
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhc-----cCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHH--HHhhcCccccccC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILD 567 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~i~~~~l~~~ld 567 (688)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ..+........+
T Consensus 156 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~- 229 (332)
T cd05623 156 GT-----VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF- 229 (332)
T ss_pred Cc-----ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccC-
Confidence 21 1123457999999999886 3568999999999999999999999997544322 222211110000
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCCc
Q 005616 568 PLAGDWPTFVARRLVDLGLQCCELYGRE--RPDIT 600 (688)
Q Consensus 568 p~~~~~~~~~~~~l~~Li~~Cl~~dP~~--RPs~~ 600 (688)
......++..+.+|+.+|+..++.. ||++.
T Consensus 230 ---p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~ 261 (332)
T cd05623 230 ---PAQVTDVSEDAKDLIRRLICSREHRLGQNGIE 261 (332)
T ss_pred ---CCccccCCHHHHHHHHHHccChhhhcCCCCHH
Confidence 0111234667888999988654433 56665
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=300.98 Aligned_cols=246 Identities=29% Similarity=0.546 Sum_probs=197.2
Q ss_pred cCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 418 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~ 418 (688)
.+|...+.||.|+||.||+|.+. +..+|+|.+..... ....|.+|+.++..++||||+++++++.. ..++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 45777889999999999999886 78899998865432 34578999999999999999999999854 5789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
+++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 999999986543 35789999999999999999999966 999999999999999999999999998865432211
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCccccccCCCCCCCCH
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l~~~ldp~~~~~~~ 575 (688)
......++.+|+|||++.++.++.++||||||+++|||++ |..||.... .....+..+. .... +.
T Consensus 157 ----~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~------~~ 224 (256)
T cd05112 157 ----SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF--RLYK------PR 224 (256)
T ss_pred ----ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC--CCCC------CC
Confidence 1223345678999999998999999999999999999998 999986433 2222222221 1111 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
..+..+.+|+.+||+.+|++||++. ++++.|
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~-~~l~~l 255 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFS-LLLHQL 255 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHH-HHHHhh
Confidence 2356899999999999999999998 555543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=311.40 Aligned_cols=248 Identities=26% Similarity=0.299 Sum_probs=201.0
Q ss_pred cCcccceeeeccCceEEEEEEECC--eEEEEEEEecCCccc---hHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~g--~~VAIK~l~~~~~~~---~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
+.|...+.||.|.-|+||++++.| ..+|+|++.+..... ..+...|-+||+.++||.++.||..|.. ..||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456677889999999999999985 789999998776543 3457789999999999999999999954 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
|||+||+|...+.+... ..++...+..++.+|+.||+|||-.| ||+|||||+||||.++|++-|+||.++......
T Consensus 157 eyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999988876543 66899999999999999999999977 999999999999999999999999998654210
Q ss_pred CCc--------------------------------------------------CCCccccCCCCCCCCCCChhhhccCCC
Q 005616 495 TLY--------------------------------------------------LPSFHRSTAPKGSFPYADPEYHRTGVL 524 (688)
Q Consensus 495 ~~~--------------------------------------------------~~~~~~~~~~~Gt~~Y~APE~~~~~~~ 524 (688)
... .+...++...+||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 111123456789999999999999999
Q ss_pred CCcchHhHHHHHHHHHHhCCCCCCChhHHHH--HhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 525 TPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 525 s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
+.++|+|+|||+|||||.|..||.+.+.-.. .+....+ ...+.+ .++..+.+||.+.|.+||.+|-...
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l------~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~ 383 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL------KFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSK 383 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC------cCCCCC-cchhHHHHHHHHHhccChhhhhccc
Confidence 9999999999999999999999976554222 1111111 111222 6678999999999999999999854
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=310.09 Aligned_cols=257 Identities=26% Similarity=0.316 Sum_probs=204.0
Q ss_pred ccCHHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccC
Q 005616 331 EFSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACP 407 (688)
Q Consensus 331 ~~~~~el~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~ 407 (688)
-+.+.++..++++|.....||+|+||.||++... +..||+|++.... .....+.+|+.++.++ +|||+++++++|.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3667788888999999999999999999999885 7899999986532 2345678899999999 8999999999873
Q ss_pred C-------CceeEEeeCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCc
Q 005616 408 E-------AWSLVYEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 479 (688)
Q Consensus 408 ~-------~~~LV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~ 479 (688)
. ..++||||+++|+|.+++... .....+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 2 378999999999999988642 22346899999999999999999999965 999999999999999999
Q ss_pred eEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccC-----CCCCcchHhHHHHHHHHHHhCCCCCCChhHHH
Q 005616 480 SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-----VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR 554 (688)
Q Consensus 480 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-----~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~ 554 (688)
+||+|||++........ ......|+..|+|||++... .++.++|||||||++|+|++|+.||.......
T Consensus 167 ~kl~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~ 240 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240 (291)
T ss_pred EEEeecccchhcccccc------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence 99999999887643221 12345689999999987543 36899999999999999999999997544322
Q ss_pred HH--hhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 555 RA--VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 555 ~~--i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.. +..+....+ ..+......+.+|+.+||+.+|.+||++.+.+
T Consensus 241 ~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 285 (291)
T cd06639 241 TLFKIPRNPPPTL------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLL 285 (291)
T ss_pred HHHHHhcCCCCCC------CcccccCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 22 111111111 11223456799999999999999999998433
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=300.74 Aligned_cols=250 Identities=25% Similarity=0.382 Sum_probs=210.0
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc----c----hHHHHHHHHHHHcC-CCCceeeEecccCC
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ----G----QLEFQQEVRVLSKL-QHPHLVTLLGACPE 408 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~----~----~~~f~~E~~iL~~l-~HpnIV~l~g~~~~ 408 (688)
.-++|.....||.|+.++|.++... |..+|+|++...... . .+.-..|+.||+++ -||+|+++.+++..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3466778889999999999998775 888999998644221 1 23466899999999 59999999999976
Q ss_pred C--ceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecC
Q 005616 409 A--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 409 ~--~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFG 486 (688)
. .++|++.|+.|.|.++|...- .++++...+|+.++..|+.|||..+ ||||||||+|||+|++.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 5 678999999999999997653 5888999999999999999999966 9999999999999999999999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhc------cCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhh
Q 005616 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR------TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVS 558 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~------~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~ 558 (688)
++..+..+. +-...+|||+|+|||.+. ...|+..+|+||+|||||.||.|.+||..... +..++.
T Consensus 169 Fa~~l~~Ge-------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im 241 (411)
T KOG0599|consen 169 FACQLEPGE-------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM 241 (411)
T ss_pred eeeccCCch-------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH
Confidence 999987665 346789999999999763 34688999999999999999999999976665 345677
Q ss_pred cCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 559 CGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 559 ~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
.|++.- ...+|. +.+....+||.+||+.||.+|.|..+.+.+.+
T Consensus 242 eGkyqF----~speWa-dis~~~KdLIsrlLqVdp~~Ritake~LaHpf 285 (411)
T KOG0599|consen 242 EGKYQF----RSPEWA-DISATVKDLISRLLQVDPTKRITAKEALAHPF 285 (411)
T ss_pred hccccc----CCcchh-hccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence 777643 233453 56778999999999999999999997776655
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=304.27 Aligned_cols=232 Identities=30% Similarity=0.463 Sum_probs=185.2
Q ss_pred eeeccCceEEEEEEECCe------------EEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC-CCceeEEe
Q 005616 349 KVGQGGFGCVYKGEMLGR------------TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLVYE 415 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~g~------------~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~-~~~~LV~E 415 (688)
.||+|+||.||+|.+.+. .|++|.+...... ...|.+|+.+++.++||||++++|+|. ...++|||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e 80 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEE 80 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEE
Confidence 599999999999988632 4888887655433 678999999999999999999999874 45789999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-------ceEEeecCcc
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-------SSKICDFGIC 488 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-------~~KL~DFGla 488 (688)
|+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 81 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 81 YVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred cCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999876542 6889999999999999999999865 99999999999999887 7999999998
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhccC--CCCCcchHhHHHHHHHHHHh-CCCCCCChhHH--HHHhhcCccc
Q 005616 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG--VLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV--RRAVSCGKLS 563 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~--~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~~--~~~i~~~~l~ 563 (688)
...... ....++..|+|||++... .++.++|||||||++|+|++ |..||...... ...+....
T Consensus 156 ~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~-- 223 (259)
T cd05037 156 ITVLSR----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH-- 223 (259)
T ss_pred cccccc----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC--
Confidence 865431 234577889999998776 78999999999999999999 57777544211 11111110
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 564 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 564 ~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
..+......+.+++.+||..+|.+||++. ++++.|
T Consensus 224 --------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~il~~l 258 (259)
T cd05037 224 --------RLPMPDCAELANLINQCWTYDPTKRPSFR-AILRDL 258 (259)
T ss_pred --------CCCCCCchHHHHHHHHHhccChhhCCCHH-HHHHhc
Confidence 01111126889999999999999999998 555443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=324.80 Aligned_cols=252 Identities=27% Similarity=0.441 Sum_probs=214.3
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
-.-+..-.++||.|-||.||.|.|. .-.||||.++.+.+ ..++|..|+.+|+.++|||+|+|+|+|.. .+|||.|
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 3344555689999999999999997 77899999987654 46789999999999999999999999965 4899999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
||.+|+|.++|..... ..++-...+.++.||+.|+.||...+ +|||||...|.|+.++..+||+|||+++++..+.
T Consensus 344 fM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred cccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 9999999999987654 45666778899999999999999955 9999999999999999999999999999998765
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCccccccCCCCCC
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l~~~ldp~~~~ 572 (688)
... .....-.+.|.|||-+....++.|+|||+|||+|||+.| |..||.+.+ +++..+..|... +
T Consensus 420 YTA-----HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM--------~ 486 (1157)
T KOG4278|consen 420 YTA-----HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM--------D 486 (1157)
T ss_pred eec-----ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc--------c
Confidence 332 122334567999999999999999999999999999999 999997654 566666665332 4
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
.|..+++.+.+|++.||+++|.+||+++ ++-+.|+.+
T Consensus 487 ~PeGCPpkVYeLMraCW~WsPsDRPsFa-eiHqafEtm 523 (1157)
T KOG4278|consen 487 GPEGCPPKVYELMRACWNWSPSDRPSFA-EIHQAFETM 523 (1157)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCccHH-HHHHHHHHH
Confidence 5667888999999999999999999999 788888776
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.72 Aligned_cols=232 Identities=24% Similarity=0.385 Sum_probs=181.3
Q ss_pred eeeccCceEEEEEEEC--------------------------CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeE
Q 005616 349 KVGQGGFGCVYKGEML--------------------------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--------------------------g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l 402 (688)
.||+|+||.||+|.+. ...|++|++..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5999999999999752 13589999876554445578899999999999999999
Q ss_pred ecccCC--CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC--
Q 005616 403 LGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-- 478 (688)
Q Consensus 403 ~g~~~~--~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-- 478 (688)
+|+|.+ ..++||||+++|+|..++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 999854 4789999999999999886543 45789999999999999999999855 99999999999997654
Q ss_pred -----ceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHH-hCCCCCCChh
Q 005616 479 -----SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLL-TGRLPVGLAG 551 (688)
Q Consensus 479 -----~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELl-tG~~Pf~~~~ 551 (688)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|..||....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cCccceeeecCCccccccccc----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3899999987644221 23357888999998865 56899999999999999985 6999986433
Q ss_pred HH--HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHH
Q 005616 552 EV--RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 552 ~~--~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~ 606 (688)
.. ........ ..+......+.+++.+||+.+|.+||++. ++++.
T Consensus 227 ~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~-~il~~ 272 (274)
T cd05076 227 PSEKERFYEKKH----------RLPEPSCKELATLISQCLTYEPTQRPSFR-TILRD 272 (274)
T ss_pred hHHHHHHHHhcc----------CCCCCCChHHHHHHHHHcccChhhCcCHH-HHHHh
Confidence 21 11111100 11112235789999999999999999998 55443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=304.00 Aligned_cols=249 Identities=24% Similarity=0.312 Sum_probs=197.1
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc--hHHHHHHHHHHHcCCCCceeeEecc----cCCCceeEE
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGA----CPEAWSLVY 414 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~--~~~f~~E~~iL~~l~HpnIV~l~g~----~~~~~~LV~ 414 (688)
+|...+.|++|.||.||+|++. +..||+|+++...... --.-.+|+.+|.+++|||||.+-.+ -.+..||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4666788999999999999987 7889999998664322 1235799999999999999998654 456799999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
|||+ .+|...+.... .++...++..+..|+++||.|||.+. |+||||||+|+|+.+.|.+||+|||+|+.+...
T Consensus 157 e~~E-hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 157 EYVE-HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHH-hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9996 47888887655 57888999999999999999999987 999999999999999999999999999998765
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhh----cCccccccCC-
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGKLSSILDP- 568 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~----~~~l~~~ldp- 568 (688)
. ...+..+-|..|.|||.+.+. .|+...|+||+|||+.||+++++-|.+..++.+.-. -|.-.+.+-|
T Consensus 231 ~------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 231 L------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred c------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 3 235677899999999987665 699999999999999999999999976655433211 1111111100
Q ss_pred -------------------CCCCCCHH-HHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 569 -------------------LAGDWPTF-VARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 569 -------------------~~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
..+.++.. .+..-.+|+...|.+||.+|.|+.+.|
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L 359 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGL 359 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhh
Confidence 01111111 446778999999999999999999544
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=316.76 Aligned_cols=241 Identities=26% Similarity=0.298 Sum_probs=187.7
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||+++.. +..||||++..... .....+.+|..++..++|+||+++++++.+ ..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47888999999999999999886 78899999875322 223458889999999999999999999854 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999997643 35788999999999999999999966 999999999999999999999999999876543
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhcc-----CCCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCccccccC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRT-----GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILD 567 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~ld 567 (688)
... ......||+.|+|||++.+ +.++.++|||||||+||+|++|+.||...... ...+......-.+.
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p 230 (331)
T cd05624 156 GTV-----QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230 (331)
T ss_pred Cce-----eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCC
Confidence 211 1234569999999999875 56889999999999999999999999654322 22221111100001
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 005616 568 PLAGDWPTFVARRLVDLGLQCCELYGRERP 597 (688)
Q Consensus 568 p~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 597 (688)
......+..+.+|+.+|+..++ +|+
T Consensus 231 ----~~~~~~~~~~~~li~~ll~~~~-~~~ 255 (331)
T cd05624 231 ----SHITDVSEEAKDLIQRLICSRE-RRL 255 (331)
T ss_pred ----CccccCCHHHHHHHHHHccCch-hhc
Confidence 1111245688899999998655 443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=300.79 Aligned_cols=242 Identities=29% Similarity=0.470 Sum_probs=194.6
Q ss_pred eeeccCceEEEEEEEC-CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCcHHH
Q 005616 349 KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQD 424 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL~~ 424 (688)
+||.|+||.||++.+. ++.||+|.+...... ....|.+|+.++++++||||+++++++.+ ..++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 6999999999999887 899999998765544 45679999999999999999999999854 4789999999999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCcccc
Q 005616 425 RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRS 504 (688)
Q Consensus 425 ~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~ 504 (688)
++.... ..+++..++.++.+++.||.|||+.+ ++||||+|+|||++.++.+||+|||++.......... ..
T Consensus 82 ~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~----~~ 152 (251)
T cd05041 82 FLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV----SD 152 (251)
T ss_pred HHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCccee----cc
Confidence 986543 35789999999999999999999966 9999999999999999999999999998654322110 11
Q ss_pred CCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHHHHH
Q 005616 505 TAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARRL 581 (688)
Q Consensus 505 ~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~~~l 581 (688)
....++..|+|||++.++.++.++|||||||++|+|+| |..||..... ....+..+. ....+...+..+
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~ 224 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY--------RMPAPQLCPEEI 224 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC--------CCCCCccCCHHH
Confidence 22334677999999998899999999999999999999 8889865432 222222211 011233456689
Q ss_pred HHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 582 VDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 582 ~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
.+++.+||..+|.+||++. +|+..|+
T Consensus 225 ~~li~~~l~~~p~~Rp~~~-ell~~l~ 250 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFS-EIYNELQ 250 (251)
T ss_pred HHHHHHHhccChhhCcCHH-HHHHHhh
Confidence 9999999999999999998 6666554
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.51 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=196.0
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeCCC
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPN 419 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~ 419 (688)
|.....||.|+||.||++... +..||||.+..........+.+|+.++..++||||+++++.+. +..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333467999999999999875 7899999987655555667899999999999999999999874 458899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC
Q 005616 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
++|.+++.. ..+++..+..++.+|+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 104 ~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--- 173 (292)
T cd06658 104 GALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--- 173 (292)
T ss_pred CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc---
Confidence 999998743 34789999999999999999999966 99999999999999999999999999876543221
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHHHHH
Q 005616 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVAR 579 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~~~~ 579 (688)
......|++.|+|||++.+..++.++|||||||++|||++|+.||........... +...+.+.. ......+.
T Consensus 174 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~ 246 (292)
T cd06658 174 ---KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IRDNLPPRV-KDSHKVSS 246 (292)
T ss_pred ---cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCCCcc-ccccccCH
Confidence 12345689999999999988999999999999999999999999965433211111 001111111 11123456
Q ss_pred HHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 580 RLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 580 ~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
.+.+++.+||..||.+||++.+.+.+.+
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~~~ 274 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQHPF 274 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 7889999999999999999985554433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.88 Aligned_cols=193 Identities=26% Similarity=0.356 Sum_probs=157.2
Q ss_pred ceeeeccCceEEEEEEEC----CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC----CceeEEeeCC
Q 005616 347 SFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLVYEYLP 418 (688)
Q Consensus 347 ~~~LG~G~~G~Vy~g~~~----g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV~E~~~ 418 (688)
..+||+|+||.||+|... +..||+|.+.... ....+.+|+.++++++||||+++++++.. ..++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 5789999986543 23457889999999999999999998732 3689999986
Q ss_pred CCcHHHHhcccC------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee----CCCCceEEeecCcc
Q 005616 419 NGSLQDRLFRKS------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL----DSELSSKICDFGIC 488 (688)
Q Consensus 419 ~gsL~~~L~~~~------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL----d~~~~~KL~DFGla 488 (688)
++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 47777764321 2235889999999999999999999966 9999999999999 45688999999999
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCC
Q 005616 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVG 548 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~ 548 (688)
+........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.
T Consensus 160 ~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 160 RLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eccCCCCcc---ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 876533211 112345678999999998876 458999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=310.11 Aligned_cols=235 Identities=25% Similarity=0.381 Sum_probs=185.4
Q ss_pred eeeccCceEEEEEEEC---------CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeC
Q 005616 349 KVGQGGFGCVYKGEML---------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~---------g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
.||.|+||.||+|... ...||+|.+..........|.+|+.++..++|||||++++++. +..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 5999999999999774 2348889886655555567899999999999999999999984 4588999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCc--------eEEeecCccc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS--------SKICDFGICR 489 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~--------~KL~DFGla~ 489 (688)
++|+|..++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. ++++|||++.
T Consensus 82 ~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 82 KFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999999987654 35789999999999999999999965 999999999999987765 6899999886
Q ss_pred cccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCC-CCCCChhHHHHHhhcCccccccC
Q 005616 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGR-LPVGLAGEVRRAVSCGKLSSILD 567 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~-~Pf~~~~~~~~~i~~~~l~~~ld 567 (688)
..... ....+++.|+|||++.+ ..++.++|||||||++|+|++|. .||..............
T Consensus 157 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~------ 220 (258)
T cd05078 157 TVLPK----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED------ 220 (258)
T ss_pred ccCCc----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc------
Confidence 54321 23468889999999876 45899999999999999999985 66654333211110010
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 568 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 568 p~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
....|......+.+|+.+||+.+|++||++. ++++.|
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~il~~l 257 (258)
T cd05078 221 --RHQLPAPKWTELANLINQCMDYEPDFRPSFR-AIIRDL 257 (258)
T ss_pred --cccCCCCCcHHHHHHHHHHhccChhhCCCHH-HHHHhc
Confidence 1122223346789999999999999999999 565554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=311.71 Aligned_cols=250 Identities=23% Similarity=0.316 Sum_probs=191.5
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
++|.....||.|+||.||+|... +..||+|.+..... .....+.+|+.++..++||||+++++++.. ..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999885 78899999875433 234467889999999999999999999843 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
++ ++|..++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 58888886543 35789999999999999999999966 99999999999999999999999999976543221
Q ss_pred cCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH--hh-------cCcccccc
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VS-------CGKLSSIL 566 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--i~-------~~~l~~~l 566 (688)
......+++.|+|||++.+ ..++.++|||||||++|+|+||++||......... +. .......+
T Consensus 160 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 160 ------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred ------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 1234467899999998765 45889999999999999999999999643321110 00 00000000
Q ss_pred C---------CC-----CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 567 D---------PL-----AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 567 d---------p~-----~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
+ +. ........+..+.+|+.+||+.||.+|||+.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil 284 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 0 00 0011123456789999999999999999988433
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=321.10 Aligned_cols=239 Identities=25% Similarity=0.324 Sum_probs=187.4
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcC---CCCceeeEecccCC--CceeEEeeCCC
Q 005616 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKL---QHPHLVTLLGACPE--AWSLVYEYLPN 419 (688)
Q Consensus 350 LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l---~HpnIV~l~g~~~~--~~~LV~E~~~~ 419 (688)
||+|+||.||+|+.. +..||||++...... ....+..|..++..+ .||||+++++++.+ ..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999886 889999999654322 223455677777665 69999999998854 48999999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC
Q 005616 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--- 151 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--- 151 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---
Confidence 9999888654 35788999999999999999999966 99999999999999999999999999875432221
Q ss_pred CccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHH
Q 005616 500 SFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~ 576 (688)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... ....+..+...- + ...
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~-----~~~ 220 (330)
T cd05586 152 ---TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---P-----KNV 220 (330)
T ss_pred ---CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCC---C-----Ccc
Confidence 12456799999999998754 589999999999999999999999965432 233333332211 0 112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 577 VARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
.+..+.+|+.+||+.||.+||+..+.+.+.++
T Consensus 221 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 221 LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 45678899999999999999987644444444
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=303.98 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=194.5
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-----cchHHHHHHHHHHHcCCCCceeeEecccCC----Cc
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-----QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AW 410 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-----~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~ 410 (688)
.+|...+.||+|+||.||+|... +..||+|.+..... .....+.+|+.+++.++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999875 78999999865432 123458899999999999999999998743 36
Q ss_pred eeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
+++|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 78999999999999986543 4788999999999999999999865 99999999999999999999999999886
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCC
Q 005616 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~ 570 (688)
........ .......|+..|+|||++.+..++.++|||||||++|+|++|+.||.............. .+..
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~-----~~~~ 227 (266)
T cd06651 156 LQTICMSG---TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT-----QPTN 227 (266)
T ss_pred cccccccC---CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc-----CCCC
Confidence 54321110 011234688999999999988999999999999999999999999975433222111110 1112
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
...+......+..++ +||..+|++||++.+.+
T Consensus 228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil 259 (266)
T cd06651 228 PQLPSHISEHARDFL-GCIFVEARHRPSAEELL 259 (266)
T ss_pred CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHh
Confidence 234445566777777 68889999999998433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=326.13 Aligned_cols=247 Identities=27% Similarity=0.404 Sum_probs=203.7
Q ss_pred eeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCCC--ceeEEeeCCCCcHH
Q 005616 348 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEA--WSLVYEYLPNGSLQ 423 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~~--~~LV~E~~~~gsL~ 423 (688)
-+||+|.||+||-|++. ...+|||-+.........-+..|+.+.+.|+|.|||+++|.|.++ .-|.||-++||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 36899999999999987 456899999877666666788999999999999999999999665 34799999999999
Q ss_pred HHhcccCCCCCC--CHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeC-CCCceEEeecCccccccCCCCcCCC
Q 005616 424 DRLFRKSNVSPL--LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD-SELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 424 ~~L~~~~~~~~l--~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd-~~~~~KL~DFGla~~~~~~~~~~~~ 500 (688)
++|...= +|+ ++..+-.+..||+.||.|||.+. |||||||-+|||++ -.|.+||+|||.++.+..-..
T Consensus 661 sLLrskW--GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP---- 731 (1226)
T KOG4279|consen 661 SLLRSKW--GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP---- 731 (1226)
T ss_pred HHHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc----
Confidence 9997643 344 67788889999999999999977 99999999999996 579999999999998754331
Q ss_pred ccccCCCCCCCCCCChhhhccC--CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH-HhhcCccccccCCCCCCCCHHH
Q 005616 501 FHRSTAPKGSFPYADPEYHRTG--VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR-AVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~~~--~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~-~i~~~~l~~~ldp~~~~~~~~~ 577 (688)
.+....||..|||||++..+ .|+.++|||||||++.||.||++||-..+.... +..-|.+. .-.+.|...
T Consensus 732 --~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK-----vHP~iPeel 804 (1226)
T KOG4279|consen 732 --CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK-----VHPPIPEEL 804 (1226)
T ss_pred --cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee-----cCCCCcHHH
Confidence 34567899999999999665 699999999999999999999999964443222 23333322 123678899
Q ss_pred HHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 578 ARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 578 ~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
+.+...+|++|+.++|.+||++.+.+.+.+-..
T Consensus 805 saeak~FilrcFepd~~~R~sA~~LL~DpFlq~ 837 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQH 837 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHHhccCccccc
Confidence 999999999999999999999997776655433
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=304.82 Aligned_cols=244 Identities=26% Similarity=0.357 Sum_probs=198.0
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeC
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
.|...+.||.|+||.||+|.+. +..||||.+..... .....+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999875 78999999875532 344578999999999999999999999854 488999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++|+|.+++.. .++++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 99999998854 35788999999999999999999965 99999999999999999999999999977643321
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHHH
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~~ 577 (688)
......++..|+|||++.+..++.++|||||||++|||+||..||............ ........+...
T Consensus 157 -----~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------~~~~~~~~~~~~ 225 (277)
T cd06640 157 -----KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI------PKNNPPTLTGEF 225 (277)
T ss_pred -----ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh------hcCCCCCCchhh
Confidence 123456889999999999889999999999999999999999999644322111100 000112334457
Q ss_pred HHHHHHHHHHcccCCCCCCCCCcHHHHH
Q 005616 578 ARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 578 ~~~l~~Li~~Cl~~dP~~RPs~~e~l~~ 605 (688)
+..+.+++.+||+.+|.+||++.+.+.+
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 7889999999999999999999855443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.61 Aligned_cols=245 Identities=25% Similarity=0.396 Sum_probs=194.4
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
++|...+.||+|+||.||++... |..||+|++.... ......|.+|+.++..++||||+++++++.. ..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46777789999999999999886 8899999986543 2345679999999999999999999999854 57899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++++|.+++... .++++..+..++.+++.||.|||+.. +++||||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 9999999988653 35899999999999999999999742 49999999999999999999999999987553221
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH------HHHhhcCccccccCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV------RRAVSCGKLSSILDPLA 570 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~------~~~i~~~~l~~~ldp~~ 570 (688)
.....|+..|+|||++.+..++.++|||||||++|+|+||..||...... ...+. ..+..++....
T Consensus 159 -------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 230 (284)
T cd06620 159 -------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL-DLLQQIVQEPP 230 (284)
T ss_pred -------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH-HHHHHHhhccC
Confidence 13457899999999998889999999999999999999999999743220 00000 00011111111
Q ss_pred CCCCH-HHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 571 GDWPT-FVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 571 ~~~~~-~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
...+. .++..+.+|+.+||+.||.+||++.
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~ 261 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQ 261 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHH
Confidence 11111 2566899999999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=307.82 Aligned_cols=244 Identities=32% Similarity=0.483 Sum_probs=194.0
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchH--HHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeC
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~--~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
|...+.||+|+||+||++... +..||+|++......... ...+|+.++.+++||||+++++++. ...++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567789999999999999997 678999999887654433 3456999999999999999999984 4578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++++|.+++... ..+++..+..++.|++.||.+||+.+ |+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~-- 152 (260)
T PF00069_consen 81 PGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENN-- 152 (260)
T ss_dssp TTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--
T ss_pred cccccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--
Confidence 999999999732 45789999999999999999999966 9999999999999999999999999997642111
Q ss_pred CCCccccCCCCCCCCCCChhhhc-cCCCCCcchHhHHHHHHHHHHhCCCCCCChh--HHHHHhhcCccccccCCCCCCCC
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHR-TGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~-~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~i~~~~l~~~ldp~~~~~~ 574 (688)
.......+|..|+|||++. +..++.++||||||+++|+|++|..||.... .....+............ ...
T Consensus 153 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 226 (260)
T PF00069_consen 153 ----ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS--QQS 226 (260)
T ss_dssp ----SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT--TSH
T ss_pred ----cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc--ccc
Confidence 1235667899999999998 8889999999999999999999999998651 111111111100000000 000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCCcH
Q 005616 575 TFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 575 ~~~~~~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
......+.+++.+||+.||.+||++.+
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~ 253 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEE 253 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHH
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHH
Confidence 011378999999999999999999884
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.52 Aligned_cols=246 Identities=25% Similarity=0.337 Sum_probs=205.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEeccc--CCCceeE
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLV 413 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~LV 413 (688)
.+.|+.-++||+||||.||-++.. |+-+|.|.+.+... .+.....+|-.||.+++.|.||.|-.+| .+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 366788899999999999988765 89999999866543 3344578999999999999999998888 4679999
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
+..|+||+|.-+|...++ ..+++..++.++.+|+.||.+||... ||.||+||+|||||+.|+++|+|+|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999988765 56899999999999999999999966 99999999999999999999999999998876
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~ 573 (688)
+. .....+||.+|||||++.++.|+...|+|||||+||||+.|+.||....+- +....+...+-.....+
T Consensus 340 g~-------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK---vk~eEvdrr~~~~~~ey 409 (591)
T KOG0986|consen 340 GK-------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK---VKREEVDRRTLEDPEEY 409 (591)
T ss_pred CC-------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh---hhHHHHHHHHhcchhhc
Confidence 54 235569999999999999999999999999999999999999999643320 11111111111123356
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
+..++++...|....|..||.+|-.-+
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhccCC
Confidence 778889999999999999999998766
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=309.41 Aligned_cols=255 Identities=24% Similarity=0.251 Sum_probs=199.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||.|+||.||+|... +..||||.+...... ....+..|+.++..++||||+++++.+.+ ..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999886 789999999765433 34568899999999999999999999854 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+.+++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999886442 246899999999999999999999966 999999999999999999999999998765432
Q ss_pred CCcC-----------------------CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh
Q 005616 495 TLYL-----------------------PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 551 (688)
Q Consensus 495 ~~~~-----------------------~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~ 551 (688)
.... +.........||..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1110 00011223468999999999999899999999999999999999999997554
Q ss_pred HHHHHh--hcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 552 EVRRAV--SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 552 ~~~~~i--~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
...... ...... . ......+..+.+++.+||..+|.+||+....+.+.|
T Consensus 237 ~~~~~~~~~~~~~~------~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 237 RDETFSNILKKEVT------F-PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred hHHHHHHHhcCCcc------C-CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 322211 111110 0 011125678999999999999999999663433333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=303.65 Aligned_cols=251 Identities=24% Similarity=0.411 Sum_probs=197.3
Q ss_pred cccceeeeccCceEEEEEEEC-----CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--------
Q 005616 344 FSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------- 408 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~-----g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------- 408 (688)
|...+.||+|+||.||+|.+. +..||||++..... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456678999999999999863 57899999876432 335568899999999999999999998732
Q ss_pred CceeEEeeCCCCcHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeec
Q 005616 409 AWSLVYEYLPNGSLQDRLFRKS---NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DF 485 (688)
..+++++|+.+|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 1368899999999998875321 2235789999999999999999999965 999999999999999999999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCcc
Q 005616 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKL 562 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l 562 (688)
|+++........ .......+++.|++||.+....++.++|||||||++|+|++ |++||..... ....+..+..
T Consensus 158 g~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05074 158 GLSKKIYSGDYY----RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233 (273)
T ss_pred cccccccCCcce----ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 999876433211 11223446678999999999999999999999999999999 8899864432 2222322211
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 563 ~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
. ..+...+..+.+++.+||+.+|++||++. ++...|+.+
T Consensus 234 ~--------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~-~~~~~l~~~ 272 (273)
T cd05074 234 L--------KQPPDCLEDVYELMCQCWSPEPKCRPSFQ-HLRDQLELI 272 (273)
T ss_pred C--------CCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHhh
Confidence 1 11223456899999999999999999998 787777754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=310.02 Aligned_cols=239 Identities=23% Similarity=0.360 Sum_probs=193.8
Q ss_pred cceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeCCCCc
Q 005616 346 ESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNGS 421 (688)
Q Consensus 346 ~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~gs 421 (688)
....||.|+||.||++... +..||||.+..........+.+|+.++..++||||++++++|. +..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999875 8899999997665555667899999999999999999999884 45889999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCc
Q 005616 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~ 501 (688)
|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~----- 172 (297)
T cd06659 105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----- 172 (297)
T ss_pred HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-----
Confidence 9997744 35789999999999999999999966 99999999999999999999999999876543221
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH--HhhcCccccccCCCCCCCCHHHHH
Q 005616 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSCGKLSSILDPLAGDWPTFVAR 579 (688)
Q Consensus 502 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~i~~~~l~~~ldp~~~~~~~~~~~ 579 (688)
......|++.|+|||++.+..++.++|||||||++|||++|+.||........ .+...... .. ..+...+.
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----~~-~~~~~~~~ 245 (297)
T cd06659 173 -KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-----KL-KNAHKISP 245 (297)
T ss_pred -cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-----Cc-cccCCCCH
Confidence 12345689999999999988999999999999999999999999965443222 11111110 00 11123456
Q ss_pred HHHHHHHHcccCCCCCCCCCcHHH
Q 005616 580 RLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 580 ~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.+.+++.+||+.+|.+||++.+.+
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll 269 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELL 269 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHh
Confidence 789999999999999999998444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=327.71 Aligned_cols=247 Identities=19% Similarity=0.222 Sum_probs=189.7
Q ss_pred hcCcccceeeeccCceEEEEEEEC----CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~----g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
..+|.....||.|+||.||++... +..||+|.+... ..+.+|+.+|..++|||||++++++.. ..++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999764 467999987643 235689999999999999999998853 578999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
|++. ++|.+++... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 166 e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9985 6788877332 46899999999999999999999965 999999999999999999999999999866543
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh------HHHHHhh---cCccc--
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG------EVRRAVS---CGKLS-- 563 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~------~~~~~i~---~~~l~-- 563 (688)
... .......||+.|+|||++....++.++|||||||++|||++|+.||.... .+...+. .....
T Consensus 239 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 239 PDT----PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred ccc----ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 211 12235679999999999999999999999999999999999999985321 1111111 00000
Q ss_pred ------------cccCCCCCC--CC-----HHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 564 ------------SILDPLAGD--WP-----TFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 ------------~~ldp~~~~--~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
......... .+ ......+.+++.+||..||.+||++.+.+
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l 373 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDIL 373 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHh
Confidence 000000000 01 12345788999999999999999999544
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=311.37 Aligned_cols=194 Identities=25% Similarity=0.351 Sum_probs=157.1
Q ss_pred ceeeeccCceEEEEEEEC----CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC----CCceeEEeeCC
Q 005616 347 SFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP----EAWSLVYEYLP 418 (688)
Q Consensus 347 ~~~LG~G~~G~Vy~g~~~----g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~----~~~~LV~E~~~ 418 (688)
..+||+|+||.||+|... +..||+|.+.... ....+.+|+.+++.++||||++++++|. ...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999864 4679999986543 2345789999999999999999999873 24689999987
Q ss_pred CCcHHHHhccc------CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee----CCCCceEEeecCcc
Q 005616 419 NGSLQDRLFRK------SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL----DSELSSKICDFGIC 488 (688)
Q Consensus 419 ~gsL~~~L~~~------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL----d~~~~~KL~DFGla 488 (688)
+ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 666665421 12235889999999999999999999965 9999999999999 56689999999999
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCC
Q 005616 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGL 549 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~ 549 (688)
+........ ........||+.|+|||++.+ ..++.++|||||||++|||+||++||..
T Consensus 160 ~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCccc---ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 876543211 112245578999999998876 4589999999999999999999999953
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=301.62 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=200.5
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC----CceeEE
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLVY 414 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV~ 414 (688)
+|...+.||.|+||.||++... |..||+|.+..... .....+..|+.+++.++||||+++++++.. ..+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777889999999999999875 78899999876543 234568899999999999999999997732 368999
Q ss_pred eeCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccC--CCceEeCCCCCCceeeCCCCceEEeecCccccc
Q 005616 415 EYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSK--PEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 415 E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~ 491 (688)
||+++++|.+++... ....++++..++.++.+++.||.|||..+ ..+|+|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998654 22357899999999999999999999432 245999999999999999999999999999877
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCC
Q 005616 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPL 569 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~ 569 (688)
..... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ....+..+..
T Consensus 161 ~~~~~------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------- 227 (265)
T cd08217 161 GHDSS------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF------- 227 (265)
T ss_pred cCCcc------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC-------
Confidence 54331 12345689999999999988899999999999999999999999975432 2222322222
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
...+...+..+.+++.+||+.+|.+||++.+.+
T Consensus 228 -~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il 260 (265)
T cd08217 228 -RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELL 260 (265)
T ss_pred -CCCccccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 233445667899999999999999999998443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=304.36 Aligned_cols=250 Identities=28% Similarity=0.440 Sum_probs=199.3
Q ss_pred cCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--Cce
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWS 411 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~ 411 (688)
.+|.....||.|+||.||+|+.. ...|++|.+...... ....|.+|+.++.+++||||++++++|.+ ..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46788899999999999999864 357999988655433 34679999999999999999999999854 588
Q ss_pred eEEeeCCCCcHHHHhcccCCC------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeec
Q 005616 412 LVYEYLPNGSLQDRLFRKSNV------SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DF 485 (688)
+||||+++|+|.+++...... ..+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998765422 26899999999999999999999966 999999999999999999999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCcc
Q 005616 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKL 562 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l 562 (688)
|++........ .......++..|+|||.+.+..+++++||||||+++|+|++ |..||.... .+...+..+.+
T Consensus 162 ~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 236 (275)
T cd05046 162 SLSKDVYNSEY-----YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236 (275)
T ss_pred ccccccCcccc-----cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc
Confidence 99875432221 12234456788999999988889999999999999999999 888986432 22233332322
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 563 ~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
... .+..++..+.+++.+||+.+|.+||++. +++..|
T Consensus 237 ~~~-------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~-~~l~~l 273 (275)
T cd05046 237 ELP-------VPEGCPSRLYKLMTRCWAVNPKDRPSFS-ELVSAL 273 (275)
T ss_pred CCC-------CCCCCCHHHHHHHHHHcCCCcccCCCHH-HHHHHh
Confidence 211 1223456899999999999999999998 565554
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=310.15 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=192.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC----C---Cce
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP----E---AWS 411 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~----~---~~~ 411 (688)
+-.|...+++|.|+||.||+|... +..||||+.-.+.. .-.+|+.+|+.++|||||+|+.+|. . ...
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 345677799999999999999986 68999998754432 1236999999999999999998872 2 245
Q ss_pred eEEeeCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC-CceEEeecCccc
Q 005616 412 LVYEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICR 489 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~-~~~KL~DFGla~ 489 (688)
||||||+. +|...+... .....++...+.-+..||++||.|||+.+ |+||||||.|||+|.+ |.+||||||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999976 677777642 12245666778889999999999999965 9999999999999976 999999999999
Q ss_pred cccCCCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhc---------
Q 005616 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC--------- 559 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~--------- 559 (688)
.+..+.. ......|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+.+.+....
T Consensus 175 ~L~~~ep-------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 175 VLVKGEP-------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred eeccCCC-------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 9876542 2345578889999977664 7999999999999999999999999765443322111
Q ss_pred -----C--ccccccCCC--CCC----CCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 560 -----G--KLSSILDPL--AGD----WPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 560 -----~--~l~~~ldp~--~~~----~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
. +..+.-.|. ... +....+.++.+|+.+++.++|.+|.+..+.+.+.+
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f 308 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF 308 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence 1 100111111 111 33456778999999999999999999987766544
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=299.81 Aligned_cols=242 Identities=29% Similarity=0.400 Sum_probs=196.7
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-----cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-----QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-----~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
+|...+.||+|+||.||+|... +..|++|.+..... .....+.+|+.+++.++||||+++++++.+ ..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667788999999999999885 88999999865432 234568999999999999999999999854 47899
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
|||+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998654 35789999999999999999999966 99999999999999999999999999887643
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCC-CCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGV-LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~ 572 (688)
.. ......|++.|++||.+.... ++.++|||||||++|+|++|..||............+.... ...
T Consensus 155 ~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~~ 222 (258)
T cd06632 155 FS-------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-----LPP 222 (258)
T ss_pred cc-------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-----CCC
Confidence 32 123456899999999987766 89999999999999999999999975543322222221111 112
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
.+..+...+.+++.+||+.+|.+||++.+.
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~ 252 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAEL 252 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHH
Confidence 233456788999999999999999998843
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=301.12 Aligned_cols=245 Identities=25% Similarity=0.329 Sum_probs=195.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-----cchHHHHHHHHHHHcCCCCceeeEecccCC----Cc
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-----QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AW 410 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-----~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~ 410 (688)
.+|...+.||+|+||.||+|... |..||||.+..... .....+.+|+.++.+++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999875 78999998864321 123468899999999999999999998854 36
Q ss_pred eeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
++||||+++++|.+++.... .+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 78999999999999986543 4788889999999999999999966 99999999999999999999999999886
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCC
Q 005616 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~ 570 (688)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||............. ..+..
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-----~~~~~ 227 (265)
T cd06652 156 LQTICLS---GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA-----TQPTN 227 (265)
T ss_pred ccccccc---ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh-----cCCCC
Confidence 5432111 011234568999999999988889999999999999999999999997543322211110 11112
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCCcH
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
...+......+.+++.+|+. +|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~ 257 (265)
T cd06652 228 PVLPPHVSDHCRDFLKRIFV-EAKLRPSADE 257 (265)
T ss_pred CCCchhhCHHHHHHHHHHhc-ChhhCCCHHH
Confidence 23455667788999999995 9999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=308.83 Aligned_cols=257 Identities=24% Similarity=0.332 Sum_probs=203.4
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEe--cCCccchHHHHHHHHHHHcCCCCceeeEecccC-------
Q 005616 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLY--SHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP------- 407 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~--~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~------- 407 (688)
.....|...+.||.|+||.|..+... |..||||++. .......++..+|+++|+.++|+|||.+++.+.
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 44556666789999999999999886 8999999997 455556678899999999999999999999872
Q ss_pred CCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCc
Q 005616 408 EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 408 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGl 487 (688)
.+.|+|+|+| +.+|...+.... .|+...+..++.|+++||.|+|+.+ |+||||||+|+|++.+..+||+|||+
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 2479999999 678888886543 4888999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhh-ccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH-----------
Q 005616 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH-RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR----------- 555 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~-~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~----------- 555 (688)
|+..... +.....+..+.|..|.|||++ ....|+...||||.||||.||++|++-|.+.+.+.+
T Consensus 172 AR~~~~~----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 172 ARYLDKF----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred eeecccc----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence 9988643 112235677899999999976 456899999999999999999999999865443221
Q ss_pred ------HhhcCccccccCCC--------CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 556 ------AVSCGKLSSILDPL--------AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 556 ------~i~~~~l~~~ldp~--------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
.+...+....+... ..-+| ...+..++|+.+||..||.+|+|+.+.+.+..
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPY 312 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPY 312 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence 11111111111110 00112 45568899999999999999999997765543
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.98 Aligned_cols=240 Identities=24% Similarity=0.349 Sum_probs=205.9
Q ss_pred cCcccceeeeccCceEEEEEEE--CCeEEEEEEEecCCccch--HHHHHHHHHHHcCCCCceeeEeccc--CCCceeEEe
Q 005616 342 CNFSESFKVGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQ--LEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~--~g~~VAIK~l~~~~~~~~--~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~LV~E 415 (688)
+=|...+.||+|.|++|-++++ .|..||||++.+...... ..+.+|+..|+.++|||||+||.+. +..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3466678899999999999876 599999999988776544 4688999999999999999999998 456999999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee-CCCCceEEeecCccccccCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL-DSELSSKICDFGICRLVTED 494 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL-d~~~~~KL~DFGla~~~~~~ 494 (688)
.-++|+|.+++.+.. ..+.+....+++.||+.|+.|+|..+ +|||||||+||.+ ..-|-+||.|||++..+.++
T Consensus 98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999998876 46888999999999999999999988 9999999999876 56689999999999887765
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCC-CcchHhHHHHHHHHHHhCCCCCCChhHHHH--HhhcCccccccCCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLT-PKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSCGKLSSILDPLAG 571 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s-~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~i~~~~l~~~ldp~~~ 571 (688)
. +-+..+|+..|.|||++.+..|+ |++||||||||||-|++|++||....+... ++..-+ .
T Consensus 173 ~-------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK---------Y 236 (864)
T KOG4717|consen 173 K-------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK---------Y 236 (864)
T ss_pred c-------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc---------c
Confidence 4 34677899999999999999886 799999999999999999999976554322 222221 2
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
..|..++.++.+||..||..||++|.+..+.
T Consensus 237 tvPshvS~eCrdLI~sMLvRdPkkRAslEeI 267 (864)
T KOG4717|consen 237 TVPSHVSKECRDLIQSMLVRDPKKRASLEEI 267 (864)
T ss_pred cCchhhhHHHHHHHHHHHhcCchhhccHHHH
Confidence 4678899999999999999999999998743
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.11 Aligned_cols=249 Identities=26% Similarity=0.346 Sum_probs=196.7
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC----CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV~ 414 (688)
++|...+.||.|++|.||+|.+. +..||+|.+..... .....+.+|+.++++++||||++++++|.+ ..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999985 78899999875433 345578999999999999999999998832 478999
Q ss_pred eeCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 415 EYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 415 E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
||+++++|.+++... .....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887542 22356788999999999999999999966 99999999999999999999999999876543
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh-------HHHHHhhcCcccccc
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG-------EVRRAVSCGKLSSIL 566 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~-------~~~~~i~~~~l~~~l 566 (688)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..||.... .....+.......+.
T Consensus 158 ~~--------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd06621 158 SL--------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229 (287)
T ss_pred cc--------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc
Confidence 22 123457889999999999999999999999999999999999997541 111111111111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 567 dp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
+.. ......+..+.+++.+||..+|.+|||+.+.+
T Consensus 230 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil 264 (287)
T cd06621 230 DEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDML 264 (287)
T ss_pred cCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 110 00112456899999999999999999998443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=300.69 Aligned_cols=242 Identities=27% Similarity=0.382 Sum_probs=196.5
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|...+.||.|+||.||++... +..||||.+..... .....+.+|+.+++.++||||+++++.+.. ..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999998875 78899999876543 234578999999999999999999998743 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC-CceEEeecCccccccCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDT 495 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~-~~~KL~DFGla~~~~~~~ 495 (688)
+++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999997643 245899999999999999999999965 9999999999999855 468999999998765432
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHH--HHhhcCccccccCCCCCCC
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~i~~~~l~~~ldp~~~~~ 573 (688)
......|+..|+|||.+.+..++.++||||||+++|+|++|..||....... ..+..+.. ...
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 221 (256)
T cd08220 157 -------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF--------API 221 (256)
T ss_pred -------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC--------CCC
Confidence 1234568999999999998889999999999999999999999997543211 11111111 122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
+...+..+.+++.+||+.+|.+||++.+.+
T Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll 251 (256)
T cd08220 222 SDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251 (256)
T ss_pred CCCcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 334566899999999999999999999544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=299.27 Aligned_cols=242 Identities=21% Similarity=0.280 Sum_probs=198.4
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|+..+.||.|+||.||.++.. +..|++|.+.... ......+.+|+.++++++|+||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5788899999999999888775 7889999986543 3345578899999999999999999999854 47889999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++|+|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999987653 246899999999999999999999966 99999999999999999999999999987654331
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~ 574 (688)
......|++.|+|||++.+..++.++||||||+++|+|++|..||..... ....+..+.... .+
T Consensus 157 ------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--------~~ 222 (256)
T cd08221 157 ------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP--------VV 222 (256)
T ss_pred ------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--------Cc
Confidence 12345689999999999888899999999999999999999999965332 222222332221 12
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 575 TFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 575 ~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
...+..+.+++.+||..+|.+||++.+.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~l 250 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEV 250 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHH
Confidence 3456689999999999999999998843
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=299.76 Aligned_cols=254 Identities=25% Similarity=0.289 Sum_probs=200.6
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEee
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
++|...+.||.|+||.||+|... +..||+|++..... .....+.+|+.+++.++||||+++++.+. +..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47888999999999999999874 78899999875443 34567899999999999999999999874 357899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++++|.+++........+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976543356899999999999999999999966 99999999999999999999999999987764432
Q ss_pred cCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHh--hcCccccccCCCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV--SCGKLSSILDPLAGDW 573 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i--~~~~l~~~ldp~~~~~ 573 (688)
.. ........|+..|+|||++... .++.++|||||||++|+|++|+.||.......... ..+... .+.. ...
T Consensus 158 ~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~--~~~ 232 (267)
T cd06610 158 RT--RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP-SLET--GAD 232 (267)
T ss_pred cc--ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCC-CcCC--ccc
Confidence 11 0112345689999999998777 78999999999999999999999997543321111 111100 0000 001
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
...++..+.+++.+||..||.+||++.+.+
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll 262 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELL 262 (267)
T ss_pred cccccHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 124567899999999999999999988433
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=302.93 Aligned_cols=248 Identities=27% Similarity=0.350 Sum_probs=198.1
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccCC-------
Q 005616 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE------- 408 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~------- 408 (688)
.++++|...+.||.|+||.||+|... +..|++|++..... ....|.+|+.++.++ .||||++++++|..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45789999999999999999999985 67899999876543 346789999999999 79999999999832
Q ss_pred -CceeEEeeCCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecC
Q 005616 409 -AWSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFG 486 (688)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 2689999999999999886532 2356899999999999999999999966 9999999999999999999999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-----CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH--hhc
Q 005616 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-----GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSC 559 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--i~~ 559 (688)
++........ ......|++.|+|||++.. ..++.++|||||||+||+|++|+.||......... +..
T Consensus 159 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 232 (275)
T cd06608 159 VSAQLDSTLG------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR 232 (275)
T ss_pred cceecccchh------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc
Confidence 9876543221 2234568999999998753 34788999999999999999999999644322111 111
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 560 ~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
+... ....+...+..+.+|+.+||..||.+|||+.+.
T Consensus 233 ~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~l 269 (275)
T cd06608 233 NPPP------TLKSPENWSKKFNDFISECLIKNYEQRPFMEEL 269 (275)
T ss_pred cCCC------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 1111 111223356789999999999999999999843
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=299.37 Aligned_cols=246 Identities=24% Similarity=0.373 Sum_probs=203.5
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecC--CccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSH--NMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~--~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
+++|+....||+|.|+.||++... |+.+|+|++... ...+.+++.+|+.|-..|+|||||+|.....+ -.|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456777788999999999998775 888999987544 23456778999999999999999999998854 378999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC---CCceEEeecCccccc
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLV 491 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~---~~~~KL~DFGla~~~ 491 (688)
|+|.|++|..-+... ..+++..+-..+.||+.+|.|+|.++ |||||+||.|+||-. ..-+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999997665443 23566778899999999999999977 999999999999953 456999999999998
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCC--hhHHHHHhhcCccccccCCC
Q 005616 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGL--AGEVRRAVSCGKLSSILDPL 569 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~--~~~~~~~i~~~~l~~~ldp~ 569 (688)
..+. .....+|||+|||||++...+|+..+|||+.|||||-||.|.+||.. ...+...+..|.+.- .
T Consensus 164 ~~g~-------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~----~ 232 (355)
T KOG0033|consen 164 NDGE-------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDY----P 232 (355)
T ss_pred CCcc-------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCC----C
Confidence 8443 34678999999999999999999999999999999999999999976 334666777665431 1
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
...|+ .+++...+|+.+||..||.+|.|+.+.+-
T Consensus 233 ~~~w~-~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 SPEWD-TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CcccC-cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 22343 57788999999999999999999986553
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=327.89 Aligned_cols=248 Identities=21% Similarity=0.290 Sum_probs=190.3
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEe
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYE 415 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E 415 (688)
...+|.....||+|+||.||++.+. +..||||... ...+.+|+.+|++++|||||++++++. +..++||+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3557999999999999999999986 6889999643 224678999999999999999999874 35789999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
++. ++|..++.... ..++|..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++......
T Consensus 241 ~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 241 KYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred ccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 995 68888775433 36899999999999999999999966 9999999999999999999999999998764322
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCCh----------hHHHHHhhcCcccc-
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA----------GEVRRAVSCGKLSS- 564 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~----------~~~~~~i~~~~l~~- 564 (688)
.. .......||+.|+|||++.+..++.++|||||||+||||++|..|+... ..+...+.......
T Consensus 315 ~~----~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 315 ST----PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred cc----ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 11 1123457999999999999999999999999999999999987664211 12223332221110
Q ss_pred ccC--------------------C--CCCCCCH--HHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 565 ILD--------------------P--LAGDWPT--FVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 565 ~ld--------------------p--~~~~~~~--~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.+. + ....|.. .....+.+|+.+||+.||.+|||+.+.|
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL 453 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELL 453 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHh
Confidence 000 0 0001111 1234788999999999999999998443
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=303.18 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=193.5
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
++|.....||+|+||.||+|.+. |..||+|++..... .....+.+|+.++..++||||+++++++.. ..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999986 78999999865432 234568899999999999999999999854 4789999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|+++++|..++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 99999998876543 35899999999999999999999965 9999999999999999999999999998765432
Q ss_pred CcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhh----cCcc--------
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGKL-------- 562 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~----~~~l-------- 562 (688)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||........... .+.+
T Consensus 155 ~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 155 D------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred c------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 1 1234467889999998865 5688999999999999999999999975433211110 0000
Q ss_pred ------ccccCCCCCC------CCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 563 ------SSILDPLAGD------WPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 563 ------~~~ldp~~~~------~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
.....+.... .-...+..+.+|+.+||+.+|++||++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 280 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL 280 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHH
Confidence 0000010000 011235678999999999999999999843
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=297.96 Aligned_cols=243 Identities=34% Similarity=0.548 Sum_probs=197.2
Q ss_pred ccceeeeccCceEEEEEEECC------eEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005616 345 SESFKVGQGGFGCVYKGEMLG------RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 345 ~~~~~LG~G~~G~Vy~g~~~g------~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
.....||.|+||.||++...+ ..||+|++...... ....+..|+.++..++||||+++++++.+ ..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999998863 78999999766544 56679999999999999999999999854 5889999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999876432 12899999999999999999999966 9999999999999999999999999998776543
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HHHHHhhcCccccccCCCCCC
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~i~~~~l~~~ldp~~~~ 572 (688)
.. ......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.... .+...+..+... .
T Consensus 158 ~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------~ 224 (258)
T smart00219 158 YY-----KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL--------P 224 (258)
T ss_pred cc-----ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--------C
Confidence 21 1112347889999999988899999999999999999998 888886432 233333333221 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHH
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~ 605 (688)
.+...+..+.+++.+||..+|.+|||+. ++++
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~-~ll~ 256 (258)
T smart00219 225 KPENCPPEIYKLMLQCWAEDPEDRPTFS-ELVE 256 (258)
T ss_pred CCCcCCHHHHHHHHHHCcCChhhCcCHH-HHHh
Confidence 1223567899999999999999999998 4443
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.09 Aligned_cols=254 Identities=21% Similarity=0.237 Sum_probs=197.8
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCCC--ceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPEA--WSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~~--~~LV~ 414 (688)
++|...+.||.|+||.||++... +..||||.+..... .....+.+|+.++..++||||+++++.+.+. .++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888899999999999999886 68899999876543 2334688999999999999999999988543 68999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999999654 35889999999999999999999965 999999999999999999999999998743211
Q ss_pred CCc---------CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--HHHHHhhcCccc
Q 005616 495 TLY---------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLS 563 (688)
Q Consensus 495 ~~~---------~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~i~~~~l~ 563 (688)
... ...........|+..|+|||++....++.++|||||||++|||++|..||.... .+......+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 234 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 100 000011123467889999999988899999999999999999999999996432 222222222211
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 564 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 564 ~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
.+.. +...+..+.+++.+||+.+|.+||++. .+.+.|+
T Consensus 235 ---~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~-~~~~ll~ 272 (305)
T cd05609 235 ---WPEG---DEALPADAQDLISRLLRQNPLERLGTG-GAFEVKQ 272 (305)
T ss_pred ---CCCc---cccCCHHHHHHHHHHhccChhhccCcc-CHHHHHh
Confidence 1111 113456789999999999999999986 4444444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=322.75 Aligned_cols=239 Identities=27% Similarity=0.366 Sum_probs=196.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc---hHHHHHHHHHHHcCCCCceeeEeccc--CCCceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~---~~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~LV~ 414 (688)
.-|...+-||.|+||-||-+++. ...||||.+.....+. ..++..|+..|.+++|||+|.+-|+| ....+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34667788999999999999885 6789999998776554 34688999999999999999999999 34588999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||| -||-.|+|.-.. .++-..++..|+.+.+.||+|||+.+ .||||||..||||++.|.|||+|||.|....+.
T Consensus 106 EYC-lGSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHH-hccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 999 467777775544 57888999999999999999999977 999999999999999999999999999887653
Q ss_pred CCcCCCccccCCCCCCCCCCChhhh---ccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH--hhcCccccccCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYH---RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPL 569 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~---~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--i~~~~l~~~ldp~ 569 (688)
..++|||.|||||++ ..+.|+-|+||||||++-.||.-.++|+.....+... +....- |.
T Consensus 180 ----------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes-----Pt 244 (948)
T KOG0577|consen 180 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----PT 244 (948)
T ss_pred ----------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC-----CC
Confidence 466899999999976 4578999999999999999999999997654433222 222211 11
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
+ ...+.+..+..++..||+.-|.+|||..+.+
T Consensus 245 L--qs~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 245 L--QSNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred C--CCchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 1 1335678899999999999999999987433
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=299.61 Aligned_cols=243 Identities=24% Similarity=0.342 Sum_probs=197.9
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|...+.||+|+||.||++... |..||||.+..... .....+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999875 78999999875432 334578999999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++++|.+++..... ..+++..++.|+.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999998865432 35789999999999999999999965 99999999999999999999999999986643221
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~ 574 (688)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+... ..+
T Consensus 157 ------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~--------~~~ 222 (256)
T cd08218 157 ------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP--------PVS 222 (256)
T ss_pred ------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC--------CCc
Confidence 12234688999999999988999999999999999999999999864332 11122222211 123
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 575 TFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 575 ~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
...+..+.+++.+||+.+|.+||++.+.+
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl 251 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence 34567899999999999999999999544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.86 Aligned_cols=245 Identities=27% Similarity=0.396 Sum_probs=201.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
++|...+.||.|++|.||+|... +..|+||++..... .....+.+|+.++.+++||||+++++++.. ..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888899999999999999886 88999999876654 345679999999999999999999999854 58899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
+++++|.+++... ..+++..++.++.+++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999764 468899999999999999999999 76 9999999999999999999999999998765433
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--HHHHHhhcCccccccCCCCCCC
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~i~~~~l~~~ldp~~~~~ 573 (688)
. ......++..|+|||.+.+..++.++||||||+++|+|+||..||.... .....+..- ........
T Consensus 155 ~------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-----~~~~~~~~ 223 (264)
T cd06623 155 D------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-----CDGPPPSL 223 (264)
T ss_pred C------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH-----hcCCCCCC
Confidence 1 1134568899999999999999999999999999999999999997553 211111110 01111122
Q ss_pred CHH-HHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 574 PTF-VARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 574 ~~~-~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
+.. ++..+.+++.+||..+|.+||++.+.+
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll 254 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELL 254 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 333 567899999999999999999998544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.37 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=193.6
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--c--------chHHHHHHHHHHHcCCCCceeeEecccCC--
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--Q--------GQLEFQQEVRVLSKLQHPHLVTLLGACPE-- 408 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~--------~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-- 408 (688)
+|...+.||.|+||.||+|... |..||||.+..... . ..+.+.+|+.++..++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999774 78999998854211 1 12357889999999999999999999854
Q ss_pred CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcc
Q 005616 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla 488 (688)
..++||||+++++|.+++... ..+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 578999999999999998765 36888999999999999999999965 999999999999999999999999999
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhccCC--CCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhc--Ccccc
Q 005616 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV--LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC--GKLSS 564 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~--~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~--~~l~~ 564 (688)
......... .......|+..|+|||++.... ++.++||||||+++|+|++|..||............ .....
T Consensus 156 ~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (272)
T cd06629 156 KKSDDIYDN----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP 231 (272)
T ss_pred ccccccccc----cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC
Confidence 765432110 1123456899999999987654 899999999999999999999999654433222211 11111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 565 ~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
.+ .......++..+.+++.+||..+|.+||++.+.
T Consensus 232 ~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 266 (272)
T cd06629 232 PI---PPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266 (272)
T ss_pred cC---CccccccCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 11 111222356789999999999999999998843
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=311.64 Aligned_cols=253 Identities=18% Similarity=0.211 Sum_probs=188.9
Q ss_pred ceeeecc--CceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeCC
Q 005616 347 SFKVGQG--GFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLP 418 (688)
Q Consensus 347 ~~~LG~G--~~G~Vy~g~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~ 418 (688)
..+||+| +||+||++... |..||||++...... ....+.+|+.+++.++|||||+++++|. +..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 78999999886 789999999765332 2345778999999999999999999984 45889999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
+|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++++|||.+..........
T Consensus 83 ~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 83 YGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999865432 35899999999999999999999966 9999999999999999999999998765432211100
Q ss_pred C-CccccCCCCCCCCCCChhhhcc--CCCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCccccccCCC----
Q 005616 499 P-SFHRSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPL---- 569 (688)
Q Consensus 499 ~-~~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~ldp~---- 569 (688)
. .........++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ......+.+...++..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 0 0001123457788999999876 46899999999999999999999999643221 1111112111111100
Q ss_pred ---------------------------------CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 570 ---------------------------------AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 570 ---------------------------------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.......++..+.+|+.+||+.||.+|||+.+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell 305 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL 305 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh
Confidence 0011223456899999999999999999998443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.29 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=205.0
Q ss_pred cCcccceeeeccCceEEEEEEECC-eEEEEEEEecCCccch-HHHHHHHHHHHcCCCCceeeEeccc--CCCceeEEeeC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEMLG-RTVAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~g-~~VAIK~l~~~~~~~~-~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~LV~E~~ 417 (688)
....+.++||+|-||.|-++...| ..||||+++.....+. .+|.+|+++|.+|+|||||.|+|+| .+.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 344567889999999999999986 8999999998876554 7899999999999999999999999 45689999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++|+|.++|....... +.-....+|+.||+.|++||.+.+ +|||||.+.|+|+|.++++||+|||+++.+-.+..+
T Consensus 618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999998774322 344567789999999999999977 999999999999999999999999999966544422
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh--CCCCCCChhHHHHHhhcCccccccCC-CCCCCC
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT--GRLPVGLAGEVRRAVSCGKLSSILDP-LAGDWP 574 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt--G~~Pf~~~~~~~~~i~~~~l~~~ldp-~~~~~~ 574 (688)
+.....+-...|||||.+..+++|.++|||+||++|||+++ ...||....+-.-.-+.+.+..--.+ .....|
T Consensus 694 ----~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 694 ----RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred ----eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 12233455678999999999999999999999999999876 77898754331111111111111000 112346
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHH
Q 005616 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 575 ~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~ 609 (688)
.-++..+.+|+++||..+-.+||++. .|...|..
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe-~lh~~lq~ 803 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFE-QLHLFLQE 803 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHH-HHHHHHHH
Confidence 66788999999999999999999998 55555543
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=304.39 Aligned_cols=249 Identities=24% Similarity=0.304 Sum_probs=191.3
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|.....||.|+||.||+|... |..||||.+..... .....+.+|+.++.+++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5788899999999999999885 78999999865432 233568899999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+. ++|..++..... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 688888865432 46899999999999999999999966 99999999999999999999999999876543221
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCC-CCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH---hhcCc-ccccc-----
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGV-LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSCGK-LSSIL----- 566 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---i~~~~-l~~~l----- 566 (688)
......+++.|+|||++.+.. ++.++|||||||++|+|+||+.||......... +.... ....+
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 156 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred ------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 123345788999999886644 688999999999999999999999654332111 11000 00000
Q ss_pred -------------CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 567 -------------DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 567 -------------dp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
..............+.+++.+||+.||.+||++.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 278 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA 278 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHH
Confidence 000001111244678899999999999999999843
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=307.52 Aligned_cols=250 Identities=25% Similarity=0.343 Sum_probs=193.7
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
++|...+.||+|+||.||+|.+. +..||+|++...... ....+.+|+.++..++||||++++++|.+ ..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999985 789999998654332 34568899999999999999999999954 4789999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|+++++|..+.... ..++|..+..++.+|+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 99999998876543 24899999999999999999999965 9999999999999999999999999998764432
Q ss_pred CcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhh----cCccc-------
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGKLS------- 563 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~----~~~l~------- 563 (688)
. ......++..|+|||++.+ ..++.++||||||+++|+|++|.+||........... .+.+.
T Consensus 155 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 155 E------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred c------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 1 1234568899999998865 4578899999999999999999999864332211000 00000
Q ss_pred -------cccCCCCC------CCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 564 -------SILDPLAG------DWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 -------~~ldp~~~------~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
....+... ...+..+..+.+|+.+||+.+|.+||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 281 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHh
Confidence 00000000 01123466899999999999999999998433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=300.24 Aligned_cols=247 Identities=23% Similarity=0.399 Sum_probs=196.5
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc------chHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ------GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~------~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
+|.....||+|+||.||+|... +..||+|++...... ....+.+|+.+++.++||||+++++++.+ ..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4777889999999999999874 889999998754321 23568899999999999999999999854 4789
Q ss_pred EEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-ceEEeecCccccc
Q 005616 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLV 491 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-~~KL~DFGla~~~ 491 (688)
||||+++++|.+++... .++++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999998654 36889999999999999999999966 99999999999998776 5999999999877
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH---HHHHhhcCccccccCC
Q 005616 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRRAVSCGKLSSILDP 568 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~---~~~~i~~~~l~~~ldp 568 (688)
........ .......|+..|+|||++.+..++.++||||||+++|+|++|..||..... .......... .
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~ 227 (268)
T cd06630 155 AAKGTGAG--EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA-----T 227 (268)
T ss_pred ccccccCC--ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc-----C
Confidence 54321110 112344689999999999888999999999999999999999999963321 1111110000 1
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 569 ~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
.....+...+..+.+++.+||..+|.+||++.+.
T Consensus 228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~l 261 (268)
T cd06630 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261 (268)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 1224455677889999999999999999999843
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.55 Aligned_cols=249 Identities=26% Similarity=0.373 Sum_probs=200.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
++|...+.||.|+||.||+|... +..||+|.+..........+.+|+.++..++||||++++++|. +..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67888899999999999999864 7889999987655555667899999999999999999999984 4588999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++++|.+++... .+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 999999998643 4788999999999999999999966 99999999999999999999999999876643321
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHHH
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~~ 577 (688)
......|++.|+|||.+....++.++|||||||++|+|++|+.||............+... ......+...
T Consensus 171 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~~~ 241 (293)
T cd06647 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG----TPELQNPEKL 241 (293)
T ss_pred -----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC----CCCCCCcccc
Confidence 1234468899999999988889999999999999999999999997544322111111000 0001122345
Q ss_pred HHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 578 ARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 578 ~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
+..+.+++.+||..+|.+||++.+.+.+.+
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h~~ 271 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 667999999999999999999986555433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.04 Aligned_cols=240 Identities=28% Similarity=0.389 Sum_probs=195.0
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCC
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 418 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~ 418 (688)
|.....||.|+||.||+|... +..||||.+..... .....|.+|+.++.+++||||+++++++.+ ..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 667788999999999999875 78999999865433 334568899999999999999999999853 4889999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
+++|..++.. ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 86 ~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 86 GGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence 9999998854 35789999999999999999999965 99999999999999999999999999876643221
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHH--HHhhcCccccccCCCCCCCCHH
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~i~~~~l~~~ldp~~~~~~~~ 576 (688)
......|+..|+|||++.+..++.++|||||||++|+|++|..||....... ..+..+.. ...+..
T Consensus 157 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~ 224 (277)
T cd06641 157 ----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP--------PTLEGN 224 (277)
T ss_pred ----hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC--------CCCCcc
Confidence 1234568899999999988889999999999999999999999997543221 11111111 122334
Q ss_pred HHHHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 577 VARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
++..+.+++.+||+.+|.+||++.+.+.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 5677899999999999999999985443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=302.66 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=195.8
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCc-eeeEecccCC--------
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPH-LVTLLGACPE-------- 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~Hpn-IV~l~g~~~~-------- 408 (688)
..|...++||+|.||+||+|+.. |+.||+|++...... .-....+|+.+|..++|+| ||.|++++..
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34666678999999999999886 889999999776442 2334689999999999999 9999999832
Q ss_pred CceeEEeeCCCCcHHHHhcccCCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCc
Q 005616 409 AWSLVYEYLPNGSLQDRLFRKSNV-SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGl 487 (688)
..++|+||++ .+|..++...... ..++...+..++.||+.||+|||+++ |+||||||.||||+.+|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 4679999995 5888888765432 34666889999999999999999976 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccc-
Q 005616 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSI- 565 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~- 565 (688)
|+...-... ..+..++|..|.|||++.+. .|++..||||+|||+.||+++++-|.+..++.+......+...
T Consensus 167 Ara~~ip~~------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 167 ARAFSIPMR------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred HHHhcCCcc------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 996653221 24567899999999998776 7999999999999999999999999766654433221111000
Q ss_pred -----------cC--CCCCCCC------HH---HHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 566 -----------LD--PLAGDWP------TF---VARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 566 -----------ld--p~~~~~~------~~---~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.+ +.-..|. .. ......+++.+|++.+|..|.++...+
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al 300 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGAL 300 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHh
Confidence 00 0001111 11 113789999999999999999998443
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.31 Aligned_cols=242 Identities=25% Similarity=0.430 Sum_probs=194.2
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCC---CCceeeEecccCC--CceeEE
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ---HPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~---HpnIV~l~g~~~~--~~~LV~ 414 (688)
.|...+.||.|+||.||+|.+. +..||||.+..... .....+.+|+.+++.++ |||+++++++|.+ ..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677789999999999999985 78999999875433 34557889999999997 9999999998854 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++++|.+++... .+++..++.++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999988542 6889999999999999999999966 999999999999999999999999999876543
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~ 573 (688)
.. ......|+..|+|||++.++ .++.++|||||||++|+|++|..||............... ..+ ..
T Consensus 155 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~~~---~~ 222 (277)
T cd06917 155 SS------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS---KPP---RL 222 (277)
T ss_pred cc------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC---CCC---CC
Confidence 31 12345689999999988654 5789999999999999999999999754432211111100 001 11
Q ss_pred CH-HHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 574 PT-FVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 574 ~~-~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
+. ..+..+.+++.+||+.||++||++.+.+
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il 253 (277)
T cd06917 223 EDNGYSKLLREFVAACLDEEPKERLSAEELL 253 (277)
T ss_pred CcccCCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence 11 1456899999999999999999988544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=318.93 Aligned_cols=190 Identities=21% Similarity=0.304 Sum_probs=160.5
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
....+|...+.||.|+||.||+|... +..||+|+.... .+..|+.++.+++|||||+++++|.+ ..++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34568999999999999999999986 578999975332 23569999999999999999999854 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+. ++|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 67888775533 46899999999999999999999966 999999999999999999999999999754322
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 547 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf 547 (688)
. ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 P-------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c-------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 123456999999999999999999999999999999999865543
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=291.85 Aligned_cols=242 Identities=27% Similarity=0.425 Sum_probs=199.8
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeCC
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLP 418 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~ 418 (688)
+|...+.||.|++|.||++... +..|++|++..........+.+|+.+++.++||||+++++++. ...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677789999999999999986 7889999998766556678999999999999999999999884 45889999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
+++|.+++.... ..+++..+..++.+++.||.|||..+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999987653 46899999999999999999999965 99999999999999999999999999987654321
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH--hhcCccccccCCCCCCCCHH
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--i~~~~l~~~ldp~~~~~~~~ 576 (688)
.....|+..|++||++....++.++||||||+++|+|++|..||......... ......... ..+..
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~ 222 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL------RNPEK 222 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCc------Ccccc
Confidence 23456889999999998888999999999999999999999999755322221 111111111 11122
Q ss_pred HHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 577 VARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
.+..+.+++.+||+.||.+||++.+.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~ 248 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQL 248 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHH
Confidence 35689999999999999999999843
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.51 Aligned_cols=248 Identities=24% Similarity=0.400 Sum_probs=195.6
Q ss_pred CcccceeeeccCceEEEEEEEC---CeEEEEEEEecCCc----------cchHHHHHHHHHHHc-CCCCceeeEecccCC
Q 005616 343 NFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHNM----------QGQLEFQQEVRVLSK-LQHPHLVTLLGACPE 408 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~---g~~VAIK~l~~~~~----------~~~~~f~~E~~iL~~-l~HpnIV~l~g~~~~ 408 (688)
+|.....||+|+||.||+|.+. +..+|+|.+..... .....+.+|+.++.+ ++||||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4777889999999999999985 47899998864321 123457788888875 799999999998854
Q ss_pred --CceeEEeeCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeec
Q 005616 409 --AWSLVYEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 409 --~~~LV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DF 485 (688)
..++||||+++++|.+++... .....+++..++.++.+++.||.|||+.+ +|+|+||+|+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 478999999999999987542 22356899999999999999999999632 4999999999999999999999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCccc
Q 005616 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLS 563 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~ 563 (688)
|++....... ......|+..|+|||++.+..++.++||||||+++|+|++|++||...... ...+..+...
T Consensus 159 g~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 159 GLAKQKQPES-------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred cceeeccccc-------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence 9998765432 123556899999999999888999999999999999999999999654332 1222222211
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 564 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 564 ~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
+.. ....+..+.+++.+||+.||++||++. ++...+
T Consensus 232 ----~~~---~~~~~~~l~~li~~cl~~~p~~Rp~~~-e~~~~~ 267 (269)
T cd08528 232 ----PLP---EGMYSEDVTDVITSCLTPDAEARPDII-QVSAMI 267 (269)
T ss_pred ----cCC---cccCCHHHHHHHHHHCCCCCccCCCHH-HHHHHh
Confidence 111 112456899999999999999999998 565554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.24 Aligned_cols=235 Identities=29% Similarity=0.388 Sum_probs=195.6
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|.....||.|+||.||++... +..||+|++..... .....+.+|+.++.+++||||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999885 78999999875432 234568899999999999999999999854 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998665 35788999999999999999999965 999999999999999999999999998876543
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~ 572 (688)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||..... ....+..+.. .
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~ 216 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV---------R 216 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc---------c
Confidence 1344689999999999888899999999999999999999999975442 2222222221 2
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
.+...+..+.+++.+||..||.+||+..
T Consensus 217 ~~~~~~~~l~~li~~~l~~~p~~R~~~~ 244 (290)
T cd05580 217 FPSFFSPDAKDLIRNLLQVDLTKRLGNL 244 (290)
T ss_pred CCccCCHHHHHHHHHHccCCHHHccCcc
Confidence 2333467899999999999999999543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.68 Aligned_cols=240 Identities=23% Similarity=0.362 Sum_probs=200.3
Q ss_pred eeeeccCceEEEEEEEC--CeEEEEEEEecC----CccchHHHHHHHHHHHcCCCCceeeEecccCC----CceeEEeeC
Q 005616 348 FKVGQGGFGCVYKGEML--GRTVAIKMLYSH----NMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLVYEYL 417 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~----~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV~E~~ 417 (688)
..||+|+|-+||+|.+. |-.||.-.++.. .......|..|+.+|+.|+|||||++|.++.+ ...+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 46999999999999886 667775444322 22344679999999999999999999999844 266899999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC-CceEEeecCccccccCCCC
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~-~~~KL~DFGla~~~~~~~~ 496 (688)
..|+|..++.+.+ .++...+..|+.||++||.|||+.. +||||||||.+||||+.+ |.|||+|+|+|.......
T Consensus 126 TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 126 TSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred cCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 9999999998765 4667889999999999999999998 589999999999999865 899999999999886543
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCC---ChhHHHHHhhcCccccccCCCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVG---LAGEVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~---~~~~~~~~i~~~~l~~~ldp~~~~~ 573 (688)
...+.|||.|||||... ..|+..+||||||++|+||+|+..||. ....+++.+..|.....+...
T Consensus 201 -------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV---- 268 (632)
T KOG0584|consen 201 -------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV---- 268 (632)
T ss_pred -------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc----
Confidence 24579999999999887 789999999999999999999999996 455678888888665544322
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
-.+++.++|.+|+.. ..+||++.+.|.+.+=
T Consensus 269 ---~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff 299 (632)
T KOG0584|consen 269 ---KDPEVREFIEKCLAT-KSERLSAKELLKDPFF 299 (632)
T ss_pred ---CCHHHHHHHHHHhcC-chhccCHHHHhhChhh
Confidence 134789999999999 9999999976665553
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.43 Aligned_cols=249 Identities=25% Similarity=0.324 Sum_probs=192.9
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-----chHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-----GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~-----~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
+|...+.||.|+||.||+|... |..||||.+...... ....+..|+.++..++||||+++++++.+ ..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677789999999999999885 789999999765433 23457789999999999999999999854 47899
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
|||+ +|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999986543 36899999999999999999999966 99999999999999999999999999987654
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH---hhc-C--------
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSC-G-------- 560 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---i~~-~-------- 560 (688)
... ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||......... ... +
T Consensus 155 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 155 PNR------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228 (298)
T ss_pred CCc------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence 321 1233457889999998854 46789999999999999999998887543322110 000 0
Q ss_pred ---ccccccCCC------CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 561 ---KLSSILDPL------AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 561 ---~l~~~ldp~------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.+....... ........+..+.+++.+||..+|++||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l 280 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQAL 280 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 000000000 0011123467899999999999999999998433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=300.11 Aligned_cols=247 Identities=25% Similarity=0.370 Sum_probs=185.4
Q ss_pred eeeccCceEEEEEEEC-C---eEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCc
Q 005616 349 KVGQGGFGCVYKGEML-G---RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~-g---~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gs 421 (688)
.||+|+||.||+|... + ..+++|.+..... .....|.+|+.++..++||||++++++|.+ ..++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999754 2 3466777654432 345679999999999999999999999854 4789999999999
Q ss_pred HHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCC
Q 005616 422 LQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 422 L~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~ 500 (688)
|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 154 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---- 154 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence 999997643 2345677788899999999999999965 99999999999999999999999999864322111
Q ss_pred ccccCCCCCCCCCCChhhhcc-------CCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCC
Q 005616 501 FHRSTAPKGSFPYADPEYHRT-------GVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~~-------~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~ 570 (688)
........|+..|+|||++.. ..++.++|||||||++|||++ |..||..... ....+..+......++.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ- 233 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc-
Confidence 011234568899999998743 245789999999999999997 5778854332 22222223223333332
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
.+......+.+++..|| .+|++||++. +|++.|
T Consensus 234 --~~~~~~~~~~~l~~~c~-~~P~~Rp~~~-~i~~~l 266 (268)
T cd05086 234 --LELPYSERWYEVLQFCW-LSPEKRATAE-EVHRLL 266 (268)
T ss_pred --cCCCCcHHHHHHHHHHh-hCcccCCCHH-HHHHHh
Confidence 22234567888999999 6799999999 566554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.64 Aligned_cols=245 Identities=24% Similarity=0.349 Sum_probs=188.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHH-HHcCCCCceeeEecccC--CCceeEEe
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRV-LSKLQHPHLVTLLGACP--EAWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~i-L~~l~HpnIV~l~g~~~--~~~~LV~E 415 (688)
++|.....||+|+||.||+|... |..||||++..... .....+..|+.+ ++.++||||+++++++. ...++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999986 88999999876532 234456667665 55668999999999984 45889999
Q ss_pred eCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 416 YLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 416 ~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
|++ |+|.+++... .....+++..++.++.||+.||.|||+.. +++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6888777543 22356899999999999999999999852 4999999999999999999999999998866432
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhcc----CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH---HhhcCccccccC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRT----GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSCGKLSSILD 567 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~----~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~---~i~~~~l~~~ld 567 (688)
. ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||........ .+..+....+
T Consensus 158 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 228 (283)
T cd06617 158 V-------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQL-- 228 (283)
T ss_pred c-------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCC--
Confidence 2 1233568899999998754 4578999999999999999999999964322111 1111111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 568 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 568 p~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
....++..+.+++.+||..+|.+||++.+.+
T Consensus 229 -----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il 259 (283)
T cd06617 229 -----PAEKFSPEFQDFVNKCLKKNYKERPNYPELL 259 (283)
T ss_pred -----CccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 0113456899999999999999999998443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.02 Aligned_cols=241 Identities=23% Similarity=0.341 Sum_probs=195.1
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeCCC
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPN 419 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~ 419 (688)
|.....||.|++|.||++... +..|++|++..........+.+|+.++..++||||+++++++. +..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444578999999999999875 7889999987655555567889999999999999999999874 458899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC
Q 005616 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
++|.+++.. ..+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--- 170 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--- 170 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc---
Confidence 999999865 34789999999999999999999966 99999999999999999999999998876543221
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCccccccCCCCCCCCHHH
Q 005616 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~ldp~~~~~~~~~ 577 (688)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ...+..+.. +.. ..+...
T Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~-----~~~-~~~~~~ 241 (285)
T cd06648 171 ---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP-----PKL-KNLHKV 241 (285)
T ss_pred ---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCC-----CCC-cccccC
Confidence 123456899999999998888999999999999999999999998654322 111222211 111 112234
Q ss_pred HHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 578 ARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 578 ~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
+..+.+++.+||+.+|.+||++.+.+
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il 267 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELL 267 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHc
Confidence 56899999999999999999998443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=302.27 Aligned_cols=243 Identities=28% Similarity=0.390 Sum_probs=196.8
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
++|...+.||.|+||.||++.+. +..||+|.+..... .....+.+|+.++++++||||++++++|.. ..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777789999999999999986 78999999876543 344578999999999999999999998844 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
+++++|.+++.... ..+++..+..++.+++.||.|||+ .+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999987653 468889999999999999999999 65 9999999999999999999999999987664322
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh----HHHHHhhcCccccccCCCCC
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG----EVRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~----~~~~~i~~~~l~~~ldp~~~ 571 (688)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||.... .....+.. .+.....
T Consensus 156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~ 222 (265)
T cd06605 156 --------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY-----IVNEPPP 222 (265)
T ss_pred --------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH-----HhcCCCC
Confidence 112668899999999999999999999999999999999999996542 11111110 0111111
Q ss_pred CCCHH-HHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 572 DWPTF-VARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 572 ~~~~~-~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
..+.. ++..+.+++.+||..+|.+||++.+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 254 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKEL 254 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 12222 56789999999999999999998843
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=303.23 Aligned_cols=250 Identities=25% Similarity=0.360 Sum_probs=194.8
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|...+.||.|+||.||+|.+. |..||||++..... .....+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777889999999999999985 78999999976543 234579999999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+ +++|.+++.... .++++..+..++.+|+.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999886544 56899999999999999999999966 99999999999999999999999999987654321
Q ss_pred cCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH---hhc-Cc----------
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSC-GK---------- 561 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---i~~-~~---------- 561 (688)
.......|+..|+|||++.+. .++.++||||||+++|+|++|.+||......... +.. +.
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 155 -----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred -----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence 112345689999999988654 4689999999999999999998888644321110 000 00
Q ss_pred ----cccccCCCC-----CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 562 ----LSSILDPLA-----GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 562 ----l~~~ldp~~-----~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
...+..+.. ..........+.+|+.+||+.+|.+||++.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l 280 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEAL 280 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHh
Confidence 000000000 011123457899999999999999999998443
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.88 Aligned_cols=248 Identities=27% Similarity=0.462 Sum_probs=208.4
Q ss_pred cccceeeeccCceEEEEEEEC----C--eEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCCC-ceeEEe
Q 005616 344 FSESFKVGQGGFGCVYKGEML----G--RTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPEA-WSLVYE 415 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~----g--~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~~-~~LV~E 415 (688)
....++||.|-||.||+|.+. | -.||||..+.+. ..+.+.|..|.-++++++|||||+|+|+|.+. .+||||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmE 470 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVME 470 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEe
Confidence 344678999999999999885 3 249999998754 45667799999999999999999999999765 789999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
.++-|.|..+|..+. ..|+......++.||+.||.|||+.. +|||||...|||+...--+||+|||+++.+.++.
T Consensus 471 L~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 471 LAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred cccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 999999999998765 46788888999999999999999955 9999999999999999999999999999998766
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCC
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~ 572 (688)
.+ ..+...-...|||||-+....++.++|||-|||++||++. |..||.+..+ +...+..|. ...
T Consensus 546 yY-----kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe--------RlP 612 (974)
T KOG4257|consen 546 YY-----KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE--------RLP 612 (974)
T ss_pred hh-----hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC--------CCC
Confidence 43 3344455678999999999999999999999999999988 9999986553 222233332 224
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
.|+.+++.|..|+.+||.++|.+||.+. ++...|..+
T Consensus 613 ~P~nCPp~LYslmskcWayeP~kRPrft-ei~~~lsdv 649 (974)
T KOG4257|consen 613 CPPNCPPALYSLMSKCWAYEPSKRPRFT-EIKAILSDV 649 (974)
T ss_pred CCCCCChHHHHHHHHHhccCcccCCcHH-HHHHHHHHH
Confidence 5777888999999999999999999998 676666554
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=301.93 Aligned_cols=247 Identities=24% Similarity=0.368 Sum_probs=202.2
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEE
Q 005616 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 414 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~ 414 (688)
..+++|.....||.|+||.||+|.+. +..|++|++..... ....+.+|+.++..++|+||++++++|. +..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35677888899999999999999987 88999999976554 5667899999999999999999999884 4588999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999997654 46899999999999999999999965 999999999999999999999999998765432
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHh--hcCccccccCCCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV--SCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i--~~~~l~~~ldp~~~~ 572 (688)
.. ......++..|++||++.+..++.++|||||||++|+|++|+.||.......... ....... ..
T Consensus 170 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------~~ 237 (286)
T cd06614 170 KS------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP------LK 237 (286)
T ss_pred hh------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------Cc
Confidence 21 1234458889999999988889999999999999999999999997554332221 1111111 11
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.+..++..+.+++.+||+.+|..||++.+.+
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 268 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELL 268 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 1222456899999999999999999998443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.72 Aligned_cols=250 Identities=22% Similarity=0.292 Sum_probs=193.4
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeC
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
+|...+.||.|++|.||+|... |..||||.+...... ....+.+|+.+++.++||||++++++|.+ ..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999985 889999999765433 34567889999999999999999999854 479999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++ +|.+++........+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 88888766544456899999999999999999999965 99999999999999999999999999976543221
Q ss_pred CCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH---HhhcC------------c
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSCG------------K 561 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~---~i~~~------------~ 561 (688)
......+++.|++||++.+. .++.++|||||||++|+|++|+.||........ ..... .
T Consensus 156 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 156 -----TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred -----ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 12344678999999988654 578999999999999999999999964432111 00000 0
Q ss_pred cccccC-------CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 562 LSSILD-------PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 562 l~~~ld-------p~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
...... .......+..+..+.+++.+|++.||.+||++.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 278 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDA 278 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHH
Confidence 000000 00011112345678999999999999999998743
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=301.69 Aligned_cols=248 Identities=22% Similarity=0.271 Sum_probs=188.5
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|...+.||.|+||.||+|... |..||+|.+...... ....+.+|+.+++.++||||+++++++.+ ..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999985 889999998754322 23467889999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+. ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 47777765433 45899999999999999999999966 99999999999999999999999999986543221
Q ss_pred cCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhc-----C--------cc
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC-----G--------KL 562 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~-----~--------~l 562 (688)
......+++.|+|||++.+. .++.++|||||||++|+|+||..|+............ + .+
T Consensus 155 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 155 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred ------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence 12345678999999988664 4799999999999999999998886422211111000 0 00
Q ss_pred ccccCC-----CC-----CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 563 SSILDP-----LA-----GDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 563 ~~~ldp-----~~-----~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
....+. .. .......+..+.+|+.+||+.||.+|||+.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~i 278 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA 278 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHH
Confidence 000000 00 01112345788999999999999999999843
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=298.24 Aligned_cols=238 Identities=26% Similarity=0.308 Sum_probs=197.0
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
+|...+.||.|+||.||+|... +..||+|.+..... .....+.+|+.++++++||||+++++++.+ ..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788899999999999999886 88999999976533 335678999999999999999999998854 4889999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|+.+++|.+++... .++++..+..|+.+++.||.|||..+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998654 36889999999999999999999966 9999999999999999999999999988765432
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCC
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~ 573 (688)
......|+..|+|||++.+..++.++||||||+++|+|++|..||..... .......... .....
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~ 221 (258)
T cd05578 155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------ADVLY 221 (258)
T ss_pred -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------ccccC
Confidence 12345688999999999988899999999999999999999999975432 1111111110 11223
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCC
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDI 599 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~ 599 (688)
+...+..+.+++.+||..||.+||++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcCCc
Confidence 34456789999999999999999999
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=296.46 Aligned_cols=242 Identities=27% Similarity=0.382 Sum_probs=195.8
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|...+.||.|+||.||+|... |..||+|.+..... .....+.+|+.+++.++||||+++++.+.+ ..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999886 78899999876432 344568899999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-ceEEeecCccccccCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLVTEDT 495 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-~~KL~DFGla~~~~~~~ 495 (688)
+++++|.+++..... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999876432 35799999999999999999999966 99999999999999885 46999999998765432
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH--HhhcCccccccCCCCCCC
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~i~~~~l~~~ldp~~~~~ 573 (688)
. ......|++.|+|||++.+..++.++||||||+++|+|++|..||........ .+..+.. . ..
T Consensus 157 ~------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~----~~ 222 (257)
T cd08225 157 E------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF----A----PI 222 (257)
T ss_pred c------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC----C----CC
Confidence 1 12334689999999999888999999999999999999999999975432111 1111111 1 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
+...+..+.+++.+||..+|++||++.+.
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 251 (257)
T cd08225 223 SPNFSRDLRSLISQLFKVSPRDRPSITSI 251 (257)
T ss_pred CCCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 22345689999999999999999999843
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=296.09 Aligned_cols=248 Identities=27% Similarity=0.383 Sum_probs=196.5
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
+|...+.||+|+||.||+|... +..|++|.+...... ....+.+|+.++..++|+||+++++++. +..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777889999999999999874 789999999876553 4567999999999999999999999884 357899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++++|.+++... ..+++..+..|+.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999998754 34788999999999999999999966 99999999999999999999999999987754432
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCC---CCCcchHhHHHHHHHHHHhCCCCCCChhHHHH-HhhcCccccccCCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGV---LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR-AVSCGKLSSILDPLAGD 572 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~---~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~-~i~~~~l~~~ldp~~~~ 572 (688)
... .......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||........ ...... ...+....
T Consensus 155 ~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~ 229 (264)
T cd06626 155 TMG--EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA---GHKPPIPD 229 (264)
T ss_pred ccc--ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc---CCCCCCCc
Confidence 110 0012456889999999988766 89999999999999999999999964422111 111111 00111111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
....+..+.+++.+||+.+|.+||++.+.
T Consensus 230 -~~~~~~~~~~li~~~l~~~p~~R~~~~~i 258 (264)
T cd06626 230 -SLQLSPEGKDFLDRCLESDPKKRPTASEL 258 (264)
T ss_pred -ccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 11236678899999999999999999843
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.45 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=195.6
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
++|...+.||.|+||.||+|.+. +..||||.++.... .....+.+|+.+++.++||||++++++|.+ ..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999886 78899999865432 334678999999999999999999999843 4799999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|++++.+..++... ..+++..+..++.+|+.||.|||..+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99998877665433 34789999999999999999999966 9999999999999999999999999998765433
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhc----Cc---------
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----GK--------- 561 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~----~~--------- 561 (688)
. .......++..|+|||++.+. .++.++||||||+++|+|++|++||............ +.
T Consensus 155 ~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 155 A-----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred c-----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence 1 112345688999999999888 8899999999999999999999999654332111100 00
Q ss_pred ----------cccccCCC--CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcH
Q 005616 562 ----------LSSILDPL--AGDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 562 ----------l~~~ldp~--~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
+....++. ...++..++..+.+|+.+||..+|++||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 281 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHH
Confidence 00000000 00123334778999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=301.08 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=189.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
++|.....||.|+||.||+|... +..||||.+...... ....+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999885 789999998754322 23457789999999999999999999854 48899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+.+ +|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 8998886544 36789999999999999999999966 99999999999999999999999999875432211
Q ss_pred cCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHh----h---cC---ccccc
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV----S---CG---KLSSI 565 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i----~---~~---~l~~~ 565 (688)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.........+ . .. .....
T Consensus 159 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred ------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence 1123357889999998865 468999999999999999999999996443111110 0 00 00000
Q ss_pred -------------cCCC-CCCCCHHH--HHHHHHHHHHcccCCCCCCCCCcH
Q 005616 566 -------------LDPL-AGDWPTFV--ARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 566 -------------ldp~-~~~~~~~~--~~~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
..+. ........ ...+.+++.+||+.+|.+||++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e 284 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAE 284 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHH
Confidence 0000 00000011 267889999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=303.93 Aligned_cols=239 Identities=27% Similarity=0.356 Sum_probs=190.6
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccC--CCceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~ 414 (688)
..|...+.||+|+||.||+|... |..||+|.+...... ....+.+|+.++..++||||++++++|. +..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999875 889999998654332 2346889999999999999999999984 4578999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+. |+|.+.+.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 56666664432 35899999999999999999999966 999999999999999999999999998765422
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhc---cCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHh--hcCccccccCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV--SCGKLSSILDPL 569 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i--~~~~l~~~ldp~ 569 (688)
....|++.|+|||++. ...++.++||||||+++|||+||.+||.......... ..+.. +.
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~ 233 (307)
T cd06607 169 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS-----PT 233 (307)
T ss_pred ----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-----CC
Confidence 2346888999999874 4568899999999999999999999997544322211 11111 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
-.+...+..+.+++.+||..+|.+||++.+.+
T Consensus 234 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 265 (307)
T cd06607 234 --LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELL 265 (307)
T ss_pred --CCchhhCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 11223566899999999999999999998444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=300.98 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=190.8
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc-hHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~-~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++++|...+.||+|+||.||+|... |..||||++....... ...+.+|+.++..++|+||+++++++.+ ..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4678999999999999999999875 8899999987554332 3467899999999999999999999854 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 66766664432 35788889999999999999999966 999999999999999999999999998764332
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhc-----C--------
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC-----G-------- 560 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~-----~-------- 560 (688)
.. ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.........+.. +
T Consensus 157 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 157 SQ------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CC------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 21 12334578999999988654 5889999999999999999999999654332111110 0
Q ss_pred ---ccccccC---CC--CCCC-----CHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 561 ---KLSSILD---PL--AGDW-----PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 561 ---~l~~~ld---p~--~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.+..... +. .... .......+.+++.+|+..||.+|||+.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 0000000 00 0000 001245788999999999999999998443
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=336.12 Aligned_cols=248 Identities=27% Similarity=0.308 Sum_probs=201.4
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC
Q 005616 334 LADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE 408 (688)
Q Consensus 334 ~~el~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~ 408 (688)
..+++.-..+|.+.+.||+|+||.|..++.. ++.||+|++++..+- ...-|..|.++|..-+.++||.|..+|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3455666678999999999999999999986 788999999885443 34459999999999999999999999976
Q ss_pred --CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecC
Q 005616 409 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 409 --~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFG 486 (688)
++|+||+||+||+|-.++.+.. .++...+..++..|+-||..||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 4889999999999999997654 6888889999999999999999987 9999999999999999999999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhc----c-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCc
Q 005616 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR----T-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGK 561 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~----~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~ 561 (688)
.|-.+..+... .....+|||.|++||++. + +.|++.+|+||+||++|||+.|..||....-+...-..-+
T Consensus 221 sClkm~~dG~V-----~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~ 295 (1317)
T KOG0612|consen 221 SCLKMDADGTV-----RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMN 295 (1317)
T ss_pred hHHhcCCCCcE-----EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhc
Confidence 99888755432 456789999999999884 2 6799999999999999999999999964443322211111
Q ss_pred cccccCCCCCCCC--HHHHHHHHHHHHHcccCCCCCCCC
Q 005616 562 LSSILDPLAGDWP--TFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 562 l~~~ldp~~~~~~--~~~~~~l~~Li~~Cl~~dP~~RPs 598 (688)
-.+.+ .+| ..++....+||.+.+. +|..|-.
T Consensus 296 hk~~l-----~FP~~~~VSeeakdLI~~ll~-~~e~RLg 328 (1317)
T KOG0612|consen 296 HKESL-----SFPDETDVSEEAKDLIEALLC-DREVRLG 328 (1317)
T ss_pred hhhhc-----CCCcccccCHHHHHHHHHHhc-Chhhhcc
Confidence 11111 233 3477888888888664 5667766
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=300.34 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=190.7
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeC
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
|...+.||.|++|.||+|.+. |..||||++..... .....+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566788999999999999875 89999999875532 223568899999999999999999999854 478999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
+ ++|.+++..... ..+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 689988865432 45899999999999999999999965 99999999999999999999999999976543221
Q ss_pred CCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhh---c-Cc-----------
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS---C-GK----------- 561 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~---~-~~----------- 561 (688)
......+++.|+|||++.+. .++.++||||||+++|+|++|++||........... . +.
T Consensus 155 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 -----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred -----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 11234578899999987654 578999999999999999999999965443221111 0 00
Q ss_pred -------cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 562 -------LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 562 -------l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
+.....+.........+..+.+++.+||+.+|.+||++.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i 277 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAA 277 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 00000000111122345688999999999999999999843
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.67 Aligned_cols=236 Identities=25% Similarity=0.362 Sum_probs=190.4
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeCCCCcH
Q 005616 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNGSL 422 (688)
Q Consensus 350 LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~gsL 422 (688)
||.|+||+||++... |..||+|.+..... .....+.+|+.++..++||||+++++++. +..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999875 88999999875432 23345778999999999999999999884 358899999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCcc
Q 005616 423 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502 (688)
Q Consensus 423 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~ 502 (688)
.+++..... ..+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~------- 149 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK------- 149 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC-------
Confidence 999876543 46899999999999999999999966 9999999999999999999999999987654322
Q ss_pred ccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHHHH
Q 005616 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARR 580 (688)
Q Consensus 503 ~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~~~ 580 (688)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..... ......+...+..
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 224 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-----EMAVEYPDKFSPE 224 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-----cccccCCccCCHH
Confidence 12345688899999999888899999999999999999999999964432 1111111111 1111233345678
Q ss_pred HHHHHHHcccCCCCCCCCCcH
Q 005616 581 LVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 581 l~~Li~~Cl~~dP~~RPs~~e 601 (688)
+.+++.+||+.+|.+||+..+
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHHccCChhHccCCCc
Confidence 999999999999999998875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.42 Aligned_cols=247 Identities=25% Similarity=0.341 Sum_probs=189.5
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCC-CCceeeEecccC--CCceeEEee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ-HPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
+|.....||+|+||.||++... +..||||.+..... .....+.+|+.++.++. ||||+++++++. ...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4455678999999999999886 78999999875433 34557889999999996 999999999874 357899999
Q ss_pred CCCCcHHHHh---cccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 417 LPNGSLQDRL---FRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 417 ~~~gsL~~~L---~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
+.. +|.++. ... ....+++..+..++.+++.||.|||+.. +|+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 544432 222 2256899999999999999999999742 499999999999999999999999999976543
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccC---CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhc---CccccccC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTG---VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC---GKLSSILD 567 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~---~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~---~~l~~~ld 567 (688)
.. ......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.........+.. +....+
T Consensus 161 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 231 (288)
T cd06616 161 SI-------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPIL-- 231 (288)
T ss_pred CC-------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcC--
Confidence 22 11334689999999998766 6899999999999999999999999754432222211 111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 568 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 568 p~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
....+..++..+.+|+.+||+.+|.+||++.+.+.
T Consensus 232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 232 --SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred --CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11122346678999999999999999999985443
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=301.80 Aligned_cols=252 Identities=23% Similarity=0.242 Sum_probs=191.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCC-CCceeeEecccCC--C-----
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQ-HPHLVTLLGACPE--A----- 409 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~--~----- 409 (688)
++|...+.||.|+||.||+|.+. |..||||.+..... .....+.+|+.++..++ ||||+++++++.. .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999985 78999998865432 23356888999999995 6999999998732 2
Q ss_pred ceeEEeeCCCCcHHHHhcccCC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC-CCceEEeecC
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSN--VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFG 486 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-~~~~KL~DFG 486 (688)
.++||||+++ +|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 6899999986 78887765432 356899999999999999999999965 999999999999998 8999999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhc------
Q 005616 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC------ 559 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~------ 559 (688)
++....... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||............
T Consensus 157 ~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 230 (295)
T cd07837 157 LGRAFSIPV------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230 (295)
T ss_pred cceecCCCc------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC
Confidence 988654321 11233457889999998865 45799999999999999999999999754433221110
Q ss_pred Cccc---ccc---C----C-----CCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 560 GKLS---SIL---D----P-----LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 560 ~~l~---~~l---d----p-----~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.... ... + + ......+..+..+.++|.+||..||.+||++.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil 289 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHh
Confidence 0000 000 0 0 00001123466799999999999999999988433
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=303.49 Aligned_cols=246 Identities=23% Similarity=0.320 Sum_probs=207.1
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEeccc--CCCceeEEeeCC
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLP 418 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~LV~E~~~ 418 (688)
-|.+..+||+|+||.||++.++ |..||||.+... .+..++..|+.|+.+.+.|++|++||.+ ..++++|||||-
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3666789999999999999876 999999988643 4567899999999999999999999977 346999999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
.|+..+++.-.. .+|++.++..++...++||.|||... -||||||..||||+.+|++||+|||.|..+.+..
T Consensus 112 AGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--- 183 (502)
T KOG0574|consen 112 AGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--- 183 (502)
T ss_pred CCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH---
Confidence 999999987655 68999999999999999999999976 7999999999999999999999999998876543
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCC-CCCCCHHH
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPL-AGDWPTFV 577 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~-~~~~~~~~ 577 (688)
.+...+.|||-|||||++..-.|+.++||||||+...||..|++||.....++...... -.|. .-.-|...
T Consensus 184 ---AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP-----T~PPPTF~KPE~W 255 (502)
T KOG0574|consen 184 ---AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP-----TKPPPTFKKPEEW 255 (502)
T ss_pred ---HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc-----CCCCCCCCChHhh
Confidence 34577899999999999999999999999999999999999999997655443221110 0111 11235667
Q ss_pred HHHHHHHHHHcccCCCCCCCCCcHHHHHH
Q 005616 578 ARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 578 ~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~ 606 (688)
+..+.+++..||-.+|++|-|+.+.+.+.
T Consensus 256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 256 SSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred hhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 88999999999999999999887554443
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=289.72 Aligned_cols=246 Identities=26% Similarity=0.397 Sum_probs=201.4
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC----CceeEE
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLVY 414 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV~ 414 (688)
+|...+.||+|++|.||+|... +..|++|++..... .....+.+|+.++++++||||+++++.+.+ ..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677789999999999999987 88999999876653 345678999999999999999999998854 478999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++++|.+++.... .+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999987653 6899999999999999999999965 999999999999999999999999999887654
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHH-HHhhcCccccccCCCCCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR-RAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~-~~i~~~~l~~~ldp~~~~~ 573 (688)
... .......++..|+|||.+.+..++.++||||||+++|+|++|..||....... ....... .......
T Consensus 155 ~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~ 225 (260)
T cd06606 155 ETG----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-----SGEPPEI 225 (260)
T ss_pred ccc----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-----cCCCcCC
Confidence 321 01234568899999999988889999999999999999999999997654211 1111110 0111233
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
+...+..+.+++.+|+..+|.+||++.+.+
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll 255 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELL 255 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHh
Confidence 445577899999999999999999998544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=348.31 Aligned_cols=256 Identities=30% Similarity=0.457 Sum_probs=201.9
Q ss_pred cCHHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC-
Q 005616 332 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE- 408 (688)
Q Consensus 332 ~~~~el~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~- 408 (688)
+++.++. ..|.....||+|+||.||+|... |..||||.+...... ...|+.++++++|||||+++|+|.+
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 4445443 45777889999999999999974 889999998644322 2346889999999999999999943
Q ss_pred -CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCc
Q 005616 409 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGl 487 (688)
..++||||+++|+|.+++. .++|..+.+|+.+||.||.|||..+.++|+||||||+||+++.++.+++. ||.
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence 5789999999999999994 37999999999999999999997655779999999999999999988876 665
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCCh--------hHHHHHhhc
Q 005616 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA--------GEVRRAVSC 559 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~--------~~~~~~i~~ 559 (688)
+..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||... .+.......
T Consensus 829 ~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 898 (968)
T PLN00113 829 PGLLCT----------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD 898 (968)
T ss_pred cccccc----------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc
Confidence 543321 12336899999999999999999999999999999999999998521 112222222
Q ss_pred CccccccCCCCC---CCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhh
Q 005616 560 GKLSSILDPLAG---DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 560 ~~l~~~ldp~~~---~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~ 612 (688)
......+|+... ..+......+.+++.+||+.+|.+||+|. ++++.|+.+..
T Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~-evl~~L~~~~~ 953 (968)
T PLN00113 899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAN-DVLKTLESASR 953 (968)
T ss_pred cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHH-HHHHHHHHhhc
Confidence 334444555431 23445667889999999999999999999 78888887643
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=293.10 Aligned_cols=235 Identities=26% Similarity=0.339 Sum_probs=192.8
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCcH
Q 005616 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 422 (688)
Q Consensus 350 LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL 422 (688)
||.|+||.||+|... +..||+|++..... .....+.+|+.++..++||||+++++++.+ ..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999997 88999999976543 234569999999999999999999999844 48899999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCcc
Q 005616 423 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502 (688)
Q Consensus 423 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~ 502 (688)
.+++.... .+++..+..++.+|+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------- 147 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------- 147 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------
Confidence 99997643 4788999999999999999999965 9999999999999999999999999998765432
Q ss_pred ccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--H--HHHHhhcCccccccCCCCCCCCHHHH
Q 005616 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--E--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 503 ~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~--~~~~i~~~~l~~~ldp~~~~~~~~~~ 578 (688)
......|++.|++||++....++.++|+||||+++|+|++|..||.... . ....+..+ .....+|...+
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 220 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG-------NGKLEFPNYID 220 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc-------CCCCCCCcccC
Confidence 1234568899999999988889999999999999999999999997544 1 11111111 11223344446
Q ss_pred HHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 579 RRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 579 ~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
..+.+++.+||..+|.+||++.+..+
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~ 246 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGI 246 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCH
Confidence 78999999999999999999654333
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=299.39 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=192.7
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccC----CCceeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACP----EAWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~----~~~~LV 413 (688)
++|...+.||.|+||.||+|.+. +..||||.++..... ....+.+|+.++.+++||||+++++++. ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788889999999999999986 788999999755432 2235778999999999999999999873 458999
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
|||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 48988886544 36899999999999999999999966 99999999999999999999999999987654
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH--hhc-----------
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSC----------- 559 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--i~~----------- 559 (688)
... ......+++.|+|||++.+. .++.++||||||+++|+|++|.+||......... +..
T Consensus 159 ~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 159 PLK------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred Ccc------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 321 12344678899999988654 4689999999999999999999999643321110 000
Q ss_pred ----------CccccccC-CCCCCCCHH-HHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 560 ----------GKLSSILD-PLAGDWPTF-VARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 560 ----------~~l~~~ld-p~~~~~~~~-~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
........ .....++.. ++..+.+++.+||+.+|++||++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell 288 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL 288 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHh
Confidence 00000000 001112222 467789999999999999999998443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=292.53 Aligned_cols=245 Identities=25% Similarity=0.330 Sum_probs=195.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-----ccchHHHHHHHHHHHcCCCCceeeEecccCC----Cc
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-----MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AW 410 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~-----~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~ 410 (688)
.+|...+.||+|+||.||+|.+. +..||+|.+.... ......+.+|+.++++++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999875 7899999885432 1233468899999999999999999998743 36
Q ss_pred eeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
++|+||+++++|.+++.... .+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 78999999999999986543 4788999999999999999999866 99999999999999999999999999986
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCC
Q 005616 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~ 570 (688)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||.............. .+..
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~ 227 (264)
T cd06653 156 IQTICMS---GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT-----QPTK 227 (264)
T ss_pred ccccccc---CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc-----CCCC
Confidence 5432110 0112345689999999999988899999999999999999999999975443322211110 1112
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCCcH
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
...|......+.+++.+||. +|..||+..+
T Consensus 228 ~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~ 257 (264)
T cd06653 228 PMLPDGVSDACRDFLKQIFV-EEKRRPTAEF 257 (264)
T ss_pred CCCCcccCHHHHHHHHHHhc-CcccCccHHH
Confidence 23455677889999999999 5799999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=289.36 Aligned_cols=242 Identities=26% Similarity=0.401 Sum_probs=199.2
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|.....||+|++|.||++... +..|++|.+..... .....+.+|++++.+++|||++++++++.+ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777889999999999999875 78899999977654 345579999999999999999999998854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998654 46899999999999999999999966 99999999999999999999999999987754332
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHH
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~ 576 (688)
. .....|+..|+|||...+..++.++||||||+++|+|++|..||.............. ......+..
T Consensus 155 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~ 222 (254)
T cd06627 155 D------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ------DDHPPLPEG 222 (254)
T ss_pred c------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc------cCCCCCCCC
Confidence 1 2345689999999999888899999999999999999999999975443322221110 001123334
Q ss_pred HHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 577 VARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
.+..+.+++.+||..+|++||++.+.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~ 248 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQL 248 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHH
Confidence 56789999999999999999999843
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=301.38 Aligned_cols=200 Identities=25% Similarity=0.301 Sum_probs=164.0
Q ss_pred CcccceeeeccCceEEEEEEE----CCeEEEEEEEecCC---ccchHHHHHHHHHHHcCCCCceeeEecccCC----Cce
Q 005616 343 NFSESFKVGQGGFGCVYKGEM----LGRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWS 411 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~----~g~~VAIK~l~~~~---~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~ 411 (688)
.|.....||+|+||.||+|.. .+..||||.+.... ......+.+|+.++..++||||++++++|.+ ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 377788999999999999988 46899999998743 3334567889999999999999999999843 378
Q ss_pred eEEeeCCCCcHHHHhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC----CCceEEeec
Q 005616 412 LVYEYLPNGSLQDRLFRKS--NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS----ELSSKICDF 485 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~----~~~~KL~DF 485 (688)
+||||+.+ +|.+.+.... ....++...+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 5666554322 2236889999999999999999999966 999999999999999 899999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCC
Q 005616 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGL 549 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~ 549 (688)
|++......... ........+++.|+|||++.+. .++.++|||||||++|+|++|++||..
T Consensus 157 g~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 218 (316)
T cd07842 157 GLARLFNAPLKP---LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218 (316)
T ss_pred ccccccCCCccc---ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 999876543211 1123445789999999987664 589999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=307.02 Aligned_cols=251 Identities=22% Similarity=0.270 Sum_probs=194.1
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC-------
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE------- 408 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~------- 408 (688)
..++|...+.||+|+||.||+|... |..||||.+.... ......+.+|+.++.+++||||++++++|..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999875 8899999986432 2334567889999999999999999998732
Q ss_pred -CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCc
Q 005616 409 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGl 487 (688)
..++||||+. ++|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 2589999996 477777643 2788899999999999999999966 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH--Hh-h-cCc--
Q 005616 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AV-S-CGK-- 561 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~i-~-~~~-- 561 (688)
+....... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.... .+ . .+.
T Consensus 165 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 165 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred ceeCCCCC-------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 98764322 12344688999999999999999999999999999999999999964332110 00 0 000
Q ss_pred -------------------------cccccC----CC-CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHH
Q 005616 562 -------------------------LSSILD----PL-AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 562 -------------------------l~~~ld----p~-~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~ 606 (688)
+...+. +. ....+...+..+.+|+.+||+.||.+||++.+.+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 000000 00 0001223466789999999999999999999655443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=318.12 Aligned_cols=245 Identities=22% Similarity=0.328 Sum_probs=203.6
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEeccc--CCCceeEEeeCCC
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPN 419 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~LV~E~~~~ 419 (688)
|.++.-||.|+||.||++... +-..|-|++........++|.-|++||+.+.||+||+|++.| .+.++|+.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 455567999999999999887 445678888777777788899999999999999999999865 6678999999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC
Q 005616 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
|-.+.++..-+ .+|+..++.-++.+++.||.|||+.+ |||||||..|||++-+|.++|+|||.+......
T Consensus 114 GAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t----- 183 (1187)
T KOG0579|consen 114 GAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST----- 183 (1187)
T ss_pred chHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-----
Confidence 99999887665 57899999999999999999999966 999999999999999999999999987654322
Q ss_pred CccccCCCCCCCCCCChhhh-----ccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcC--ccccccCCCCCC
Q 005616 500 SFHRSTAPKGSFPYADPEYH-----RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCG--KLSSILDPLAGD 572 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~-----~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~--~l~~~ldp~~~~ 572 (688)
......+.|||.|||||+. ...+|+.++||||||++|.||..+.+|-.....++..+... .-..+ -
T Consensus 184 -~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTL------l 256 (1187)
T KOG0579|consen 184 -RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL------L 256 (1187)
T ss_pred -HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcc------c
Confidence 2345678999999999976 45689999999999999999999999977665554444322 22222 2
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHH
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~ 605 (688)
.|...+..+.+++.+||..||..||++++.+.+
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 345667789999999999999999999965544
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.76 Aligned_cols=251 Identities=23% Similarity=0.276 Sum_probs=189.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
++|.....||.|++|.||+|... |+.||||.+..... .....+.+|+.+++.++||||+++++++.+ ..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999875 78899999865433 233568899999999999999999999854 5889999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC-CCceEEeecCccccccCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFGICRLVTED 494 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-~~~~KL~DFGla~~~~~~ 494 (688)
|++ ++|.+++..... ..+++..+..++.+|+.||.|||+.+ |+|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 577777754432 34678888999999999999999965 999999999999985 567999999999765432
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH---hhc-Cc-ccccc--
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSC-GK-LSSIL-- 566 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---i~~-~~-l~~~l-- 566 (688)
.. ......|++.|+|||++.+ ..++.++|||||||++|+|+||.+||......... ... +. .....
T Consensus 157 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 157 VR------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred cc------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 21 1234467899999998865 45789999999999999999999999644322111 100 00 00000
Q ss_pred -----C----------CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 567 -----D----------PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 567 -----d----------p~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
+ ..........+..+.+++.+|++.+|.+||++.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l 282 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL 282 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHh
Confidence 0 000001123456789999999999999999998544
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=304.93 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=190.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC-------Cc
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------AW 410 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------~~ 410 (688)
+++|...+.||+|+||.||+|... |..||||.+..... .....+.+|+.++..++||||+++++++.. ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 578999999999999999999875 78999999864332 234568889999999999999999987632 26
Q ss_pred eeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
++|+||+.+ +|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999974 77777643 35899999999999999999999966 99999999999999999999999999987
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH------hhcC---
Q 005616 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA------VSCG--- 560 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~------i~~~--- 560 (688)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+..... +...
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHT---GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred cccccccc---CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 64332111 11234578999999998754 56899999999999999999999999643221100 0000
Q ss_pred ccccccCC----------C--CCCC---CHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 561 KLSSILDP----------L--AGDW---PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 561 ~l~~~ldp----------~--~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.+..+.+. . ...+ .+..+..+.+++.+||+.+|.+||++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l 290 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEAL 290 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHh
Confidence 00000000 0 0000 112356789999999999999999998444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.82 Aligned_cols=253 Identities=19% Similarity=0.217 Sum_probs=191.4
Q ss_pred ceeeeccCceEEEEEEECCeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCcH
Q 005616 347 SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 422 (688)
Q Consensus 347 ~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL 422 (688)
.+.+|.|+++.||++...+..||||++.... ......+.+|+.+++.++||||+++++++.+ ..+++|||+++|+|
T Consensus 7 ~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 7 GKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred hHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3445666777777777779999999997652 3345679999999999999999999998843 57899999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC-CCc
Q 005616 423 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL-PSF 501 (688)
Q Consensus 423 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~-~~~ 501 (688)
.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||.+.......... ...
T Consensus 87 ~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 999876432 35788999999999999999999966 9999999999999999999999999987654322110 001
Q ss_pred cccCCCCCCCCCCChhhhcc--CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhh--cCccccccC----------
Q 005616 502 HRSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS--CGKLSSILD---------- 567 (688)
Q Consensus 502 ~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~--~~~l~~~ld---------- 567 (688)
.......++..|+|||++.. ..++.++|||||||++|||++|..||.........+. .+.....++
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence 11234567889999999865 3588999999999999999999999975443222211 111111110
Q ss_pred ----------C-----CCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 568 ----------P-----LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 568 ----------p-----~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
+ .....+..+...+.+|+.+||..||++||++.+.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 293 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHh
Confidence 0 01112334567899999999999999999998544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=299.92 Aligned_cols=237 Identities=25% Similarity=0.351 Sum_probs=188.7
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
|...+.||+|+||.||+|... +..||+|.+...... ....+.+|+.+++.++|||+++++++|.+ ..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667789999999999999875 789999998754332 23468899999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+.+ +|.+.+.... .+++|..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 975 7777665433 45899999999999999999999966 999999999999999999999999998754321
Q ss_pred cCCCccccCCCCCCCCCCChhhhc---cCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCccccccCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~ldp~~~ 571 (688)
....|++.|+|||++. .+.++.++|||||||++|+|++|+.||...... ...+..+....
T Consensus 179 --------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------- 243 (317)
T cd06635 179 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT------- 243 (317)
T ss_pred --------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC-------
Confidence 2346889999999873 457899999999999999999999998654321 11222111110
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
......+..+.+|+.+||+.+|.+||++.+.+
T Consensus 244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 275 (317)
T cd06635 244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELL 275 (317)
T ss_pred CCCccccHHHHHHHHHHccCCcccCcCHHHHH
Confidence 11223456799999999999999999998444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.98 Aligned_cols=256 Identities=21% Similarity=0.274 Sum_probs=180.3
Q ss_pred cCcccceeeeccCceEEEEEEECC-----eEEEEEEEecCCccch-----------HHHHHHHHHHHcCCCCceeeEecc
Q 005616 342 CNFSESFKVGQGGFGCVYKGEMLG-----RTVAIKMLYSHNMQGQ-----------LEFQQEVRVLSKLQHPHLVTLLGA 405 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~g-----~~VAIK~l~~~~~~~~-----------~~f~~E~~iL~~l~HpnIV~l~g~ 405 (688)
+.|...+.||+|+||.||+|...+ ..+|+|+......... .....+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 678999999999999999998763 3567776433322111 112234445667789999999987
Q ss_pred cCCC------ceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCc
Q 005616 406 CPEA------WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 479 (688)
Q Consensus 406 ~~~~------~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~ 479 (688)
+... .+++++++.. ++.+.+... ...++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 6322 3567776643 555555432 23567889999999999999999965 999999999999999999
Q ss_pred eEEeecCccccccCCCCcC-CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH---HHH
Q 005616 480 SKICDFGICRLVTEDTLYL-PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRR 555 (688)
Q Consensus 480 ~KL~DFGla~~~~~~~~~~-~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~---~~~ 555 (688)
++|+|||+|+.+....... ..........||+.|+|||++.+..++.++|||||||+||||++|+.||..... ...
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999998764322111 011112345799999999999999999999999999999999999999975421 111
Q ss_pred HhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 556 AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 556 ~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
....+-+..+..+. .. ....+..+.+++..|+..+|.+||++. +|.+.|
T Consensus 245 ~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~rp~~~-~l~~~~ 293 (294)
T PHA02882 245 AAKCDFIKRLHEGK-IK-IKNANKFIYDFIECVTKLSYEEKPDYD-ALIKIF 293 (294)
T ss_pred HhHHHHHHHhhhhh-hc-cCCCCHHHHHHHHHHHhCCCCCCCCHH-HHHHhh
Confidence 11111011111110 00 112356799999999999999999998 666544
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.87 Aligned_cols=243 Identities=23% Similarity=0.340 Sum_probs=185.0
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
-|..++.||-|+||.|.+++-. ...+|+|.|.+.+.- ....+..|.+||+...+++||+||..|.+ ++|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 4667789999999999998654 567999999776542 33458899999999999999999999965 5899999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|++||++..+|.+.+ .+.+..+..++.++.+|+++.|..| +|||||||+|||||.+|++||+|||||.-+....
T Consensus 710 YIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999998765 4667778888999999999999987 9999999999999999999999999997553211
Q ss_pred C--cCC--------Cc--------------------------cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHH
Q 005616 496 L--YLP--------SF--------------------------HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQ 539 (688)
Q Consensus 496 ~--~~~--------~~--------------------------~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~E 539 (688)
. +.. ++ ......+||+.|+|||++....|+..||+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 0 000 00 01124579999999999999999999999999999999
Q ss_pred HHhCCCCCCChhHHHHHhhcCccccccCC-CCCCCCHHHHHHHHHHHHH-cccCCCCCCC
Q 005616 540 LLTGRLPVGLAGEVRRAVSCGKLSSILDP-LAGDWPTFVARRLVDLGLQ-CCELYGRERP 597 (688)
Q Consensus 540 LltG~~Pf~~~~~~~~~i~~~~l~~~ldp-~~~~~~~~~~~~l~~Li~~-Cl~~dP~~RP 597 (688)
|+.|++||-............++...++. ..++ .+.+..+||.+ |+. ++.|-
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~----ls~e~~~li~kLc~s--ad~RL 917 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGN----LSKEALDLIQKLCCS--ADSRL 917 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhccccccccc----cCHHHHHHHHHHhcC--hhhhh
Confidence 99999999543332222222333333332 2333 34455555554 443 34554
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=289.86 Aligned_cols=243 Identities=28% Similarity=0.348 Sum_probs=193.5
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCcH
Q 005616 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 422 (688)
Q Consensus 350 LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL 422 (688)
||.|+||.||++... |..|++|++..... .....+.+|+.++.+++||||+++++.+.. ..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 88999999976544 344568899999999999999999998854 47899999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC--CC
Q 005616 423 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL--PS 500 (688)
Q Consensus 423 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~--~~ 500 (688)
.+++.... .+++..+..++.||+.||.|||..+ |+|+||+|+||+++.++.++|+|||++.......... ..
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99987643 5889999999999999999999965 9999999999999999999999999987654321100 00
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHH--
Q 005616 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF-- 576 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~-- 576 (688)
........++..|++||.+....++.++||||||+++|+|++|..||..... ....+..+.. .++..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~ 225 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI---------EWPEDVE 225 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc---------CCCcccc
Confidence 0122345688899999999888899999999999999999999999964432 2222222221 12222
Q ss_pred HHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 577 VARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
.+..+.+++.+||+.+|.+||++. .+.+.|+
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~-~~~~~l~ 256 (265)
T cd05579 226 VSDEAIDLISKLLVPDPEKRLGAK-SIEEIKN 256 (265)
T ss_pred CCHHHHHHHHHHhcCCHhhcCCCc-cHHHHhc
Confidence 267889999999999999999996 4444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=298.90 Aligned_cols=247 Identities=23% Similarity=0.333 Sum_probs=190.6
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCC-CCceeeEecccCC--CceeEEe
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ-HPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~--~~~LV~E 415 (688)
++|.....||.|+||.||+|.+. +..||||.+..... .....+..|+.++.+.. ||||++++++|.+ ..++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 56788899999999999999997 88999999976543 23445777887777775 9999999999854 4789999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|+. ++|.+++.... ..+++..+..++.+++.||.|||+.+ +|+||||+|+||+++.++.+||+|||++.......
T Consensus 95 ~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 985 46777665433 36899999999999999999999742 49999999999999999999999999987664322
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCC----CCCcchHhHHHHHHHHHHhCCCCCCChhH---HHHHhhcCccccccCC
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGV----LTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRRAVSCGKLSSILDP 568 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~----~s~ksDVwSfGviL~ELltG~~Pf~~~~~---~~~~i~~~~l~~~ldp 568 (688)
. .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||..... ....+..+.....
T Consensus 170 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 239 (296)
T cd06618 170 A-------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL--- 239 (296)
T ss_pred c-------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC---
Confidence 1 12345788999999986553 88999999999999999999999965322 1111111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHH
Q 005616 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 569 ~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~ 606 (688)
.....++..+.+|+.+||+.||.+||++.+.+.+.
T Consensus 240 ---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 240 ---PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 11112456799999999999999999998555443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.92 Aligned_cols=247 Identities=25% Similarity=0.358 Sum_probs=190.0
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC----CceeEEe
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLVYE 415 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV~E 415 (688)
|.....||.|+||.||+|... |..||+|++.... ......+.+|+.++..++|||++++++++.+ ..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 556788999999999999886 6899999998764 2334568899999999999999999999843 4889999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|+++ +|.+++.... ..+++..++.++.+|+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 8888886543 46899999999999999999999966 9999999999999999999999999998765432
Q ss_pred CcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH--hhc--C-----ccc--
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSC--G-----KLS-- 563 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--i~~--~-----~l~-- 563 (688)
.. ......++..|+|||.+.+ ..+++++||||||+++|+|+||+.||......... +.. + ...
T Consensus 155 ~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 155 SA-----DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred cc-----cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence 10 1233467889999997754 46899999999999999999999999644321110 000 0 000
Q ss_pred -cc-----cCCCC-------CCCCHHHHHHHHHHHHHcccCCCCCCCCCcH
Q 005616 564 -SI-----LDPLA-------GDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 564 -~~-----ldp~~-------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
.+ ..+.. ..+...++..+.+++.+||..+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 280 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQ 280 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 00 00000 0001112668999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.53 Aligned_cols=239 Identities=21% Similarity=0.307 Sum_probs=186.7
Q ss_pred HHHHHHHhcCcccceee--eccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccC-
Q 005616 334 LADLQTATCNFSESFKV--GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACP- 407 (688)
Q Consensus 334 ~~el~~at~~f~~~~~L--G~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~- 407 (688)
..++....++|...+.+ |.|+||.||++... +..+|+|.+........ |+.+...+ +||||++++++|.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 44555556777777766 99999999999875 78899999865432211 22222223 7999999999984
Q ss_pred -CCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-ceEEeec
Q 005616 408 -EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDF 485 (688)
Q Consensus 408 -~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-~~KL~DF 485 (688)
+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .++|+||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecC
Confidence 45899999999999999986543 6899999999999999999999966 99999999999999998 9999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHH---HHhhcCcc
Q 005616 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR---RAVSCGKL 562 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~---~~i~~~~l 562 (688)
|++...... ....|+..|+|||++.+..++.++||||||+++|+|++|..||....... ..+... .
T Consensus 155 g~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~ 223 (267)
T PHA03390 155 GLCKIIGTP----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR-Q 223 (267)
T ss_pred ccceecCCC----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh-h
Confidence 998765432 23468999999999999999999999999999999999999996432110 111110 0
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCC
Q 005616 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDI 599 (688)
Q Consensus 563 ~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 599 (688)
. .....+...+..+.+++.+||+.+|.+||+.
T Consensus 224 ~-----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 255 (267)
T PHA03390 224 Q-----KKLPFIKNVSKNANDFVQSMLKYNINYRLTN 255 (267)
T ss_pred c-----ccCCcccccCHHHHHHHHHHhccChhhCCch
Confidence 1 0112233567789999999999999999974
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=313.16 Aligned_cols=242 Identities=29% Similarity=0.486 Sum_probs=203.7
Q ss_pred ceeeeccCceEEEEEEEC---Ce--EEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEeeCCC
Q 005616 347 SFKVGQGGFGCVYKGEML---GR--TVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPN 419 (688)
Q Consensus 347 ~~~LG~G~~G~Vy~g~~~---g~--~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~~ 419 (688)
.++||+|.||+|++|.|. |+ .||||.+...... ....|.+|+.+|.+|+|||+|+|||+..+ ...+|+|.++.
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELapl 194 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAPL 194 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhccc
Confidence 357999999999999997 43 5999999887665 56689999999999999999999999975 47799999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC
Q 005616 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
|||.+.|.+ .....|.......++.|||.|+.||.+.+ +|||||...||||-....+||+|||+.+-+..+....
T Consensus 195 GSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y- 269 (1039)
T KOG0199|consen 195 GSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY- 269 (1039)
T ss_pred chHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcce-
Confidence 999999988 33456778888999999999999999955 9999999999999999999999999999887654321
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH--HHHHhhcCccccccCCCCCCCCHH
Q 005616 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~ 576 (688)
.......-.+.|+|||.+....++.++|||+|||+||||+| |..||.+... +...+..|.. -..|..
T Consensus 270 --vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er--------LpRPk~ 339 (1039)
T KOG0199|consen 270 --VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER--------LPRPKY 339 (1039)
T ss_pred --EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc--------CCCCCC
Confidence 12234455678999999999999999999999999999999 8899976553 4444443322 234667
Q ss_pred HHHHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 577 VARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
+++.+.+++..||..+|.+||++. .|.
T Consensus 340 csedIY~imk~cWah~paDRptFs-air 366 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFS-AIR 366 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHH-HHH
Confidence 889999999999999999999999 554
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.01 Aligned_cols=257 Identities=24% Similarity=0.318 Sum_probs=194.0
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecC--CccchHHHHHHHHHHHcC-CCCceeeEecccCC----Cc
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSH--NMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE----AW 410 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~--~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~----~~ 410 (688)
..++|...+.||.|+||.||+|.+. |..||||++... .......+.+|+.++.++ +||||++++++|.. ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888899999999999999885 788999988643 223345677899999999 99999999998742 36
Q ss_pred eeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
++||||++ ++|..++... .++|..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 89999997 5888887543 5789999999999999999999965 99999999999999999999999999987
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH---Hhhc-Cc----
Q 005616 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSC-GK---- 561 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~---~i~~-~~---- 561 (688)
........ .........||+.|+|||++.+ ..++.++||||||+++|+|+||+.||........ .... +.
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 157 LSELEENP-ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred cccccccc-cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 65433210 0012234568999999998754 5678999999999999999999999964332111 0000 00
Q ss_pred ---------cccccC----C---CCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHH
Q 005616 562 ---------LSSILD----P---LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 562 ---------l~~~ld----p---~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~ 605 (688)
...+++ . .........+..+.+++.+||+.+|.+||++.+.+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000 0 0011111246689999999999999999999965544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.02 Aligned_cols=247 Identities=26% Similarity=0.331 Sum_probs=194.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecC--CccchHHHHHHHHHHHcCC-CCceeeEeccc--CCCceeEE
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSH--NMQGQLEFQQEVRVLSKLQ-HPHLVTLLGAC--PEAWSLVY 414 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~--~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~--~~~~~LV~ 414 (688)
...|+..++||+||.+.||++... ...||+|++... +.+....|.+|+..|.+|+ |.+||+||+|- .+.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 456888899999999999999887 456788876544 3345567999999999995 99999999986 34588999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||- ..+|..+|...... ...| .+..+..|++.|+.++|..+ |||.||||.|+|+-. |.+||+|||+|..+..+
T Consensus 440 E~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred ecc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 986 56999999876542 3345 67788899999999999976 999999999999954 68999999999998876
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccC-----------CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccc
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTG-----------VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLS 563 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-----------~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~ 563 (688)
.... .....+||+.||+||.+... +.++++||||||||||+|+.|++||+.....+. ++.
T Consensus 513 TTsI----~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a-----Kl~ 583 (677)
T KOG0596|consen 513 TTSI----VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA-----KLH 583 (677)
T ss_pred ccce----eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH-----HHH
Confidence 6443 34567899999999987533 256899999999999999999999986554333 234
Q ss_pred cccCCC-CCCCCHHHH-HHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 564 SILDPL-AGDWPTFVA-RRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 ~~ldp~-~~~~~~~~~-~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.+.||. ..+||..-. ..+++++..||..||++||++.+.|
T Consensus 584 aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLL 625 (677)
T KOG0596|consen 584 AITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELL 625 (677)
T ss_pred hhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHh
Confidence 455552 123322111 2399999999999999999998443
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=292.75 Aligned_cols=246 Identities=29% Similarity=0.371 Sum_probs=198.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCC-CCceeeEecccCC--CceeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQ-HPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~--~~~LV 413 (688)
++|.....||.|+||.||+|... |..||+|++..... .....+..|+.++.+++ ||||+++++++.+ ..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999885 88999999876432 23456889999999998 9999999999854 48899
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
|||+.+++|.+++.... .+++..+..|+.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999997643 6899999999999999999999966 99999999999999999999999999987654
Q ss_pred CCCcCC--------------CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhc
Q 005616 494 DTLYLP--------------SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC 559 (688)
Q Consensus 494 ~~~~~~--------------~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~ 559 (688)
...... .........|+..|+|||++....++.++||||||++++++++|..||............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 331100 011233456889999999998888999999999999999999999999765532211110
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 560 ~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
. .....++...+..+.+++.+||+.+|.+||++.
T Consensus 235 ~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 268 (280)
T cd05581 235 L-------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVN 268 (280)
T ss_pred H-------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcc
Confidence 0 011123344567899999999999999999994
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=304.51 Aligned_cols=255 Identities=20% Similarity=0.262 Sum_probs=194.7
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccC------CCc
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP------EAW 410 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~------~~~ 410 (688)
..+|...+.||.|+||.||+|... |..||+|++..... .....+.+|+.+|..++||||++++++|. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468888999999999999999875 88999999875432 33456788999999999999999998873 236
Q ss_pred eeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
++||||+. |+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999995 6898888654 34899999999999999999999966 99999999999999999999999999987
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH-------------
Q 005616 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA------------- 556 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~------------- 556 (688)
........ ........|+..|+|||++.. ..++.++|||||||++|+|++|++||.........
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 157 LSSSPTEH--KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred ecccCcCC--CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 64432110 111234578999999998765 46899999999999999999999999643321100
Q ss_pred ----hhcCccccccCC--CCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 557 ----VSCGKLSSILDP--LAGD-----WPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 557 ----i~~~~l~~~ldp--~~~~-----~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
+....+...++. .... .....+..+.+++.+||+.+|.+||++.+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000001100000 0001 11234678999999999999999999985443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.17 Aligned_cols=246 Identities=24% Similarity=0.289 Sum_probs=185.9
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCC-CCceeeEecccC----CCceeEEe
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ-HPHLVTLLGACP----EAWSLVYE 415 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~----~~~~LV~E 415 (688)
|...+.||.|+||.||+|... +..||+|.++.... .......+|+.++.++. ||||+++++++. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 556788999999999999875 78999999875432 22334567899999885 999999999984 34789999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|+. |+|.+.+.... ..++|..+..++.|++.||.|||+.+ |+||||+|+||+++. +.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 57777775433 46899999999999999999999966 999999999999999 999999999998764332
Q ss_pred CcCCCccccCCCCCCCCCCChhhhc-cCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHH---HHhh-------------
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHR-TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR---RAVS------------- 558 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~-~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~---~~i~------------- 558 (688)
. .....++..|+|||++. ++.++.++|||||||++|||++|.+||...+... ....
T Consensus 154 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 154 P-------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred C-------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 1 12345789999999764 4567899999999999999999999996443211 0000
Q ss_pred -cCccccccCCC-C----CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 559 -CGKLSSILDPL-A----GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 559 -~~~l~~~ldp~-~----~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.........+. . .......+..+.+|+.+||+.+|.+||++.+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l 277 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHh
Confidence 00000000000 0 001123567899999999999999999998433
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.62 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=191.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc--hHHHHHHHHHHHcCCCCceeeEecccCC----Ccee
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSL 412 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~--~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~L 412 (688)
.++|...+.||.|+||.||+|.+. |..||+|.+....... ...+.+|+.++.+++|+||+++++++.+ ..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357888999999999999999885 8899999987543322 2356789999999999999999998742 3789
Q ss_pred EEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccccc
Q 005616 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~ 492 (688)
||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999974 7888776543 46899999999999999999999976 9999999999999999999999999998765
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH--Hhhc--C----ccc
Q 005616 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSC--G----KLS 563 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~i~~--~----~l~ 563 (688)
.... ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||........ .+.. + ...
T Consensus 160 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 160 LPAK------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred CccC------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 4321 1233456888999998865 5689999999999999999999999965433211 1110 0 000
Q ss_pred ---------cccCCCCCCC------CHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 564 ---------SILDPLAGDW------PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 ---------~~ldp~~~~~------~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
..+.-....+ ....+..+.+|+.+||+.||.+||++.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il 288 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 0000000000 012356788999999999999999988444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=286.94 Aligned_cols=241 Identities=27% Similarity=0.404 Sum_probs=198.9
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|...+.||.|+||.||++... +..+|+|.+..... .....+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777889999999999999875 78899999876543 234568899999999999999999988744 47899999
Q ss_pred CCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 417 LPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 417 ~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
+++++|..++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999986632 2356899999999999999999999966 9999999999999999999999999998775431
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCC
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~ 573 (688)
.....|++.|++||.+.+..++.++|+||||+++|+|++|+.||...+. ....+..+... ..
T Consensus 158 --------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~ 221 (256)
T cd08530 158 --------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP--------PI 221 (256)
T ss_pred --------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--------CC
Confidence 1234688999999999999999999999999999999999999975443 22222222221 22
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
+...+..+.+++.+||..+|.+||++.+.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~ 250 (256)
T cd08530 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250 (256)
T ss_pred chhhCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 33566789999999999999999999843
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=289.15 Aligned_cols=244 Identities=27% Similarity=0.394 Sum_probs=200.6
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|...+.||.|+||.||++... +..||+|++..... .....+.+|+.+++.++|||++++++.+.. ..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999987 88999999976544 455678999999999999999999988743 57899999
Q ss_pred CCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCC
Q 005616 417 LPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 417 ~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999987642 2357899999999999999999999965 9999999999999999999999999998765432
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCC
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~ 573 (688)
. ......|++.|+|||.+....++.++||||||+++|+|++|..||..... +......+.. ...
T Consensus 158 ~------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~ 223 (258)
T cd08215 158 D------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY--------PPI 223 (258)
T ss_pred c------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC--------CCC
Confidence 1 12345689999999999888999999999999999999999999965432 2122212111 122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
+...+..+.+++.+||..+|.+||++.+.+
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll 253 (258)
T cd08215 224 PSQYSSELRNLVSSLLQKDPEERPSIAQIL 253 (258)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 334557899999999999999999998433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=296.07 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=192.9
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC------
Q 005616 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE------ 408 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~------ 408 (688)
.+.++|.....||.|+||.||+|... |..||||++..... .....+.+|+.++..++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678889999999999999999985 78999999976532 233467889999999999999999998743
Q ss_pred ------CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEE
Q 005616 409 ------AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI 482 (688)
Q Consensus 409 ------~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL 482 (688)
..++|+||+++ +|...+... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 46899999986 666666543 246899999999999999999999976 999999999999999999999
Q ss_pred eecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH--h--
Q 005616 483 CDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--V-- 557 (688)
Q Consensus 483 ~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--i-- 557 (688)
+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+|++|++||......... +
T Consensus 158 ~dfg~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 158 ADFGLARLYNSEESR-----PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred CcccccccccCCccc-----ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999876543211 1123456888999998764 45789999999999999999999999754432211 0
Q ss_pred -hcCccc----cc--------cCCCC------CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 558 -SCGKLS----SI--------LDPLA------GDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 558 -~~~~l~----~~--------ldp~~------~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
..+... .+ .++.. .......+..+.+++.+||+.+|.+||++.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 296 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEA 296 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 000000 00 00000 00011245789999999999999999998843
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=295.51 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=188.5
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccCC---------
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--------- 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--------- 408 (688)
++|.....||.|+||.||+|... +..||||.+...... ....+.+|+.++++++||||++++++|..
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 47889999999999999999885 789999998654322 23356789999999999999999998732
Q ss_pred -CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCc
Q 005616 409 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGl 487 (688)
..++||||+.+ +|.+.+.... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 24899999964 7877775433 35899999999999999999999966 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH--Hhh--cCcc
Q 005616 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVS--CGKL 562 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~i~--~~~l 562 (688)
+.......... ........++..|+|||++.+. .++.++||||||+++|+|++|.+||........ .+. .+.+
T Consensus 166 ~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 166 ARAFSLSKNSK--PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred cccccCCcccC--CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 98764332111 0112345678899999988654 478999999999999999999999864432111 000 0110
Q ss_pred ccccCCC------------CCC---------CCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 563 SSILDPL------------AGD---------WPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 563 ~~~ldp~------------~~~---------~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
...+-+. ... .+......+.+|+.+||..||.+||++.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~ 304 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA 304 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence 0000000 000 000123467899999999999999999843
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=295.10 Aligned_cols=231 Identities=25% Similarity=0.344 Sum_probs=179.0
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHc---CCCCceeeEecccC--CCceeEEeeCC
Q 005616 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSK---LQHPHLVTLLGACP--EAWSLVYEYLP 418 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~---l~HpnIV~l~g~~~--~~~~LV~E~~~ 418 (688)
.||+|+||.||++... +..||||.+...... ....+.+|..++.. .+||||+.+++++. +..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999885 789999998764332 12234455544433 47999999998884 45789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
+|+|.+++... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 99999988654 35899999999999999999999966 9999999999999999999999999987553221
Q ss_pred CCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhH-HHHHhhcCccccccCCCCCCCCHH
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGE-VRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~-~~~~i~~~~l~~~ldp~~~~~~~~ 576 (688)
.....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||..... ....+..... ......+..
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~ 221 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-----TVNVELPDS 221 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-----cCCcCCccc
Confidence 123469999999998864 5689999999999999999999999964321 1111111110 001123445
Q ss_pred HHHHHHHHHHHcccCCCCCCCC
Q 005616 577 VARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RPs 598 (688)
.+..+.+++.+||+.||.+||+
T Consensus 222 ~~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 222 FSPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred cCHHHHHHHHHHhcCCHHHhcC
Confidence 6678999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=296.45 Aligned_cols=238 Identities=22% Similarity=0.331 Sum_probs=191.8
Q ss_pred eeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeCCCCcHH
Q 005616 348 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNGSLQ 423 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~gsL~ 423 (688)
.+||+|+||.||+|... |..||||.+..........+.+|+.+++.++||||+++++++. +..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 56999999999999885 7899999986555445567999999999999999999999884 4588999999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCccc
Q 005616 424 DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503 (688)
Q Consensus 424 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~ 503 (688)
+++.. ..+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~------~~ 172 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV------PR 172 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc------cc
Confidence 98743 24789999999999999999999965 9999999999999999999999999987654322 11
Q ss_pred cCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHH--HHhhcCccccccCCCCCCCCHHHHHHH
Q 005616 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWPTFVARRL 581 (688)
Q Consensus 504 ~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~i~~~~l~~~ldp~~~~~~~~~~~~l 581 (688)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||....... ..+..+ +.. ... .....+..+
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~----~~~-~~~~~~~~l 246 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPP----KLK-NLHKVSPSL 246 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-CCc----ccC-CcccCCHHH
Confidence 234568999999999988889999999999999999999999997543321 112111 111 010 112345578
Q ss_pred HHHHHHcccCCCCCCCCCcHHHH
Q 005616 582 VDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 582 ~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
.+++.+||+.+|.+||++.+.+.
T Consensus 247 ~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 247 KGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHhCCcccCcCHHHHhc
Confidence 89999999999999999985443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=288.13 Aligned_cols=239 Identities=24% Similarity=0.348 Sum_probs=187.7
Q ss_pred eeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCC-CCceeeEecccC--CCceeEEeeCCCCc
Q 005616 348 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ-HPHLVTLLGACP--EAWSLVYEYLPNGS 421 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~--~~~~LV~E~~~~gs 421 (688)
..||.|..|.|++++.. |...|||.+..... ...+++...++++..-+ .|+||+.+|+|. ....+.||.|. .-
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TC 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HH
Confidence 45999999999999987 68999999977654 34556888888877764 999999999994 35778888873 34
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCc
Q 005616 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~ 501 (688)
++.+|.+.. .++++..+-++...+++||.||...+ +|||||+||+|||||..|++||||||++-.+.+...
T Consensus 177 ~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA----- 247 (391)
T KOG0983|consen 177 AEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA----- 247 (391)
T ss_pred HHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc-----
Confidence 445554433 46788888899999999999999865 799999999999999999999999999988765542
Q ss_pred cccCCCCCCCCCCChhhhcc---CCCCCcchHhHHHHHHHHHHhCCCCCCChh---HHHHHhhcCccccccCCCCCCCCH
Q 005616 502 HRSTAPKGSFPYADPEYHRT---GVLTPKSDSYSFGLIILQLLTGRLPVGLAG---EVRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 502 ~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSfGviL~ELltG~~Pf~~~~---~~~~~i~~~~l~~~ldp~~~~~~~ 575 (688)
.+..+|-+.|||||.+.. ..|+.++||||||+.|+||.||+.||.+.+ ++...+... .. |.+ ....
T Consensus 248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~-eP----P~L-~~~~ 319 (391)
T KOG0983|consen 248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE-EP----PLL-PGHM 319 (391)
T ss_pred --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc-CC----CCC-Cccc
Confidence 245679999999998754 478999999999999999999999998643 222223221 11 211 1122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
.++..+.+++..||..|+.+||...+.+.
T Consensus 320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 36789999999999999999999985443
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=302.51 Aligned_cols=245 Identities=26% Similarity=0.324 Sum_probs=187.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--------
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------- 408 (688)
.++|.....||.|+||.||+|... |..||||++..... .....+.+|+.++..++||||++++++|..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999875 88999999865422 223468899999999999999999998742
Q ss_pred CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcc
Q 005616 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla 488 (688)
..++|++|+.+ +|..++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 25899999964 6766542 35789999999999999999999966 999999999999999999999999998
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH---HhhcC----
Q 005616 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSCG---- 560 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~---~i~~~---- 560 (688)
+..... .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||........ .+...
T Consensus 165 ~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (342)
T cd07879 165 RHADAE---------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235 (342)
T ss_pred cCCCCC---------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 765321 134467889999998866 4689999999999999999999999975432111 11100
Q ss_pred ----------ccccccC--CC--CCCC---CHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 561 ----------KLSSILD--PL--AGDW---PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 561 ----------~l~~~ld--p~--~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.....+. +. ...+ .+..+..+.+|+.+||+.||.+||++.+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l 295 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 0000000 00 0000 012345788999999999999999998544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=299.09 Aligned_cols=292 Identities=26% Similarity=0.375 Sum_probs=219.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCCCCCCccccccCCCCCcccCHHHHHHHhcCcccceeeeccCceEEEE
Q 005616 281 IATLQQEKQRIRRQKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYK 360 (688)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~el~~at~~f~~~~~LG~G~~G~Vy~ 360 (688)
.+.++-+++++.+.+..-+|.+.|...... -.|.|-....++|-..++||+|||+.||+
T Consensus 423 EaeiqaElERLErvrnlHiRELKRi~NEdn---------------------SQFkDHptLn~RYLlLhLLGrGGFSEVyK 481 (775)
T KOG1151|consen 423 EAEIQAELERLERVRNLHIRELKRIHNEDN---------------------SQFKDHPTLNDRYLLLHLLGRGGFSEVYK 481 (775)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhcccch---------------------hhhccCcchHHHHHHHHHhccccHHHHHH
Confidence 344455566666666666666665421100 01223334556788889999999999999
Q ss_pred EEEC--CeEEEEEEEecCC-ccc------hHHHHHHHHHHHcCCCCceeeEeccc---CCCceeEEeeCCCCcHHHHhcc
Q 005616 361 GEML--GRTVAIKMLYSHN-MQG------QLEFQQEVRVLSKLQHPHLVTLLGAC---PEAWSLVYEYLPNGSLQDRLFR 428 (688)
Q Consensus 361 g~~~--g~~VAIK~l~~~~-~~~------~~~f~~E~~iL~~l~HpnIV~l~g~~---~~~~~LV~E~~~~gsL~~~L~~ 428 (688)
+.+. .+.||+|+-..+. +.+ .+...+|.+|...|.||.||++|++| .+.+|-|+|||+|.+|+-+|..
T Consensus 482 AFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQ 561 (775)
T KOG1151|consen 482 AFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ 561 (775)
T ss_pred hcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHh
Confidence 9775 7889999875432 111 23467899999999999999999999 3568999999999999999976
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC---CCceEEeecCccccccCCCCc-CCCcccc
Q 005616 429 KSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLVTEDTLY-LPSFHRS 504 (688)
Q Consensus 429 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~---~~~~KL~DFGla~~~~~~~~~-~~~~~~~ 504 (688)
.. .+++.++..|+.||+.||.||.... .||||-||||.||||-+ .|.+||+|||+++.+.++... ......+
T Consensus 562 hk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLT 637 (775)
T KOG1151|consen 562 HK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELT 637 (775)
T ss_pred hh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeee
Confidence 54 5788999999999999999999988 68999999999999954 488999999999998765543 2233445
Q ss_pred CCCCCCCCCCChhhhcc----CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCC--CHHHH
Q 005616 505 TAPKGSFPYADPEYHRT----GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW--PTFVA 578 (688)
Q Consensus 505 ~~~~Gt~~Y~APE~~~~----~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~--~~~~~ 578 (688)
...+||..|++||.|.- .+.+.|+||||+|||+|.++.|+.||+....-...+....+ +....-.+ .+.++
T Consensus 638 SQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI---lkAtEVqFP~KPvVs 714 (775)
T KOG1151|consen 638 SQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI---LKATEVQFPPKPVVS 714 (775)
T ss_pred cccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch---hcceeccCCCCCccC
Confidence 67899999999997743 35788999999999999999999999854433333322221 11111122 23567
Q ss_pred HHHHHHHHHcccCCCCCCCCCc
Q 005616 579 RRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 579 ~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
.+...+|.+||++.-++|.+..
T Consensus 715 seAkaFIRRCLaYRKeDR~DV~ 736 (775)
T KOG1151|consen 715 SEAKAFIRRCLAYRKEDRIDVQ 736 (775)
T ss_pred HHHHHHHHHHHHhhhhhhhhHH
Confidence 7899999999999999998765
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=291.50 Aligned_cols=248 Identities=25% Similarity=0.303 Sum_probs=193.5
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeC
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
|.....||.|++|.||+|... |..+++|.+...... ....+.+|+.++++++||||+++++++.+ ..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456678999999999999885 888999998765433 34578899999999999999999998854 578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++ +|..++.... ..+++..+..++.+++.||.|||..+ |+|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 75 8888776543 46899999999999999999999966 99999999999999999999999999987754331
Q ss_pred CCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH---hhc-Cc-----cccccC
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSC-GK-----LSSILD 567 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---i~~-~~-----l~~~ld 567 (688)
......++..|+|||.+.+. .++.++||||||+++|+|+||+.||......... ... +. .....+
T Consensus 154 -----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 154 -----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred -----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence 12334688899999998776 7899999999999999999999999654432211 000 00 000000
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 568 --------------PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 568 --------------p~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
..........+..+.+++.+||+.||.+||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll 278 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHh
Confidence 000111224567899999999999999999998443
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=316.36 Aligned_cols=255 Identities=28% Similarity=0.409 Sum_probs=198.7
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC--------Cce
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--------AWS 411 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--------~~~ 411 (688)
.|.....||+||||.||+|+.+ |..||||.++... ....+...+|+++|++++|||||++++.-.+ ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3455678999999999999976 9999999998754 4566778999999999999999999988533 357
Q ss_pred eEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeC--CCC--ceEEeecCc
Q 005616 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD--SEL--SSKICDFGI 487 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd--~~~--~~KL~DFGl 487 (688)
+|||||.||||...|....+...|++.+.+.++.+++.||.|||.++ ||||||||.||++- .+| ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999999888889999999999999999999999866 99999999999984 333 489999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhc-cCCCCCcchHhHHHHHHHHHHhCCCCCCChhH-------HHHHhhc
Q 005616 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR-TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE-------VRRAVSC 559 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~-------~~~~i~~ 559 (688)
|+.+.++. .....+||..|++||.+. .+.|+.-+|.|||||++|+++||..||..... ++..+..
T Consensus 171 Arel~d~s-------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk 243 (732)
T KOG4250|consen 171 ARELDDNS-------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK 243 (732)
T ss_pred cccCCCCC-------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc
Confidence 99988765 346789999999999988 58899999999999999999999999953221 1111111
Q ss_pred ---Ccccccc----CC--------CCCCCCHHHHHHHHHHHHHcccCCCCCCC--CCcHHHHHHHH
Q 005616 560 ---GKLSSIL----DP--------LAGDWPTFVARRLVDLGLQCCELYGRERP--DITPSLVKELE 608 (688)
Q Consensus 560 ---~~l~~~l----dp--------~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP--s~~e~l~~~Le 608 (688)
+...-.. +| ............+-..+..+|..+|.+|- ... .....+.
T Consensus 244 kp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~-~~Fa~~~ 308 (732)
T KOG4250|consen 244 KPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFD-RFFAEVD 308 (732)
T ss_pred CCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcc-hHHHHHH
Confidence 0000000 01 01112233455677777888889999998 444 3333333
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=302.94 Aligned_cols=257 Identities=23% Similarity=0.266 Sum_probs=196.3
Q ss_pred ccCHHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEeccc
Q 005616 331 EFSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406 (688)
Q Consensus 331 ~~~~~el~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~ 406 (688)
.....++..++++|.....||+|+||.||+|... |..||+|++.... ......+.+|+.++.+++||||+++++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 3456678889999999999999999999999874 8899999987542 22345688999999999999999999987
Q ss_pred CC--------CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC
Q 005616 407 PE--------AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL 478 (688)
Q Consensus 407 ~~--------~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~ 478 (688)
.. ..+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 157 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence 32 256777776 7899887754 24889999999999999999999966 99999999999999999
Q ss_pred ceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH--
Q 005616 479 SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR-- 555 (688)
Q Consensus 479 ~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~-- 555 (688)
.+||+|||++...... .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 158 ~~kl~dfg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 228 (345)
T cd07877 158 ELKILDFGLARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 228 (345)
T ss_pred CEEEeccccccccccc---------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999998764322 234568899999998866 5689999999999999999999999964332111
Q ss_pred -Hhh-cCc-cccc---------------cC----CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 556 -AVS-CGK-LSSI---------------LD----PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 556 -~i~-~~~-l~~~---------------ld----p~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
... .+. ...+ +. ....+.....+..+.+|+.+|++.||.+||++.+.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 229 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 000 000 0000 00 0000001123557899999999999999999885443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=295.01 Aligned_cols=256 Identities=25% Similarity=0.335 Sum_probs=190.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc--hHHHHHHHHHHHcCCCCceeeEecccCC--------
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGACPE-------- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~--~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------- 408 (688)
.++|...+.||.|+||.||+|... +..||||++....... ...+.+|+.++..++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999985 7889999986554322 3457889999999999999999987632
Q ss_pred --CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecC
Q 005616 409 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 409 --~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFG 486 (688)
..++||+|+.+ +|...+.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 25899999975 5666665432 46899999999999999999999966 9999999999999999999999999
Q ss_pred ccccccCCCCcCC-----CccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH---Hh
Q 005616 487 ICRLVTEDTLYLP-----SFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AV 557 (688)
Q Consensus 487 la~~~~~~~~~~~-----~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~---~i 557 (688)
++........... .........|++.|+|||++.+. .++.++|||||||++|+|++|++||........ .+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9987653322111 11122345678999999987654 589999999999999999999999964332111 00
Q ss_pred hc-Cc-----------cccccC-CCCCCCC-------HHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 558 SC-GK-----------LSSILD-PLAGDWP-------TFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 558 ~~-~~-----------l~~~ld-p~~~~~~-------~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
.. +. +....+ ......+ ......+.+++.+||+.||.+|||+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~el 305 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA 305 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHH
Confidence 00 00 000000 0000011 1123578899999999999999998743
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.26 Aligned_cols=252 Identities=22% Similarity=0.283 Sum_probs=193.7
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC-------C
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------A 409 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------~ 409 (688)
.++|.....||.|+||.||+|... +..||||.+.... ......+.+|+.++..++||||+++++++.. .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457889999999999999999875 8899999987542 2334567889999999999999999998742 2
Q ss_pred ceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccc
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~ 489 (688)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 689999996 6888887643 35889999999999999999999966 9999999999999999999999999998
Q ss_pred cccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH-------------
Q 005616 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR------------- 555 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~------------- 555 (688)
....... ......|+..|+|||++.. ..++.++|||||||++|+|++|++||........
T Consensus 157 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 157 TTSEKGD------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred ccCCCcc------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 7643321 1234467899999998765 4689999999999999999999999964321100
Q ss_pred ----HhhcCcccccc-------CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHH
Q 005616 556 ----AVSCGKLSSIL-------DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 556 ----~i~~~~l~~~l-------dp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~ 605 (688)
.+..+.....+ ++.........+..+.+|+.+||+.+|.+||++.+.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000000 000011122356788999999999999999999855544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=295.14 Aligned_cols=241 Identities=27% Similarity=0.359 Sum_probs=189.6
Q ss_pred CcccceeeeccCceEEEEEEE-----CCeEEEEEEEecCCc----cchHHHHHHHHHHHcC-CCCceeeEecccCC--Cc
Q 005616 343 NFSESFKVGQGGFGCVYKGEM-----LGRTVAIKMLYSHNM----QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AW 410 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~-----~g~~VAIK~l~~~~~----~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~ 410 (688)
+|.....||.|+||.||++.. .|..||+|++..... .....+.+|+.++..+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477788999999999999986 478899999975432 2345688999999999 59999999988854 36
Q ss_pred eeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 8999999999999998654 35788999999999999999999966 99999999999999999999999999987
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccC--CCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCcccccc
Q 005616 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG--VLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSIL 566 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~--~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~l 566 (688)
....... ......|+..|+|||++... .++.++||||||+++|+|++|..||...... ...+... +
T Consensus 155 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-----~ 224 (290)
T cd05613 155 FHEDEVE-----RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR-----I 224 (290)
T ss_pred ccccccc-----ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH-----h
Confidence 6433211 12345689999999988653 5788999999999999999999999632210 0111000 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCC
Q 005616 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDI 599 (688)
Q Consensus 567 dp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 599 (688)
......++..+...+.+++.+||+.+|.+||+.
T Consensus 225 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~ 257 (290)
T cd05613 225 LKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGC 257 (290)
T ss_pred hccCCCCCccCCHHHHHHHHHHhcCCHHHhcCC
Confidence 001112344456788999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=301.91 Aligned_cols=250 Identities=22% Similarity=0.283 Sum_probs=193.1
Q ss_pred HHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC----
Q 005616 337 LQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE---- 408 (688)
Q Consensus 337 l~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~---- 408 (688)
+...+++|...+.||+|+||.||+|... |..||||++..... .....+.+|+.++..++||||+++++++..
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445788999999999999999999875 88999999864322 223468899999999999999999998843
Q ss_pred ----CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEee
Q 005616 409 ----AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICD 484 (688)
Q Consensus 409 ----~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~D 484 (688)
..++||+|+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 247999999 7799888753 35889999999999999999999966 99999999999999999999999
Q ss_pred cCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH---hhc-
Q 005616 485 FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSC- 559 (688)
Q Consensus 485 FGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---i~~- 559 (688)
||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||......... ...
T Consensus 162 fg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07880 162 FGLARQTDSE---------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232 (343)
T ss_pred cccccccccC---------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9998865432 133467899999998866 46889999999999999999999999754321111 000
Q ss_pred -------------CccccccCCC-------CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 560 -------------GKLSSILDPL-------AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 560 -------------~~l~~~ldp~-------~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
......+... .......++..+.+++.+|++.||.+||++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0000000000 0011123455789999999999999999998544
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=288.80 Aligned_cols=248 Identities=27% Similarity=0.374 Sum_probs=189.5
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcC---CCCceeeEecccCC--C-----
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKL---QHPHLVTLLGACPE--A----- 409 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l---~HpnIV~l~g~~~~--~----- 409 (688)
|.+...||.|+||.||+|... +..||||++...... ....+.+|+.++.++ +||||++++++|.. .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999986 789999999754332 234566788877666 59999999999842 3
Q ss_pred ceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccc
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~ 489 (688)
.+++|||+.+ +|.+++..... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 7899999975 78888865432 35899999999999999999999966 9999999999999999999999999998
Q ss_pred cccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH---HhhcCc----c
Q 005616 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSCGK----L 562 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~---~i~~~~----l 562 (688)
....... .....++..|+|||++.+..++.++|||||||++|+|++|.+||........ ....-. .
T Consensus 156 ~~~~~~~-------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 156 IYSFEMA-------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228 (287)
T ss_pred eccCCcc-------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChH
Confidence 7644321 1234578899999999999999999999999999999999999865432211 111000 0
Q ss_pred c---------cccCCC----CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 563 S---------SILDPL----AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 563 ~---------~~ldp~----~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
. ...... ...........+.+++.+||+.||.+||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 0 000000 0111123457889999999999999999998443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=286.80 Aligned_cols=232 Identities=25% Similarity=0.292 Sum_probs=183.7
Q ss_pred eeeeccCceEEEEEEEC--CeEEEEEEEecCCccc---hHHHHHHHHHH-HcCCCCceeeEecccCC--CceeEEeeCCC
Q 005616 348 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---QLEFQQEVRVL-SKLQHPHLVTLLGACPE--AWSLVYEYLPN 419 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~---~~~f~~E~~iL-~~l~HpnIV~l~g~~~~--~~~LV~E~~~~ 419 (688)
+.||.|+||.||+|... |..||||++....... ...+..|..++ ...+||||+++++++.+ ..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999885 7899999987554322 22345555544 44589999999999854 48899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC
Q 005616 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 9999998654 35788999999999999999999966 99999999999999999999999999876432
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHH
Q 005616 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~ 577 (688)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||..... ....+..+.... .......+
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 220 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW-----PEEVKEFC 220 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCC-----CCcccccC
Confidence 1234688999999999888899999999999999999999999965432 222222222110 01112235
Q ss_pred HHHHHHHHHHcccCCCCCCCCCc
Q 005616 578 ARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 578 ~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
+..+.+++.+||+.+|++||++.
T Consensus 221 ~~~~~~~i~~~l~~~p~~R~~~~ 243 (260)
T cd05611 221 SPEAVDLINRLLCMDPAKRLGAN 243 (260)
T ss_pred CHHHHHHHHHHccCCHHHccCCC
Confidence 67899999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=292.78 Aligned_cols=247 Identities=25% Similarity=0.332 Sum_probs=189.0
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCC-CCceeeEecccCC--CceeEEeeC
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ-HPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
|...+.||.|+||.||+|... +..|+||.+..... .......+|+..+.+++ ||||+++++++.+ ..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 556788999999999999985 78899999865432 22334567999999999 9999999999844 578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
+|+|.+++.... ...+++..+..++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889998886654 246899999999999999999999966 99999999999999999999999999986643321
Q ss_pred CCCccccCCCCCCCCCCChhhhc-cCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhc-----------------
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHR-TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----------------- 559 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~-~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~----------------- 559 (688)
.....|+..|+|||++. ...++.++||||||+++|+|++|++||............
T Consensus 155 ------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 155 ------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred ------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 13346889999999874 456899999999999999999999999644322111000
Q ss_pred --CccccccCCC----CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 560 --GKLSSILDPL----AGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 560 --~~l~~~ldp~----~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
......+... ..+........+.+++.+||+.+|.+||++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei 277 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQA 277 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHH
Confidence 0000000000 001111124679999999999999999999843
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=322.14 Aligned_cols=256 Identities=16% Similarity=0.248 Sum_probs=180.0
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC---CeEEEEEEEe--------------c---CCccchHHHHHHHHHHHcCCCCc
Q 005616 339 TATCNFSESFKVGQGGFGCVYKGEML---GRTVAIKMLY--------------S---HNMQGQLEFQQEVRVLSKLQHPH 398 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~~G~Vy~g~~~---g~~VAIK~l~--------------~---~~~~~~~~f~~E~~iL~~l~Hpn 398 (688)
...++|.+...||+|+||.||++... +..+++|.+. . ........+.+|+.+|.+++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998764 2222222110 0 11122345889999999999999
Q ss_pred eeeEecccC--CCceeEEeeCCCCcHHHHhcccCC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee
Q 005616 399 LVTLLGACP--EAWSLVYEYLPNGSLQDRLFRKSN--VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 474 (688)
Q Consensus 399 IV~l~g~~~--~~~~LV~E~~~~gsL~~~L~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL 474 (688)
||++++++. +..++|++++. ++|..++..... ........+..|+.||+.||.|||+.+ ||||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 999999984 45788999985 566666543221 122345667889999999999999965 9999999999999
Q ss_pred CCCCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCC-CCCChh--
Q 005616 475 DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL-PVGLAG-- 551 (688)
Q Consensus 475 d~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~-Pf~~~~-- 551 (688)
+.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||+||||++|.. ||....
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-----FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-----ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 99999999999999876543211 1234679999999999999999999999999999999999875 443211
Q ss_pred ---HHHHHhhcC-----ccc-------cccCC-----CCCCCCH-----HHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 552 ---EVRRAVSCG-----KLS-------SILDP-----LAGDWPT-----FVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 552 ---~~~~~i~~~-----~l~-------~~ldp-----~~~~~~~-----~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.+...+..- .+. ..++. .....+. .....+.+++.+||+.||.+||++.+.+
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL 452 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL 452 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence 111111100 000 00000 0000000 1234678889999999999999999544
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=292.67 Aligned_cols=249 Identities=27% Similarity=0.355 Sum_probs=193.7
Q ss_pred CcccceeeeccCceEEEEEEEC-----CeEEEEEEEecCCc----cchHHHHHHHHHHHcC-CCCceeeEecccCC--Cc
Q 005616 343 NFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM----QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AW 410 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~-----g~~VAIK~l~~~~~----~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~ 410 (688)
+|...+.||.|+||.||++... +..||||+++.... .....+.+|+.++.++ +||||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4677889999999999998753 57899999875432 2334688999999999 59999999988854 47
Q ss_pred eeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 8999999999999998654 35788999999999999999999865 99999999999999999999999999877
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccCC--CCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCcccccc
Q 005616 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV--LTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSIL 566 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~--~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~l 566 (688)
....... ......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||...... ...+......
T Consensus 155 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--- 226 (288)
T cd05583 155 FLAEEEE-----RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--- 226 (288)
T ss_pred ccccccc-----ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc---
Confidence 5433211 123456899999999987665 788999999999999999999999632211 0111110000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 567 dp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
.....+...+..+.+++.+||+.+|++|||+. .+...|+
T Consensus 227 --~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~-~~~~~l~ 265 (288)
T cd05583 227 --SKPPFPKTMSAEARDFIQKLLEKDPKKRLGAN-GADEIKN 265 (288)
T ss_pred --cCCCCCcccCHHHHHHHHHHhcCCHhhccCcc-hHHHHhc
Confidence 01122334556789999999999999999987 5555544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=292.01 Aligned_cols=239 Identities=26% Similarity=0.308 Sum_probs=200.7
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchH---HHHHHHHHHHcCCCCceeeEecccC--CCceeE
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL---EFQQEVRVLSKLQHPHLVTLLGACP--EAWSLV 413 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~---~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV 413 (688)
-++|...++||+|.||.|-+++-. |+.+|||++++...-... .-..|-++|...+||.+..|-..|+ +.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 367888999999999999999876 899999999987664444 3567899999999999999988884 468999
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
|||..||.|.-+|.+.. .+++.....+-..|+.||.|||+.+ ||.||||.+|+|||.+|++||+|||+++.--.
T Consensus 247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999999887754 4666777778899999999999966 99999999999999999999999999987543
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~ 571 (688)
.. ..+...+|||.|+|||++....|+..+|+|.+||++|||++|+.||...+. ....+..+. -
T Consensus 321 ~g------~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed---------~ 385 (516)
T KOG0690|consen 321 YG------DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED---------L 385 (516)
T ss_pred cc------ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh---------c
Confidence 33 235788999999999999999999999999999999999999999965432 223332222 2
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
.+|...+++...|+...|..||.+|-.-.
T Consensus 386 kFPr~ls~eAktLLsGLL~kdP~kRLGgG 414 (516)
T KOG0690|consen 386 KFPRTLSPEAKTLLSGLLKKDPKKRLGGG 414 (516)
T ss_pred cCCccCCHHHHHHHHHHhhcChHhhcCCC
Confidence 46667788899999999999999996543
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=308.28 Aligned_cols=252 Identities=26% Similarity=0.321 Sum_probs=196.2
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCC-CC-----ceeeEeccc--CCCcee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HP-----HLVTLLGAC--PEAWSL 412 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-Hp-----nIV~l~g~~--~~~~~L 412 (688)
+|.+...||+|.||.|-+|.+. +..||||+++.... -..+-..|+.+|..|+ |. |+|+++++| .+..||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7889999999999999999886 78999999976532 2234567999999997 43 899999998 567999
Q ss_pred EEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC--CceEEeecCcccc
Q 005616 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE--LSSKICDFGICRL 490 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~--~~~KL~DFGla~~ 490 (688)
|+|.+ ..+|.++|..+. +.+|+...+..|+.||+.||.+||..+ |||+||||+||||..- ..+||+|||.|..
T Consensus 266 VfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99998 569999997654 567999999999999999999999976 9999999999999654 3699999999988
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH--------------
Q 005616 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA-------------- 556 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~-------------- 556 (688)
..... ....-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+..+..+.
T Consensus 341 ~~q~v---------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 341 ESQRV---------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred cCCcc---------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 76543 2445678899999999999999999999999999999998888644432111
Q ss_pred hhcC-cccccc------------------------------------CC-CCCCC----CHHHHHHHHHHHHHcccCCCC
Q 005616 557 VSCG-KLSSIL------------------------------------DP-LAGDW----PTFVARRLVDLGLQCCELYGR 594 (688)
Q Consensus 557 i~~~-~l~~~l------------------------------------dp-~~~~~----~~~~~~~l~~Li~~Cl~~dP~ 594 (688)
+..+ +....+ .| ....+ +......+++++.+||..||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 0000 000000 01 00011 112345789999999999999
Q ss_pred CCCCCcHHHHHHHHH
Q 005616 595 ERPDITPSLVKELEQ 609 (688)
Q Consensus 595 ~RPs~~e~l~~~Le~ 609 (688)
.|+|..+.+.+.+-.
T Consensus 492 ~R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 492 ERITPAQALNHPFLT 506 (586)
T ss_pred hcCCHHHHhcCcccc
Confidence 999999777665543
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=288.95 Aligned_cols=230 Identities=26% Similarity=0.342 Sum_probs=178.3
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHH---HHcCCCCceeeEecccCC--CceeEEeeCC
Q 005616 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRV---LSKLQHPHLVTLLGACPE--AWSLVYEYLP 418 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~i---L~~l~HpnIV~l~g~~~~--~~~LV~E~~~ 418 (688)
.||+|+||.||++... ++.||||.+...... ....+..|..+ +....||||+.+++++.+ ..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999875 789999998765332 12234445443 444579999999998853 5789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
||+|..++... ..+++..+..|+.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 99999988643 36899999999999999999999966 9999999999999999999999999987653321
Q ss_pred CCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHH-HHhhcCccccccCCCCCCCCHH
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR-RAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~-~~i~~~~l~~~ldp~~~~~~~~ 576 (688)
.....|+..|+|||++.++ .++.++|||||||++|+|++|+.||....... ....... ......++..
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 221 (278)
T cd05606 152 -----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-----LTMAVELPDS 221 (278)
T ss_pred -----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-----hccCCCCCCc
Confidence 1344689999999998754 68999999999999999999999996442110 0000000 0011123334
Q ss_pred HHHHHHHHHHHcccCCCCCCC
Q 005616 577 VARRLVDLGLQCCELYGRERP 597 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RP 597 (688)
.+..+.+++.+|+..+|.+||
T Consensus 222 ~s~~~~~li~~~l~~~p~~R~ 242 (278)
T cd05606 222 FSPELRSLLEGLLQRDVNRRL 242 (278)
T ss_pred CCHHHHHHHHHHhhcCHHhcc
Confidence 567899999999999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=285.21 Aligned_cols=243 Identities=24% Similarity=0.311 Sum_probs=191.5
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-----ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-----MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~-----~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
+|...+.||+|+||.||++... +..+++|+++... ......+..|+.++..++||||+++++++.+ ..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4677789999999999999886 4556666665422 1233457789999999999999999999843 57899
Q ss_pred EeeCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccccc
Q 005616 414 YEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~ 492 (688)
|||+++++|.+++... .....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988653 22356899999999999999999999965 999999999999975 569999999988764
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH--HhhcCccccccCCCC
Q 005616 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSCGKLSSILDPLA 570 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~i~~~~l~~~ldp~~ 570 (688)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|..||........ .+..+. .
T Consensus 157 ~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~--------~ 222 (260)
T cd08222 157 GSCD------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP--------T 222 (260)
T ss_pred CCcc------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC--------C
Confidence 3321 12345688999999999888899999999999999999999999964433221 111111 1
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
...+..++..+.+++.+||..+|.+||++.+.+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 255 (260)
T cd08222 223 PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEIL 255 (260)
T ss_pred CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 123445667899999999999999999998433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=336.15 Aligned_cols=252 Identities=27% Similarity=0.341 Sum_probs=204.4
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEeccc--CCC
Q 005616 336 DLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEA 409 (688)
Q Consensus 336 el~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~--~~~ 409 (688)
-+...+-++.....||.|.||.||.|... |...|+|-++.... .....+.+|+.+|..|+|||+|++||+- .+.
T Consensus 1229 ~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1229 SLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred HhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence 35566778888999999999999999875 88899998765443 3344688999999999999999999986 456
Q ss_pred ceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccc
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~ 489 (688)
.+|.||||.+|+|.+.+..... .++.....+..|++.|+.|||+.+ ||||||||.||||+.+|.+|++|||.|.
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccccee
Confidence 8999999999999999876542 444555667899999999999976 9999999999999999999999999999
Q ss_pred cccCCCCcCCCccccCCCCCCCCCCChhhhccC---CCCCcchHhHHHHHHHHHHhCCCCCCChhH---HHHHhhcCccc
Q 005616 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG---VLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRRAVSCGKLS 563 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~---~~s~ksDVwSfGviL~ELltG~~Pf~~~~~---~~~~i~~~~l~ 563 (688)
.+.......+ ..-....||+.|||||++.+. +...+.||||+|||++||+||+.||...+. +...+..|...
T Consensus 1383 ki~~~~~~~~--~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1383 KIKNNAQTMP--GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP 1460 (1509)
T ss_pred EecCchhcCC--HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC
Confidence 8876542222 223467899999999999654 466799999999999999999999975543 22334455443
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 564 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 ~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
+.|...+..-.+++.+||+.||+.|.++.|.+
T Consensus 1461 --------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1461 --------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred --------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHH
Confidence 45666888899999999999999997765433
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.67 Aligned_cols=237 Identities=26% Similarity=0.355 Sum_probs=187.1
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEee
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
|.....||.|+||.||+|... |..|+||.+...... ....+.+|+.++..++|||++++++++.+ ..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999875 889999998754332 23468899999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+. |+|.+.+.... .++++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 57777765433 46899999999999999999999966 99999999999999999999999999864321
Q ss_pred cCCCccccCCCCCCCCCCChhhhc---cCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH--hhcCccccccCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPLAG 571 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--i~~~~l~~~ldp~~~ 571 (688)
.....|+..|+|||++. .+.++.++|||||||++|+|++|.+||......... +..+.....
T Consensus 174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 240 (313)
T cd06633 174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL------ 240 (313)
T ss_pred -------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------
Confidence 23456889999999874 466889999999999999999999998654332211 111111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
.....+..+.+|+.+||+.+|.+||++.+.+
T Consensus 241 -~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l 271 (313)
T cd06633 241 -QSNEWTDSFRGFVDYCLQKIPQERPASAELL 271 (313)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1112345789999999999999999998444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=296.26 Aligned_cols=250 Identities=25% Similarity=0.321 Sum_probs=192.6
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccC---C
Q 005616 336 DLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP---E 408 (688)
Q Consensus 336 el~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~---~ 408 (688)
++..++++|.....||.|+||.||++... +..||||++..... .....+..|+.++..++||||++++++|. .
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34557889999999999999999999875 78999998864322 23456889999999999999999999873 3
Q ss_pred CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcc
Q 005616 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla 488 (688)
..++|+||+ +++|..++.. .++++..+..++.|++.||.|||+.+ |+||||+|+|||++.++.++|+|||++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence 478999998 5688888753 34788888999999999999999966 999999999999999999999999998
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHH-------------
Q 005616 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR------------- 554 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~------------- 554 (688)
...... .....++..|+|||++.+ ..++.++|||||||++|+|+||++||.......
T Consensus 156 ~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 226 (328)
T cd07856 156 RIQDPQ---------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226 (328)
T ss_pred cccCCC---------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 754321 123467889999998765 578999999999999999999999996433211
Q ss_pred ----HHhhcCccccccCCC--CCCCC-----HHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 555 ----RAVSCGKLSSILDPL--AGDWP-----TFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 555 ----~~i~~~~l~~~ldp~--~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
..+..+.....+... ....+ ...+..+.+++.+||+.+|.+||++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~el 285 (328)
T cd07856 227 DDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA 285 (328)
T ss_pred HHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 000001100010000 00111 1245689999999999999999998843
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.85 Aligned_cols=239 Identities=26% Similarity=0.346 Sum_probs=188.6
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~ 414 (688)
+.|...+.||.|+||.||+|+.. +..||||.+..... .....+.+|+.+++.++|||++++++++. +..++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666788999999999999885 78899999865322 23346889999999999999999999874 3578999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+. |+|.+.+.... .++++..+..++.+++.||.|||+.+ ++||||+|+|||++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 57777765433 45789999999999999999999965 999999999999999999999999998765432
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhc---cCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCccccccCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPL 569 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~l~~~ldp~ 569 (688)
....|++.|+|||++. ...++.++|||||||++|+|++|..||...... ...+..+....
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----- 233 (308)
T cd06634 169 ----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA----- 233 (308)
T ss_pred ----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCC-----
Confidence 2346889999999874 356889999999999999999999998654322 11222221111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
..+...+..+.+|+.+||..+|.+||++.+.+
T Consensus 234 --~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll 265 (308)
T cd06634 234 --LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265 (308)
T ss_pred --cCcccccHHHHHHHHHHhhCCcccCCCHHHHh
Confidence 11224566789999999999999999988433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=296.58 Aligned_cols=252 Identities=26% Similarity=0.306 Sum_probs=195.2
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC-------Cce
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------AWS 411 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------~~~ 411 (688)
+|.....||.|+||.||+|... +..||||.+.... ......+.+|+.++..++||||+++++++.. ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999985 7899999987654 3345678999999999999999999999843 368
Q ss_pred eEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccc
Q 005616 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~ 491 (688)
+||+|+. ++|.+++.... .+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 47888886543 6899999999999999999999966 999999999999999999999999999887
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHH--H-hhc-C------
Q 005616 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--A-VSC-G------ 560 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~-i~~-~------ 560 (688)
...... ........+++.|+|||++.+. .++.++||||||+++|+|++|.+||........ . ... +
T Consensus 154 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDE---KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred cccccc---cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 544210 0112345688999999999887 899999999999999999999999964432111 0 000 0
Q ss_pred -------ccccccC---CC----CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 561 -------KLSSILD---PL----AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 561 -------~l~~~ld---p~----~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
.....+. .. ........+..+.+++.+||+.+|.+||++.+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0000000 00 00011224567899999999999999999985443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=293.69 Aligned_cols=254 Identities=19% Similarity=0.242 Sum_probs=187.6
Q ss_pred eeecc--CceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCC
Q 005616 349 KVGQG--GFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G--~~G~Vy~g~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+| +||+||++.+. |+.||||++...... ..+.+.+|+.++..++||||++++++|.. ..++||||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 99999999884 899999998754332 34568899999999999999999999854 478999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC-
Q 005616 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP- 499 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~- 499 (688)
+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++++|||.+...........
T Consensus 85 ~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99998876432 35889999999999999999999865 99999999999999999999999986544322111100
Q ss_pred CccccCCCCCCCCCCChhhhccC--CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhh--cCccc------------
Q 005616 500 SFHRSTAPKGSFPYADPEYHRTG--VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS--CGKLS------------ 563 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~~~--~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~--~~~l~------------ 563 (688)
.........++..|+|||++.+. .++.++|||||||++|+|++|..||........... .+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 00011123456779999998764 578999999999999999999999964432111110 00000
Q ss_pred -------------------------cccCC-CCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHH
Q 005616 564 -------------------------SILDP-LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 564 -------------------------~~ldp-~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~ 606 (688)
.+.+. .....+..++..+.+|+.+||+.||.+|||+.+.+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 00000 00111234667899999999999999999999655443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=286.17 Aligned_cols=247 Identities=26% Similarity=0.345 Sum_probs=191.7
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeC
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
|.....||.|+||.||+|... +..||+|++.... ......+..|+.+++.++||||+++++++.+ ..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999886 7899999997654 2334568899999999999999999999854 588999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
. ++|.+++.... ..+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58999987653 35899999999999999999999966 99999999999999999999999999987654321
Q ss_pred CCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhc---------------Cc
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC---------------GK 561 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~---------------~~ 561 (688)
......++..|+|||++.+. .++.++|||||||++|||++|.+||............ ..
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 154 -----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred -----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence 12234567889999998766 8899999999999999999999999654332111000 00
Q ss_pred c---ccccCCC----CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 562 L---SSILDPL----AGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 562 l---~~~ldp~----~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
+ ...+... .....+.....+.+++.+||..+|.+||++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~ 276 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEA 276 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHH
Confidence 0 0000000 000011235689999999999999999998843
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=298.76 Aligned_cols=252 Identities=22% Similarity=0.301 Sum_probs=190.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC----------
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE---------- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~---------- 408 (688)
.++|...+.||.|+||.||+|... |..||+|.+..........+.+|+.++..++||||+++++++..
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368899999999999999999885 78999999977666666778999999999999999999987632
Q ss_pred ------CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeC-CCCceE
Q 005616 409 ------AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD-SELSSK 481 (688)
Q Consensus 409 ------~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd-~~~~~K 481 (688)
..++||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++ .++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 2579999997 588887743 35789999999999999999999966 99999999999997 456789
Q ss_pred EeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhh--
Q 005616 482 ICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS-- 558 (688)
Q Consensus 482 L~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~-- 558 (688)
|+|||++.......... .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||...........
T Consensus 156 l~dfg~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 156 IGDFGLARIVDPHYSHK---GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred ECCcccceecCCccccc---cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999998654321110 01123467889999997654 5688999999999999999999999964432211110
Q ss_pred -cCc-------------ccccc-----CCC--CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 559 -CGK-------------LSSIL-----DPL--AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 559 -~~~-------------l~~~l-----dp~--~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
... +...+ .+. ........+..+.+|+.+||+.||.+||++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 000 00000 000 0001112456788999999999999999988433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=322.36 Aligned_cols=252 Identities=29% Similarity=0.370 Sum_probs=191.9
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC-------
Q 005616 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE------- 408 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~------- 408 (688)
.-.++|.+...||+||||.||+++.. |..||||++..... .....+.+|+.+|++|+|||||++|..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45578889999999999999999876 99999999976642 223458899999999999999999642100
Q ss_pred --------------------------------------------------------------------------------
Q 005616 409 -------------------------------------------------------------------------------- 408 (688)
Q Consensus 409 -------------------------------------------------------------------------------- 408 (688)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 005616 409 ----------------------------------AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454 (688)
Q Consensus 409 ----------------------------------~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yL 454 (688)
.+||=||||+..+|.+++..+.-.. .-...++++.+|+.||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 0145677888877777776654221 2467889999999999999
Q ss_pred hccCCCceEeCCCCCCceeeCCCCceEEeecCcccccc----C--------CCCcCCCccccCCCCCCCCCCChhhhccC
Q 005616 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT----E--------DTLYLPSFHRSTAPKGSFPYADPEYHRTG 522 (688)
Q Consensus 455 H~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~----~--------~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 522 (688)
|+.+ ||||||||.||+||.++.|||+|||+|.... . ...........+..+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9976 9999999999999999999999999998722 0 00011122234677899999999998665
Q ss_pred ---CCCCcchHhHHHHHHHHHHhCCCCCCChhH---HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 005616 523 ---VLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRER 596 (688)
Q Consensus 523 ---~~s~ksDVwSfGviL~ELltG~~Pf~~~~~---~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~R 596 (688)
.|+.|+|+|||||||+||+. ||+..-+ +...++.|.+... .++.......-..+|.++++.||.+|
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-----~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-----ADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-----cccccccchHHHHHHHHHhcCCCccC
Confidence 49999999999999999996 6764433 3444555555432 23334445567889999999999999
Q ss_pred CCCcHHH
Q 005616 597 PDITPSL 603 (688)
Q Consensus 597 Ps~~e~l 603 (688)
||+.+.|
T Consensus 863 PtA~eLL 869 (1351)
T KOG1035|consen 863 PTATELL 869 (1351)
T ss_pred CCHHHHh
Confidence 9998544
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=304.12 Aligned_cols=248 Identities=28% Similarity=0.420 Sum_probs=208.0
Q ss_pred HHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccC--CCce
Q 005616 338 QTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWS 411 (688)
Q Consensus 338 ~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~ 411 (688)
..-.+.|.....||+|.|+.|..|+.. +..||||.+.+.... ....+.+|+++|..|+|||||+++.+.. ..+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 345678999999999999999999886 899999999876543 3345889999999999999999999974 5699
Q ss_pred eEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccc
Q 005616 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~ 491 (688)
+||||+.+|.+.++|.+.+. +.......++.|+.+|++|||+.+ |||||||.+||||+.+.++||+|||++..+
T Consensus 132 lV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence 99999999999999987764 344778899999999999999965 999999999999999999999999999988
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccCCC-CCcchHhHHHHHHHHHHhCCCCCCChh--HHHHHhhcCccccccCC
Q 005616 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL-TPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDP 568 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~i~~~~l~~~ldp 568 (688)
.... .....+|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||.+.. .....+..|++
T Consensus 206 ~~~~-------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~------ 272 (596)
T KOG0586|consen 206 DYGL-------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY------ 272 (596)
T ss_pred cccc-------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee------
Confidence 7544 3467789999999999998876 689999999999999999999997432 23333333332
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 569 ~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
..|..++.++.+|+.+++..+|.+|+++.+...+.+
T Consensus 273 ---rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 273 ---RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred ---cccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 234456778999999999999999999996655544
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=294.73 Aligned_cols=255 Identities=23% Similarity=0.278 Sum_probs=188.6
Q ss_pred cCccc-ceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc--------------hHHHHHHHHHHHcCCCCceeeEec
Q 005616 342 CNFSE-SFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--------------QLEFQQEVRVLSKLQHPHLVTLLG 404 (688)
Q Consensus 342 ~~f~~-~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~--------------~~~f~~E~~iL~~l~HpnIV~l~g 404 (688)
++|.. ...||.|+||.||+|.+. +..||||.+....... ...+.+|+.++..++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45543 467999999999999875 8899999986543221 124778999999999999999999
Q ss_pred ccC--CCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEE
Q 005616 405 ACP--EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI 482 (688)
Q Consensus 405 ~~~--~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL 482 (688)
++. +..++||||+. |+|.+++... ..+++.....++.|++.||.|||+.+ |+|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 984 34789999997 6888888543 35788999999999999999999965 999999999999999999999
Q ss_pred eecCccccccCCCCcC--------CCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHH
Q 005616 483 CDFGICRLVTEDTLYL--------PSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEV 553 (688)
Q Consensus 483 ~DFGla~~~~~~~~~~--------~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~ 553 (688)
+|||++.......... ..........+++.|+|||++.+. .++.++|||||||++|+|++|.+||...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999998765211100 000112234578899999988664 4799999999999999999999999755432
Q ss_pred HHH------hhcCc---cccc--------cCC----CCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 554 RRA------VSCGK---LSSI--------LDP----LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 554 ~~~------i~~~~---l~~~--------ldp----~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
... +.... +... ..+ .........+..+.+++.+||+.+|.+||++.+.+
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 211 00000 0000 000 00001112356789999999999999999998544
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=305.07 Aligned_cols=247 Identities=29% Similarity=0.456 Sum_probs=208.5
Q ss_pred cceeeeccCceEEEEEEEC------CeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEeeC
Q 005616 346 ESFKVGQGGFGCVYKGEML------GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYL 417 (688)
Q Consensus 346 ~~~~LG~G~~G~Vy~g~~~------g~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~ 417 (688)
..++||+|+||+||+|.+- .-+||||++.... .+...+|..|+-+|.+|+|||+++|+|+|.. ...||++||
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~m 779 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLM 779 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhc
Confidence 3478999999999999884 3579999986654 4456789999999999999999999999954 478999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
+.|+|.+++...+ ..+--+..+.|+.|||+|+.|||.. .++||||-..|||+..-.++||.|||+++.+..+...
T Consensus 780 P~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 780 PLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred ccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999998755 4577789999999999999999985 4999999999999999999999999999998766532
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCC--hhHHHHHhhcCccccccCCCCCCCC
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGL--AGEVRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~--~~~~~~~i~~~~l~~~ldp~~~~~~ 574 (688)
. ......-.+-|||-|.+....|+.++|||||||++|||+| |..|+.. ..++...++.|... ..|
T Consensus 855 y----~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRL--------sqP 922 (1177)
T KOG1025|consen 855 Y----SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERL--------SQP 922 (1177)
T ss_pred c----cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccC--------CCC
Confidence 1 2334445677999999999999999999999999999999 9999864 44666666666431 346
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 575 ~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
+.++.++..++.+||..|++.||+++ ++...+..+
T Consensus 923 piCtiDVy~~mvkCwmid~~~rp~fk-el~~~fs~~ 957 (1177)
T KOG1025|consen 923 PICTIDVYMVMVKCWMIDADSRPTFK-ELAEEFSRM 957 (1177)
T ss_pred CCccHHHHHHHHHHhccCcccCccHH-HHHHHHHHH
Confidence 67788999999999999999999999 676666654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=292.85 Aligned_cols=252 Identities=27% Similarity=0.446 Sum_probs=194.2
Q ss_pred ccceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHc--CCCCceeeEecccCC------CceeEEee
Q 005616 345 SESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSK--LQHPHLVTLLGACPE------AWSLVYEY 416 (688)
Q Consensus 345 ~~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~--l~HpnIV~l~g~~~~------~~~LV~E~ 416 (688)
....+||+|.||.||+|++.++.||||++.. .....|.+|-+|.+. ++|+||++++++-.. .+.||++|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hhHHHhhcCccceeehhhccCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 3345699999999999999999999999964 445678889888875 489999999998632 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCC------CceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP------EKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~------~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
.+.|+|.++|.. ..++|....+|+..+++||+|||...+ ++|+|||||+.||||.+|+++.|+|||+|..
T Consensus 290 h~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 290 HPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred ccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 999999999965 458999999999999999999998543 4799999999999999999999999999999
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccCC-CC-----CcchHhHHHHHHHHHHhCCCCC------------C----
Q 005616 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV-LT-----PKSDSYSFGLIILQLLTGRLPV------------G---- 548 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s-----~ksDVwSfGviL~ELltG~~Pf------------~---- 548 (688)
+..+... ......+||..|||||++.+.. +. ...||||+|.|||||++....+ .
T Consensus 366 ~~p~~~~----~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 366 LEPGKPQ----GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred ecCCCCC----cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 8755432 1234579999999999986542 22 3699999999999999965332 1
Q ss_pred ---ChhHHHHHhhcCccccccCCCCCCCC-HHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhh
Q 005616 549 ---LAGEVRRAVSCGKLSSILDPLAGDWP-TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 549 ---~~~~~~~~i~~~~l~~~ldp~~~~~~-~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~ 611 (688)
..++++..+...+....+.. .|- ......|.+.+..||+.||+-|-|+. =+.+.+..+.
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~---~W~~h~~~~~l~et~EeCWDhDaeARLTA~-Cv~eR~~~l~ 504 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPD---AWRKHAGMAVLCETIEECWDHDAEARLTAG-CVEERMAELM 504 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChh---hhhcCccHHHHHHHHHHHcCCchhhhhhhH-HHHHHHHHHh
Confidence 11223333322222111110 111 12456799999999999999999987 5555555553
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=277.66 Aligned_cols=230 Identities=28% Similarity=0.374 Sum_probs=191.3
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCcH
Q 005616 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 422 (688)
Q Consensus 350 LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL 422 (688)
||.|+||.||++... +..||+|++...... ....+..|+.+++.++||||+++++.+.+ ..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999886 789999998765443 34578999999999999999999999854 47899999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCcc
Q 005616 423 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502 (688)
Q Consensus 423 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~ 502 (688)
.+++.... .+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------ 148 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------ 148 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC------
Confidence 99986543 5889999999999999999999965 99999999999999999999999999987654321
Q ss_pred ccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCCCCCHHHHHH
Q 005616 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARR 580 (688)
Q Consensus 503 ~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~~~ 580 (688)
......|+..|++||...+...+.++|+||||+++|+|++|..||..... ....+..+ ...++...+..
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~~~ 219 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD---------PLRFPEFLSPE 219 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC---------CCCCCCCCCHH
Confidence 12455688999999999888899999999999999999999999975543 11222111 11233344678
Q ss_pred HHHHHHHcccCCCCCCCCCc
Q 005616 581 LVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 581 l~~Li~~Cl~~dP~~RPs~~ 600 (688)
+.+++.+||..||++||++.
T Consensus 220 l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 220 ARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred HHHHHHHHhcCCHhhCCCcc
Confidence 89999999999999999996
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=287.65 Aligned_cols=263 Identities=26% Similarity=0.364 Sum_probs=204.4
Q ss_pred HHHhcCcccceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcC--CCCceeeEecccCC------C
Q 005616 338 QTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL--QHPHLVTLLGACPE------A 409 (688)
Q Consensus 338 ~~at~~f~~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l--~HpnIV~l~g~~~~------~ 409 (688)
++........+.||+|.||.||+|.++|..||||++...+ ...+.+|.+|++.+ +|+||+.++++-.. .
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccccCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3445667788899999999999999999999999997543 45678888888764 99999999988621 3
Q ss_pred ceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-----cCCCceEeCCCCCCceeeCCCCceEEee
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-----SKPEKIVHGDLKPQNILLDSELSSKICD 484 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-----~~~~~IiHrDIKp~NILLd~~~~~KL~D 484 (688)
++||.+|.+.|||.|+|.+ ..++....++++..+|.||++||. .+.+.|.|||||+.|||+..+|.+-|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 7899999999999999976 458889999999999999999995 3445799999999999999999999999
Q ss_pred cCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCC----CC--CcchHhHHHHHHHHHHhC----------CCCCC
Q 005616 485 FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV----LT--PKSDSYSFGLIILQLLTG----------RLPVG 548 (688)
Q Consensus 485 FGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~----~s--~ksDVwSfGviL~ELltG----------~~Pf~ 548 (688)
+|+|........... -.....+||..|||||++...- +. ..+||||||.|+||+.-. ++||.
T Consensus 360 LGLAv~h~~~t~~id--i~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTID--IPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred ceeeEEecccCCccc--CCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999988766543322 1346778999999999985432 21 368999999999998763 35663
Q ss_pred C-------hhHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhh
Q 005616 549 L-------AGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 549 ~-------~~~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~ 612 (688)
. ..++..-+...++...+++.- ........+.+|+..||..||.-|-|+- -+.+.|..+..
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW--~s~~~l~~m~klMkeCW~~Np~aRltAL-riKKtl~~l~~ 505 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRW--KSDPALRVMAKLMKECWYANPAARLTAL-RIKKTLAKLSN 505 (513)
T ss_pred cCCCCCCCHHHHhcceeecccCCCCCccc--ccCHHHHHHHHHHHHhhcCCchhhhHHH-HHHHHHHHHhc
Confidence 1 122333333333333222211 1235677899999999999999999987 77777777654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=298.92 Aligned_cols=247 Identities=24% Similarity=0.301 Sum_probs=191.3
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC------
Q 005616 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE------ 408 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~------ 408 (688)
...++|.....||.|+||.||+|... +..||||++.... ......+.+|+.+++.++||||+++++++..
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45678999999999999999999986 7889999986532 2233567789999999999999999987732
Q ss_pred --CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecC
Q 005616 409 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 409 --~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFG 486 (688)
..++|+||+ +++|.+++.. ..+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 268999998 6799988864 35899999999999999999999966 9999999999999999999999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH--hhc--Cc
Q 005616 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSC--GK 561 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--i~~--~~ 561 (688)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... +.. +.
T Consensus 164 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~ 234 (343)
T cd07851 164 LARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234 (343)
T ss_pred cccccccc---------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence 99865432 134467889999998865 46889999999999999999999999643322110 000 00
Q ss_pred -------------cccccCCC----CCCC---CHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 562 -------------LSSILDPL----AGDW---PTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 562 -------------l~~~ldp~----~~~~---~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
....+... ...+ ....+..+.+++.+||+.+|.+|||+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~el 295 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA 295 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHH
Confidence 00000000 0000 01236689999999999999999999843
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=290.06 Aligned_cols=238 Identities=28% Similarity=0.356 Sum_probs=199.0
Q ss_pred cCcccceeeeccCceEEEEEEECC--eEEEEEEEecCCcc---chHHHHHHHHHHHcC-CCCceeeEecccC--CCceeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQ---GQLEFQQEVRVLSKL-QHPHLVTLLGACP--EAWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~g--~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l-~HpnIV~l~g~~~--~~~~LV 413 (688)
.+|....+||+|+||.|.++..+| ..+|||+++++..- +.+--..|-++|+.. +-|.+++|..+|+ +.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 468889999999999999998885 46999999887542 222245677788776 6788999998885 579999
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
|||+.||+|..++...+. +.++.+..++.+||-||-|||+.+ ||.||||.+|||||.+|++||+|||+++.--.
T Consensus 429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999999876654 445778899999999999999955 99999999999999999999999999986443
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~ 571 (688)
+. ..+...+|||.|+|||++...+|+.++|+|||||+||||+.|++||.+.++ +..++...+.
T Consensus 503 ~~------~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--------- 567 (683)
T KOG0696|consen 503 DG------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--------- 567 (683)
T ss_pred CC------cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC---------
Confidence 33 235678999999999999999999999999999999999999999987654 4444444332
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
.+|...+.+...++...+...|.+|-...
T Consensus 568 syPKslSkEAv~ickg~ltK~P~kRLGcg 596 (683)
T KOG0696|consen 568 SYPKSLSKEAVAICKGLLTKHPGKRLGCG 596 (683)
T ss_pred cCcccccHHHHHHHHHHhhcCCccccCCC
Confidence 56778889999999999999999996543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=280.58 Aligned_cols=242 Identities=25% Similarity=0.352 Sum_probs=199.1
Q ss_pred HhcCcccc-eeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccCC------C
Q 005616 340 ATCNFSES-FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE------A 409 (688)
Q Consensus 340 at~~f~~~-~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~------~ 409 (688)
.|.+|... .+||-|-.|.|..+..+ |..+|+|++... ....+|+++.-.. .|||||.++++|.+ .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 56777664 57999999999999776 889999998543 3456788876655 59999999999854 3
Q ss_pred ceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC---CCceEEeecC
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFG 486 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~---~~~~KL~DFG 486 (688)
+.+|||+|+||.|...+...+. ..+++.++..|+.+|+.|+.|||+.+ |.||||||+|+|... |..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 6789999999999999987654 56899999999999999999999987 999999999999964 4579999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCC------hhHHHHHhhcC
Q 005616 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGL------AGEVRRAVSCG 560 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~------~~~~~~~i~~~ 560 (688)
+|+.-.... .....+-||.|.|||++...+|+..+|+||+||++|-||+|.+||.. ...+...+..|
T Consensus 210 FAK~t~~~~-------~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g 282 (400)
T KOG0604|consen 210 FAKETQEPG-------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG 282 (400)
T ss_pred cccccCCCc-------cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence 999765432 23567889999999999999999999999999999999999999953 23455666666
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 561 KLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 561 ~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
.+.- ...+| ..+++...++|..+|..+|.+|-|+.+.
T Consensus 283 qy~F----P~pEW-s~VSe~aKdlIR~LLkt~PteRlTI~~~ 319 (400)
T KOG0604|consen 283 QYEF----PEPEW-SCVSEAAKDLIRKLLKTEPTERLTIEEV 319 (400)
T ss_pred CccC----CChhH-hHHHHHHHHHHHHHhcCCchhheeHHHh
Confidence 5432 12234 3578899999999999999999998843
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=290.62 Aligned_cols=253 Identities=23% Similarity=0.253 Sum_probs=187.8
Q ss_pred CcccceeeeccCceEEEEEEEC----CeEEEEEEEecCCc--cchHHHHHHHHHHHcC-CCCceeeEecccC------CC
Q 005616 343 NFSESFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKL-QHPHLVTLLGACP------EA 409 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~----g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~------~~ 409 (688)
+|...+.||+|+||.||++... +..||||.+..... .....+.+|+.++.++ .||||+++++++. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999986 55899999864322 2345688899999999 5999999998642 23
Q ss_pred ceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccc
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~ 489 (688)
.+++++|+. ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 577888885 6888888543 35889999999999999999999966 9999999999999999999999999998
Q ss_pred cccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHH--------------
Q 005616 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR-------------- 554 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~-------------- 554 (688)
......... ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.......
T Consensus 154 ~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 154 GFSENPGEN--AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred ecccccccc--cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 765432211 111234578999999998765 468999999999999999999999996433110
Q ss_pred ---HHhhcCccccc---cC--C--CCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 555 ---RAVSCGKLSSI---LD--P--LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 555 ---~~i~~~~l~~~---ld--p--~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
..+........ +. + ............+.+|+.+||+.||.+||++.+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 00 0 000011123567999999999999999999985443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=283.04 Aligned_cols=250 Identities=27% Similarity=0.369 Sum_probs=197.2
Q ss_pred cccCHHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcC-CCCceeeEecc
Q 005616 330 AEFSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGA 405 (688)
Q Consensus 330 ~~~~~~el~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l-~HpnIV~l~g~ 405 (688)
-.|+-++|+.. ..||.|+||+|++..++ |+..|||++..... ..+.++..|.+...+- +.||||++||+
T Consensus 59 ~~F~~~~Lqdl-------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 59 HTFTSDNLQDL-------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccchHHHH-------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 45666666554 45999999999999886 89999999988766 5667899999877665 79999999998
Q ss_pred c--CCCceeEEeeCCCCcHHHHh---cccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCce
Q 005616 406 C--PEAWSLVYEYLPNGSLQDRL---FRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 406 ~--~~~~~LV~E~~~~gsL~~~L---~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~ 480 (688)
+ +...++.||.|+ .||+.+. .... ...+++.-.-.|....+.||.||-... .||||||||+|||||..|.+
T Consensus 132 ~F~EGdcWiCMELMd-~SlDklYk~vy~vq-~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 132 LFSEGDCWICMELMD-ISLDKLYKRVYSVQ-KSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhcCCceeeeHHHHh-hhHHHHHHHHHHHH-hccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCE
Confidence 7 345789999994 4555433 2222 245788888899999999999998854 59999999999999999999
Q ss_pred EEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc--CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH--
Q 005616 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA-- 556 (688)
Q Consensus 481 KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~-- 556 (688)
||||||++-.+.... ..+.-+|-..|||||.+.. ..|+.+|||||||++|||+.||..||...+.+...
T Consensus 208 KLCDFGIcGqLv~Si-------AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~ 280 (361)
T KOG1006|consen 208 KLCDFGICGQLVDSI-------AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC 280 (361)
T ss_pred eeecccchHhHHHHH-------HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH
Confidence 999999998776543 2345578889999998743 35999999999999999999999999877765544
Q ss_pred -hhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 557 -VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 557 -i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
+..|....++.+. -..+++..+..+|..|+.+|-.+||...
T Consensus 281 ~Vv~gdpp~l~~~~---~~~~~s~~~~~fintCl~Kd~~~Rpky~ 322 (361)
T KOG1006|consen 281 QVVIGDPPILLFDK---ECVHYSFSMVRFINTCLIKDRSDRPKYD 322 (361)
T ss_pred HHHcCCCCeecCcc---cccccCHHHHHHHHHHhhcccccCcchh
Confidence 4445444332211 1124677899999999999999999998
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=275.92 Aligned_cols=218 Identities=24% Similarity=0.198 Sum_probs=176.3
Q ss_pred cCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCcHHHHhcc
Q 005616 353 GGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQDRLFR 428 (688)
Q Consensus 353 G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL~~~L~~ 428 (688)
|.||.||++.+. +..||+|.+.... .+..|...+....||||+++++++.+ ..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999885 8899999987643 23455556666679999999998854 58899999999999999865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCccccCCCC
Q 005616 429 KSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 508 (688)
Q Consensus 429 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~ 508 (688)
.. .+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||.+....... ....
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---------~~~~ 143 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---------DGEA 143 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc---------ccCC
Confidence 43 4889999999999999999999965 9999999999999999999999999886654321 2345
Q ss_pred CCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHc
Q 005616 509 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQC 588 (688)
Q Consensus 509 Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~C 588 (688)
++..|+|||++....+++++||||||+++|||++|..|+....... .. ......|...+..+.+++.+|
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---~~--------~~~~~~~~~~~~~~~~li~~~ 212 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---NT--------HTTLNIPEWVSEEARSLLQQL 212 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---cc--------ccccCCcccCCHHHHHHHHHH
Confidence 6778999999988889999999999999999999998875322110 00 001123344567899999999
Q ss_pred ccCCCCCCCCCcH
Q 005616 589 CELYGRERPDITP 601 (688)
Q Consensus 589 l~~dP~~RPs~~e 601 (688)
++.||.+||++.+
T Consensus 213 l~~dp~~R~~~~~ 225 (237)
T cd05576 213 LQFNPTERLGAGV 225 (237)
T ss_pred ccCCHHHhcCCCc
Confidence 9999999999863
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-33 Score=298.84 Aligned_cols=235 Identities=23% Similarity=0.309 Sum_probs=203.0
Q ss_pred cccceeeeccCceEEEEEEECCeE--EEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCCC--ceeEEee
Q 005616 344 FSESFKVGQGGFGCVYKGEMLGRT--VAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPEA--WSLVYEY 416 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~g~~--VAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~~--~~LV~E~ 416 (688)
+..+..||-||||.|-++...+.. +|+|++++.... .++.+..|-.||...+.|+||+||..|.+. .|++||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 334457999999999999988655 899999877553 345688999999999999999999999664 7899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
|-||.|...|...+. ++......++..+..|+.|||+.+ ||+|||||+|.+||.+|-+||.|||+|+.+..+.
T Consensus 502 ClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~- 574 (732)
T KOG0614|consen 502 CLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR- 574 (732)
T ss_pred hcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence 999999999987753 566778889999999999999966 9999999999999999999999999999987655
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHH--HHhhcCccccccCCCCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~i~~~~l~~~ldp~~~~~~ 574 (688)
++.+.+|||.|.|||++.+...+.++|.||||+++|||++|.+||...+.+. ..+..|- | .-.||
T Consensus 575 ------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi-----d--~i~~P 641 (732)
T KOG0614|consen 575 ------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI-----D--KIEFP 641 (732)
T ss_pred ------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh-----h--hhhcc
Confidence 5678899999999999999999999999999999999999999999887653 3344431 1 12677
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC
Q 005616 575 TFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 575 ~~~~~~l~~Li~~Cl~~dP~~RPs 598 (688)
..+.....+|+.+.|..+|.+|-.
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhc
Confidence 888899999999999999999987
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=311.81 Aligned_cols=143 Identities=29% Similarity=0.405 Sum_probs=126.5
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccC--CCceeEE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~ 414 (688)
++|.+.++||+|+||.||+|.+. +..||||++...... ....+..|+.++..++||||+++++++. +..+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999997 889999999765432 2356889999999999999999998874 4589999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
||+.+++|.+++.... .+++..++.|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+++.
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999986543 5788999999999999999999965 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=308.65 Aligned_cols=253 Identities=30% Similarity=0.471 Sum_probs=208.2
Q ss_pred hcCcccceeeeccCceEEEEEEEC---------CeEEEEEEEecCCcc-chHHHHHHHHHHHcC-CCCceeeEecccCC-
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML---------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACPE- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~---------g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~- 408 (688)
.++....+.||.|.||.|++|... ...||||.++..... ....+..|+++|..+ +|||||.++|+|..
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 344455569999999999999764 246999999866544 556799999999999 69999999999955
Q ss_pred -CceeEEeeCCCCcHHHHhcccC-----CC--------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee
Q 005616 409 -AWSLVYEYLPNGSLQDRLFRKS-----NV--------SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 474 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~-----~~--------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL 474 (688)
..++|+||+..|+|.++|.... .. ..++..+.+.++.|||.|++||++.. +|||||-..|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 5789999999999999998765 01 23889999999999999999999955 9999999999999
Q ss_pred CCCCceEEeecCccccccCCCCcCCCccccCCCCC--CCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCC--
Q 005616 475 DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG--SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGL-- 549 (688)
Q Consensus 475 d~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~G--t~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~-- 549 (688)
..+..+||+|||+|+.......+. .....| ...|||||.+....|+.++|||||||+||||+| |..||..
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~-----~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYR-----TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred cCCCEEEEccccceeccCCCCceE-----ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 999999999999999766544321 122222 345999999999999999999999999999999 8999975
Q ss_pred -hhHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 550 -AGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 550 -~~~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
..++...+..|... +.|..+..++.+++..||+.+|.+||++. ++...|+..
T Consensus 527 ~~~~l~~~l~~G~r~--------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~-~~~~~~~~~ 579 (609)
T KOG0200|consen 527 PTEELLEFLKEGNRM--------EQPEHCSDEIYDLMKSCWNADPEDRPTFS-ECVEFFEKH 579 (609)
T ss_pred cHHHHHHHHhcCCCC--------CCCCCCCHHHHHHHHHHhCCCcccCCCHH-HHHHHHHHH
Confidence 44555566666543 33556678999999999999999999999 788888874
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=291.17 Aligned_cols=238 Identities=29% Similarity=0.439 Sum_probs=201.4
Q ss_pred ceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEeccc--CCCceeEEeeCCCC
Q 005616 347 SFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNG 420 (688)
Q Consensus 347 ~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~LV~E~~~~g 420 (688)
.+.||+|-||+||-|+.+ |+.||||++.+... .....+.+|+.||.+++||.||.|-..| .+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999886 99999999976533 3446799999999999999999999888 45689999999877
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC---CceEEeecCccccccCCCCc
Q 005616 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE---LSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~---~~~KL~DFGla~~~~~~~~~ 497 (688)
-|.-+|.... ..|+......++.||+.||.|||..+ |+|+||||+||||... -.+||||||+|+.+....
T Consensus 649 MLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 649 MLEMILSSEK--GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred HHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 7776665544 46788877888999999999999955 9999999999999654 469999999999987654
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHHH
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~~ 577 (688)
....++|||.|+|||++....|...-|+||.|||+|--|+|..||+...++...+.+..+.-... .| .++
T Consensus 722 -----FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~----PW-~ei 791 (888)
T KOG4236|consen 722 -----FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPN----PW-SEI 791 (888)
T ss_pred -----hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCC----ch-hhc
Confidence 34688999999999999999999999999999999999999999998888888877765543221 23 356
Q ss_pred HHHHHHHHHHcccCCCCCCCCCcH
Q 005616 578 ARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 578 ~~~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
+...++||...|+..-.+|-+...
T Consensus 792 s~~AidlIn~LLqVkm~kRysvdk 815 (888)
T KOG4236|consen 792 SPEAIDLINNLLQVKMRKRYSVDK 815 (888)
T ss_pred CHHHHHHHHHHHHHHHHHhcchHh
Confidence 778899999999998888888764
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=274.00 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=200.0
Q ss_pred CHHHHHHHhcCcccceeeeccCceEEEEEEE--CCeEEEEEEEecCCccchHHHHHHHHHHHcCC-CCceeeEecccCC-
Q 005616 333 SLADLQTATCNFSESFKVGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACPE- 408 (688)
Q Consensus 333 ~~~el~~at~~f~~~~~LG~G~~G~Vy~g~~--~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~- 408 (688)
.|.|+-..|. ..||+|+|+.|-.+.. .|..+|||++.+.....+..+.+|++++...+ |+||++|+.||.+
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3677777775 6799999999998865 48999999998887777888999999999995 9999999999965
Q ss_pred -CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC---ceEEee
Q 005616 409 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL---SSKICD 484 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~---~~KL~D 484 (688)
.+|||||.|.||+|..++.+.. .+++.++.++..+|+.||.|||..+ |.||||||+|||-.... -+||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeec
Confidence 4899999999999999997764 4778999999999999999999955 99999999999986543 489999
Q ss_pred cCccccccCCCCcCC-CccccCCCCCCCCCCChhhhc-----cCCCCCcchHhHHHHHHHHHHhCCCCCCChhH------
Q 005616 485 FGICRLVTEDTLYLP-SFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE------ 552 (688)
Q Consensus 485 FGla~~~~~~~~~~~-~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~------ 552 (688)
|.+..-+.......+ +...-.+++|+..|||||+.. ...|+.++|.||||||||-||+|.+||.+.-.
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 998876543322212 222345778999999999652 23689999999999999999999999963322
Q ss_pred -----------HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcH
Q 005616 553 -----------VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 553 -----------~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
....+..|++.-. ..+| ..++....+|+...+..++.+|-++.+
T Consensus 303 rGe~Cr~CQ~~LFesIQEGkYeFP----dkdW-ahIS~eakdlisnLlvrda~~rlsa~~ 357 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGKYEFP----DKDW-AHISSEAKDLISNLLVRDAKQRLSAAQ 357 (463)
T ss_pred CCCccHHHHHHHHHHHhccCCcCC----hhhh-HHhhHHHHHHHHHHHhccHHhhhhhhh
Confidence 2233444443210 1122 246778889999999999999988773
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=297.77 Aligned_cols=256 Identities=27% Similarity=0.384 Sum_probs=213.0
Q ss_pred cCHHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEeccc--
Q 005616 332 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGAC-- 406 (688)
Q Consensus 332 ~~~~el~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~-- 406 (688)
+.++.+..-++-|.+...||.|.+|.||+++.. ++.+|+|++.... ...+++..|.++|..+ .|||++.+||+|
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 345555666788999999999999999998764 8899999987654 3455778899999988 699999999997
Q ss_pred -----CCCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceE
Q 005616 407 -----PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSK 481 (688)
Q Consensus 407 -----~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~K 481 (688)
.+.++||||||.+||..+++.... ...+.|..+..|+..++.||.+||.+. +||||||-.||||+.+|.+|
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 345899999999999999997766 577999999999999999999999977 99999999999999999999
Q ss_pred EeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-----CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH
Q 005616 482 ICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-----GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA 556 (688)
Q Consensus 482 L~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~ 556 (688)
|+|||.+..+.... .......|||.|||||++.- ..|+..+|+||||++..||--|.+|+.....+..+
T Consensus 164 LvDFGvSaQldsT~------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL 237 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTV------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL 237 (953)
T ss_pred Eeeeeeeeeeeccc------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh
Confidence 99999998876433 35677899999999998853 35788999999999999999999999766665554
Q ss_pred hhcCccccccCCCC-CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 557 VSCGKLSSILDPLA-GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 557 i~~~~l~~~ldp~~-~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
+.... +|.+ -..|...+.++.++|..||..|...||++.+.+
T Consensus 238 F~IpR-----NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 238 FLIPR-----NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred ccCCC-----CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhc
Confidence 43221 1211 123567788999999999999999999988443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=293.03 Aligned_cols=238 Identities=25% Similarity=0.331 Sum_probs=195.1
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccCCC--ceeEE
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPEA--WSLVY 414 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~~--~~LV~ 414 (688)
++..|.....+|.|+|+.|-.+... +...++|++..... +..+|+.++... +||||+++.+.|.++ .++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3567777888999999999999886 78899999976622 234577677666 799999999999764 78999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee-CCCCceEEeecCccccccC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL-DSELSSKICDFGICRLVTE 493 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL-d~~~~~KL~DFGla~~~~~ 493 (688)
|.+.|+-|.+.+..... ....+..|+.+|+.|+.|||..+ ||||||||+|||+ +..|+++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~~----~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE----FCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcch----hHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999988887766542 22677889999999999999955 9999999999999 5889999999999998765
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh---HHHHHhhcCccccccCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG---EVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~---~~~~~i~~~~l~~~ldp~~ 570 (688)
.. ...+-|..|.|||++....|+++|||||||++||+||+|+.||.... ++...+..+.
T Consensus 469 ~~---------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~--------- 530 (612)
T KOG0603|consen 469 SC---------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK--------- 530 (612)
T ss_pred hh---------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc---------
Confidence 41 34567889999999999999999999999999999999999996432 3444444333
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
+...++....+|+.+||+.||.+||++.+...+.+-
T Consensus 531 --~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 --FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred --cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 235678899999999999999999999965554444
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=260.29 Aligned_cols=230 Identities=29% Similarity=0.376 Sum_probs=188.7
Q ss_pred CceEEEEEEEC--CeEEEEEEEecCCccc-hHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeCCCCcHHHHhcc
Q 005616 354 GFGCVYKGEML--GRTVAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNGSLQDRLFR 428 (688)
Q Consensus 354 ~~G~Vy~g~~~--g~~VAIK~l~~~~~~~-~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~gsL~~~L~~ 428 (688)
+||.||+|... |..||+|++....... ...+.+|+..+++++|+||+++++++. ...+++|||+.+++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 68999999986 6899999998766555 678999999999999999999999985 458899999999999999865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCccccCCCC
Q 005616 429 KSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 508 (688)
Q Consensus 429 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~ 508 (688)
.. .+++..++.++.+++.+|.|||..+ |+|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~ 147 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-------LLTTFV 147 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-------cccccc
Confidence 43 2789999999999999999999966 9999999999999999999999999998876532 124556
Q ss_pred CCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH---HHHHhhcCccccccCCCCCCCCHHHHHHHHHHH
Q 005616 509 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLG 585 (688)
Q Consensus 509 Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~---~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li 585 (688)
++..|++||.+....++.++||||||+++|+|++|..||..... .......+..... .....++..+.+++
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~i 221 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP------PPEWKISPEAKDLI 221 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc------cccccCCHHHHHHH
Confidence 88999999999988899999999999999999999999965222 2222222211100 00001456899999
Q ss_pred HHcccCCCCCCCCCcHH
Q 005616 586 LQCCELYGRERPDITPS 602 (688)
Q Consensus 586 ~~Cl~~dP~~RPs~~e~ 602 (688)
.+|+..+|++||++.+.
T Consensus 222 ~~~l~~~p~~Rp~~~~~ 238 (244)
T smart00220 222 RKLLVKDPEKRLTAEEA 238 (244)
T ss_pred HHHccCCchhccCHHHH
Confidence 99999999999999843
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=267.83 Aligned_cols=246 Identities=22% Similarity=0.275 Sum_probs=193.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcC-CCCceeeEecccCC--CceeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~---~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV 413 (688)
++|....+||+|+|+.|..+++. .+.+|+|++++.-.. +..=++.|-.+.... +||.+|-|..+|+. .+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 67899999999999999999886 678999999775332 223356677777766 79999999999954 48899
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
.||++||+|.-++.+.. .|+++.+..+...|+.||.|||+.+ ||.||||.+|||||..|++||+|+|+++..-.
T Consensus 330 ieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999987776543 5888999999999999999999966 99999999999999999999999999987543
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HHHHhhcCccccccCCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~i~~~~l~~~ldp~~~ 571 (688)
... .+...+|||.|+|||++.+..|+..+|+|+|||+++||+.|+.||...+. ..... ...+..++-....
T Consensus 404 ~gd------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nt-edylfqvilekqi 476 (593)
T KOG0695|consen 404 PGD------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNT-EDYLFQVILEKQI 476 (593)
T ss_pred CCc------ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccch-hHHHHHHHhhhcc
Confidence 332 34678999999999999999999999999999999999999999974331 00000 0000111111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
..|...+-....++...|++||.+|-.-.
T Consensus 477 riprslsvkas~vlkgflnkdp~erlgc~ 505 (593)
T KOG0695|consen 477 RIPRSLSVKASHVLKGFLNKDPKERLGCR 505 (593)
T ss_pred cccceeehhhHHHHHHhhcCCcHHhcCCC
Confidence 33445566777888899999999986543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=267.67 Aligned_cols=200 Identities=26% Similarity=0.345 Sum_probs=164.9
Q ss_pred cCcccceeeeccCceEEEEEEEC------CeEEEEEEEecCCccc--hHHHHHHHHHHHcCCCCceeeEecccCC---Cc
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML------GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGACPE---AW 410 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~------g~~VAIK~l~~~~~~~--~~~f~~E~~iL~~l~HpnIV~l~g~~~~---~~ 410 (688)
..|.....||+|.||.||++... ...+|||.++...... .....+|+.+++.++|||||.|..+|.. ..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 35777889999999999999553 2369999997653321 2357799999999999999999988843 47
Q ss_pred eeEEeeCCCCcHHHHhccc--CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC----CceEEee
Q 005616 411 SLVYEYLPNGSLQDRLFRK--SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE----LSSKICD 484 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~----~~~KL~D 484 (688)
+++++|.+. +|..++... .....++-..+..|+.||+.|+.|||++. |+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 899999965 677766543 23356888999999999999999999988 9999999999999887 9999999
Q ss_pred cCccccccCCCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCC
Q 005616 485 FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVG 548 (688)
Q Consensus 485 FGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~ 548 (688)
||+++.+.+..... .....++.|+.|.|||.+.+. .||++.||||.|||+.||+|-.+-|.
T Consensus 180 lGlaR~~~~plkpl---~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 180 LGLARLFNNPLKPL---ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ccHHHHhhcccccc---ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 99999987654322 234567889999999988765 69999999999999999999988774
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=283.48 Aligned_cols=256 Identities=21% Similarity=0.239 Sum_probs=178.6
Q ss_pred HhcCcccceeeeccCceEEEEEEE------------------CCeEEEEEEEecCCccchHH--------------HHHH
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEM------------------LGRTVAIKMLYSHNMQGQLE--------------FQQE 387 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~------------------~g~~VAIK~l~~~~~~~~~~--------------f~~E 387 (688)
..++|...++||+|+||.||+|.+ .++.||||.+.........+ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 24679999987544332233 3446
Q ss_pred HHHHHcCCCCce-----eeEecccC----------CCceeEEeeCCCCcHHHHhcccCC---------------------
Q 005616 388 VRVLSKLQHPHL-----VTLLGACP----------EAWSLVYEYLPNGSLQDRLFRKSN--------------------- 431 (688)
Q Consensus 388 ~~iL~~l~HpnI-----V~l~g~~~----------~~~~LV~E~~~~gsL~~~L~~~~~--------------------- 431 (688)
+.++.+++|.++ +.++++|. ...+|||||+++|+|.+++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766654 66777763 236899999999999999864321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCccccCCCCCCC
Q 005616 432 VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511 (688)
Q Consensus 432 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~ 511 (688)
...++|..+..|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ......+|+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-----~~~~g~~tp 374 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-----NPLYGMLDP 374 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-----CccccCCCc
Confidence 123578889999999999999999965 999999999999999999999999999765432211 112334589
Q ss_pred CCCChhhhccCC----------------------CCCcchHhHHHHHHHHHHhCCC-CCCChhHHHHHhhc--Cccc--c
Q 005616 512 PYADPEYHRTGV----------------------LTPKSDSYSFGLIILQLLTGRL-PVGLAGEVRRAVSC--GKLS--S 564 (688)
Q Consensus 512 ~Y~APE~~~~~~----------------------~s~ksDVwSfGviL~ELltG~~-Pf~~~~~~~~~i~~--~~l~--~ 564 (688)
.|+|||.+.... ...+.||||+||++|+|++|.. ||............ ..+. .
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r 454 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR 454 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH
Confidence 999999875332 1235799999999999999875 66432211111100 0000 0
Q ss_pred ccCCCCCCC--CHHHHHHHHHHHHHcccCCC---CCCCCCcHHH
Q 005616 565 ILDPLAGDW--PTFVARRLVDLGLQCCELYG---RERPDITPSL 603 (688)
Q Consensus 565 ~ldp~~~~~--~~~~~~~l~~Li~~Cl~~dP---~~RPs~~e~l 603 (688)
.......++ .........+|+.++|..+| .+|+|+.+.+
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 000000011 12346788999999999766 6899998544
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=290.97 Aligned_cols=253 Identities=25% Similarity=0.236 Sum_probs=166.0
Q ss_pred HhcCcccceeeeccCceEEEEEEEC------CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecc--------
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA-------- 405 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~------g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~-------- 405 (688)
..++|...+.||+|+||.||+|.+. +..||||++..... .+.+..+ .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999885 56899998764321 1111111 1222223333333222
Q ss_pred cCCCceeEEeeCCCCcHHHHhcccCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCC
Q 005616 406 CPEAWSLVYEYLPNGSLQDRLFRKSNV-----------------SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLK 468 (688)
Q Consensus 406 ~~~~~~LV~E~~~~gsL~~~L~~~~~~-----------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIK 468 (688)
.....+|||||+.+++|.+++...... .......+..|+.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 123578999999999999988653210 01122345679999999999999965 9999999
Q ss_pred CCceeeCC-CCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccC----------------------CCC
Q 005616 469 PQNILLDS-ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG----------------------VLT 525 (688)
Q Consensus 469 p~NILLd~-~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~----------------------~~s 525 (688)
|+||||+. ++.+||+|||+|+.+...... ......||+.|+|||.+... .++
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-----~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-----IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-----CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 99999985 689999999999866433221 23456789999999965322 234
Q ss_pred CcchHhHHHHHHHHHHhCCCCCCChhH-HHHHhhcCcc-----ccccCCCC-CC------CCHHHHHHHHHHHHHcccCC
Q 005616 526 PKSDSYSFGLIILQLLTGRLPVGLAGE-VRRAVSCGKL-----SSILDPLA-GD------WPTFVARRLVDLGLQCCELY 592 (688)
Q Consensus 526 ~ksDVwSfGviL~ELltG~~Pf~~~~~-~~~~i~~~~l-----~~~ldp~~-~~------~~~~~~~~l~~Li~~Cl~~d 592 (688)
.++|||||||+||||+++..|+..... ....+..... ...+.+.. .+ ..........+|+.+||+.|
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 567999999999999998777543211 1111111100 00111100 00 00011224568999999999
Q ss_pred CCCCCCCcHHHH
Q 005616 593 GRERPDITPSLV 604 (688)
Q Consensus 593 P~~RPs~~e~l~ 604 (688)
|.+|||+.+.+.
T Consensus 438 P~kR~ta~e~L~ 449 (566)
T PLN03225 438 GRQRISAKAALA 449 (566)
T ss_pred cccCCCHHHHhC
Confidence 999999985443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=267.23 Aligned_cols=250 Identities=24% Similarity=0.293 Sum_probs=193.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCC--CC----ceeeEecccC--CCc
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ--HP----HLVTLLGACP--EAW 410 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~--Hp----nIV~l~g~~~--~~~ 410 (688)
+++|.....+|+|.||.|-.+.+. +..||||+++.-. .-.+...-|+++|.++. -| -+|++.+||. ...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 788999999999999999999876 6789999986432 22344667999999993 22 3788888884 457
Q ss_pred eeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC--------------
Q 005616 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-------------- 476 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-------------- 476 (688)
|||+|.+ |-|+.++|..+. ..+++...+..|+.|++.+++|||+++ ++|.||||+|||+..
T Consensus 167 Civfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 8899988 669999997654 467899999999999999999999987 999999999999932
Q ss_pred ------CCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCCh
Q 005616 477 ------ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA 550 (688)
Q Consensus 477 ------~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~ 550 (688)
+..++|+|||.|..-.... ...+.|..|.|||++.+-+++..+||||+||||+||.||...|...
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h---------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH---------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc---------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 3458999999998765433 4668899999999999999999999999999999999999988654
Q ss_pred hHHHHH-----------------------hhcCcc-----------ccccCC---CC--CCCCHHHHHHHHHHHHHcccC
Q 005616 551 GEVRRA-----------------------VSCGKL-----------SSILDP---LA--GDWPTFVARRLVDLGLQCCEL 591 (688)
Q Consensus 551 ~~~~~~-----------------------i~~~~l-----------~~~ldp---~~--~~~~~~~~~~l~~Li~~Cl~~ 591 (688)
++.+.. ...|.+ ....++ .. ..........|.+|+.+||..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 432111 011111 001110 00 011224556899999999999
Q ss_pred CCCCCCCCcHHHHH
Q 005616 592 YGRERPDITPSLVK 605 (688)
Q Consensus 592 dP~~RPs~~e~l~~ 605 (688)
||.+|+|+.+++.+
T Consensus 393 DP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 393 DPARRITLREALSH 406 (415)
T ss_pred CccccccHHHHhcC
Confidence 99999999966544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=288.20 Aligned_cols=246 Identities=31% Similarity=0.399 Sum_probs=189.6
Q ss_pred cccceeeeccCceE-EEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccCCC--ceeEEeeCCC
Q 005616 344 FSESFKVGQGGFGC-VYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPEA--WSLVYEYLPN 419 (688)
Q Consensus 344 f~~~~~LG~G~~G~-Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~~--~~LV~E~~~~ 419 (688)
|...+.+|.|..|+ ||+|.+.|+.||||++-... ..-..+|+..|..- .|||||++|+.-.+. .||..|.| .
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence 44556789998765 69999999999999885432 23457899999988 699999999887554 78999999 5
Q ss_pred CcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC---C--CceEEeecCccccccC
Q 005616 420 GSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---E--LSSKICDFGICRLVTE 493 (688)
Q Consensus 420 gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~---~--~~~KL~DFGla~~~~~ 493 (688)
.+|.+++... .......-...+.+..|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++.+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 6999999763 11111111345778899999999999977 999999999999975 3 5699999999999876
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhC-CCCCCChhHHHHHhhcCccccccCCCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG-RLPVGLAGEVRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG-~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~ 572 (688)
+... +.......||-+|+|||++....-+.++||||||||+|+.++| .+||+..-.-...+..|...-. ... .
T Consensus 664 ~~sS---~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~--~L~-~ 737 (903)
T KOG1027|consen 664 GKSS---FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLV--HLE-P 737 (903)
T ss_pred Ccch---hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcccee--eec-c
Confidence 6543 3345778899999999999999889999999999999999995 9999866554444544443211 100 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHH
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~ 605 (688)
.+ +. ...+||.+|++++|..||++.+.+.+
T Consensus 738 ~~-d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 738 LP-DC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred Cc-hH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 11 11 78899999999999999999965543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=244.06 Aligned_cols=205 Identities=25% Similarity=0.401 Sum_probs=165.5
Q ss_pred HHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-ccchHHHHHHHHHHHcC-CCCceeeEeccc--CCCc
Q 005616 337 LQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGAC--PEAW 410 (688)
Q Consensus 337 l~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~--~~~~ 410 (688)
+....+....+..||+|++|.|-+-++. |...|+|.+...- .+.+....+|+++..+. .+|.+|.+||.. ..+.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 3344445555677999999999877775 8999999997653 34566788999988776 799999999986 3458
Q ss_pred eeEEeeCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccc
Q 005616 411 SLVYEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~ 489 (688)
++.||.|+ .||+.+-... .....+++..+-+|+..|..||.|||+.- .|||||+||+||||+.+|.+|+||||++-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 89999994 5776654432 23356788888999999999999999954 69999999999999999999999999998
Q ss_pred cccCCCCcCCCccccCCCCCCCCCCChhhhc----cCCCCCcchHhHHHHHHHHHHhCCCCCCChh
Q 005616 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHR----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 551 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~----~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~ 551 (688)
.+.+... .+...|-..|||||.+. ...|+.++||||||+.++||.+++.||....
T Consensus 198 ~L~dSiA-------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 198 YLVDSIA-------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred eehhhhH-------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 8866542 23356888999999774 3479999999999999999999999997543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=253.38 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=189.4
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC---------
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--------- 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--------- 408 (688)
+.|....+||+|.||.||+++.. |+.||+|++...+. .--....+|+++|..|+|+|++.++..|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34555678999999999999875 78899987644322 223356789999999999999999998821
Q ss_pred -CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCc
Q 005616 409 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGl 487 (688)
.+++||.+|+ .+|..+|.... ..++..++.+++.++..||.|+|.+. |+|||+||.|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 2789999995 47777775543 45788999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHH--h--hcCcc
Q 005616 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--V--SCGKL 562 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--i--~~~~l 562 (688)
++.+........ ...+..+.|..|.+||.+.+ ..|+++.|||+-|||+.||.||.+-+....+.... + ..|.+
T Consensus 171 ar~fs~~~n~~k--prytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 171 ARAFSTSKNVVK--PRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccceecccccCC--CCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 987654432211 23466778999999997765 57999999999999999999999988654432211 0 11111
Q ss_pred -------------cccc--CCCCC-CCC--HHH------HHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 563 -------------SSIL--DPLAG-DWP--TFV------ARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 563 -------------~~~l--dp~~~-~~~--~~~------~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
...+ .|... .+. .+. .+...+|+..++..||.+||++.+.+
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 1111 11110 000 011 22678999999999999999998544
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=232.32 Aligned_cols=246 Identities=22% Similarity=0.273 Sum_probs=185.0
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
+|...++||+|.||+||+|+.. +..||+|.+..+... -.....+|+-+|+.++|.|||++++... ....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556678999999999999876 788999998765432 2356789999999999999999999874 358899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
|. .+|..++.... ..++...+..++.|+++||.|+|+.+ +.|||+||.|+||+.+|.+||+|||+++.+.-...
T Consensus 83 cd-qdlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 95 46777776544 45788889999999999999999976 99999999999999999999999999998764331
Q ss_pred cCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHh-CCCCCCChhHHHHH---h-hcCc--------c
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRA---V-SCGK--------L 562 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~~~~~---i-~~~~--------l 562 (688)
.....+.|..|.+|.++.+. -|++..|+||-|||+.|+.. |++.|.+.+-..+. . .-|. +
T Consensus 157 ------cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 157 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred ------eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence 23456789999999988765 58999999999999999998 55555433321111 1 1111 1
Q ss_pred ccccCCCC-CCCCH---------HHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 563 SSILDPLA-GDWPT---------FVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 563 ~~~ldp~~-~~~~~---------~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
..+.|-.. .-+|. .....=.+|++..+.-+|..|.++.
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisae 278 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAE 278 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHH
Confidence 11111100 01111 1222346788888889999999887
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=254.95 Aligned_cols=263 Identities=24% Similarity=0.350 Sum_probs=214.8
Q ss_pred CHHHHHHHhcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEec
Q 005616 333 SLADLQTATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLG 404 (688)
Q Consensus 333 ~~~el~~at~~f~~~~~LG~G~~G~Vy~g~~~-------g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g 404 (688)
...+|..-.++|.....+-+|.||.||.|.+. .+.|.+|.++....+ ....|..|.-.+..+.|||+..+.|
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 45677778888999999999999999999775 234777877655433 3345888999999999999999999
Q ss_pred ccCC---CceeEEeeCCCCcHHHHhc-----ccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC
Q 005616 405 ACPE---AWSLVYEYLPNGSLQDRLF-----RKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS 476 (688)
Q Consensus 405 ~~~~---~~~LV~E~~~~gsL~~~L~-----~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~ 476 (688)
++.+ ..+++|.++.-|+|..+|. +......++-.+...++.|++.|+.|||+.+ |||.||...|.+||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 9843 4789999999999999998 3344456777888899999999999999976 999999999999999
Q ss_pred CCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--HH
Q 005616 477 ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EV 553 (688)
Q Consensus 477 ~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~ 553 (688)
...+||+|-.+++.+-+.+... -.........||+||.+.+..|+..+|||||||+||||+| |+.|+...+ ++
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhc----LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm 507 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHC----LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM 507 (563)
T ss_pred heeEEeccchhccccCcccccc----cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence 9999999999999776554321 1223334567999999999999999999999999999999 999997655 45
Q ss_pred HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhh
Q 005616 554 RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 554 ~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~ 611 (688)
...+.+|... ..|.+++++|..++..||...|++||++. .++.-|....
T Consensus 508 ~~ylkdGyRl--------aQP~NCPDeLf~vMacCWallpeeRPsf~-Qlv~cLseF~ 556 (563)
T KOG1024|consen 508 EHYLKDGYRL--------AQPFNCPDELFTVMACCWALLPEERPSFS-QLVICLSEFH 556 (563)
T ss_pred HHHHhcccee--------cCCCCCcHHHHHHHHHHHhcCcccCCCHH-HHHHHHHHHH
Confidence 5566666432 23456788999999999999999999999 6777776654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=232.09 Aligned_cols=203 Identities=37% Similarity=0.551 Sum_probs=177.6
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEeeCCCCcHHH
Q 005616 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQD 424 (688)
Q Consensus 350 LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL~~ 424 (688)
||.|++|.||++... +..+++|++...... ....+.+|+.++..++|++|+++++++.. ..++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999997 899999999766543 34679999999999999999999999865 6889999999999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC-CCceEEeecCccccccCCCCcCCCccc
Q 005616 425 RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFGICRLVTEDTLYLPSFHR 503 (688)
Q Consensus 425 ~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-~~~~KL~DFGla~~~~~~~~~~~~~~~ 503 (688)
++.... ..+++..+..++.+++.+|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------~ 149 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------L 149 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc------h
Confidence 987643 35789999999999999999999975 999999999999999 89999999999987654321 1
Q ss_pred cCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHHHHHHHH
Q 005616 504 STAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 582 (688)
Q Consensus 504 ~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~ 582 (688)
.....+...|++||.+... .++.++|+|+||+++++| ..+.
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------~~~~ 191 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------PELK 191 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------HHHH
Confidence 2345688899999999877 889999999999999999 4788
Q ss_pred HHHHHcccCCCCCCCCCcH
Q 005616 583 DLGLQCCELYGRERPDITP 601 (688)
Q Consensus 583 ~Li~~Cl~~dP~~RPs~~e 601 (688)
+++..|++.+|.+||++.+
T Consensus 192 ~~l~~~l~~~p~~R~~~~~ 210 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKE 210 (215)
T ss_pred HHHHHHhhCCcccCcCHHH
Confidence 9999999999999999873
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=266.77 Aligned_cols=250 Identities=25% Similarity=0.315 Sum_probs=206.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEeccc--CCCceeEEee
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEY 416 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~LV~E~ 416 (688)
..+|.....+|.|.||.||++++. +...|+|+++.....+....+.|+-++...+|||||.++|.+ .+...++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 457888899999999999999886 889999999988888888889999999999999999999998 4679999999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCC
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
|.+|+|.+.-+-. .++++.++...+.....||.|||+.+ -+|||||-.|||++..|.+|++|||.+..+....
T Consensus 94 cgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred cCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-
Confidence 9999999976543 47888999999999999999999976 7999999999999999999999999988776433
Q ss_pred cCCCccccCCCCCCCCCCChhhh---ccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYH---RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~---~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~ 573 (688)
.+.....||+.|||||+. ..+.|...+|||++|+...|+---++|.......+...... ...++|..-.-
T Consensus 167 -----~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT--kS~~qpp~lkD 239 (829)
T KOG0576|consen 167 -----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT--KSGFQPPTLKD 239 (829)
T ss_pred -----hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh--ccCCCCCcccC
Confidence 356788999999999965 57789999999999999999999888865444333221110 11122222222
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
+......|.+++..|+-.+|++||+....|.
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 3345678999999999999999999875443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=230.05 Aligned_cols=196 Identities=36% Similarity=0.515 Sum_probs=169.3
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEeeCC
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLP 418 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~ 418 (688)
|.....||.|++|.||+|... +..+|+|.+...... ....+.+|+..+.+++|+|++++++++. ...++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 456788999999999999986 689999999876555 5678999999999999999999999885 45889999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
+++|.+++..... .+++..+..++.+++.+|.|||..+ ++|+||+|.||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-- 153 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-- 153 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc--
Confidence 9999999876432 1789999999999999999999965 99999999999999999999999999988754320
Q ss_pred CCccccCCCCCCCCCCChhhh-ccCCCCCcchHhHHHHHHHHHHhCCCCCCC
Q 005616 499 PSFHRSTAPKGSFPYADPEYH-RTGVLTPKSDSYSFGLIILQLLTGRLPVGL 549 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~-~~~~~s~ksDVwSfGviL~ELltG~~Pf~~ 549 (688)
.......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 154 ---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ---ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ---ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 012345678899999998 677788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=231.78 Aligned_cols=244 Identities=22% Similarity=0.348 Sum_probs=190.1
Q ss_pred hcCcccceeeeccCceEEEEEEE--CCeEEEEEEEecCCccchHHHHHHHHHHHcCC-CCceeeEecccCCC----ceeE
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACPEA----WSLV 413 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~--~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~~----~~LV 413 (688)
.++|...+++|+|.|+.||.|.. ....++||++++- ..+.+.+|+.||..|+ |||||+|++...+. ..||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46788899999999999999985 4788999999753 3456889999999997 99999999998553 6799
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC-CceEEeecCcccccc
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVT 492 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~-~~~KL~DFGla~~~~ 492 (688)
+||+.+.+...+. +.|+..++..++.+++.||.|+|+.| |+|||+||.|++||.. -.++|+|+|+|.+..
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999999887765 45677889999999999999999977 9999999999999965 569999999999887
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCC-hhHHHHHhhc-----------
Q 005616 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGL-AGEVRRAVSC----------- 559 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~-~~~~~~~i~~----------- 559 (688)
++.. ....+.+..|--||.+.. ..|+.+-|+|||||+|..|+..+.||.. .++..+.+..
T Consensus 185 p~~e-------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 185 PGKE-------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred CCce-------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence 6542 245567778899998755 4688999999999999999999999842 1111111110
Q ss_pred --CccccccCCC---------CCCCCH--------HHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 560 --GKLSSILDPL---------AGDWPT--------FVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 560 --~~l~~~ldp~---------~~~~~~--------~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
++..-.+||. ...|.. -.+++.++|+.+.|..|-.+|||+.+.+
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 0011112221 111211 1347889999999999999999998544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-28 Score=241.10 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=183.2
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecC--CccchHHHHHHHHHHHcCCCCceeeEecccC-------CCcee
Q 005616 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSH--NMQGQLEFQQEVRVLSKLQHPHLVTLLGACP-------EAWSL 412 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~--~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~-------~~~~L 412 (688)
....+.||-|+||.||.+.+. |+.||+|++..- +...-+.+.+|+++|.-++|.|++..++... +..|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 345678999999999999886 899999988543 3344567889999999999999999987752 23677
Q ss_pred EEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccccc
Q 005616 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~ 492 (688)
|.|.| ..+|..++... .+|+-..+.-++.||++||.|||+.+ |+||||||.|+|++.|..+||||||+++.-.
T Consensus 135 ~TELm-QSDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHH-HhhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 88877 44666666443 45677778888999999999999977 9999999999999999999999999999765
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhHHH-----------------
Q 005616 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR----------------- 554 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~----------------- 554 (688)
.+... ..+..+-|..|.|||++.+. .|+...||||.|||+.||+..+..|...+.+.
T Consensus 208 ~d~~~-----hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 208 QRDRL-----NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred hhhhh-----hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence 54322 23445678899999988765 69999999999999999999888775322211
Q ss_pred HHhhcCccccccCC--CCCCC--------CHHHHHHHHHHHHHcccCCCCCCCCCcHHH
Q 005616 555 RAVSCGKLSSILDP--LAGDW--------PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 555 ~~i~~~~l~~~ldp--~~~~~--------~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l 603 (688)
....+|.-.-++.. ...++ +..-......+...++..||+.|.+..+.+
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~ 341 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEAL 341 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhc
Confidence 11112211111110 00111 112233567788889999999999877433
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-27 Score=251.63 Aligned_cols=193 Identities=22% Similarity=0.333 Sum_probs=165.0
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc------c--chHHHHHHHHHHHcCC---CCceeeEecccCC
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM------Q--GQLEFQQEVRVLSKLQ---HPHLVTLLGACPE 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~------~--~~~~f~~E~~iL~~l~---HpnIV~l~g~~~~ 408 (688)
.+|.....+|.|+||.|+.+.++ ...|+||.+.+... . ..-.+--|+.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45788899999999999999987 67799999876542 1 1123567999999997 9999999999965
Q ss_pred --CceeEEeeC-CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeec
Q 005616 409 --AWSLVYEYL-PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 409 --~~~LV~E~~-~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DF 485 (688)
.+||+||-- ++-+|.+++..+. .+++.+...|+.||+.|+++||+.+ |||||||-+||+++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 477888865 4568889887653 5888999999999999999999976 999999999999999999999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCC-CCcchHhHHHHHHHHHHhCCCCCC
Q 005616 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL-TPKSDSYSFGLIILQLLTGRLPVG 548 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSfGviL~ELltG~~Pf~ 548 (688)
|.|.....+. ....+||.+|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus 715 gsaa~~ksgp--------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP--------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC--------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998876554 246789999999999999887 567999999999999999999974
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-27 Score=249.33 Aligned_cols=262 Identities=23% Similarity=0.298 Sum_probs=199.0
Q ss_pred CcccCHHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCC------CCcee
Q 005616 329 SAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ------HPHLV 400 (688)
Q Consensus 329 ~~~~~~~el~~at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~------HpnIV 400 (688)
.-.+.+-|+ ..+.|.+....|+|-|++|..|.+. |..||||++..+..-. +.=..|+.||.+|+ --+++
T Consensus 421 YYrv~igE~--LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 421 YYRVRIGEL--LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred eEEEehhhh--hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHH
Confidence 334444444 4578888899999999999999886 8899999998654322 22357999999995 33789
Q ss_pred eEecccC--CCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC-
Q 005616 401 TLLGACP--EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE- 477 (688)
Q Consensus 401 ~l~g~~~--~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~- 477 (688)
+|+..|. ..+|||+|-+ ..+|.++|.+.+..-.|....+..++.|+.-||..|-..+ |+|.||||+|||++++
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCc
Confidence 9988874 4689999987 4689999988876677888999999999999999999976 9999999999999865
Q ss_pred CceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH--HH-
Q 005616 478 LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VR- 554 (688)
Q Consensus 478 ~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~- 554 (688)
..+||||||.|.....+.. +....+.-|.|||++.+-+|+...|+||.||+||||.||+..|.+..+ +.
T Consensus 574 ~iLKLCDfGSA~~~~enei--------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEI--------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred ceeeeccCccccccccccc--------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 5689999999988765542 223345569999999999999999999999999999999988854322 11
Q ss_pred -----------HHhhcCcc---------------------------ccccCCC---------CCCCC---HHHHHHHHHH
Q 005616 555 -----------RAVSCGKL---------------------------SSILDPL---------AGDWP---TFVARRLVDL 584 (688)
Q Consensus 555 -----------~~i~~~~l---------------------------~~~ldp~---------~~~~~---~~~~~~l~~L 584 (688)
.++..|.+ ...+.|. ...+| ......|.+|
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 11111111 0111110 00122 2345689999
Q ss_pred HHHcccCCCCCCCCCcHHHHH
Q 005616 585 GLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 585 i~~Cl~~dP~~RPs~~e~l~~ 605 (688)
+..|+..||.+|.+..++|.+
T Consensus 726 Ldkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHhccChhhcCCHHHHhcC
Confidence 999999999999999866643
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=235.77 Aligned_cols=248 Identities=23% Similarity=0.269 Sum_probs=187.9
Q ss_pred hcCcccceeeeccCceEEEEEEE--CCeEEEEEEEecC--CccchHHHHHHHHHHHcCCCCceeeEecccC--------C
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEM--LGRTVAIKMLYSH--NMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--------E 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~--~g~~VAIK~l~~~--~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--------~ 408 (688)
..+|.....+|.|.- .|--+-+ .+++||+|.+... .........+|..++..++|+|||+++.+|. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 457777788999988 5555544 3899999987543 2334556789999999999999999999982 1
Q ss_pred CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcc
Q 005616 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla 488 (688)
+.|+|||+|. ++|...+.. .++-..+..|+.|++.|+.|||+.+ |+||||||+||++..++.+||.|||+|
T Consensus 95 e~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 4789999994 577776652 2455778899999999999999977 999999999999999999999999999
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhc---------
Q 005616 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC--------- 559 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~--------- 559 (688)
+....+. ..+..+.|..|.|||++.+..|...+||||+||++.||++|..-|.+.+.+.+....
T Consensus 166 r~e~~~~-------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 166 RTEDTDF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cccCccc-------ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence 8765441 346778999999999999888999999999999999999999888643322111000
Q ss_pred ----------------------Ccccccc-CC---CCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHH
Q 005616 560 ----------------------GKLSSIL-DP---LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 560 ----------------------~~l~~~l-dp---~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~ 605 (688)
-.+.+.+ |. ...+.+......+.+|+.+||-.||++|-++.+.|.+
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0001111 00 0011122234568899999999999999999865543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-25 Score=233.98 Aligned_cols=129 Identities=27% Similarity=0.373 Sum_probs=107.2
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCC-----CC---ceeeEecccCC--
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-----HP---HLVTLLGACPE-- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-----Hp---nIV~l~g~~~~-- 408 (688)
.++|.+.++||.|-|++||++.+. .+.||+|+.+.... -.+....|+++|++++ |+ +||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 368899999999999999999887 67899999875432 2334678999999984 33 69999999932
Q ss_pred ----CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee
Q 005616 409 ----AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 474 (688)
Q Consensus 409 ----~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL 474 (688)
..|+|+|++ |.+|..++.... ...++...+.+|+.||+.||.|||..+ +|||.||||+||||
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 378999999 667777776543 356889999999999999999999987 79999999999999
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=267.91 Aligned_cols=200 Identities=17% Similarity=0.126 Sum_probs=139.8
Q ss_pred HcCCC-CceeeEecccC---------CCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc
Q 005616 392 SKLQH-PHLVTLLGACP---------EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461 (688)
Q Consensus 392 ~~l~H-pnIV~l~g~~~---------~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ 461 (688)
+.++| +||+.++++|. +..++++||+ +++|.++|.... ..+++..++.|+.||+.||.|||+.+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 34566 68888998871 1245678877 669999996532 46899999999999999999999965
Q ss_pred eEeCCCCCCceeeCCCC-------------------ceEEeecCccccccCCCC----c------CCCccccCCCCCCCC
Q 005616 462 IVHGDLKPQNILLDSEL-------------------SSKICDFGICRLVTEDTL----Y------LPSFHRSTAPKGSFP 512 (688)
Q Consensus 462 IiHrDIKp~NILLd~~~-------------------~~KL~DFGla~~~~~~~~----~------~~~~~~~~~~~Gt~~ 512 (688)
|+||||||+||||+..| .+||+|||+++....... . .+.........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 99999999999996544 455555555543211000 0 000001122468999
Q ss_pred CCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCC
Q 005616 513 YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELY 592 (688)
Q Consensus 513 Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~d 592 (688)
|||||++.+..++.++|||||||+||||++|.+|+.........+.... +.+. . .........++.+||+++
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~----~~~~---~-~~~~~~~~~~~~~~L~~~ 252 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRV----LPPQ---I-LLNWPKEASFCLWLLHPE 252 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhh----cChh---h-hhcCHHHHHHHHHhCCCC
Confidence 9999999999999999999999999999999998764332222222111 1110 0 112334678889999999
Q ss_pred CCCCCCCcHHHHH
Q 005616 593 GRERPDITPSLVK 605 (688)
Q Consensus 593 P~~RPs~~e~l~~ 605 (688)
|.+||++.+.+.+
T Consensus 253 P~~Rps~~eil~h 265 (793)
T PLN00181 253 PSCRPSMSELLQS 265 (793)
T ss_pred hhhCcChHHHhhc
Confidence 9999999965543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=231.93 Aligned_cols=257 Identities=25% Similarity=0.336 Sum_probs=191.3
Q ss_pred HHHHhcCcccceeeeccCceEEEEEEEC-----CeEEEEEEEecCCccchHHHHHHHHHHHcCC-CCceeeEeccc--CC
Q 005616 337 LQTATCNFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGAC--PE 408 (688)
Q Consensus 337 l~~at~~f~~~~~LG~G~~G~Vy~g~~~-----g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~--~~ 408 (688)
+....+.|...++||.|.|++||++.+. ...||+|.+.... ....+.+|+++|..+. +.||+++.+++ .+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445577889999999999999999663 5679999986543 3345889999999995 99999999998 45
Q ss_pred CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC-CCceEEeecCc
Q 005616 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFGI 487 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-~~~~KL~DFGl 487 (688)
...+|+||++.....+++. .++...+..++..+..||.++|..| ||||||||+|+|.+. .+.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 6899999999999999884 4667889999999999999999976 999999999999985 47789999999
Q ss_pred cccccCCC------C-----cC-----------------CC----------ccccCCCCCCCCCCChhhhcc-CCCCCcc
Q 005616 488 CRLVTEDT------L-----YL-----------------PS----------FHRSTAPKGSFPYADPEYHRT-GVLTPKS 528 (688)
Q Consensus 488 a~~~~~~~------~-----~~-----------------~~----------~~~~~~~~Gt~~Y~APE~~~~-~~~s~ks 528 (688)
|....... . .. +. .......+||+||.|||++.. ..-++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97221100 0 00 00 011124579999999998765 4578999
Q ss_pred hHhHHHHHHHHHHhCCCCCCChh----------------HHH-HHhhcCc--ccc--------------------ccCC-
Q 005616 529 DSYSFGLIILQLLTGRLPVGLAG----------------EVR-RAVSCGK--LSS--------------------ILDP- 568 (688)
Q Consensus 529 DVwSfGviL~ELltG~~Pf~~~~----------------~~~-~~i~~~~--l~~--------------------~ldp- 568 (688)
||||.|||++-+++++.||.... .+. .+...|. +.+ .+.+
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 99999999999999999984211 111 1111222 111 0001
Q ss_pred -----CCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHH
Q 005616 569 -----LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 569 -----~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~ 604 (688)
....+....+..+.+|+.+|+..||.+|.++.++|.
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 011223334558999999999999999999986553
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=221.70 Aligned_cols=237 Identities=24% Similarity=0.343 Sum_probs=179.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecc-cC--CCceeEEe
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGA-CP--EAWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~-~~--~~~~LV~E 415 (688)
+.|.+.+.||+|.||.+-++.++ .+.+++|.+... .....+|.+|..---.| .|.|||.-|.. |+ +.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 46888899999999999999998 567999987643 34567899998776666 59999998865 43 34678999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeC-C-CCceEEeecCccccccC
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD-S-ELSSKICDFGICRLVTE 493 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd-~-~~~~KL~DFGla~~~~~ 493 (688)
|++.|+|..-+... .+-+....+++.|+++||.|+|+.+ +||||||.+||||- . ...+||||||+....+.
T Consensus 103 ~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999999877553 4666778899999999999999955 99999999999993 3 34799999999876543
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccC-----CCCCcchHhHHHHHHHHHHhCCCCCCChh------HHHHHhhcCcc
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTG-----VLTPKSDSYSFGLIILQLLTGRLPVGLAG------EVRRAVSCGKL 562 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-----~~s~ksDVwSfGviL~ELltG~~Pf~~~~------~~~~~i~~~~l 562 (688)
.. ....-+..|.+||..... ...+.+|||.||+++|.++||++||.... +-+..+..++.
T Consensus 176 tV---------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 176 TV---------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred ee---------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC
Confidence 22 233456789999966432 35789999999999999999999996221 22344555544
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 563 ~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
..+.+ .+. ..++.+..+..+-+..+|++|--..
T Consensus 247 ~~~P~----~F~-~fs~~a~r~Fkk~lt~~~~drcki~ 279 (378)
T KOG1345|consen 247 PALPK----KFN-PFSEKALRLFKKSLTPRFKDRCKIW 279 (378)
T ss_pred ccCch----hhc-ccCHHHHHHHHHhcCCcccccchhH
Confidence 43211 121 2456788888999999999995444
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=209.19 Aligned_cols=162 Identities=22% Similarity=0.212 Sum_probs=123.3
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC
Q 005616 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
|+|.+++...+ .+++|..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence 78999887543 46899999999999999999999954 999999999999999 9999876432
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH---HHHhhcCccccccCCCCCCCCHH
Q 005616 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV---RRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~---~~~i~~~~l~~~ldp~~~~~~~~ 576 (688)
...||+.|+|||++.+..++.++|||||||++|||+||+.||...... ...+..+... .++.....+..
T Consensus 63 ------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 134 (176)
T smart00750 63 ------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA--DDPRDRSNLES 134 (176)
T ss_pred ------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc--CCccccccHHH
Confidence 125899999999999999999999999999999999999999644321 1111111111 11111112223
Q ss_pred HHH--HHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 577 VAR--RLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 577 ~~~--~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
... .+.+++.+||..+|.+||++. +++..+.
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~-~ll~~~~ 167 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAAN-HYLAHCR 167 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHH-HHHHHHH
Confidence 333 699999999999999999999 4444433
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-23 Score=223.04 Aligned_cols=172 Identities=19% Similarity=0.188 Sum_probs=132.4
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEEC---CeEEEEEEEecCC-----ccchHHHHHHHHHHHcCCCCceee-Eeccc
Q 005616 336 DLQTATCNFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHN-----MQGQLEFQQEVRVLSKLQHPHLVT-LLGAC 406 (688)
Q Consensus 336 el~~at~~f~~~~~LG~G~~G~Vy~g~~~---g~~VAIK~l~~~~-----~~~~~~f~~E~~iL~~l~HpnIV~-l~g~~ 406 (688)
.+....++|.....||+|+||+||+|.+. +..||||++.... ......|.+|+.+|..++|+|+|+ ++++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 34556688999999999999999999874 6778999875331 112456999999999999999985 5443
Q ss_pred CCCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCC-CCCceeeCCCCceEEeec
Q 005616 407 PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDL-KPQNILLDSELSSKICDF 485 (688)
Q Consensus 407 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDI-Kp~NILLd~~~~~KL~DF 485 (688)
+..+|||||++|++|... . .. . ...++.+++.||.|||+.+ |+|||| ||+|||++.++.+||+||
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~-~~-----~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-R-PH-----G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-C-cc-----c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 457999999999999632 1 10 1 2467889999999999965 999999 999999999999999999
Q ss_pred CccccccCCCCcCC--CccccCCCCCCCCCCChhhhccC
Q 005616 486 GICRLVTEDTLYLP--SFHRSTAPKGSFPYADPEYHRTG 522 (688)
Q Consensus 486 Gla~~~~~~~~~~~--~~~~~~~~~Gt~~Y~APE~~~~~ 522 (688)
|+|+.+........ ....-....+++.|+|||++...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99998765432111 11112466789999999988644
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-21 Score=202.01 Aligned_cols=258 Identities=29% Similarity=0.404 Sum_probs=196.5
Q ss_pred cccceeeeccCceEEEEEEECCeEEEEEEEecCCccc---hHHHHHHHHHHHcCCCC-ceeeEecccCCC--ceeEEeeC
Q 005616 344 FSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHP-HLVTLLGACPEA--WSLVYEYL 417 (688)
Q Consensus 344 f~~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~---~~~f~~E~~iL~~l~Hp-nIV~l~g~~~~~--~~LV~E~~ 417 (688)
|.....||.|+||.||++... ..+++|.+....... ...|.+|+.++..+.|+ +|+++++++... .+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 566788999999999999988 889999997765543 56799999999999988 799999988543 58999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-ceEEeecCccccccCCCC
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLVTEDTL 496 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-~~KL~DFGla~~~~~~~~ 496 (688)
.++++.+++........+.......++.+++.++.|+|..+ ++|||+||+||+++..+ .++++|||++........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999966654321125788899999999999999999976 99999999999999998 799999999986554332
Q ss_pred cCCCccccCCCCCCCCCCChhhhcc---CCCCCcchHhHHHHHHHHHHhCCCCCCChh------HHHHHhhcCccccccC
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRT---GVLTPKSDSYSFGLIILQLLTGRLPVGLAG------EVRRAVSCGKLSSILD 567 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSfGviL~ELltG~~Pf~~~~------~~~~~i~~~~l~~~ld 567 (688)
............||..|+|||.+.+ ..++...|+||+|++++++++|..||.... .....+..........
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 1100012467789999999999987 688999999999999999999999986543 2222222221110000
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHH
Q 005616 568 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 568 p~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~ 605 (688)
+.....+......+.+++..|+..+|..|.+....+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00011112223578899999999999999998855544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-21 Score=209.73 Aligned_cols=261 Identities=23% Similarity=0.270 Sum_probs=192.0
Q ss_pred CcccceeeeccCceEEEEEEECC---eEEEEEEEecCCccchHHHHHHHHHHHcCCC----CceeeEecccC-C--Ccee
Q 005616 343 NFSESFKVGQGGFGCVYKGEMLG---RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH----PHLVTLLGACP-E--AWSL 412 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~g---~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~H----pnIV~l~g~~~-~--~~~L 412 (688)
+|....+||+|+||.||.|.... ..+|+|............+..|+.++..+.. +++..+++... . ..++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999999863 4699998876644433377889999988863 57788877762 3 3688
Q ss_pred EEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC-----CceEEeecCc
Q 005616 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-----LSSKICDFGI 487 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~-----~~~KL~DFGl 487 (688)
||+.+ |.+|.++..... ...++-.+++.|+.|++.+|.+||+.+ ++||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 88877 889999775554 467889999999999999999999976 9999999999999865 4699999999
Q ss_pred cc--cccCCCCc--CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH--HHHhhcCc
Q 005616 488 CR--LVTEDTLY--LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGK 561 (688)
Q Consensus 488 a~--~~~~~~~~--~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~i~~~~ 561 (688)
++ ........ .+.........||..|.++....+...+++.|+||++.++.+++.|..||...... ...+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 33222211 11111123456999999999999999999999999999999999999999644321 11111111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhhhc
Q 005616 562 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVA 613 (688)
Q Consensus 562 l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~~~ 613 (688)
....... .....+..+..+...+-..+..++|... .+...|......
T Consensus 254 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~-~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 254 RKLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYE-KLAELLKDVFDS 300 (322)
T ss_pred hhhcccc----ccCCChHHHHHHHHHhhccCCcCCCCHH-HHHHHHHHHHHh
Confidence 1111111 1112334566666666668999999998 777777665443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.4e-23 Score=204.32 Aligned_cols=254 Identities=23% Similarity=0.415 Sum_probs=195.4
Q ss_pred cccCHHHHHHHhcCcccceeeeccCceEEEEEEECCeEEEEEEEecCCccc--hHHHHHHHHHHHcCCCCceeeEecccC
Q 005616 330 AEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGACP 407 (688)
Q Consensus 330 ~~~~~~el~~at~~f~~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~--~~~f~~E~~iL~~l~HpnIV~l~g~~~ 407 (688)
.-+++.+|.-.| +|.....|..|+|++.|..++.|++....... ..+|..|.-.|+.+.||||+.++|.|.
T Consensus 185 ~gid~~~lnl~t-------kl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn 257 (448)
T KOG0195|consen 185 TGIDVSSLNLIT-------KLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN 257 (448)
T ss_pred cCcchhhhhhhh-------hhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc
Confidence 334555555444 58899999999999999999999987654433 346999999999999999999999996
Q ss_pred C--CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEe-CCCCCCceeeCCCCceEEee
Q 005616 408 E--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH-GDLKPQNILLDSELSSKICD 484 (688)
Q Consensus 408 ~--~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiH-rDIKp~NILLd~~~~~KL~D 484 (688)
. ++.++..||+.|||...|+.... -.++-.+..+++.+||+|++|||+..| ++- --|.+..|++|++.+++|+-
T Consensus 258 sppnlv~isq~mp~gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarism 334 (448)
T KOG0195|consen 258 SPPNLVIISQYMPFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISM 334 (448)
T ss_pred CCCCceEeeeeccchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheec
Confidence 5 57889999999999999987653 235667889999999999999999873 444 46899999999998887752
Q ss_pred cCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCC---CcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCc
Q 005616 485 FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLT---PKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGK 561 (688)
Q Consensus 485 FGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s---~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~ 561 (688)
+-+++. + ......-.|.||+||.+...+-+ ..+|+|||.++||||.|...||.....+..-...
T Consensus 335 -ad~kfs---------f-qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-- 401 (448)
T KOG0195|consen 335 -ADTKFS---------F-QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-- 401 (448)
T ss_pred -ccceee---------e-eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh--
Confidence 111110 0 11233457899999998766543 5899999999999999999999865554332211
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHh
Q 005616 562 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 562 l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l 610 (688)
.+.-.....|+..+..+..|+.-|++.||.+||.+. .++-.|+.+
T Consensus 402 ---aleglrv~ippgis~hm~klm~icmnedpgkrpkfd-mivpilekm 446 (448)
T KOG0195|consen 402 ---ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFD-MIVPILEKM 446 (448)
T ss_pred ---hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcc-eehhhHHHh
Confidence 112223356778889999999999999999999998 777777754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=199.52 Aligned_cols=259 Identities=21% Similarity=0.266 Sum_probs=195.4
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccCCC--ceeEE
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPEA--WSLVY 414 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~~--~~LV~ 414 (688)
..-+|.++++||.|+||+++.|... +.+||||.-...+. .-++..|....+.| ..++|..+|.|-+++ ..||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 3458999999999999999999864 89999998654332 23466788888887 578998888776665 56999
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC-----CceEEeecCccc
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-----LSSKICDFGICR 489 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~-----~~~KL~DFGla~ 489 (688)
|.+ |-||.|++.-++ ..++.+.++.|+.|++.-+.|+|+.+ +|.|||||+|+||..- ..+.|+|||+|+
T Consensus 104 dLL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 988 889999887665 46888999999999999999999966 9999999999999754 348999999999
Q ss_pred cccCCCCcC-CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhH-----HHHHhhcCccc
Q 005616 490 LVTEDTLYL-PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE-----VRRAVSCGKLS 563 (688)
Q Consensus 490 ~~~~~~~~~-~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~-----~~~~i~~~~l~ 563 (688)
...+..... ..+.......||..||+---..+...+.+.|.-|||-|++..|-|..||.+... -...+...+-.
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 887654321 123445678899999999999999999999999999999999999999975432 22223332222
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhh
Q 005616 564 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 564 ~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~ 611 (688)
..+.-++..+|. ++..-+.-.-..+-.+-|+.. -+...+..+.
T Consensus 258 T~i~~Lc~g~P~----efa~Yl~yvR~L~F~E~PDYd-ylr~Lf~dvl 300 (449)
T KOG1165|consen 258 TPIEVLCEGFPE----EFATYLRYVRRLDFFETPDYD-YLRKLFDDVL 300 (449)
T ss_pred CCHHHHHhcCHH----HHHHHHHHHHhcCcccCCCHH-HHHHHHHHHH
Confidence 222223334443 444444455566778888876 6665555543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=186.25 Aligned_cols=258 Identities=23% Similarity=0.282 Sum_probs=198.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCC-CceeeEecccCC--CceeEEe
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH-PHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~H-pnIV~l~g~~~~--~~~LV~E 415 (688)
.+.|...++||.|+||.+|.|..- |..||||+-...... -.+.-|.++...|++ ..|..+..+..+ ...+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 467999999999999999999874 899999987654433 346678999999975 455555555543 4679999
Q ss_pred eCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC---CceEEeecCcccccc
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE---LSSKICDFGICRLVT 492 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~---~~~KL~DFGla~~~~ 492 (688)
.+ |.||.+++.-.. ..++..+++-++.|++.-++|+|..+ +|||||||+|+|..-+ ..+.|+|||+|+.+.
T Consensus 92 LL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 889999887654 35788999999999999999999966 9999999999999643 468999999999875
Q ss_pred CCCCcC-CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHH-----HHHhhcCcccccc
Q 005616 493 EDTLYL-PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV-----RRAVSCGKLSSIL 566 (688)
Q Consensus 493 ~~~~~~-~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~-----~~~i~~~~l~~~l 566 (688)
+..... ..+.......||..|.+--...+...+...|+-|+|.+|..+.-|..||.+.... ...+...++...+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 433221 1233456778999999998888888899999999999999999999999754432 2334444554444
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhh
Q 005616 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 567 dp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~ 611 (688)
...+..+|. ++.-.+.-|-...-++-|+.. -+.+.+.-+-
T Consensus 246 e~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~-ylrqlFriLf 285 (341)
T KOG1163|consen 246 EVLCKGFPA----EFAMYLNYCRGLGFEEKPDYM-YLRQLFRILF 285 (341)
T ss_pred HHHhCCCcH----HHHHHHHHHhhcCCCCCCcHH-HHHHHHHHHH
Confidence 444555554 566677789999999999987 6666665553
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=190.77 Aligned_cols=169 Identities=14% Similarity=0.089 Sum_probs=134.1
Q ss_pred HhcCcccceeeeccCceEEEEEEECCeEEEEEEEecCCccchHH---------HHHHHHHHHcCCCCceeeEecccC---
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLE---------FQQEVRVLSKLQHPHLVTLLGACP--- 407 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~---------f~~E~~iL~~l~HpnIV~l~g~~~--- 407 (688)
..++|...+.||.|+||.||.....+..+|||++.......... |.+|+..+.++.||+|..+..++.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 46899999999999999999987778899999997665443332 689999999999999999887742
Q ss_pred -------CCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCce
Q 005616 408 -------EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 408 -------~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~ 480 (688)
...+|||||++|.+|.++.. ++. ....+++.+|..||..+ ++|||+||+||+++.+| +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 23789999999999988731 221 34569999999999976 99999999999999988 9
Q ss_pred EEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHH
Q 005616 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLL 541 (688)
Q Consensus 481 KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELl 541 (688)
+|+|||........... .-+.....|..++|+||||+.+.-+.
T Consensus 174 ~liDfg~~~~~~e~~a~------------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK------------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH------------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999987655322110 11445556778999999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.4e-20 Score=184.03 Aligned_cols=138 Identities=18% Similarity=0.222 Sum_probs=107.3
Q ss_pred eeeeccCceEEEEEEEC-CeEEEEEEEecCCcc--c-------hHH-----------------HHHHHHHHHcCCCCcee
Q 005616 348 FKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ--G-------QLE-----------------FQQEVRVLSKLQHPHLV 400 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~--~-------~~~-----------------f~~E~~iL~~l~HpnIV 400 (688)
..||+|+||.||+|... |..||||+++..... . ... ...|+.++.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 57999999999999885 899999999765321 1 112 23499999999877764
Q ss_pred eEecccCCCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH-hccCCCceEeCCCCCCceeeCCCCc
Q 005616 401 TLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL-HSSKPEKIVHGDLKPQNILLDSELS 479 (688)
Q Consensus 401 ~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~IiHrDIKp~NILLd~~~~ 479 (688)
....+.....+|||||++++++...+... .++++..+..++.|++.+|.|| |+.+ |+||||||+|||++ ++.
T Consensus 83 ~p~~~~~~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 83 CPEPILLKSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCcEEEecCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCc
Confidence 33332233458999999998776543222 3578899999999999999999 6755 99999999999998 578
Q ss_pred eEEeecCcccccc
Q 005616 480 SKICDFGICRLVT 492 (688)
Q Consensus 480 ~KL~DFGla~~~~ 492 (688)
++|+|||+|....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=8e-20 Score=181.57 Aligned_cols=189 Identities=17% Similarity=0.100 Sum_probs=143.3
Q ss_pred ccceeeeccCceEEEEEEECCeEEEEEEEecCCccc----hHHHHHHHHHHHcCC-CCceeeEecccCCCceeEEeeCCC
Q 005616 345 SESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQG----QLEFQQEVRVLSKLQ-HPHLVTLLGACPEAWSLVYEYLPN 419 (688)
Q Consensus 345 ~~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~----~~~f~~E~~iL~~l~-HpnIV~l~g~~~~~~~LV~E~~~~ 419 (688)
.+...|++|+||+||.+...+.+++.+.+.....-. ...|.+|+++|.+|. |+++++++++ +..+++|+|+.|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~~~~lvmeyI~G 82 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--DGRHLDRSYLAG 82 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--cCEEEEEeeecC
Confidence 345789999999999888888999988886654411 125889999999995 5889999886 457999999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCC-CCCceeeCCCCceEEeecCccccccCCCCcC
Q 005616 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDL-KPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDI-Kp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
.+|...+.. ....++.+++.+|.++|..+ |+|||| ||+|||++.+|.++|+|||+|..........
T Consensus 83 ~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 83 AAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 999754321 12457889999999999976 999999 7999999999999999999998654332100
Q ss_pred CCcc-------ccCCCCCCCCCCChhhhcc--CCCCCcchHhHHHHHHHHHHhCCCCCC
Q 005616 499 PSFH-------RSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRLPVG 548 (688)
Q Consensus 499 ~~~~-------~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSfGviL~ELltG~~Pf~ 548 (688)
.-.. .......++.|++|+...- ..--+..++++.|..+|.++||..|.-
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0000 0112347889999985432 222367899999999999999998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-20 Score=215.80 Aligned_cols=247 Identities=21% Similarity=0.275 Sum_probs=179.6
Q ss_pred ccceeeeccCceEEEEEEEC--CeEEEEEEEecC--Cccch----HHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005616 345 SESFKVGQGGFGCVYKGEML--GRTVAIKMLYSH--NMQGQ----LEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 345 ~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~--~~~~~----~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
.....+|.|.+|.|+..... ...++.|.+... ..... ..+..|+-+-..++|||++..+..+.+ ...-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34578999999988877654 344444443211 11111 125567777788899999887766643 233459
Q ss_pred eeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCC
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
|||++ +|..++.... .+...++..++.|++.|+.|||+.+ |.||||||+|++++.+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 9999987652 4666788999999999999999977 999999999999999999999999999877543
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCC-cchHhHHHHHHHHHHhCCCCCCChhHHHHH----hhcCccccccCCC
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTP-KSDSYSFGLIILQLLTGRLPVGLAGEVRRA----VSCGKLSSILDPL 569 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~-ksDVwSfGviL~ELltG~~Pf~~~~~~~~~----i~~~~l~~~ldp~ 569 (688)
... ........+|+..|+|||++.+..|.+ ..||||.|++++.|++|+.||.....-... ...+...... .
T Consensus 474 ~e~--~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~--~ 549 (601)
T KOG0590|consen 474 WEK--NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFE--G 549 (601)
T ss_pred cch--hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccccccc--C
Confidence 321 123456788999999999999999976 699999999999999999999644322111 1111111100 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHH
Q 005616 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 602 (688)
........+.....++.++|+.+|.+|.++.+.
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i 582 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQI 582 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHH
Confidence 111223456678899999999999999999843
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-19 Score=176.69 Aligned_cols=140 Identities=19% Similarity=0.212 Sum_probs=110.4
Q ss_pred ceeeeccCceEEEEEEEC-CeEEEEEEEecCCcc--c------------------------hHHHHHHHHHHHcCCCCce
Q 005616 347 SFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ--G------------------------QLEFQQEVRVLSKLQHPHL 399 (688)
Q Consensus 347 ~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~--~------------------------~~~f~~E~~iL~~l~HpnI 399 (688)
...||+|+||.||+|.+. |..||||+++..... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 357999999999999886 999999999765321 0 1124678999999999987
Q ss_pred eeEecccCCCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceEeCCCCCCceeeCCCC
Q 005616 400 VTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSEL 478 (688)
Q Consensus 400 V~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILLd~~~ 478 (688)
.....+.....+|||||++|+++....... ..++......++.+++.+|.+||+ .+ |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CC
Confidence 544333333468999999998654432221 346778899999999999999999 66 99999999999999 89
Q ss_pred ceEEeecCccccccC
Q 005616 479 SSKICDFGICRLVTE 493 (688)
Q Consensus 479 ~~KL~DFGla~~~~~ 493 (688)
.++|+|||++.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4e-20 Score=203.94 Aligned_cols=222 Identities=27% Similarity=0.342 Sum_probs=180.8
Q ss_pred eeccCceEEEEEE-----ECCeEEEEEEEecCCccc--hHHHHHHHHHHHcCC-CCceeeEecccC--CCceeEEeeCCC
Q 005616 350 VGQGGFGCVYKGE-----MLGRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQ-HPHLVTLLGACP--EAWSLVYEYLPN 419 (688)
Q Consensus 350 LG~G~~G~Vy~g~-----~~g~~VAIK~l~~~~~~~--~~~f~~E~~iL~~l~-HpnIV~l~g~~~--~~~~LV~E~~~~ 419 (688)
+|.|.||.|+.++ +.|.-+|+|++++..... ......|..++..++ ||.+|++...+. ...+++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999653 347889999987764322 225667889999997 999999998884 458999999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCC
Q 005616 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
|.|...+.... .+++.....+...++-++.++|..+ |+|||+|++||+++.+|++++.|||+++..-...
T Consensus 82 g~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 82 GDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred chhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 99988886654 3566677778889999999999977 9999999999999999999999999999875433
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHHHHH
Q 005616 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVAR 579 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~~~~ 579 (688)
..+||..|||||++. ......|+||||++++||+||..||.. ++...+... ....|.....
T Consensus 152 ------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--~~~~~Il~~---------~~~~p~~l~~ 212 (612)
T KOG0603|consen 152 ------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--DTMKRILKA---------ELEMPRELSA 212 (612)
T ss_pred ------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--HHHHHHhhh---------ccCCchhhhH
Confidence 228999999999998 678899999999999999999999986 322222211 2245677888
Q ss_pred HHHHHHHHcccCCCCCCCCCc
Q 005616 580 RLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 580 ~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
....++..++..+|..|--..
T Consensus 213 ~a~~~~~~l~~r~p~nrLg~~ 233 (612)
T KOG0603|consen 213 EARSLFRQLFKRNPENRLGAG 233 (612)
T ss_pred HHHHHHHHHHhhCHHHHhccC
Confidence 888999999999999997764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-18 Score=179.59 Aligned_cols=230 Identities=22% Similarity=0.321 Sum_probs=149.6
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCC---C-------c------eee
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQH---P-------H------LVT 401 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~H---p-------n------IV~ 401 (688)
.+.....||.|+++.||.+++. |..+|||++..... ...+.+.+|.-....+.+ | . +++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3445678999999999999997 69999999865542 244567777766555432 1 1 122
Q ss_pred Eecc---c---C-------CCceeEEeeCCCCcHHHHhc---ccCC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEe
Q 005616 402 LLGA---C---P-------EAWSLVYEYLPNGSLQDRLF---RKSN-VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464 (688)
Q Consensus 402 l~g~---~---~-------~~~~LV~E~~~~gsL~~~L~---~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiH 464 (688)
+-+- + . -+.+++|+-+ .++|.+++. .... ...+....++.+..|+++.+++||+.+ |+|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 1110 1 1 0235677776 567777643 2222 123445566778899999999999976 999
Q ss_pred CCCCCCceeeCCCCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc--------CCCCCcchHhHHHHH
Q 005616 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT--------GVLTPKSDSYSFGLI 536 (688)
Q Consensus 465 rDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--------~~~s~ksDVwSfGvi 536 (688)
+||+|+|+|++.+|.++|+||+.....+.... ....+..|.+||.... -.++.+.|.|+||++
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee---------ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 99999999999999999999988776543221 1335578999997643 257889999999999
Q ss_pred HHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 005616 537 ILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRER 596 (688)
Q Consensus 537 L~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~R 596 (688)
+|.|.+|..||+........ +..-..+. .+++.+..||..+|+.||.+|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~----------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADP----------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTS----------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccc----------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999854331000 00122344 778899999999999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.2e-18 Score=169.20 Aligned_cols=134 Identities=22% Similarity=0.285 Sum_probs=103.8
Q ss_pred ccceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcC-----CCCceeeEecccCCC-----ce-eE
Q 005616 345 SESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-----QHPHLVTLLGACPEA-----WS-LV 413 (688)
Q Consensus 345 ~~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l-----~HpnIV~l~g~~~~~-----~~-LV 413 (688)
.....||+|+||.||.....+.. +||++..........+.+|+.++..+ .||||++++|++.+. .+ +|
T Consensus 5 ~~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 5 SEQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CCcceecCCCceEEEECCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 34578999999999962222334 79998776555667899999999999 579999999999554 12 68
Q ss_pred Eee--CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHH-HHHhccCCCceEeCCCCCCceeeCC----CCceEEeecC
Q 005616 414 YEY--LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL-CFLHSSKPEKIVHGDLKPQNILLDS----ELSSKICDFG 486 (688)
Q Consensus 414 ~E~--~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL-~yLH~~~~~~IiHrDIKp~NILLd~----~~~~KL~DFG 486 (688)
+|| +.+|+|.+++... .+++. ..++.+++.++ .|||+.+ |+||||||+|||++. ++.++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 6689999999553 24444 35678888887 8999976 999999999999974 3479999954
Q ss_pred cc
Q 005616 487 IC 488 (688)
Q Consensus 487 la 488 (688)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-18 Score=200.89 Aligned_cols=251 Identities=22% Similarity=0.252 Sum_probs=172.8
Q ss_pred CcccceeeeccCceEEEEEEECCeEEEEEEEecCCc-cchHHHHHHHHH--HHcCCCCceeeEecccC--CCceeEEeeC
Q 005616 343 NFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNM-QGQLEFQQEVRV--LSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~-~~~~~f~~E~~i--L~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
+|...+.||.+.|=.|.+|+++...|+||++.+... -....|.+++.- ...++|||++++.-+-. ...|||-+|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 667778899999999999999866699999976653 334444443333 45568999999876643 2367888887
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccc--ccCCC
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL--VTEDT 495 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~--~~~~~ 495 (688)
. .+|.|.|..+ +.|..-+..-|+.|++.||.-+|..+ |+|||||.+||||+.-.=+.|+||..-+- ++.+.
T Consensus 104 k-hnLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 104 K-HNLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred h-hhhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 4 4788877543 34566677789999999999999976 99999999999999988899999976543 22222
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccC----------C-CCCcchHhHHHHHHHHHHh-CCCCCCChhHHHHHhhcCccc
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTG----------V-LTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLS 563 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~----------~-~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~~~~~i~~~~l~ 563 (688)
.....+...+. ..-..|+|||.|... . ++++.||||+||++.||++ |++||....-. +.+.|. .
T Consensus 177 Padf~fFFDTS-rRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~--aYr~~~-~ 252 (1431)
T KOG1240|consen 177 PADFTFFFDTS-RRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL--AYRSGN-A 252 (1431)
T ss_pred cccceEEEecC-CceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH--hHhccC-c
Confidence 11111111111 223469999976431 2 7889999999999999999 78998754332 122221 0
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHH
Q 005616 564 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 564 ~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le 608 (688)
.......... ....+.+|++.|++.||..|-++. +.++...
T Consensus 253 ~~~e~~Le~I---ed~~~Rnlil~Mi~rdPs~RlSAe-dyL~~yr 293 (1431)
T KOG1240|consen 253 DDPEQLLEKI---EDVSLRNLILSMIQRDPSKRLSAE-DYLQKYR 293 (1431)
T ss_pred cCHHHHHHhC---cCccHHHHHHHHHccCchhccCHH-HHHHhhh
Confidence 0000000111 122688999999999999999998 4444433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.9e-18 Score=185.01 Aligned_cols=210 Identities=30% Similarity=0.416 Sum_probs=156.2
Q ss_pred HHcCCCCceeeEecccCC--CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCC
Q 005616 391 LSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLK 468 (688)
Q Consensus 391 L~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIK 468 (688)
|..+.|.|+.+++|.+.+ ..++|.+||..|+|.+.+.... ..++|.-...++.+|+.||.|||+.. -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 356789999999999854 4678999999999999998743 56899999999999999999999954 23999999
Q ss_pred CCceeeCCCCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccC-------CCCCcchHhHHHHHHHHHH
Q 005616 469 PQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-------VLTPKSDSYSFGLIILQLL 541 (688)
Q Consensus 469 p~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-------~~s~ksDVwSfGviL~ELl 541 (688)
+.|.++|..+.+||+|||+.......... .......-..-|.|||.+... ..+.+.||||||++++|++
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~----~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEP----EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccc----cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 99999999999999999998876431100 011122234569999988763 1467899999999999999
Q ss_pred hCCCCCCChh------HHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHHhh
Q 005616 542 TGRLPVGLAG------EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 542 tG~~Pf~~~~------~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~l~ 611 (688)
+...||.... ++...+..+ -...+.|...... ...+.+..++..||..+|.+||++. .+...++.+.
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~~~~~-~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~-~i~~~~~~~~ 225 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILRVKKG-GSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIE-QIRSKLLTIN 225 (484)
T ss_pred hccCccccccccCChHHHHHHHHhc-CCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHH-HHHhhhhhhc
Confidence 9999996422 233333331 1122222221111 3445799999999999999999998 6666665543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.6e-17 Score=191.96 Aligned_cols=198 Identities=23% Similarity=0.281 Sum_probs=156.1
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCC---CCceeeEecc--cCC
Q 005616 335 ADLQTATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ---HPHLVTLLGA--CPE 408 (688)
Q Consensus 335 ~el~~at~~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~---HpnIV~l~g~--~~~ 408 (688)
.++......|.+...||.|+||.||+|... |+.||||+-+....-. |.-=..++.+|+ -+.|..+..+ |.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 345555678888999999999999999876 8999999987655321 222234455555 2233333332 477
Q ss_pred CceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC-------CCceE
Q 005616 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-------ELSSK 481 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-------~~~~K 481 (688)
..+||++|.+.|+|.+++.. ...++|..+..++.+++..+..||..+ |||+||||+|+||.. +..++
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cceeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 88999999999999999983 356899999999999999999999977 999999999999942 35699
Q ss_pred EeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCC
Q 005616 482 ICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL 545 (688)
Q Consensus 482 L~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~ 545 (688)
|+|||.+..+.--. ....-....+|-++-.+|...+..++..+|.|.|..+++-||.|+.
T Consensus 842 lIDfG~siDm~lfp----~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFP----DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcC----CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999987653211 1123456788999999999999999999999999999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.3e-17 Score=162.87 Aligned_cols=132 Identities=24% Similarity=0.392 Sum_probs=110.5
Q ss_pred eeeeccCceEEEEEEECCeEEEEEEEecCCccc--------hHHHHHHHHHHHcCCCCceeeEecc--cCCCceeEEeeC
Q 005616 348 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQG--------QLEFQQEVRVLSKLQHPHLVTLLGA--CPEAWSLVYEYL 417 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~--------~~~f~~E~~iL~~l~HpnIV~l~g~--~~~~~~LV~E~~ 417 (688)
+.||+|++|.||+|.+.|..|+||+........ ...+.+|+.++..+.|++|+....+ ..+..++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 469999999999999999999999876543221 2357889999999999987655444 456788999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
+|++|.+.+.... + .+..++.+++.+|.+||..+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999885422 2 78899999999999999966 99999999999999 78999999998765
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.7e-17 Score=169.51 Aligned_cols=200 Identities=21% Similarity=0.274 Sum_probs=141.7
Q ss_pred CCCceeeEecccCCC-----------------------------ceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHH
Q 005616 395 QHPHLVTLLGACPEA-----------------------------WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA 445 (688)
Q Consensus 395 ~HpnIV~l~g~~~~~-----------------------------~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~ 445 (688)
+|||||.++++|.+. .|+||.-. ..+|..++.... .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC----CchHHHHHHHH
Confidence 599999999887321 35666655 347888886543 45567778899
Q ss_pred HHHHHHHHHhccCCCceEeCCCCCCceee--CCCC--ceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc
Q 005616 446 EIASGLCFLHSSKPEKIVHGDLKPQNILL--DSEL--SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521 (688)
Q Consensus 446 qia~aL~yLH~~~~~~IiHrDIKp~NILL--d~~~--~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~ 521 (688)
|+++|+.|||.++ |.|||+|++|||| |.++ .+.|+|||++---.......+-....-...|...-||||++..
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999966 9999999999998 3444 4789999998654332222222222345568888999998865
Q ss_pred CCC------CCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCC
Q 005616 522 GVL------TPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRE 595 (688)
Q Consensus 522 ~~~------s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~ 595 (688)
.+- -.|.|.|+.|.+.||+++...||...+++.-... .+.+ ......|..++..+.+|+...|+.||.+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r--~Yqe---~qLPalp~~vpp~~rqlV~~lL~r~psk 500 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR--TYQE---SQLPALPSRVPPVARQLVFDLLKRDPSK 500 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh--hhhh---hhCCCCcccCChHHHHHHHHHhcCCccc
Confidence 421 2489999999999999999999976443211111 1111 1123345567778999999999999999
Q ss_pred CCCCcHHHHHHHH
Q 005616 596 RPDITPSLVKELE 608 (688)
Q Consensus 596 RPs~~e~l~~~Le 608 (688)
||+.. ....+|+
T Consensus 501 Rvsp~-iAANvl~ 512 (598)
T KOG4158|consen 501 RVSPN-IAANVLN 512 (598)
T ss_pred cCCcc-HHHhHHH
Confidence 99987 6666665
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.6e-17 Score=161.32 Aligned_cols=129 Identities=25% Similarity=0.412 Sum_probs=106.1
Q ss_pred eeeccCceEEEEEEECCeEEEEEEEecCCcc--------chHHHHHHHHHHHcCCCCce--eeEecccCCCceeEEeeCC
Q 005616 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQ--------GQLEFQQEVRVLSKLQHPHL--VTLLGACPEAWSLVYEYLP 418 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~--------~~~~f~~E~~iL~~l~HpnI--V~l~g~~~~~~~LV~E~~~ 418 (688)
.||+|+||.||+|.+.|..|++|........ ....+.+|+.++..++|+++ ..+++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 3899999999999999999999997543221 12457789999999988754 4555555667899999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccc
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~ 491 (688)
|++|.+.+.... ..++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++|+|||++...
T Consensus 81 g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999998874421 178999999999999966 99999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-17 Score=181.11 Aligned_cols=175 Identities=25% Similarity=0.315 Sum_probs=138.7
Q ss_pred ceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccc
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~ 489 (688)
++|.|++|...+|.++|.+.......+|...+.|+.|++.|+.| ++.+|+|+||.||++..+..+||+|||+..
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhee
Confidence 68999999999999999887777778999999999999999999 359999999999999999999999999998
Q ss_pred cccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhHHHHHhhcCccccccCC
Q 005616 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDP 568 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~~~~~i~~~~l~~~ldp 568 (688)
.........+.....+..+||..||+||.+.+..|+.|+||||||+||+||++ =..++.... ....++.|.+...
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~-t~~d~r~g~ip~~--- 480 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA-TLTDIRDGIIPPE--- 480 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-hhhhhhcCCCChH---
Confidence 87766544455556778899999999999999999999999999999999998 233332111 1122333333210
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCC
Q 005616 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDI 599 (688)
Q Consensus 569 ~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~ 599 (688)
...++| .-..|+++++.+.|.+||++
T Consensus 481 ~~~d~p-----~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 481 FLQDYP-----EEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred HhhcCc-----HHHHHHHHhcCCCcccCchH
Confidence 011222 34578999999999999944
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.3e-17 Score=188.79 Aligned_cols=213 Identities=23% Similarity=0.272 Sum_probs=144.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCCCceeEEeeCC
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLP 418 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~~~~LV~E~~~ 418 (688)
..+|..++.|..|+||-||.+++. -+++|+|+-+ ... ||+. +.-|.++.+.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l-----------ilRn---------ilt~a~npfvv----- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL-----------ILRN---------ILTFAGNPFVV----- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cch-----------hhhc---------cccccCCccee-----
Confidence 368888999999999999999887 6788985432 211 1111 22223333333
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCc-
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY- 497 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~- 497 (688)
|+-...+.. ..+++. +++.+++|||+.+ |+|||+||+|.+|+.-|++|++|||+++........
T Consensus 136 -gDc~tllk~---~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -GDCATLLKN---IGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -chhhhhccc---CCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 333333322 223332 2378999999966 999999999999999999999999999865322111
Q ss_pred C--------CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--HHHHHhhcCccccccC
Q 005616 498 L--------PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILD 567 (688)
Q Consensus 498 ~--------~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~i~~~~l~~~ld 567 (688)
. ........++|||.|+|||++....|+..+|||++|+|+||.+.|+.||.... +....+....+. .
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~-w-- 277 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE-W-- 277 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc-c--
Confidence 0 01112356789999999999999999999999999999999999999997542 211111111100 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 568 PLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 568 p~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
| +-......+..+++.+.|+.+|.+|--..
T Consensus 278 p---E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 278 P---EEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred c---ccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 0 11123456889999999999999997554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-16 Score=163.88 Aligned_cols=147 Identities=18% Similarity=0.184 Sum_probs=112.3
Q ss_pred HHHhcCcccceeeeccCceEEEEEE-E--CCeEEEEEEEecCCcc------------------------chHHHHHHHHH
Q 005616 338 QTATCNFSESFKVGQGGFGCVYKGE-M--LGRTVAIKMLYSHNMQ------------------------GQLEFQQEVRV 390 (688)
Q Consensus 338 ~~at~~f~~~~~LG~G~~G~Vy~g~-~--~g~~VAIK~l~~~~~~------------------------~~~~f~~E~~i 390 (688)
..-...|.....||.|+||.||+|. . .|..||||+++..... ....+..|+.+
T Consensus 24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence 3333457888999999999999998 3 4899999998754311 01235689999
Q ss_pred HHcCCCC--ceeeEecccCCCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCC
Q 005616 391 LSKLQHP--HLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLK 468 (688)
Q Consensus 391 L~~l~Hp--nIV~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIK 468 (688)
+.++.+. .+.+++++ ...+|||||+++++|...+... ..+.......++.+++.+|.+||..+ +|+|||||
T Consensus 104 L~~L~~~~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dik 176 (237)
T smart00090 104 LQRLYEAGVPVPKPIAW--RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLS 176 (237)
T ss_pred HHHHHhcCCCCCeeeEe--cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCC
Confidence 9999753 34455543 3458999999999887654322 23455667899999999999999954 29999999
Q ss_pred CCceeeCCCCceEEeecCcccccc
Q 005616 469 PQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 469 p~NILLd~~~~~KL~DFGla~~~~ 492 (688)
|+||+++ ++.++|+|||.+....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 8899999999987644
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.7e-16 Score=156.86 Aligned_cols=144 Identities=23% Similarity=0.212 Sum_probs=111.8
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCcc----------------------chHHHHHHHHHHH
Q 005616 336 DLQTATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ----------------------GQLEFQQEVRVLS 392 (688)
Q Consensus 336 el~~at~~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~----------------------~~~~f~~E~~iL~ 392 (688)
++......|...+.||.|+||.||+|... |..||||++...... ....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 34444445777889999999999999885 899999997653310 0123678899999
Q ss_pred cCCCC--ceeeEecccCCCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCC
Q 005616 393 KLQHP--HLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQ 470 (688)
Q Consensus 393 ~l~Hp--nIV~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~ 470 (688)
.+.|+ +++..++. ...++||||++|++|...... .....++.+++.++.++|..+ |+||||||+
T Consensus 89 ~l~~~~i~v~~~~~~--~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~ 154 (198)
T cd05144 89 ALYEEGFPVPKPIDW--NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEF 154 (198)
T ss_pred HHHHcCCCCCceeec--CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcc
Confidence 99877 44555543 346899999999999775421 235678899999999999965 999999999
Q ss_pred ceeeCCCCceEEeecCccccccC
Q 005616 471 NILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 471 NILLd~~~~~KL~DFGla~~~~~ 493 (688)
||+++.++.++|+|||++.....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.9e-16 Score=181.50 Aligned_cols=142 Identities=25% Similarity=0.334 Sum_probs=114.4
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEECCeEEEEEEEecCCc--------cchHHHHHHHHHHHcCCCCceeeEeccc
Q 005616 335 ADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNM--------QGQLEFQQEVRVLSKLQHPHLVTLLGAC 406 (688)
Q Consensus 335 ~el~~at~~f~~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~--------~~~~~f~~E~~iL~~l~HpnIV~l~g~~ 406 (688)
.........|...+.||+|+||.||+|.+.+..+++|+...... .....+.+|+.++..++|++++..+.++
T Consensus 326 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~ 405 (535)
T PRK09605 326 IKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYD 405 (535)
T ss_pred ccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEE
Confidence 33344455667788999999999999999877777765432211 1124588999999999999988765554
Q ss_pred --CCCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEee
Q 005616 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICD 484 (688)
Q Consensus 407 --~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~D 484 (688)
.+..++||||+++++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.++|+|
T Consensus 406 ~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liD 470 (535)
T PRK09605 406 VDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLID 470 (535)
T ss_pred EeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEe
Confidence 446889999999999999874 35778999999999999966 9999999999999 678999999
Q ss_pred cCccccc
Q 005616 485 FGICRLV 491 (688)
Q Consensus 485 FGla~~~ 491 (688)
||+++..
T Consensus 471 FGla~~~ 477 (535)
T PRK09605 471 FGLGKYS 477 (535)
T ss_pred CcccccC
Confidence 9998764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.9e-15 Score=138.96 Aligned_cols=132 Identities=23% Similarity=0.230 Sum_probs=112.8
Q ss_pred ceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCC--CceeeEecccCC--CceeEEeeCCCCcH
Q 005616 347 SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH--PHLVTLLGACPE--AWSLVYEYLPNGSL 422 (688)
Q Consensus 347 ~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~H--pnIV~l~g~~~~--~~~LV~E~~~~gsL 422 (688)
.+.||.|+++.||++...+..++||....... ...+..|+.++..++| ++++++++++.. ..+++|||+.++.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 46799999999999999888999999865543 5678999999999976 588888887754 68999999998877
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 423 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 423 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
..+ +......++.+++.+|.+||.....+++|+|++|.||+++..+.++++|||.+..
T Consensus 81 ~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 543 4466778899999999999997656799999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.5e-15 Score=144.87 Aligned_cols=136 Identities=23% Similarity=0.264 Sum_probs=97.2
Q ss_pred ceeeeccCceEEEEEEEC-CeEEEEEEEecCCccc--hHH----------------------HHHHHHHHHcCCCCc--e
Q 005616 347 SFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQG--QLE----------------------FQQEVRVLSKLQHPH--L 399 (688)
Q Consensus 347 ~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~--~~~----------------------f~~E~~iL~~l~Hpn--I 399 (688)
.+.||+|+||.||+|... |..||||++....... ... ...|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 357999999999999887 8999999987543211 111 135566666664332 3
Q ss_pred eeEecccCCCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceEeCCCCCCceeeCCCC
Q 005616 400 VTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSEL 478 (688)
Q Consensus 400 V~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILLd~~~ 478 (688)
.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+|+||||+||+++ ++
T Consensus 82 ~~~~~~--~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL--NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec--CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CC
Confidence 444443 346899999999543321111100 01 5578899999999999999 65 99999999999999 89
Q ss_pred ceEEeecCcccccc
Q 005616 479 SSKICDFGICRLVT 492 (688)
Q Consensus 479 ~~KL~DFGla~~~~ 492 (688)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.6e-14 Score=145.21 Aligned_cols=133 Identities=22% Similarity=0.218 Sum_probs=105.1
Q ss_pred eeee-ccCceEEEEEEECCeEEEEEEEecCCc-------------cchHHHHHHHHHHHcCCCCce--eeEecccCC---
Q 005616 348 FKVG-QGGFGCVYKGEMLGRTVAIKMLYSHNM-------------QGQLEFQQEVRVLSKLQHPHL--VTLLGACPE--- 408 (688)
Q Consensus 348 ~~LG-~G~~G~Vy~g~~~g~~VAIK~l~~~~~-------------~~~~~f~~E~~iL~~l~HpnI--V~l~g~~~~--- 408 (688)
..|| .||.|+||.+...+..++||.+..... .....+.+|+.++.+|+|++| +..++++..
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 5788 899999999999999999998854221 123457889999999998775 666665421
Q ss_pred ---CceeEEeeCCC-CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEee
Q 005616 409 ---AWSLVYEYLPN-GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICD 484 (688)
Q Consensus 409 ---~~~LV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~D 484 (688)
..++||||++| .+|.+++... +++.. .+.+|+.+|.+||..+ |+||||||.|||++.++.++|+|
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEE
Confidence 13599999997 6898887542 34432 3678999999999966 99999999999999999999999
Q ss_pred cCccccc
Q 005616 485 FGICRLV 491 (688)
Q Consensus 485 FGla~~~ 491 (688)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9987653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=6.8e-15 Score=169.28 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=181.1
Q ss_pred cCcccceeeeccCceEEEEEEEC---CeEEEEEEEecCC--ccchHHHHHHHHHHHcCC-CCceeeEecccC--CCceeE
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQ-HPHLVTLLGACP--EAWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~~G~Vy~g~~~---g~~VAIK~l~~~~--~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~--~~~~LV 413 (688)
..|.+...||+|+|+.|-..... ...+|+|.+.... .........|..+-..+. |+|++.+++... +..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45667778999999999887664 4457777665443 222233455777777776 999999999874 457899
Q ss_pred EeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHh-ccCCCceEeCCCCCCceeeCCCC-ceEEeecCccccc
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH-SSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLV 491 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~IiHrDIKp~NILLd~~~-~~KL~DFGla~~~ 491 (688)
++|..++++...+.... ....+....-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999988874221 113444667788999999999999 644 99999999999999999 9999999999987
Q ss_pred cC-CCCcCCCccccCCCCC-CCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCC
Q 005616 492 TE-DTLYLPSFHRSTAPKG-SFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDP 568 (688)
Q Consensus 492 ~~-~~~~~~~~~~~~~~~G-t~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp 568 (688)
.. .... .......| ++.|+|||...+ ....+..|+||.|+++.-+++|..|+....... +........
T Consensus 176 ~~~~g~~----~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-----~~~~~~~~~ 246 (601)
T KOG0590|consen 176 RNKNGAE----RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-----GRYSSWKSN 246 (601)
T ss_pred cccCCcc----eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-----ccceeeccc
Confidence 76 3321 23345667 999999998877 456789999999999999999999986543321 111111111
Q ss_pred C---CCCCCHHHHHHHHHHHHHcccCCCCCCCCCcH
Q 005616 569 L---AGDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 569 ~---~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e 601 (688)
. .............+++.+++..+|..|.+..+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~ 282 (601)
T KOG0590|consen 247 KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEE 282 (601)
T ss_pred ccccccCccccCChhhhhcccccccCCchhcccccc
Confidence 0 01112234567888899999999999999883
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.5e-12 Score=125.59 Aligned_cols=130 Identities=20% Similarity=0.151 Sum_probs=101.1
Q ss_pred eeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCce-eeEecccCCCceeEEeeCCCCcHHHHh
Q 005616 348 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL-VTLLGACPEAWSLVYEYLPNGSLQDRL 426 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnI-V~l~g~~~~~~~LV~E~~~~gsL~~~L 426 (688)
..|+.|.++.||++...+..|++|+...... ....+..|+.++..+.+.++ .++++++.+..++||||++|.++....
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~~ 82 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTED 82 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccccc
Confidence 5689999999999999999999999765432 22356789999999865554 456666665678999999998876430
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHHHHHHhccC--CCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 427 FRKSNVSPLLWKDRARIAAEIASGLCFLHSSK--PEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 427 ~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
.....++.+++.+|..||..+ +..++|+|++|.||+++ ++.++|+|||.+..
T Consensus 83 -----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 83 -----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred -----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 011345678999999999976 34579999999999999 67899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.4e-12 Score=145.59 Aligned_cols=137 Identities=23% Similarity=0.290 Sum_probs=98.8
Q ss_pred eeeeccCceEEEEEEEC-CeEEEEEEEecCCccc----------------------------------------hHHHHH
Q 005616 348 FKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQG----------------------------------------QLEFQQ 386 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~----------------------------------------~~~f~~ 386 (688)
..||.|++|.||+|++. |+.||||+.++..... ..+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999986 9999999986542110 012556
Q ss_pred HHHHHHcCC-----CCce--eeEecccCCCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHH-HHHHHhccC
Q 005616 387 EVRVLSKLQ-----HPHL--VTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIAS-GLCFLHSSK 458 (688)
Q Consensus 387 E~~iL~~l~-----HpnI--V~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~-aL~yLH~~~ 458 (688)
|+..+.+++ ++++ .+++..+....+|||||++|++|.+....... .+ .+..++..++. .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 666666652 3332 23343334568999999999999887643211 11 23456666665 467888855
Q ss_pred CCceEeCCCCCCceeeCCCCceEEeecCcccccc
Q 005616 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 459 ~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~ 492 (688)
++|+|+||.||+++.+|.++|+|||++..+.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF04564 U-box: U-box domain; InterPro: IPR003613 Quality control of intracellular proteins is essential for cellular homeostasis | Back alignment and domain information |
|---|
Probab=99.31 E-value=6.3e-13 Score=110.86 Aligned_cols=70 Identities=46% Similarity=0.847 Sum_probs=61.9
Q ss_pred CCCcccchhhhhhhcCCCcCCCCccccccchhhhhccCCCCCCCcccccCCCCCCcchHHHHHHHHHhhh
Q 005616 618 VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCK 687 (688)
Q Consensus 618 ~Ps~~~~pilqeim~dP~va~dg~tye~~~I~~wl~~g~~~SPmtn~~l~~~~l~Pn~~lr~~~~~~~~~ 687 (688)
+|..|.||+..++|.||.+.++|.+|+..+|..|+..++.++|+|+..++...|+||.+||++|++|+++
T Consensus 1 iP~~f~CpIt~~lM~dPVi~~~G~tyer~~I~~~l~~~~~~~P~t~~~l~~~~l~pn~~Lk~~I~~~~~~ 70 (73)
T PF04564_consen 1 IPDEFLCPITGELMRDPVILPSGHTYERSAIERWLEQNGGTDPFTRQPLSESDLIPNRALKSAIEEWCAE 70 (73)
T ss_dssp SSGGGB-TTTSSB-SSEEEETTSEEEEHHHHHHHHCTTSSB-TTT-SB-SGGGSEE-HHHHHHHHHHHHH
T ss_pred CCcccCCcCcCcHhhCceeCCcCCEEcHHHHHHHHHcCCCCCCCCCCcCCcccceECHHHHHHHHHHHHH
Confidence 5889999999999999999999999999999999999999999999999999999999999999999975
|
Molecular chaperones recognise and contribute to the refolding of misfolded or unfolded proteins, whereas the ubiquitin-proteasome system mediates the degradation of such abnormal proteins. Ubiquitin-protein ligases (E3s) determine the substrate specificity for ubiquitylation and have been classified into HECT and RING-finger families. More recently, however, U-box proteins, which contain a domain (the U box) of about 70 amino acids that is conserved from yeast to humans, have been identified as a new type of E3 []. Members of the U-box family of proteins constitute a class of ubiquitin-protein ligases (E3s) distinct from the HECT-type and RING finger-containing E3 families []. Using yeast two-hybrid technology, all mammalian U-box proteins have been reported to interact with molecular chaperones or co-chaperones, including Hsp90, Hsp70, DnaJc7, EKN1, CRN, and VCP. This suggests that the function of U box-type E3s is to mediate the degradation of unfolded or misfolded proteins in conjunction with molecular chaperones as receptors that recognise such abnormal proteins [, ]. Unlike the RING finger domain, IPR001841 from INTERPRO, that is stabilised by Zn2+ ions coordinated by the cysteines and a histidine, the U-box scaffold is probably stabilised by a system of salt-bridges and hydrogen bonds. The charged and polar residues that participate in this network of bonds are more strongly conserved in the U-box proteins than in classic RING fingers, which supports their role in maintaining the stability of the U box. Thus, the U box appears to have evolved from a RING finger domain by appropriation of a new set of residues required to stabilise its structure, concomitant with the loss of the original, metal-chelating residues [].; GO: 0004842 ubiquitin-protein ligase activity, 0016567 protein ubiquitination, 0000151 ubiquitin ligase complex; PDB: 1T1H_A 2C2L_D 2C2V_V 1WGM_A 2KR4_A 3L1Z_B 3L1X_A 2KRE_A 3M63_A 2QIZ_A .... |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.5e-12 Score=134.13 Aligned_cols=206 Identities=22% Similarity=0.254 Sum_probs=142.2
Q ss_pred HHHHHcCCCCceeeEecccCCC-------ceeEEeeCCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCC
Q 005616 388 VRVLSKLQHPHLVTLLGACPEA-------WSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKP 459 (688)
Q Consensus 388 ~~iL~~l~HpnIV~l~g~~~~~-------~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~ 459 (688)
..-|-.+-|-|||++..|+.+. ..++.|||..|+|..+|.+.. ....+....-.+|+.||..||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 3445566799999999988542 468999999999999998653 3455677777899999999999999988
Q ss_pred CceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHH
Q 005616 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQ 539 (688)
Q Consensus 460 ~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~E 539 (688)
++|+|+++..+-|++..+|-+|++--.-...-.. .............|-++|.+||+=.....+..+|||+||++.++
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s--~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPS--VNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchh--hhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 6899999999999999999888863221111000 00001112233457889999999888888899999999999999
Q ss_pred HHhCCCC-CCChhHHHHHhhcCccc-cccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHH
Q 005616 540 LLTGRLP-VGLAGEVRRAVSCGKLS-SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 540 LltG~~P-f~~~~~~~~~i~~~~l~-~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~L 607 (688)
|..|..- -.....+.......+.. ..-++ .-..++..|++..|..||+|+.++.+.|
T Consensus 275 mailEiq~tnseS~~~~ee~ia~~i~~len~-----------lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVEVEENIANVIIGLENG-----------LQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred HHHheeccCCCcceeehhhhhhhheeeccCc-----------cccCcCcccccCCCCCCcchhhhhcCce
Confidence 9887643 22211111111111100 00011 1234677899999999999997665544
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=8.9e-12 Score=138.27 Aligned_cols=243 Identities=25% Similarity=0.251 Sum_probs=170.7
Q ss_pred Ccccceeeec--cCceEEEEEEE--C--CeEEEEEEEe--cCCccchHHHHHHHHHHHcC-CCCceeeEecccCCC--ce
Q 005616 343 NFSESFKVGQ--GGFGCVYKGEM--L--GRTVAIKMLY--SHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPEA--WS 411 (688)
Q Consensus 343 ~f~~~~~LG~--G~~G~Vy~g~~--~--g~~VAIK~l~--~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~~--~~ 411 (688)
.|.....+|. |.+|.||.+.. . +..+|+|.-+ .........=.+|+....++ .|+|.|+.+..+.+. .+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4555678999 99999999877 3 7789999733 22223333334566666666 499999988877543 45
Q ss_pred eEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHH----HHHHHhccCCCceEeCCCCCCceeeCCC-CceEEeecC
Q 005616 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIAS----GLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFG 486 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~----aL~yLH~~~~~~IiHrDIKp~NILLd~~-~~~KL~DFG 486 (688)
+-+|++ +.+|..+...... .++....+.++.+... ||.++|+.+ ++|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 555665 5778777665442 2445566666777777 999999966 9999999999999999 889999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCCh-hHHHHHhhcCccccc
Q 005616 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA-GEVRRAVSCGKLSSI 565 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~-~~~~~~i~~~~l~~~ 565 (688)
+...+....... .+.......|...|++||... +-++...|+|++|.++.+..+|..+.... ...|..+..+.+..
T Consensus 269 ~v~~i~~~~~~~-~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~- 345 (524)
T KOG0601|consen 269 LVSKISDGNFSS-VFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL- 345 (524)
T ss_pred eeEEccCCcccc-ceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch-
Confidence 999887665322 222334447888999999864 46889999999999999999987665322 12222222222111
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 566 ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
++-......+..++..+++.+|..|++..
T Consensus 346 ------e~~~~~s~~l~~~~~~~~d~~~~~~~~~q 374 (524)
T KOG0601|consen 346 ------EFCEGGSSSLRSVTSQMLDEDPRLRLTAQ 374 (524)
T ss_pred ------hhhcCcchhhhhHHHHhcCcchhhhhHHH
Confidence 11112234556689999999999999876
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.16 E-value=7.7e-11 Score=133.60 Aligned_cols=142 Identities=17% Similarity=0.230 Sum_probs=93.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---------------------------------------
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--------------------------------------- 379 (688)
Q Consensus 341 t~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~~--------------------------------------- 379 (688)
-..|+. ..||+|++|.||+|++. |+.||||++++....
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 78999999999999985 899999999754210
Q ss_pred -chHHHHHHHHHHHcCC----CCcee---eEecccCCCceeEEeeCCCCcHHHHh--cccC-CCCCCCHHHHHHHHHHHH
Q 005616 380 -GQLEFQQEVRVLSKLQ----HPHLV---TLLGACPEAWSLVYEYLPNGSLQDRL--FRKS-NVSPLLWKDRARIAAEIA 448 (688)
Q Consensus 380 -~~~~f~~E~~iL~~l~----HpnIV---~l~g~~~~~~~LV~E~~~~gsL~~~L--~~~~-~~~~l~~~~~~~i~~qia 448 (688)
...+|.+|+..+.+++ +.+.| ++|.-+....+|||||++|+.+.++- ...+ ....+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 0012556666665553 33333 33433355688999999999998742 2211 00112222222333333
Q ss_pred HHHHHHhccCCCceEeCCCCCCceeeCCCC----ceEEeecCccccccC
Q 005616 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSEL----SSKICDFGICRLVTE 493 (688)
Q Consensus 449 ~aL~yLH~~~~~~IiHrDIKp~NILLd~~~----~~KL~DFGla~~~~~ 493 (688)
.. .+++|+|+||.||+++.+| .++++|||++..++.
T Consensus 277 ------f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 23 3499999999999999888 999999999987754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.2e-11 Score=141.45 Aligned_cols=249 Identities=21% Similarity=0.193 Sum_probs=174.3
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecc--cCCCcee
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGA--CPEAWSL 412 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~--~~~~~~L 412 (688)
..+.|...+-+-+|.++.++.+.-. |...++|+...... ........+-.++-..++|.++..... |....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456666778889999999977654 44455555433221 122233334444444567777777665 4667899
Q ss_pred EEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccccc
Q 005616 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~ 492 (688)
|++|..+++|...|+... ..+..-....+..+..+++|||... ++|+|++|.|+|+..+|+.+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999987654 2333445556777889999999955 8999999999999999999999998443321
Q ss_pred CC---CCc-----------------CCC-----ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCC
Q 005616 493 ED---TLY-----------------LPS-----FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 547 (688)
Q Consensus 493 ~~---~~~-----------------~~~-----~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf 547 (688)
.- ... .+. ........||+.|.+||...+......+|+|++|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 10 000 000 01234567999999999999999999999999999999999999999
Q ss_pred CChhH--HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 548 GLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 548 ~~~~~--~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
..... +...+..+.+.. ...+...+....+++...+..+|.+|-.+.
T Consensus 1036 na~tpq~~f~ni~~~~~~~------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPW------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCCCCC------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 75432 222222222221 233445566788899999999999998876
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.3e-10 Score=112.90 Aligned_cols=139 Identities=24% Similarity=0.338 Sum_probs=108.7
Q ss_pred eeeeccCceEEEEEEECC-eEEEEEEEecCCc-cchHHHHHHHHHHHcCCC--CceeeEecccCC-----CceeEEeeCC
Q 005616 348 FKVGQGGFGCVYKGEMLG-RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQH--PHLVTLLGACPE-----AWSLVYEYLP 418 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~g-~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~H--pnIV~l~g~~~~-----~~~LV~E~~~ 418 (688)
..||.|.++.||++...+ ..+++|....... .....+..|+.++..+.+ .++.++++++.+ ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 568999999999998875 8999999765432 234568899999999975 445667777754 4589999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccC----------------------------------------
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK---------------------------------------- 458 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~---------------------------------------- 458 (688)
|.++.+.+.. ..++......++.+++.+|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988775532 24566778888888888888888531
Q ss_pred -------------CCceEeCCCCCCceeeCC--CCceEEeecCcccc
Q 005616 459 -------------PEKIVHGDLKPQNILLDS--ELSSKICDFGICRL 490 (688)
Q Consensus 459 -------------~~~IiHrDIKp~NILLd~--~~~~KL~DFGla~~ 490 (688)
+..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246899999999999998 66789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.2e-10 Score=109.38 Aligned_cols=136 Identities=15% Similarity=0.115 Sum_probs=98.4
Q ss_pred eeeeccCceEEEEEEEC--------CeEEEEEEEecCCc----------------------cchHHHH----HHHHHHHc
Q 005616 348 FKVGQGGFGCVYKGEML--------GRTVAIKMLYSHNM----------------------QGQLEFQ----QEVRVLSK 393 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~--------g~~VAIK~l~~~~~----------------------~~~~~f~----~E~~iL~~ 393 (688)
..||.|-=+.||.|... +..+|||+.+.... .....+. +|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999764 36899998753210 0012233 89999999
Q ss_pred CC--CCceeeEecccCCCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH-hccCCCceEeCCCCCC
Q 005616 394 LQ--HPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL-HSSKPEKIVHGDLKPQ 470 (688)
Q Consensus 394 l~--HpnIV~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~IiHrDIKp~ 470 (688)
+. .-++..++++ ...+|||||+.++.+..-.... ..++......+..+++.+|..| |..+ |||+||++.
T Consensus 83 l~~~Gv~vP~pi~~--~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL--KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe--cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 85 3566666654 6789999999875443211111 1234455677889999999999 7765 999999999
Q ss_pred ceeeCCCCceEEeecCcccccc
Q 005616 471 NILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 471 NILLd~~~~~KL~DFGla~~~~ 492 (688)
|||++ ++.++|+|||.+....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCC
Confidence 99997 4689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.6e-10 Score=106.72 Aligned_cols=128 Identities=26% Similarity=0.386 Sum_probs=104.2
Q ss_pred eeeccCceEEEEEEECCeEEEEEEEecCCcc--------chHHHHHHHHHHHcCC--CCceeeEecccCCCceeEEeeCC
Q 005616 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQ--------GQLEFQQEVRVLSKLQ--HPHLVTLLGACPEAWSLVYEYLP 418 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~--------~~~~f~~E~~iL~~l~--HpnIV~l~g~~~~~~~LV~E~~~ 418 (688)
.|++|+=+.+|.+.+.|.++++|.-.+.... ......+|+.++.+++ --+...+|.+.++...|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 5789999999999998888888864333211 1234678999999985 45666778888888999999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
|..|.+.+... ...++..|-.-+.-||..+ |||+||.++||++..++ +.++|||++..
T Consensus 83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999988654 2567888888899999977 99999999999998765 99999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=8.6e-11 Score=130.52 Aligned_cols=245 Identities=22% Similarity=0.205 Sum_probs=172.3
Q ss_pred ccCHHH-HHHHhcCcccceeeeccCceEEEEEEEC---CeEEEEEEEecCCccchHH--HHHHHHHHHcC-CCCceeeEe
Q 005616 331 EFSLAD-LQTATCNFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQGQLE--FQQEVRVLSKL-QHPHLVTLL 403 (688)
Q Consensus 331 ~~~~~e-l~~at~~f~~~~~LG~G~~G~Vy~g~~~---g~~VAIK~l~~~~~~~~~~--f~~E~~iL~~l-~HpnIV~l~ 403 (688)
.|...+ ....+.+|.....||.|.|+.|+....+ +..+++|.+.........+ -..|+-+...+ .|.+++..+
T Consensus 253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~ 332 (524)
T KOG0601|consen 253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN 332 (524)
T ss_pred eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence 344444 4555678999999999999999987654 6789999876543332222 23466666666 588888877
Q ss_pred ccc--CCCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC-Cce
Q 005616 404 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSS 480 (688)
Q Consensus 404 g~~--~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~-~~~ 480 (688)
..+ ....++-.|||.++++.....-. ..+....++++..+++.++.++|+.. ++|+|+||+||++..+ +..
T Consensus 333 ~~W~~~r~~~ip~e~~~~~s~~l~~~~~---~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~ 406 (524)
T KOG0601|consen 333 SSWSQLRQGYIPLEFCEGGSSSLRSVTS---QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFS 406 (524)
T ss_pred CCccccccccCchhhhcCcchhhhhHHH---HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhh
Confidence 655 34578999999999988766222 23555678899999999999999855 9999999999999886 889
Q ss_pred EEeecCccccccCCCCcCCCccccCCCCCCCCC-CChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCC-ChhHHHHHhh
Q 005616 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY-ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVG-LAGEVRRAVS 558 (688)
Q Consensus 481 KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y-~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~-~~~~~~~~i~ 558 (688)
+++|||++..+.-.. .....++..| .+|.......+..+.|+||||.-+.+.++|..--. ...+ ..+.
T Consensus 407 ~~~~~~~~t~~~~~~--------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~--~~i~ 476 (524)
T KOG0601|consen 407 KLGDFGCWTRLAFSS--------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS--LTIR 476 (524)
T ss_pred hccccccccccceec--------ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc--eeee
Confidence 999999987532111 1122233344 35666667788999999999999999999875322 1111 1222
Q ss_pred cCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCc
Q 005616 559 CGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 559 ~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
.|.+. ..+. ....+..+...+..+++..||.+.
T Consensus 477 ~~~~p--------~~~~-~~~~~q~~~kv~~~~~~~~~~l~~ 509 (524)
T KOG0601|consen 477 SGDTP--------NLPG-LKLQLQVLLKVMINPDRKRRPSAV 509 (524)
T ss_pred ccccc--------CCCc-hHHhhhhhhhhhcCCccccchhhh
Confidence 22221 1222 236788888889999999999876
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.4e-09 Score=122.05 Aligned_cols=161 Identities=20% Similarity=0.242 Sum_probs=119.1
Q ss_pred CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCCC--ceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHH
Q 005616 365 GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR 442 (688)
Q Consensus 365 g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~~--~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ 442 (688)
+.+|.|...+...........+-++.|+.++||||++++..+... .|||+|-+. .|..++... .-..+.-
T Consensus 37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~~v~~ 108 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKEEVCL 108 (690)
T ss_pred CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHHHHHH
Confidence 778888887765553334577888999999999999999998554 699999884 455555332 2345566
Q ss_pred HHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccC
Q 005616 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522 (688)
Q Consensus 443 i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~ 522 (688)
.+.||+.||.|||+.+ +++|++|.-+.|+++..|..||++|.++........ ......--..|..|+.+...
T Consensus 109 Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~------~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 109 GLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA------PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc------ccccchhhhcccChhhcCcc
Confidence 7899999999999866 599999999999999999999999998865433221 00111122346677654332
Q ss_pred CCCCcchHhHHHHHHHHHHhC
Q 005616 523 VLTPKSDSYSFGLIILQLLTG 543 (688)
Q Consensus 523 ~~s~ksDVwSfGviL~ELltG 543 (688)
. -..|.|-||++++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 356999999999999999
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.7e-09 Score=111.25 Aligned_cols=251 Identities=20% Similarity=0.277 Sum_probs=165.3
Q ss_pred ceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceee--------EecccCCC-ceeEEee
Q 005616 347 SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVT--------LLGACPEA-WSLVYEY 416 (688)
Q Consensus 347 ~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~--------l~g~~~~~-~~LV~E~ 416 (688)
+..||+||-+.+|-.---+.. +-|+.+........+ -+..|... .||-+-. |+|--... ..++|..
T Consensus 16 gr~LgqGgea~ly~l~e~~d~-VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRDQ-VAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CccccCCccceeeecchhhch-hheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 467999999999954332333 346665544433332 23334444 4654433 22322222 4577888
Q ss_pred CCCCcHHHHhc----ccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcccccc
Q 005616 417 LPNGSLQDRLF----RKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 417 ~~~gsL~~~L~----~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~ 492 (688)
+++..--..+. +........|.-.++.+..+|.+.+.||..| .+-+|+.++|+|+++++.+.|.|-..-....
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINA 168 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeecc
Confidence 77753222222 2334566899999999999999999999977 8889999999999999999999854433322
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhhc-----cCCCCCcchHhHHHHHHHHHHhC-CCCCCChh-------HHHHHhhc
Q 005616 493 EDTLYLPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTG-RLPVGLAG-------EVRRAVSC 559 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSfGviL~ELltG-~~Pf~~~~-------~~~~~i~~ 559 (688)
++. .....+|...|.+||.-. +..-+...|-|.|||++|+||.| ++||.+.. ..+..+..
T Consensus 169 ng~-------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 169 NGT-------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred CCc-------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 222 234678999999999543 44567889999999999999996 99996432 12334545
Q ss_pred CccccccC------CCCCCCCHH-HHHHHHHHHHHcccC--CCCCCCCCcHHHHHHHHHhhh
Q 005616 560 GKLSSILD------PLAGDWPTF-VARRLVDLGLQCCEL--YGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 560 ~~l~~~ld------p~~~~~~~~-~~~~l~~Li~~Cl~~--dP~~RPs~~e~l~~~Le~l~~ 612 (688)
|.+...-+ |....+|-. .+..+..|..+|+.. ++.-||+.. ..+..|..+..
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~-aW~aAl~al~~ 302 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK-AWVAALDALRQ 302 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH-HHHHHHHHHHH
Confidence 54433322 223344433 456788888899874 467899998 67677766543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=8.3e-09 Score=99.53 Aligned_cols=142 Identities=24% Similarity=0.310 Sum_probs=104.0
Q ss_pred cceeeeccCceEEEEEEECCeEEEEEEEecCCcc--------chHHHHHHHHHHHcCCCCce--eeEecccCCCceeEEe
Q 005616 346 ESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQ--------GQLEFQQEVRVLSKLQHPHL--VTLLGACPEAWSLVYE 415 (688)
Q Consensus 346 ~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~--------~~~~f~~E~~iL~~l~HpnI--V~l~g~~~~~~~LV~E 415 (688)
....|-+|+-+.|+++.+.|+.++||.-...... ......+|+++|.+++--.| ..+|-+-.....|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 4567899999999999999999999864332211 23457889999999863333 3333333556889999
Q ss_pred eCCC-CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCc---eEEeecCccccc
Q 005616 416 YLPN-GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS---SKICDFGICRLV 491 (688)
Q Consensus 416 ~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~---~KL~DFGla~~~ 491 (688)
|++| .++.+++........ .-.....++..|-..+.-||.++ |||+||..+||+|..++. +.|+|||++..-
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9988 477777765443222 22233688899999999999977 999999999999976543 589999997643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.4e-08 Score=99.91 Aligned_cols=138 Identities=17% Similarity=0.111 Sum_probs=98.9
Q ss_pred eeeccCceEEEEEEECCeEEEEEEEecCCcc-----------chHHHHHHHHHHHcCCCCc--eeeEeccc-------CC
Q 005616 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQ-----------GQLEFQQEVRVLSKLQHPH--LVTLLGAC-------PE 408 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~-----------~~~~f~~E~~iL~~l~Hpn--IV~l~g~~-------~~ 408 (688)
.+-......|+++.+.|+.|.||........ ....+.+|...+.++..-+ .+.++++. ..
T Consensus 29 ~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 29 VFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 3433444457788888999999977543321 1124789999998884322 23333333 12
Q ss_pred CceeEEeeCCCC-cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC-------CCce
Q 005616 409 AWSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-------ELSS 480 (688)
Q Consensus 409 ~~~LV~E~~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-------~~~~ 480 (688)
..+||+|++++. +|.+++..... .+.+...+..++.+++..+.-||..+ |+|+|+++.|||++. ++.+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 367999999986 89998853321 23455677889999999999999976 999999999999975 4689
Q ss_pred EEeecCcccc
Q 005616 481 KICDFGICRL 490 (688)
Q Consensus 481 KL~DFGla~~ 490 (688)
.|+||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.3e-07 Score=99.56 Aligned_cols=203 Identities=22% Similarity=0.221 Sum_probs=141.3
Q ss_pred ceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC------CCceeEEeeCCC-CcHHHH
Q 005616 355 FGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP------EAWSLVYEYLPN-GSLQDR 425 (688)
Q Consensus 355 ~G~Vy~g~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~------~~~~LV~E~~~~-gsL~~~ 425 (688)
..+.|++... |..|++|+++............-+++++++.|+|||++..+|. ...+|||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4577888764 9999999995544333323344578899999999999988774 237899999986 478776
Q ss_pred hcccCC------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 426 LFRKSN------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 426 L~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
.+.... ...+++..+|.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+..|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 654321 124677889999999999999999977 88899999999999999999999998776654
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCC
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~ 573 (688)
+... | + .--.+-|.=.||.+++.|.||..--...+..... . ....
T Consensus 446 d~~~------------------~--l---e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s----~--------~~~I 490 (655)
T KOG3741|consen 446 DPTE------------------P--L---ESQQQNDLRDLGLLLLALATGTENSNRTDSTQSS----H--------LTRI 490 (655)
T ss_pred CCCc------------------c--h---hHHhhhhHHHHHHHHHHHhhcccccccccchHHH----H--------HHHh
Confidence 3200 0 0 0113578999999999999996442111110000 0 0011
Q ss_pred CHHHHHHHHHHHHHcccCCCCC
Q 005616 574 PTFVARRLVDLGLQCCELYGRE 595 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~ 595 (688)
...++.++.+++.-....++.+
T Consensus 491 ~~~yS~D~rn~v~yl~s~~~~~ 512 (655)
T KOG3741|consen 491 TTTYSTDLRNVVEYLESLNFRE 512 (655)
T ss_pred hhhhhHHHHHHHHHHHhcCccc
Confidence 2245566667777777777765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.5e-07 Score=93.16 Aligned_cols=125 Identities=26% Similarity=0.281 Sum_probs=81.5
Q ss_pred EEEEEEEC-CeEEEEEEEecCCc-------------c--------c-----hHHHHHHHHHHHcCCCC--ceeeEecccC
Q 005616 357 CVYKGEML-GRTVAIKMLYSHNM-------------Q--------G-----QLEFQQEVRVLSKLQHP--HLVTLLGACP 407 (688)
Q Consensus 357 ~Vy~g~~~-g~~VAIK~l~~~~~-------------~--------~-----~~~f~~E~~iL~~l~Hp--nIV~l~g~~~ 407 (688)
.||.|... |..||||+.+.... . . .....+|...|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 48999875 88999998754210 0 0 12367899999999755 45666644
Q ss_pred CCceeEEeeCC--CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHH-HhccCCCceEeCCCCCCceeeCCCCceEEee
Q 005616 408 EAWSLVYEYLP--NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCF-LHSSKPEKIVHGDLKPQNILLDSELSSKICD 484 (688)
Q Consensus 408 ~~~~LV~E~~~--~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~y-LH~~~~~~IiHrDIKp~NILLd~~~~~KL~D 484 (688)
...+|||||++ |..+..+.... ++......++.+++..+.. +|..+ |+|+||.+.|||++.+ .+.|+|
T Consensus 79 ~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence 36789999999 65554433221 1123356677788886555 56755 9999999999999988 999999
Q ss_pred cCcccccc
Q 005616 485 FGICRLVT 492 (688)
Q Consensus 485 FGla~~~~ 492 (688)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.7e-08 Score=112.29 Aligned_cols=151 Identities=24% Similarity=0.382 Sum_probs=104.9
Q ss_pred HHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcC-CC--ccccCCCCCCCCCCChhhhc
Q 005616 444 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL-PS--FHRSTAPKGSFPYADPEYHR 520 (688)
Q Consensus 444 ~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~-~~--~~~~~~~~Gt~~Y~APE~~~ 520 (688)
+.+++.||.|+|..- .+||++|.|++|.++.+|..||+.|+++........+. .. ........-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 445669999999965 69999999999999999999999999988765532210 00 01112233556899999999
Q ss_pred cCCCCCcchHhHHHHHHHHHHh-CCCCCCChhH-HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 005616 521 TGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE-VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 521 ~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~-~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs 598 (688)
+...++++|+|||||++|.+.. |+.-+...+. .......+ ..+.....+...++.++.+-+.+++..++.-||+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~----~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~ 258 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN----LLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT 258 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc----ccccccccccccCcHHHHHHHHHHhcCCcccCcc
Confidence 9889999999999999999995 4444432211 11111100 0111112334566778888999999999999996
Q ss_pred Cc
Q 005616 599 IT 600 (688)
Q Consensus 599 ~~ 600 (688)
+.
T Consensus 259 ~~ 260 (700)
T KOG2137|consen 259 LD 260 (700)
T ss_pred hh
Confidence 55
|
|
| >smart00504 Ubox Modified RING finger domain | Back alignment and domain information |
|---|
Probab=98.49 E-value=6.4e-08 Score=78.07 Aligned_cols=62 Identities=50% Similarity=0.903 Sum_probs=59.4
Q ss_pred ccchhhhhhhcCCCcCCCCccccccchhhhhccCCCCCCCcccccCCCCCCcchHHHHHHHHH
Q 005616 622 FLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 684 (688)
Q Consensus 622 ~~~pilqeim~dP~va~dg~tye~~~I~~wl~~g~~~SPmtn~~l~~~~l~Pn~~lr~~~~~~ 684 (688)
+.||+..++|.+|.+.+.|++|+.++|..|+.+ +.++|+++..++..+|+||.+||++|++|
T Consensus 2 ~~Cpi~~~~~~~Pv~~~~G~v~~~~~i~~~~~~-~~~cP~~~~~~~~~~l~~~~~l~~~i~~~ 63 (63)
T smart00504 2 FLCPISLEVMKDPVILPSGQTYERRAIEKWLLS-HGTDPVTGQPLTHEDLIPNLALKSAIQEW 63 (63)
T ss_pred cCCcCCCCcCCCCEECCCCCEEeHHHHHHHHHH-CCCCCCCcCCCChhhceeCHHHHHHHHhC
Confidence 679999999999999999999999999999988 68999999999999999999999999998
|
Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.48 E-value=6.2e-07 Score=90.24 Aligned_cols=123 Identities=26% Similarity=0.305 Sum_probs=89.1
Q ss_pred ECCeEEEEEEEecCCc-------cchHHHHHHHHHHHcCCCC--ceeeEecccCC------CceeEEeeCCCC-cHHHHh
Q 005616 363 MLGRTVAIKMLYSHNM-------QGQLEFQQEVRVLSKLQHP--HLVTLLGACPE------AWSLVYEYLPNG-SLQDRL 426 (688)
Q Consensus 363 ~~g~~VAIK~l~~~~~-------~~~~~f~~E~~iL~~l~Hp--nIV~l~g~~~~------~~~LV~E~~~~g-sL~~~L 426 (688)
..++.+.+|.+..... -....+.+|...+..|..- .+...+++... ..+||+|++++. +|.+++
T Consensus 30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~ 109 (206)
T PF06293_consen 30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLL 109 (206)
T ss_pred ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHH
Confidence 3466677775432211 2344678899888888432 33444444322 357999999985 899988
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC---ceEEeecCccccc
Q 005616 427 FRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL---SSKICDFGICRLV 491 (688)
Q Consensus 427 ~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~---~~KL~DFGla~~~ 491 (688)
..... ++......++.+++..+.-||..+ |+|+|+++.|||++.++ .+.|+||+-++..
T Consensus 110 ~~~~~---~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 110 QQWEQ---LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred Hhhcc---cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 65332 344667889999999999999976 99999999999999887 8999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.3e-06 Score=89.54 Aligned_cols=145 Identities=22% Similarity=0.206 Sum_probs=99.8
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCc----------------------cchHHHHHHHHH
Q 005616 334 LADLQTATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNM----------------------QGQLEFQQEVRV 390 (688)
Q Consensus 334 ~~el~~at~~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~----------------------~~~~~f~~E~~i 390 (688)
+..+..-..=...+.+||-|-=+.||.|... |.++|||.-+.... -......+|..+
T Consensus 83 L~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 83 LHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 3344333334456789999999999999997 99999997532211 012236789999
Q ss_pred HHcCCCC--ceeeEecccCCCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCC
Q 005616 391 LSKLQHP--HLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLK 468 (688)
Q Consensus 391 L~~l~Hp--nIV~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIK 468 (688)
|.+|... .+.+.+++ +...+||||++|-.|...-. +-...-.|+..|+.-+.-+-..| |||+|++
T Consensus 163 L~~L~~~G~~VP~P~~~--nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G---iVHGDlS 229 (304)
T COG0478 163 LQRLYPEGVKVPKPIAW--NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG---IVHGDLS 229 (304)
T ss_pred HHHhhhcCCCCCCcccc--ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC---ccccCCc
Confidence 9998644 55555554 34679999999977755321 12233444555555555444544 9999999
Q ss_pred CCceeeCCCCceEEeecCccccc
Q 005616 469 PQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 469 p~NILLd~~~~~KL~DFGla~~~ 491 (688)
+-|||++++|.+.++||--+...
T Consensus 230 efNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 230 EFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred hheEEEecCCCEEEEeCcccccC
Confidence 99999999999999999766543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.3e-06 Score=83.76 Aligned_cols=147 Identities=20% Similarity=0.190 Sum_probs=109.3
Q ss_pred HHhcCcccceeeeccCceEEEEEEECCeEEEEEEEecC---C---ccchHHHHHHHHHHHcCC--CCceeeEecccC---
Q 005616 339 TATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSH---N---MQGQLEFQQEVRVLSKLQ--HPHLVTLLGACP--- 407 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~---~---~~~~~~f~~E~~iL~~l~--HpnIV~l~g~~~--- 407 (688)
.....+.+.---|+||.+.|+...+.|..+-+|.-... + +.+...|.+|...|.+|. .-++.+++ ++.
T Consensus 15 ~~~~~wve~pN~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k 93 (216)
T PRK09902 15 ATEGDWVEEPNYRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVK 93 (216)
T ss_pred hCCCceecCCCcCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeec
Confidence 33334433344688999999999999888999976421 1 346678999999999995 33344444 331
Q ss_pred C----CceeEEeeCCC-CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCc--e
Q 005616 408 E----AWSLVYEYLPN-GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS--S 480 (688)
Q Consensus 408 ~----~~~LV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~--~ 480 (688)
. ..+||+|-+.| -+|.+++.... ..+.+...+..++.+|+.++.-||..+ +.|+|+.+.|||++.+|. +
T Consensus 94 ~~~~~rA~LVTe~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v 169 (216)
T PRK09902 94 IEGEWRALLVTEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEA 169 (216)
T ss_pred cCCceEEEEEEEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeE
Confidence 1 25799998865 48888875532 234566778899999999999999976 999999999999987777 9
Q ss_pred EEeecCcccc
Q 005616 481 KICDFGICRL 490 (688)
Q Consensus 481 KL~DFGla~~ 490 (688)
+++||.-++.
T Consensus 170 ~lIDlEk~r~ 179 (216)
T PRK09902 170 GFLDLEKSRR 179 (216)
T ss_pred EEEEhhccch
Confidence 9999987654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=6.4e-07 Score=101.34 Aligned_cols=138 Identities=20% Similarity=0.273 Sum_probs=93.1
Q ss_pred eeeeccCceEEEEEEEC-CeEEEEEEEecCCccc----------------------------------------hHHHHH
Q 005616 348 FKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQG----------------------------------------QLEFQQ 386 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~----------------------------------------~~~f~~ 386 (688)
..|+.++-|.||+|++. |+.||||+.++.-... .-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999998 9999999986542100 112456
Q ss_pred HHHHHHcCC-----CCce--eeEecccCCCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHH-HHHHhccC
Q 005616 387 EVRVLSKLQ-----HPHL--VTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG-LCFLHSSK 458 (688)
Q Consensus 387 E~~iL~~l~-----HpnI--V~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~a-L~yLH~~~ 458 (688)
|...+.+++ .|++ .++|--+.....|+|||++|..+.+...... ..++-.. ++..++.+ +.-+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhc-
Confidence 666666552 3332 3333334567899999999999988753322 1233233 33333332 1222222
Q ss_pred CCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 459 ~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
+++|.|.+|.||+++.+|.+.+.|||+...+..
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 499999999999999999999999999876654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.27 E-value=7.7e-06 Score=83.55 Aligned_cols=137 Identities=15% Similarity=0.202 Sum_probs=82.2
Q ss_pred eeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCc--eeeEeccc--CCCceeEEeeCCCCc-H
Q 005616 348 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH--LVTLLGAC--PEAWSLVYEYLPNGS-L 422 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~Hpn--IV~l~g~~--~~~~~LV~E~~~~gs-L 422 (688)
..||.|..+.||+. .|..+++|...... ......+|.+++..+..-+ +.+.++++ .+...+||++++|.. +
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 57999999999984 36678888876433 3345788999998885333 35556554 334678999999963 2
Q ss_pred HHH---------------------hcccCCCCCCCHHHHHH-H---HH-------HHHH-HHHHHhcc-CCCceEeCCCC
Q 005616 423 QDR---------------------LFRKSNVSPLLWKDRAR-I---AA-------EIAS-GLCFLHSS-KPEKIVHGDLK 468 (688)
Q Consensus 423 ~~~---------------------L~~~~~~~~l~~~~~~~-i---~~-------qia~-aL~yLH~~-~~~~IiHrDIK 468 (688)
... |+... ........... + +. .+.. ...+|... .+..++|+|+.
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 111 11110 01111111110 0 00 0111 12222211 12357899999
Q ss_pred CCceeeCCCCceEEeecCcccc
Q 005616 469 PQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 469 p~NILLd~~~~~KL~DFGla~~ 490 (688)
|.||+++.++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.26 E-value=9.1e-06 Score=81.80 Aligned_cols=142 Identities=25% Similarity=0.264 Sum_probs=86.0
Q ss_pred eeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCC--ceeeEecccC-----CCceeEEeeCCCC
Q 005616 348 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP--HLVTLLGACP-----EAWSLVYEYLPNG 420 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~Hp--nIV~l~g~~~-----~~~~LV~E~~~~g 420 (688)
..|+.|..+.||+....+..+++|..... .....+.+|..++..+... .+.+++.++. ...+++|++++|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 57999999999999998889999997554 4456788899998888432 3556665431 1257899999999
Q ss_pred cHHH----------------Hhc---cc-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHhc--
Q 005616 421 SLQD----------------RLF---RK-SNVSPLLWKDR---------ARI------------AAEIAS-GLCFLHS-- 456 (688)
Q Consensus 421 sL~~----------------~L~---~~-~~~~~l~~~~~---------~~i------------~~qia~-aL~yLH~-- 456 (688)
.+.. .+. .. ....++.+... ... ...+.. .+..++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8877 111 11 11111121110 000 112222 3333432
Q ss_pred --cCCCceEeCCCCCCceeeC-CCCceEEeecCccccc
Q 005616 457 --SKPEKIVHGDLKPQNILLD-SELSSKICDFGICRLV 491 (688)
Q Consensus 457 --~~~~~IiHrDIKp~NILLd-~~~~~KL~DFGla~~~ 491 (688)
..+..++|+|+.|.|||++ .++.+-|+||+.+...
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2346799999999999999 6666689999887543
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=3.7e-06 Score=94.99 Aligned_cols=139 Identities=16% Similarity=0.204 Sum_probs=93.5
Q ss_pred eeeeccCceEEEEEEEC-CeEEEEEEEecCCcc-------------------------------------chHHHHHHHH
Q 005616 348 FKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ-------------------------------------GQLEFQQEVR 389 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~-------------------------------------~~~~f~~E~~ 389 (688)
..||.-+.|.||++++. |..||||+-++.-.. ..-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 56899999999999998 889999997653210 0113556665
Q ss_pred HHHcC----CCCc------eeeEecccCCCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCC
Q 005616 390 VLSKL----QHPH------LVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459 (688)
Q Consensus 390 iL~~l----~Hpn------IV~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~ 459 (688)
...++ .|-+ |.++|-.+.....|+||||+|..+.+.-.-.. ..++-.. |+..+.++...+ .-.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~---i~~~l~~~~~~q--If~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHD---ILNKLVEAYLEQ--IFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHH---HHHHHHHHHHHH--HHh
Confidence 55444 3555 56666666778999999999998776543222 1233333 333333332221 111
Q ss_pred CceEeCCCCCCceeeC----CCCceEEeecCccccccC
Q 005616 460 EKIVHGDLKPQNILLD----SELSSKICDFGICRLVTE 493 (688)
Q Consensus 460 ~~IiHrDIKp~NILLd----~~~~~KL~DFGla~~~~~ 493 (688)
.|++|+|-+|.||+++ .++.+.+-|||+...+..
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3599999999999998 367899999999887654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.4e-05 Score=77.55 Aligned_cols=106 Identities=25% Similarity=0.267 Sum_probs=84.6
Q ss_pred HHHHHHHHcCCC-CceeeEecccCCCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceE
Q 005616 385 QQEVRVLSKLQH-PHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463 (688)
Q Consensus 385 ~~E~~iL~~l~H-pnIV~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~Ii 463 (688)
.+|.-++..+.+ +++++++|+|. .++|.||...+++...-..-......+|..+.+|+.+++..+.+|+......+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG--~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG--RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC--CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 458888888875 69999999994 478999998876643211111112458999999999999999999987655688
Q ss_pred eCCCCCCceeeCCCCceEEeecCcccccc
Q 005616 464 HGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 464 HrDIKp~NILLd~~~~~KL~DFGla~~~~ 492 (688)
-.|++|+|+-++++|++|+.|.+.+....
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcchhH
Confidence 89999999999999999999998776553
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.18 E-value=7.9e-06 Score=82.21 Aligned_cols=136 Identities=19% Similarity=0.178 Sum_probs=93.5
Q ss_pred HhcCcccceeeeccCceEEEEEEECCeEEEEEEEecCCccchHH---------HHHHHHHHHcCCCC---ceeeEecc--
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLE---------FQQEVRVLSKLQHP---HLVTLLGA-- 405 (688)
Q Consensus 340 at~~f~~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~---------f~~E~~iL~~l~Hp---nIV~l~g~-- 405 (688)
..++|...+.+-......|.+-...|..+++|.........+.. ..+.+..+.+++.. ....++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 44778887888888888888888899999999987654433222 23444444444322 22222221
Q ss_pred -----cCCCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCce
Q 005616 406 -----CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 406 -----~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~ 480 (688)
+....+|||||++|..|.+... ++. .+...+..++.-||..| ++|+|++|.|++++.++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence 1334668999999988876532 111 24566778899999976 99999999999998655 9
Q ss_pred EEeecCcccc
Q 005616 481 KICDFGICRL 490 (688)
Q Consensus 481 KL~DFGla~~ 490 (688)
++.||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.8e-05 Score=79.97 Aligned_cols=139 Identities=18% Similarity=0.139 Sum_probs=85.0
Q ss_pred eeeccCc-eEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCC-CCceeeEecccCC--CceeEEeeCCCCcHHH
Q 005616 349 KVGQGGF-GCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACPE--AWSLVYEYLPNGSLQD 424 (688)
Q Consensus 349 ~LG~G~~-G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~--~~~LV~E~~~~gsL~~ 424 (688)
.|-.|.+ ..||+....+..++||+..... ...+.+|+.++..+. +-.+.++++++.. ..++||++++|.+|..
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 3445555 8899998777788999876543 335678999988883 4445567776643 4789999999988764
Q ss_pred Hhc-------------------ccCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHhc----cC
Q 005616 425 RLF-------------------RKSN-VSPLL--WKDRARIAA--------------------EIASGLCFLHS----SK 458 (688)
Q Consensus 425 ~L~-------------------~~~~-~~~l~--~~~~~~i~~--------------------qia~aL~yLH~----~~ 458 (688)
... .... ..++. +...+.... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 321 1100 00111 001110000 01111222211 12
Q ss_pred CCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 459 ~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
+..++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 34599999999999999988889999987653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.98 E-value=4.8e-05 Score=77.92 Aligned_cols=138 Identities=22% Similarity=0.288 Sum_probs=77.3
Q ss_pred eeeeccCce-EEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCC---ceeeEecccCC-----CceeEEeeCC
Q 005616 348 FKVGQGGFG-CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP---HLVTLLGACPE-----AWSLVYEYLP 418 (688)
Q Consensus 348 ~~LG~G~~G-~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~Hp---nIV~l~g~~~~-----~~~LV~E~~~ 418 (688)
..|+.||.. .||+. +..+++|..+.. .....+.+|..+|..+... .+..+++.... ..+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 467877776 48875 346778875432 2344788999999887532 33444444322 2478999999
Q ss_pred CCcHHHH------------------hcccCCCC-C------------C-CHHHHH-----HHH----HHHHHH-HH-HHh
Q 005616 419 NGSLQDR------------------LFRKSNVS-P------------L-LWKDRA-----RIA----AEIASG-LC-FLH 455 (688)
Q Consensus 419 ~gsL~~~------------------L~~~~~~~-~------------l-~~~~~~-----~i~----~qia~a-L~-yLH 455 (688)
|.++... |+...... + + .|.... .+. .+.... +. +++
T Consensus 78 G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 157 (235)
T cd05155 78 GETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAALR 157 (235)
T ss_pred CCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHhc
Confidence 9776322 11110000 0 0 121110 000 011111 11 111
Q ss_pred c--cCCCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 456 S--SKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 456 ~--~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
. ..+..++|+|+.|.|||++.++..-|+||+.+..
T Consensus 158 ~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 158 APWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 1 1334599999999999998776667999998654
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.5e-06 Score=97.55 Aligned_cols=191 Identities=20% Similarity=0.145 Sum_probs=133.8
Q ss_pred HHHHhcCcccceeeeccCceEEEEEEECC-eEEEEEEEecCCccchHHHHHHHHHHHcCCCCc-eeeEecccCC--Ccee
Q 005616 337 LQTATCNFSESFKVGQGGFGCVYKGEMLG-RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH-LVTLLGACPE--AWSL 412 (688)
Q Consensus 337 l~~at~~f~~~~~LG~G~~G~Vy~g~~~g-~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~Hpn-IV~l~g~~~~--~~~L 412 (688)
++..|.-+...+-+++|+++.+||.+... +....+.+... ....-++++|.+++||| .+..++-+.. ...+
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 34445555555678999999999987662 22334443322 44566889999999999 6666666633 3668
Q ss_pred EEeeCCCC-cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCccccc
Q 005616 413 VYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 413 V~E~~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~ 491 (688)
+++++.++ +......... ..+...+...+...-.++|++||+.. =+|+| ||+..+ +..+.+||+....+
T Consensus 312 ~~~i~s~~rs~~~~~~~se--~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSE--IALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred hhhhhcCCccccccCChhh--Hhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCccc
Confidence 99999877 2221111100 11222344556677788999999943 38888 777765 68999999998877
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCC
Q 005616 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGL 549 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~ 549 (688)
.... ......+|+.++|||+...+.+..+.|+|++|+--.++--|-+|-..
T Consensus 382 ~~~~-------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 382 TRTM-------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred Cccc-------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 6543 34667899999999999999999999999999988888888777543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.95 E-value=4.1e-05 Score=74.08 Aligned_cols=130 Identities=19% Similarity=0.205 Sum_probs=90.7
Q ss_pred ccceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceee-EecccCCCceeEEeeCCCCcHH
Q 005616 345 SESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT-LLGACPEAWSLVYEYLPNGSLQ 423 (688)
Q Consensus 345 ~~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~-l~g~~~~~~~LV~E~~~~gsL~ 423 (688)
.....||+|.+|.||+|.+.|..+|+|+-+.++ ....+..|+++|..+.--++-+ +|.+-. .++.|||+.|-.|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~--~~i~me~i~G~~L~ 100 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE--DFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech--hhhhhhhhcCcchh
Confidence 345679999999999999999999999876554 3456889999999988766644 333322 23459999998887
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCC-CCceeeCCCCceEEeecCccccc
Q 005616 424 DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLK-PQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 424 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIK-p~NILLd~~~~~KL~DFGla~~~ 491 (688)
+.-... + .+-+..++..---|-..+ |-|+.|. |..++|-+++.+.|+||..|+..
T Consensus 101 ~~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 101 KLEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 765321 1 122334455544444444 8898886 55555555559999999988743
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.93 E-value=9.7e-05 Score=75.33 Aligned_cols=153 Identities=22% Similarity=0.228 Sum_probs=97.6
Q ss_pred cCHHHHHHHhcCcccce---eeeccCceEEEEEEEC-CeEEEEEEEecCCccc-------------------hHH-----
Q 005616 332 FSLADLQTATCNFSESF---KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQG-------------------QLE----- 383 (688)
Q Consensus 332 ~~~~el~~at~~f~~~~---~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~-------------------~~~----- 383 (688)
.+++.|.....+..... .|+.|--+.||+|... +..||||+++...... ...
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34455555554444444 4556777899998765 8899999986543211 111
Q ss_pred HHHHHHHHHcCC--CCceeeEecccCCCceeEEeeCCCCcH-HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCC
Q 005616 384 FQQEVRVLSKLQ--HPHLVTLLGACPEAWSLVYEYLPNGSL-QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460 (688)
Q Consensus 384 f~~E~~iL~~l~--HpnIV~l~g~~~~~~~LV~E~~~~gsL-~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~ 460 (688)
..+|...|.++. +-.+.+-+++. ...|||||+....+ .-.|.. -++...+...+..+++..+.-|-...
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~--~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR--NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec--CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 235666676663 33334444433 45799999965411 111111 11222256677778888888777733
Q ss_pred ceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 461 ~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
++||+||+.-|||+. ++.+.|+|||-|....+
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 499999999999999 88999999998876653
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00015 Score=87.75 Aligned_cols=147 Identities=19% Similarity=0.270 Sum_probs=93.7
Q ss_pred ceeeeccCceEEEEEEECC----eEEEEEEEecCCc-cchHHHHHHHHHHHcCC-CCce--eeEecccCC-----CceeE
Q 005616 347 SFKVGQGGFGCVYKGEMLG----RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ-HPHL--VTLLGACPE-----AWSLV 413 (688)
Q Consensus 347 ~~~LG~G~~G~Vy~g~~~g----~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~-HpnI--V~l~g~~~~-----~~~LV 413 (688)
...|+.|.++.+|+....+ ..+++|+...... .....+.+|+.+|..+. |+++ .+++++|.+ ..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 4678999999999987763 4688887654332 23456889999999995 6654 777888754 37899
Q ss_pred EeeCCCCcHHH--------------------H---hcccCC--------CCCCCH--HHHHHHH---------------H
Q 005616 414 YEYLPNGSLQD--------------------R---LFRKSN--------VSPLLW--KDRARIA---------------A 445 (688)
Q Consensus 414 ~E~~~~gsL~~--------------------~---L~~~~~--------~~~l~~--~~~~~i~---------------~ 445 (688)
|||++|..+.+ . |+.... ..+..+ .++..|. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99999865321 1 111110 001111 1111111 1
Q ss_pred HHHHHHHHHhccCC--------CceEeCCCCCCceeeCCC-C-ceEEeecCccccccC
Q 005616 446 EIASGLCFLHSSKP--------EKIVHGDLKPQNILLDSE-L-SSKICDFGICRLVTE 493 (688)
Q Consensus 446 qia~aL~yLH~~~~--------~~IiHrDIKp~NILLd~~-~-~~KL~DFGla~~~~~ 493 (688)
.+...+.+|..+-| ..+||+|+++.|||++.+ + .+-|.||+++....+
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP 260 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ 260 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence 23344667755433 249999999999999853 3 357999999876543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00018 Score=73.41 Aligned_cols=140 Identities=21% Similarity=0.281 Sum_probs=83.4
Q ss_pred eeeeccCceEEEEEEEC---CeEEEEEEEecCCccchHHHHHHHHHHHcCC-CCceeeEecccCCCceeEEeeCCCCcHH
Q 005616 348 FKVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACPEAWSLVYEYLPNGSLQ 423 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~---g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~~~~LV~E~~~~gsL~ 423 (688)
..|..|-...+|+.... +..|++|+...... ......+|+.++..+. +....++++.+. ..+||||++|.++.
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~~~l~e~i~G~~l~ 80 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ--NGLIYEFIPGRTLE 80 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--CcEEEEeeCCCcCC
Confidence 56788888999999876 57899997654321 1123457888888884 333455555543 35899999987653
Q ss_pred HH-----------------hcccCCC---------CCCCHHHHHHHHHH----------------------HH---HHHH
Q 005616 424 DR-----------------LFRKSNV---------SPLLWKDRARIAAE----------------------IA---SGLC 452 (688)
Q Consensus 424 ~~-----------------L~~~~~~---------~~l~~~~~~~i~~q----------------------ia---~aL~ 452 (688)
.. ++..... ..-.|..+..+... +. ..|.
T Consensus 81 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 160 (235)
T cd05157 81 PEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWLK 160 (235)
T ss_pred HHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHHH
Confidence 21 1111110 11123232222111 11 1111
Q ss_pred -HHhcc-CCCceEeCCCCCCceeeCC-CCceEEeecCcccc
Q 005616 453 -FLHSS-KPEKIVHGDLKPQNILLDS-ELSSKICDFGICRL 490 (688)
Q Consensus 453 -yLH~~-~~~~IiHrDIKp~NILLd~-~~~~KL~DFGla~~ 490 (688)
.+-.. .+..++|+|+.+.|||++. ++.+.|+||..|..
T Consensus 161 ~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 161 ELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 12221 2356999999999999998 57899999987653
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.80 E-value=7.4e-05 Score=77.51 Aligned_cols=138 Identities=17% Similarity=0.111 Sum_probs=81.6
Q ss_pred eeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCce-eeEecccCCCceeEEeeCCCCcHHHH---
Q 005616 350 VGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL-VTLLGACPEAWSLVYEYLPNGSLQDR--- 425 (688)
Q Consensus 350 LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnI-V~l~g~~~~~~~LV~E~~~~gsL~~~--- 425 (688)
+..|-.+.+|+....+..+++|........-.....+|..++..+....+ .++++.+. ..+||+|++|..+...
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~--~~~v~e~i~G~~~~~~~~~ 81 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE--HWLLVEWLEGEVITLDQFV 81 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC--CEEEEEeccCccccccccc
Confidence 56677889999987788899997654322211235789999988854333 34444443 4789999998765321
Q ss_pred --------------hcccCC-CCCCCHHHH-HHHHHH---------HHHHHHHHhcc-----CCCceEeCCCCCCceeeC
Q 005616 426 --------------LFRKSN-VSPLLWKDR-ARIAAE---------IASGLCFLHSS-----KPEKIVHGDLKPQNILLD 475 (688)
Q Consensus 426 --------------L~~~~~-~~~l~~~~~-~~i~~q---------ia~aL~yLH~~-----~~~~IiHrDIKp~NILLd 475 (688)
|+.... ..+++.... ..+..+ +...+..+-.. .+..++|+|+.|.||+++
T Consensus 82 ~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~ 161 (256)
T TIGR02721 82 ALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVT 161 (256)
T ss_pred CchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEe
Confidence 111111 112222211 111111 11112222111 134589999999999999
Q ss_pred CCCceEEeecCcccc
Q 005616 476 SELSSKICDFGICRL 490 (688)
Q Consensus 476 ~~~~~KL~DFGla~~ 490 (688)
.++ +.|+||..|..
T Consensus 162 ~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 162 PQG-LKLIDWEYASD 175 (256)
T ss_pred CCC-CEEEeccccCc
Confidence 877 78999988754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00037 Score=74.26 Aligned_cols=74 Identities=19% Similarity=0.052 Sum_probs=55.6
Q ss_pred ceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCC---CceeeEecccC-----CCceeEEeeCC
Q 005616 347 SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH---PHLVTLLGACP-----EAWSLVYEYLP 418 (688)
Q Consensus 347 ~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~H---pnIV~l~g~~~-----~~~~LV~E~~~ 418 (688)
...||.|..+.||.....+..+++|..+. ......|..|...|..|.- ..+.+++++|. +..+||||+++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 35699999999999887766778887543 1133578899999998842 46777887763 34799999999
Q ss_pred CCcH
Q 005616 419 NGSL 422 (688)
Q Consensus 419 ~gsL 422 (688)
++++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00039 Score=69.29 Aligned_cols=132 Identities=27% Similarity=0.387 Sum_probs=94.7
Q ss_pred CCcccCHHHHHHHhcCcccceeeeccCc-eEEEEEEECCeEEEEEEEecC---Cc-------c-----------chHHHH
Q 005616 328 ESAEFSLADLQTATCNFSESFKVGQGGF-GCVYKGEMLGRTVAIKMLYSH---NM-------Q-----------GQLEFQ 385 (688)
Q Consensus 328 ~~~~~~~~el~~at~~f~~~~~LG~G~~-G~Vy~g~~~g~~VAIK~l~~~---~~-------~-----------~~~~f~ 385 (688)
....|+. -+.+|...+.||.|.- |.||+++..|..+|||++..- .. . ...-|.
T Consensus 28 KL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~ 102 (207)
T PF13095_consen 28 KLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFN 102 (207)
T ss_pred CcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHH
Confidence 3445555 3378999999999999 999999999999999994321 10 0 012488
Q ss_pred HHHHHHHcCC---CCce--eeEeccc--C-C-----------------CceeEEeeCCCCcHHHHhcccCCCCCCCHHHH
Q 005616 386 QEVRVLSKLQ---HPHL--VTLLGAC--P-E-----------------AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDR 440 (688)
Q Consensus 386 ~E~~iL~~l~---HpnI--V~l~g~~--~-~-----------------~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~ 440 (688)
.|.+...+|+ +.++ |+.+||. . + -+.||.||++... .+ .
T Consensus 103 ~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~ 166 (207)
T PF13095_consen 103 CECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----Q 166 (207)
T ss_pred HHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----c
Confidence 9999999885 3345 9999986 1 0 0357888886543 11 2
Q ss_pred HHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCcc
Q 005616 441 ARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 441 ~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla 488 (688)
..-+.+|.+-|..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 167 ~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 IRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 233556777788899976 999999999975 3589999864
|
|
| >KOG4642 consensus Chaperone-dependent E3 ubiquitin protein ligase (contains TPR repeats) [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.61 E-value=5.7e-05 Score=75.61 Aligned_cols=73 Identities=30% Similarity=0.552 Sum_probs=69.0
Q ss_pred CCCCCCcccchhhhhhhcCCCcCCCCccccccchhhhhccCCCCCCCcccccCCCCCCcchHHHHHHHHHhhh
Q 005616 615 ERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCK 687 (688)
Q Consensus 615 ~~~~Ps~~~~pilqeim~dP~va~dg~tye~~~I~~wl~~g~~~SPmtn~~l~~~~l~Pn~~lr~~~~~~~~~ 687 (688)
...+|.+..+.|..++|.+|++.++|.||++..|.+++...+...|.|.-+|..-+++||++|+-+|..|+..
T Consensus 205 ~rEvpd~lcgkIt~el~~~pvi~psgIty~ra~I~Ehl~rvghfdpvtr~~Lte~q~ipN~alkevIa~fl~~ 277 (284)
T KOG4642|consen 205 KREVPDYLCGKITLELMREPVITPSGITYDRADIEEHLQRVGHFDPVTRWPLTEYQLIPNLALKEVIAAFLKE 277 (284)
T ss_pred cccccchhhhhhhHHhhcCCccCccccchhHHHHHHHHHHhccCCchhcccCCHHhhccchHHHHHHHHHHHh
Confidence 3568999999999999999999999999999999999999999999999999999999999999999998863
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00041 Score=73.41 Aligned_cols=141 Identities=18% Similarity=0.184 Sum_probs=87.3
Q ss_pred ceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCC--ceeeEeccc--------CCCceeEEee
Q 005616 347 SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP--HLVTLLGAC--------PEAWSLVYEY 416 (688)
Q Consensus 347 ~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~Hp--nIV~l~g~~--------~~~~~LV~E~ 416 (688)
...|..|....+|+....+..+++|+... ........|+.++..+.+. .+.+++... .+..++|++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 45677888889999887777899998764 2344566788888877432 244554432 2335789999
Q ss_pred CCCCcHHH--------------HhcccC-C-------CCCCCHHHHH----------HHHHHHHHHHHHHhc----cCCC
Q 005616 417 LPNGSLQD--------------RLFRKS-N-------VSPLLWKDRA----------RIAAEIASGLCFLHS----SKPE 460 (688)
Q Consensus 417 ~~~gsL~~--------------~L~~~~-~-------~~~l~~~~~~----------~i~~qia~aL~yLH~----~~~~ 460 (688)
++|..+.. .|+... . .....|.... .....+..++.++.. ..+.
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99876531 011110 0 0112332221 011123344455443 2235
Q ss_pred ceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 461 KIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 461 ~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
.++|+|+.|.|||++.++.+.|.||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 699999999999999987789999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0012 Score=72.86 Aligned_cols=74 Identities=15% Similarity=0.082 Sum_probs=56.0
Q ss_pred eeeeccCceEEEEEEECC--eEEEEEEEecC------C-ccchHHHHHHHHHHHcCC---CCceeeEecccCCCceeEEe
Q 005616 348 FKVGQGGFGCVYKGEMLG--RTVAIKMLYSH------N-MQGQLEFQQEVRVLSKLQ---HPHLVTLLGACPEAWSLVYE 415 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~g--~~VAIK~l~~~------~-~~~~~~f~~E~~iL~~l~---HpnIV~l~g~~~~~~~LV~E 415 (688)
..||.|.+..||++...+ +.|+||.-... . .-....+..|...|..+. -.++.+++.+..+..++|||
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVME 111 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVME 111 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEEe
Confidence 468999999999999874 48999985322 1 124456778888888763 34678888888888899999
Q ss_pred eCCCCc
Q 005616 416 YLPNGS 421 (688)
Q Consensus 416 ~~~~gs 421 (688)
|+++..
T Consensus 112 ~L~~~~ 117 (401)
T PRK09550 112 DLSDHK 117 (401)
T ss_pred cCCCcc
Confidence 998744
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.50 E-value=4.6e-05 Score=92.53 Aligned_cols=186 Identities=12% Similarity=-0.028 Sum_probs=130.7
Q ss_pred EEEEEEECC---eEEEEEEEecCCccchHH-----HHHHHHHHHcCCCCceeeEecccC----CCceeEEeeCCCCcHHH
Q 005616 357 CVYKGEMLG---RTVAIKMLYSHNMQGQLE-----FQQEVRVLSKLQHPHLVTLLGACP----EAWSLVYEYLPNGSLQD 424 (688)
Q Consensus 357 ~Vy~g~~~g---~~VAIK~l~~~~~~~~~~-----f~~E~~iL~~l~HpnIV~l~g~~~----~~~~LV~E~~~~gsL~~ 424 (688)
.-++|.+.+ ..+-+|+.+....+...+ ...|.+.++...|++++..+.-.+ ...+.+++|+.+|.+.+
T Consensus 1241 ~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~ 1320 (2724)
T KOG1826|consen 1241 FHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFS 1320 (2724)
T ss_pred eeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHH
Confidence 334555432 234555555443333222 334555566678999988765542 24678999999999999
Q ss_pred HhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccC--CCceEeCCCCCCceeeCCCCceEEeecCccccccCCCCcCCCc
Q 005616 425 RLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSK--PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 425 ~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~ 501 (688)
.+.+.. ..++++..-+.....+...+..-+|+.. ..-.+|+++|+-|.+|..+.++|++++|+.+...+...
T Consensus 1321 iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s----- 1395 (2724)
T KOG1826|consen 1321 IIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS----- 1395 (2724)
T ss_pred HHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHh-----
Confidence 887653 3444444444444444355655655543 23478999999999999999999999999995544332
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCC
Q 005616 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVG 548 (688)
Q Consensus 502 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~ 548 (688)
......+++.|+.|++...-.++.++|+|..|+.+|++.-|..+|.
T Consensus 1396 -f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1396 -FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred -hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 2355678889999999999999999999999999999999998874
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00059 Score=72.49 Aligned_cols=140 Identities=24% Similarity=0.329 Sum_probs=84.7
Q ss_pred eeeeccCceEEEEEEEC--------CeEEEEEEEecCCccchHHHHHHHHHHHcCCCC-ceeeEecccCCCceeEEeeCC
Q 005616 348 FKVGQGGFGCVYKGEML--------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP-HLVTLLGACPEAWSLVYEYLP 418 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~--------g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~Hp-nIV~l~g~~~~~~~LV~E~~~ 418 (688)
..|..|-...||+.... +..+++|+..... .......+|..++..+... -..++++++.+ .+|++|++
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~--~~v~e~i~ 80 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN--GRIEEFIP 80 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC--CchhheeC
Confidence 45667777899988765 3789999965543 2233567788888888532 23456666643 46899998
Q ss_pred CCcHHHH-----------------hcccCCC--------CCCCHHHHHHH--------------------------HHHH
Q 005616 419 NGSLQDR-----------------LFRKSNV--------SPLLWKDRARI--------------------------AAEI 447 (688)
Q Consensus 419 ~gsL~~~-----------------L~~~~~~--------~~l~~~~~~~i--------------------------~~qi 447 (688)
|..+... |+..... .+.-|.....+ ...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 8766431 1111110 01112111111 1122
Q ss_pred HHHHHHHhc------cCCCceEeCCCCCCceeeCCC----CceEEeecCcccc
Q 005616 448 ASGLCFLHS------SKPEKIVHGDLKPQNILLDSE----LSSKICDFGICRL 490 (688)
Q Consensus 448 a~aL~yLH~------~~~~~IiHrDIKp~NILLd~~----~~~KL~DFGla~~ 490 (688)
...+.+|-. ..+..++|+|+.|.|||++.+ +.+.|+||..|..
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 223344432 234679999999999999985 8899999987653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0019 Score=69.09 Aligned_cols=155 Identities=16% Similarity=0.221 Sum_probs=84.9
Q ss_pred cCHHHHHHHhcCccc-----ceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCC-----CCceee
Q 005616 332 FSLADLQTATCNFSE-----SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-----HPHLVT 401 (688)
Q Consensus 332 ~~~~el~~at~~f~~-----~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-----HpnIV~ 401 (688)
++.+++...-..|.. ...|+.|....+|+....+..+++|++. . ........|+.++..|. .|.++.
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQGEYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCCcEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCccee
Confidence 455555554445543 3456677778999988776689999875 2 12233344555555552 333332
Q ss_pred Ee-c----ccCCCceeEEeeCCCCcHH-----------HH---hcccC-C-------CCCCCH-HHHHH-----------
Q 005616 402 LL-G----ACPEAWSLVYEYLPNGSLQ-----------DR---LFRKS-N-------VSPLLW-KDRAR----------- 442 (688)
Q Consensus 402 l~-g----~~~~~~~LV~E~~~~gsL~-----------~~---L~~~~-~-------~~~l~~-~~~~~----------- 442 (688)
-. | ...+..+++++|++|..+. .. ++... . ...+.| .....
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 10 1 1233468999999987431 11 11110 0 011222 22111
Q ss_pred -HHHH-HHHHHHHHhcc----CCCceEeCCCCCCceeeCCCCceEEeecCccc
Q 005616 443 -IAAE-IASGLCFLHSS----KPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 443 -i~~q-ia~aL~yLH~~----~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~ 489 (688)
.+.. +...+..+... -+.++||+|++|.|||++.+...-|+||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11122333211 35679999999999999976656899999764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0045 Score=66.02 Aligned_cols=141 Identities=16% Similarity=0.186 Sum_probs=83.1
Q ss_pred ceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCC--ceeeEeccc--------CCCceeEEee
Q 005616 347 SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP--HLVTLLGAC--------PEAWSLVYEY 416 (688)
Q Consensus 347 ~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~Hp--nIV~l~g~~--------~~~~~LV~E~ 416 (688)
...++.|-...+|+....+..+++|+..... .......|+.++..|... ++.+++... .+..+++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 3456677778999987776678899875432 233455677777777422 244444332 2235789999
Q ss_pred CCCCcHH-----------H---HhcccC-CC--------CCCCHHHHHH------------HHHHHHHHHHHHhc----c
Q 005616 417 LPNGSLQ-----------D---RLFRKS-NV--------SPLLWKDRAR------------IAAEIASGLCFLHS----S 457 (688)
Q Consensus 417 ~~~gsL~-----------~---~L~~~~-~~--------~~l~~~~~~~------------i~~qia~aL~yLH~----~ 457 (688)
++|..+. . .++... .. ..-.|..... ....+...+.++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 9986432 1 111110 00 0012221111 01123344555543 2
Q ss_pred CCCceEeCCCCCCceeeCCCCceEEeecCccc
Q 005616 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 458 ~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~ 489 (688)
.+.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 34679999999999999998877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.004 Score=62.33 Aligned_cols=126 Identities=22% Similarity=0.269 Sum_probs=84.8
Q ss_pred ceeeeccCceEEEEEEECCeEEEEEEEecCC----------------ccchHHHHHHHHHHHcCC------CCceeeEec
Q 005616 347 SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHN----------------MQGQLEFQQEVRVLSKLQ------HPHLVTLLG 404 (688)
Q Consensus 347 ~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~----------------~~~~~~f~~E~~iL~~l~------HpnIV~l~g 404 (688)
...||+|+.=.||.--. .....||+..... .....++.+|+.-...+. +.+|.+++|
T Consensus 6 ~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 45799999999986322 4456788887655 223456777777766665 888999999
Q ss_pred ccCC--CceeEEeeCCC------CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC
Q 005616 405 ACPE--AWSLVYEYLPN------GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS 476 (688)
Q Consensus 405 ~~~~--~~~LV~E~~~~------gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~ 476 (688)
+... +..+|+|.+.+ -+|.+++... .++. ..... +-.-..||-..+ |+.+|++|.||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEEe
Confidence 9855 46788888753 2677777433 2333 33333 333445666654 999999999999964
Q ss_pred C--C--ceEEee
Q 005616 477 E--L--SSKICD 484 (688)
Q Consensus 477 ~--~--~~KL~D 484 (688)
+ + .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 3 2 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0036 Score=68.07 Aligned_cols=140 Identities=19% Similarity=0.259 Sum_probs=84.7
Q ss_pred eeeeccCceEEEEEEEC------CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCce-eeEecccCCCceeEEeeCCCC
Q 005616 348 FKVGQGGFGCVYKGEML------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL-VTLLGACPEAWSLVYEYLPNG 420 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~------g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnI-V~l~g~~~~~~~LV~E~~~~g 420 (688)
..|-.|-...+|+.... +..|++|+...... ..-.-.+|..++..+..-++ .++++.+.++ .|++|+++.
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g--~v~efi~g~ 118 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG--RVEEFIHAR 118 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc--eEEEeeCCC
Confidence 45656778899998753 25789998765432 22223678888888854333 4566777554 689999877
Q ss_pred cHHHH-----------------hcccC---CCCCCCHHHHHHHHHHH-----------------HHHHHHH----hc-cC
Q 005616 421 SLQDR-----------------LFRKS---NVSPLLWKDRARIAAEI-----------------ASGLCFL----HS-SK 458 (688)
Q Consensus 421 sL~~~-----------------L~~~~---~~~~l~~~~~~~i~~qi-----------------a~aL~yL----H~-~~ 458 (688)
+|... ++... ...+..|..+.++..++ ...+..| .. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 66421 11111 01122344444443222 1112222 22 22
Q ss_pred CCceEeCCCCCCceeeCC-CCceEEeecCcccc
Q 005616 459 PEKIVHGDLKPQNILLDS-ELSSKICDFGICRL 490 (688)
Q Consensus 459 ~~~IiHrDIKp~NILLd~-~~~~KL~DFGla~~ 490 (688)
+..++|+|+++.|||++. ++.+.|+||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 346899999999999986 47899999987653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0018 Score=77.87 Aligned_cols=197 Identities=20% Similarity=0.200 Sum_probs=133.9
Q ss_pred HHHHHHHHHcCCCCceeeEecccCCC------ceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcc
Q 005616 384 FQQEVRVLSKLQHPHLVTLLGACPEA------WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457 (688)
Q Consensus 384 f~~E~~iL~~l~HpnIV~l~g~~~~~------~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~ 457 (688)
..-|...+.++.|+|++.+++|..+. ..+..+++..-++...+... ..++....+.+..++.+||.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v---~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV---GSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc---cccCHHHHHHHHHHHhhhHHHHHHh
Confidence 44577778888999999999886332 22456788888888777654 3567788888999999999999996
Q ss_pred CCCceEeCCCCCC---ceeeCCCCceEEe--ecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCC--cchH
Q 005616 458 KPEKIVHGDLKPQ---NILLDSELSSKIC--DFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTP--KSDS 530 (688)
Q Consensus 458 ~~~~IiHrDIKp~---NILLd~~~~~KL~--DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~--ksDV 530 (688)
. ..|.-+..+ +...+..+.+.++ ||+..+....... .....-+..|.+||......+.. ..|+
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-------~~~~~~~~~~~~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-------SFSDLLAEIRNADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCccc-------chhhcCccccccccccccccchhhhhhHH
Confidence 4 444444433 4445666777777 9988877665432 22334456688888776655544 4799
Q ss_pred hHHHHHHHHHHhCCCCCCChhHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCCcHHHHHHHHH
Q 005616 531 YSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 531 wSfGviL~ELltG~~Pf~~~~~~~~~i~~~~l~~~ldp~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~e~l~~~Le~ 609 (688)
|.+|..+..+..|..+-....... .+++. .....+.+....|+..++++|++..+.+-..+..
T Consensus 376 ~~lgll~~~~~~~~~i~~~~~~~~---------~~l~~-------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~ 438 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDISEKSAVPV---------SLLDV-------LSTSELLDALPKCLDEDSEERLSALELLTHPFLR 438 (1351)
T ss_pred HHHHHHHhhhhhcCcccccccchh---------hhhcc-------ccchhhhhhhhhhcchhhhhccchhhhhhchhcc
Confidence 999999999999876643211110 01110 0111567788889999999999998665554443
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0097 Score=65.72 Aligned_cols=73 Identities=16% Similarity=0.064 Sum_probs=53.7
Q ss_pred ceeeeccCceEEEEEEECCeEEEEEEEecCCc-------cchHHHHHHHHHHHcCC---CCceeeEecccCCCceeEEee
Q 005616 347 SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNM-------QGQLEFQQEVRVLSKLQ---HPHLVTLLGACPEAWSLVYEY 416 (688)
Q Consensus 347 ~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~-------~~~~~f~~E~~iL~~l~---HpnIV~l~g~~~~~~~LV~E~ 416 (688)
.+.||.|....||+....+..|+||.-..... .....-..|...|..+. ..++.++|.+|.+..+++|||
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~vlvME~ 116 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMALIGMRY 116 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCCEEEEee
Confidence 35689999999999988777899997642111 12333344566666653 357888999999999999999
Q ss_pred CCC
Q 005616 417 LPN 419 (688)
Q Consensus 417 ~~~ 419 (688)
+++
T Consensus 117 L~~ 119 (418)
T PLN02756 117 LEP 119 (418)
T ss_pred cCC
Confidence 977
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.013 Score=62.82 Aligned_cols=140 Identities=19% Similarity=0.317 Sum_probs=81.0
Q ss_pred cCceEEEEEEECCeEEEEEEEec--CCccchHHHHHHHHHHHcCC--CCceeeEecccCCCc----eeEEeeCCCCcHHH
Q 005616 353 GGFGCVYKGEMLGRTVAIKMLYS--HNMQGQLEFQQEVRVLSKLQ--HPHLVTLLGACPEAW----SLVYEYLPNGSLQD 424 (688)
Q Consensus 353 G~~G~Vy~g~~~g~~VAIK~l~~--~~~~~~~~f~~E~~iL~~l~--HpnIV~l~g~~~~~~----~LV~E~~~~gsL~~ 424 (688)
|..-.+|.....++++++. ... ..........+|..+++.+. -.-+...++.|.++. +.||+|+.|..+.+
T Consensus 36 G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~ 114 (321)
T COG3173 36 GWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWS 114 (321)
T ss_pred CcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccC
Confidence 3334455555557888888 332 12233345667888888774 334555678886665 89999999843322
Q ss_pred HhcccCC-----------------------------------CCCCCHHHHHHH--------HHHHHHHHHHHhccC---
Q 005616 425 RLFRKSN-----------------------------------VSPLLWKDRARI--------AAEIASGLCFLHSSK--- 458 (688)
Q Consensus 425 ~L~~~~~-----------------------------------~~~l~~~~~~~i--------~~qia~aL~yLH~~~--- 458 (688)
.+..... ...-.|...... .-....-..||+.+.
T Consensus 115 ~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~ 194 (321)
T COG3173 115 ALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPW 194 (321)
T ss_pred cCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCc
Confidence 2211000 000011111110 011122234444433
Q ss_pred --CCceEeCCCCCCceeeCCCCceEEeecCccccccC
Q 005616 459 --PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 459 --~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
+..++|+|+.+.||+++.++-+=|.||+++....+
T Consensus 195 ~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 195 AGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred CCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 35699999999999999998899999999876544
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0014 Score=69.23 Aligned_cols=146 Identities=16% Similarity=0.178 Sum_probs=96.5
Q ss_pred CHHHHHHHh---cCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCc-----------------c-----chHHHHH
Q 005616 333 SLADLQTAT---CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNM-----------------Q-----GQLEFQQ 386 (688)
Q Consensus 333 ~~~el~~at---~~f~~~~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~-----------------~-----~~~~f~~ 386 (688)
.+--|.+.. .-++.+++||-|--+.||.+-+. |++.++|.-..... . .+....+
T Consensus 80 DyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~k 159 (465)
T KOG2268|consen 80 DYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATK 159 (465)
T ss_pred hHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHH
Confidence 344444444 34578899999999999999887 99999996422110 0 0122456
Q ss_pred HHHHHHcCC-CC-ceeeEecccCCCceeEEeeCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEe
Q 005616 387 EVRVLSKLQ-HP-HLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464 (688)
Q Consensus 387 E~~iL~~l~-Hp-nIV~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiH 464 (688)
|...|+.|. |. -+.+.++++ ..++|||++.|-.|...-.-. ....+...+..-+.-|...| +||
T Consensus 160 EfafmkaL~e~gfpVPkpiD~~--RH~Vvmelv~g~Pl~~v~~v~---------d~~~ly~~lm~~Iv~la~~G---lIH 225 (465)
T KOG2268|consen 160 EFAFMKALYERGFPVPKPIDHN--RHCVVMELVDGYPLRQVRHVE---------DPPTLYDDLMGLIVRLANHG---LIH 225 (465)
T ss_pred HHHHHHHHHHcCCCCCCccccc--ceeeHHHhhcccceeeeeecC---------ChHHHHHHHHHHHHHHHHcC---cee
Confidence 777777774 22 334444443 357899999888776543221 12334444444555566644 999
Q ss_pred CCCCCCceeeCCCCceEEeecCcccccc
Q 005616 465 GDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 465 rDIKp~NILLd~~~~~KL~DFGla~~~~ 492 (688)
+|..-=||+++.++.++++||--+....
T Consensus 226 gDFNEFNimv~dd~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 226 GDFNEFNIMVKDDDKIVVIDFPQMVSTS 253 (465)
T ss_pred cccchheeEEecCCCEEEeechHhhccC
Confidence 9999999999999999999997655443
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0073 Score=60.70 Aligned_cols=116 Identities=17% Similarity=0.177 Sum_probs=75.3
Q ss_pred cCceEEEEEEECCeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCCCceeEEeeCCCCcHHHHhcccCC
Q 005616 353 GGFGCVYKGEMLGRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSN 431 (688)
Q Consensus 353 G~~G~Vy~g~~~g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~ 431 (688)
||.++.-+|.-.-.+..+|++...... ...-|.++.++++++. .|++|..--...+.++.|+|.....
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~NDn~~~yGvIlE~Cy~~~i--------- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKNDNNYKYGVILERCYKIKI--------- 141 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecCCCceeEEEEeeccCccc---------
Confidence 344444444433234556666555444 5566788899998875 4677764323346789998843111
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCceEEeecCc
Q 005616 432 VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 432 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGl 487 (688)
. -..++.-=+.+|.-.|+.+ .+.+|+|..|+||+-|..|.+||.|-+.
T Consensus 142 ---~----~~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 ---N----FSNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ---c----hhHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 0 0112222246788889765 5799999999999999999999999764
|
The function of this family is unknown. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.014 Score=63.33 Aligned_cols=71 Identities=18% Similarity=0.109 Sum_probs=49.8
Q ss_pred eeccCceEEEEEEECC--eEEEEEEEecC------C-ccchHHHHHHHHHHHcCC--CC-ceeeEecccCCCceeEEeeC
Q 005616 350 VGQGGFGCVYKGEMLG--RTVAIKMLYSH------N-MQGQLEFQQEVRVLSKLQ--HP-HLVTLLGACPEAWSLVYEYL 417 (688)
Q Consensus 350 LG~G~~G~Vy~g~~~g--~~VAIK~l~~~------~-~~~~~~f~~E~~iL~~l~--Hp-nIV~l~g~~~~~~~LV~E~~ 417 (688)
||.|....||++...+ +.|+||.-... + .-...+..-|...|.... -| .+.++|.+-.+...+|||++
T Consensus 3 igdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEdL 82 (370)
T TIGR01767 3 VGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMEDL 82 (370)
T ss_pred CCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhhC
Confidence 7999999999999874 58999964211 1 223445556777776663 44 45667777777788999999
Q ss_pred CCC
Q 005616 418 PNG 420 (688)
Q Consensus 418 ~~g 420 (688)
+..
T Consensus 83 ~~~ 85 (370)
T TIGR01767 83 SHH 85 (370)
T ss_pred ccc
Confidence 654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.016 Score=62.67 Aligned_cols=140 Identities=18% Similarity=0.285 Sum_probs=83.0
Q ss_pred eeeeccCceEEEEEEECC-----eEEEEEEEecCCccchHHHHHHHHHHHcCCCCce-eeEecccCCCceeEEeeCCCCc
Q 005616 348 FKVGQGGFGCVYKGEMLG-----RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL-VTLLGACPEAWSLVYEYLPNGS 421 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~g-----~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnI-V~l~g~~~~~~~LV~E~~~~gs 421 (688)
..|..|-...+|+....+ ..|++|+...... ..-.-.+|..++..+..-++ .++++++.++ +|.+|+++..
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G--~i~~fi~g~~ 96 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG--MIQSFINART 96 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc--EeehhhcCCC
Confidence 456567788899887653 2788998765432 22234678888888864444 4566666543 5899998765
Q ss_pred HHH-----------------HhcccC-C--CCCCCHHHHHHHHHHH----------------------HHHHHH----Hh
Q 005616 422 LQD-----------------RLFRKS-N--VSPLLWKDRARIAAEI----------------------ASGLCF----LH 455 (688)
Q Consensus 422 L~~-----------------~L~~~~-~--~~~l~~~~~~~i~~qi----------------------a~aL~y----LH 455 (688)
|.. .|+... . ..+-.|..+.++..++ ..-+.. +.
T Consensus 97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~ 176 (330)
T PLN02421 97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD 176 (330)
T ss_pred CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence 521 111111 0 1122344443333222 111111 11
Q ss_pred c-cCCCceEeCCCCCCceeeCC-CCceEEeecCcccc
Q 005616 456 S-SKPEKIVHGDLKPQNILLDS-ELSSKICDFGICRL 490 (688)
Q Consensus 456 ~-~~~~~IiHrDIKp~NILLd~-~~~~KL~DFGla~~ 490 (688)
. ..+..++|.|+.+.|||++. ++.++++||..|..
T Consensus 177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 12345899999999999975 57899999987643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.015 Score=62.68 Aligned_cols=139 Identities=19% Similarity=0.181 Sum_probs=94.0
Q ss_pred eeeeccCceEEEEEEEC-CeEEEEEEEecCCc---------cc-------------hHH----HHHHHHHHHcCCCCcee
Q 005616 348 FKVGQGGFGCVYKGEML-GRTVAIKMLYSHNM---------QG-------------QLE----FQQEVRVLSKLQHPHLV 400 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~---------~~-------------~~~----f~~E~~iL~~l~HpnIV 400 (688)
..|..|--+.||.+.-. |..+|||+++..-. .+ ++. ...|+..|.+|+...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 46889999999999876 88899998754321 01 111 24677777777655432
Q ss_pred eEecccCCCceeEEeeCCCCcHHH-HhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCc
Q 005616 401 TLLGACPEAWSLVYEYLPNGSLQD-RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 479 (688)
Q Consensus 401 ~l~g~~~~~~~LV~E~~~~gsL~~-~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~ 479 (688)
-.--.......|||+|+....... .| ....++...+..+..+++.-+.-|...+ .+||.||+--|+|+ .+|.
T Consensus 230 ~PePIlLk~hVLVM~FlGrdgw~aPkL----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 230 CPEPILLKNHVLVMEFLGRDGWAAPKL----KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred CCCceeeecceEeeeeccCCCCcCccc----ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-ECCE
Confidence 111111224679999995322211 11 1134566778888899999999998877 59999999999988 4578
Q ss_pred eEEeecCccccccC
Q 005616 480 SKICDFGICRLVTE 493 (688)
Q Consensus 480 ~KL~DFGla~~~~~ 493 (688)
+.|+|.+-+.....
T Consensus 303 lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 303 LYIIDVSQSVEHDH 316 (520)
T ss_pred EEEEEccccccCCC
Confidence 99999987765443
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.014 Score=61.86 Aligned_cols=72 Identities=19% Similarity=0.202 Sum_probs=46.3
Q ss_pred cceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCC---CCceeeEeccc--CCCceeEEeeCCCC
Q 005616 346 ESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ---HPHLVTLLGAC--PEAWSLVYEYLPNG 420 (688)
Q Consensus 346 ~~~~LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~---HpnIV~l~g~~--~~~~~LV~E~~~~g 420 (688)
....||.|....+|+....+..+.||+-. ......|..|..-|+.|. --.+.+++++. .+..+|||||++.+
T Consensus 21 ~~~~v~GG~i~~a~~~~~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLDTDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEEE--SSSSEEEEEETTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eeEecCCCChhheEEEECCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 34678989999999999778999999876 223346888888888883 33455666554 55679999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.014 Score=64.29 Aligned_cols=73 Identities=16% Similarity=0.091 Sum_probs=52.0
Q ss_pred eeeeccCceEEEEEEEC--CeEEEEEEEecC-----C-ccchHHHHHHHHHHHcCC--CC-ceeeEecccCCCceeEEee
Q 005616 348 FKVGQGGFGCVYKGEML--GRTVAIKMLYSH-----N-MQGQLEFQQEVRVLSKLQ--HP-HLVTLLGACPEAWSLVYEY 416 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~--g~~VAIK~l~~~-----~-~~~~~~f~~E~~iL~~l~--Hp-nIV~l~g~~~~~~~LV~E~ 416 (688)
..||.|....||++.+. +..|+||.-... + .-...+..-|..+|..+. -| .+.++|.+-.+...+|||+
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~~~~vMEd 114 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVMNCCVMED 114 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHHhhHHHHh
Confidence 56899999999999985 678999964221 1 223456667778887763 44 4566777777778899999
Q ss_pred CCCC
Q 005616 417 LPNG 420 (688)
Q Consensus 417 ~~~g 420 (688)
++..
T Consensus 115 L~~~ 118 (409)
T PRK12396 115 LSDH 118 (409)
T ss_pred Cccc
Confidence 8653
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.01 Score=59.63 Aligned_cols=123 Identities=19% Similarity=0.265 Sum_probs=62.8
Q ss_pred CeEEEEEEEecCCccchHHHHHHHHHHHcCC-CCceeeEecccCCCceeEEeeCCCCcHHHH-----------------h
Q 005616 365 GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACPEAWSLVYEYLPNGSLQDR-----------------L 426 (688)
Q Consensus 365 g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~~~~LV~E~~~~gsL~~~-----------------L 426 (688)
++.|+|++.... ......-..|..+++.+. +..-.++++++.++ +|++|+++..|... +
T Consensus 2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g--~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~l 78 (211)
T PF01633_consen 2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFENG--RVEEFIEGRTLSPEDFRNPEILKRIAKLLAKL 78 (211)
T ss_dssp TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE--EEEE--SSEE--CGGGGSHHHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC--cEEEEecccccChhhccChHHHHHHHHHHHHH
Confidence 356788877655 233445677888988885 44446677776554 57799977664321 1
Q ss_pred cc--c--CCCCCCCHHHHHHH----------------------HHHHHHHHHHHh----c-cCCCceEeCCCCCCceee-
Q 005616 427 FR--K--SNVSPLLWKDRARI----------------------AAEIASGLCFLH----S-SKPEKIVHGDLKPQNILL- 474 (688)
Q Consensus 427 ~~--~--~~~~~l~~~~~~~i----------------------~~qia~aL~yLH----~-~~~~~IiHrDIKp~NILL- 474 (688)
+. . .....-.|.....+ +..+..-+..+. . ..+..++|+|+.|.|||+
T Consensus 79 H~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~~ 158 (211)
T PF01633_consen 79 HSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILIN 158 (211)
T ss_dssp HTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEET
T ss_pred hhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEec
Confidence 10 0 01111123333222 111222222222 1 123468999999999999
Q ss_pred CCCCceEEeecCcccc
Q 005616 475 DSELSSKICDFGICRL 490 (688)
Q Consensus 475 d~~~~~KL~DFGla~~ 490 (688)
+.++.++|+||..|..
T Consensus 159 ~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 159 NKDGEVKLIDFEYAGY 174 (211)
T ss_dssp SSSSCEEE--GTT-EE
T ss_pred cCCCeEEEecHHHHhh
Confidence 8889999999988754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.025 Score=59.67 Aligned_cols=32 Identities=31% Similarity=0.619 Sum_probs=26.2
Q ss_pred CceEeCCCCCCceeeCCCCc-eEEeecCccccc
Q 005616 460 EKIVHGDLKPQNILLDSELS-SKICDFGICRLV 491 (688)
Q Consensus 460 ~~IiHrDIKp~NILLd~~~~-~KL~DFGla~~~ 491 (688)
..++|+|++|.|||++.++. .-|.||+.+...
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 35899999999999997555 569999987653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.083 Score=56.11 Aligned_cols=30 Identities=30% Similarity=0.450 Sum_probs=25.8
Q ss_pred CCceEeCCCCCCceeeCCCCceEEeecCccc
Q 005616 459 PEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 459 ~~~IiHrDIKp~NILLd~~~~~KL~DFGla~ 489 (688)
+.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 357999999999999988 678999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.085 Score=56.97 Aligned_cols=138 Identities=25% Similarity=0.361 Sum_probs=82.7
Q ss_pred eeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCC---CCceee---Eec----ccCC--CceeEEeeC
Q 005616 350 VGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ---HPHLVT---LLG----ACPE--AWSLVYEYL 417 (688)
Q Consensus 350 LG~G~~G~Vy~g~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~---HpnIV~---l~g----~~~~--~~~LV~E~~ 417 (688)
|.+ .-..||+....+..+++|+.... ....++.-|...|..|. .|-.++ +=| .... ..+-|++|+
T Consensus 34 l~s-~eN~~f~~~~~~g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEecCCCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 45678988888666799988765 44556666777777773 222222 212 2234 456799999
Q ss_pred CCCcHHH---------------Hhccc---------CCCCCCCHHH----H---------HHHHHHHHHHHHHHhcc---
Q 005616 418 PNGSLQD---------------RLFRK---------SNVSPLLWKD----R---------ARIAAEIASGLCFLHSS--- 457 (688)
Q Consensus 418 ~~gsL~~---------------~L~~~---------~~~~~l~~~~----~---------~~i~~qia~aL~yLH~~--- 457 (688)
+|..+.. .|+.. .......|.. . ......+...+..+...
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 9988772 01110 0111334531 0 11233344444444432
Q ss_pred -CCCc---eEeCCCCCCceeeCCCCc-eEEeecCcccc
Q 005616 458 -KPEK---IVHGDLKPQNILLDSELS-SKICDFGICRL 490 (688)
Q Consensus 458 -~~~~---IiHrDIKp~NILLd~~~~-~KL~DFGla~~ 490 (688)
-|.. +||+|+.|+||+++.+.. +-+.|||-+..
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 2333 999999999999999875 89999997653
|
|
| >KOG1029 consensus Endocytic adaptor protein intersectin [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=95.60 E-value=2.2 Score=49.64 Aligned_cols=17 Identities=29% Similarity=0.347 Sum_probs=7.6
Q ss_pred HHHHHHHHHHHHhHHHH
Q 005616 181 NSAFAEFLRRKKLESEA 197 (688)
Q Consensus 181 ~~~~~e~~rR~~~e~~~ 197 (688)
+.||+|--||.+.|...
T Consensus 333 Rq~leeqqqreree~eq 349 (1118)
T KOG1029|consen 333 RQALEEQQQREREEVEQ 349 (1118)
T ss_pred HHHHHHHHHHHHHHHHH
Confidence 44444444444444443
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.066 Score=57.20 Aligned_cols=32 Identities=22% Similarity=0.362 Sum_probs=28.5
Q ss_pred CCceEeCCCCCCceeeCCCCceEEeecCcccc
Q 005616 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 459 ~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
+.+++|+|+.++|||++.++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45799999999999999999999999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.09 Score=54.65 Aligned_cols=73 Identities=26% Similarity=0.239 Sum_probs=55.9
Q ss_pred eeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHH---HHHHcCCCCceeeEecccCCCceeEEeeC-CCCcHH
Q 005616 349 KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEV---RVLSKLQHPHLVTLLGACPEAWSLVYEYL-PNGSLQ 423 (688)
Q Consensus 349 ~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~~~~f~~E~---~iL~~l~HpnIV~l~g~~~~~~~LV~E~~-~~gsL~ 423 (688)
.+..|..+.|+.++.. |.++++|+...... +..|. ..|...+-...|++++.-.+...|++|.+ ++.+|.
T Consensus 9 ~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~-----~~~E~~g~~~L~~w~G~GaVrll~~d~~~~AlLLErl~~g~~L~ 83 (253)
T PF04655_consen 9 PPAHGSSSLVVPVRRADGTPAVLKLAPPHAE-----AEHEARGEAALRWWNGRGAVRLLAADPERGALLLERLDPGRSLA 83 (253)
T ss_pred CCCCCcceEEEEEEcCCCCeEEEEecCCccc-----chhhhhHHhHhheeCCCCceeeeccccccchhhhhhccCCCchh
Confidence 4667899999999765 89999999865432 22233 55777888889999999988899999999 555776
Q ss_pred HHh
Q 005616 424 DRL 426 (688)
Q Consensus 424 ~~L 426 (688)
+..
T Consensus 84 ~~~ 86 (253)
T PF04655_consen 84 SLP 86 (253)
T ss_pred hcc
Confidence 554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.3 Score=52.68 Aligned_cols=92 Identities=13% Similarity=0.009 Sum_probs=53.5
Q ss_pred CcccCHHHHHHHhcCcccc---e-eeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCC--ceee
Q 005616 329 SAEFSLADLQTATCNFSES---F-KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP--HLVT 401 (688)
Q Consensus 329 ~~~~~~~el~~at~~f~~~---~-~LG~G~~G~Vy~g~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~Hp--nIV~ 401 (688)
+..++.+.+..+...+... . ..-.|.-..||+.... |..+++|+..... .....+..|+..+..|... .++.
T Consensus 8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~ 86 (325)
T PRK11768 8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVA 86 (325)
T ss_pred CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCC
Confidence 5566777777666555332 1 2223445678988775 6789999875332 3455667788777766321 1222
Q ss_pred Ee---c----ccCCCceeEEeeCCCCc
Q 005616 402 LL---G----ACPEAWSLVYEYLPNGS 421 (688)
Q Consensus 402 l~---g----~~~~~~~LV~E~~~~gs 421 (688)
.. | .+.+..+.|+++++|..
T Consensus 87 p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 87 PLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 12 1 11233567899988764
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.2 Score=55.27 Aligned_cols=73 Identities=14% Similarity=0.162 Sum_probs=45.7
Q ss_pred eeeeccCceEEEEEEECC---eE-----EEEEEEecCCccchHHHHHHHHHHHcCCCC-ceeeEecccCCCceeEEeeCC
Q 005616 348 FKVGQGGFGCVYKGEMLG---RT-----VAIKMLYSHNMQGQLEFQQEVRVLSKLQHP-HLVTLLGACPEAWSLVYEYLP 418 (688)
Q Consensus 348 ~~LG~G~~G~Vy~g~~~g---~~-----VAIK~l~~~~~~~~~~f~~E~~iL~~l~Hp-nIV~l~g~~~~~~~LV~E~~~ 418 (688)
..|..|-...+|++...+ .. |.++... ....-.-.-.+|+.++..+... .-.++++.+.+ .+|+||++
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~--g~l~efIe 132 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD--FTIQEWVE 132 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC--EEEEEEec
Confidence 456668889999987652 22 3333321 1111112335689999999644 44667777754 69999999
Q ss_pred CCcHH
Q 005616 419 NGSLQ 423 (688)
Q Consensus 419 ~gsL~ 423 (688)
|.+|.
T Consensus 133 Gr~l~ 137 (383)
T PTZ00384 133 GNTMG 137 (383)
T ss_pred cccCC
Confidence 87764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 688 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-37 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-37 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-29 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-29 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 1t1h_A | 78 | Nmr Solution Structure Of The U Box Domain From Atp | 3e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 7e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1T1H|A Chain A, Nmr Solution Structure Of The U Box Domain From Atpub14, An Armadillo Repeat Containing Protein From Arabidopsis Thaliana Length = 78 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 1e-95
Identities = 107/291 (36%), Positives = 149/291 (51%), Gaps = 22/291 (7%)
Query: 332 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRV 390
L DL+ AT NF F +G G FG VYKG + G VA+K + QG EF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 391 LSKLQHPHLVTLLGACPEAWS--LVYEYLPNGSLQDRLFRKSN-VSPLLWKDRARIAAEI 447
LS +HPHLV+L+G C E L+Y+Y+ NG+L+ L+ + W+ R I
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 448 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP 507
A GL +LH+ I+H D+K NILLD KI DFGI + TE H ST
Sbjct: 149 ARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELD----QTHLSTVV 201
Query: 508 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV---------GLAGEVRRAVS 558
KG+ Y DPEY G LT KSD YSFG+++ ++L R + LA + +
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 559 CGKLSSILDP-LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608
G+L I+DP LA R+ D ++C L +RP + ++ +LE
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMG-DVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 5e-88
Identities = 99/302 (32%), Positives = 148/302 (49%), Gaps = 29/302 (9%)
Query: 332 FSLADLQTATCNFSESF------KVGQGGFGCVYKGEMLGRTVAIKMLYSHN----MQGQ 381
FS +L+ T NF E K+G+GGFG VYKG + TVA+K L + + +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 382 LEFQQEVRVLSKLQHPHLVTLLGACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKD 439
+F QE++V++K QH +LV LLG + LVY Y+PNGSL DRL PL W
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 440 RARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499
R +IA A+G+ FLH +H D+K NILLD ++KI DFG+ R +
Sbjct: 135 RCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA---- 187
Query: 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE----VRR 555
++ G+ Y PE G +TPKSD YSFG+++L+++TG V E +
Sbjct: 188 QTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246
Query: 556 A----VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611
+ +D D + + + QC +RPDI + + L+++
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIK-KVQQLLQEMT 305
Query: 612 VA 613
+
Sbjct: 306 AS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 3e-81
Identities = 109/302 (36%), Positives = 163/302 (53%), Gaps = 27/302 (8%)
Query: 332 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQG-QLEFQQEVR 389
FSL +LQ A+ NFS +G+GGFG VYKG + G VA+K L QG +L+FQ EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 390 VLSKLQHPHLVTLLGACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLL-WKDRARIAAE 446
++S H +L+ L G C LVY Y+ NGS+ L + P L W R RIA
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 447 IASGLCFLH-SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE-DTLYLPSFHRS 504
A GL +LH P KI+H D+K NILLD E + + DFG+ +L+ DT H +
Sbjct: 140 SARGLAYLHDHCDP-KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT------HVT 192
Query: 505 TAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV---GLAGE--------V 553
TA +G+ + PEY TG + K+D + +G+++L+L+TG+ LA + V
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 554 RRAVSCGKLSSILDP-LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612
+ + KL +++D L G++ +L+ + L C + ERP ++ +V+ LE +
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS-EVVRMLEGDGL 311
Query: 613 AE 614
AE
Sbjct: 312 AE 313
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 8e-63
Identities = 83/303 (27%), Positives = 130/303 (42%), Gaps = 30/303 (9%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 408
VG+G FG V K + + VAIK + S + + F E+R LS++ HP++V L GAC
Sbjct: 15 VVGRGAFGVVCKAKWRAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLK 468
LV EY GSL + L + + + G+ +LHS +P+ ++H DLK
Sbjct: 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132
Query: 469 PQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPK 527
P N+LL + + KICDFG + T KGS + PE + K
Sbjct: 133 PPNLLLVAGGTVLKICDFGTACDIQTHM---------TNNKGSAAWMAPEVFEGSNYSEK 183
Query: 528 SDSYSFGLIILQLLTGRLP----VGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVD 583
D +S+G+I+ +++T R P G A + AV G + + + +
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL--------IKNLPKPIES 235
Query: 584 LGLQCCELYGRERPDITPSLVKELEQLHVA-----EERPVPSFFLCPILQEIMHDPQVAA 638
L +C +RP + +VK + L E P P ++ +P V
Sbjct: 236 LMTRCWSKDPSQRPSME-EIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDF 294
Query: 639 DGF 641
F
Sbjct: 295 AEF 297
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 8e-62
Identities = 65/316 (20%), Positives = 114/316 (36%), Gaps = 39/316 (12%)
Query: 324 EDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLE 383
+ +L + +G FGCV+K ++L VA+K+ + Q +
Sbjct: 6 HHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSW-Q 64
Query: 384 FQQEVRVLSKLQHPHLVTLLGACPEA------WSLVYEYLPNGSLQDRLFRKSNVSPLLW 437
+ EV L ++H +++ +GA L+ + GSL D L + W
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSW 120
Query: 438 KDRARIAAEIASGLCFLHS--------SKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+ IA +A GL +LH KP I H D+K +N+LL + L++ I DFG+
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKP-AISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL-----TPKSDSYSFGLIILQLLTGR 544
S + G+ Y PE + + D Y+ GL++ +L +
Sbjct: 180 KFEAGK----SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 545 LPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604
+ ++ P D V + L + +++
Sbjct: 236 TAADGPVDEYMLPFEEEIGQ--HPSLEDMQEVVVHKKKRP-----VLRDYWQKHAGMAML 288
Query: 605 KELEQL---HVAEERP 617
E + H AE R
Sbjct: 289 CETIEECWDHDAEARL 304
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-59
Identities = 82/268 (30%), Positives = 130/268 (48%), Gaps = 21/268 (7%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLGAC 406
K+G G FG V++ E G VA+K+L + + EF +EV ++ +L+HP++V +GA
Sbjct: 44 KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
P S+V EYL GSL L + L + R +A ++A G+ +LH+ P IVH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVH 162
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 524
+LK N+L+D + + K+CDFG+ RL L S + G+ + PE R
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS------SKSAAGTPEWMAPEVLRDEPS 216
Query: 525 TPKSDSYSFGLIILQLLTGRLP-VGL-AGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 582
KSD YSFG+I+ +L T + P L +V AV + P + ++
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI-------PRNLNPQVA 269
Query: 583 DLGLQCCELYGRERPDITPSLVKELEQL 610
+ C +RP +++ L L
Sbjct: 270 AIIEGCWTNEPWKRPSFA-TIMDLLRPL 296
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 3e-56
Identities = 72/278 (25%), Positives = 119/278 (42%), Gaps = 36/278 (12%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQL----EFQQEVRVLSKLQHPHLVTLLG 404
+G GGFG VY+ +G VA+K + +QE ++ + L+HP+++ L G
Sbjct: 14 IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 405 AC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
C LV E+ G L L K + A +IA G+ +LH I
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 463 VHGDLKPQNILLDSELSS--------KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
+H DLK NIL+ ++ + KI DFG+ R T + G++ +
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT--------KMSAAGAYAWM 181
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP-VGL-AGEVRRAVSCGKLSSILDPLAGD 572
PE R + + SD +S+G+++ +LLTG +P G+ V V+ KL+ +
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI------ 235
Query: 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
P+ L C RP T +++ +L +
Sbjct: 236 -PSTCPEPFAKLMEDCWNPDPHSRPSFT-NILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-55
Identities = 82/283 (28%), Positives = 133/283 (46%), Gaps = 42/283 (14%)
Query: 349 KVGQGGFGCVYKGEMLGR--TVAIKMLYSHNMQGQL-------EFQQEVRVLSKLQHPHL 399
++G+GGFG V+KG ++ VAIK L + +G+ EFQ+EV ++S L HP++
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 400 VTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
V L G +V E++P G L RL K++ P+ W + R+ +IA G+ ++ + P
Sbjct: 86 VKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 460 EKIVHGDLKPQNILLDS-----ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
IVH DL+ NI L S + +K+ DFG+ + + G+F +
Sbjct: 144 -PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---------VSGLLGNFQWM 193
Query: 515 DPE--YHRTGVLTPKSDSYSFGLIILQLLTGRLP----VGLAGEVRRAVSCGKLS-SILD 567
PE T K+D+YSF +I+ +LTG P + + L +I
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI-- 251
Query: 568 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
P RL ++ C ++RP + +VKEL +L
Sbjct: 252 ------PEDCPPRLRNVIELCWSGDPKKRPHFS-YIVKELSEL 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-55
Identities = 77/271 (28%), Positives = 129/271 (47%), Gaps = 24/271 (8%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLGAC 406
++G G FG VYKG+ G VA+KML Q F+ EV VL K +H +++ +G
Sbjct: 31 RIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 407 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
++V ++ SL L ++ + K IA + A G+ +LH+ I+H
Sbjct: 90 TAPQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---YHRTG 522
DLK NI L + + KI DFG+ + + H+ GS + PE +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS----HQFEQLSGSILWMAPEVIRMQDSN 200
Query: 523 VLTPKSDSYSFGLIILQLLTGRLP---VGLAGEVRRAVSCGKLSSILDPLAGDWPTFVAR 579
+ +SD Y+FG+++ +L+TG+LP + ++ V G LS L + + P +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP----K 256
Query: 580 RLVDLGLQCCELYGRERPDITPSLVKELEQL 610
R+ L +C + ERP ++ E+E+L
Sbjct: 257 RMKRLMAECLKKKRDERPSFP-RILAEIEEL 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 5e-53
Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 31/237 (13%)
Query: 331 EFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRV 390
E + ++ N +G+G +G VYKG + R VA+K+ N Q F E +
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ---NFINEKNI 58
Query: 391 --LSKLQHPHLVTLLGAC-------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRA 441
+ ++H ++ + + LV EY PNGSL L + W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114
Query: 442 RIAAEIASGLCFLHSSKPE------KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495
R+A + GL +LH+ P I H DL +N+L+ ++ + I DFG+ +T +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 496 LYLPSF--HRSTAPKGSFPYADPEY-------HRTGVLTPKSDSYSFGLIILQLLTG 543
L P + + + G+ Y PE + D Y+ GLI ++
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 6e-52
Identities = 42/207 (20%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLGAC 406
K+ + G ++KG G + +K+L + + +F +E L HP+++ +LGAC
Sbjct: 17 KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 407 ----PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
+L+ ++P GSL + L + + + A ++A G+ FLH+ +P I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLHTLEP-LI 134
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---YH 519
L +++++D +++++I + +S + + PE
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKF-----------SFQSPGRMYAPAWVAPEALQKK 183
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLP 546
+D +SF +++ +L+T +P
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 1e-51
Identities = 63/277 (22%), Positives = 106/277 (38%), Gaps = 31/277 (11%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLGAC 406
+G+G FG VY G G VAI+++ F++EV + +H ++V +GAC
Sbjct: 40 LIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
P +++ +L + L +IA EI G+ +LH+ + I+H
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHA---KGILH 153
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 524
DLK +N+ D I DFG+ + + G + PE R
Sbjct: 154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE-DKLRIQNGWLCHLAPEIIRQLSP 211
Query: 525 ---------TPKSDSYSFGLIILQLLTGRLP-VGL-AGEVRRAVSCGKLSSILDPLAGDW 573
+ SD ++ G I +L P A + + G ++
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS------- 264
Query: 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+ + + D+ L C ERP T L+ LE+L
Sbjct: 265 QIGMGKEISDILLFCWAFEQEERPTFT-KLMDMLEKL 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 9e-51
Identities = 68/286 (23%), Positives = 119/286 (41%), Gaps = 24/286 (8%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
+G+G FG K G + +K L + + Q F +EV+V+ L+HP+++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
+ + + EY+ G+L+ + KS S W R A +IASG+ +LHS I+H
Sbjct: 77 YKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIH 131
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDT--------LYLPSFHRSTAPKGSFPYADP 516
DL N L+ + + DFG+ RL+ ++ L P + G+ + P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTF 576
E K D +SFG+++ +++ + + P
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPP- 250
Query: 577 VARRLVDLGLQCCELYGRERPDITPSLVKELEQL--HVAEERPVPS 620
+ ++CC+L +RP L LE L H+A P+
Sbjct: 251 ---SFFPITVRCCDLDPEKRPS-FVKLEHWLETLRMHLAGHLPLGP 292
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 5e-48
Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 28/225 (12%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRV--LSKLQHPHLVTLLGAC 406
VG+G +G V++G G VA+K+ S + + + +E + L+H +++ + +
Sbjct: 15 CVGKGRYGEVWRGSWQGENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIASD 71
Query: 407 ------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
L+ Y GSL D L L RI IASGL LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 461 -----KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
I H DLK +NIL+ I D G+ + ++ T L + G+ Y
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV--GNNPRVGTKRYMA 185
Query: 516 PE------YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR 554
PE + D ++FGL++ ++ + G+ + +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 6e-47
Identities = 55/223 (24%), Positives = 90/223 (40%), Gaps = 24/223 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC-- 406
++G+G +G V+ G+ G VA+K+ ++ + E+ ++H +++ + A
Sbjct: 44 QIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 407 ----PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE-- 460
L+ +Y NGSL D L L K ++A SGLC LH+
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 461 ---KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
I H DLK +NIL+ + I D G+ DT G+ Y PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT--NEVDIPPNTRVGTKRYMPPE 216
Query: 518 ------YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR 554
+D YSFGLI+ ++ + G+ E +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-45
Identities = 55/227 (24%), Positives = 91/227 (40%), Gaps = 36/227 (15%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC-- 406
+G+G FG V++G+ G VA+K+ S + + E+ L+H +++ + A
Sbjct: 49 SIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 407 -----PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE- 460
+ W LV +Y +GSL D L R + + ++A ASGL LH
Sbjct: 108 DNGTWTQLW-LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 461 ----KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
I H DLK +NIL+ + I D G+ D+ G+ Y P
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR--HDSATDTIDIAPNHRVGTKRYMAP 220
Query: 517 EYHRTGVL-----------TPKSDSYSFGLIILQLLTGRLPVGLAGE 552
E VL ++D Y+ GL+ ++ G+ +
Sbjct: 221 E-----VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 66/274 (24%), Positives = 116/274 (42%), Gaps = 32/274 (11%)
Query: 349 KVGQGGFGCVYKGEMLGRT--VAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTLLGA 405
++G+G FG V+ G + VA+K +F QE R+L + HP++V L+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 406 CPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
C + + V E + G L ++ + L K ++ + A+G+ +L S +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY---ADPEYHR 520
H DL +N L+ + KI DFG+ R + ++ P A PE
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYA------ASGGLRQVPVKWTA-PEALN 288
Query: 521 TGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPTFV 577
G + +SD +SFG+++ + + G P L+ + R V G L P
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG---RLPC-----PELC 340
Query: 578 ARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611
+ L QC +RP + ++ +EL+ +
Sbjct: 341 PDAVFRLMEQCWAYEPGQRPSFS-TIYQELQSIR 373
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 405
+GQG V++G G AIK+ + + ++ +E VL KL H ++V L A
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-A 74
Query: 406 CPEAWS-----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
E + L+ E+ P GSL L SN L + + ++ G+ L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131
Query: 461 KIVHGDLKPQNILL----DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
IVH ++KP NI+ D + K+ DFG R + +D S + G+ Y P
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLY------GTEEYLHP 184
Query: 517 EYHRTGVL--------TPKSDSYSFGLIILQLLTGRLP 546
+ + VL D +S G+ TG LP
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
K+G GG VY E +L VAIK + + F++EV S+L H ++V+++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 404 --GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+ + LV EY+ +L + + PL +I G+ H +
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR--- 131
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK---GSFPYADPEY 518
IVH D+KPQNIL+DS + KI DFGI + ++E +L T G+ Y PE
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL--------TQTNHVLGTVQYFSPEQ 183
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ +D YS G+++ ++L G P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-36
Identities = 78/219 (35%), Positives = 106/219 (48%), Gaps = 19/219 (8%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+GQG FG V+ G G T VAIK L M + F QE +V+ KL+H LV L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 408 EA-WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466
E +V EY+ GSL D L + L +AA+IASG+ ++ VH D
Sbjct: 250 EEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 305
Query: 467 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTGVL 524
L+ NIL+ L K+ DFG+ RL+ ++ FP PE G
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRF 358
Query: 525 TPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
T KSD +SFG+++ +L T GR+P G+ EV V G
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 71/297 (23%), Positives = 113/297 (38%), Gaps = 33/297 (11%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G+GGF V E L G A+K + H Q + E Q+E + HP+++ L+ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 407 PEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRA-RIAAEIASGLCFLHSSKP 459
L+ + G+L + + R + L +D+ + I GL +H+
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRS---TAPKGSFPYADP 516
+ H DLKP NILL E + D G A + + Y P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 517 E---YHRTGVLTPKSDSYSFGLIILQLLTGRLP---VGLAGEVRRAVSCGKLSSILDPLA 570
E V+ ++D +S G ++ ++ G P V G+ +LS P
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSP-- 270
Query: 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPSFFLCPIL 627
+ L L + +RP I P L+ +LE L + P P IL
Sbjct: 271 -----RHSSALWQLLNSMMTVDPHQRPHI-PLLLSQLEAL----QPPAPGQHTTQIL 317
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-36
Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 21/221 (9%)
Query: 349 KVGQGGFGCVYKGEMLGRT--VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G G +G VY+G + VA+K L M+ + EF +E V+ +++HP+LV LLG C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 407 PEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
+ E++ G+L D L R+ N + +A +I+S + +L + +H
Sbjct: 286 TREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 341
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTG 522
+L +N L+ K+ DFG+ RL+T DT Y FP PE
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAH------AGAKFPIKWTAPESLAYN 394
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLPV-GLAG-EVRRAVSCG 560
+ KSD ++FG+++ ++ T G P G+ +V +
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 435
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-36
Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 405
+GQG V++G G AIK+ + + ++ +E VL KL H ++V L A
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-A 74
Query: 406 CPEAWS-----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
E + L+ E+ P GSL L SN L + + ++ G+ L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131
Query: 461 KIVHGDLKPQNILL----DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
IVH ++KP NI+ D + K+ DFG R + +D S + G+ Y P
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLY------GTEEYLHP 184
Query: 517 EYHRTGVL--------TPKSDSYSFGLIILQLLTGRLP 546
+ + VL D +S G+ TG LP
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-35
Identities = 78/219 (35%), Positives = 106/219 (48%), Gaps = 19/219 (8%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+GQG FG V+ G G T VAIK L M + F QE +V+ KL+H LV L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 408 EA-WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466
E +V EY+ GSL D L + L +AA+IASG+ ++ VH D
Sbjct: 333 EEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 388
Query: 467 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTGVL 524
L+ NIL+ L K+ DFG+ RL+ ++ FP PE G
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRF 441
Query: 525 TPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
T KSD +SFG+++ +L T GR+P G+ EV V G
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 71/311 (22%), Positives = 125/311 (40%), Gaps = 57/311 (18%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
++G+G FG V VA+K L + +F++E+ +L LQH ++V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 403 LGACPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G C A L+ EYLP GSL+D L + + + + ++I G+ +L +
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT-- 132
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YAD 515
++ +H DL +NIL+++E KI DFG+ +++ +D + + P G P YA
Sbjct: 133 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF----FKVKEP-GESPIFWYA- 185
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPT 575
PE + SD +SFG+++ +L T + + G+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT------------YIEKSKSPPAEFMRMIGNDK- 232
Query: 576 FVARRLVDLGLQCCELYGR-------ERPDITPSLVKELEQL---HVAEERPVPSF-FLC 624
+ L RPD P + + + +R PSF L
Sbjct: 233 -------QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR--PSFRDLA 283
Query: 625 PILQEIMHDPQ 635
+ +I +
Sbjct: 284 LRVDQIRDNMA 294
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 72/308 (23%), Positives = 120/308 (38%), Gaps = 69/308 (22%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVT 401
+G G FG VYKG + VAIK L E E V++ + +PH+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 402 LLGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
LLG C L+ + +P G L D + + + + + +IA G+ +L +
Sbjct: 82 LLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL-EDR-- 136
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPE 517
++VH DL +N+L+ + KI DFG+ +L+ + A G P A E
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE------YHAEGGKVPIKWMA-LE 189
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWP 574
+ T +SD +S+G+ + +L+T G P G+ E+ + G+
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------------- 236
Query: 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL------HVAEERPVPSF-FLCPIL 627
RL +P I ++ + A+ R P F L
Sbjct: 237 -----RL-------------PQPPICT---IDVYMIMRKCWMIDADSR--PKFRELIIEF 273
Query: 628 QEIMHDPQ 635
++ DPQ
Sbjct: 274 SKMARDPQ 281
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 86/282 (30%), Positives = 125/282 (44%), Gaps = 33/282 (11%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
++G G FG V+ G G T VA+K L +M F E ++ +LQH LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 408 -EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466
E ++ EY+ NGSL D L + + L +AA+IA G+ F+ +H D
Sbjct: 79 QEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134
Query: 467 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY---ADPEYHRTGV 523
L+ NIL+ LS KI DFG+ RL+ ++ FP A PE G
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYT-------AREGAKFPIKWTA-PEAINYGT 186
Query: 524 LTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPTFVARR 580
T KSD +SFG+++ +++T GR+P G+ EV + + G + P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---RMVR-----PDNCPEE 238
Query: 581 LVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE---RPVP 619
L L C + +RP L LE A E +P P
Sbjct: 239 LYQLMRLCWKERPEDRPTFD-YLRSVLEDFFTATEGQYQPQP 279
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 24/199 (12%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
++G+G FG V VA+K L + +F++E+ +L LQH ++V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 403 LGAC----PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G C L+ EYLP GSL+D L + + + + ++I G+ +L +
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT-- 163
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YAD 515
++ +H DL +NIL+++E KI DFG+ +++ +D Y ++ P G P YA
Sbjct: 164 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY----YKVKEP-GESPIFWYA- 216
Query: 516 PEYHRTGVLTPKSDSYSFG 534
PE + SD +SFG
Sbjct: 217 PESLTESKFSVASDVWSFG 235
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 28/211 (13%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIK-MLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLG 404
++G+G F VYKG VA + + + + F++E +L LQHP++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 405 AC------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
+ + LV E + +G+L+ L R + + + +I GL FLH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR---SWCRQILKGLQFLHTRT 149
Query: 459 PEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--AD 515
P I+H DLK NI + S KI D G+ L + + P A
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGT-------PEFMA- 198
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE + D Y+FG+ +L++ T P
Sbjct: 199 PEMYEEKY-DESVDVYAFGMCMLEMATSEYP 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 83/305 (27%), Positives = 131/305 (42%), Gaps = 46/305 (15%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
++G+G FG V VA+K L Q +FQ+E+++L L +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 403 LGACPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G LV EYLP+G L+D L + + + L +++I G+ +L S
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS-- 145
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YAD 515
+ VH DL +NIL++SE KI DFG+ +L+ D Y + P G P YA
Sbjct: 146 -RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY----YVVREP-GQSPIFWYA- 198
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574
PE + + +SD +SFG+++ +L T C + L + +
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKS------------CSPSAEFLRMMGCERD 246
Query: 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL---HVAEERPVPSF-FLCPILQEI 630
RL++L L+ E P P+ V EL +L ++R PSF L P L +
Sbjct: 247 VPALSRLLEL-LE--EGQRLPAPPACPAEVHELMKLCWAPSPQDR--PSFSALGPQLDML 301
Query: 631 MHDPQ 635
+
Sbjct: 302 WSGSR 306
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 36/295 (12%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGA 405
+ +GGF VY+ + + GR A+K L S+ + QEV + KL HP++V A
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 406 CPEAWS---------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
L+ L G L + L + + PL +I + + +H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK------GS 510
KP I+H DLK +N+LL ++ + K+CDFG ++ Y S R + +
Sbjct: 155 QKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 511 FPYADPE---YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILD 567
Y PE + + K D ++ G I+ L + P + + GK S
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE--DGAKLRIVNGKYS---- 267
Query: 568 PLAGDWPTFVAR--RLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPS 620
P + L ++ ER I +V +L+++ A S
Sbjct: 268 -----IPPHDTQYTVFHSLIRAMLQVNPEERLSI-AEVVHQLQEIAAARNVNPKS 316
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 64/271 (23%), Positives = 110/271 (40%), Gaps = 38/271 (14%)
Query: 349 KVGQGGFGCVYKGE-MLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHP--HLVTLL 403
++G GG V++ + AIK + Q ++ E+ L+KLQ ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 404 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+ +V E N L L +K ++ P +R + + +H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQ---HG 128
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 517
IVH DLKP N L+ + K+ DFGI + DT S + + G+ Y PE
Sbjct: 129 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT---TSVVKDS-QVGTVNYMPPEAIKD 183
Query: 518 -------YHRTGVLTPKSDSYSFGLIILQLLTGRLP-VGLAGEVRRAVSCGKLSSILDP- 568
++PKSD +S G I+ + G+ P + ++ KL +I+DP
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------KLHAIIDPN 237
Query: 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDI 599
++P + L D+ C + ++R I
Sbjct: 238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 268
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 72/301 (23%), Positives = 117/301 (38%), Gaps = 45/301 (14%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVT 401
+G+G FG V VA+K L + + + ++E+ +L L H ++V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 402 LLGACPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
G C E L+ E+LP+GSL++ L N + + K + + A +I G+ +L S
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS- 144
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YA 514
+ VH DL +N+L++SE KI DFG+ + + D Y + P YA
Sbjct: 145 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY----YTVKDD-RDSPVFWYA 197
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574
PE SD +SFG+ + +LLT + + L I G
Sbjct: 198 -PECLMQSKFYIASDVWSFGVTLHELLTY-------CDSDSSPMALFLKMIGPTH-GQMT 248
Query: 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL---HVAEERPVPSF-FLCPILQEI 630
+ G P P V +L + R SF L + +
Sbjct: 249 VTRLVNTLKEG------KRLPCPPNCPDEVYQLMRKCWEFQPSNR--TSFQNLIEGFEAL 300
Query: 631 M 631
+
Sbjct: 301 L 301
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 64/271 (23%), Positives = 110/271 (40%), Gaps = 38/271 (14%)
Query: 349 KVGQGGFGCVYKG-EMLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHP--HLVTLL 403
++G GG V++ + AIK + Q ++ E+ L+KLQ ++ L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 404 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+ +V E N L L +K ++ P +R + + +H
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQ---HG 147
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 517
IVH DLKP N L+ + K+ DFGI + DT S + + G+ Y PE
Sbjct: 148 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT---TSVVKDS-QVGTVNYMPPEAIKD 202
Query: 518 -------YHRTGVLTPKSDSYSFGLIILQLLTGRLP-VGLAGEVRRAVSCGKLSSILDP- 568
++PKSD +S G I+ + G+ P + ++ KL +I+DP
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------KLHAIIDPN 256
Query: 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDI 599
++P + L D+ C + ++R I
Sbjct: 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 287
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-35
Identities = 78/303 (25%), Positives = 124/303 (40%), Gaps = 53/303 (17%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVT 401
+G+G FG V VA+K L + ++QE+ +L L H H++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 402 LLGACPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
G C +A + LV EY+P GSL+D L + ++ A +I G+ +LH+
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGL---AQLLLFAQQICEGMAYLHA- 152
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YA 514
+ +H DL +N+LLD++ KI DFG+ + V E Y +R G P YA
Sbjct: 153 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY----YRVRED-GDSPVFWYA 205
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574
PE + SD +SFG+ + +LLT + ++ L I
Sbjct: 206 -PECLKEYKFYYASDVWSFGVTLYELLTH-------CDSSQSPPTKFLELIGIAQGQ-MT 256
Query: 575 TFVARRLVDLG--LQC---C--ELYG----------RERPDITPSLVKELEQLHVAEERP 617
L++ G L C E+Y RP +L+ L+ +H +
Sbjct: 257 VLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFE-NLIPILKTVHEKYQGQ 315
Query: 618 VPS 620
PS
Sbjct: 316 APS 318
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-35
Identities = 65/261 (24%), Positives = 108/261 (41%), Gaps = 39/261 (14%)
Query: 349 KVGQGGFGCVYKGEML-GRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHP--HLVTLL 403
++G GG V++ + AIK L + Q ++ E+ L+KLQ ++ L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 404 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+ +V E N L L +K ++ P +R + + +H
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQ---HG 175
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 517
IVH DLKP N L+ K+ DFGI + DT S + + G+ Y PE
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT---TSVVKDS-QVGAVNYMPPEAIKD 230
Query: 518 -------YHRTGVLTPKSDSYSFGLIILQLLTGRLP-VGLAGEVRRAVSCGKLSSILDP- 568
++PKSD +S G I+ + G+ P + ++ KL +I+DP
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------KLHAIIDPN 284
Query: 569 LAGDWPTFVARRLVDLGLQCC 589
++P + L D+ L+CC
Sbjct: 285 HEIEFPDIPEKDLQDV-LKCC 304
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-34
Identities = 72/220 (32%), Positives = 110/220 (50%), Gaps = 21/220 (9%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+G G FG V+ T VA+K + +M F E V+ LQH LV L
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 408 -EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466
E ++ E++ GSL D L + S +A+IA G+ F+ +H D
Sbjct: 254 KEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRD 309
Query: 467 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FPY--ADPEYHRTGV 523
L+ NIL+ + L KI DFG+ R++ ++ Y TA +G+ FP PE G
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNE-Y-------TAREGAKFPIKWTAPEAINFGS 361
Query: 524 LTPKSDSYSFGLIILQLLT-GRLPV-GLAG-EVRRAVSCG 560
T KSD +SFG+++++++T GR+P G++ EV RA+ G
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 408
+G+G FG V G+ G VA+K + + F E V+++L+H +LV LLG E
Sbjct: 200 TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 409 AWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
+Y EY+ GSL D L R S L + + ++ + +L VH
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHR 313
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTGV 523
DL +N+L+ + +K+ DFG+ + + G P PE R
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----------GKLPVKWTAPEALREKK 362
Query: 524 LTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
+ KSD +SFG+++ ++ + GR+P + +V V G
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402
|
| >1t1h_A Gspef-atpub14, armadillo repeat containing protein; ubiquitin ligase, E3 ligase, U-BOX,; NMR {Arabidopsis thaliana} SCOP: g.44.1.2 Length = 78 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 1e-34
Identities = 28/68 (41%), Positives = 39/68 (57%)
Query: 618 VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHAL 677
P +F CPI E+M DP + + G TYE +I+ WL+ G +T P + L H LTPN+ L
Sbjct: 5 FPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVL 64
Query: 678 RHAIQDWL 685
+ I W
Sbjct: 65 KSLIALWC 72
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 79/283 (27%), Positives = 123/283 (43%), Gaps = 34/283 (12%)
Query: 349 KVGQGGFGCVYKGEMLGR-----TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
+G+G FG VY GE + + AIK L MQ F +E ++ L HP+++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 403 LGACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
+G L + Y+ +G L F +S KD ++A G+ +L + +
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQ--FIRSPQRNPTVKDLISFGLQVARGMEYL-AEQ- 143
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADP 516
K VH DL +N +LD + K+ DFG+ R + + Y HR P A
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR----HARLPVKWTA-L 197
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDW 573
E +T T KSD +SFG+++ +LLT G P + ++ ++ G+ L
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR---RLPQ----- 249
Query: 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 616
P + L + QC E RP LV E+EQ+ A
Sbjct: 250 PEYCPDSLYQVMQQCWEADPAVRPTFR-VLVGEVEQIVSALLG 291
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 30/276 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRT--VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G G +G VY+G + VA+K L M+ + EF +E V+ +++HP+LV LLG C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 407 PEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
+ E++ G+L D L R+ N + +A +I+S + +L K +H
Sbjct: 79 TREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL-EKK--NFIH 134
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTG 522
DL +N L+ K+ DFG+ RL+T DT Y FP PE
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAH------AGAKFPIKWTAPESLAYN 187
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPTFVAR 579
+ KSD ++FG+++ ++ T G P G+ +V + ++ P
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMER-----PEGCPE 239
Query: 580 RLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 615
++ +L C + +RP + + E +
Sbjct: 240 KVYELMRACWQWNPSDRPSFA-EIHQAFETMFQESS 274
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 75/275 (27%), Positives = 125/275 (45%), Gaps = 30/275 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
++G G FG V G+ G+ VA+KM+ +M EF QE + + KL HP LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 408 EAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
+ + + V EY+ NG L + L +S+ L + ++ G+ FL S + +H
Sbjct: 74 KEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHR 128
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTGV 523
DL +N L+D +L K+ DFG+ R V +D ++ FP + PE
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-------SSVGTKFPVKWSAPEVFHYFK 181
Query: 524 LTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPTFVARR 580
+ KSD ++FG+++ ++ + G++P EV VS G L P +
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH---RLYR-----PHLASDT 233
Query: 581 LVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 615
+ + C +RP L+ +E L ++
Sbjct: 234 IYQIMYSCWHELPEKRPTFQ-QLLSSIEPLREKDK 267
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
+G GG V+ R VA+K+L + + L F++E + + L HP +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 404 ------GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
+V EY+ +L+D + + P+ K + A+ L F H +
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN 135
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
I+H D+KP NI++ + + K+ DFGI R + + S ++ A G+ Y PE
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG---NSVTQTAAVIGTAQYLSPE 189
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
R + +SD YS G ++ ++LTG P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTL- 402
VG+GG G VY+ E + R VA+K++ S + + Q+E R +LQ PH+V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 403 -LGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRA-RIAAEIASGLCFLHSSKPE 460
G + + L L R+ ++P RA I +I S L H++
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAP----PRAVAIVRQIGSALDAAHAAG-- 154
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK---GSFPYADPE 517
H D+KP+NIL+ ++ + + DFGI T++ L T G+ Y PE
Sbjct: 155 -ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL--------TQLGNTVGTLYYMAPE 205
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
T ++D Y+ ++ + LTG P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 408
+G+G FG V G+ G VA+K + + F E V+++L+H +LV LLG E
Sbjct: 28 TIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 409 AWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
+Y EY+ GSL D L R S L + + ++ + +L VH
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL-EGN--NFVHR 141
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY---ADPEYHRTG 522
DL +N+L+ + +K+ DFG+ + + T G P A PE R
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASS-----------TQDTGKLPVKWTA-PEALREK 189
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLP 546
+ KSD +SFG+++ ++ + GR+P
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-34
Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 26/212 (12%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGACP 407
G GGFG V + G VAIK E + E++++ KL HP++V+ P
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR-EVP 81
Query: 408 EAWS---------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
+ L EY G L+ L + N L + ++I+S L +LH ++
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 459 PEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
I+H DLKP+NI+L KI D G + + + L F G+ Y
Sbjct: 142 ---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEF------VGTLQYLA 191
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 547
PE T D +SFG + + +TG P
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 23/221 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 406
++G G FG V+ G L + VAIK + M + +F +E V+ KL HP LV L G C
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 407 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
LV E++ +G L D + ++ + + ++ G+ +L + ++H
Sbjct: 74 EQAPICLVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEYHRTG 522
DL +N L+ K+ DFG+ R V +D ++ FP + PE
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-------SSTGTKFPVKWAS-PEVFSFS 180
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
+ KSD +SFG+++ ++ + G++P + EV +S G
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 21/220 (9%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 406
++G G FG V G+ G+ VAIKM+ +M EF +E +V+ L H LV L G C
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 407 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
++ EY+ NG L + + + + + ++ + +L S ++ +H
Sbjct: 90 KQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHR 144
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTGV 523
DL +N L++ + K+ DFG+ R V +D ++ FP + PE
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-------SSVGSKFPVRWSPPEVLMYSK 197
Query: 524 LTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
+ KSD ++FG+++ ++ + G++P E ++ G
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 349 KVGQGGFGCVYKGEMLGRT-----VAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTL 402
+G+G FG VY+G VA+K +F E ++ L HPH+V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 403 LGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+G E ++ E P G L L + N + L + +I + +L S
Sbjct: 79 IGIIEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 133
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEY 518
VH D+ +NIL+ S K+ DFG+ R + ++ Y A P + PE
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-------KASVTRLPIKWMS-PES 185
Query: 519 HRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
T SD + F + + ++L+ G+ P L +V + G
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 71/281 (25%), Positives = 113/281 (40%), Gaps = 35/281 (12%)
Query: 349 KVGQGGFGCVYKGEMLGR-----TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTL 402
+G+G FG V++G + VAIK + +F QE + + HPH+V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 403 LGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+G ++ E G L+ L + L A ++++ L +L SK +
Sbjct: 82 IGVITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL-ESK--R 136
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEY 518
VH D+ +N+L+ S K+ DFG+ R + + T Y A KG P A PE
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-------KASKGKLPIKWMA-PES 188
Query: 519 HRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPT 575
T SD + FG+ + ++L G P G+ +V + G+ L P
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPM-----PP 240
Query: 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 616
L L +C RP T L +L + E+
Sbjct: 241 NCPPTLYSLMTKCWAYDPSRRPRFT-ELKAQLSTILEEEKA 280
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 45/292 (15%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
++G+G FG V+ E VA+K L + + +FQ+E +L+ LQH H+V
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 402 LLGACPEA--WSLVYEYLPNGSLQDRL-------------FRKSNVSPLLWKDRARIAAE 446
G C + +V+EY+ +G L L + L IA++
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 506
IASG+ +L +S+ VH DL +N L+ + L KI DFG+ R V Y R
Sbjct: 142 IASGMVYL-ASQ--HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY-----RVGG 193
Query: 507 PKGSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGK 561
P + PE T +SD +SFG+I+ ++ T G+ P L+ EV ++ G+
Sbjct: 194 -HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 252
Query: 562 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVA 613
+L+ P + + D+ L C + ++R +I + K L L A
Sbjct: 253 ---VLER-----PRVCPKEVYDVMLGCWQREPQQRLNIK-EIYKILHALGKA 295
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 62/290 (21%), Positives = 114/290 (39%), Gaps = 42/290 (14%)
Query: 349 KVGQGGFGCVYKGEMLGR-----TVAIKML--YSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
+G+G FG V +G + VA+K + + + + EF E + HP+++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 402 LLGAC----PEAWSLVY---EYLPNGSLQD--RLFR-KSNVSPLLWKDRARIAAEIASGL 451
LLG C + ++ G L R ++ + + + +IA G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
+L S++ +H DL +N +L +++ + DFG+ + + Y R
Sbjct: 161 EYL-SNR--NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY-----RQGR-IAKM 211
Query: 512 P---YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSI 565
P A E V T KSD ++FG+ + ++ T G P G+ E+ + G
Sbjct: 212 PVKWIA-IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR--- 267
Query: 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 615
L P L ++ C +RP + L +LE+L +
Sbjct: 268 LKQ-----PEDCLDELYEIMYSCWRTDPLDRPTFS-VLRLQLEKLLESLP 311
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 405
+G+GGFG V++ + + AIK + N + E +EV+ L+KL+HP +V A
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 406 CPEAWS--------------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 451
E + + + +L+D + + + I +IA +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT------LYLPSFHRST 505
FLHS + ++H DLKP NI + K+ DFG+ + +D +P++ R T
Sbjct: 132 EFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 506 APKGSFPYADPE------YHRTGVLTPKSDSYSFGLIILQLLT 542
G+ Y PE Y + K D +S GLI+ +LL
Sbjct: 189 GQVGTKLYMSPEQIHGNSY------SHKVDIFSLGLILFELLY 225
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 72/294 (24%), Positives = 121/294 (41%), Gaps = 46/294 (15%)
Query: 349 KVGQGGFGCVYKGEMLGR-------TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
++G+G FG V+ E VA+K L + + +FQ+E +L+ LQH H+V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 402 LLGACPEA--WSLVYEYLPNGSLQDRL------------FRKSNVSPLLWKDRARIAAEI 447
G C E +V+EY+ +G L L PL +A+++
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 448 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP 507
A+G+ +L + VH DL +N L+ L KI DFG+ R + Y R
Sbjct: 168 AAGMVYL-AGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY-----RVGG- 218
Query: 508 KGSFP---YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGK 561
+ P PE T +SD +SFG+++ ++ T G+ P L+ E ++ G+
Sbjct: 219 RTMLPIRWMP-PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277
Query: 562 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 615
L+ P + + C + ++R I + L+ L A
Sbjct: 278 ---ELER-----PRACPPEVYAIMRGCWQREPQQRHSIK-DVHARLQALAQAPP 322
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKL-QHPHL 399
+G G FG V + G TVA+KML S ++ + E++VLS L H ++
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 400 VTLLGAC--PEAWSLVYEYLPNGSLQDRL---------------FRKSNVSPLLWKDRAR 442
V LLGAC ++ EY G L + L + + L +D
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502
+ ++A G+ FL +SK +H DL +NILL +KICDFG+ R + D+ Y+
Sbjct: 150 FSYQVAKGMAFL-ASK--NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK-- 204
Query: 503 RSTAPKGSFPY---ADPEYHRTGVLTPKSDSYSFG 534
P A PE V T +SD +S+G
Sbjct: 205 ----GNARLPVKWMA-PESIFNCVYTFESDVWSYG 234
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 60/228 (26%), Positives = 93/228 (40%), Gaps = 34/228 (14%)
Query: 343 NFSESFKVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLV 400
+F E +GQG FG V K + R AIK + + EV +L+ L H ++V
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQYVV 65
Query: 401 TLLGACPEAWS---------------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRA-RIA 444
A E + + EY NG+L D + ++ +D R+
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ---RDEYWRLF 122
Query: 445 AEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRS 504
+I L ++HS + I+H DLKP NI +D + KI DFG+ + V L ++
Sbjct: 123 RQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 505 TAPK--------GSFPYADPE-YHRTGVLTPKSDSYSFGLIILQLLTG 543
G+ Y E TG K D YS G+I +++
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 26/226 (11%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVT 401
+G G FG VYKG + VAIK L E E V++ + +PH+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 402 LLGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
LLG C L+ + +P G L D + + + + + +IA G+ +L
Sbjct: 82 LLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLED---R 136
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPE 517
++VH DL +N+L+ + KI DFG+ +L+ + A G P A E
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY------HAEGGKVPIKWMA-LE 189
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
+ T +SD +S+G+ + +L+T G P G+ E+ + G
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 35/211 (16%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKL-QHPHL 399
+G G FG V + G VA+KML + + + E++++S L QH ++
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 400 VTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNV-----------SPLLWKDRARIAAE 446
V LLGAC ++ EY G L + L RKS V S +D +++
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 506
+A G+ FL +SK +H D+ +N+LL + +KI DFG+ R + D+ Y+
Sbjct: 173 VAQGMAFL-ASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK------ 223
Query: 507 PKGSFPY---ADPEYHRTGVLTPKSDSYSFG 534
P A PE V T +SD +S+G
Sbjct: 224 GNARLPVKWMA-PESIFDCVYTVQSDVWSYG 253
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 65/285 (22%), Positives = 113/285 (39%), Gaps = 40/285 (14%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLG 404
+G G +G K G+ + K L +M + EV +L +L+HP++V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 405 ACPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRA-RIAAEIASGLCFLHSSKP 459
+ + +V EY G L + + + L ++ R+ ++ L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 460 E--KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
++H DLKP N+ LD + + K+ DFG+ R++ DT + +F G+ Y PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF------VGTPYYMSPE 186
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP------VGLAGEVRRAVSCGKLSSILDPLAG 571
KSD +S G ++ +L P LAG++R GK I
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE----GKFRRI------ 236
Query: 572 DWPTFVARRLVDLGLQCCELYGRERPDIT-----PSLVKELEQLH 611
P + L ++ + L RP + P +++ H
Sbjct: 237 --PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH 279
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 78/320 (24%), Positives = 125/320 (39%), Gaps = 50/320 (15%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
+G G FG V+KG + V IK++ Q + + L H H+V
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 402 LLGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
LLG CP + LV +YLP GSL D + + + L + +IA G+ +L
Sbjct: 80 LLGLCPGSSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYLEE---H 134
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPE 517
+VH +L +N+LL S ++ DFG+ L+ D + P A E
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ------LLYSEAKTPIKWMA-LE 187
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWP 574
G T +SD +S+G+ + +L+T G P GL EV + G+ L P
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE---RLAQ-----P 239
Query: 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER---------------PVP 619
+ + ++C + RP L E ++ R P P
Sbjct: 240 QICTIDVYMVMVKCWMIDENIRPTFK-ELANEFTRMARDPPRYLVIKRESGPGIAPGPEP 298
Query: 620 SFFLCPILQEIMHDPQVAAD 639
L+E+ +P++ D
Sbjct: 299 HGLTNKKLEEVELEPELDLD 318
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 70/278 (25%), Positives = 122/278 (43%), Gaps = 34/278 (12%)
Query: 349 KVGQGGFGCVYKGEMLGR-----TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
+G+G FGCVY G +L A+K L ++ +F E ++ HP++++L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 403 LGACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
LG C + Y+ +G L++ F ++ KD ++A G+ +L +SK
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL-ASK- 147
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADP 516
K VH DL +N +LD + + K+ DFG+ R + + Y P A
Sbjct: 148 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT----GAKLPVKWMA-L 201
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDW 573
E +T T KSD +SFG+++ +L+T G P + ++ + G+ L
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---LLQ----- 253
Query: 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611
P + L ++ L+C RP + LV + +
Sbjct: 254 PEYCPDPLYEVMLKCWHPKAEMRPSFS-ELVSRISAIF 290
|
| >2f42_A STIP1 homology and U-box containing protein 1; chaperone; 2.50A {Danio rerio} PDB: 2c2v_S 2oxq_C Length = 179 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 24/139 (17%), Positives = 53/139 (38%), Gaps = 5/139 (3%)
Query: 552 EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL- 610
E R + + + + + + R+ + + ++++L
Sbjct: 32 EKRISQENELHAYLSKLILAEKERELDDRVKQSDDSQNGGDISKMKSKHDKYLMDMDELF 91
Query: 611 ----HVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRL 666
++R +P + I E+M +P + G TY+ K I + L+ P+T L
Sbjct: 92 SQVDEKRKKREIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPL 151
Query: 667 SHLHLTPNHALRHAIQDWL 685
+ L PN A++ I ++
Sbjct: 152 TQDQLIPNLAMKEVIDAFI 170
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 68/291 (23%), Positives = 117/291 (40%), Gaps = 43/291 (14%)
Query: 349 KVGQGGFGCVYKGEMLGR-----TVAIKMLYSHNMQGQ--LEFQQEVRVLSKLQHPHLVT 401
+G+G FG V + ++ VA+KML + + EF +E + + HPH+
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 402 LLGAC----PEAWS----LVYEYLPNGSLQD--RLFRKS-NVSPLLWKDRARIAAEIASG 450
L+G + ++ ++ +G L R N L + R +IA G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS 510
+ +L SS+ +H DL +N +L +++ + DFG+ R + Y R
Sbjct: 150 MEYL-SSR--NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-----RQGC-ASK 200
Query: 511 FP---YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSS 564
P A E + T SD ++FG+ + +++T G+ P G+ E+ + G
Sbjct: 201 LPVKWLA-LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR-- 257
Query: 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 615
L P + DL QC ++RP T L ELE +
Sbjct: 258 -LKQ-----PPECMEEVYDLMYQCWSADPKQRPSFT-CLRMELENILGHLS 301
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 72/305 (23%), Positives = 128/305 (41%), Gaps = 42/305 (13%)
Query: 349 KVGQGGFGCVYKGEMLGR-------TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLV 400
+G G FG VY+G++ G VA+K L + Q +L+F E ++SK H ++V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 401 TLLGACPEA--WSLVYEYLPNGSLQD----RLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
+G ++ ++ E + G L+ R S S L D +A +IA G +L
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
+H D+ +N LL KI DFG+ R + + Y
Sbjct: 157 -EEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY------RKGGCAML 207
Query: 512 P--YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSIL 566
P + PE G+ T K+D++SFG+++ ++ + G +P + EV V+ G +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR---M 264
Query: 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE--RPVPSFFLC 624
DP P + + QC + +RP+ +++ +E +
Sbjct: 265 DP-----PKNCPGPVYRIMTQCWQHQPEDRPNFA-IILERIEYCTQDPDVINTALPIEYG 318
Query: 625 PILQE 629
P+++E
Sbjct: 319 PLVEE 323
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 38/214 (17%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPHL 399
+G+G FG V + + G RTVA+KML + E+++L + H ++
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 400 VTLLGACPEA---WSLVYEYLPNGSLQDRL-------------FRKSNVSPLLWKDRARI 443
V LLGAC + ++ E+ G+L L L +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 444 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503
+ ++A G+ FL +S+ K +H DL +NILL + KICDFG+ R + +D Y
Sbjct: 154 SFQVAKGMEFL-ASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-----V 205
Query: 504 STAPKGSFPY---ADPEYHRTGVLTPKSDSYSFG 534
P A PE V T +SD +SFG
Sbjct: 206 RKG-DARLPLKWMA-PETIFDRVYTIQSDVWSFG 237
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 72/281 (25%), Positives = 115/281 (40%), Gaps = 34/281 (12%)
Query: 349 KVGQGGFGCVYKGEMLGR-----TVAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVTL 402
+G G G V G + VAIK L + + Q +F E ++ + HP+++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 403 LGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
G V EY+ NGSL F +++ + + +G+ +L S
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYL-SDL-- 170
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPE 517
VH DL +N+L+DS L K+ DFG+ R++ +D T G P A PE
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA-----YTTTGGKIPIRWTA-PE 224
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWP 574
+ SD +SFG+++ ++L G P + +V +V G L P
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY---RLPA-----P 276
Query: 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 615
L L L C +RP + +V L+ L + E
Sbjct: 277 MGCPHALHQLMLDCWHKDRAQRPRFS-QIVSVLDALIRSPE 316
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 66/225 (29%), Positives = 108/225 (48%), Gaps = 25/225 (11%)
Query: 349 KVGQGGFGCVYKGEMLGR----TVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTL 402
++G G FG V KG + TVA+K+L + L E E V+ +L +P++V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 403 LGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+G C E+W LV E G L L + +V K+ + +++ G+ +L
Sbjct: 84 IGICEAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYL-EES--N 137
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEY 518
VH DL +N+LL ++ +KI DFG+ + + D Y G +P YA PE
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-----KAQTHGKWPVKWYA-PEC 191
Query: 519 HRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
+ KSD +SFG+++ + + G+ P G+ G EV + G
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 63/220 (28%), Positives = 91/220 (41%), Gaps = 44/220 (20%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLV 400
+G+G FG V K TVA+KML + +L + E VL ++ HPH++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 401 TLLGAC--PEAWSLVYEYLPNGSLQDRL---------------------FRKSNVSPLLW 437
L GAC L+ EY GSL+ L + L
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 438 KDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497
D A +I+ G+ +L + K+VH DL +NIL+ KI DFG+ R V E+ Y
Sbjct: 150 GDLISFAWQISQGMQYL-AEM--KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 498 LPSFHRSTAPKGSFP---YADPEYHRTGVLTPKSDSYSFG 534
+ +G P A E + T +SD +SFG
Sbjct: 207 -----VKRS-QGRIPVKWMA-IESLFDHIYTTQSDVWSFG 239
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-31
Identities = 71/305 (23%), Positives = 115/305 (37%), Gaps = 63/305 (20%)
Query: 349 KVGQGGFGCVYKGEMLGR-----TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTL 402
+G+G FG V++G + VAIK + +F QE + + HPH+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 403 LGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+G ++ E G L+ L + L A ++++ L +L SK +
Sbjct: 457 IGVITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL-ESK--R 511
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEY 518
VH D+ +N+L+ S K+ DFG+ R + + T Y A KG P A PE
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-------KASKGKLPIKWMA-PES 563
Query: 519 HRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPT 575
T SD + FG+ + ++L G P G+ +V + G+
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------------- 609
Query: 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQL---HVAEERPVPSF-FLCPILQEIM 631
RL P P + L + R P F L L I+
Sbjct: 610 ----RL-------------PMPPNCPPTLYSLMTKCWAYDPSRR--PRFTELKAQLSTIL 650
Query: 632 HDPQV 636
+ ++
Sbjct: 651 EEEKL 655
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 23/224 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRT----VAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTLL 403
++G G FG V +G R VAIK+L + E +E +++ +L +P++V L+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 404 GACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
G C EA LV E G L L + + A + +++ G+ +L K
Sbjct: 77 GVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL-EEK--NF 131
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEYH 519
VH DL +N+LL + +KI DFG+ + + D Y + G +P YA PE
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-----TARSAGKWPLKWYA-PECI 185
Query: 520 RTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
+ +SD +S+G+ + + L+ G+ P + G EV + G
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 349 KVGQGGFGCVYKGEMLGRT-----VAIKMLYSHNMQGQL---EFQQEVRVLSKLQHPHLV 400
K+G G FG V +GE + VA+K L + +F +EV + L H +L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 401 TLLGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
L G +V E P GSL DRL + + L +R A ++A G+ +L S
Sbjct: 85 RLYGVVLTPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYLES--- 139
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLV-TEDTLYLPSFHRSTAPKGSFP---YAD 515
++ +H DL +N+LL + KI DFG+ R + D Y P A
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY------VMQEHRKVPFAWCA- 192
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
PE +T + SD++ FG+ + ++ T G+ P
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 72/302 (23%), Positives = 126/302 (41%), Gaps = 51/302 (16%)
Query: 349 KVGQGGFGCVYKGEMLG---------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKL-QHP 397
+G+G FG V E +G TVA+KML + + E+ ++ + +H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 398 HLVTLLGAC--PEAWSLVYEYLPNGSLQDRL-------------FRKSNVSPLLWKDRAR 442
+++ LLGAC ++ EY G+L++ L + + +KD
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502
++A G+ +L +S+ K +H DL +N+L+ KI DFG+ R + Y
Sbjct: 162 CTYQLARGMEYL-ASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----- 213
Query: 503 RSTAPKGSFPY---ADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRA 556
+ T G P A PE V T +SD +SFG+++ ++ T G P G+ E+ +
Sbjct: 214 KKTT-NGRLPVKWMA-PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 557 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 616
+ G +D P L + C +RP LV++L+++
Sbjct: 272 LKEGHR---MDK-----PANCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRILTLTTN 322
Query: 617 PV 618
Sbjct: 323 EE 324
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 30/206 (14%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLV 400
++GQG FG VY+G G VAIK + + +M+ ++EF E V+ + H+V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 401 TLLGACPEA--WSLVYEYLPNGSLQD-------RLFRKSNVSPLLWKDRARIAAEIASGL 451
LLG + ++ E + G L+ + ++P ++A EIA G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
+L+++ K VH DL +N ++ + + KI DFG+ R + E Y R KG
Sbjct: 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-----RKGG-KGLL 202
Query: 512 PY---ADPEYHRTGVLTPKSDSYSFG 534
P + PE + GV T SD +SFG
Sbjct: 203 PVRWMS-PESLKDGVFTTYSDVWSFG 227
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 351 GQGGFGCVYKGEML--GRTVAIKMLY-----SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G+G FG VY +A+K+L+ ++ QL ++EV + S L+HP+++ L
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL--RREVEIQSHLRHPNILRLY 75
Query: 404 G--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPE 460
G L+ EY P G++ L + S R E+A+ L + HS +
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANALSYCHS---K 128
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
+++H D+KP+N+LL S KI DFG ++ PS R+ G+ Y PE
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLC-GTLDYLPPEMIE 180
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLP 546
+ K D +S G++ + L G+ P
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 37/212 (17%)
Query: 351 GQGGFGCVYKGEML--GRTVAIKMLY-----SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G+GGF ++ A K++ + + ++ E+ + L H H+V
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKM--SMEISIHRSLAHQHVVGFH 81
Query: 404 GACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKP 459
G E V+ E SL + R+ ++ AR +I G +LH
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEARYYLRQIVLGCQYLHR--- 133
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
+++H DLK N+ L+ +L KI DFG+ V D + G+ Y PE
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG----ERKKVLC--GTPNYIAPE-- 185
Query: 520 RTGVLT-----PKSDSYSFGLIILQLLTGRLP 546
VL+ + D +S G I+ LL G+ P
Sbjct: 186 ---VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 52/235 (22%), Positives = 88/235 (37%), Gaps = 38/235 (16%)
Query: 349 KVGQGGFGCVYKGEMLGR---------TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL 399
+GQG F ++KG V +K+L + F + ++SKL H HL
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 400 VTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
V G C + LV E++ GSL + K N + + + +A ++A+ + FL
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDT--YLKKNKNCINILWKLEVAKQLAAAMHFL-EE 131
Query: 458 KPEKIVHGDLKPQNILLDSELSS--------KICDFGICRLVTEDTLY-LPSFHRSTAPK 508
++HG++ +NILL E K+ D GI V + P+
Sbjct: 132 N--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI--PWVPPE 187
Query: 509 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
L +D +SFG + ++ + G P L +
Sbjct: 188 -CIEN-------PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-31
Identities = 72/306 (23%), Positives = 129/306 (42%), Gaps = 44/306 (14%)
Query: 349 KVGQGGFGCVYKGEMLGR-------TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLV 400
+G G FG VY+G++ G VA+K L + Q +L+F E ++SK H ++V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 401 TLLGACPEA--WSLVYEYLPNGSLQDRLFRKS-----NVSPLLWKDRARIAAEIASGLCF 453
+G ++ ++ E + G L+ L R++ S L D +A +IA G +
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGS 510
L +H D+ +N LL KI DFG+ R + Y
Sbjct: 197 L-EEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY------RKGGCAM 247
Query: 511 FP--YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSI 565
P + PE G+ T K+D++SFG+++ ++ + G +P + EV V+ G
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR--- 304
Query: 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE--RPVPSFFL 623
+DP P + + QC + +RP+ +++ +E +
Sbjct: 305 MDP-----PKNCPGPVYRIMTQCWQHQPEDRPNFA-IILERIEYCTQDPDVINTALPIEY 358
Query: 624 CPILQE 629
P+++E
Sbjct: 359 GPLVEE 364
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-31
Identities = 81/382 (21%), Positives = 151/382 (39%), Gaps = 38/382 (9%)
Query: 250 MRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRG 309
M + + RRR + + + S I +
Sbjct: 1 MSPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGI--CSIEELSTSLYKKAGSENLYF 58
Query: 310 QAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGR--- 366
Q + L +L ++ + + + +F+E +G+G FGCVY G +L
Sbjct: 59 QGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGK 116
Query: 367 --TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVY---EYLPNG 420
A+K L ++ +F E ++ HP++++LLG C + Y+ +G
Sbjct: 117 KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 176
Query: 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480
L++ F ++ KD ++A G+ FL +SK K VH DL +N +LD + +
Sbjct: 177 DLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL-ASK--KFVHRDLAARNCMLDEKFTV 231
Query: 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEYHRTGVLTPKSDSYSFGLII 537
K+ DFG+ R + + + +++ P A E +T T KSD +SFG+++
Sbjct: 232 KVADFGLARDMYDKE-FDSVHNKT---GAKLPVKWMA-LESLQTQKFTTKSDVWSFGVLL 286
Query: 538 LQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGR 594
+L+T G P + ++ + G+ L P + L ++ L+C
Sbjct: 287 WELMTRGAPPYPDVNTFDITVYLLQGRR---LLQ-----PEYCPDPLYEVMLKCWHPKAE 338
Query: 595 ERPDITPSLVKELEQLHVAEER 616
RP + LV + +
Sbjct: 339 MRPSFS-ELVSRISAIFSTFIG 359
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 44/220 (20%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKL-QHPHL 399
+G G FG V G VA+KML + + E++++++L H ++
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 400 VTLLGAC--PEAWSLVYEYLPNGSLQD--------------------RLFRKSNVSPLLW 437
V LLGAC L++EY G L + RL + +++ L +
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 438 KDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497
+D A ++A G+ FL K VH DL +N+L+ KICDFG+ R + D+ Y
Sbjct: 172 EDLLCFAYQVAKGMEFL-EFK--SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 498 LPSFHRSTAPKGSFPY---ADPEYHRTGVLTPKSDSYSFG 534
+ P A PE G+ T KSD +S+G
Sbjct: 229 VVR------GNARLPVKWMA-PESLFEGIYTIKSDVWSYG 261
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-31
Identities = 50/216 (23%), Positives = 87/216 (40%), Gaps = 24/216 (11%)
Query: 343 NFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLV 400
+F +G G G + M R VA+K + +EV++L + +HP+++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSF---ADREVQLLRESDEHPNVI 81
Query: 401 TLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
+ + E +LQ+ + +K L + + + SGL LHS
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 459 PEKIVHGDLKPQNILL-----DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 513
IVH DLKP NIL+ ++ + I DFG+C+ + SF R + G+ +
Sbjct: 139 ---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR---HSFSRRSGVPGTEGW 192
Query: 514 ADPEY---HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE T D +S G + +++
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 28/210 (13%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLG 404
K+G+G FG + GR IK + M + + E ++EV VL+ ++HP++V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 405 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
+ E SL V +Y G L R+ +I L +H KI
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHD---RKI 146
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE----- 517
+H D+K QNI L + + ++ DFGI R++ + G+ Y PE
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC------IGTPYYLSPEICENK 200
Query: 518 -YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y KSD ++ G ++ +L T +
Sbjct: 201 PY------NNKSDIWALGCVLYELCTLKHA 224
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 75/306 (24%), Positives = 132/306 (43%), Gaps = 51/306 (16%)
Query: 349 KVGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHP 397
+G+G FG V E +G VA+KML S + L + E+ ++ + +H
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 398 HLVTLLGAC--PEAWSLVYEYLPNGSLQD--RLFRKSNV-----------SPLLWKDRAR 442
+++ LLGAC ++ EY G+L++ + R + L KD
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502
A ++A G+ +L +SK K +H DL +N+L+ + KI DFG+ R + Y
Sbjct: 196 CAYQVARGMEYL-ASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----- 247
Query: 503 RSTAPKGSFPY---ADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRA 556
+ T G P A PE + T +SD +SFG+++ ++ T G P G+ E+ +
Sbjct: 248 KKTT-NGRLPVKWMA-PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 557 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 616
+ G +D P+ L + C +RP LV++L+++
Sbjct: 306 LKEGHR---MDK-----PSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRIVALTSN 356
Query: 617 PVPSFF 622
++
Sbjct: 357 QEMGYY 362
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 76/285 (26%), Positives = 127/285 (44%), Gaps = 39/285 (13%)
Query: 349 KVGQGGFGCVYKGEMLGRT------VAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVT 401
+G G FG VYKG + + VAIK L + + Q ++F E ++ + H +++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 402 LLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
L G + + + EY+ NG+L F + + IA+G+ +L ++
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKYL-ANM- 166
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTED--TLYLPSFHRSTAPKGSFP---YA 514
VH DL +NIL++S L K+ DFG+ R++ +D Y T G P A
Sbjct: 167 -NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY-------TTSGGKIPIRWTA 218
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAG 571
PE T SD +SFG+++ +++T G P L+ EV +A++ G L
Sbjct: 219 -PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF---RLPT--- 271
Query: 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 616
P + L +QC + RP +V L++L A +
Sbjct: 272 --PMDCPSAIYQLMMQCWQQERARRPKFA-DIVSILDKLIRAPDS 313
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 27/206 (13%)
Query: 351 GQGGFGCVYKGEML--GRTVAIKMLY-----SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G+G FG VY +A+K+L+ ++ QL ++E+ + S L+HP+++ +
Sbjct: 23 GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL--RREIEIQSHLRHPNILRMY 80
Query: 404 G--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPE 460
+ L+ E+ P G L L + R+ E+A L + H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE----QRSATFMEELADALHYCHE---R 133
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
K++H D+KP+N+L+ + KI DFG PS R T G+ Y PE
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHA-------PSLRRRTMC-GTLDYLPPEMIE 185
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLP 546
K D + G++ + L G P
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 60/240 (25%), Positives = 100/240 (41%), Gaps = 35/240 (14%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
+G GGFG V+K + G+T IK + +N + ++EV+ L+KL H ++V G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCW 73
Query: 407 PEAWS------------------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIA 448
+ E+ G+L+ + K L + +I
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQIT 132
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 508
G+ ++HS +K+++ DLKP NI L KI DFG+ + D R+ + K
Sbjct: 133 KGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK------RTRS-K 182
Query: 509 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDP 568
G+ Y PE + + D Y+ GLI+ +LL + + G +S I D
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDK 242
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 36/212 (16%)
Query: 349 KVGQGGFGCVYKGEMLGR-------TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLV 400
++G+ FG VYKG + G VAIK L + EF+ E + ++LQHP++V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 401 TLLGACPEA--WSLVYEYLPNGSLQDRL-------------FRKSNVSPLLWKDRARIAA 445
LLG + S+++ Y +G L + L ++ S L D + A
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505
+IA+G+ +L SS +VH DL +N+L+ +L+ KI D G+ R V Y +
Sbjct: 136 QIAAGMEYL-SSH--HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY-----KLL 187
Query: 506 APKGSFP---YADPEYHRTGVLTPKSDSYSFG 534
P A PE G + SD +S+G
Sbjct: 188 G-NSLLPIRWMA-PEAIMYGKFSIDSDIWSYG 217
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 53/212 (25%), Positives = 85/212 (40%), Gaps = 37/212 (17%)
Query: 351 GQGGFGCVYKGEML--GRTVAIKM-----LYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G+GGF ++ A K+ L + + ++ E+ + L H H+V
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKM--SMEISIHRSLAHQHVVGFH 107
Query: 404 GACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKP 459
G E V+ E SL + R+ ++ AR +I G +LH
Sbjct: 108 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEARYYLRQIVLGCQYLHR--- 159
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
+++H DLK N+ L+ +L KI DFG+ V D + G+ Y PE
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG----ERKKVLC--GTPNYIAPE-- 211
Query: 520 RTGVLT-----PKSDSYSFGLIILQLLTGRLP 546
VL+ + D +S G I+ LL G+ P
Sbjct: 212 ---VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 33/210 (15%)
Query: 349 KVGQGGFGCVYKGE---MLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL-- 402
+ GG G +Y + GR V +K L +S + + Q E + L+++ HP +V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 403 ------LGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
P + +V EY+ SL+ + L + EI L +LHS
Sbjct: 147 FVEHTDRHGDPVGY-IVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS 200
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
+V+ DLKP+NI+L E K+ D G + G+ + P
Sbjct: 201 ---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY----------GTPGFQAP 246
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E RTG T +D Y+ G + L
Sbjct: 247 EIVRTGP-TVATDIYTVGRTLAALTLDLPT 275
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 349 KVGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHP 397
+G+G FG V E +G TVA+KML + L + E+ ++ + +H
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 398 HLVTLLGAC--PEAWSLVYEYLPNGSLQDRL-------------FRKSNVSPLLWKDRAR 442
+++ LLGAC ++ EY G+L++ L + + +KD
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502
++A G+ +L +S+ K +H DL +N+L+ KI DFG+ R + Y
Sbjct: 208 CTYQLARGMEYL-ASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----- 259
Query: 503 RSTAPKGSFPY---ADPEYHRTGVLTPKSDSYSFG 534
+ T G P A PE V T +SD +SFG
Sbjct: 260 KKTT-NGRLPVKWMA-PEALFDRVYTHQSDVWSFG 292
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 64/226 (28%), Positives = 106/226 (46%), Gaps = 25/226 (11%)
Query: 349 KVGQGGFGCVYKGEMLGRT-----VAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVTL 402
VG G FG V G + + VAIK L + Q +F E ++ + HP+++ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 403 LGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
G ++ + V EY+ NGSL F + + + + IASG+ +L S
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL-SDM-- 166
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPE 517
VH DL +NIL++S L K+ DFG+ R++ +D T G P + PE
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA-----YTTRGGKIPIRWTS-PE 220
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
T SD +S+G+++ ++++ G P ++ +V +AV G
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-30
Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 23/225 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRT----VAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTLL 403
++G G FG V +G R VAIK+L + E +E +++ +L +P++V L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 404 GAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
G C EA LV E G L L + + A + +++ G+ +L K
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL-EEK--NF 457
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEYH 519
VH +L +N+LL + +KI DFG+ + + D Y + G +P YA PE
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-----TARSAGKWPLKWYA-PECI 511
Query: 520 RTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGK 561
+ +SD +S+G+ + + L+ G+ P + G EV + GK
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 556
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 38/228 (16%), Positives = 84/228 (36%), Gaps = 48/228 (21%)
Query: 351 GQGGFGCVYKGEMLGRTVAIKMLY-------------------SHNMQGQLEFQQEVRVL 391
QG F + E + A+K + + E++++
Sbjct: 40 NQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK--NELQII 97
Query: 392 SKLQHPHLVTLLGACPEAWS------LVYEYLPNGSLQDRL-----FRKSNVSPLLWKDR 440
+ +++ + +T + ++YEY+ N S+ K+ + +
Sbjct: 98 TDIKNEYCLTCE----GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 441 ARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500
I + + ++H+ K I H D+KP NIL+D K+ DFG + + +
Sbjct: 154 KCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--- 208
Query: 501 FHRSTAPKGSFPYADPE--YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ +G++ + PE + + K D +S G+ + + +P
Sbjct: 209 ----GS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 351 GQGGFGCVYKGEML--GRTVAIKMLY-----SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G+G F VY+ E + G VAIKM+ M +++ EV++ +L+HP ++ L
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQ--NEVKIHCQLKHPSILELY 77
Query: 404 GACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKP 459
E + VY E NG + L + ++ AR +I +G+ +LHS
Sbjct: 78 N-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEARHFMHQIITGMLYLHS--- 130
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
I+H DL N+LL ++ KI DFG+ + H + G+ Y PE
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH----EKHYTLC--GTPNYISPE-- 182
Query: 520 RTGVLT-----PKSDSYSFGLIILQLLTGRLP 546
+ T +SD +S G + LL GR P
Sbjct: 183 ---IATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 37/213 (17%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE--FQQEVRVLSKLQHPHLVTLLG 404
+VG+G FG V++ + G A+K + +LE +E+ + L P +V L G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVK-------KVRLEVFRVEELVACAGLSSPRIVPLYG 117
Query: 405 ACPEAWSL--VYEYLPNGSLQDRL-----FRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
A E + E L GSL + + + GL +LH+
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA--------LYYLGQALEGLEYLHT- 168
Query: 458 KPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--A 514
+I+HGD+K N+LL S+ + +CDFG + D L G+ A
Sbjct: 169 --RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI-PGT-ETHMA 224
Query: 515 DPE-YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE K D +S ++L +L G P
Sbjct: 225 -PEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHP 255
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 37/216 (17%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLL 403
K+G+G F VY+ L G VA+K + ++ +E+ +L +L HP+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 404 GACPEAWSL--VYEYLPNGSLQDRL--FRKSNVS---PLLWKDRARIAAEIASGLCFLHS 456
+ E L V E G L + F+K +WK ++ S L +HS
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK----YFVQLCSALEHMHS 154
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
+++H D+KP N+ + + K+ D G+ R + T S G+ Y P
Sbjct: 155 ---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL------VGTPYYMSP 205
Query: 517 E------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E Y KSD +S G ++ ++ + P
Sbjct: 206 ERIHENGY------NFKSDIWSLGCLLYEMAALQSP 235
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 44/220 (20%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLV 400
+G+G FG V++ G VA+KML + Q +FQ+E ++++ +P++V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 401 TLLGACPEA--WSLVYEYLPNGSLQDRL---------------------FRKSNVSPLLW 437
LLG C L++EY+ G L + L PL
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 438 KDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497
++ IA ++A+G+ +L S + K VH DL +N L+ + KI DFG+ R + Y
Sbjct: 174 AEQLCIARQVAAGMAYL-SER--KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 498 LPSFHRSTAPKGSFP---YADPEYHRTGVLTPKSDSYSFG 534
++ + P PE T +SD +++G
Sbjct: 231 -----KADG-NDAIPIRWMP-PESIFYNRYTTESDVWAYG 263
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 36/211 (17%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKML----YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
G+G F V + GR VAIK++ + +L +EVR++ L HP++V L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL--FREVRIMKILNHPNIVKLFE 81
Query: 405 --ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPEK 461
+ L+ EY G + D L + AR +I S + + H ++
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKE----KEARSKFRQIVSAVQYCHQ---KR 134
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 517
IVH DLK +N+LLD++++ KI DFG T G+ PYA PE
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK----LDAFC---GAPPYAAPELFQG 187
Query: 518 --YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y G P+ D +S G+I+ L++G LP
Sbjct: 188 KKYD--G---PEVDVWSLGVILYTLVSGSLP 213
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 18/205 (8%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
+G+G +G VY G L +AIK + + + +E+ + L+H ++V LG+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 408 EAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
E + E +P GSL L K + +I GL +LH +IVH
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHR 146
Query: 466 DLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---YHRT 521
D+K N+L+++ KI DFG + + +F G+ Y PE
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF------TGTLQYMAPEIIDKGPR 200
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
G +D +S G I+++ TG+ P
Sbjct: 201 GY-GKAADIWSLGCTIIEMATGKPP 224
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 56/216 (25%), Positives = 78/216 (36%), Gaps = 29/216 (13%)
Query: 344 FSESF----KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKL- 394
F +SF ++G G +G V+K GR A+K S + + EV K+
Sbjct: 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 395 QHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSP--LLWKDRARIAAEIASG 450
QHP V L A E L E SLQ P +W +
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWG----YLRDTLLA 169
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS 510
L LHS +VH D+KP NI L K+ DFG+ + +G
Sbjct: 170 LAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA-------GEVQEGD 219
Query: 511 FPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y PE + +D +S GL IL++
Sbjct: 220 PRYMAPELLQGS-YGTAADVFSLGLTILEVACNMEL 254
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-28
Identities = 63/265 (23%), Positives = 100/265 (37%), Gaps = 40/265 (15%)
Query: 349 KVGQGGFGCV-YKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGAC 406
+G G G V ++G GR VA+K + E+++L++ HP+++ +
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIRYYCSE 78
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE----IASGLCFLHSSKPE 460
+ E N +LQD + K+ L + IASG+ LHS
Sbjct: 79 TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 134
Query: 461 KIVHGDLKPQNILLDSELSS-------------KICDFGICRLVTEDTLYLPSFHRSTAP 507
KI+H DLKPQNIL+ + I DFG+C+ + + P
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT--NLNNP 192
Query: 508 KGSFPYADPE-------YHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSC 559
G+ + PE LT D +S G + +L+ G+ P G +
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 252
Query: 560 GKLSSILDPLAGDWPTFVARRLVDL 584
G S LD + + DL
Sbjct: 253 GIFS--LDEMKCLHDRSLIAEATDL 275
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 36/228 (15%)
Query: 337 LQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE---FQQE 387
+Q +T FS+ +K G+G FG V + G+ A+K++ ++ + + +E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 388 VRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA 445
V++L +L HP+++ L + LV E G L D + + S D ARI
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE---VDAARIIR 133
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLVTEDTLYLPSFH 502
++ SG+ ++H KIVH DLKP+N+LL+S + + +I DFG+
Sbjct: 134 QVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-------K 183
Query: 503 RSTAPKGSFPYADPEYHRTGVL----TPKSDSYSFGLIILQLLTGRLP 546
+ G+ Y PE VL K D +S G+I+ LL+G P
Sbjct: 184 KMKDKIGTAYYIAPE-----VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 35/220 (15%), Positives = 65/220 (29%), Gaps = 29/220 (13%)
Query: 349 KVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
+G+G F VY+ + +K+ N Q + L +
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMK 131
Query: 402 LLGAC--PEAWSLVYEYLPNGSLQDRL--FRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
A LV E G+L + + ++ + + A + + +H
Sbjct: 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC 191
Query: 458 KPEKIVHGDLKPQNILLDSELSS-----------KICDFGICRLVTEDTLYLPSFHRSTA 506
+ I+HGD+KP N +L + + D G D P TA
Sbjct: 192 E---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI----DMKLFPKGTIFTA 244
Query: 507 PKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ + E + D + + +L G
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 65/211 (30%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 349 KVGQGGFGCVYKGEMLG----RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPHLVTL 402
+G+G FG V K + AIK + + + +F E+ VL KL HP+++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 403 LGACPEAWSL--VYEYLPNGSLQDRLFRKSNV--------------SPLLWKDRARIAAE 446
LGAC L EY P+G+L D L RKS V S L + AA+
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 506
+A G+ +L S K + +H DL +NIL+ +KI DFG+ R +
Sbjct: 151 VARGMDYL-SQK--QFIHRDLAARNILVGENYVAKIADFGLSR----GQEV----YVKKT 199
Query: 507 PKGSFPY---ADPEYHRTGVLTPKSDSYSFG 534
G P A E V T SD +S+G
Sbjct: 200 -MGRLPVRWMA-IESLNYSVYTTNSDVWSYG 228
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 37/244 (15%), Positives = 70/244 (28%), Gaps = 60/244 (24%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQ--------- 395
+GQ + + G + + + Y + ++EV L L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 396 ----------------HPHLVTLLGACPEAWSLVY---EYLPNGSLQDRLF----RKSNV 432
++ + + W L +LQ S
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 433 SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492
L+ R ++ ++ L LH +VH L+P +I+LD + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 493 EDTLYLPSFHRSTAPKGSFPYADPEY----------HRTGVLTPKSDSYSFGLIILQLLT 542
+ +A PE H ++T D+++ GL I +
Sbjct: 263 ASAV----------SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 543 GRLP 546
LP
Sbjct: 313 ADLP 316
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-28
Identities = 68/258 (26%), Positives = 103/258 (39%), Gaps = 41/258 (15%)
Query: 337 LQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEV 388
+ + + SE ++ G G +G V AIK++ ++ + +EV
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 389 RVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE 446
VL L HP+++ L + LV E G L D + + + D A I +
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE---VDAAVIIKQ 144
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLVTEDTLYLPSFHR 503
+ SG+ +LH IVH DLKP+N+LL+S + KI DFG+ +
Sbjct: 145 VLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM------ 195
Query: 504 STAPKGSFPYADPEYHRTGVL----TPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAV 557
G+ Y PE VL K D +S G+I+ LL G P G E+ R V
Sbjct: 196 -KERLGTAYYIAPE-----VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249
Query: 558 SCGKLSSILDPLAGDWPT 575
GK + W
Sbjct: 250 EKGKYTFDSPE----WKN 263
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 37/212 (17%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKML-----YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G G FG V GE + G VA+K+L S ++ G+++ +E++ L +HPH++ L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKLY 77
Query: 404 G--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPE 460
+ P + +V EY+ G L D + + V AR + +I S + + H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVEE----MEARRLFQQILSAVDYCHR---H 130
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE--- 517
+VH DLKP+N+LLD+ +++KI DFG+ ++++ S GS YA PE
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF----LRTSC---GSPNYAAPEVIS 183
Query: 518 ---YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y G P+ D +S G+I+ LL G LP
Sbjct: 184 GRLYA--G---PEVDIWSCGVILYALLCGTLP 210
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 34/276 (12%), Positives = 66/276 (23%), Gaps = 57/276 (20%)
Query: 351 GQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLLGA 405
G V+ A+K+ + E + ++L
Sbjct: 71 RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130
Query: 406 CPEAWS----------------------------LVYEYLPNGSLQDRL----FRKSNVS 433
L+ + L+ F
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTLDFVYVFRG 189
Query: 434 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493
+ A++ L S + +VHG P N+ + + + D V
Sbjct: 190 DEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 494 DTLYLPSFHRSTAPKGSFPYADPEY--HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 551
R A YA E+ T T +++ GL I ++ LP GL
Sbjct: 247 ---------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 552 EVRRAVSCGKLSSILDPLAGDWPTFV-----ARRLV 582
+ + + + + + L+
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLI 333
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 62/238 (26%), Positives = 98/238 (41%), Gaps = 46/238 (19%)
Query: 337 LQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL-------- 382
++ ES+ G G +G V + AIK++
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 383 -----EFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPL 435
E E+ +L L HP+++ L + + LV E+ G L +++ +
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDE- 145
Query: 436 LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLVT 492
D A I +I SG+C+LH IVH D+KP+NILL++ L+ KI DFG+ +
Sbjct: 146 --CDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200
Query: 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL----TPKSDSYSFGLIILQLLTGRLP 546
+D ++ G+ Y PE VL K D +S G+I+ LL G P
Sbjct: 201 KD-------YKLRDRLGTAYYIAPE-----VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-27
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ--LEFQQEVRVLSKLQHPHLVTLLG 404
+G+G FG V K + + A+K++ + + + +EV +L KL HP+++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 405 AC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
++ +V E G L D + ++ S D ARI ++ SG+ ++H I
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE---HDAARIIKQVFSGITYMHK---HNI 142
Query: 463 VHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
VH DLKP+NILL+S+ KI DFG+ ++ + G+ Y PE
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-------TKMKDRIGTAYYIAPE-- 193
Query: 520 RTGVL----TPKSDSYSFGLIILQLLTGRLP 546
VL K D +S G+I+ LL+G P
Sbjct: 194 ---VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 50/209 (23%), Positives = 84/209 (40%), Gaps = 29/209 (13%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
+G+G +G V A K + + ++ F+QE+ ++ L HP+++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
LV E G L +R+ K D ARI ++ S + + H + H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRE---SDAARIMKDVLSAVAYCHK---LNVAH 129
Query: 465 GDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
DLKP+N L ++ K+ DFG+ + G+ Y P+
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-------RTKVGTPYYVSPQ---- 178
Query: 522 GVL----TPKSDSYSFGLIILQLLTGRLP 546
VL P+ D +S G+++ LL G P
Sbjct: 179 -VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 27/215 (12%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 405
+G G V VAIK + Q ++ +E++ +S+ HP++V+ +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 406 ---CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWK--DRARIAA---EIASGLCFLHSS 457
E W LV + L GS+ D + D + IA E+ GL +LH
Sbjct: 82 FVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK- 139
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF---PY- 513
+H D+K NILL + S +I DFG+ + + R T F P
Sbjct: 140 --NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT-----FVGTPCW 192
Query: 514 -ADPE-YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
A PE + K+D +SFG+ ++L TG P
Sbjct: 193 MA-PEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIK-MLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 405
++G G G V+K G +A K + + + +E++VL + P++V GA
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 406 --CPEAWSLVYEYLPNGSLQDRLFRKSNVS-PLLWKDRARIAAEIASGLCFLHSSKPEKI 462
S+ E++ GSL L + + +L +++ + GL +L KI
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL----GKVSIAVIKGLTYLREKH--KI 153
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
+H D+KP NIL++S K+CDFG+ + + S S G+ Y PE +
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID------SMANSFV--GTRSYMSPERLQGT 205
Query: 523 VLTPKSDSYSFGLIILQLLTGRLP 546
+ +SD +S GL ++++ GR P
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 37/244 (15%), Positives = 68/244 (27%), Gaps = 61/244 (25%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKMLYS----------------------------HNMQG 380
GQ + G + + + Y +
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 381 QLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVY---EYLPNGSLQDR---LFRKSNVSP 434
L F ++ Q ++ + + W L +LQ L S+
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 435 LL-WKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493
L R ++ ++ L LH +VH L+P +I+LD + F
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258
Query: 494 DTLYLPSFHRSTAPKGSFPYADPEY-----------HRTGVLTPKSDSYSFGLIILQLLT 542
+ S + PE R ++T D+++ GL+I +
Sbjct: 259 RVV----------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 543 GRLP 546
LP
Sbjct: 309 ADLP 312
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 35/211 (16%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKML-----YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G G FG V G+ + G VA+K+L S ++ G++ +E++ L +HPH++ L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKLY 82
Query: 404 GACPEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHS 456
+ S +V EY+ G L D + + + +R + +I SG+ + H
Sbjct: 83 ----QVISTPSDIFMVMEYVSGGELFDYICKNGRLDE----KESRRLFQQILSGVDYCHR 134
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
+VH DLKP+N+LLD+ +++KI DFG+ ++++ S GS YA P
Sbjct: 135 ---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF----LRTSC---GSPNYAAP 184
Query: 517 E-YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E P+ D +S G+I+ LL G LP
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 46/216 (21%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKM-----LYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G+G FG V + VA+K L +M ++E +E+ L L+HPH++ L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKLY 75
Query: 404 GACPEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHS 456
+ + +V EY G L D + K ++ D R +I + + H
Sbjct: 76 ----DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTE----DEGRRFFQQIICAIEYCHR 126
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
KIVH DLKP+N+LLD L+ KI DFG+ ++T+ S GS YA P
Sbjct: 127 ---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF----LKTSC---GSPNYAAP 176
Query: 517 E------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E Y G P+ D +S G+++ +L GRLP
Sbjct: 177 EVINGKLYA--G---PEVDVWSCGIVLYVMLVGRLP 207
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 49/242 (20%), Positives = 85/242 (35%), Gaps = 61/242 (25%)
Query: 343 NFSESF----KVGQGGFGCVYKGEML--GRTVAIK--MLYSHNMQGQLEFQQEVRVLSKL 394
++ F K+G G FG V+K G AIK + +EV + L
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 395 -QHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDR-ARIAAEIASG 450
QH H+V A E + EY GSL D + + + + ++ G
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLD-------------------SELSSKICDFGICRLV 491
L ++HS +VH D+KP NI + +++ KI D G +
Sbjct: 128 LRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 492 TE------DTLYLPSFHRSTAP---KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
+ D+ +L A + ++ + PK+D ++ L ++
Sbjct: 185 SSPQVEEGDSRFL-------ANEVLQENYTH-----------LPKADIFALALTVVCAAG 226
Query: 543 GR 544
Sbjct: 227 AE 228
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 28/211 (13%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 405
K+G G FG V+ E G IK + Q +E + E+ VL L HP+++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 406 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLW-KDRARIAAEIASGLCFLHSSKPEKI 462
+V E G L +R+ L A + ++ + L + HS + +
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHV 145
Query: 463 VHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
VH DLKP+NIL KI DFG+ L D T G+ Y PE
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-------TNAAGTALYMAPE-- 196
Query: 520 RTGVL----TPKSDSYSFGLIILQLLTGRLP 546
V T K D +S G+++ LLTG LP
Sbjct: 197 ---VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 49/233 (21%), Positives = 97/233 (41%), Gaps = 22/233 (9%)
Query: 324 EDLPESAEFSLADLQTATCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKMLYSHN 377
++ ++ + + + + G G FG V++ GR K + +
Sbjct: 29 FYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY 88
Query: 378 MQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPL 435
+ + E+ ++++L HP L+ L A L+ E+L G L DR+ + +
Sbjct: 89 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--M 146
Query: 436 LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS--KICDFGICRLVTE 493
+ + GL +H IVH D+KP+NI+ +++ +S KI DFG+ +
Sbjct: 147 SEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203
Query: 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
D + + + +A PE + +D ++ G++ LL+G P
Sbjct: 204 DEIVKVTT-------ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-25
Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
++G G FG V++ G A K + + + + ++E++ +S L+HP LV L A
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
++YE++ G L +++ + N + + ++ GLC +H + VH
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHEN---NYVH 278
Query: 465 GDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
DLKP+NI+ ++ S+ K+ DFG+ + + G+ +A PE
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-------GTAEFAAPEVAEGK 331
Query: 523 VLTPKSDSYSFGLIILQLLTGRLP 546
+ +D +S G++ LL+G P
Sbjct: 332 PVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 69/229 (30%), Positives = 106/229 (46%), Gaps = 34/229 (14%)
Query: 333 SLADLQTATCNFSESF----KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQ 385
L +Q + E F K+G+G FG V+KG + VAIK++ + ++E Q
Sbjct: 9 GLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ 68
Query: 386 QEVRVLSKLQHPHLVTLLGA---CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR 442
QE+ VLS+ P++ G+ + W ++ EYL GS D L PL A
Sbjct: 69 QEITVLSQCDSPYVTKYYGSYLKDTKLW-IIMEYLGGGSALDLLEPG----PLDETQIAT 123
Query: 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502
I EI GL +LHS EK +H D+K N+LL K+ DFG+ +T+
Sbjct: 124 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--------- 171
Query: 503 RSTAPKGSF---PY--ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ + +F P+ A PE + K+D +S G+ ++L G P
Sbjct: 172 -TQIKRNTFVGTPFWMA-PEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2kre_A Ubiquitin conjugation factor E4 B; U-box domain, E3 ubiquitin ligase, E4 polyubiquitin chain EL factor, phosphoprotein, UBL conjugation pathway; NMR {Homo sapiens} PDB: 3l1x_A 3l1z_B Length = 100 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-25
Identities = 21/89 (23%), Positives = 33/89 (37%), Gaps = 7/89 (7%)
Query: 603 LVKELEQLHVAEERP------VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGR 656
+++E++ R P F P++ +M DP G + I L N
Sbjct: 5 FAEKVEEIVAKNARAEIDYSDAPDEFRDPLMDTLMTDPVRLPSGTIMDRSIILRHLLNSP 64
Query: 657 ETSPMTNLRLSHLHLTPNHALRHAIQDWL 685
T P L+ L P L+ IQ W+
Sbjct: 65 -TDPFNRQTLTESMLEPVPELKEQIQAWM 92
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE--FQQEVRVLSKLQHPHLVTLLG 404
+G+G FG V K + + A+K++ + + + +EV +L KL HP+++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 405 AC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
++ +V E G L D + ++ S D ARI ++ SG+ ++H I
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE---HDAARIIKQVFSGITYMHK---HNI 142
Query: 463 VHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
VH DLKP+NILL+S+ KI DFG+ ++T G+ Y PE
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-------KDRIGTAYYIAPE-- 193
Query: 520 RTGVL----TPKSDSYSFGLIILQLLTGRLP 546
VL K D +S G+I+ LL+G P
Sbjct: 194 ---VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 13/150 (8%)
Query: 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
++ K+GQG G VY + G+ VAI+ + + E+ V+ + ++P++V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 402 LLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
L + E W +V EYL GSL D + + A + E L FLHS
Sbjct: 82 YLDSYLVGDELW-VVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS-- 134
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGIC 488
+++H D+K NILL + S K+ DFG C
Sbjct: 135 -NQVIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 15/152 (9%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHL 399
F K+G+G +G VYK G+ VAIK + ++ L+ +E+ ++ + PH+
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESDLQEIIKEISIMQQCDSPHV 86
Query: 400 VTLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
V G+ + W +V EY GS+ D + + L + A I GL +LH
Sbjct: 87 VKYYGSYFKNTDLW-IVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488
+ +H D+K NILL++E +K+ DFG+
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFGVA 172
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 45/216 (20%), Positives = 85/216 (39%), Gaps = 39/216 (18%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKML--------YSHNMQGQLEFQQEVRVLSKLQHPHLV 400
G G FG V+ + V +K + + E+ +LS+++H +++
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 401 TLLG--ACPEAWSLVYEYLPNGS-LQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHS 456
+L + LV E +G L + R + A I ++ S + +L
Sbjct: 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE----PLASYIFRQLVSAVGYLRL 148
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
+ I+H D+K +NI++ + + K+ DFG + L F+ G+ Y P
Sbjct: 149 ---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL----FYTFC---GTIEYCAP 198
Query: 517 EYHRTGVLT------PKSDSYSFGLIILQLLTGRLP 546
E VL P+ + +S G+ + L+ P
Sbjct: 199 E-----VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2kr4_A Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ring, E3 ligase, UBL conjugation pathway; NMR {Mus musculus} Length = 85 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 8e-25
Identities = 19/73 (26%), Positives = 27/73 (36%), Gaps = 1/73 (1%)
Query: 613 AEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLT 672
+ P F P++ +M DP G + I L N T P L+ L
Sbjct: 6 IDYSDAPDEFRDPLMDTLMTDPVRLPSGTVMDRSIILRHLLNSP-TDPFNRQMLTESMLE 64
Query: 673 PNHALRHAIQDWL 685
P L+ IQ W+
Sbjct: 65 PVPELKEQIQAWM 77
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 28/208 (13%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLG--A 405
G+G +G V + VA+K++ E ++E+ + L H ++V G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 406 CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPEKIVH 464
L EY G L DR+ + A+ ++ +G+ +LH I H
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHG---IGITH 128
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE------Y 518
D+KP+N+LLD + KI DFG+ + + G+ PY PE +
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMC--GTLPYVAPELLKRREF 184
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
H D +S G+++ +L G LP
Sbjct: 185 H--A---EPVDVWSCGIVLTAMLAGELP 207
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 45/219 (20%)
Query: 351 GQGGFGCVYKGEML--GRTVAIKML--------YSHNMQGQLEFQQEVRVLSKLQH--PH 398
G GGFG VY G + VAIK + ++ EV +L K+
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP--MEVVLLKKVSSGFSG 109
Query: 399 LVTLLG--ACPEAWSLVYEY-LPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFL 454
++ LL P+++ L+ E P L D + + + + AR ++ +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE----ELARSFFWQVLEAVRHC 165
Query: 455 HSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 513
H+ ++H D+K +NIL+D K+ DFG L+ DT+Y G+ Y
Sbjct: 166 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDF-------DGTRVY 214
Query: 514 ADPE------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ PE YH G + +S G+++ ++ G +P
Sbjct: 215 SPPEWIRYHRYH--G---RSAAVWSLGILLYDMVCGDIP 248
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 13/150 (8%)
Query: 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
K+G+G G V GR VA+KM+ Q + EV ++ QH ++V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 402 LLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
+ + E W ++ E+L G+L D + + L + A + + L +LH+
Sbjct: 107 MYKSYLVGEELW-VLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHA-- 159
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGIC 488
+ ++H D+K +ILL + K+ DFG C
Sbjct: 160 -QGVIHRDIKSDSILLTLDGRVKLSDFGFC 188
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 68/271 (25%), Positives = 108/271 (39%), Gaps = 24/271 (8%)
Query: 288 KQRIRRQKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSES 347
Q R EA + + V+ A F + +
Sbjct: 29 DQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSF 88
Query: 348 FKV------GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL 399
+ V G G FG V+K E G +A K++ + M+ + E + E+ V+++L H +L
Sbjct: 89 YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL 148
Query: 400 VTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
+ L A LV EY+ G L DR+ +S L D +I G+ +H
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM 206
Query: 458 KPEKIVHGDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
I+H DLKP+NIL + + KI DFG+ R +F G+ +
Sbjct: 207 ---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-------GTPEFLA 256
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE ++ +D +S G+I LL+G P
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA- 405
+G G F V+ + G+ A+K + + E+ VL K++H ++VTL
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 406 -CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
+ LV + + G L DR+ + + KD + + ++ S + +LH IVH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTE---KDASLVIQQVLSAVKYLHE---NGIVH 129
Query: 465 GDLKPQNILL-----DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
DLKP+N+L +S++ I DFG+ ++ + + G+ Y PE
Sbjct: 130 RDLKPENLLYLTPEENSKI--MITDFGLSKMEQNGIM--------STACGTPGYVAPEVL 179
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ D +S G+I LL G P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 43/219 (19%)
Query: 351 GQGGFGCVYKGEML--GRTVAIKML------YSHNMQGQLEFQQEVRVLSKL----QHPH 398
G+GGFG V+ G L VAIK++ + + EV +L K+ HP
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99
Query: 399 LVTLLG--ACPEAWSLVYEY-LPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFL 454
++ LL E + LV E LP L D + K + +R ++ + +
Sbjct: 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE----GPSRCFFGQVVAAIQHC 155
Query: 455 HSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 513
HS +VH D+K +NIL+D +K+ DFG L D Y G+ Y
Sbjct: 156 HSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEPYTDF-------DGTRVY 204
Query: 514 ADPE------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ PE YH + +S G+++ ++ G +P
Sbjct: 205 SPPEWISRHQYH--A---LPATVWSLGILLYDMVCGDIP 238
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 17/148 (11%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLL 403
++G G FG VYK + G A K++ + + E + E+ +L+ HP++V LL
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATCDHPYIVKLL 82
Query: 404 GAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
GA + W ++ E+ P G++ + L + ++ L FLHS +
Sbjct: 83 GAYYHDGKLW-IMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS---K 136
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGIC 488
+I+H DLK N+L+ E ++ DFG+
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 37/214 (17%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM--QGQLEF-QQEVRVLSKLQHPHLVTLLG 404
+G+G F V + R AIK+L ++ + ++ + +E V+S+L HP V L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 405 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
+ L Y NG L + RK R AEI S L +LH +
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDE---TCTRFYTAEIVSALEYLHG---KG 150
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF---P-YADPE 517
I+H DLKP+NILL+ ++ +I DFG ++++ ++ A SF Y PE
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--------KQARANSFVGTAQYVSPE 202
Query: 518 YHRTGVLTPK-----SDSYSFGLIILQLLTGRLP 546
+LT K SD ++ G II QL+ G P
Sbjct: 203 -----LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 51/159 (32%), Positives = 77/159 (48%), Gaps = 22/159 (13%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKL-QHPHLVTLL 403
VG G +G VYKG + G+ AIK++ ++ G E +QE+ +L K H ++ T
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATYY 87
Query: 404 GA---------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
GA + W LV E+ GS+ D L + + + L + A I EI GL L
Sbjct: 88 GAFIKKNPPGMDDQLW-LVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493
H K++H D+K QN+LL K+ DFG+ +
Sbjct: 146 HQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 28/208 (13%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLG--A 405
G+G +G V + VA+K++ E ++E+ + L H ++V G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 406 CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPEKIVH 464
L EY G L DR+ + A+ ++ +G+ +LH I H
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHG---IGITH 128
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE------Y 518
D+KP+N+LLD + KI DFG+ + + G+ PY PE +
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMC--GTLPYVAPELLKRREF 184
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
H D +S G+++ +L G LP
Sbjct: 185 H--A---EPVDVWSCGIVLTAMLAGELP 207
|
| >1wgm_A Ubiquitin conjugation factor E4A; ubiquitinating enzyme, KIAA0126, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.44.1.2 Length = 98 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 8e-24
Identities = 24/85 (28%), Positives = 33/85 (38%), Gaps = 2/85 (2%)
Query: 602 SLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADG-FTYEGKAIRDWLENGRETSP 660
S L+Q FL PI+ +M DP V T + I L + +T P
Sbjct: 3 SGSSGLQQQEEETYADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSD-QTDP 61
Query: 661 MTNLRLSHLHLTPNHALRHAIQDWL 685
L+ + PN L+ IQ WL
Sbjct: 62 FNRSPLTMDQIRPNTELKEKIQRWL 86
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 27/205 (13%), Positives = 49/205 (23%), Gaps = 48/205 (23%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G ++ L R VA+ + E LS++ P + +L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 404 --GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+V E++ GSLQ+ + R +A+ H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHR---AG 149
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
+ P + + + +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPAT-----------------MPD-------------- 178
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
P+ D G + LL R P
Sbjct: 179 --ANPQDDIRGIGASLYALLVNRWP 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 31/224 (13%)
Query: 341 TCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQL------EFQQEV 388
+ + + G G F V K G A K + + E ++EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 389 RVLSKLQHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE 446
+L ++ H +++TL L+ E + G L D L +K ++S ++ +
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQ 123
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFH 502
I G+ +LH+ K I H DLKP+NI+L + K+ DFG+ + + + F
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF- 179
Query: 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G+ + PE L ++D +S G+I LL+G P
Sbjct: 180 ------GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 53/237 (22%), Positives = 93/237 (39%), Gaps = 34/237 (14%)
Query: 331 EFSLADLQTATCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKML--------YSH 376
+ ++ D + + + G G G V + VAI+++ +
Sbjct: 120 DLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAR 179
Query: 377 NMQGQLEFQQEVRVLSKLQHPHLVTLLGAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPL 435
L + E+ +L KL HP ++ + E + +V E + G L D++ +
Sbjct: 180 EADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKE- 238
Query: 436 LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLVT 492
++ + +LH I+H DLKP+N+LL S + KI DFG +++
Sbjct: 239 --ATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293
Query: 493 EDTLYLPSFHRSTAPKGSFPYADPE---YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E +L T G+ Y PE T D +S G+I+ L+G P
Sbjct: 294 ETSLM------RTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 31/224 (13%)
Query: 341 TCNFSESFKV----GQGGFGCVYKGEML--GRTVAIK------MLYSHNMQGQLEFQQEV 388
N + + G G F V K G A K S + + ++EV
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 389 RVLSKLQHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE 446
+L ++QHP+++TL L+ E + G L D L K +++ ++ +
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQ 122
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFH 502
I +G+ +LHS + I H DLKP+NI+L KI DFG+ + + F
Sbjct: 123 ILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 178
Query: 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G+ + PE L ++D +S G+I LL+G P
Sbjct: 179 ------GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 42/219 (19%), Positives = 72/219 (32%), Gaps = 35/219 (15%)
Query: 349 KVGQG--GFGCVYKGEML--GRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
+G+G V G V ++ L + + + Q E+ V HP++V
Sbjct: 32 VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 403 LGA---CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCFLHS 456
E W +V ++ GS +D L + + + IA + L ++H
Sbjct: 92 RATFIADNELW-VVTSFMAYGSAKD-LICTHFMDGM---NELAIAYILQGVLKALDYIHH 146
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--A 514
VH +K +IL+ + + + H +
Sbjct: 147 ---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 515 DPEYHRTGVLT-------PKSDSYSFGLIILQLLTGRLP 546
PE VL KSD YS G+ +L G +P
Sbjct: 204 -PE-----VLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 31/219 (14%)
Query: 343 NFSESFKV----GQGGFGCVYKGE--MLGRTVAIK------MLYSHNMQGQLEFQQEVRV 390
+ +++ G G F V K G+ A K + S + E ++EV +
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 391 LSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIA 448
L +++HP+++TL L+ E + G L D L K +++ + + +I
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE---DEATQFLKQIL 118
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFHRS 504
G+ +LHS + I H DLKP+NI+L + K+ DFGI + + F
Sbjct: 119 DGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--- 172
Query: 505 TAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG 543
G+ + PE L ++D +S G+I LL+G
Sbjct: 173 ----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 341 TCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQ--LEFQQEVRVLS 392
+ FS+++ V G+G F V + G A K++ + + + + ++E R+
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 393 KLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG 450
KLQHP++V L + LV++ + G L + + + S D + +I
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE---ADASHCIQQILES 117
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAP 507
+ + HS+ IVH +LKP+N+LL S+ K+ DFG+ V + A
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----EAWHGFA- 168
Query: 508 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G+ Y PE + + D ++ G+I+ LL G P
Sbjct: 169 -GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 41/233 (17%)
Query: 340 ATCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKML---------YSHNMQGQLEF 384
+T F E+++ G+G V + + A+K++ + +
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 385 QQEVRVLSKL-QHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRA 441
+EV +L K+ HP+++ L + LV++ + G L D L K +S K+
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE---KETR 127
Query: 442 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL--- 498
+I + +C LH IVH DLKP+NILLD +++ K+ DFG +
Sbjct: 128 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184
Query: 499 --PSFHRSTAP---KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PS+ AP + S P Y + D +S G+I+ LL G P
Sbjct: 185 GTPSY---LAPEIIECSMNDNHPGY------GKEVDMWSTGVIMYTLLAGSPP 228
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 46/204 (22%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
+G+G FG V++ +T K + ++E+ +L+ +H +++ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHESF 70
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
E +++E++ + +R+ + L ++ ++ L FLHS I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLHSHN---IGH 125
Query: 465 GDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
D++P+NI+ + SS KI +FG R + + F + Y PE H+
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-------TAPEYYAPEVHQHD 178
Query: 523 VLTPKSDSYSFGLIILQLLTGRLP 546
V++ +D +S G ++ LL+G P
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINP 202
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 31/224 (13%)
Query: 341 TCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKML------YSHNMQGQLEFQQEV 388
+ + + G G F V K G A K + S + E ++EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 389 RVLSKLQHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE 446
+L ++ HP+++TL L+ E + G L D L +K ++S ++ +
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQ 123
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFH 502
I G+ +LH+ K I H DLKP+NI+L + K+ DFG+ + + + F
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF- 179
Query: 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G+ + PE L ++D +S G+I LL+G P
Sbjct: 180 ------GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 53/238 (22%), Positives = 89/238 (37%), Gaps = 62/238 (26%)
Query: 351 GQGGFGCVYKG--EMLGRTVAIKML----------------------------YSHNMQG 380
G+G +G V E A+K+L
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 381 QLEFQQEVRVLSKLQHPHLVTLLGACPEAWS--------LVYEYLPNGSLQDRLFRKSNV 432
Q+ QE+ +L KL HP++V L+ E +V+E + G + + K
Sbjct: 82 QVY--QEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-- 133
Query: 433 SPLLWKDRAR-IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491
L +D+AR ++ G+ +LH +KI+H D+KP N+L+ + KI DFG+
Sbjct: 134 ---LSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 492 TEDTLYLPSFHRSTAPKGSFPYADPE---YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
L S G+ + PE R D ++ G+ + + G+ P
Sbjct: 188 KGSDALL-----SNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 26/228 (11%)
Query: 336 DLQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKM-----LYSHNMQGQLEF 384
D+ F + +++ G+G F V + G+ A+K+ S +
Sbjct: 14 DMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73
Query: 385 QQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLW-KDRA 441
++E + L+HPH+V LL +V+E++ L + ++++ + +
Sbjct: 74 KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133
Query: 442 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYL 498
+I L + H + I+H D+KP +LL S+ +S K+ FG+ + E L
Sbjct: 134 HYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 190
Query: 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G+ + PE + D + G+I+ LL+G LP
Sbjct: 191 ------GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 30/215 (13%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKML--------YSHNMQGQLEFQQEVRVLSKLQHPH 398
+G G G V + VAIK++ + L + E+ +L KL HP
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 399 LVTLLGAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
++ + E + +V E + G L D++ + ++ + +LH +
Sbjct: 77 IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKE---ATCKLYFYQMLLAVQYLHEN 133
Query: 458 KPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
I+H DLKP+N+LL S + KI DFG +++ E S R+ G+ Y
Sbjct: 134 G---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-----SLMRTLC--GTPTYL 183
Query: 515 DPE---YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE T D +S G+I+ L+G P
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 54/229 (23%), Positives = 98/229 (42%), Gaps = 36/229 (15%)
Query: 337 LQTATC-NFSESFKV----GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE--FQQE 387
+ T TC F+E +++ G+G F V + + G+ A ++ + + + ++E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 388 VRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA 445
R+ L+HP++V L + L+++ + G L + + + S D +
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE---ADASHCIQ 117
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFH 502
+I + H +VH +LKP+N+LL S+L K+ DFG+ V + F
Sbjct: 118 QILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF- 173
Query: 503 RSTAPKGSFPYADPEYHRTGVL-----TPKSDSYSFGLIILQLLTGRLP 546
G+ Y PE VL D ++ G+I+ LL G P
Sbjct: 174 -----AGTPGYLSPE-----VLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 55/230 (23%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 341 TCNFSESFKV-----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSK 393
+ F + +++ G+G V L + A+K++ + +EV +L +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 394 LQ-HPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG 450
Q H +++ L+ + + LV+E + GS+ + ++ + + + + + ++AS
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE---LEASVVVQDVASA 123
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDS--ELSS-KICDFGICRLVTEDTLYLPSFHRS-TA 506
L FLH+ I H DLKP+NIL + ++S KICDF + + + P
Sbjct: 124 LDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 507 PKGSFPYADPEYHRTGVL----------TPKSDSYSFGLIILQLLTGRLP 546
P GS Y PE V+ + D +S G+I+ LL+G P
Sbjct: 181 PCGSAEYMAPE-----VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIK-MLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLG 404
++G+G +G V K + G+ +A+K + + + + Q + ++ V+ + P++V G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 405 AC---PEAWSLVYEYLPNGSLQD--RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
A + W + E + + S + + + +I L L +
Sbjct: 89 ALFREGDCW-ICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL- 145
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGIC-RLVTEDTLYLPSFHRSTAPKGSFPYADPE- 517
KI+H D+KP NILLD + K+CDFGI +LV D++ A G PY PE
Sbjct: 146 -KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSI----AKTRDA--GCRPYMAPER 196
Query: 518 ---YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+SD +S G+ + +L TGR P
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 49/151 (32%), Positives = 69/151 (45%), Gaps = 21/151 (13%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ------LEFQQEVRVLSKLQHPHLV 400
++G G FG VY + VAIK + + G+ + +EVR L KL+HP+ +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKM---SYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 117
Query: 401 TLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
G AW LV EY GS D L + + PL + A + GL +LHS
Sbjct: 118 QYRGCYLREHTAW-LVMEYCL-GSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS- 172
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGIC 488
++H D+K NILL K+ DFG
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 51/213 (23%), Positives = 95/213 (44%), Gaps = 35/213 (16%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEF-QQEVRVLSKLQHPHLVTLLG 404
+G+G FG V + + A+K + + ++ +E++++ L+HP LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
+ E +V + L G L+ L + + ++ ++ E+ L +L + ++
Sbjct: 83 SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK----EETVKLFICELVMALDYLQN---QR 135
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
I+H D+KP NILLD I DF I ++ +T + + G+ PY PE
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-ITTM------AGTKPYMAPE---- 184
Query: 522 GVLTPKS--------DSYSFGLIILQLLTGRLP 546
+ + + D +S G+ +LL GR P
Sbjct: 185 -MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 32/231 (13%)
Query: 329 SAEFSLADLQTATCNFSESFKVGQGGFGCVYKG--EMLGRTVAIK-MLYSHNMQGQLEFQ 385
S E DL+ ++G+G +G V K G+ +A+K + + N Q Q
Sbjct: 1 SMEVKADDLEPIM-------ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLL 53
Query: 386 QEVRV-LSKLQHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDR-- 440
++ + + + P VT GA + E + + SL D+ +++ +
Sbjct: 54 MDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSL-DKFYKQVIDKGQTIPEDIL 111
Query: 441 ARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC-RLVTEDTLYLP 499
+IA I L LHS ++H D+KP N+L+++ K+CDFGI LV D +
Sbjct: 112 GKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKD 167
Query: 500 SFHRSTAPKGSFPYADPE----YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G PY PE + KSD +S G+ +++L R P
Sbjct: 168 ID------AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 35/210 (16%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTL--LGA 405
G G FG + VA+K + + + Q+E+ L+HP++V +
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV--QREIINHRSLRHPNIVRFKEVIL 86
Query: 406 CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPEKIVH 464
P +++ EY G L +R+ S D AR ++ SG+ + HS +I H
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSE----DEARFFFQQLLSGVSYCHS---MQICH 139
Query: 465 GDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
DLK +N LLD + KICDFG + S +ST G+ Y PE
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTV--GTPAYIAPE----- 187
Query: 523 VLT------PKSDSYSFGLIILQLLTGRLP 546
VL +D +S G+ + +L G P
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 26/223 (11%)
Query: 337 LQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE--FQQEV 388
+ A+ FS+++ V G+G F V + G A K++ + + + ++E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 389 RVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE 446
R+ KLQHP++V L + LV++ + G L + + + S D + +
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE---ADASHCIQQ 136
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHR 503
I + + HS+ IVH +LKP+N+LL S+ K+ DFG+ V + +
Sbjct: 137 ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-----H 188
Query: 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
A G+ Y PE + + D ++ G+I+ LL G P
Sbjct: 189 GFA--GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKML--------YSHNMQGQLEFQQEVRVLSKL-QHP 397
+G+G V + G A+K++ + + ++E +L ++ HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 398 HLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
H++TL+ + LV++ + G L D L K +S K+ I + + FLH
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE---KETRSIMRSLLEAVSFLH 217
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL-----PSFHRSTAP--- 507
+ IVH DLKP+NILLD + ++ DFG + P + AP
Sbjct: 218 A---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGY---LAPEIL 271
Query: 508 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
K S P Y + D ++ G+I+ LL G P
Sbjct: 272 KCSMDETHPGY------GKEVDLWACGVILFTLLAGSPP 304
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGA 405
+G+G F K + A+K++ Q+E+ L + HP++V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA---NTQKEITALKLCEGHPNIVKLHEV 74
Query: 406 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
LV E L G L +R+ +K + S + + I ++ S + +H +V
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSE---TEASYIMRKLVSAVSHMHD---VGVV 128
Query: 464 HGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
H DLKP+N+L E + KI DFG RL D L P + YA PE
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL------KTPCFTLHYAAPE--- 179
Query: 521 TGVLT-----PKSDSYSFGLIILQLLTGRLP 546
+L D +S G+I+ +L+G++P
Sbjct: 180 --LLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 47/215 (21%), Positives = 87/215 (40%), Gaps = 35/215 (16%)
Query: 351 GQGGFGCVYKGEML--GRTVAIKML------YSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
G+G +G V + A+K+L N + ++ +E+++L +L+H +++ L
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK--KEIQLLRRLRHKNVIQL 71
Query: 403 ----LGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
+ +V EY G + + ++ GL +LHS
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS-- 127
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE- 517
+ IVH D+KP N+LL + + KI G+ + + T+ +GS + PE
Sbjct: 128 -QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP---FAADDTCRTS-QGSPAFQPPEI 182
Query: 518 ------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ G K D +S G+ + + TG P
Sbjct: 183 ANGLDTFS--G---FKVDIWSAGVTLYNITTGLYP 212
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 4e-22
Identities = 58/253 (22%), Positives = 92/253 (36%), Gaps = 65/253 (25%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKM-----LYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
+GQG +G V AIK+ + N + + EVR++ KL HP++
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 402 LLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLW---------------------- 437
L + LV E G L D+L + S
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 438 ---------------KDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS-- 480
K + I +I S L +LH+ + I H D+KP+N L + S
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEI 209
Query: 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSY-------SF 533
K+ DFG+ + + + A G+ + PE VL ++SY S
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKA--GTPYFVAPE-----VLNTTNESYGPKCDAWSA 262
Query: 534 GLIILQLLTGRLP 546
G+++ LL G +P
Sbjct: 263 GVLLHLLLMGAVP 275
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 6e-22
Identities = 40/175 (22%), Positives = 70/175 (40%), Gaps = 11/175 (6%)
Query: 377 NMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSP 434
+ ++R + + V L L + +L+D + R+ ++
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 435 LLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494
I +IA + FLHS + ++H DLKP NI + K+ DFG+ + +D
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 495 T------LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG 543
+P++ T G+ Y PE + K D +S GLI+ +LL
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 51/212 (24%), Positives = 87/212 (41%), Gaps = 29/212 (13%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIK-MLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLG 404
++G G G V+K G +A+K M S N + ++ V+ K P++V G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 405 AC---PEAWSLVYEYLPNGSLQDRLFRKSNVS-PLLWKDRARIAAEIASGLCFLHSSKPE 460
+ + + E + + + + + + +L ++ I L +L
Sbjct: 92 TFITNTDVF-IAMELMGTCAEKLKKRMQGPIPERIL----GKMTVAIVKALYYLKEKH-- 144
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGIC-RLVTEDTLYLPSFHRSTAPKGSFPYADPE-- 517
++H D+KP NILLD K+CDFGI RLV D G Y PE
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRS------AGCAAYMAPERI 196
Query: 518 ---YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
++D +S G+ +++L TG+ P
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 57/241 (23%), Positives = 95/241 (39%), Gaps = 44/241 (18%)
Query: 328 ESAEFSLADLQTATCNFSESFKV-----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQG 380
E + ++ +++ G G G V + G+ A+K+LY
Sbjct: 10 SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-- 67
Query: 381 QLEFQQEVRVLSKLQ-HPHLVTLLGACPEAWS------LVYEYLPNGSLQDRLFRKSNVS 433
+QEV + PH+V +L ++ E + G L R+ + +
Sbjct: 68 ---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD-Q 123
Query: 434 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRL 490
++ A I +I + + FLHS I H D+KP+N+L S+ K+ DFG +
Sbjct: 124 AFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180
Query: 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRL 545
T++ L P + Y PE VL P+ D +S G+I+ LL G
Sbjct: 181 TTQNAL--------QTPCYTPYYVAPE-----VLGPEKYDKSCDMWSLGVIMYILLCGFP 227
Query: 546 P 546
P
Sbjct: 228 P 228
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 30/233 (12%)
Query: 327 PESAEFSLADLQTATCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQG 380
S + S+ F+V G+G VY+ + + A+K+L +
Sbjct: 34 TASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK 93
Query: 381 QLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWK 438
+ E+ VL +L HP+++ L P SLV E + G L DR+ K S +
Sbjct: 94 IVR--TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE---R 148
Query: 439 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL-----DSELSSKICDFGICRLVTE 493
D A +I + +LH + IVH DLKP+N+L D+ L KI DFG+ ++V
Sbjct: 149 DAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPL--KIADFGLSKIVEH 203
Query: 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
L G+ Y PE R P+ D +S G+I LL G P
Sbjct: 204 QVLM-------KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 52/228 (22%), Positives = 100/228 (43%), Gaps = 39/228 (17%)
Query: 337 LQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRV 390
L + F++ ++V G G + + A+K++ + + + +E+ +
Sbjct: 13 LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEIEI 68
Query: 391 LSKL-QHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEI 447
L + QHP+++TL + +V E + G L D++ R+ S ++ + + I
Sbjct: 69 LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE---REASAVLFTI 125
Query: 448 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFHR 503
+ +LH+ + +VH DLKP NIL E + +ICDFG + + + L
Sbjct: 126 TKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL----- 177
Query: 504 STAPKGSFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
P + + PE VL + D +S G+++ +LTG P
Sbjct: 178 -MTPCYTANFVAPE-----VLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 5e-21
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 24/210 (11%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHLVTLLG 404
+G+G FG V ++ + A+K+L M + + F++E VL + TL
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A LV +Y G L L S L ++ AR AE+ + +H
Sbjct: 142 AFQDDNNLYLVMDYYVGGDL---LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LH 195
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 517
VH D+KP NIL+D ++ DFG C + ED +S+ G+ Y PE
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-----QSSVAVGTPDYISPEILQA 250
Query: 518 -YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G P+ D +S G+ + ++L G P
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 57/219 (26%), Positives = 84/219 (38%), Gaps = 26/219 (11%)
Query: 343 NFSESFKV-----GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSK 393
NF+ + + G+G F V + G+ A K L E E+ VL
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 394 LQH-PHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG 450
+ P ++ L L+ EY G + + + D R+ +I G
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM-VSENDVIRLIKQILEG 143
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAP 507
+ +LH + IVH DLKPQNILL S KI DFG+ R +
Sbjct: 144 VYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM------ 194
Query: 508 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G+ Y PE +T +D ++ G+I LLT P
Sbjct: 195 -GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 9e-21
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 42/220 (19%)
Query: 348 FKV-GQGGFGCVYKGEM--LGRTVAIKML----------YSHNMQGQLEFQQEVRVLSKL 394
F+V G+GGFG V+ +M G+ A K L Y M E ++L+K+
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV-------EKKILAKV 242
Query: 395 QHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGL 451
+V+L A LV + G ++ ++ +P + RA A+I SGL
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
LH I++ DLKP+N+LLD + + +I D G+ + + G+
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY------AGTP 353
Query: 512 PYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
+ PE +L + D ++ G+ + +++ R P
Sbjct: 354 GFMAPE-----LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 26/212 (12%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHLVTLLG 404
+G+G F V +M G+ A+K++ +M +G++ F++E VL + L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A LV EY G L L S + + AR AEI + +H
Sbjct: 129 AFQDENYLYLVMEYYVGGDL---LTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LG 182
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
VH D+KP NILLD ++ DFG C + D RS G+ Y PE +
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-----RSLVAVGTPDYLSPEILQA 237
Query: 522 GVLTPKSDSY-------SFGLIILQLLTGRLP 546
P + SY + G+ ++ G+ P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 9e-20
Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 40/215 (18%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
+G+G FG V K + GR A+K+L + + E E RVL +HP L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 405 A--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHS 456
+ + V EY G L ++R+F + DRAR AEI S L +LHS
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSE---------DRARFYGAEIVSALDYLHS 266
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
K +V+ DLK +N++LD + KI DFG+C+ +D + +F G+ P
Sbjct: 267 EK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF------CGT-----P 313
Query: 517 EYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
EY VL D + G+++ +++ GRLP
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLG 404
+G+GGFG V ++ G+ A K L + +G+ E ++L K+ +V+L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A +A LV + G L+ ++ + RA AAEI GL LH E+
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHR---ER 306
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
IV+ DLKP+NILLD +I D G+ V E G+ Y PE
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-------TIKGRVGTVGYMAPE---- 355
Query: 522 GVLTPKS-----DSYSFGLIILQLLTGRLP 546
V+ + D ++ G ++ +++ G+ P
Sbjct: 356 -VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 52/156 (33%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 350 VGQGGFGCVY----KGEMLGRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHLVTL 402
+G G FG V+ + GR A+K+L + Q+E E +LS + HP ++ +
Sbjct: 14 LGTGSFGRVHLIRSRHN--GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 403 LGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKP 459
G +A + + +Y+ G L L RKS P A+ AAE+ L +LHS
Sbjct: 72 WGTFQDAQQIFMIMDYIEGGELFSLL-RKSQRFP---NPVAKFYAAEVCLALEYLHS--- 124
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495
+ I++ DLKP+NILLD KI DFG + V + T
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 58/232 (25%), Positives = 93/232 (40%), Gaps = 43/232 (18%)
Query: 337 LQTATCNFSESFKV-----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVR 389
LQ + +KV G G G V + A+KML Q + ++EV
Sbjct: 52 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVE 106
Query: 390 VLSKLQ-HPHLVTLLGACPEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR 442
+ + PH+V ++ ++ +V E L G L R+ + + ++ +
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASE 165
Query: 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLP 499
I I + +LHS I H D+KP+N+L S+ + K+ DFG + T
Sbjct: 166 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 220
Query: 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
T P + Y PE VL P+ D +S G+I+ LL G P
Sbjct: 221 -----TTPCYTPYYVAPE-----VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 48/217 (22%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHLVTLLG 404
+G G FG V K + G A+K+L + Q+E E R+L + P LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 405 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
+ + +L V EY+ G + L R S AR AA+I +LHS
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE----PHARFYAAQIVLTFEYLHS---LD 161
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL-------YLPSFHRSTAP-----KG 509
+++ DLKP+N+L+D + ++ DFG + V T L AP KG
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEAL-------APEIILSKG 214
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ V D ++ G++I ++ G P
Sbjct: 215 ---------YNKAV-----DWWALGVLIYEMAAGYPP 237
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 6e-19
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 49/220 (22%)
Query: 350 VGQGGFGCVY-----KGEMLGRTVAIKML-----YSHNMQGQLEFQQEVRVLSKLQHPHL 399
+GQG FG V+ G + A+K+L + ++ + E +L ++ HP +
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD---RVRTKMERDILVEVNHPFI 88
Query: 400 VTLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGL 451
V L A L+ ++L G L ++ +F + + + AE+A L
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE---------EDVKFYLAELALAL 139
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
LHS I++ DLKP+NILLD E K+ DFG+ + + SF G+
Sbjct: 140 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF------CGTV 190
Query: 512 PYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
Y PE V+ + D +SFG+++ ++LTG LP
Sbjct: 191 EYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >2c2l_A CHIP, carboxy terminus of HSP70-interacting protein; chaperone, E3 ligase, ubiquitinylation, TPR, heat-shock protein complex; 3.3A {Mus musculus} SCOP: a.118.8.1 g.44.1.2 Length = 281 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 8e-19
Identities = 20/72 (27%), Positives = 37/72 (51%)
Query: 614 EERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTP 673
++R +P + I E+M +P + G TY+ K I + L+ +P+T L+ L P
Sbjct: 201 KKRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIP 260
Query: 674 NHALRHAIQDWL 685
N A++ I ++
Sbjct: 261 NLAMKEVIDAFI 272
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 26/154 (16%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHP 397
VG+G +G V K GR VAIK E+++L +L+H
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKF-------LESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 398 HLVTLLGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
+LV LL C + W LV+E++ + ++ D L + + L ++ + +I +G+ F H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
S I+H D+KP+NIL+ K+CDFG R
Sbjct: 142 SHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 42/154 (27%), Positives = 64/154 (41%), Gaps = 26/154 (16%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHP 397
K+G+G +G V+K G+ VAIK E+R+L +L+HP
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKF-------LESEDDPVIKKIALREIRMLKQLKHP 62
Query: 398 HLVTLLGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
+LV LL LV+EY + ++ L + I + + F H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+H D+KP+NIL+ K+CDFG R
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 45/219 (20%)
Query: 350 VGQGGFGCVYKGEML-----GRTVAIKMLY-SHNMQGQLEFQQ---EVRVLSKLQHPHLV 400
+G+GG+G V++ + G+ A+K+L + ++ + E +L +++HP +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 401 TLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLC 452
L+ A L+ EYL G L ++ +F + D A AEI+ L
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME---------DTACFYLAEISMALG 135
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 512
LH + I++ DLKP+NI+L+ + K+ DFG+C+ D +F G+
Sbjct: 136 HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF------CGTIE 186
Query: 513 YADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
Y PE +L D +S G ++ +LTG P
Sbjct: 187 YMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3m62_A Ubiquitin conjugation factor E4; armadillo-like repeats, UBL conjugation pathway, DNA damage, nucleus, phosphoprotein; HET: 1PE; 2.40A {Saccharomyces cerevisiae} PDB: 3m63_A* 2qiz_A 2qj0_A Length = 968 | Back alignment and structure |
|---|
Score = 89.4 bits (221), Expect = 1e-18
Identities = 22/82 (26%), Positives = 35/82 (42%), Gaps = 2/82 (2%)
Query: 605 KELEQLHVAEERPVPSFFLCPILQEIMHDPQV-AADGFTYEGKAIRDWLENGRETSPMTN 663
++ ++ E VP FL P++ IM DP + A + I+ L + T P
Sbjct: 875 RKADEEEDLEYGDVPDEFLDPLMYTIMKDPVILPASKMNIDRSTIKAHLLSDS-TDPFNR 933
Query: 664 LRLSHLHLTPNHALRHAIQDWL 685
+ L +TPN LR I +
Sbjct: 934 MPLKLEDVTPNEELRQKILCFK 955
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 55/222 (24%)
Query: 350 VGQGGFGCVYKGEM--LGRTVAIKML----------YSHNMQGQLEFQQEVRVLSKLQHP 397
+G+G FG V GR A+K+L +H + E RVL +HP
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-------ESRVLQNTRHP 65
Query: 398 HLVTLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIAS 449
L L A + V EY G L ++R+F + +RAR AEI S
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE---------ERARFYGAEIVS 116
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 509
L +LHS +V+ D+K +N++LD + KI DFG+C+ D + +F G
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC------G 167
Query: 510 SFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
+ PEY VL D + G+++ +++ GRLP
Sbjct: 168 T-----PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 25/209 (11%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHLVTLLG 404
+G+G FG V + + + A+K+L M + F +E +++ P +V L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A +V EY+P G L L +V AR AE+ L +HS
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPE----KWARFYTAEVVLALDAIHSMG--- 188
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 517
+H D+KP N+LLD K+ DFG C + ++ + R G+ Y PE
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-----RCDTAVGTPDYISPEVLKS 243
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G + D +S G+ + ++L G P
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 59/219 (26%), Positives = 90/219 (41%), Gaps = 38/219 (17%)
Query: 346 ESFKV-GQGGFGCVYKGEML--GRTVAIKMLYSH---NMQGQLEFQQEVRVLSKL---QH 396
++ G+GGFG VY G+ A+K L QG+ E +LS +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 397 PHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCF 453
P +V + A P+ S + + + G L L + S + R AAEI GL
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYAAEIILGLEH 307
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 513
+H+ +V+ DLKP NILLD +I D G+ ++ + + G+ Y
Sbjct: 308 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--AS------VGTHGY 356
Query: 514 ADPEYHRTGVLTPKS------DSYSFGLIILQLLTGRLP 546
PE VL D +S G ++ +LL G P
Sbjct: 357 MAPE-----VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 4e-18
Identities = 46/156 (29%), Positives = 77/156 (49%), Gaps = 29/156 (18%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHP 397
K+G+G +G VYK G VA+K + +L+ + E+ +L +L HP
Sbjct: 10 KIGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHP 62
Query: 398 HLVTLLGACPEAWS--LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRARIAAEIASGLCF 453
++V LL LV+E+L QD + S ++ + ++ GL F
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
HS + ++H DLKPQN+L+++E + K+ DFG+ R
Sbjct: 119 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 24/155 (15%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ--------EVRVLSKLQHPH 398
K+G G + VYKG G VA+K + +L+ ++ E+ ++ +L+H +
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEV-------KLDSEEGTPSTAIREISLMKELKHEN 64
Query: 399 LVTLLGACPEAWS--LVYEYLPN--GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
+V L LV+E++ N D + L ++ GL F
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
H +K I+H DLKPQN+L++ K+ DFG+ R
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 37/149 (24%), Positives = 63/149 (42%), Gaps = 21/149 (14%)
Query: 351 GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACP 407
G G G V + A+KML ++EV + + Q PH+V ++
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDVYE 81
Query: 408 EAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
++ +V E L G L R+ + + ++ + I I + +LHS
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS---IN 137
Query: 462 IVHGDLKPQNILLDSELSS---KICDFGI 487
I H D+KP+N+L S+ + K+ DFG
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 27/154 (17%)
Query: 349 KVGQGGFGCVYKG-EMLGRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHPH 398
K+G+G +G VYK G T A+K + +LE + E+ +L +L+H +
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKI-------RLEKEDEGIPSTTIREISILKELKHSN 61
Query: 399 LVTLLGACPEAWS--LVYEYLPNGSLQD-RLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
+V L LV+E+L QD + L ++ +G+ + H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+ ++H DLKPQN+L++ E KI DFG+ R
Sbjct: 118 DRR---VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 5e-17
Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 23/154 (14%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ--------EVRVLSKLQHPH 398
+G+G F VYK + VAIK + + + E + E+++L +L HP+
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTALREIKLLQELSHPN 73
Query: 399 LVTLLGACPEAWS--LVYEYLPNGSLQD-RLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
++ LL A + LV++++ D + K N L GL +LH
Sbjct: 74 IIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
I+H DLKP N+LLD K+ DFG+ +
Sbjct: 130 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 6e-17
Identities = 41/170 (24%), Positives = 73/170 (42%), Gaps = 38/170 (22%)
Query: 346 ESFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
E KVG+G +G VYK + + A+K + + + +E+ +L +L+HP++++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVIS 82
Query: 402 LLGACPEAWS----LVYEYL-------------PNGSLQDRLFRKSNVSPLLWKDRARIA 444
L L+++Y + + + V LL+
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY------- 135
Query: 445 AEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRL 490
+I G+ +LH++ ++H DLKP NIL+ E KI D G RL
Sbjct: 136 -QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 27/154 (17%)
Query: 349 KVGQGGFGCVYKG-EMLGRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHPH 398
KVG+G +G VYK + GR VA+K + +L+ + E+ +L +L HP+
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRI-------RLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 399 LVTLLGACPEAWS--LVYEYLPNGSLQD-RLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
+V+L+ LV+E++ +D + N + L ++ G+ H
Sbjct: 81 IVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+ I+H DLKPQN+L++S+ + K+ DFG+ R
Sbjct: 137 QHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 7e-17
Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 28/155 (18%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHP 397
K+G+G +G V+K + VA+K + +L+ E+ +L +L+H
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDEGVPSSALREICLLKELKHK 61
Query: 398 HLVTLLGACPEAWS--LVYEYLPNGSLQD-RLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
++V L LV+E+ QD + + S L + ++ GL F
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
HS ++H DLKPQN+L++ K+ +FG+ R
Sbjct: 118 HS---RNVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 71/229 (31%), Positives = 98/229 (42%), Gaps = 68/229 (29%)
Query: 350 VGQGGFGCVY----KGEMLGRTVAIKML----------YSHNMQGQLEFQQEVRVLSK-L 394
+G+G FG V K E A+K+L H M E VL K +
Sbjct: 46 IGKGSFGKVLLARHKAE--EVFYAVKVLQKKAILKKKEEKHIMS-------ERNVLLKNV 96
Query: 395 QHPHLVTLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAE 446
+HP LV L + + V +Y+ G L ++R F + RAR AAE
Sbjct: 97 KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE---------PRARFYAAE 147
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 506
IAS L +LHS IV+ DLKP+NILLDS+ + DFG+C+ E ST
Sbjct: 148 IASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--------STT 196
Query: 507 PKGSF---P-YADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
+F P Y PE VL + D + G ++ ++L G P
Sbjct: 197 --STFCGTPEYLAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 67/221 (30%), Positives = 94/221 (42%), Gaps = 49/221 (22%)
Query: 349 KV-GQGGFGCV----YKGEMLGRTVAIKMLYSHNMQGQLEF---QQEVRVLSK-LQHPHL 399
K+ G+G FG V +K + AIK L + + E RVLS +HP L
Sbjct: 23 KMLGKGSFGKVFLAEFKKT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 400 VTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHS 456
+ E V EYL G L + RA AAEI GL FLHS
Sbjct: 81 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD----LSRATFYAAEIILGLQFLHS 136
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDTLYLPSFHRSTAPKGSF--- 511
+ IV+ DLK NILLD + KI DFG+C+ ++ + +F
Sbjct: 137 ---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN------------TFCGT 181
Query: 512 P-YADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
P Y PE +L + D +SFG+++ ++L G+ P
Sbjct: 182 PDYIAPE-----ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 27/154 (17%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ--------EVRVLSKLQHPH 398
K+G+G + VYKG+ VA+K + +LE ++ EV +L L+H +
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 399 LVTLLGACPEAWS--LVYEYLPNGSLQD-RLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
+VTL S LV+EYL +D + + + + + ++ GL + H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
K ++H DLKPQN+L++ K+ DFG+ R
Sbjct: 118 RQK---VLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 57/222 (25%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQH------PH 398
+G+G FG V K + + VA+KM+ + Q E +R+L L+ +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMN 160
Query: 399 LVTLLGA-------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 451
++ +L C + +E L + +L + L +K+ + A I L
Sbjct: 161 VIHMLENFTFRNHIC-----MTFELL-SMNLYE-LIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSS--KICDFG-ICRLVTEDTLYLPS-FHRSTAP 507
LH ++ I+H DLKP+NILL + S K+ DFG C Y+ S F+R+
Sbjct: 214 DALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRA--- 267
Query: 508 KGSFPYADPEYHRTGVL-----TPKSDSYSFGLIILQLLTGR 544
PE V+ D +S G I+ +LLTG
Sbjct: 268 --------PE-----VILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 55/223 (24%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHP------ 397
+G+G FG V K VAIK++ + Q Q+E VR+L +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE----VRLLELMNKHDTEMKY 116
Query: 398 HLVTLLGA-------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG 450
++V L C LV+E L + +L D L R +N + + A ++ +
Sbjct: 117 YIVHLKRHFMFRNHLC-----LVFEML-SYNLYD-LLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSS--KICDFGICRLVTED-TLYLPS-FHRSTA 506
L FL + + I+H DLKP+NILL + S KI DFG + + Y+ S F+RS
Sbjct: 170 LLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRS-- 226
Query: 507 PKGSFPYADPEYHRTGVL-----TPKSDSYSFGLIILQLLTGR 544
PE VL D +S G I++++ TG
Sbjct: 227 ---------PE-----VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 42/216 (19%)
Query: 350 VGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEF---QQEVRVLSK-LQHPHLVTLL 403
+G+G FG V E A+K+L + + E RVL+ + P L L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 404 GA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 455
+ V EY+ G L Q F++ A AAEIA GL FL
Sbjct: 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE---------PHAVFYAAEIAIGLFFLQ 138
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
S + I++ DLK N++LDSE KI DFG+C+ D + +F G+ Y
Sbjct: 139 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC------GTPDYIA 189
Query: 516 PEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
PE ++ + D ++FG+++ ++L G+ P
Sbjct: 190 PE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 44/217 (20%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF---QQEVRVLSK-LQHPHLVTLL 403
+G+G + V + R A+K++ + + Q E V + HP LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 404 GAC---PEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFL 454
+C V EY+ G L + R + + AR +AEI+ L +L
Sbjct: 77 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE---------EHARFYSAEISLALNYL 126
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
H I++ DLK N+LLDSE K+ D+G+C+ +F G+ Y
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC------GTPNYI 177
Query: 515 DPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
PE +L + D ++ G+++ +++ GR P
Sbjct: 178 APE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 48/191 (25%), Positives = 81/191 (42%), Gaps = 44/191 (23%)
Query: 325 DLPESAEFSLADLQTATCNFSESF----KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNM 378
+ S++ + + + K+G+G +G VYK + TVAIK +
Sbjct: 13 EAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI----- 67
Query: 379 QGQLEFQQ---------EVRVLSKLQHPHLVTLLGACPEAWS--LVYEYLPN--GSLQDR 425
+LE ++ EV +L +LQH +++ L L++EY N D+
Sbjct: 68 --RLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDK 125
Query: 426 L--FRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS--- 480
+ L+ ++ +G+ F HS + +H DLKPQN+LL +S
Sbjct: 126 NPDVSMRVIKSFLY--------QLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETP 174
Query: 481 --KICDFGICR 489
KI DFG+ R
Sbjct: 175 VLKIGDFGLAR 185
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 56/223 (25%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF---QQEVRVLSK-LQHPHLVTLL 403
+G+G + V + R A++++ + + Q E V + HP LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 404 GAC---PEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFL 454
+C V EY+ G L + R + + AR +AEI+ L +L
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE---------EHARFYSAEISLALNYL 169
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDTLYLPSFHRSTAPKGSF- 511
H I++ DLK N+LLDSE K+ D+G+C+ L DT +F
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS------------TFC 214
Query: 512 --P-YADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
P Y PE +L + D ++ G+++ +++ GR P
Sbjct: 215 GTPNYIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 50/153 (32%), Positives = 69/153 (45%), Gaps = 26/153 (16%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF---QQEVRVLSK-LQHPHLVTLL 403
+G+G FG V + G A+K+L + + E R+LS HP L L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 404 GAC--PEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 455
P+ V E++ G L + R F + RAR AAEI S L FLH
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE---------ARARFYAAEIISALMFLH 141
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488
+ I++ DLK N+LLD E K+ DFG+C
Sbjct: 142 D---KGIIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 54/226 (23%), Positives = 87/226 (38%), Gaps = 55/226 (24%)
Query: 350 VGQGGFGCVY-----KGEMLGRTVAIKMLYSHNMQGQLEFQQ----EVRVLSKLQH-PHL 399
+G G +G V+ G G+ A+K+L + + + + E +VL ++ P L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 400 VTLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGL 451
VTL A L+ +Y+ G L Q F + +I EI L
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE---------HEVQIYVGEIVLAL 172
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
LH I++ D+K +NILLDS + DFG+ + D A F
Sbjct: 173 EHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-------ETERA--YDF 220
Query: 512 ---P-YADPEYHRTGVLTPKSDSY-------SFGLIILQLLTGRLP 546
Y P+ ++ + S G+++ +LLTG P
Sbjct: 221 CGTIEYMAPD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 7e-16
Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 34/165 (20%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ-EVRVLSKLQHPHLVTLLGA 405
+G G FG VY+ ++ G VAIK + F+ E++++ KL H ++V L
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYF 115
Query: 406 CPEAWS--------LVYEYLPNGSLQD-----RLFRKSN--VSPLLWKDRARIAAEIASG 450
+ LV +Y+P + R + ++ + + K ++
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVK---LYMYQLFRS 168
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTED 494
L ++HS I H D+KPQN+LLD + + K+CDFG + +
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 2e-15
Identities = 62/223 (27%), Positives = 93/223 (41%), Gaps = 56/223 (25%)
Query: 350 VGQGGFGCVYKGEM--LGRTVAIKML----------YSHNMQGQLEFQQEVRVLSK-LQH 396
+G+G FG V E A+K+L M E RVL+ +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV-------EKRVLALPGKP 401
Query: 397 PHLVTLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIA 448
P L L + V EY+ G L Q F++ A AAEIA
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE---------PHAVFYAAEIA 452
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 508
GL FL S + I++ DLK N++LDSE KI DFG+C+ D + +F
Sbjct: 453 IGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC------ 503
Query: 509 GSFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
G+ Y PE ++ + D ++FG+++ ++L G+ P
Sbjct: 504 GTPDYIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 30/171 (17%)
Query: 342 CNFSESF----KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQ----EVRV 390
+ + ++G G +G VYK G VA+K + N G EV +
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 391 LSKLQ---HPHLVTLLGACPEAWS-------LVYEYLPNGSLQD--RLFRKSNVSPLLWK 438
L +L+ HP++V L+ C + + LV+E++ QD K+ L +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAE 120
Query: 439 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+ + GL FLH++ IVH DLKP+NIL+ S + K+ DFG+ R
Sbjct: 121 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 48/222 (21%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA- 405
GQG FG V G+ G +VAIK + E Q ++ L+ L HP++V L
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSYF 88
Query: 406 CPEAWS--------LVYEYLPNGSLQD-----RLFRKSN--VSPLLWKDRARIAAEIASG 450
+V EY+P R + + P+L K ++
Sbjct: 89 YTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIK---VFLFQLIRS 141
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTED---TLYLPS-FHRST 505
+ LH + H D+KP N+L++ + K+CDFG + ++ Y+ S ++R
Sbjct: 142 IGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYR-- 198
Query: 506 APK---GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
AP+ G+ Y T D +S G I +++ G
Sbjct: 199 APELIFGNQHY-----------TTAVDIWSVGCIFAEMMLGE 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 34/171 (19%)
Query: 342 CNFSESF----KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-F----QQEVRV 390
C+ + K+GQG FG V+K G+ VA+K + M+ + E F +E+++
Sbjct: 13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKI 69
Query: 391 LSKLQHPHLVTLLGACPEAWS----------LVYEYLPNGSLQD--RLFRKSNVSPLLWK 438
L L+H ++V L+ C S LV+++ D L V
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLV-KFTLS 124
Query: 439 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+ R+ + +GL ++H +K I+H D+K N+L+ + K+ DFG+ R
Sbjct: 125 EIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 33/156 (21%)
Query: 349 KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
+G G FG V++ +++ VAIK + +Q + +E++++ ++HP++V L
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 408 EAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE--------IASGL 451
LV EY+P + ++R S K + + + L
Sbjct: 103 SNGDKKDEVFLNLVLEYVP----ET-VYR---ASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFG 486
++HS I H D+KPQN+LLD K+ DFG
Sbjct: 155 AYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG 187
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 38/165 (23%)
Query: 349 KVGQGGFGCVYKG---EMLGRTVAIKMLYSHNMQGQLEFQQE------------VRVLSK 393
++G+G +G V+K + GR VA+K + +++ +E +R L
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRV-------RVQTGEEGMPLSTIREVAVLRHLET 70
Query: 394 LQHPHLVTLLGACPEAWS-------LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRARIA 444
+HP++V L C + + LV+E++ QD K + + +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMM 126
Query: 445 AEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
++ GL FLHS ++VH DLKPQNIL+ S K+ DFG+ R
Sbjct: 127 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 29/194 (14%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQQ----EVRVLSKLQHPHLVTL 402
+G G +G V + ++ R VAIK + + L + E+ +L++L H H+V +
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRLNHDHVVKV 117
Query: 403 LG-ACPEAWS------LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRAR-IAAEIASGLC 452
L P+ +V E D +LFR L + + + + G+
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIAD----SDFKKLFRTPVY---LTELHIKTLLYNLLVGVK 170
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV-TEDTLYLPSFHRSTAPKGSF 511
++HS+ I+H DLKP N L++ + S K+CDFG+ R V + +
Sbjct: 171 YVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 512 PYADPEYHRTGVLT 525
+ LT
Sbjct: 228 VTFPHTKNLKRQLT 241
|
| >2yu4_A E3 SUMO-protein ligase NSE2; SP-ring domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 94 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 1e-13
Identities = 21/73 (28%), Positives = 32/73 (43%), Gaps = 9/73 (12%)
Query: 622 FLCPILQEIMHDP-QVAADGFTYEGKAIRDWLENGRETS-----PMT---NLRLSHLHLT 672
F CPI +E M P + G TYE AI +E+ ++ P + + L
Sbjct: 8 FTCPITKEEMKKPVKNKVCGHTYEEDAIVRMIESRQKRKKKAYCPQIGCSHTDIRKSDLI 67
Query: 673 PNHALRHAIQDWL 685
+ ALR AI++
Sbjct: 68 QDEALRRAIENHN 80
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 41/167 (24%), Positives = 61/167 (36%), Gaps = 27/167 (16%)
Query: 349 KVGQGGFGCVYKG-EMLGRTVAIKMLYSHNMQGQLE--FQQ---------EVRVLSKLQH 396
+ G +G V G + G VAIK +++ G+ E+R+L+ H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 397 PHLVTLLGA-CPEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIA 448
P+++ L LV E + L + + + I
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVIS-PQHIQYFMYHIL 144
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495
GL LH + +VH DL P NILL ICDF + R T D
Sbjct: 145 LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 54/241 (22%), Positives = 93/241 (38%), Gaps = 45/241 (18%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQQ----EVRVLSKLQHPHLVTL 402
+G+G +G VY + + VAIK + + M L + E+ +L++L+ +++ L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 403 LGAC-PEAWS------LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRAR-IAAEIASGLC 452
P+ +V E D +LF+ L ++ + I + G
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIAD----SDLKKLFKTPIF---LTEEHIKTILYNLLLGEN 143
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 512
F+H S I+H DLKP N LL+ + S K+CDFG+ R + + +
Sbjct: 144 FIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 513 YADPEYHRTG-VLT-----P----KSDSY-------SFGLIILQLLTGRLPVGLAGEVRR 555
+ + T V+T P ++Y S G I +LL R
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260
Query: 556 A 556
Sbjct: 261 P 261
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 50/231 (21%), Positives = 92/231 (39%), Gaps = 59/231 (25%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQ-------- 395
K+G G F V+ + + VA+K++ + + E +++L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----IKLLQRVNDADNTKED 81
Query: 396 ---HPHLVTLL------GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE 446
H++ LL G +V+E L +L L +K + +I+ +
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLA-LIKKYEHRGIPLIYVKQISKQ 139
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS------KICDFGICRLVTED-TLYLP 499
+ GL ++H + I+H D+KP+N+L++ S KI D G E T +
Sbjct: 140 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 500 S-FHRSTAPKGSFPYADPEYHRTGVL-----TPKSDSYSFGLIILQLLTGR 544
+ +RS PE VL +D +S +I +L+TG
Sbjct: 198 TREYRS-----------PE-----VLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 36/150 (24%), Positives = 54/150 (36%), Gaps = 22/150 (14%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKL-QHPHL 399
+G+G FG V + + G RTVA+KML E+++L + H ++
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 400 VTLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
V LLGAC ++ E+ G+L L R G F
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLST----------YLRSKRNEFVPYKTKGARFRQG 138
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFG 486
+ DLK + + S SS F
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFV 168
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 36/118 (30%), Positives = 55/118 (46%), Gaps = 14/118 (11%)
Query: 433 SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492
L + + ++A G+ FL S K +H DL +NILL + KICDFG+ R +
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIY 244
Query: 493 EDTLYLPSFHRSTAPKGSFPY---ADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
+D Y P A PE V T +SD +SFG+++ ++ + G P
Sbjct: 245 KDPDY-----VRKG-DARLPLKWMA-PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 36/166 (21%), Positives = 70/166 (42%), Gaps = 27/166 (16%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 405
+G GG G V+ + VAIK + + + + E++++ +L H ++V +
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEI 76
Query: 406 -CPEAWSLVYEYLPNGSLQD-------------RLFRKSNVSPLLWKDRAR-IAAEIASG 450
P L + L + + + + AR ++ G
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE----EHARLFMYQLLRG 132
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDT 495
L ++HS+ ++H DLKP N+ +++E L KI DFG+ R++
Sbjct: 133 LKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 37/158 (23%), Positives = 74/158 (46%), Gaps = 22/158 (13%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGA 405
K+G+G + V++ + V +K+L + + ++E+++L L+ P+++TL
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADI 99
Query: 406 CPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPE 460
+ S LV+E++ N + +L++ L R EI L + HS
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFK-QLYQT------LTDYDIRFYMYEILKALDYCHSMG-- 150
Query: 461 KIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLY 497
I+H D+KP N+++D E ++ D+G+ Y
Sbjct: 151 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 50/215 (23%), Positives = 93/215 (43%), Gaps = 44/215 (20%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKMLY---SHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
+G G G V +L R VAIK L + + ++ E+ ++ + H ++++LL
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 128
Query: 405 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLH 455
+ LV E + +L ++ + L +R + ++ G+ LH
Sbjct: 129 VFTPQKTLEEFQDVYLVMELMDA-NLC-QVIQME-----LDHERMSYLLYQMLCGIKHLH 181
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED---TLYLPS-FHRSTAPK--G 509
S+ I+H DLKP NI++ S+ + KI DFG+ R T Y+ + ++R AP+
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR--APEVIL 236
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
Y D +S G I+ +++ +
Sbjct: 237 GMGY-----------KENVDIWSVGCIMGEMVRHK 260
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 54/211 (25%), Positives = 86/211 (40%), Gaps = 25/211 (11%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH-PHLVTLL-- 403
K+G G FG +Y G + G VAIK+ QL E ++ +Q + T+
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWC 73
Query: 404 GACPEAWSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
GA + +V E L G SL+D LF + L K +A ++ S + ++HS
Sbjct: 74 GAEGDYNVMVMELL--GPSLED-LFNFCSRKFSL-KTVLLLADQMISRIEYIHSK---NF 126
Query: 463 VHGDLKPQNILLDSELSSK---ICDFGICRLVTEDTLYLPSFHRSTAPKGSFP----YAD 515
+H D+KP N L+ I DFG+ + + + H + YA
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ---HIPYRENKNLTGTARYAS 183
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
H + + D S G +++ G LP
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 3e-12
Identities = 39/250 (15%), Positives = 66/250 (26%), Gaps = 61/250 (24%)
Query: 340 ATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHN--------MQGQLEFQQEVRVL 391
T K+G+G FG V++ VAIK++ + E E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 392 SKLQ---------HPHLVTLL------GACPEAWSLVYEYLP--NGSLQDRLFRKSNVSP 434
+L + L G+ P +++ GS DR +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 435 LL--------------------WKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 474
+ I ++ + L + H DL N+LL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGNVLL 195
Query: 475 DSELSSKICD-----------FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 523
K+ G+ V+ L R D + TG
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSCGLQ--VSIIDYTLSRLERDGIVVFCDVSMDEDL-FTGD 252
Query: 524 LTPKSDSYSF 533
+ D Y
Sbjct: 253 GDYQFDIYRL 262
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 49/236 (20%), Positives = 85/236 (36%), Gaps = 55/236 (23%)
Query: 349 KVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP---- 397
+GQGGFGC+Y +M +K+ S N G L E++ + P
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN--GPLFT--ELKFYQRAAKPEQIQ 97
Query: 398 -----HLVTLLGACPEAWS------------LVYEYLPNG-SLQDRLFRKSNVSPLLWKD 439
+ LG S ++ + G LQ ++ + K
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQK-IYEANA-KRFSRKT 153
Query: 440 RARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI--CDFGICRLVTEDTLY 497
+++ I L ++H + VHGD+K N+LL+ + ++ D+G+ Y
Sbjct: 154 VLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY------RY 204
Query: 498 LPS---FHRSTAPKGSFP----YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
P + PK + + H + + D G ++Q LTG LP
Sbjct: 205 CPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 44/215 (20%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
+G G G V +L R VAIK L + + + ++ E+ ++ + H +++ LL
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 91
Query: 405 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLH 455
S +V E + +L ++ + L +R + ++ G+ LH
Sbjct: 92 VFTPQKSLEEFQDVYIVMELMDA-NLC-QVIQME-----LDHERMSYLLYQMLCGIKHLH 144
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED---TLYLPS-FHRSTAPK--G 509
S+ I+H DLKP NI++ S+ + KI DFG+ R T Y+ + ++R AP+
Sbjct: 145 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR--APEVIL 199
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
Y D +S G I+ +++ G
Sbjct: 200 GMGY-----------KENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 49/218 (22%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
VG G +G V + G VAIK L + + + ++ E+ +L +QH +++ LL
Sbjct: 31 HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLL 89
Query: 404 GACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFL 454
A S LV ++ LQ + S ++ + + ++ GL ++
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQT-DLQKIM--GLKFSE----EKIQYLVYQMLKGLKYI 142
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED-TLYLPSFHRST----APK- 508
HS+ +VH DLKP N+ ++ + KI DFG+ R + T Y+ T AP+
Sbjct: 143 HSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV-----VTRWYRAPEV 194
Query: 509 --GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
Y D +S G I+ ++LTG+
Sbjct: 195 ILSWMHY-----------NQTVDIWSVGCIMAEMLTGK 221
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 52/251 (20%), Positives = 99/251 (39%), Gaps = 80/251 (31%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ-EVRVLSKLQHPHLVTLL-- 403
+G G FG V + + G+ A+K + ++ E+ ++ L H +++ L+
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHVNIIKLVDY 68
Query: 404 --------------------------------GACPEAWS------LVYEYLPNGSLQD- 424
+ S ++ EY+P+ +L
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKV 127
Query: 425 -RLFRKSN--VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS- 480
+ F +S + L ++ + F+HS I H D+KPQN+L++S+ ++
Sbjct: 128 LKSFIRSGRSIPMNLIS---IYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTL 181
Query: 481 KICDFGICRLVTED---TLYLPS-FHRSTAPK---GSFPYADPEYHRTGVLTPKSDSYSF 533
K+CDFG + + Y+ S F+R AP+ G+ Y TP D +S
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYR--APELMLGATEY-----------TPSIDLWSI 228
Query: 534 GLIILQLLTGR 544
G + +L+ G+
Sbjct: 229 GCVFGELILGK 239
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 30/190 (15%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLY---SHNMQGQLEFQQEVRVLSKLQ-HPHLVTL 402
K+G+G +G V+K G VA+K ++ ++ Q F+ E+ +L++L H ++V L
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNL 74
Query: 403 LGAC-PEAWS---LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRAR-IAAEIASGLCFLH 455
L + LV++Y+ D + R + +L + + ++ + +LH
Sbjct: 75 LNVLRADNDRDVYLVFDYME----TDLHAVIR----ANILEPVHKQYVVYQLIKVIKYLH 126
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
S ++H D+KP NILL++E K+ DFG+ R + + P +
Sbjct: 127 SGG---LLHRDMKPSNILLNAECHVKVADFGLSR-----SFVNIRRVTNNIPLSINENTE 178
Query: 516 PEYHRTGVLT 525
+LT
Sbjct: 179 NFDDDQPILT 188
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 44/228 (19%), Positives = 83/228 (36%), Gaps = 42/228 (18%)
Query: 349 KVGQGGFGCVYKGEML--GRTVA---IKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
K+G GGFG +Y A +K+ Y N G L E++ ++ +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN--GPLFS--ELKFYQRVAKKDCIKKW 99
Query: 404 GACPEA---------WS------------LVYEYLPNG-SLQDRLFRKSNVSPLLWKDRA 441
+ S +V E L G LQ + ++
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKK--STVL 154
Query: 442 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI--CDFGICRLVTEDTLYLP 499
++ + L ++H ++ VHGD+K N+LL + ++ D+G+ + +
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 500 SFHRSTAP-KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G+ + + H+ L+ +SD G +L+ L G+LP
Sbjct: 212 YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 44/226 (19%), Positives = 77/226 (34%), Gaps = 35/226 (15%)
Query: 349 KVGQGGFGCVYKGEML----------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH 398
+ G +Y+ + ++K L + + + E R LQ
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 399 LVTLLGACPEA-----WS---------LVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARI 443
L A LV L G SLQ S L + ++
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSERSVLQV 164
Query: 444 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI--CDFGICRLVTEDTLYLP-S 500
A + L FLH ++ VHG++ +NI +D E S++ +G ++
Sbjct: 165 ACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221
Query: 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ +G + + H+ + +SD S G +L+ L G LP
Sbjct: 222 EGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 26/160 (16%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKML--YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 405
+G+G +G V + VAIK + + H Q + E+++L + +H +++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 406 -CPEAWS------LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRAR-IAAEIASGLCFLH 455
+V + + D +L + ++S D +I GL ++H
Sbjct: 94 IRAPTIEQMKDVYIVQDLME----TDLYKLLKTQHLSN----DHICYFLYQILRGLKYIH 145
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495
S+ ++H DLKP N+LL++ KICDFG+ R+ D
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 47/226 (20%), Positives = 89/226 (39%), Gaps = 53/226 (23%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKML--YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
+G+G +G V + G VAIK + + + + E+++L +H +++T+
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFN 76
Query: 405 A-CPEAWS------LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRAR-IAAEIASGLCFL 454
P+++ ++ E + D R+ + +L D + + + L
Sbjct: 77 IQRPDSFENFNEVYIIQELMQ----TDLHRVIS----TQMLSDDHIQYFIYQTLRAVKVL 128
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST--------- 505
H S ++H DLKP N+L++S K+CDFG+ R++ E
Sbjct: 129 HGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 506 ----APK---GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
AP+ S Y + D +S G I+ +L R
Sbjct: 186 RWYRAPEVMLTSAKY-----------SRAMDVWSCGCILAELFLRR 220
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 46/239 (19%), Positives = 82/239 (34%), Gaps = 73/239 (30%)
Query: 349 KVGQGGFGCVYK---GEMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHP----- 397
+G+G FG V + VA+K++ + +LE + VL K++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKENK 81
Query: 398 -HLVTLLGA-------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIAS 449
V + C + +E L + + +++N P +A ++
Sbjct: 82 FLCVLMSDWFNFHGHMC-----IAFELL-GKNTFE-FLKENNFQPYPLPHVRHMAYQLCH 134
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSS-------------------KICDFGICRL 490
L FLH ++ + H DLKP+NIL + ++ DFG
Sbjct: 135 ALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191
Query: 491 VTED-TLYLPS-FHRSTAPKGSFPYADPEYHRTGVL----TPKSDSYSFGLIILQLLTG 543
E T + + +R PE +L D +S G I+ + G
Sbjct: 192 DHEHHTTIVATRHYRP-----------PE----VILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 52/244 (21%), Positives = 88/244 (36%), Gaps = 79/244 (32%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQH-----PH 398
K+G G FG V + A+K++ + ++E +L K+Q+ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNNN 97
Query: 399 LVTLLGA-------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 451
+V G C L++E L SL + + ++N + +D EI L
Sbjct: 98 IVKYHGKFMYYDHMC-----LIFEPL-GPSLYE-IITRNNYNGFHIEDIKLYCIEILKAL 150
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSS-------------------------KICDFG 486
+L + H DLKP+NILLD K+ DFG
Sbjct: 151 NYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
Query: 487 ICRLVTED-TLYLPS-FHRSTAPKGSFPYADPEYHRTGVL-----TPKSDSYSFGLIILQ 539
++ + + +R+ PE V+ SD +SFG ++ +
Sbjct: 208 CATFKSDYHGSIINTRQYRA-----------PE-----VILNLGWDVSSDMWSFGCVLAE 251
Query: 540 LLTG 543
L TG
Sbjct: 252 LYTG 255
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 48/217 (22%)
Query: 350 VGQGGFGCVYK--GEMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
VG G +G V G VA+K L + + + ++ E+R+L ++H +++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 405 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLH 455
A S LV + L + + K L D + + +I GL ++H
Sbjct: 96 VFTPARSLEEFNDVYLVTHLMGA-DLNNIV--KCQK---LTDDHVQFLIYQILRGLKYIH 149
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED-TLYLPSFHRST----APK-- 508
S+ I+H DLKP N+ ++ + KI DFG+ R ++ T Y+ +T AP+
Sbjct: 150 SAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-----ATRWYRAPEIM 201
Query: 509 -GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
Y D +S G I+ +LLTGR
Sbjct: 202 LNWMHY-----------NQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 46/216 (21%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
VG G +G V G VAIK L + + + ++ E+R+L ++H +++ LL
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLD 91
Query: 405 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
+ LV ++ L + L + ++ GL ++H+
Sbjct: 92 VFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 146
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED-TLYLPSFHRST----APK--- 508
+ I+H DLKP N+ ++ + KI DFG+ R + T Y+ T AP+
Sbjct: 147 AG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV-----VTRWYRAPEVIL 198
Query: 509 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
Y T D +S G I+ +++TG+
Sbjct: 199 NWMRY-----------TQTVDIWSVGCIMAEMITGK 223
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 52/239 (21%), Positives = 89/239 (37%), Gaps = 73/239 (30%)
Query: 349 KVGQGGFGCVYKG---EMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHP----- 397
+G+G FG V + + GR VA+K++ + + + E ++VL L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE----IQVLEHLNTTDPNST 76
Query: 398 -HLVTLLGA-------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIAS 449
V +L C +V+E L S D +++ P ++A +I
Sbjct: 77 FRCVQMLEWFEHHGHIC-----IVFELL-GLSTYD-FIKENGFLPFRLDHIRKMAYQICK 129
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSS-------------------KICDFGICRL 490
+ FLHS K+ H DLKP+NIL + K+ DFG
Sbjct: 130 SVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY 186
Query: 491 VTED-TLYLPS-FHRSTAPKGSFPYADPEYHRTGVL----TPKSDSYSFGLIILQLLTG 543
E + + + +R+ PE +L + D +S G I+++ G
Sbjct: 187 DDEHHSTLVSTRHYRA-----------PE----VILALGWSQPCDVWSIGCILIEYYLG 230
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 25/211 (11%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLL-- 403
K+G G FG +Y G VAIK+ QL + E ++ LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWF 71
Query: 404 GACPEAWSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
G + LV + L G SL+D LF + L K +A ++ + + F+HS +
Sbjct: 72 GVEGDYNVLVMDLL--GPSLED-LFNFCSRKLSL-KTVLMLADQMINRVEFVHS---KSF 124
Query: 463 VHGDLKPQNILLDSELSSK---ICDFGICRLVTEDTLYLPSFHRSTAPKGSFP----YAD 515
+H D+KP N L+ + I DFG+ + + + + H + YA
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ---HIPYRENKNLTGTARYAS 181
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
H + + D S G +++ L G LP
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 2e-10
Identities = 99/616 (16%), Positives = 190/616 (30%), Gaps = 209/616 (33%)
Query: 207 FESAYAREMHL--RKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQEAN 264
FE+ E + + + F +++ +++ L
Sbjct: 9 FETG---EHQYQYKDILSVFEDAFVDN---------FDCKDVQDMPKSI-LSKEEIDHII 55
Query: 265 RRRDEATGELKLIQASIATLQQEKQRIRRQKVEAV-----RWL-ERWRSRGQAGAANYDG 318
+D +G L+L TL +++ + ++ VE V ++L ++ + +
Sbjct: 56 MSKDAVSGTLRLFW----TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM 111
Query: 319 FIGLVEDLPESAE-FS---------LADLQTATCNFSESFKVG-QGGFGCVYKGEMLGRT 367
+I + L + F+ L+ A + V G G G+T
Sbjct: 112 YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS-------GKT 164
Query: 368 V-AIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEA-----WSLVYEYLPN 419
A+ + S+ +Q +++F+ + + L C PE L+Y+ PN
Sbjct: 165 WVALDVCLSYKVQCKMDFK----I-------FWLNL-KNCNSPETVLEMLQKLLYQIDPN 212
Query: 420 GSLQDRLFRKSNVSPLL--WKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE 477
R SN+ + + R L SKP + L ++L +
Sbjct: 213 --WTSRSDHSSNIKLRIHSIQAELRR----------LLKSKPYENC---L----LVLLNV 253
Query: 478 LSSKICD-FGI-CR-LVT----EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDS 530
++K + F + C+ L+T + T +L + + H + LTP
Sbjct: 254 QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLD---------HHSMTLTP---D 301
Query: 531 YSFGLI--ILQLLTGRLP----------VGLAGE-VR---------RAVSCGKLSSI--- 565
L+ L LP + + E +R + V+C KL++I
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES 361
Query: 566 -LDPLAGDWPTFVARRLVDLG------------LQCCELYGRERPDITPSLVKELEQLHV 612
L+ L P + L L ++ +V +L + +
Sbjct: 362 SLNVLE---PAEYRKMFDRLSVFPPSAHIPTILL--SLIWFDVIKSDVMVVVNKLHKYSL 416
Query: 613 AEERP------VPSFFL---CPILQEI-MHD-----------------PQVAADG--FTY 643
E++P +PS +L + E +H D +++
Sbjct: 417 VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH 476
Query: 644 EG---KAIR---------------DWLENG-RETSPMTNLRLSHL-----------HLTP 673
G K I +LE R S N S L ++
Sbjct: 477 IGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICD 536
Query: 674 NHALRH----AIQDWL 685
N AI D+L
Sbjct: 537 NDPKYERLVNAILDFL 552
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 5e-08
Identities = 63/430 (14%), Positives = 119/430 (27%), Gaps = 131/430 (30%)
Query: 3 IHGIQKLVMGAFPDNCMKVKMGSRK---ASYAAKNAP----MFCEIWFVNKGK------- 48
I G + GS K A + M +I+++N
Sbjct: 155 IDG-----VL-----------GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETV 198
Query: 49 ------------HVWTKEASESPNSFLPFCGAETRSAKMLRSRSLENCNGTSLFNPESIL 96
WT + S N L + ++L+S+ ENC L +L
Sbjct: 199 LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC----LL----VL 250
Query: 97 SRSATTLTHVGITDWVQSDPVHMVFPSSPTISCSDMNLFSPRSSS----AGSGYMSEKRE 152
VQ+ F +SC L + R + +
Sbjct: 251 -------------LNVQNAKAWNAF----NLSCK--ILLTTRFKQVTDFLSAATTTHISL 291
Query: 153 STDSDSKVEEDPLYVQHREVSIKAEELRNSA----------FAEFLRR--------KKLE 194
S + ++ + + + + ++L AE +R K +
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVN 351
Query: 195 SEAMEAIGK--VKAFESAYAREMH-----LRKEA---EDALQTTIQDQEKLKQEKAFVTQ 244
+ + I + + E A R+M A L + + +K + V
Sbjct: 352 CDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLS--LIWFDVIKSDVMVVVN 409
Query: 245 ELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLER 304
+LH+ +L+ ++ E+T + I + + + + R V+ +
Sbjct: 410 KLHKY----SLVE-------KQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKT 458
Query: 305 WRSRGQAGAANYDG----FIG----LVEDLPESAEFS--LADLQTATCNFSESFKVGQGG 354
+ S D IG +E F D F E K+
Sbjct: 459 FDSDD-LIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDF-----RFLEQ-KIRHDS 511
Query: 355 FGCVYKGEML 364
G +L
Sbjct: 512 TAWNASGSIL 521
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 49/217 (22%), Positives = 83/217 (38%), Gaps = 35/217 (16%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH----PHLVTL 402
++G+G FG +++G + + VAIK + QL E R L P++
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYY- 73
Query: 403 LGACPEAWSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
G LV + L G SL+D L + K A A ++ + + +H +
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLED-LLDLCGRKFSV-KTVAMAAKQMLARVQSIHE---KS 126
Query: 462 IVHGDLKPQNILLDSELSSK-----ICDFGICRLVTEDTLYLPSFHRSTAPK-------G 509
+V+ D+KP N L+ S + DFG+ + Y + P G
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK------FYRDPVTKQHIPYREKKNLSG 180
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ Y H + + D + G + + L G LP
Sbjct: 181 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 35/217 (16%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH----PHLVTL 402
K+G G FG + G+ L VAIK+ + QL E R +L P +
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYF 73
Query: 403 LGACPEAWSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
G C + ++V E L G SL+D LF + + L K IA ++ S + ++HS +
Sbjct: 74 -GPCGKYNAMVLELL--GPSLED-LFDLCDRTFSL-KTVLMIAIQLISRMEYVHS---KN 125
Query: 462 IVHGDLKPQNILLDSELSSK-----ICDFGICRLVTEDTLYLPSF---HRSTAPKGSFP- 512
+++ D+KP+N L+ + I DF + + Y+ H S
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK------EYIDPETKKHIPYREHKSLTG 179
Query: 513 ---YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y H + + D + G + + L G LP
Sbjct: 180 TARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 40/151 (26%), Positives = 63/151 (41%), Gaps = 33/151 (21%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-----HP---H 398
K+G G F V+ + VA+K++ S + E+R+L ++ P
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102
Query: 399 LVTLLGA-----------CPEAWSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAE 446
+V LL C +V+E L G L KSN L +I +
Sbjct: 103 VVQLLDDFKISGVNGTHIC-----MVFEVL--GHHLLK-WIIKSNYQGLPLPCVKKIIQQ 154
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSE 477
+ GL +LH+ +I+H D+KP+NILL
Sbjct: 155 VLQGLDYLHTKC--RIIHTDIKPENILLSVN 183
|
| >2bay_A PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin ligase, E3 ligase; 1.50A {Saccharomyces cerevisiae} SCOP: g.44.1.2 PDB: 1n87_A Length = 61 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-06
Identities = 11/55 (20%), Positives = 23/55 (41%), Gaps = 2/55 (3%)
Query: 620 SFFLCPILQEIMHDPQVA-ADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTP 673
S LC I ++ P ++ +E + ++++ P+TN LS +
Sbjct: 2 SHMLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVE 55
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 30/148 (20%), Positives = 54/148 (36%), Gaps = 14/148 (9%)
Query: 175 KAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYA----------REMHLRKEAEDA 224
+ +L E R+KL+ E + A GK+K E +E L +E
Sbjct: 956 QMLDLEEQLEEEEAARQKLQLEKVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSD 1015
Query: 225 LQTTIQDQE----KLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQAS 280
L T + ++E L + K + + QE + + + GE +
Sbjct: 1016 LTTNLAEEEEKAKNLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRKLEGESSDLHEQ 1075
Query: 281 IATLQQEKQRIRRQKVEAVRWLERWRSR 308
IA LQ + ++ Q + L+ +R
Sbjct: 1076 IAELQAQIAELKAQLAKKEEELQAALAR 1103
|
| >3htk_C E3 SUMO-protein ligase MMS21; SUMO E3 ligase, SPL-ring, ring, ATP-binding, chromosomal protein, coiled coil, DNA damage; 2.31A {Saccharomyces cerevisiae} Length = 267 | Back alignment and structure |
|---|
Score = 44.6 bits (104), Expect = 5e-05
Identities = 8/67 (11%), Positives = 22/67 (32%), Gaps = 4/67 (5%)
Query: 622 FLCPILQEIMHDPQVAAD-GFTYEGKAIRDWLENGRETS-PMT--NLRLSHLHLTPNHAL 677
CPI + P ++ ++ I+++L+ P + +S + +
Sbjct: 182 LTCPITCKPYEAPLISRKCNHVFDRDGIQNYLQGYTTRDCPQAACSQVVSMRDFVRDPIM 241
Query: 678 RHAIQDW 684
+
Sbjct: 242 ELRCKIA 248
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 22/124 (17%), Positives = 46/124 (37%), Gaps = 7/124 (5%)
Query: 175 KAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEK 234
+A+E A R K+LE E + K+KA E + +AL+ + E
Sbjct: 21 RADEAEADKKAAEDRSKQLEDELVSLQKKLKATEDE-------LDKYSEALKDAQEKLEL 73
Query: 235 LKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQ 294
+++ ++ R + L A R A +L+ + + ++ + I +
Sbjct: 74 AEKKATDAEADVASLNRRIQLFEEELDRAQERLATALQKLEEAEKAADESERGMKVIESR 133
Query: 295 KVEA 298
+
Sbjct: 134 AQKD 137
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 24/134 (17%), Positives = 48/134 (35%), Gaps = 7/134 (5%)
Query: 161 EEDPLYVQHREVSIKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKE 220
E D + K EE +A K +ES A + K++ E H+ ++
Sbjct: 98 ELDRAQERLATALQKLEEAEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAED 157
Query: 221 AEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQAS 280
A+ + E++ ++ + +L R L + E T LK ++A
Sbjct: 158 AD-------RKYEEVARKLVIIESDLERAEERAELSEGKCAELEEEIKTVTNNLKSLEAQ 210
Query: 281 IATLQQEKQRIRRQ 294
Q++ + +
Sbjct: 211 AEKYSQKEDKYEEE 224
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 19/171 (11%), Positives = 53/171 (30%), Gaps = 18/171 (10%)
Query: 149 EKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFE 208
K+ ++K+ + + I + + E + LE K+++
Sbjct: 919 YKKLHIGLENKIMQ-------LQRKIDEQNKEYKSLLE--KMNNLEITYSTETEKLRSDV 969
Query: 209 SAYAREM-------HLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQ 261
+ ++ + ++ + + EK + + + L S +
Sbjct: 970 ERLRMSEEEAKNATNRVLSLQEEIAKLRKELHQTQTEKKTIEEWADKYKHETEQLVSELK 1029
Query: 262 EANRRRDEATGEL--KLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQ 310
E N EL ++ + + ++++ + + L R R Q
Sbjct: 1030 EQNTLLKTEKEELNRRIHDQAKEITETMEKKLVEETKQLELDLNDERLRYQ 1080
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 688 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-19 | |
| d1t1ha_ | 78 | g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cre | 9e-19 | |
| d2c2la2 | 80 | g.44.1.2 (A:225-304) STIP1 homology and U box-cont | 1e-14 | |
| d1wgma_ | 98 | g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Hu | 3e-11 | |
| d1jm7a_ | 103 | g.44.1.1 (A:) brca1 RING domain {Human (Homo sapie | 2e-06 | |
| d2es4d1 | 280 | a.137.15.1 (D:53-332) Lipase chaperone LifO (LipB) | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 1e-63
Identities = 75/271 (27%), Positives = 123/271 (45%), Gaps = 24/271 (8%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
++G G FG VYKG+ VA+KML Q F+ EV VL K +H +++ +G
Sbjct: 15 RIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 407 PEAW-SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
++V ++ SL L IA + A G+ +LH + I+H
Sbjct: 74 TAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT---G 522
DLK NI L +L+ KI DFG+ + + + H+ GS + PE R
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS----HQFEQLSGSILWMAPEVIRMQDKN 184
Query: 523 VLTPKSDSYSFGLIILQLLTGRLP---VGLAGEVRRAVSCGKLSSILDPLAGDWPTFVAR 579
+ +SD Y+FG+++ +L+TG+LP + ++ V G LS L + + P +
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP----K 240
Query: 580 RLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+ L +C + ERP ++ +E L
Sbjct: 241 AMKRLMAECLKKKRDERPLFP-QILASIELL 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-56
Identities = 74/269 (27%), Positives = 111/269 (41%), Gaps = 18/269 (6%)
Query: 349 KVGQGGFGCVYKGEM-LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 406
++G G FG V+ G VA+K L +M F E ++ +LQH LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 407 PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466
E ++ EY+ NGSL D L S + L +AA+IA G+ F+ +H D
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134
Query: 467 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTP 526
L+ NIL+ LS KI DFG+ RL+ ++ + K + PE G T
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNE-----YTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 527 KSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGL 586
KSD +SFG+++ +++T + ++ P L L
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEV-----IQNLERGYRMVRPDNCPEELYQLMR 244
Query: 587 QCCELYGRERPDITPSLVKELEQLHVAEE 615
C + +RP L LE A E
Sbjct: 245 LCWKERPEDRPTFD-YLRSVLEDFFTATE 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 9e-56
Identities = 62/265 (23%), Positives = 109/265 (41%), Gaps = 24/265 (9%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 408
+G+G FG V G+ G VA+K + N F E V+++L+H +LV LLG E
Sbjct: 14 TIGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 409 AWS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
+V EY+ GSL D L + S L + + ++ + +L VH
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHR 127
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLT 525
DL +N+L+ + +K+ DFG+ + + K + PE R +
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ---------DTGKLPVKWTAPEALREKKFS 178
Query: 526 PKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLG 585
KSD +SFG+++ ++ + ++ + + D P + ++
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----VPRVEKGYKMDAPDGCPPAVYEVM 233
Query: 586 LQCCELYGRERPDITPSLVKELEQL 610
C L RP L ++LE +
Sbjct: 234 KNCWHLDAAMRPSFL-QLREQLEHI 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-55
Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 337 LQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSK 393
++ +F + ++G G G V+K G +A K+++ +E++VL +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 394 LQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 451
P++V GA S+ E++ GSL L + + + +++ + GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
+L KI+H D+KP NIL++S K+CDFG+ + + + + G+
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------MANSFVGTR 167
Query: 512 PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y PE + + +SD +S GL ++++ GR P
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 8e-55
Identities = 60/266 (22%), Positives = 110/266 (41%), Gaps = 22/266 (8%)
Query: 349 KVGQGGFGCVYKGEM-LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 406
++G G FG V G+ VAIKM+ + EF +E +V+ L H LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 407 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
++ EY+ NG L + L + + + ++ + +L ++ +H
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 124
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLT 525
DL +N L++ + K+ DFG+ R V +D + S K ++ PE +
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDE-----YTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 526 PKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDL 584
KSD ++FG+++ ++ + G++P I L P + ++ +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMP--YERFTNSET----AEHIAQGLRLYRPHLASEKVYTI 233
Query: 585 GLQCCELYGRERPDITPSLVKELEQL 610
C ERP L+ + +
Sbjct: 234 MYSCWHEKADERPTFK-ILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-54
Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 20/265 (7%)
Query: 349 KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 406
++G G FG V+ G L VAIK + + +F +E V+ KL HP LV L G C
Sbjct: 12 EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 407 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
LV+E++ +G L D L + + + + ++ G+ +L ++H
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLEE---ACVIHR 125
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLT 525
DL +N L+ K+ DFG+ R V +D + ST K +A PE +
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQ-----YTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 526 PKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLG 585
KSD +SFG+++ ++ + + I P + + +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDISTGFRLYKPRLASTHVYQIM 235
Query: 586 LQCCELYGRERPDITPSLVKELEQL 610
C + +RP + L+++L ++
Sbjct: 236 NHCWKERPEDRPAFS-RLLRQLAEI 259
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (472), Expect = 3e-54
Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 31/297 (10%)
Query: 332 FSLADLQTATCNFSESF---------KVGQGGFGCVYKGEM-----LGRTVAIKMLYSHN 377
F+ D A F++ +G G FG V G + VAIK L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 378 MQGQL-EFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSP 434
+ Q +F E ++ + HP+++ L G ++ E++ NGSL F + N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ 124
Query: 435 LLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494
+ IA+G+ +L VH DL +NIL++S L K+ DFG+ R + +D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV 553
T P++ + K + PE + T SD +S+G+++ ++++ G P
Sbjct: 182 T-SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMT 238
Query: 554 RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+ V +++I P L L L C + RP +V L+++
Sbjct: 239 NQDV----INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG-QIVNTLDKM 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-53
Identities = 73/296 (24%), Positives = 129/296 (43%), Gaps = 24/296 (8%)
Query: 324 EDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM 378
+L ++ + + + +F+E +G+G FGCVY G +L A+K L
Sbjct: 11 PELVQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 68
Query: 379 QGQLE-FQQEVRVLSKLQHPHLVTLLGACPEAWS---LVYEYLPNGSLQDRLFRKSNVSP 434
G++ F E ++ HP++++LLG C + +V Y+ +G L++ F ++
Sbjct: 69 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHN 126
Query: 435 LLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494
KD ++A G+ FL +K VH DL +N +LD + + K+ DFG+ R + +
Sbjct: 127 PTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183
Query: 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR 554
S H T K + E +T T KSD +SFG+++ +L+T P
Sbjct: 184 EFD--SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241
Query: 555 RAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+L P + L ++ L+C RP + LV + +
Sbjct: 242 DI-----TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS-ELVSRISAI 291
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-53
Identities = 69/272 (25%), Positives = 116/272 (42%), Gaps = 24/272 (8%)
Query: 346 ESFKVGQGGFGCVYKGEM----LGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHL 399
E ++G G FG V KG + +TVA+K+L + L E E V+ +L +P++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 400 VTLLGAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
V ++G C E+W LV E G L L + + K+ + +++ G+ +L
Sbjct: 71 VRMIGICEAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE--- 124
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
VH DL +N+LL ++ +KI DFG+ + + D Y + T K + PE
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY---YKAQTHGKWPVKWYAPEC 181
Query: 519 HRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577
+ KSD +SFG+++ + + G+ P G V + + P
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEV----TAMLEKGERMGCPAGC 235
Query: 578 ARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609
R + DL C RP ++ L
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFA-AVELRLRN 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-53
Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 22/282 (7%)
Query: 346 ESFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLV 400
++G G FG V +G VAIK+L + E +E +++ +L +P++V
Sbjct: 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 401 TLLGACPEA-WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
L+G C LV E G L L K + + A + +++ G+ +L
Sbjct: 73 RLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLE---E 127
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
+ VH DL +N+LL + +KI DFG+ + + D Y +A K + PE
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY---TARSAGKWPLKWYAPECI 184
Query: 520 RTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA 578
+ +SD +S+G+ + + L+ G+ P V ++ I + P
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGPEV----MAFIEQGKRMECPPECP 238
Query: 579 RRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPS 620
L L C +RPD ++ + + + + V
Sbjct: 239 PELYALMSDCWIYKWEDRPDFL-TVEQRMRACYYSLASKVEG 279
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 4e-53
Identities = 62/294 (21%), Positives = 105/294 (35%), Gaps = 40/294 (13%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 408
+G+G FG V++G+ G VA+K+ S + + E+ L+H +++ + A +
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 409 AWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE-- 460
LV +Y +GSL D L R + + ++A ASGL LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 461 ---KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
I H DLK +NIL+ + I D G+ T + G+ Y PE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID--IAPNHRVGTKRYMAPE 182
Query: 518 YHRTGV------LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC------------ 559
+ ++D Y+ GL+ ++ G+ + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 560 -GKLSSILDPLAGDWPTF--VARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
L P + R + + +C G R + K L QL
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL-RIKKTLSQL 295
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (459), Expect = 2e-52
Identities = 64/267 (23%), Positives = 119/267 (44%), Gaps = 22/267 (8%)
Query: 349 KVGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G G +G VY+G TVA+K L M+ + EF +E V+ +++HP+LV LLG C
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
+ ++ E++ G+L D L + + +A +I+S + +L +H
Sbjct: 83 TREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIH 138
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 524
DL +N L+ K+ DFG+ RL+T DT K + PE
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY-----TAHAGAKFPIKWTAPESLAYNKF 193
Query: 525 TPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDP-LAGDWPTFVARRLVD 583
+ KSD ++FG+++ ++ T + + ++ +L+ + P ++ +
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMS------PYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247
Query: 584 LGLQCCELYGRERPDITPSLVKELEQL 610
L C + +RP + + E +
Sbjct: 248 LMRACWQWNPSDRPSFA-EIHQAFETM 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 4e-52
Identities = 83/271 (30%), Positives = 113/271 (41%), Gaps = 18/271 (6%)
Query: 349 KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 406
K+GQG FG V+ G VAIK L M + F QE +V+ KL+H LV L
Sbjct: 24 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 82
Query: 407 PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466
E +V EY+ GSL + L +AA+IASG+ ++ VH D
Sbjct: 83 EEPIYIVTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 138
Query: 467 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTP 526
L+ NIL+ L K+ DFG+ RL+ ++ + K + PE G T
Sbjct: 139 LRAANILVGENLVCKVADFGLARLIEDNE-----YTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 527 KSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGL 586
KSD +SFG+++ +L T G V R V L + P L DL
Sbjct: 194 KSDVWSFGILLTELTTKGRVP-YPGMVNREV----LDQVERGYRMPCPPECPESLHDLMC 248
Query: 587 QCCELYGRERPDITPSLVKELEQLHVAEERP 617
QC ERP L LE + E
Sbjct: 249 QCWRKEPEERPTFE-YLQAFLEDYFTSTEPQ 278
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-51
Identities = 64/262 (24%), Positives = 104/262 (39%), Gaps = 28/262 (10%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLG 404
++G+G F VYKG VA L + + F++E +L LQHP++V
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 405 AC------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
+ + LV E + +G+L+ L R + K +I GL FLH+
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 459 PEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
P I+H DLK NI + S KI D G+ L + A G+ + PE
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--------SFAKAVIGTPEFMAPE 183
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577
+ D Y+FG+ +L++ T P + A +++S + P +
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVKPA--SFDKVA 238
Query: 578 ARRLVDLGLQCCELYGRERPDI 599
+ ++ C ER I
Sbjct: 239 IPEVKEIIEGCIRQNKDERYSI 260
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (448), Expect = 7e-51
Identities = 66/309 (21%), Positives = 118/309 (38%), Gaps = 44/309 (14%)
Query: 333 SLADLQTATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQL-EF 384
L L+ N +G+G FG V++ VA+KML +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 385 QQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKS------------ 430
Q+E ++++ +P++V LLG C + L++EY+ G L + L S
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 431 ---------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSK 481
PL ++ IA ++A+G+ +L K VH DL +N L+ + K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 482 ICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLL 541
I DFG+ R + Y + PE T +SD +++G+++ ++
Sbjct: 181 IADFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 542 TGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITP 601
+ L + + D P L +L C +RP
Sbjct: 237 SYGLQPYYGMAHEEV-----IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC- 290
Query: 602 SLVKELEQL 610
S+ + L+++
Sbjct: 291 SIHRILQRM 299
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-50
Identities = 57/262 (21%), Positives = 102/262 (38%), Gaps = 23/262 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLG 404
+G G +G K G+ + K L +M EV +L +L+HP++V
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 405 ACPEAWS----LVYEYLPNGSLQDRLFRKSNVS-PLLWKDRARIAAEIASGLCFLH--SS 457
+ + +V EY G L + + + L + R+ ++ L H S
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
++H DLKP N+ LD + + K+ DFG+ R++ DT + +F + Y PE
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG------TPYYMSPE 184
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577
KSD +S G ++ +L P ++ + I + P
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKEL----AGKIREGKFRRIPYRY 238
Query: 578 ARRLVDLGLQCCELYGRERPDI 599
+ L ++ + L RP +
Sbjct: 239 SDELNEIITRMLNLKDYHRPSV 260
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 3e-50
Identities = 55/260 (21%), Positives = 98/260 (37%), Gaps = 24/260 (9%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
++G G FG VYK + A K++ + + + ++ E+ +L+ HP++V LL A
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
++ E+ G++ + PL + + L +LH +K I+H
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---IIH 133
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY-----H 519
DLK NIL + K+ DFG+ T R + G+ + PE
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTI------QRRDSFIGTPYWMAPEVVMCETS 187
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVAR 579
+ K+D +S G+ ++++ P V S L P+ +
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPP--HHELNPMRVLLKIAKSEPPTL--AQPSRWSS 243
Query: 580 RLVDLGLQCCELYGRERPDI 599
D +C E R
Sbjct: 244 NFKDFLKKCLEKNVDARWTT 263
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-49
Identities = 66/277 (23%), Positives = 115/277 (41%), Gaps = 23/277 (8%)
Query: 343 NFSESFKVGQGGFGCVYKGEM------LGRTVAIKMLYSHNMQGQL-EFQQEVRVLSKLQ 395
+ +G G FG VYKG + VAIK L + + Q +F E ++ +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 396 HPHLVTLLGACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCF 453
H +++ L G + ++ EY+ NG+L L K + IA+G+ +
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKY 125
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 513
L + VH DL +NIL++S L K+ DFG+ R++ +D + ++ K +
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT---YTTSGGKIPIRW 179
Query: 514 ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 573
PE T SD +SFG+++ +++T + +I D
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-----MKAINDGFRLPT 234
Query: 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
P + L +QC + RP +V L++L
Sbjct: 235 PMDCPSAIYQLMMQCWQQERARRPKFA-DIVSILDKL 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 3e-49
Identities = 65/261 (24%), Positives = 110/261 (42%), Gaps = 32/261 (12%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLL 403
+G+G FG VY +A+K+L+ + + + ++EV + S L+HP+++ L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 404 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
G L+ EY P G++ L + S + A E+A+ L + HS +
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR--- 126
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
++H D+KP+N+LL S KI DFG R T G+ Y PE
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--------RRTTLCGTLDYLPPEMIEG 178
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTFVAR 579
+ K D +S G++ + L G+ P E + +S + +P FV
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF---------TFPDFVTE 229
Query: 580 RLVDLGLQCCELYGRERPDIT 600
DL + + +RP +
Sbjct: 230 GARDLISRLLKHNPSQRPMLR 250
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 8e-49
Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 21/255 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+GQG G VY + G+ VAI+ + + E+ V+ + ++P++V L +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
+ +V EYL GSL D + A + E L FLHS +++H
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLHS---NQVIH 139
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 524
D+K NILL + S K+ DFG C +T + + + G+ + PE
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------SKRSTMVGTPYWMAPEVVTRKAY 193
Query: 525 TPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDL 584
PK D +S G++ ++++ G P E ++ L P ++ D
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIATNGTPEL--QNPEKLSAIFRDF 249
Query: 585 GLQCCELYGRERPDI 599
+C ++ +R
Sbjct: 250 LNRCLDMDVEKRGSA 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-48
Identities = 68/272 (25%), Positives = 117/272 (43%), Gaps = 24/272 (8%)
Query: 349 KVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLV 400
K+G G FG V +GE +VA+K L + + +F +EV + L H +L+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 401 TLLGACPEAW-SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
L G +V E P GSL DRL + L +R A ++A G+ +L S
Sbjct: 75 RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLES--- 129
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
++ +H DL +N+LL + KI DFG+ R + ++ + K F + PE
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND---DHYVMQEHRKVPFAWCAPESL 186
Query: 520 RTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA 578
+T + SD++ FG+ + ++ T G+ P + K + P
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-----EGERLPRPEDCP 241
Query: 579 RRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+ + ++ +QC +RP +L L +
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFV-ALRDFLLEA 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-48
Identities = 71/288 (24%), Positives = 115/288 (39%), Gaps = 38/288 (13%)
Query: 349 KVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKL-QHPHL 399
+G G FG V + TVA+KML + E E++VLS L H ++
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 400 VTLLGAC--PEAWSLVYEYLPNGSLQDRLFRK---------------SNVSPLLWKDRAR 442
V LLGAC ++ EY G L + L RK + L +D
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502
+ ++A G+ FL S + +H DL +NILL +KICDFG+ R + D+ ++
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS----NYV 202
Query: 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKL 562
+ + PE V T +SD +S+G+ + +L + V
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF----Y 258
Query: 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
I + P + D+ C + +RP +V+ +E+
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK-QIVQLIEKQ 305
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 2e-48
Identities = 61/267 (22%), Positives = 97/267 (36%), Gaps = 31/267 (11%)
Query: 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ---LEFQQEVRVLSKLQHPH 398
FS+ ++G G FG VY + VAIK + Q + +EVR L KL+HP+
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 399 LVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
+ G LV EY + K PL + A + GL +LHS
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHS 133
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
++H D+K NILL K+ DFG ++ ++ G+ + P
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV----------GTPYWMAP 180
Query: 517 EY---HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 573
E G K D +S G+ ++L + P L + + L
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQNESPALQ--- 235
Query: 574 PTFVARRLVDLGLQCCELYGRERPDIT 600
+ + C + ++RP
Sbjct: 236 SGHWSEYFRNFVDSCLQKIPQDRPTSE 262
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 170 bits (432), Expect = 5e-48
Identities = 56/257 (21%), Positives = 104/257 (40%), Gaps = 21/257 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
++G G FG V++ G A K + + + + ++E++ +S L+HP LV L A
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
++YE++ G L +++ + N + + ++ GLC +H VH
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNYVH 147
Query: 465 GDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
DLKP+NI+ ++ S+ K+ DFG+ + G+ +A PE
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-------QSVKVTTGTAEFAAPEVAEGK 200
Query: 523 VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 582
+ +D +S G++ LL+G P GE S + + ++
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSP--FGGENDDETLRNVKSCDWNMDDSAFSG-ISEDGK 257
Query: 583 DLGLQCCELYGRERPDI 599
D + R I
Sbjct: 258 DFIRKLLLADPNTRMTI 274
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 6e-48
Identities = 68/291 (23%), Positives = 117/291 (40%), Gaps = 43/291 (14%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQLE-FQQEVRVLSKL-QHPHL 399
+G G FG V G VA+KML + E E++++++L H ++
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 400 VTLLGAC--PEAWSLVYEYLPNGSLQDRLFRK--------------------SNVSPLLW 437
V LLGAC L++EY G L + L K +++ L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 438 KDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497
+D A ++A G+ FL + VH DL +N+L+ KICDFG+ R + D+
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS-- 218
Query: 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV 557
++ + + PE G+ T KSD +S+G+++ ++ + + V
Sbjct: 219 --NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 276
Query: 558 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608
I + D P + + + C R+RP +L L
Sbjct: 277 ----YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP-NLTSFLG 322
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 2e-47
Identities = 65/282 (23%), Positives = 118/282 (41%), Gaps = 25/282 (8%)
Query: 344 FSESFKVGQGGFGCVYK------GEMLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQH 396
F + +G G FG VYK GE + VAIK L + + + E E V++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 397 PHLVTLLGACPEA-WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
PH+ LLG C + L+ + +P G L D + + + +IA G+ +L
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAKGMNYLE 128
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
++VH DL +N+L+ + KI DFG+ +L+ + + + K +
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE----EKEYHAEGGKVPIKWMA 181
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574
E + T +SD +S+G+ + +L+T G P G + S + P
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD--GIPASEI----SSILEKGERLPQP 235
Query: 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 616
+ + ++C + RP L+ E ++ +R
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMARDPQR 276
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 4e-47
Identities = 61/269 (22%), Positives = 108/269 (40%), Gaps = 23/269 (8%)
Query: 349 KVGQGGFGCVYKGEML-----GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTL 402
+G+G FG V++G + VAIK + E F QE + + HPH+V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 403 LGACPEAWS-LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+G E ++ E G L+ F + L A ++++ L +L S ++
Sbjct: 74 IGVITENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLES---KR 128
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
VH D+ +N+L+ S K+ DFG+ R + + T +++++ K + PE
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-----YYKASKGKLPIKWMAPESINF 183
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRL 581
T SD + FG+ + ++L + + + I + P L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-----IGRIENGERLPMPPNCPPTL 238
Query: 582 VDLGLQCCELYGRERPDITPSLVKELEQL 610
L +C RP T L +L +
Sbjct: 239 YSLMTKCWAYDPSRRPRFT-ELKAQLSTI 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 5e-47
Identities = 67/289 (23%), Positives = 112/289 (38%), Gaps = 37/289 (12%)
Query: 343 NFSESFKVGQGGFGCVYKGEMLG----RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QH 396
+ +G+G FG V K + AIK + + + +F E+ VL KL H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 397 PHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRK-------------SNVSPLLWKDRA 441
P+++ LLGAC L EY P+G+L D L + S S L +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 442 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501
AA++A G+ +L + +H DL +NIL+ +KI DFG+ R
Sbjct: 131 HFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV------ 181
Query: 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGK 561
+ T + + E V T SD +S+G+++ ++++
Sbjct: 182 -KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----- 235
Query: 562 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+ + P + DL QC ERP ++ L ++
Sbjct: 236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRM 283
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-46
Identities = 69/297 (23%), Positives = 127/297 (42%), Gaps = 30/297 (10%)
Query: 343 NFSESFKVGQGGFGCVYKG-------EMLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKL 394
+ S ++GQG FG VY+G + VAIK + + +M+ ++EF E V+ +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 395 QHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLF-------RKSNVSPLLWKDRARIAA 445
H+V LLG + ++ E + G L+ L ++P ++A
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505
EIA G+ +L+++K VH DL +N ++ + + KI DFG+ R + E Y +
Sbjct: 141 EIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGG 193
Query: 506 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSI 565
+ PE + GV T SD +SFG+++ ++ T + L +
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-----LRFV 248
Query: 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPSFF 622
++ D P L +L C + + RP ++ +++ R V ++
Sbjct: 249 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL-EIISSIKEEMEPGFREVSFYY 304
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-46
Identities = 56/257 (21%), Positives = 94/257 (36%), Gaps = 20/257 (7%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 405
+G+G +G V VA+K++ E ++E+ + L H ++V G
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 406 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
L EY G L DR+ + D R ++ +G+ +LH I
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG---IGIT 125
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG- 522
H D+KP+N+LLD + KI DFG+ + + G+ PY PE +
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNN----RERLLNKMCGTLPYVAPELLKRRE 181
Query: 523 VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 582
D +S G+++ +L G LP + + S K + +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP----WKKIDSAPL 237
Query: 583 DLGLQCCELYGRERPDI 599
L + R I
Sbjct: 238 ALLHKILVENPSARITI 254
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (412), Expect = 5e-46
Identities = 65/274 (23%), Positives = 118/274 (43%), Gaps = 23/274 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ---LEFQQEVRVLSKLQHPHLVTLL 403
+G GG V+ L R VA+K+L + + L F++E + + L HP +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 404 GACPEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
+V EY+ +L+D + + P+ K + A+ L F H +
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN 130
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
I+H D+KP NI++ + + K+ DFGI R + + S ++ A G+ Y PE
Sbjct: 131 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG---NSVTQTAAVIGTAQYLSPE 184
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577
R + +SD YS G ++ ++LTG P G+ +V+ + P + +
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAYQHVREDPIPPSARHEG-L 241
Query: 578 ARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611
+ L + L+ R + +L ++H
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-45
Identities = 67/270 (24%), Positives = 104/270 (38%), Gaps = 24/270 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLL 403
+G+G F V L R AIK+L ++ +E V+S+L HP V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 404 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
E Y NG L + + AEI S L +LH +
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG---KG 128
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
I+H DLKP+NILL+ ++ +I DFG ++++ ++ R+ + G+ Y PE
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES----KQARANSFVGTAQYVSPELLTE 184
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRL 581
SD ++ G II QL+ G P + I+ L D+P +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLI----FQKIIK-LEYDFPEKFFPKA 237
Query: 582 VDLGLQCCELYGRERPDITPSLVKELEQLH 611
DL + L +R + H
Sbjct: 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 161 bits (408), Expect = 1e-44
Identities = 56/257 (21%), Positives = 105/257 (40%), Gaps = 21/257 (8%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
++G G FG V++ GR K + + + + E+ ++++L HP L+ L A
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
L+ E+L G L DR+ + + + + GL +H IVH
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEH---SIVH 150
Query: 465 GDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
D+KP+NI+ +++ +S KI DFG+ + D + + + +A PE
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-------TATAEFAAPEIVDRE 203
Query: 523 VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 582
+ +D ++ G++ LL+G P AGE + + + V+
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDWEFDEDAFSS-VSPEAK 260
Query: 583 DLGLQCCELYGRERPDI 599
D + R+R +
Sbjct: 261 DFIKNLLQKEPRKRLTV 277
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-43
Identities = 49/258 (18%), Positives = 109/258 (42%), Gaps = 22/258 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
+G+G FG V++ +T K + Q+ ++E+ +L+ +H +++ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
E +++E++ + +R+ ++ L ++ ++ L FLHS I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHSHN---IGH 125
Query: 465 GDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
D++P+NI+ + SS KI +FG R + + + Y PE H+
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-------RLLFTAPEYYAPEVHQHD 178
Query: 523 VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 582
V++ +D +S G ++ LL+G P E + + +++ + ++ +
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINP--FLAETNQQIIENIMNAEYTFDEEAFKE-ISIEAM 235
Query: 583 DLGLQCCELYGRERPDIT 600
D + + R +
Sbjct: 236 DFVDRLLVKERKSRMTAS 253
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 4e-43
Identities = 65/288 (22%), Positives = 122/288 (42%), Gaps = 39/288 (13%)
Query: 349 KVGQGGFGCVYKGEML---------GRTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHP 397
+G+G FG V E + VA+KML S + L + E+ ++ + +H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 398 HLVTLLGACPEAWS--LVYEYLPNGSLQDRLFRK-------------SNVSPLLWKDRAR 442
+++ LLGAC + ++ EY G+L++ L + + L KD
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502
A ++A G+ +L S +K +H DL +N+L+ + KI DFG+ R + +
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID----YYK 192
Query: 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKL 562
++T + + PE + T +SD +SFG+++ ++ T V
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL--- 249
Query: 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+ + D P+ L + C +RP LV++L+++
Sbjct: 250 --LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRI 294
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 5e-42
Identities = 60/260 (23%), Positives = 103/260 (39%), Gaps = 24/260 (9%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 405
+G G F V E + VAIK + ++G+ + E+ VL K++HP++V L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 406 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
L+ + + G L DR+ K +D +R+ ++ + +LH IV
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHD---LGIV 129
Query: 464 HGDLKPQNILL---DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
H DLKP+N+L D + I DFG+ ++ ++ + G+ Y PE
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL-------STACGTPGYVAPEVLA 182
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARR 580
+ D +S G+I LL G P E + L + + + W ++
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPP--FYDENDAKLFEQILKAEYEFDSPYWDD-ISDS 239
Query: 581 LVDLGLQCCELYGRERPDIT 600
D E +R
Sbjct: 240 AKDFIRHLMEKDPEKRFTCE 259
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-41
Identities = 69/287 (24%), Positives = 116/287 (40%), Gaps = 37/287 (12%)
Query: 349 KVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQL-EFQQEVRVLSK-LQHPHL 399
+G+G FG V + + RTVA+KML + E+++L H ++
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 400 VTLLGACPEAWS---LVYEYLPNGSLQDRLFRKSNV-------------SPLLWKDRARI 443
V LLGAC + ++ E+ G+L L K N L +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 444 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503
+ ++A G+ FL S K +H DL +NILL + KICDFG+ R + +D P + R
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PDYVR 192
Query: 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLS 563
+ + PE V T +SD +SFG+++ ++ + ++
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----CR 248
Query: 564 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+ + P + + L C +RP + LV+ L L
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS-ELVEHLGNL 294
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 151 bits (383), Expect = 4e-41
Identities = 64/278 (23%), Positives = 111/278 (39%), Gaps = 29/278 (10%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ------LEFQQEVRVLSKL 394
+FS +G+GGFG VY G+ A+K L ++ + L + + ++S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 395 QHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLC 452
P +V + A P+ S + + + G L L + D AAEI GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLE 121
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 512
+H+ +V+ DLKP NILLD +I D G+ ++ + A G+
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------KPHASVGTHG 170
Query: 513 YADPEYHRTGV-LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAG 571
Y PE + GV +D +S G ++ +LL G P + ++ + +A
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLTMAV 226
Query: 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609
+ P + L L + R +E+++
Sbjct: 227 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 148 bits (375), Expect = 7e-41
Identities = 60/280 (21%), Positives = 108/280 (38%), Gaps = 40/280 (14%)
Query: 344 FSESFKV----GQGGFGCVYKGEML--GRTVAIKML---------YSHNMQGQLEFQQEV 388
F E+++ G+G V + + A+K++ + + +EV
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 389 RVLSKLQ-HPHLVTLLGACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA 445
+L K+ HP+++ L LV++ + G L D L K L K+ +I
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMR 117
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505
+ +C LH IVH DLKP+NILLD +++ K+ DFG + +
Sbjct: 118 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-------EKLR 167
Query: 506 APKGSFPYADPEYHRTGVL------TPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC 559
G+ Y PE + + D +S G+I+ LL G P + +
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWHRKQMLMLR 225
Query: 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDI 599
+S + +W + + DL + + ++R
Sbjct: 226 MIMSGNYQFGSPEWDD-YSDTVKDLVSRFLVVQPQKRYTA 264
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-40
Identities = 56/268 (20%), Positives = 99/268 (36%), Gaps = 14/268 (5%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 405
+G+G +G V VAIK + Q + +E+++L + +H +++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 406 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
P + YL + L++ L +I GL ++HS ++
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 131
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 523
H DLKP N+LL++ KICDFG+ R+ D T + Y PE
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 524 L-TPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 582
T D +S G I+ ++L+ R G+ L + P D + +
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRPI--FPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 583 DLGLQCCELYGRERPDITPSLVKELEQL 610
+ L + P+ + L
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDL 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (370), Expect = 8e-40
Identities = 64/268 (23%), Positives = 106/268 (39%), Gaps = 29/268 (10%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
+G G FG V+ GR A+K+L ++ E +LS + HP ++ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 404 GACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
G +A + + +Y+ G L L + AAE+ L +LHS +
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVCLALEYLHS---KD 124
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
I++ DLKP+NILLD KI DFG + V + + G+ Y PE T
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---------VTYTLCGTPDYIAPEVVST 175
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRL 581
D +SFG++I ++L G P IL+ +P F +
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTP--FYDSNTMKT----YEKILNA-ELRFPPFFNEDV 228
Query: 582 VDLGLQCCELYGRERPDITPSLVKELEQ 609
DL + +R + ++++
Sbjct: 229 KDLLSRLITRDLSQRLGNLQNGTEDVKN 256
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-39
Identities = 67/265 (25%), Positives = 103/265 (38%), Gaps = 27/265 (10%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE---FQQEVRVLSK-LQHPHLVTL 402
+G+G FG V+ E + AIK L + + E RVLS +HP L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 403 LGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
E V EYL G L + AAEI GL FLHS +
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHS---K 122
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
IV+ DLK NILLD + KI DFG+C+ ++ G+ Y PE
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD------AKTNTFCGTPDYIAPEILL 176
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARR 580
D +SFG+++ ++L G+ P +L + +P ++ +
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSP-------FHGQDEEELFHSIRMDNPFYPRWLEKE 229
Query: 581 LVDLGLQCCELYGRERPDITPSLVK 605
DL ++ +R + + +
Sbjct: 230 AKDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (362), Expect = 5e-39
Identities = 55/276 (19%), Positives = 98/276 (35%), Gaps = 27/276 (9%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G G FG +Y G + G VAIK+ Q E ++ +Q + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 71
Query: 407 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
+ +V E L F K +A ++ S + ++HS +
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFI 125
Query: 464 HGDLKPQNILLDSELSSKIC---DFGICRLVTEDTLYLPSF-HRSTAPKGSFPYADPEYH 519
H D+KP N L+ + DFG+ + + + + G+ YA H
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLPVGL-----AGEVRRAVSCGKLSSILDPLAGDWP 574
+ + D S G +++ G LP + +S K+S+ ++ L +P
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
C L ++PD + L + L
Sbjct: 246 ----SEFATYLNFCRSLRFDDKPDYS-YLRQLFRNL 276
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-38
Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLV 400
+++++ +G G FG VY+ ++ G VAIK + +Q + +E++++ KL H ++V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 401 TLLGACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLC 452
L + LV +Y+P + L ++ L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
++HS I H D+KPQN+LLD + K+CDFG + + + +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE------PNVSYICSRY 187
Query: 512 PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
A T D +S G ++ +LL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 140 bits (354), Expect = 6e-38
Identities = 48/278 (17%), Positives = 86/278 (30%), Gaps = 29/278 (10%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
++G+G FG +++G L + VAIK + + E R L + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 407 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
LV + L K A A ++ + + +H +V
Sbjct: 70 GQEGLHNVLVIDLLGPSLED---LLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LV 123
Query: 464 HGDLKPQNILLDSELSS-----KICDFGICRLVTED-TLYLPSFHRSTAPKGSFPYADPE 517
+ D+KP N L+ S + DFG+ + + T + G+ Y
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGR-----LPVGLAGEVRRAVSCGKLSSILDPLAGD 572
H + + D + G + + L G L + + K S+ L L
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243
Query: 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+P L PD L ++
Sbjct: 244 FP----EEFYKYMHYARNLAFDATPDYD-YLQGLFSKV 276
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 8e-38
Identities = 56/265 (21%), Positives = 98/265 (36%), Gaps = 31/265 (11%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGAC 406
+G G G V + A+KML Q + ++EV + + Q PH+V ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 407 PEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
++ +V E L G L R+ + + ++ + I I + +LHS
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN-- 131
Query: 461 KIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
I H D+KP+N+L S+ + K+ DFG + T + + Y PE
Sbjct: 132 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-------TPYYVAPE 183
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLPV--GLAGEVRRAVSCGKLSSILDPLAGDWPT 575
D +S G+I+ LL G P + + + +W
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 576 FVARRLVDLGLQCCELYGRERPDIT 600
V+ + L + +R IT
Sbjct: 244 -VSEEVKMLIRNLLKTEPTQRMTIT 267
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 9e-38
Identities = 69/286 (24%), Positives = 109/286 (38%), Gaps = 31/286 (10%)
Query: 349 KVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKL---QHPHLV 400
++G+G +G V+K L GR VA+K + + L +EV VL L +HP++V
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 401 TLLGACPEAWS-------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCF 453
L C + + LV+E++ K + + + ++ GL F
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMMFQLLRGLDF 131
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 513
LHS ++VH DLKPQNIL+ S K+ DFG+ R+ + T+ + Y
Sbjct: 132 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-------QMALTSVVVTLWY 181
Query: 514 ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 573
PE D +S G I ++ + G L I P DW
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL--FRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL--HVAEERP 617
P VA + + + DI L + +R
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 285
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 1e-35
Identities = 60/265 (22%), Positives = 106/265 (40%), Gaps = 30/265 (11%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL------EFQQEVRVLSKLQHPHLV 400
++G G F V K G A K + + + ++EV +L ++QHP+++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 401 TLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
TL L+ E + G L D L K L ++ +I +G+ +LHS
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS-- 131
Query: 459 PEKIVHGDLKPQNILLDSE----LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
+I H DLKP+NI+L KI DFG+ + G+ +
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-------EFKNIFGTPEFV 183
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574
PE L ++D +S G+I LL+G P G+ ++ +S++ ++
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQET-LANVSAVNYEFEDEYF 240
Query: 575 TFVARRLVDLGLQCCELYGRERPDI 599
+ + D + ++R I
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTI 265
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (334), Expect = 2e-35
Identities = 54/269 (20%), Positives = 99/269 (36%), Gaps = 20/269 (7%)
Query: 349 KVGQGGFGCVYKGEM-LGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLGA 405
K+G+G +G VYK + G T A+K + + +E+ +L +L+H ++V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 406 CPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
LV+E+L + + L ++ +G+ + H + ++
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR---VL 122
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 523
H DLKPQN+L++ E KI DFG+ R + + A +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL-----WYRAPDVLMGSKK 177
Query: 524 LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVD 583
+ D +S G I +++ G G + P + +WP D
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPL--FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 584 LGLQCCELYGRER--PDITPSLVKELEQL 610
E E + S + L ++
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKM 264
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-35
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPH 398
NF + K+G+G +G VYK G VA+K + + +E+ +L +L HP+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 399 LVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
+V LL LV+E+L + S ++ + ++ GL F HS
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
+++H DLKPQN+L+++E + K+ DFG+ R P + + A
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-----PVRTYTHEVVTLWYRAPE 172
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ D +S G I +++T R
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 3e-35
Identities = 55/269 (20%), Positives = 92/269 (34%), Gaps = 24/269 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-----FQQEVRVLSKLQHPHLVT 401
+G+G F VYK + VAIK + + + +E+++L +L HP+++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 402 LLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
LL A SLV++++ L GL +LH
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQ--- 118
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE-Y 518
I+H DLKP N+LLD K+ DFG+ + T + Y PE
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP------NRAYTHQVVTRWYRAPELL 172
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA 578
+ D ++ G I+ +LL L G+ ++ P WP +
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPF--LPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 579 RRLVDLGLQCCELYGRERPDITPSLVKEL 607
+ + +L
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDL 259
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 4e-35
Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 23/213 (10%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLG 404
K+GQG FG V+K G+ VA+K + N + +E+++L L+H ++V L+
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 405 ACPEAWS----------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
C S LV+++ + + R+ + +GL ++
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYI 133
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
H KI+H D+K N+L+ + K+ DFG+ R + P+ + + + Y
Sbjct: 134 HR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV--VTLWYR 188
Query: 515 DPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLP 546
PE P D + G I+ ++ T
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 5e-35
Identities = 67/274 (24%), Positives = 109/274 (39%), Gaps = 30/274 (10%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHP 397
+F +G+G FG V GR A+K+L + + E E RVL +HP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 398 HLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
L L A + V EY G L L R+ + AEI S L +LH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLH 122
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
S +V+ D+K +N++LD + KI DFG+C+ D + +F G+ Y
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC------GTPEYLA 173
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGDW 573
PE D + G+++ +++ GRLP + + ++ +
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------RF 224
Query: 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607
P ++ L + ++R PS KE+
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 1e-34
Identities = 54/265 (20%), Positives = 95/265 (35%), Gaps = 40/265 (15%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE------FQQEVRVLSKLQHPH-- 398
+G GGFG VY G + VAIK + + E EV +L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 399 LVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
++ LL P+++ L+ E + L + ++ + H+
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN 128
Query: 457 SKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
++H D+K +NIL+D K+ DFG L+ + T G+ Y+
Sbjct: 129 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD--------TVYTDFDGTRVYSP 177
Query: 516 PEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574
PE+ R + +S G+++ ++ G +P E+ R +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV-------------FFR 224
Query: 575 TFVARRLVDLGLQCCELYGRERPDI 599
V+ L C L +RP
Sbjct: 225 QRVSSECQHLIRWCLALRPSDRPTF 249
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (326), Expect = 1e-33
Identities = 55/268 (20%), Positives = 102/268 (38%), Gaps = 29/268 (10%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLL 403
+G G FG V + G A+K+L + + E R+L + P LV L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 404 GACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+ + +L V EY+ G + L R AA+I +LHS
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
+++ DLKP+N+L+D + ++ DFG + R+ G+ PE +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK---------RVKGRTWTLCGTPEALAPEIILS 212
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRL 581
D ++ G++I ++ G P A ++ + +P+ + L
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP-------FFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 582 VDLGLQCCELYGRERPDITPSLVKELEQ 609
DL ++ +R + V +++
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-33
Identities = 42/204 (20%), Positives = 79/204 (38%), Gaps = 17/204 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLG 404
K+G+G +G V+K + VA+K + + + +E+ +L +L+H ++V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 405 ACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
LV+E+ + ++ + ++ GL F H +
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH---SRNV 122
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
+H DLKPQN+L++ K+ +FG+ R P S +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGI-----PVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 523 VLTPKSDSYSFGLIILQLLTGRLP 546
+ + D +S G I +L P
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 7e-32
Identities = 54/295 (18%), Positives = 99/295 (33%), Gaps = 34/295 (11%)
Query: 332 FSLADLQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--E 383
F ++ ++ G G +G V G VAIK LY
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 384 FQQEVRVLSKLQHPHLVTLLGACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPL 435
+E+R+L ++H +++ LL + LV ++ G+ +L + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE---KL 118
Query: 436 LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495
+ ++ GL ++H+ I+H DLKP N+ ++ + KI DFG+ R
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-- 173
Query: 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR 555
+ + A T D +S G I+ +++TG+ G
Sbjct: 174 ------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL--FKGSDHL 225
Query: 556 AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+ P A + + EL ++ I + L
Sbjct: 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNL 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (297), Expect = 6e-30
Identities = 42/207 (20%), Positives = 84/207 (40%), Gaps = 28/207 (13%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGA 405
K+G+G + V++ + V +K+L + + ++E+++L L+ P+++TL
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADI 98
Query: 406 CPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+ S LV+E++ N + L D EI L + HS
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---G 149
Query: 462 IVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
I+H D+KP N+++D E ++ D+G+ S + PE
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-------EYNVRVASRYFKGPELLV 202
Query: 521 T-GVLTPKSDSYSFGLIILQLLTGRLP 546
+ D +S G ++ ++ + P
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-29
Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 28/210 (13%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLY--SHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
+G G G V +L R VAIK L N +E+ ++ + H ++++LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 405 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
+ LV E + Q + + + ++ G+ LHS
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCGIKHLHS 137
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
I+H DLKP NI++ S+ + KI DFG+ R T + Y P
Sbjct: 138 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-------FMMTPYVVTRYYRAP 187
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E D +S G I+ +++ ++
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 6e-29
Identities = 49/209 (23%), Positives = 79/209 (37%), Gaps = 26/209 (12%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLG 404
VG G +G V G VA+K L +E+R+L ++H +++ LL
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 405 ACPEAWSL-------VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
A SL + +L L + + + L + +I GL ++HS
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHS- 139
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
I+H DLKP N+ ++ + KI DFG+ + + A
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLA--------RHTDDEMTGYVATRWYRAPEI 189
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
D +S G I+ +LLTGR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 7e-29
Identities = 64/273 (23%), Positives = 108/273 (39%), Gaps = 28/273 (10%)
Query: 349 KVGQGGFGCVYKGEML-----GRTVAIKML----YSHNMQGQLEFQQEVRVLSKLQH-PH 398
+G G +G V+ + G+ A+K+L + + E +VL ++ P
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 399 LVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
LVTL A L + +Y+ G L L ++ + EI L LH
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHK 147
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
I++ D+K +NILLDS + DFG+ + D R+ G+ Y P
Sbjct: 148 ---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-----ERAYDFCGTIEYMAP 199
Query: 517 EYHRTGV--LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574
+ R G D +S G+++ +LLTG P + GE S ++S + +P
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSEPPYP 256
Query: 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607
++ DL + ++R P E+
Sbjct: 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (261), Expect = 4e-25
Identities = 42/250 (16%), Positives = 89/250 (35%), Gaps = 26/250 (10%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G G F V+ + + VA+K++ + + + E+++L ++
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMG 78
Query: 407 ---------------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 451
P +V + G L +K + +I+ ++ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS 510
++H I+H D+KP+N+L++ + I L + +
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS----IQT 192
Query: 511 FPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLA 570
Y PE +D +S +I +L+TG ++ I++ L
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL- 251
Query: 571 GDWPTFVARR 580
G+ P+++ R
Sbjct: 252 GELPSYLLRN 261
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.7 bits (206), Expect = 4e-19
Identities = 27/152 (17%), Positives = 45/152 (29%), Gaps = 19/152 (12%)
Query: 349 KVGQGGFGCVYKGEML-GRTVAIKML----------YSHNMQGQLEFQQEVRVLSKLQHP 397
+G+G V+ +K G L F ++ +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 398 HLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
L L G Y + N L + L + + ++ + I + +
Sbjct: 67 ALQKLQGLAVPKV---YAWEGNAVLME-LIDAKELYRVRVENPDEVLDMILEEVAKFYH- 121
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
IVHGDL N+L+ E I DF
Sbjct: 122 --RGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 78 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 79.0 bits (194), Expect = 9e-19
Identities = 28/68 (41%), Positives = 39/68 (57%)
Query: 618 VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHAL 677
P +F CPI E+M DP + + G TYE +I+ WL+ G +T P + L H LTPN+ L
Sbjct: 5 FPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVL 64
Query: 678 RHAIQDWL 685
+ I W
Sbjct: 65 KSLIALWC 72
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 80 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 67.6 bits (164), Expect = 1e-14
Identities = 20/74 (27%), Positives = 38/74 (51%)
Query: 615 ERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPN 674
+R +P + I E+M +P + G TY+ K I + L+ +P+T L+ L PN
Sbjct: 1 KRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPN 60
Query: 675 HALRHAIQDWLCKS 688
A++ I ++ ++
Sbjct: 61 LAMKEVIDAFISEN 74
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} Length = 98 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.9 bits (139), Expect = 3e-11
Identities = 20/81 (24%), Positives = 29/81 (35%)
Query: 605 KELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNL 664
L+Q FL PI+ +M DP V ++ +T P
Sbjct: 6 SGLQQQEEETYADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSDQTDPFNRS 65
Query: 665 RLSHLHLTPNHALRHAIQDWL 685
L+ + PN L+ IQ WL
Sbjct: 66 PLTMDQIRPNTELKEKIQRWL 86
|
| >d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} Length = 103 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: brca1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (105), Expect = 2e-06
Identities = 13/90 (14%), Positives = 32/90 (35%), Gaps = 6/90 (6%)
Query: 598 DITPSLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLE--NG 655
D++ V+E++ + + CPI E++ +P + + L G
Sbjct: 2 DLSALRVEEVQNV----INAMQKILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKG 57
Query: 656 RETSPMTNLRLSHLHLTPNHALRHAIQDWL 685
P+ ++ L + +++ L
Sbjct: 58 PSQCPLCKNDITKRSLQESTRFSQLVEELL 87
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 688 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1wgma_ | 98 | Ubiquitin conjugation factor E4A {Human (Homo sapi | 98.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.84 | |
| d1t1ha_ | 78 | E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsi | 98.8 | |
| d2c2la2 | 80 | STIP1 homology and U box-containing protein 1, STU | 98.76 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.34 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.06 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.81 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.56 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.38 | |
| d2baya1 | 56 | Pre-mRNA splicing factor Prp19 {Baker's yeast (Sac | 95.07 | |
| d1jm7b_ | 97 | bard1 RING domain {Human (Homo sapiens) [TaxId: 96 | 94.04 | |
| d1jm7a_ | 103 | brca1 RING domain {Human (Homo sapiens) [TaxId: 96 | 81.68 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.40 Aligned_cols=257 Identities=29% Similarity=0.452 Sum_probs=208.8
Q ss_pred HCCCCCCEEEECCCCEEEEEEEECCEEEEEEEEECCCC--CCHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCEEEEEEC
Q ss_conf 26954340340138658999999890999999713893--346999999999970799951257053378-743588617
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYL 417 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~ 417 (688)
.++|...+.||+|+||.||+|++.+ .||||+++.... .....|.+|+.++.+++|||||+++|++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~ 85 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 85 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred CCCEEEEEEEEECCCCEEEEEEECC-EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCEEEEEEECC
T ss_conf 4518998898307885899999999-899999973469989999999999999847998786456797155899999658
Q ss_pred CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 89968888612499998999999999999999999985069981672899999622079996699105731001578876
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++|+|.+++.... ..+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+........
T Consensus 86 ~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 86 EGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCCCCCC
T ss_conf 9988899985235--78999999999999999988875099---951614789979818997887500221333556776
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCHH---HHHHHHHCCCCCCCCCCCCC
Q ss_conf 777655689988988888010104---999982027679999999980999999825---78988521963223578789
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRT---GVLTPKSDSYSFGLIILQLLTGRLPVGLAG---EVRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGviL~ELltG~~P~~~~~---~i~~~i~~~~l~~~ld~~~~ 571 (688)
.......||+.|||||++.+ ..|+.++|||||||+||||+||+.||.... .+...+..+... |...
T Consensus 161 ----~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----p~~~ 232 (276)
T d1uwha_ 161 ----HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS----PDLS 232 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC----CCGG
T ss_pred ----CCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC----CCCH
T ss_conf ----31256655743179999950568999953151635999999997889989989699999999658889----8600
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 99979999999999872227999999992789999998430
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~~ 612 (688)
..+..++..+.+|+.+||+.||.+|||+. +++..|+.+..
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~-~il~~Le~l~~ 272 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLAR 272 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred HCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 03655549999999997588976892999-99999999997
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=376.14 Aligned_cols=265 Identities=26% Similarity=0.411 Sum_probs=210.5
Q ss_pred CCHHHHHHHHC---------CCCCCEEEECCCCEEEEEEEEC--C---EEEEEEEEECCCCC-CHHHHHHHHHHHHCCCC
Q ss_conf 38888998726---------9543403401386589999998--9---09999997138933-46999999999970799
Q 005616 332 FSLADLQTATC---------NFSESFKVGQGGFGCVYKGEML--G---RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQH 396 (688)
Q Consensus 332 ~~~~el~~at~---------~f~~~~~LG~G~fG~Vykg~~~--g---~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~H 396 (688)
|+++++..++. +|...+.||+|+||+||+|.+. | ..||||.+...... ....|.+|+.++++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHHHHCHHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC
T ss_conf 88798999996046220800427856980278829999999579978899999997844598999999999999985799
Q ss_pred CCEEEEECCCC--CCCEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEE
Q ss_conf 95125705337--8743588617899688886124999989999999999999999999850699816728999996220
Q 005616 397 PHLVTLLGACP--EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 474 (688)
Q Consensus 397 pnIV~l~g~~~--~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILL 474 (688)
||||+++|+|. +..++||||+++|+|.+++.... ..++|..++.|+.|++.||.|||+.+ |+||||||+||||
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl 161 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILV 161 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CCCCCEEEEEEECCEEEEEEEECCCCCCEEEECCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEE
T ss_conf 888618999962887799997227985300210456--79999999999999999889885279---8357615044898
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHHH-
Q ss_conf 79996699105731001578876777655689988988888010104999982027679999999980-9999998257-
Q 005616 475 DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE- 552 (688)
Q Consensus 475 d~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~P~~~~~~- 552 (688)
+.++.+||+|||+++......... .........||+.|+|||++.+..++.++|||||||++|||+| |++||.....
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDP-TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp CTTCCEEECCC------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred CCCCCEEECCCCCCEECCCCCCCC-EEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH
T ss_conf 899919988844315756777765-3650256668830038788836997861214453578999986799999999999
Q ss_pred -HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf -89885219632235787899997999999999987222799999999278999999843
Q 005616 553 -VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 553 -i~~~i~~~~l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~ 611 (688)
+...+..+.. ...+..++..+.+|+.+||+.||.+||++. +++..|+.+.
T Consensus 241 ~~~~~i~~~~~--------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-ei~~~L~~~l 291 (299)
T d1jpaa_ 241 DVINAIEQDYR--------LPPPMDCPSALHQLMLDCWQKDRNHRPKFG-QIVNTLDKMI 291 (299)
T ss_dssp HHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHH-HHHHHHHHHH
T ss_pred HHHHHHHCCCC--------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 99999973788--------999742269999999997587976892999-9999999984
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.86 Aligned_cols=252 Identities=29% Similarity=0.421 Sum_probs=206.8
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC-CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCEEEEEECC
Q ss_conf 269543403401386589999998-90999999713893346999999999970799951257053378-7435886178
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLP 418 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~ 418 (688)
.++|.....||+|+||.||+|.+. +..||||++.... .....|.+|+.++.+++|||||+++|+|.+ ..++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEECC
T ss_conf 89938867981079828999999999999999986476-88899999999998679998857873104597699999578
Q ss_pred CCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 99688886124999989999999999999999999850699816728999996220799966991057310015788767
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
+|+|.+++..... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+........
T Consensus 91 ~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~- 165 (272)
T d1qpca_ 91 NGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT- 165 (272)
T ss_dssp TCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-
T ss_pred CCCHHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCCC-
T ss_conf 9828888751478-98878899999999999999997489---546756422515620244042341014773588644-
Q ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCC-CCCCHH--HHHHHHHCCCCCCCCCCCCCCCCH
Q ss_conf 77655689988988888010104999982027679999999980999-999825--789885219632235787899997
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL-PVGLAG--EVRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~-P~~~~~--~i~~~i~~~~l~~~ld~~~~~~~~ 575 (688)
......||+.|+|||++.+..++.++|||||||++|||+||.. |+.... .+...+..+. ....|.
T Consensus 166 ----~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~--------~~~~p~ 233 (272)
T d1qpca_ 166 ----AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--------RMVRPD 233 (272)
T ss_dssp ----CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------CCCCCT
T ss_pred ----CCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC--------CCCCCC
T ss_conf ----20356774444582898379998245645257999999968988888889999999997068--------888965
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 999999999987222799999999278999999843
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~ 611 (688)
.++..+.+|+.+||+.||.+|||+. ++++.|+.+.
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~-ei~~~L~~~f 268 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFD-YLRSVLEDFF 268 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred CCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 5719999999997588976893999-9999861132
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.14 Aligned_cols=243 Identities=25% Similarity=0.391 Sum_probs=203.8
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCC--CCCEEEEEEC
Q ss_conf 69543403401386589999998--9099999971389334699999999997079995125705337--8743588617
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
.+|.....||+|+||.||+|... |..||||++..........+.+|+.+++.++|||||++++++. +..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 89968888612499998999999999999999999985069981672899999622079996699105731001578876
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++|+|.+++.. ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC-
T ss_conf 79808988641----59999999999999999999999879---72267768886887899686425156413213666-
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHH--HHCCCCCCCCCCCCCCCCH
Q ss_conf 77765568998898888801010499998202767999999998099999982578988--5219632235787899997
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~i~~~--i~~~~l~~~ld~~~~~~~~ 575 (688)
.....+||+.|+|||++.+..++.++|||||||++|+|+||+.||......... +..+... ....+.
T Consensus 172 -----~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------~~~~~~ 240 (293)
T d1yhwa1 172 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP------ELQNPE 240 (293)
T ss_dssp -----CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC------CCSSGG
T ss_pred -----CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC------CCCCCC
T ss_conf -----444444477736826644799880120313729999980488998997999999999857999------888855
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 9999999999872227999999992789
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.++..+.+|+.+||+.||.+|||+.+.+
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil 268 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELL 268 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 3799999999998669966890999996
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.54 Aligned_cols=251 Identities=27% Similarity=0.475 Sum_probs=207.8
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC-CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCC--CCCEEEEEECC
Q ss_conf 69543403401386589999998-9099999971389334699999999997079995125705337--87435886178
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLP 418 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~ 418 (688)
++|.....||+|+||.||+|.+. +..||||++.... .....|.+|+.++.+++|||||+++|+|. +..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 9958888982088829999998899999999987886-768999999999996689975653524315993379998369
Q ss_pred CCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 99688886124999989999999999999999999850699816728999996220799966991057310015788767
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
+|+|.+++.... ..+++..++.|+.|+|.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCE-
T ss_conf 991899752013--47889999999999999877653164---310443153266668877686553210023688733-
Q ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHH--HHHHHHHCCCCCCCCCCCCCCCCH
Q ss_conf 77655689988988888010104999982027679999999980-999999825--789885219632235787899997
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~P~~~~~--~i~~~i~~~~l~~~ld~~~~~~~~ 575 (688)
......||+.|+|||++.+..++.++|||||||++|||+| |.+||.... .+...+..+.. ...|.
T Consensus 158 ----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~--------~~~p~ 225 (263)
T d1sm2a_ 158 ----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--------LYKPR 225 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC--------CCCCT
T ss_pred ----EECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC--------CCCCC
T ss_conf ----504300176667857860799984033210599999998789888778999999999980688--------89954
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 9999999999872227999999992789999998430
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~~ 612 (688)
.++..+.+|+.+||+.||.+||++. ++++.|+.+..
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~-~il~~L~~i~e 261 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFS-RLLRQLAEIAE 261 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 3679999999997657976891999-99999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.00 Aligned_cols=254 Identities=27% Similarity=0.411 Sum_probs=207.8
Q ss_pred CCCCCCE-EEECCCCEEEEEEEEC----CEEEEEEEEECCCC-CCHHHHHHHHHHHHCCCCCCEEEEECCCC-CCCEEEE
Q ss_conf 6954340-3401386589999998----90999999713893-34699999999997079995125705337-8743588
Q 005616 342 CNFSESF-KVGQGGFGCVYKGEML----GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLVY 414 (688)
Q Consensus 342 ~~f~~~~-~LG~G~fG~Vykg~~~----g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~-~~~~LV~ 414 (688)
++|.... +||+|+||.||+|.+. +..||||+++.... .....|.+|+.++.+++|||||+++|+|. +..++||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCEEEEEE
T ss_conf 47188784873060809999999608976899999988203978999999999999867998880686560368079999
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 61789968888612499998999999999999999999985069981672899999622079996699105731001578
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... ..+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 88 E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp ECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf 8078996899752125--69999999999999999878998688---105767646604546885420331342115543
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHH--HHHHHHHCCCCCCCCCCCCC
Q ss_conf 876777655689988988888010104999982027679999999980-999999825--78988521963223578789
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~P~~~~~--~i~~~i~~~~l~~~ld~~~~ 571 (688)
.... .......||+.|+|||++....++.++|||||||++|||+| |+.||.... .+...+..+...
T Consensus 163 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~-------- 231 (285)
T d1u59a_ 163 DSYY---TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-------- 231 (285)
T ss_dssp SCEE---CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC--------
T ss_pred CCCC---CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC--------
T ss_conf 4321---13562113743358688727999954123220178999993899999997999999999818999--------
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 99979999999999872227999999992789999998430
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~~ 612 (688)
..|..++..+.+|+.+||+.+|.+||++. .+.+.|+....
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~-~i~~~L~~~~~ 271 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFL-TVEQRMRACYY 271 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 99976789999999997577976890999-99999999999
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=369.96 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=208.0
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEEE
Q ss_conf 269543403401386589999998--90999999713893346999999999970799951257053378--74358861
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
.++|.....||+|+||+||+|.+. |..||||+++... .....|.+|+.++.+++|||||+++|+|.+ ..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEEC
T ss_conf 799398659820888089999999999699999977761-0399999999999867999882677527457854787631
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 78996888861249999899999999999999999998506998167289999962207999669910573100157887
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++|+|.+++..... ..+++..++.|+.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.......
T Consensus 95 ~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred CCCCCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEECCCCCC
T ss_conf 467606777530355-41579999999999999788898789---30576045768998999289832445465378872
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCC-CHH--HHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 6777655689988988888010104999982027679999999980999999-825--7898852196322357878999
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVG-LAG--EVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~-~~~--~i~~~i~~~~l~~~ld~~~~~~ 573 (688)
. ......|++.|+|||++.+..|+.++|||||||++|||++|..|+. ... .+...+..+. ....
T Consensus 171 ~-----~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~--------~~~~ 237 (287)
T d1opja_ 171 T-----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--------RMER 237 (287)
T ss_dssp E-----EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC--------CCCC
T ss_pred E-----EECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC--------CCCC
T ss_conf 2-----10355665466692787279998104302178999999867998877425999999985588--------8888
Q ss_pred CHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 97999999999987222799999999278999999843
Q 005616 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 574 ~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~ 611 (688)
+..++..+.+|+.+||+.||.+|||+. ++.+.|+.+.
T Consensus 238 ~~~~~~~l~~li~~cl~~dP~~Rps~~-ei~~~L~~~~ 274 (287)
T d1opja_ 238 PEGCPEKVYELMRACWQWNPSDRPSFA-EIHQAFETMF 274 (287)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHTT
T ss_pred CCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 743309999999997577976893999-9999999998
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.50 Aligned_cols=244 Identities=22% Similarity=0.303 Sum_probs=202.3
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCC--CCCEEEEEEC
Q ss_conf 69543403401386589999998--9099999971389334699999999997079995125705337--8743588617
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
+.|.....||+|+||.||+|++. |..||+|++..........|.+|+.++++++|||||++++++. +..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 89968888612499998999999999999999999985069981672899999622079996699105731001578876
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++|+|.+++.... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC--
T ss_conf 9981889998628--99999999999999999999999889---8871407003148789998997161230357786--
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHC-----CCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCC
Q ss_conf 77765568998898888801010-----49999820276799999999809999998257--898852196322357878
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~--i~~~i~~~~l~~~ld~~~ 570 (688)
.......||+.|+|||++. ...|+.++|||||||++|||+||+.||..... +...+..+....
T Consensus 165 ----~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~------ 234 (288)
T d2jfla1 165 ----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT------ 234 (288)
T ss_dssp ----HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC------
T ss_pred ----CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC------
T ss_conf ----4100102562647999983202578888806657878999999820889999989999999997079987------
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHH
Q ss_conf 99997999999999987222799999999278
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~ 602 (688)
...+...+..+.+|+.+||+.||.+|||+.+.
T Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~el 266 (288)
T d2jfla1 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266 (288)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 77656699999999999766996689199999
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.18 Aligned_cols=251 Identities=28% Similarity=0.451 Sum_probs=204.7
Q ss_pred CCCCCCEEEECCCCEEEEEEEECC-------EEEEEEEEECCC-CCCHHHHHHHHHHHHCC-CCCCEEEEECCCCC--CC
Q ss_conf 695434034013865899999989-------099999971389-33469999999999707-99951257053378--74
Q 005616 342 CNFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AW 410 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g-------~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~ 410 (688)
++|.+..+||+|+||.||+|++.+ ..||+|.+.... ......|.+|+.++.++ +|||||+++|+|.+ ..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEE
T ss_conf 99397019830788199999985788554204999999663358789999999999999715899686877888629958
Q ss_pred EEEEEECCCCCHHHHHCCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCC
Q ss_conf 358861789968888612499--------------------998999999999999999999985069981672899999
Q 005616 411 SLVYEYLPNGSLQDRLFRKSN--------------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQ 470 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~--------------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~ 470 (688)
++||||+++|+|.++|..... ...+++..++.|+.|++.||.|||+.+ |+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHH
T ss_conf 99997279995999998625777510221000012220012577899999999999999999997399---050527032
Q ss_pred CEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCC
Q ss_conf 622079996699105731001578876777655689988988888010104999982027679999999980-9999998
Q 005616 471 NILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGL 549 (688)
Q Consensus 471 NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~P~~~ 549 (688)
|||++.++.+||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||+| |++||..
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTS----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CCCCCCCCEEEEEECCCCCCCCCCCCE----EEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCC
T ss_conf 144345982898514222204577861----5623435787657838872799996330300039999998389999999
Q ss_pred HHH---HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 257---89885219632235787899997999999999987222799999999278999999
Q 005616 550 AGE---VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 550 ~~~---i~~~i~~~~l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le 608 (688)
... +...+..+. ..+.|..++..+.+|+.+||+.||.+|||+. ++++.|.
T Consensus 270 ~~~~~~~~~~~~~~~--------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~-ei~~~L~ 322 (325)
T d1rjba_ 270 IPVDANFYKLIQNGF--------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFP-NLTSFLG 322 (325)
T ss_dssp CCCSHHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHH
T ss_pred CCHHHHHHHHHHCCC--------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHH
T ss_conf 898999999985699--------8998876789999999997588966893999-9999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=364.98 Aligned_cols=246 Identities=22% Similarity=0.358 Sum_probs=204.0
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEEE
Q ss_conf 269543403401386589999998--90999999713893346999999999970799951257053378--74358861
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
-++|.+...||+|+||.||+|+.. |..||||++..........+.+|+.++.+++|||||++++++.+ ..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCCCCC
Q ss_conf 78996888861249999899999999999999999998506998167289999962207--9996699105731001578
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD--SELSSKICDFGICRLVTED 494 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd--~~~~~KL~DFGla~~~~~~ 494 (688)
+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.....
T Consensus 105 ~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf 79988999997623--78999999999999999999997569---76000154673641688986999545210442565
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767776556899889888880101049999820276799999999809999998257--89885219632235787899
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~--i~~~i~~~~l~~~ld~~~~~ 572 (688)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... +...+..+.... ...
T Consensus 180 ~-------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-----~~~ 247 (350)
T d1koaa2 180 Q-------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM-----DDS 247 (350)
T ss_dssp S-------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS-----CCG
T ss_pred C-------CCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC-----CCC
T ss_conf 4-------3200068624218899758998726765546599999985989989979999999998478898-----942
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 9979999999999872227999999992789
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
....++..+.+|+.+||..||.+|||+.+.+
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil 278 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQAL 278 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 2358999999999997568966790899986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.55 Aligned_cols=245 Identities=28% Similarity=0.436 Sum_probs=202.2
Q ss_pred EEEECCCCEEEEEEEEC----CEEEEEEEEECCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCEEEEEECCCC
Q ss_conf 03401386589999998----909999997138933--46999999999970799951257053378-743588617899
Q 005616 348 FKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPNG 420 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~----g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~~g 420 (688)
++||+|+||.||+|.+. +..||||+++..... ....|.+|+.++.+++|||||+++|+|.+ ..++||||+++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEECCCCC
T ss_conf 78345878299999981697385999999880108989999999999999867998985277775059779999747889
Q ss_pred CHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCC
Q ss_conf 68888612499998999999999999999999985069981672899999622079996699105731001578876777
Q 005616 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~ 500 (688)
+|.+++... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 93 ~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~-- 164 (277)
T d1xbba_ 93 PLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-- 164 (277)
T ss_dssp EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE--
T ss_pred CHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC--
T ss_conf 689997522---57899999999999999976687479---5567776113102356751234134533134323443--
Q ss_pred CCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHH--HHHHHHHCCCCCCCCCCCCCCCCHHH
Q ss_conf 655689988988888010104999982027679999999980-999999825--78988521963223578789999799
Q 005616 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~P~~~~~--~i~~~i~~~~l~~~ld~~~~~~~~~~ 577 (688)
.......||+.|+|||++....++.++|||||||++|||+| |++||.... .+...+..+.. ...|..+
T Consensus 165 -~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~--------~~~p~~~ 235 (277)
T d1xbba_ 165 -KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER--------MGCPAGC 235 (277)
T ss_dssp -EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------CCCCTTC
T ss_pred -CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--------CCCCCCC
T ss_conf -2244567784203916653799984344303403132896589999999899999999982899--------9998656
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 999999998722279999999927899999984
Q 005616 578 ARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 578 ~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l 610 (688)
+..+.+|+.+||+.||.+||++. ++...|+..
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~-~i~~~L~~~ 267 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFA-AVELRLRNY 267 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHH-HHHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHCH
T ss_conf 79999999997588976890989-999985288
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.99 Aligned_cols=254 Identities=26% Similarity=0.399 Sum_probs=205.8
Q ss_pred CCCCCCEEEECCCCEEEEEEEECC------EEEEEEEEECCCCC-CHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEE
Q ss_conf 695434034013865899999989------09999997138933-46999999999970799951257053378--7435
Q 005616 342 CNFSESFKVGQGGFGCVYKGEMLG------RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g------~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
..|...+.||+|+||.||+|.+.+ ..||||++...... ....|.+|+.++.+++|||||+++|+|.+ ..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 99686159811779099999996899878799999998844596899999999999985689878323677833880389
Q ss_pred EEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 88617899688886124999989999999999999999999850699816728999996220799966991057310015
Q 005616 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~ 492 (688)
||||+.+|++.+.+.... ..++|..++.|+.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEECCCCCCHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHCCC
T ss_conf 997213574022210234--54208999999999998541212123---4257656442788899849984551030035
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCC-CCHH--HHHHHHHCCCCCCCCCCC
Q ss_conf 7887677765568998898888801010499998202767999999998099999-9825--789885219632235787
Q 005616 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV-GLAG--EVRRAVSCGKLSSILDPL 569 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~-~~~~--~i~~~i~~~~l~~~ld~~ 569 (688)
...... .......||+.|+|||++....++.++|||||||++|||++|..|+ .... .+...+..+.
T Consensus 162 ~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-------- 230 (283)
T d1mqba_ 162 DDPEAT---YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-------- 230 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC--------
T ss_pred CCCCCC---EEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC--------
T ss_conf 787652---674267777343488887049999735563448989999967988655689999999986357--------
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 8999979999999999872227999999992789999998430
Q 005616 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~~ 612 (688)
....+..++..+.+|+.+||+.+|.+||++. ++++.|+.+..
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-eil~~L~~l~~ 272 (283)
T d1mqba_ 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFA-DIVSILDKLIR 272 (283)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHH-HHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 8998504579999999997767976893999-99999999866
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.79 Aligned_cols=253 Identities=24% Similarity=0.379 Sum_probs=201.1
Q ss_pred HHCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCC-CCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEE
Q ss_conf 7269543403401386589999998--90999999713893-346999999999970799951257053378--743588
Q 005616 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
..++|....+||+|+||+||+|+.. |..||+|+++.... .....+.+|+.+++.++|||||+++++|.+ ..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 6178996888861249999899999999999999999998506-998167289999962207999669910573100157
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS-KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~-~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
||+++|+|.+++.+.. .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+|+...+
T Consensus 84 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 7679986899874249---99999999999999999999998599---97144577994687899899954877625678
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH-----CCCCCC----
Q ss_conf 88767776556899889888880101049999820276799999999809999998257898852-----196322----
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS-----CGKLSS---- 564 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~i~~~i~-----~~~l~~---- 564 (688)
.. ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||........... .+....
T Consensus 158 ~~--------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 158 SM--------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp HT--------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred CC--------CCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 86--------2111377141194687589989488899899999999988899899887899999988751775457742
Q ss_pred ---------------------------CCCCCCCCCC-HHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHH
Q ss_conf ---------------------------3578789999-79999999999872227999999992789999
Q 005616 565 ---------------------------ILDPLAGDWP-TFVARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 565 ---------------------------~ld~~~~~~~-~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~ 606 (688)
+........+ ...+..+.+|+.+||+.||.+|||+.+.+.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hp 299 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCH
T ss_conf 1233322111122235413477887665026876676444899999999998689946790899996098
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=363.07 Aligned_cols=246 Identities=23% Similarity=0.333 Sum_probs=205.0
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEEE
Q ss_conf 269543403401386589999998--90999999713893346999999999970799951257053378--74358861
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
.++|.+...||+|+||.||+|+.. |..||||++..........+.+|+.++.+++|||||++++++.+ ..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCCCCC
Q ss_conf 78996888861249999899999999999999999998506998167289999962207--9996699105731001578
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD--SELSSKICDFGICRLVTED 494 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd--~~~~~KL~DFGla~~~~~~ 494 (688)
+++|+|.+.+.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf 89980888898638--99899999999999999999999779---26513144553113467884899525630343788
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHH--HHHHHCCCCCCCCCCCCCC
Q ss_conf 87677765568998898888801010499998202767999999998099999982578--9885219632235787899
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~i--~~~i~~~~l~~~ld~~~~~ 572 (688)
. ......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... ...+..+... ....
T Consensus 183 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----~~~~ 250 (352)
T d1koba_ 183 E-------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-----FDED 250 (352)
T ss_dssp S-------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-----CCSS
T ss_pred C-------CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC-----CCCC
T ss_conf 7-------201004764534899974799897633389899999999688998997999999999847889-----8930
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 9979999999999872227999999992789
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.+..++..+.+|+.+||+.||.+|||+.+.+
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 281 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 281 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 0247999999999997569966891899996
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.52 Aligned_cols=243 Identities=23% Similarity=0.302 Sum_probs=198.4
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCC-CHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEEE
Q ss_conf 69543403401386589999998--909999997138933-46999999999970799951257053378--74358861
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
++|...+.||+|+||.||+|+.. |..||||++...... ....+.+|+.++++++|||||++++++.+ ..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEEC
T ss_conf 46089989721748099999999999799999984566412799999999999857998884696540467436798864
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 78996888861249999899999999999999999998506998167289999962207999669910573100157887
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+++|+|.+++... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 ~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC
T ss_conf 5898089997537---99999999999999999999999759---83575468997887899879832314224046886
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCHHHH---HHHHHCCCCCCCCCCCCCC
Q ss_conf 6777655689988988888010104999-98202767999999998099999982578---9885219632235787899
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTGVL-TPKSDSYSFGLIILQLLTGRLPVGLAGEV---RRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGviL~ELltG~~P~~~~~~i---~~~i~~~~l~~~ld~~~~~ 572 (688)
. ......+||+.|+|||++.+..+ +.++|||||||++|||+||++||...... ...+..... ...
T Consensus 159 ~----~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-------~~~ 227 (271)
T d1nvra_ 159 E----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------YLN 227 (271)
T ss_dssp E----CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-------TST
T ss_pred C----CCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC-------CCC
T ss_conf 5----31113255747428728618999997101617379999998299788889859999999863888-------788
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCH
Q ss_conf 99799999999998722279999999927
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~ 601 (688)
....++..+.+|+.+||+.||.+|||+.+
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e 256 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPD 256 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 64469999999999976799668909999
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.47 Aligned_cols=239 Identities=27% Similarity=0.418 Sum_probs=202.0
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCC---CCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEE
Q ss_conf 69543403401386589999998--9099999971389---3346999999999970799951257053378--743588
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~---~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||+|+.. |..||+|++.... ......+.+|+.++..++|||||++++++.+ ..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 61789968888612499998999999999999999999985069981672899999622079996699105731001578
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCCC
T ss_conf 5047985898875048---9999999999999999999999889---465220234414668998711555633544888
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767776556899889888880101049999820276799999999809999998257--89885219632235787899
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~--i~~~i~~~~l~~~ld~~~~~ 572 (688)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... +...+..+. ..
T Consensus 160 ~--------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------~~ 222 (263)
T d2j4za1 160 R--------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE---------FT 222 (263)
T ss_dssp C--------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------CC
T ss_pred C--------CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC---------CC
T ss_conf 5--------235578876349999758998931440467599999832999988899999999997189---------99
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 9979999999999872227999999992789
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
+|...+..+.+|+.+||+.||.+|||+.+.+
T Consensus 223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil 253 (263)
T d2j4za1 223 FPDFVTEGARDLISRLLKHNPSQRPMLREVL 253 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 9866899999999997647976890999997
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.99 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=205.0
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCCC----CCEEE
Q ss_conf 69543403401386589999998--909999997138933--46999999999970799951257053378----74358
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV 413 (688)
++|.....||+|+||.||+|+.. |..||+|.+...... ....|.+|+.++.+++|||||++++++.+ ..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EEECCCCCHHHHHCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHCCCC--CCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 86178996888861249-99989999999999999999999850699--8167289999962207999669910573100
Q 005616 414 YEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKP--EKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~ia~qia~aL~yLH~~~~--~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
|||+++|+|.+++.... ....+++..++.|+.|++.||.|||+.++ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf 95689993899998515457899999999999999999999997167788788586765425747888579800100032
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCC
Q ss_conf 15788767776556899889888880101049999820276799999999809999998257--8988521963223578
Q 005616 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDP 568 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~--i~~~i~~~~l~~~ld~ 568 (688)
...... ......||+.|+|||++.+..|+.++|||||||++|||+||+.||..... +...+..+...
T Consensus 164 ~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~----- 232 (269)
T d2java1 164 LNHDTS------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR----- 232 (269)
T ss_dssp C-----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-----
T ss_pred CCCCCC------CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC-----
T ss_conf 245777------556677882327999983999993898875278999980188998998999999999718998-----
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 78999979999999999872227999999992789
Q 005616 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 569 ~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
..|...+..+.+|+.+||+.||.+|||+.+.+
T Consensus 233 ---~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell 264 (269)
T d2java1 233 ---RIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264 (269)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf ---89743599999999997679955791899997
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.24 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=207.7
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CE----EEEEEEEECCC-CCCHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCEEE
Q ss_conf 69543403401386589999998--90----99999971389-3346999999999970799951257053378-74358
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GR----TVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~----~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV 413 (688)
.+|...+.||+|+||+||+|.+. |. .||+|.+.... ......|.+|+.++.+++|||||+++|+|.+ ..+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
T ss_conf 99978319820899299999995899889899999996513497999999999999986799888158999961983699
Q ss_pred EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 86178996888861249999899999999999999999998506998167289999962207999669910573100157
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
++|+.+|+|.+.+.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 89 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEECCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf 98426874010111334--57999999999999999999998769---50476212031167998758602552223354
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHH--HHHHHHHCCCCCCCCCCCC
Q ss_conf 8876777655689988988888010104999982027679999999980-999999825--7898852196322357878
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~P~~~~~--~i~~~i~~~~l~~~ld~~~ 570 (688)
.... .......||+.|+|||++.++.++.++|||||||++|||+| |.+||.... .+...+..+..
T Consensus 164 ~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~-------- 231 (317)
T d1xkka_ 164 EEKE----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-------- 231 (317)
T ss_dssp TCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC--------
T ss_pred CCCC----CCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--------
T ss_conf 4453----2236510586446708874699983565440799999999779999999998999999975998--------
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 99997999999999987222799999999278999999843
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~ 611 (688)
...|..++..+.+|+.+||+.||.+|||+. +++..|+.+.
T Consensus 232 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~-eil~~l~~~~ 271 (317)
T d1xkka_ 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMA 271 (317)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 999855689999999984789934691999-9999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.00 Aligned_cols=242 Identities=27% Similarity=0.368 Sum_probs=203.6
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCC---CCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEE
Q ss_conf 69543403401386589999998--90999999713893---346999999999970799951257053378--743588
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|.....||+|+||.||+|+.. |..||||++..... .....+.+|+.++++++|||||++++++.+ ..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 61789968888612499998999999999999999999985069981672899999622079996699105731001578
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf 7048987777653159---9999999999999999997621650---884767741236688853886032102422567
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767776556899889888880101049999820276799999999809999998257--89885219632235787899
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~--i~~~i~~~~l~~~ld~~~~~ 572 (688)
... ......+||+.|+|||++.+..|+.++|||||||++|||+||+.||..... +...+..+.+ .
T Consensus 162 ~~~----~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~---------~ 228 (288)
T d1uu3a_ 162 SKQ----ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY---------D 228 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC---------C
T ss_pred CCC----CCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC---------C
T ss_conf 764----333555677552584400268989666230456999998038899899599999999971899---------9
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCHH
Q ss_conf 997999999999987222799999999278
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~ 602 (688)
+|..++..+.+|+.+||+.||.+|||+.+.
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~ 258 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEM 258 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGG
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 985479999999999855797689197897
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=360.25 Aligned_cols=260 Identities=27% Similarity=0.450 Sum_probs=212.7
Q ss_pred HHHHHHCCCCCCEEEECCCCEEEEEEEECC-------EEEEEEEEECCCCC-CHHHHHHHHHHHHCCCCCCEEEEECCCC
Q ss_conf 899872695434034013865899999989-------09999997138933-4699999999997079995125705337
Q 005616 336 DLQTATCNFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACP 407 (688)
Q Consensus 336 el~~at~~f~~~~~LG~G~fG~Vykg~~~g-------~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~ 407 (688)
+++...++|.+.+.||+|+||.||+|++.| ..||||+++..... ....|.+|+.+++.++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred HCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
T ss_conf 11389889388679820788399999988876577882999999882108579999999999999668997655246660
Q ss_pred C--CCEEEEEECCCCCHHHHHCCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEE
Q ss_conf 8--7435886178996888861249---------------------9998999999999999999999985069981672
Q 005616 408 E--AWSLVYEYLPNGSLQDRLFRKS---------------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464 (688)
Q Consensus 408 ~--~~~LV~E~~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiH 464 (688)
+ ..++||||+++|+|.+++.... ....+++..++.|+.|++.||.|||+.+ |+|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---EEE
T ss_conf 59803899981589929999985275542100001110012103467889899999999999999855413578---685
Q ss_pred CCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCC
Q ss_conf 89999962207999669910573100157887677765568998898888801010499998202767999999998099
Q 005616 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544 (688)
Q Consensus 465 rDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~ 544 (688)
|||||+|||+|.++.+||+|||+|+........ .......|++.|+|||++....+++++|||||||++|||++|.
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~ 239 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB----C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred EEECCCCEEECCCCCEEECCCHHHEECCCCCCC----CCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCC
T ss_conf 488401168989992898331442113677641----1157777676767989972688980563025236299998068
Q ss_pred -CCCCCHHH--HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf -99998257--89885219632235787899997999999999987222799999999278999999843
Q 005616 545 -LPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 545 -~P~~~~~~--i~~~i~~~~l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~ 611 (688)
+||..... +...+..+... ..|..++..+.+|+.+||+.+|++|||+. ++.+.|+++.
T Consensus 240 ~~p~~~~~~~e~~~~v~~~~~~--------~~p~~~~~~~~~li~~cl~~~P~~RPt~~-ev~~~L~~i~ 300 (301)
T d1lufa_ 240 LQPYYGMAHEEVIYYVRDGNIL--------ACPENCPLELYNLMRLCWSKLPADRPSFC-SIHRILQRMC 300 (301)
T ss_dssp CCTTTTSCHHHHHHHHHTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHTT
T ss_pred CCCCCCCCHHHHHHHHHCCCCC--------CCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHC
T ss_conf 9999998999999999739978--------88732529999999997488965793999-9999999842
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.20 Aligned_cols=247 Identities=24% Similarity=0.422 Sum_probs=205.8
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC-CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEEECC
Q ss_conf 69543403401386589999998-90999999713893346999999999970799951257053378--7435886178
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 418 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~ 418 (688)
++|...++||+|+||+||+|++. +..||||+++... .....|.+|+.++.+++|||||+++|+|.+ ..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 9979968982078839999998899899999987475-778999999999996689860158899850781699997048
Q ss_pred CCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 99688886124999989999999999999999999850699816728999996220799966991057310015788767
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
+|+|..++.... ..+++..+.+|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCE-
T ss_conf 993888641024--67768999999999999999875468---434665413588769984798861442023578722-
Q ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHHH--HHHHHHCCCCCCCCCCCCCCCCH
Q ss_conf 77655689988988888010104999982027679999999980-9999998257--89885219632235787899997
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~P~~~~~~--i~~~i~~~~l~~~ld~~~~~~~~ 575 (688)
......||+.|+|||++....++.++|||||||++|||+| |+.||..... +...+..+.. ...|.
T Consensus 157 ----~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~--------~~~p~ 224 (258)
T d1k2pa_ 157 ----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR--------LYRPH 224 (258)
T ss_dssp ----CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC--------CCCCT
T ss_pred ----EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC--------CCCCC
T ss_conf ----524657887757807863799885210336432467397559999889999999999980797--------89965
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 999999999987222799999999278999999
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le 608 (688)
..+..+.+|+.+||+.||.+|||+. +++..|.
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~-eil~~L~ 256 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFK-ILLSNIL 256 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHH-HHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHH
T ss_conf 4659999999997668976893999-9998741
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=360.60 Aligned_cols=245 Identities=23% Similarity=0.309 Sum_probs=202.1
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCC-CHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEE
Q ss_conf 269543403401386589999998--909999997138933-46999999999970799951257053378--7435886
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
.+.|.....||+|+||+||+|+.. |..||||++...... ....+.+|+.++..++|||||++++++.+ ..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 66669988994065839999999999989999998157731289999999999986799899919899998998889885
Q ss_pred ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCCCCC
Q ss_conf 178996888861249999899999999999999999998506998167289999962207---99966991057310015
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD---SELSSKICDFGICRLVT 492 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd---~~~~~KL~DFGla~~~~ 492 (688)
|++||+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+. .++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred CCCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEECC
T ss_conf 26898488865303---67887899999999999987524130---5568704630011046888249983154358725
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCC
Q ss_conf 788767776556899889888880101049999820276799999999809999998257--898852196322357878
Q 005616 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~--i~~~i~~~~l~~~ld~~~ 570 (688)
... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||..... +...+..+.... .
T Consensus 162 ~~~-------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~ 229 (307)
T d1a06a_ 162 PGS-------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF-----D 229 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC-----C
T ss_pred CCC-------EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC-----C
T ss_conf 897-------0440032842259188737999807873451599999985979999989999999986168777-----8
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 999979999999999872227999999992789
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
...+...+..+.+|+.+||+.||.+|||+.+.+
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 262 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQAL 262 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 766667899999999997608975791899986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.30 Aligned_cols=251 Identities=33% Similarity=0.422 Sum_probs=206.8
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC-CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCEEEEEECCC
Q ss_conf 69543403401386589999998-90999999713893346999999999970799951257053378-74358861789
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPN 419 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~~ 419 (688)
++|.+...||+|+||.||+|.+. +..||||+++... .....|.+|+.++.+++|||||+++|+|.+ ..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEECCC
T ss_conf 9979846993079809999999999999999988044-888999999999986666788689999823975999994479
Q ss_pred CCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 96888861249999899999999999999999998506998167289999962207999669910573100157887677
Q 005616 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~~ 499 (688)
|+|...+..... ..++|..++.|+.+|+.||.|||..+ |+||||||+||||+.++.+||+|||+++........
T Consensus 96 g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-- 169 (285)
T d1fmka3 96 GSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-- 169 (285)
T ss_dssp CBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCHHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCCE--
T ss_conf 943542000035-53059999999999999999875411---433531230799989992998442555425688733--
Q ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCC-CCHH--HHHHHHHCCCCCCCCCCCCCCCCHH
Q ss_conf 765568998898888801010499998202767999999998099999-9825--7898852196322357878999979
Q 005616 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV-GLAG--EVRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~-~~~~--~i~~~i~~~~l~~~ld~~~~~~~~~ 576 (688)
......||+.|+|||++....++.++||||||+++|||+||..|+ .... .+...+..+.. ...+..
T Consensus 170 ---~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~--------~~~~~~ 238 (285)
T d1fmka3 170 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------MPCPPE 238 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------CCCCTT
T ss_pred ---EECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC--------CCCCCC
T ss_conf ---524545566545808983799891774132358999998689999988889999999982689--------999832
Q ss_pred HHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 99999999987222799999999278999999843
Q 005616 577 VARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~ 611 (688)
++..+.+|+.+||+.||++||++. .++..|+...
T Consensus 239 ~~~~l~~li~~cl~~dP~~Rps~~-~i~~~L~~~~ 272 (285)
T d1fmka3 239 CPESLHDLMCQCWRKEPEERPTFE-YLQAFLEDYF 272 (285)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHTTT
T ss_pred CCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 379999999997566975891999-9999876662
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.91 Aligned_cols=238 Identities=26% Similarity=0.308 Sum_probs=201.8
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCC---CCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEE
Q ss_conf 69543403401386589999998--9099999971389---3346999999999970799951257053378--743588
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~---~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|.+.+.||+|+||.||+|+.. |..||||++.+.. ......+.+|+.+|+.++|||||++++++.+ ..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCE
T ss_conf 74289889831768499999998999899999981565449799999999999998679998877876403564211100
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 61789968888612499998999999999999999999985069981672899999622079996699105731001578
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf 0357986055553256---7759999999999965211343159---622464777847658998888205652003567
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767776556899889888880101049999820276799999999809999998257--89885219632235787899
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~--i~~~i~~~~l~~~ld~~~~~ 572 (688)
.. .....+||+.|+|||++.+..|+.++|||||||++|||++|++||..... +...+..+. ..
T Consensus 159 ~~------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~---------~~ 223 (337)
T d1o6la_ 159 GA------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------IR 223 (337)
T ss_dssp TC------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------CC
T ss_pred CC------CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC---------CC
T ss_conf 86------2055100889966665048988833310223067889987899999969999999985289---------98
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 9979999999999872227999999992
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
+|..++..+.+|+.+||+.||.+||+..
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~ 251 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGG 251 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCS
T ss_pred CCCCCCHHHHHHHHHHCCCCCHHHCCCC
T ss_conf 9866899999999866638934422565
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.05 Aligned_cols=239 Identities=27% Similarity=0.390 Sum_probs=193.5
Q ss_pred CCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCC--CCHHHHHHHHHHHHCCCCCCEEEEECCCCC------CCEEEE
Q ss_conf 43403401386589999998--90999999713893--346999999999970799951257053378------743588
Q 005616 345 SESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE------AWSLVY 414 (688)
Q Consensus 345 ~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~------~~~LV~ 414 (688)
....+||+|+||+||+|.+. +..||+|.+..... .....|.+|+.++++++|||||++++++.+ ..++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC-CCCCEEEEECCCCCCCCC
Q ss_conf 6178996888861249999899999999999999999998506998167289999962207-999669910573100157
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD-SELSSKICDFGICRLVTE 493 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd-~~~~~KL~DFGla~~~~~ 493 (688)
||+++|+|.+++.... .+++..+..|+.|++.||.|||+.+ .+|+||||||+|||++ .++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEECCC
T ss_conf 5789894899975135---5469999999999999999999789-97996876743511667999889800576542368
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH---HHHHHHCCCCCCCCCCCC
Q ss_conf 88767776556899889888880101049999820276799999999809999998257---898852196322357878
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~---i~~~i~~~~l~~~ld~~~ 570 (688)
.. ....+||+.|+|||++.+ .++.++|||||||++|||++|+.||..... +...+..+....
T Consensus 168 ~~--------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~------ 232 (270)
T d1t4ha_ 168 SF--------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA------ 232 (270)
T ss_dssp TS--------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG------
T ss_pred CC--------CCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC------
T ss_conf 76--------677553813008988478-999867110079999999878899987655999999997389986------
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 999979999999999872227999999992789
Q 005616 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.++...++.+.+|+.+||+.||++|||+.+.+
T Consensus 233 -~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell 264 (270)
T d1t4ha_ 233 -SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264 (270)
T ss_dssp -GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf -56755789999999997637975892999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=358.55 Aligned_cols=240 Identities=25% Similarity=0.344 Sum_probs=196.1
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCC---HHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEE
Q ss_conf 69543403401386589999998--9099999971389334---6999999999970799951257053378--743588
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~---~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
..|...+.||+|+||.||+|+.. |..||||++....... ...|.+|+.++.+++|||||++++++.+ ..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 61789968888612499998999999999999999999985069981672899999622079996699105731001578
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+.+|+|...+... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EECCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCC-
T ss_conf 806999457899737---99999999999999999999998689---76667884217987999789844365334677-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHH--HHHHCCCCCCCCCCC
Q ss_conf 876777655689988988888010104---999982027679999999980999999825789--885219632235787
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRT---GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPL 569 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGviL~ELltG~~P~~~~~~i~--~~i~~~~l~~~ld~~ 569 (688)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|..||....... ..+..+.....
T Consensus 168 ---------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 234 (309)
T d1u5ra_ 168 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---- 234 (309)
T ss_dssp ---------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC----
T ss_pred ---------CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC----
T ss_conf ---------8731347663688998346788867214545589999999878899999799999999982899988----
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHH
Q ss_conf 89999799999999998722279999999927899
Q 005616 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~ 604 (688)
.+...+..+.+|+.+||+.||.+|||+.+.+.
T Consensus 235 ---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 ---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf ---87888999999999977379657918999971
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=350.74 Aligned_cols=233 Identities=27% Similarity=0.368 Sum_probs=197.4
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCC---CCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEE
Q ss_conf 69543403401386589999998--9099999971389---3346999999999970799951257053378--743588
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~---~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|.....||+|+||.||+|+.. |..||||++.... ......+.+|+.+++.++|||||++++++.+ ..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 61789968888612499998999999999999999999985069981672899999622079996699105731001578
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+.||+|...+.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EECCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECCC
T ss_conf 5037863223432222---1110079999999987655412476---770556810503868998898317521671245
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767776556899889888880101049999820276799999999809999998257--89885219632235787899
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~--i~~~i~~~~l~~~ld~~~~~ 572 (688)
....+||+.|+|||++.+..|+.++|||||||++|||+||+.||..... +...+..+.. .
T Consensus 158 ---------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---------~ 219 (316)
T d1fota_ 158 ---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL---------R 219 (316)
T ss_dssp ---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC---------C
T ss_pred ---------CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC---------C
T ss_conf ---------6434576343599998389998043046533368999759899999699999999970898---------8
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 99799999999998722279999999
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs 598 (688)
+|...+..+.+++.+||..||.+||+
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~~ 245 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRLG 245 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTT
T ss_pred CCCCCCHHHHHHHHHHHHHCHHHCCC
T ss_conf 99778999999999995449976664
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=351.19 Aligned_cols=232 Identities=24% Similarity=0.323 Sum_probs=197.3
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCC---CCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEE
Q ss_conf 69543403401386589999998--9099999971389---3346999999999970799951257053378--743588
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~---~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||+|++. |..||||++.... ......+.+|+.++..++|||||++++++.+ ..++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 61789968888612499998999999999999999999985069981672899999622079996699105731001578
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+.+|+|...+.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf 2334662266675158---9899999999999999899998599---861767999936077897886101033322566
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767776556899889888880101049999820276799999999809999998257--89885219632235787899
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~--i~~~i~~~~l~~~ld~~~~~ 572 (688)
.....||+.|||||++.+..++.++|||||||++|||+||+.||..... +...+..+.. .
T Consensus 195 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---------~ 256 (350)
T d1rdqe_ 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV---------R 256 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------C
T ss_pred ---------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC---------C
T ss_conf ---------6433676356788997179988533114500789999758899899599999999861798---------8
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 9979999999999872227999999
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERP 597 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RP 597 (688)
.|..++..+.+|+.+||+.||.+|+
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCT
T ss_pred CCCCCCHHHHHHHHHHHHHCHHHCC
T ss_conf 9766899999999998340998606
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=353.04 Aligned_cols=239 Identities=26% Similarity=0.319 Sum_probs=192.5
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCC---CCHHHHHH---HHHHHHCCCCCCEEEEECCCCC--CCE
Q ss_conf 69543403401386589999998--90999999713893---34699999---9999970799951257053378--743
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQ---EVRVLSKLQHPHLVTLLGACPE--AWS 411 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~---~~~~~f~~---E~~iL~~l~HpnIV~l~g~~~~--~~~ 411 (688)
++|.+.+.||+|+||.||+|+.. |..||||++..... .....+.+ ++.++..++|||||++++++.+ ..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 58861789968888612499998999999999999999999985069981672899999622079996699105731001
Q 005616 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~ 491 (688)
+||||+++|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEEC
T ss_conf 9999148983899987325---5327899999999999999999779---622044422167858896798220102333
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCC
Q ss_conf 578876777655689988988888010104-9999820276799999999809999998257--8988521963223578
Q 005616 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDP 568 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~ELltG~~P~~~~~~--i~~~i~~~~l~~~ld~ 568 (688)
.... .....||+.|+|||++.. ..|+.++|||||||+||||+||+.||..... ........ ..
T Consensus 158 ~~~~--------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~------~~ 223 (364)
T d1omwa3 158 SKKK--------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------LT 223 (364)
T ss_dssp SSSC--------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS------SS
T ss_pred CCCC--------CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC------CC
T ss_conf 7886--------433113455421687603899984410467789999998599988889989999999860------46
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 78999979999999999872227999999992
Q 005616 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 569 ~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
....++..++..+.+|+.+||+.||.+||++.
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 255 (364)
T d1omwa3 224 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCL 255 (364)
T ss_dssp CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTS
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCHHHHCCCC
T ss_conf 88878877899999999998566988808874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.21 Aligned_cols=247 Identities=27% Similarity=0.440 Sum_probs=207.3
Q ss_pred CCCCCCEEEECCCCEEEEEEEECCEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC---CCEEEEEECC
Q ss_conf 6954340340138658999999890999999713893346999999999970799951257053378---7435886178
Q 005616 342 CNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE---AWSLVYEYLP 418 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~---~~~LV~E~~~ 418 (688)
++|.....||+|+||.||+|++.|..||||+++.. .....|.+|+.++++++|||||+++|+|.+ ..++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHEEEEEEEECCCCEEEEEEEECCEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECCC
T ss_conf 99488579820798089999999909999998857--7799999999999867898985498788723892899996369
Q ss_pred CCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 99688886124999989999999999999999999850699816728999996220799966991057310015788767
Q 005616 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~~ 498 (688)
+|+|.++|..... ..++|..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 85 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHHCCC-CCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCCC---
T ss_conf 9989999874578-88899999999999985232113376---5536665676014689977632456003447877---
Q ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHH--HHHHHHHCCCCCCCCCCCCCCCCH
Q ss_conf 77655689988988888010104999982027679999999980-999999825--789885219632235787899997
Q 005616 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~P~~~~~--~i~~~i~~~~l~~~ld~~~~~~~~ 575 (688)
....++..|+|||++.+..+++++||||||+++|||+| |++||.... .+...+..+... ..+.
T Consensus 158 ------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~--------~~~~ 223 (262)
T d1byga_ 158 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM--------DAPD 223 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC--------CCCT
T ss_pred ------CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC--------CCCC
T ss_conf ------65566646778178727988858877757999999997899999999999999999808999--------9976
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 9999999999872227999999992789999998430
Q 005616 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~~ 612 (688)
..+..+.+|+.+||+.||.+|||+. ++.+.|+.+..
T Consensus 224 ~~~~~~~~li~~cl~~dP~~Rps~~-~l~~~L~~i~~ 259 (262)
T d1byga_ 224 GCPPAVYEVMKNCWHLDAAMRPSFL-QLREQLEHIKT 259 (262)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 5799999999997566976893999-99999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.98 Aligned_cols=245 Identities=25% Similarity=0.320 Sum_probs=201.1
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCC------CCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CC
Q ss_conf 269543403401386589999998--90999999713893------346999999999970799951257053378--74
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM------QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AW 410 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~------~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~ 410 (688)
.+.|.....||+|+||.||+|+.. |..||||++..... .....|.+|+.++.+++|||||++++++.+ ..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC----CEEEEECC
Q ss_conf 35886178996888861249999899999999999999999998506998167289999962207999----66991057
Q 005616 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL----SSKICDFG 486 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~----~~KL~DFG 486 (688)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEECCCCCCCCCHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf 99998677864310010356---4215578999999999987666254---22113330127982589866646964334
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCC
Q ss_conf 310015788767776556899889888880101049999820276799999999809999998257--898852196322
Q 005616 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSS 564 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~--i~~~i~~~~l~~ 564 (688)
+|....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..+....
T Consensus 163 ~a~~~~~~~-------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1jksa_ 163 LAHKIDFGN-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235 (293)
T ss_dssp TCEECTTSC-------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC
T ss_pred HHHHCCCCC-------CCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf 421057776-------3122477774309999818999976652214099999970889988999999999998168888
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 357878999979999999999872227999999992789
Q 005616 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 565 ~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
....+...+..+.+|+.+||+.||.+|||+.+.+
T Consensus 236 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 269 (293)
T d1jksa_ 236 -----EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269 (293)
T ss_dssp -----CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred -----CCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf -----7010478899999999998638966891999996
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.02 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=207.1
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC-----CEEEEEEEEECCCCC-CHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCEEEE
Q ss_conf 69543403401386589999998-----909999997138933-46999999999970799951257053378-743588
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-----g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~ 414 (688)
++|.....||+|+||.||+|.+. +..||||.+...... ....|.+|+.++++++|||||+++|+|.+ ..++||
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~ 86 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM 86 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEE
T ss_pred HHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCEEEEEE
T ss_conf 99698779930788299999993699644999999936566879999999999999868999985698899537479999
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 61789968888612499998999999999999999999985069981672899999622079996699105731001578
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 87 E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp ECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEECCCC
T ss_conf 8406980776542247--89999999999999987752302267---441410265532067896787650342133677
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHH--HHHHHHHCCCCCCCCCCCCC
Q ss_conf 876777655689988988888010104999982027679999999980-999999825--78988521963223578789
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~P~~~~~--~i~~~i~~~~l~~~ld~~~~ 571 (688)
... ......||+.|+|||++....++.++|||||||++|||+| |.+||.... .+...+..+...
T Consensus 162 ~~~-----~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~-------- 228 (273)
T d1mp8a_ 162 TYY-----KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-------- 228 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--------
T ss_pred CCE-----ECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC--------
T ss_conf 623-----3054005831032667516998874524442478999982699998889999999999818999--------
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 9997999999999987222799999999278999999843
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~ 611 (688)
..+..++..+.+|+.+||..||.+|||+. ++++.|+.+.
T Consensus 229 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~-ei~~~L~~i~ 267 (273)
T d1mp8a_ 229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFT-ELKAQLSTIL 267 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 89877799999999997687976892999-9999999997
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.63 Aligned_cols=250 Identities=27% Similarity=0.458 Sum_probs=201.6
Q ss_pred CEEEECCCCEEEEEEEECC-----EEEEEEEEECCC-CCCHHHHHHHHHHHHCCCCCCEEEEECCCCC---CCEEEEEEC
Q ss_conf 4034013865899999989-----099999971389-3346999999999970799951257053378---743588617
Q 005616 347 SFKVGQGGFGCVYKGEMLG-----RTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE---AWSLVYEYL 417 (688)
Q Consensus 347 ~~~LG~G~fG~Vykg~~~g-----~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~---~~~LV~E~~ 417 (688)
..+||+|+||+||+|.+.. ..||||+++... ......|.+|+.++.+++|||||+++|+|.+ ..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 89968888612499998999999999999999999985069981672899999622079996699105731001578876
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ECCCHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf 0674144210134--54048999999999887652003367---625776687576779998899106523225566555
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH---HHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 7776556899889888880101049999820276799999999809999998257---8988521963223578789999
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~---i~~~i~~~~l~~~ld~~~~~~~ 574 (688)
. ........||+.|+|||++....++.++||||||+++|||+||..||..... +...+..+... ..|
T Consensus 187 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~--------~~p 256 (311)
T d1r0pa_ 187 S--VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL--------LQP 256 (311)
T ss_dssp C--TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC--------CCC
T ss_pred C--CEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC--------CCC
T ss_conf 3--100256555645567688743799974574661999999997899998889999999999808988--------996
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 79999999999872227999999992789999998430
Q 005616 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 575 ~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~~ 612 (688)
..++..+.+|+.+||+.||.+||++. ++++.|+.+..
T Consensus 257 ~~~~~~l~~li~~cl~~dP~~RPs~~-ei~~~L~~i~~ 293 (311)
T d1r0pa_ 257 EYCPDPLYEVMLKCWHPKAEMRPSFS-ELVSRISAIFS 293 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 44759999999997688976893999-99999999997
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.49 Aligned_cols=254 Identities=29% Similarity=0.439 Sum_probs=203.6
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC-------CEEEEEEEEECCCCC-CHHHHHHHHHHHHCC-CCCCEEEEECCCCC---C
Q ss_conf 69543403401386589999998-------909999997138933-469999999999707-99951257053378---7
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACPE---A 409 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-------g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~---~ 409 (688)
++|.....||+|+||.||+|.+. ++.||||+++..... ....+.+|..++.++ +|+|||.+++++.+ .
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCE
T ss_conf 99798449841678399999986777555783999999860017178999999999988614998499741154047975
Q ss_pred CEEEEEECCCCCHHHHHCCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC
Q ss_conf 4358861789968888612499-------------998999999999999999999985069981672899999622079
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS 476 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~ 476 (688)
.++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECG
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECC
T ss_conf 79999845899299999853666665322202332146899999999999999999887379---717867731065779
Q ss_pred CCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCHH---H
Q ss_conf 9966991057310015788767776556899889888880101049999820276799999999809-99999825---7
Q 005616 477 ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG-RLPVGLAG---E 552 (688)
Q Consensus 477 ~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG-~~P~~~~~---~ 552 (688)
++.+||+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||+|| .+||.... .
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp GGCEEECC------CCSCTTS----CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred CCCEEECCCCCHHHCCCCCCC----CCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHH
T ss_conf 982898457520011356652----2247516672102036864688996632213678999998688999989998999
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 89885219632235787899997999999999987222799999999278999999843
Q 005616 553 VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 553 i~~~i~~~~l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~ 611 (688)
+...+..+... ..|...+..+.+|+.+||+.||.+|||+. ++++.|+.+.
T Consensus 246 ~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-eil~~L~~il 295 (299)
T d1ywna1 246 FCRRLKEGTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFS-ELVEHLGNLL 295 (299)
T ss_dssp HHHHHHHTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred HHHHHHCCCCC--------CCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 99999638988--------88865789999999997677966791999-9999997998
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.52 Aligned_cols=241 Identities=28% Similarity=0.358 Sum_probs=199.8
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCC---CCCHHHHHHHHHHHH-CCCCCCEEEEECCCCC--CCEEE
Q ss_conf 69543403401386589999998--9099999971389---334699999999997-0799951257053378--74358
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLS-KLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~---~~~~~~f~~E~~iL~-~l~HpnIV~l~g~~~~--~~~LV 413 (688)
++|.+.+.||+|+||+||+|+.. |..||||++.+.. ......+..|..++. .++|||||++++++.+ ..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 86178996888861249999899999999999999999998506998167289999962207999669910573100157
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~ 493 (688)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEECCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf 75037980899864047---8999999999999999999998689---34034765404444899630155530232356
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCC
Q ss_conf 88767776556899889888880101049999820276799999999809999998257--8988521963223578789
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~--i~~~i~~~~l~~~ld~~~~ 571 (688)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... +...+..+. .
T Consensus 156 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~---------~ 220 (320)
T d1xjda_ 156 GDA------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN---------P 220 (320)
T ss_dssp TTC------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------C
T ss_pred CCC------CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC---------C
T ss_conf 653------3454578777689999827998832320112278989873889999989999999997189---------9
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 99979999999999872227999999992789
Q 005616 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.+|..++..+.+|+.+||..||.+||++..++
T Consensus 221 ~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l 252 (320)
T d1xjda_ 221 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252 (320)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf 89756799999999996544898783889999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.69 Aligned_cols=258 Identities=26% Similarity=0.357 Sum_probs=198.2
Q ss_pred CCCCCCEEEECCCCEEEEEEEECCEEEEEEEEECCCCCCHHHHH--HHHHHHHCCCCCCEEEEECCCCC------CCEEE
Q ss_conf 69543403401386589999998909999997138933469999--99999970799951257053378------74358
Q 005616 342 CNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPHLVTLLGACPE------AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g~~VAIK~l~~~~~~~~~~f~--~E~~iL~~l~HpnIV~l~g~~~~------~~~LV 413 (688)
.+|...+.||+|+||.||+|++.|..||||++.... ...+. .|+..+..++|||||+++|+|.+ ..++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf 689998898207881999999999899999987200---46799999999996279986832688998379860489999
Q ss_pred EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC-----CCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 861789968888612499998999999999999999999985069-----981672899999622079996699105731
Q 005616 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK-----PEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~-----~~~IiHrDIKp~NILLd~~~~~KL~DFGla 488 (688)
|||+++|+|.++|... .++|..+++++.++|.||.|||+.. .++|+||||||+|||++.++.+||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EECCCCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCC
T ss_conf 9646698989998658----999899999999999999998876652046898661531731357868877688763866
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCC------CCCCCHHHHHHHHHHHHHHCCCCCCCHH-----------
Q ss_conf 00157887677765568998898888801010499------9982027679999999980999999825-----------
Q 005616 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV------LTPKSDSYSFGLIILQLLTGRLPVGLAG----------- 551 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~------~s~ksDVwSlGviL~ELltG~~P~~~~~----------- 551 (688)
+......... ........||+.|+|||++.... ++.++|||||||+||||+||.+|+....
T Consensus 156 ~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 156 VRHDSATDTI--DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp EEEETTTTEE--CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCCCCCCCCE--ECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC
T ss_conf 2346777620--01355250354767822105654546777675012201599999996289988766311241012255
Q ss_pred ------HHHHHHHCCCCCCCCCCCCC-CC-CHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf ------78988521963223578789-99-9799999999998722279999999927899999984300
Q 005616 552 ------EVRRAVSCGKLSSILDPLAG-DW-PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVA 613 (688)
Q Consensus 552 ------~i~~~i~~~~l~~~ld~~~~-~~-~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~~~ 613 (688)
........+. ++|... .+ +......+.+|+.+||+.||.+|||+. ++.+.|+.+...
T Consensus 234 ~~~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-ei~~~L~~i~~~ 298 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL-RIKKTLSQLSQQ 298 (303)
T ss_dssp SSCCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHH-HHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHCCC----CCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHHH
T ss_conf 6430999999875024----6888776557768999999999997606985895999-999999988886
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=343.67 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=207.8
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCC---HHHHHHHHHHHHCCCCCCEEEEECCCCC------C
Q ss_conf 269543403401386589999998--9099999971389334---6999999999970799951257053378------7
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHPHLVTLLGACPE------A 409 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~---~~~f~~E~~iL~~l~HpnIV~l~g~~~~------~ 409 (688)
.++|.+...||+|+||.||+|... |..||||++....... ...|.+|+.++..++|||||++++++.. .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred CEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 43588617899688886124999989999999999999999999850699816728999996220799966991057310
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~ 489 (688)
.++||||++||+|.+.+.... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++..+|+|||++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEEHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf 999997788987101120358---9999999999999999999998579---5276346755665754320100344432
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHH---HHHCCCCCCCC
Q ss_conf 015788767776556899889888880101049999820276799999999809999998257898---85219632235
Q 005616 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSCGKLSSIL 566 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~i~~---~i~~~~l~~~l 566 (688)
........ .......+||+.|+|||++.+..+++++|||||||++|||+||++||........ .+..+...
T Consensus 160 ~~~~~~~~---~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~--- 233 (277)
T d1o6ya_ 160 AIADSGNS---VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--- 233 (277)
T ss_dssp ECC-------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC---
T ss_pred HHCCCCCC---CCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC---
T ss_conf 21235443---333464257624369999839999966320265289999976979989969999999998469999---
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 787899997999999999987222799999999278999999843
Q 005616 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 567 d~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~ 611 (688)
+ ......++..+.+|+.+||+.||.+||+..+++.+.|.++.
T Consensus 234 -~--~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 -P--SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -G--GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -C--CHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf -7--10034789999999999866797677739999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.50 Aligned_cols=252 Identities=28% Similarity=0.422 Sum_probs=205.1
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CE--EEEEEEEECCCC-CCHHHHHHHHHHHHCC-CCCCEEEEECCCCC--CCEEE
Q ss_conf 69543403401386589999998--90--999999713893-3469999999999707-99951257053378--74358
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GR--TVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~--~VAIK~l~~~~~-~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV 413 (688)
++|....+||+|+||.||+|.+. |. .||||++..... .....|.+|+.++.++ +|||||+++|+|.+ ..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHHHCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf 8617899688886124-------------999989999999999999999999850699816728999996220799966
Q 005616 414 YEYLPNGSLQDRLFRK-------------SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~-------------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~ 480 (688)
|||+++|+|.++|... .....+++..+.+++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663089---5455505204898688763
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCHH--HHHHHH
Q ss_conf 9910573100157887677765568998898888801010499998202767999999998099-9999825--789885
Q 005616 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR-LPVGLAG--EVRRAV 557 (688)
Q Consensus 481 KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~-~P~~~~~--~i~~~i 557 (688)
||+|||+++...... ......||..|+|||.+....++.++|||||||++|||++|. +||.... .+...+
T Consensus 167 kl~DfG~a~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp EECCTTCEESSCEEC-------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred EECCCCCCCCCCCCC-------CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 874344322444223-------4553013775555387526999962215313889999983689999999999999999
Q ss_pred HCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 2196322357878999979999999999872227999999992789999998430
Q 005616 558 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 558 ~~~~l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~~ 612 (688)
..+.. ...+..++..+.+|+.+||+.||++||++. ++++.|+.+..
T Consensus 240 ~~~~~--------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-eil~~L~~i~~ 285 (309)
T d1fvra_ 240 PQGYR--------LEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRMLE 285 (309)
T ss_dssp GGTCC--------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred HHCCC--------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 82688--------888766789999999997678966894999-99999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.26 Aligned_cols=249 Identities=22% Similarity=0.264 Sum_probs=195.2
Q ss_pred HCCCCCCE-EEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCC-CCCCEEEEECCCCC------CC
Q ss_conf 26954340-3401386589999998--909999997138933469999999999707-99951257053378------74
Q 005616 341 TCNFSESF-KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE------AW 410 (688)
Q Consensus 341 t~~f~~~~-~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~------~~ 410 (688)
.++|.+.. .||+|+||.||+|++. |..||||++.. ...+.+|+.++.++ +|||||++++++.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 14879810796545486999999889998999999897-----4779999999998669999782989995034689789
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC---CCCEEEEECCC
Q ss_conf 358861789968888612499998999999999999999999985069981672899999622079---99669910573
Q 005616 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGI 487 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~---~~~~KL~DFGl 487 (688)
++|||||+||+|.+++..... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCCHHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 999977899849999986278-77579999999999999999999769---86444100220113555566311354551
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHH--HHHHCCCCCCC
Q ss_conf 1001578876777655689988988888010104999982027679999999980999999825789--88521963223
Q 005616 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSI 565 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~i~--~~i~~~~l~~~ 565 (688)
|+...... ......||+.|+|||++.+..|+.++|||||||+||+|+||++||....... ..+........
T Consensus 161 a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~ 233 (335)
T d2ozaa1 161 AKETTSHN-------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233 (335)
T ss_dssp CEECCCCC-------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS
T ss_pred EEECCCCC-------CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCC
T ss_conf 23336888-------64322677563792777489888888887645167788658899889887788999999985388
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHH
Q ss_conf 57878999979999999999872227999999992789999
Q 005616 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 566 ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~ 606 (688)
.+ ........++..+.+|+.+||+.||.+||++.+.+.+.
T Consensus 234 ~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 273 (335)
T d2ozaa1 234 YE-FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273 (335)
T ss_dssp SS-CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSH
T ss_pred CC-CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 88-89854346999999999997569965790999997098
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.26 Aligned_cols=255 Identities=27% Similarity=0.452 Sum_probs=209.2
Q ss_pred CCCCCCEEEECCCCEEEEEEEECC---------EEEEEEEEECCCCC-CHHHHHHHHHHHHCC-CCCCEEEEECCCCC--
Q ss_conf 695434034013865899999989---------09999997138933-469999999999707-99951257053378--
Q 005616 342 CNFSESFKVGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACPE-- 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g---------~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~-- 408 (688)
++|...+.||+|+||.||+|+..+ ..||||+++..... ....+.+|...+.++ +|||||+++|+|.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCCC
T ss_conf 99697009851678289999985787555667549999998811286889999999999998139996973465220188
Q ss_pred CCEEEEEECCCCCHHHHHCCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC
Q ss_conf 74358861789968888612499-------------99899999999999999999998506998167289999962207
Q 005616 409 AWSLVYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD 475 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd 475 (688)
..++||||+.+|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEEEC
T ss_conf 689999736999099999860677643222334574346799999999999999998766379---78630221022454
Q ss_pred CCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHH--H
Q ss_conf 9996699105731001578876777655689988988888010104999982027679999999980-999999825--7
Q 005616 476 SELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--E 552 (688)
Q Consensus 476 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~P~~~~~--~ 552 (688)
.++.+||+|||+++........ .......|++.|+|||++.++.|+.++|||||||++|||++ |.+||.... .
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTT----CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred CCCCEEECCCHHHCCCCCCCCC----CCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHH
T ss_conf 7897676221110113555554----314667888466326675179888255547758888874017989899999999
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 898852196322357878999979999999999872227999999992789999998430
Q 005616 553 VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 553 i~~~i~~~~l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~~ 612 (688)
+...+..+.. ...|..++..+.+|+.+||+.||.+|||+. ++++.|+.+..
T Consensus 246 ~~~~i~~~~~--------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~-eil~~L~~i~a 296 (299)
T d1fgka_ 246 LFKLLKEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHTTCC--------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred HHHHHHCCCC--------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 9999972888--------898743529999999997667976793999-99999988860
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.67 Aligned_cols=253 Identities=28% Similarity=0.452 Sum_probs=205.7
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC-------CEEEEEEEEECCCC-CCHHHHHHHHHHHHCCCCCCEEEEECCCC--CCCE
Q ss_conf 69543403401386589999998-------90999999713893-34699999999997079995125705337--8743
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWS 411 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~ 411 (688)
++|...+.||+|+||+||+|.+. +..||||+++.... .....|.+|+.++.+++|||||+++|+|. +..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 99188359820788189999987864477896899999870128689999999999999769998841254784288106
Q ss_pred EEEEECCCCCHHHHHCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf 588617899688886124-------9999899999999999999999998506998167289999962207999669910
Q 005616 412 LVYEYLPNGSLQDRLFRK-------SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICD 484 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~-------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~D 484 (688)
+||||+++|+|.+++... .....+++..+.+++.+++.||.|||..+ |+||||||+|||++.++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEEEEEE
T ss_conf 777604899889998750332113444688799999999999999999876479---65432867754035996499942
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCHHH--HHHHHHCCC
Q ss_conf 57310015788767776556899889888880101049999820276799999999809-999998257--898852196
Q 005616 485 FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG-RLPVGLAGE--VRRAVSCGK 561 (688)
Q Consensus 485 FGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG-~~P~~~~~~--i~~~i~~~~ 561 (688)
||+|+........ .......||+.|+|||.+.+..++.++||||||+++|||+|| .+||..... +...+..+.
T Consensus 177 FGla~~~~~~~~~----~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 177 FGMTRDIYETDYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp TTCCCGGGGGGCE----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred CCCCEECCCCCCE----EECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC
T ss_conf 4542023577630----313402316323788887369988333444378999999968999999989999999998088
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 3223578789999799999999998722279999999927899999984
Q 005616 562 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 562 l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l 610 (688)
.. ..|..++..+.+|+.+||+.+|.+|||+. .+++.|+..
T Consensus 253 ~~--------~~p~~~~~~l~~li~~cl~~~P~~RPs~~-~il~~L~~~ 292 (308)
T d1p4oa_ 253 LL--------DKPDNCPDMLFELMRMCWQYNPKMRPSFL-EIISSIKEE 292 (308)
T ss_dssp CC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHGGG
T ss_pred CC--------CCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHH
T ss_conf 88--------88633539999999997577965893999-999997876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.70 Aligned_cols=253 Identities=27% Similarity=0.404 Sum_probs=204.7
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC---C--EEEEEEEEECCCC---CCHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCEE
Q ss_conf 69543403401386589999998---9--0999999713893---346999999999970799951257053378-7435
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML---G--RTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSL 412 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~---g--~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~L 412 (688)
.+|.+...||+|+||.||+|++. + ..||||++..... .....|.+|+.++.+++|||||+++|+|.+ ..++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCHHE
T ss_conf 89199789803888399999998899907999999998355579899999999999998689999878987774010011
Q ss_pred EEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 88617899688886124999989999999999999999999850699816728999996220799966991057310015
Q 005616 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~ 492 (688)
||||+++|++.+.+.... ..+++..++.++.|+|.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf 465423861254442126--89999999999999999998752178---7520566888156556543325611555303
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHHHH--HHHHHCCCCCCCCCCC
Q ss_conf 78876777655689988988888010104999982027679999999980-99999982578--9885219632235787
Q 005616 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV--RRAVSCGKLSSILDPL 569 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~P~~~~~~i--~~~i~~~~l~~~ld~~ 569 (688)
...... .......|++.|+|||++.+..++.++|||||||++|||+| |+.||...... ...+.....
T Consensus 163 ~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~------- 232 (273)
T d1u46a_ 163 QNDDHY---VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE------- 232 (273)
T ss_dssp C-CCEE---EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC-------
T ss_pred CCCCCC---EECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC-------
T ss_conf 588752---6547632573107999983799994215661489999999689999999699999999984799-------
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 89999799999999998722279999999927899999984
Q 005616 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l 610 (688)
..+.+..++..+.+|+.+||+.||++|||+. ++.+.|+..
T Consensus 233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-ei~~~L~~~ 272 (273)
T d1u46a_ 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV-ALRDFLLEA 272 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHC
T ss_conf 9998544539999999997688966792999-999999964
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.88 Aligned_cols=248 Identities=19% Similarity=0.282 Sum_probs=201.0
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCC--CCCEEEEEE
Q ss_conf 269543403401386589999998--9099999971389334699999999997079995125705337--874358861
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
.++|.+...||+|+||+||+|... |..||+|.++... .....+.+|+.+|..++|||||++++++. +..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 010588789831778399999998999699999975786-6599999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCC--CCEEEEECCCCCCCCCC
Q ss_conf 7899688886124999989999999999999999999850699816728999996220799--96699105731001578
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE--LSSKICDFGICRLVTED 494 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~--~~~KL~DFGla~~~~~~ 494 (688)
++||+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC
T ss_conf 89980889987538--99999999999999999999998769---97513554443443788518997644111003467
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767776556899889888880101049999820276799999999809999998257--89885219632235787899
Q 005616 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~--i~~~i~~~~l~~~ld~~~~~ 572 (688)
. ......||+.|+|||.+.+..++.++|||||||++|+|++|..||..... +...+..+...- ...
T Consensus 158 ~-------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-----~~~ 225 (321)
T d1tkia_ 158 D-------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF-----DEE 225 (321)
T ss_dssp C-------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC-----CHH
T ss_pred C-------CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC-----CHH
T ss_conf 7-------5321223322234021048777840113027999999982899999989999999998389998-----802
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHH
Q ss_conf 9979999999999872227999999992789999
Q 005616 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~ 606 (688)
....++..+.+|+.+||..||.+|||+.+.+.+.
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 259 (321)
T d1tkia_ 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 2367899999999998669966890999996399
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.36 Aligned_cols=253 Identities=29% Similarity=0.413 Sum_probs=206.2
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC-------CEEEEEEEEECCCCC-CHHHHHHHHHHHHCC-CCCCEEEEECCCCC--CC
Q ss_conf 69543403401386589999998-------909999997138933-469999999999707-99951257053378--74
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AW 410 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-------g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~ 410 (688)
++|.+.++||+|+||.||+|++. +..||||+++..... ....|.+|+.++.++ +|||||+++|+|.+ ..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 99698549820688299999980664477886999999874248779999999999987626999887899898319978
Q ss_pred EEEEEECCCCCHHHHHCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC
Q ss_conf 35886178996888861249---------------999899999999999999999998506998167289999962207
Q 005616 411 SLVYEYLPNGSLQDRLFRKS---------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD 475 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~---------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd 475 (688)
++||||+++|+|.+++.... ....+++..+..|+.||+.||.|||+.+ ++||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCC
T ss_conf 999973799879999985356654444453322233458899999999999999999887579---26662410210000
Q ss_pred CCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHH---
Q ss_conf 9996699105731001578876777655689988988888010104999982027679999999980-999999825---
Q 005616 476 SELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--- 551 (688)
Q Consensus 476 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~P~~~~~--- 551 (688)
.++.+||+|||+++........ .......||+.|+|||++....++.++|||||||++|||+| |.+||....
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNY----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTS----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred CCCCCCCCCCCHHEECCCCCCC----EEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH
T ss_conf 2575210234010233678861----586201359687677886179999740010258999999858998877899899
Q ss_pred HHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 78988521963223578789999799999999998722279999999927899999984
Q 005616 552 EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 552 ~i~~~i~~~~l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l 610 (688)
.+...+..+.. ...+...+..+.+|+.+||+.||.+|||+. .+++.|+..
T Consensus 256 ~~~~~i~~~~~--------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~-~il~~L~~~ 305 (311)
T d1t46a_ 256 KFYKMIKEGFR--------MLSPEHAPAEMYDIMKTCWDADPLKRPTFK-QIVQLIEKQ 305 (311)
T ss_dssp HHHHHHHHTCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHH
T ss_pred HHHHHHHCCCC--------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHH
T ss_conf 99999866898--------898543659999999997577965792999-999999876
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=334.57 Aligned_cols=243 Identities=24% Similarity=0.325 Sum_probs=200.1
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCC---------HHHHHHHHHHHHCCC-CCCEEEEECCCCC-
Q ss_conf 69543403401386589999998--9099999971389334---------699999999997079-9951257053378-
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---------QLEFQQEVRVLSKLQ-HPHLVTLLGACPE- 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~---------~~~f~~E~~iL~~l~-HpnIV~l~g~~~~- 408 (688)
++|.....||+|+||+||+|+.. |..||||++....... ...+.+|+.++.+++ |||||++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf 63888528841768499999999999899999996244641147888999999999999999850799747997621467
Q ss_pred -CCEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf -7435886178996888861249999899999999999999999998506998167289999962207999669910573
Q 005616 409 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGl 487 (688)
..++||||+++|+|.+++.... .+++..+..++.||+.||.|||..+ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCEEEEEECCCCCHHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCHH
T ss_conf 60599997689866899998659---9999999999999999999998759---94323462548986899838712403
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC------CCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHC
Q ss_conf 1001578876777655689988988888010104------9999820276799999999809999998257--8988521
Q 005616 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT------GVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSC 559 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVwSlGviL~ELltG~~P~~~~~~--i~~~i~~ 559 (688)
++...... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..... +...+..
T Consensus 157 a~~~~~~~-------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~ 229 (277)
T d1phka_ 157 SCQLDPGE-------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229 (277)
T ss_dssp CEECCTTC-------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEECCCCC-------CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHHHH
T ss_conf 16726887-------21345246788898886053445678899233185656023103228889889999999999981
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHH
Q ss_conf 9632235787899997999999999987222799999999278
Q 005616 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 560 ~~l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~ 602 (688)
+...- ........+..+.+|+.+||+.||.+||++.+.
T Consensus 230 ~~~~~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~ei 267 (277)
T d1phka_ 230 GNYQF-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267 (277)
T ss_dssp TCCCC-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCC-----CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 89888-----985434689999999999765896689199999
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.89 Aligned_cols=245 Identities=24% Similarity=0.254 Sum_probs=190.0
Q ss_pred CEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCC-----HHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEEEC
Q ss_conf 403401386589999998--9099999971389334-----6999999999970799951257053378--743588617
Q 005616 347 SFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG-----QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 347 ~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~-----~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
..+||+|+||+||+|... |..||||++....... ...+.+|+.++..++|||||++++++.+ ..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 89968888612499998999999999999999999985069981672899999622079996699105731001578876
Q 005616 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~~ 497 (688)
.++++....... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp SEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred CCHHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC-
T ss_conf 450776554126---67789999999999999998863163---55035776258853778411465761000578755-
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH--C--CC-----CCCCC-
Q ss_conf 7776556899889888880101049-999820276799999999809999998257898852--1--96-----32235-
Q 005616 498 LPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS--C--GK-----LSSIL- 566 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ELltG~~P~~~~~~i~~~i~--~--~~-----l~~~l- 566 (688)
.....+||+.|+|||++... .|+.++|||||||++|||+||.+||........... . +. .....
T Consensus 156 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 -----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp -----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred -----CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHC
T ss_conf -----433020473336399972677888056436304289999859699999999999999998518997254521000
Q ss_pred --C----CCCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf --7----8789999-----79999999999872227999999992789
Q 005616 567 --D----PLAGDWP-----TFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 567 --d----~~~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
. ......+ ...+..+.+|+.+||+.||++|||+.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L 278 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 213443034789886785656899999999997638945690899996
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.70 Aligned_cols=251 Identities=26% Similarity=0.336 Sum_probs=193.0
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC---CEEEEEEEEECCCC--CCHHHHHHHHHHHHCC---CCCCEEEEECCCC-----
Q ss_conf 269543403401386589999998---90999999713893--3469999999999707---9995125705337-----
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKL---QHPHLVTLLGACP----- 407 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~---g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l---~HpnIV~l~g~~~----- 407 (688)
.++|.....||+|+||+||+|++. +..||||++..... .....+.+|+.++..+ +|||||+++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred --CCCEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf --874358861789968888612499998999999999999999999985069981672899999622079996699105
Q 005616 408 --EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 408 --~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DF 485 (688)
...++++||+.++.+........ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCEEEEEEEECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECCH
T ss_conf 6746999997405871444443037--89998999999999999999997588---983579862789858997542100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH----CCC
Q ss_conf 7310015788767776556899889888880101049999820276799999999809999998257898852----196
Q 005616 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGK 561 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~i~~~i~----~~~ 561 (688)
|+++...... ......||+.|+|||++.+..|+.++||||+||++|||++|++||........... .+.
T Consensus 161 g~~~~~~~~~-------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 161 GLARIYSFQM-------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp CSCCCCCGGG-------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred HHHHHHCCCC-------CCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCC
T ss_conf 0101100234-------577765485114831001798881110003289999998787998998989999999984079
Q ss_pred ----------------CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf ----------------322357878999979999999999872227999999992789
Q 005616 562 ----------------LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 562 ----------------l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
...........++...+..+.+|+.+||+.||.+|||+.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L 291 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 9611053211110333022345645440445899999999998748966791899996
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.29 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=194.0
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCC--CCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEE
Q ss_conf 69543403401386589999998--90999999713893--346999999999970799951257053378--7435886
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
++|...++||+|+||+||+|.+. |..||||+++.... .....+.+|+.++++++|||||++++++.+ ..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 17899688886124999989999999999999999999850699816728999996220799966991057310015788
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
|+.++.+. .+... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~-~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKK-FMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHH-HHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ECCCCHHH-HHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf 23774455-54420-2568888999999999999999865288---9921357114011346762103578613436886
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH----CCCCCC------
Q ss_conf 7677765568998898888801010499-99820276799999999809999998257898852----196322------
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGV-LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGKLSS------ 564 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGviL~ELltG~~P~~~~~~i~~~i~----~~~l~~------ 564 (688)
. ......||+.|+|||++.... ++.++|||||||++|+|++|+.||........... .+...+
T Consensus 157 ~------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 157 R------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp B------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred C------CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCC
T ss_conf 4------1001036521541122136657774221033331342796687998988999999999983289833314442
Q ss_pred --CCC--CCCCCC--------CHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf --357--878999--------979999999999872227999999992789
Q 005616 565 --ILD--PLAGDW--------PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 565 --~ld--~~~~~~--------~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
..+ .....+ ....+..+.+|+.+||+.||.+|||+.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell 281 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 224212434543222204441667899999999997639955791899996
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.93 Aligned_cols=247 Identities=24% Similarity=0.314 Sum_probs=189.1
Q ss_pred CCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--------CCEE
Q ss_conf 9543403401386589999998--90999999713893346999999999970799951257053378--------7435
Q 005616 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--------AWSL 412 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--------~~~L 412 (688)
+|...++||+|+||+||+|++. |..||||++...... +.+|+.++.+++|||||+++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH----HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 767516982176839999999999979999998816068----9999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCCCC
Q ss_conf 886178996888861249999899999999999999999998506998167289999962207999-6699105731001
Q 005616 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLV 491 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-~~KL~DFGla~~~ 491 (688)
||||++++.+............+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 9841688607888863103689999999999999999999998668---7645788603787358971167336605440
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH------------
Q ss_conf 578876777655689988988888010104-9999820276799999999809999998257898852------------
Q 005616 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS------------ 558 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~ELltG~~P~~~~~~i~~~i~------------ 558 (688)
.... ......|++.|+|||.+.+ ..++.++||||+||++|||++|++||...........
T Consensus 174 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 174 VRGE-------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CTTS-------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCCC-------CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHH
T ss_conf 4776-------532002555556827764046888210002465277855028799898799999999999748981776
Q ss_pred -----CC----CCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf -----19----6322357-878999979999999999872227999999992789
Q 005616 559 -----CG----KLSSILD-PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 559 -----~~----~l~~~ld-~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.. .+..... +.........+..+.+|+.+||..||.+|||+.+.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 301 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 5430621011035544567444431568999999999997658955792999996
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.77 Aligned_cols=236 Identities=23% Similarity=0.353 Sum_probs=192.2
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCC------CHHHHHHHHHHHHCCC--CCCEEEEECCCCC--
Q ss_conf 269543403401386589999998--909999997138933------4699999999997079--9951257053378--
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ------GQLEFQQEVRVLSKLQ--HPHLVTLLGACPE-- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~------~~~~f~~E~~iL~~l~--HpnIV~l~g~~~~-- 408 (688)
.++|...+.||+|+||.||+|+.. |..||||++...... ....+.+|+.++.+++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred CCEEEEEECCC-CCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC-CCCEEEEECC
Q ss_conf 74358861789-968888612499998999999999999999999985069981672899999622079-9966991057
Q 005616 409 AWSLVYEYLPN-GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFG 486 (688)
Q Consensus 409 ~~~LV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-~~~~KL~DFG 486 (688)
..++||||+.+ +++.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEEECCCCCHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf 6899998336862289998615---89999999999999999999998779---75566761114774478848977546
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 31001578876777655689988988888010104999-98202767999999998099999982578988521963223
Q 005616 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL-TPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSI 565 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGviL~ELltG~~P~~~~~~i~~~i~~~~l~~~ 565 (688)
+|+...... .....||+.|+|||++.+..+ +.++|||||||++|||+||+.||.....+.. +..
T Consensus 157 ~a~~~~~~~--------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~----~~~--- 221 (273)
T d1xwsa_ 157 SGALLKDTV--------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR----GQV--- 221 (273)
T ss_dssp TCEECCSSC--------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH----CCC---
T ss_pred CCEECCCCC--------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHHHHH----CCC---
T ss_conf 535324445--------56656587747999984899788653325540345367568899887367761----544---
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 57878999979999999999872227999999992789
Q 005616 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 566 ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.++...+..+.+|+.+||..||.+|||+.+.+
T Consensus 222 ------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 253 (273)
T d1xwsa_ 222 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253 (273)
T ss_dssp ------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf ------77877999999999997608975893999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=324.50 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=195.7
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC-CEEEEEEEEECCCC--CCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEEE
Q ss_conf 69543403401386589999998-90999999713893--346999999999970799951257053378--74358861
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
++|....+||+|+||+||+|++. |..||||++..... .....+.+|+.++++++|||||++++++.+ ..++++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 78996888861249999899999999999999999998506998167289999962207999669910573100157887
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~~ 496 (688)
+.++.+....... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EHHHHHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC
T ss_conf 0045678998604---77514456899999999999860574---88267877505686899787323664301146765
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH----CCC--------CC
Q ss_conf 67776556899889888880101049-999820276799999999809999998257898852----196--------32
Q 005616 497 YLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGK--------LS 563 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ELltG~~P~~~~~~i~~~i~----~~~--------l~ 563 (688)
......|++.|+|||.+... .++.++|||||||++|||++|+.||........... .+. ..
T Consensus 156 ------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ------CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHH
T ss_conf ------41010243110137887178888841002111758999977979989889899999999863899711042123
Q ss_pred CC------CC---CC-CCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 23------57---87-8999979999999999872227999999992789
Q 005616 564 SI------LD---PL-AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 ~~------ld---~~-~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.. .. +. ........+..+.+|+.+||+.||++|||+.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 33221433333567646665125899999999998668966890999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.75 Aligned_cols=253 Identities=22% Similarity=0.267 Sum_probs=194.5
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCC-CCHHHHHHHHHHHHCCCCCCEEEEECCCCCC------CE
Q ss_conf 269543403401386589999998--90999999713893-3469999999999707999512570533787------43
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPEA------WS 411 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~~------~~ 411 (688)
+.+|.....||+|+||+||+|... |..||||++..... .....+.+|+.+|..++|||||++++++... .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 58861789968888612499998999999999999999999985069981672899999622079996699105731001
Q 005616 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~ 491 (688)
++++++.+|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEECCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 999962598656644058----9999999999999999999999789---867778764378879997787545705650
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHH-CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHC----CCCC---
Q ss_conf 5788767776556899889888880101-0499998202767999999998099999982578988521----9632---
Q 005616 492 TEDTLYLPSFHRSTAPKGSFPYADPEYH-RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----GKLS--- 563 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~i~~~i~~----~~l~--- 563 (688)
...... ........||+.|+|||++ ....++.++||||+||++|+|++|+.||............ ....
T Consensus 160 ~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDH---TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp CGGGCB---CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred CCCCCC---CEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf 477764---10101102652000387860478887410100467013377669799788888999998765206997566
Q ss_pred ----------C--CCCCCCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf ----------2--3578789999-----79999999999872227999999992789
Q 005616 564 ----------S--ILDPLAGDWP-----TFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 ----------~--~ld~~~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
. ...+.....+ ...+..+.+|+.+||+.||.+|||+.+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L 293 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 423433222202446775577877783789999999999997648956790899986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.24 Aligned_cols=247 Identities=23% Similarity=0.295 Sum_probs=193.8
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCCC--------
Q ss_conf 269543403401386589999998--909999997138933--46999999999970799951257053378--------
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE-------- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------- 408 (688)
.++|....+||+|+||+||+|.+. |..||||++...... ....+.+|+.+|+.++|||||+++++|..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred CCEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 74358861789968888612499998999999999999999999985069981672899999622079996699105731
Q 005616 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla 488 (688)
..++||||+ +++|...+.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEECC-CCCHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf 599998405-5218999874----02269999999999999999987378---764566851111210012211343102
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH----CCC--
Q ss_conf 0015788767776556899889888880101049-999820276799999999809999998257898852----196--
Q 005616 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGK-- 561 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ELltG~~P~~~~~~i~~~i~----~~~-- 561 (688)
+..... .+...||+.|+|||++.+. .++.++||||+||++|+|++|++||........... .+.
T Consensus 169 ~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 169 RQADSE---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp EECCSS---------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ECCCCC---------CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf 206876---------31024553335889981787899650103003899999978699888976899999985037884
Q ss_pred ------------------CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHH
Q ss_conf ------------------3223578789999799999999998722279999999927899
Q 005616 562 ------------------LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 562 ------------------l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~ 604 (688)
+...............+..+.+|+.+||..||.+|||+.+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 8888653000344331157866655667755689999999999977299557929999963
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=324.91 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=196.5
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCC---CCCCEEEEEE
Q ss_conf 69543403401386589999998--909999997138933469999999999707999512570533---7874358861
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC---PEAWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~---~~~~~LV~E~ 416 (688)
++|.....||+|+||.||+|++. |..||||++...... ..+..|+.++..++|+|+|..++.| .+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC--HHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEE
T ss_conf 8899968985078809999999889989999997210058--88999999999703899601799999519877899987
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCCCCCC
Q ss_conf 78996888861249999899999999999999999998506998167289999962207---999669910573100157
Q 005616 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD---SELSSKICDFGICRLVTE 493 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd---~~~~~KL~DFGla~~~~~ 493 (688)
+ +|+|.+.+.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ .+..+||+|||+|+....
T Consensus 85 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred C-CCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCC
T ss_conf 3-871333244306--88768999999999999999999799---44266787660643357776156504675134255
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHH-----HHCCCCCCCCC
Q ss_conf 887677-765568998898888801010499998202767999999998099999982578988-----52196322357
Q 005616 494 DTLYLP-SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA-----VSCGKLSSILD 567 (688)
Q Consensus 494 ~~~~~~-~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~i~~~-----i~~~~l~~~ld 567 (688)
...... .........||+.|+|||++.+..++.++|||||||++|||+||+.||......... .....+..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--- 235 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--- 235 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS---
T ss_pred CCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCC---
T ss_conf 44554100013577678735329999918998983218861778999984987665530577999999852356789---
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 8789999799999999998722279999999927899999984300
Q 005616 568 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVA 613 (688)
Q Consensus 568 ~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~~~ 613 (688)
+ ....+..++..+.+++..||..+|.+||++. .+.+.|+.+...
T Consensus 236 ~-~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~-~i~~~l~~~~~~ 279 (299)
T d1ckia_ 236 P-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYS-YLRQLFRNLFHR 279 (299)
T ss_dssp C-HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHH-HHHHHHHHHHHH
T ss_pred C-HHHHCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHHH
T ss_conf 8-3575347889999999998439955791999-999999999997
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.06 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=193.8
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCC--CCHHHHHHHHHHHHCCCCCCEEEEECCCCC---------
Q ss_conf 69543403401386589999998--90999999713893--346999999999970799951257053378---------
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--------- 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--------- 408 (688)
++|....+||+|+||+||+|++. |..||||++..... .....+.+|+.+|.+++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCC
T ss_conf 79889999722748299999998999799999984222463789999999999998359996606765402465444457
Q ss_pred -CCEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf -7435886178996888861249999899999999999999999998506998167289999962207999669910573
Q 005616 409 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGl 487 (688)
..++||||+.++.+....... ..++...+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEECCCCCCCCHHHHCC---CCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEECCE
T ss_conf 6389998535787410122203---44330899999999999998852299---88567672220366899687631350
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH----CCCC
Q ss_conf 10015788767776556899889888880101049-999820276799999999809999998257898852----1963
Q 005616 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGKL 562 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ELltG~~P~~~~~~i~~~i~----~~~l 562 (688)
++......... .......+||+.|+|||++.+. .++.++|||||||++|||++|++||........... .+..
T Consensus 164 ~~~~~~~~~~~--~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 164 ARAFSLAKNSQ--PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp CEECCC-------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEECCCCCCCC--CCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCC
T ss_conf 02235544432--1135660249787428997079998917870067864661744879989989999999999841899
Q ss_pred CCCC-------------CCCC-CCCCH-------HHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 2235-------------7878-99997-------9999999999872227999999992789
Q 005616 563 SSIL-------------DPLA-GDWPT-------FVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 563 ~~~l-------------d~~~-~~~~~-------~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.... .... ...+. .....+.+|+.+||+.||++|||+.+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 82553443203444332013344555033404445998999999998738965890999997
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.38 Aligned_cols=246 Identities=21% Similarity=0.238 Sum_probs=194.8
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCC--------CC
Q ss_conf 69543403401386589999998--909999997138933--4699999999997079995125705337--------87
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACP--------EA 409 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~--------~~ 409 (688)
++|....+||+|+||+||+|.+. |..||||++...... ....+.+|+.++.+++|||||+++++|. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred CEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 43588617899688886124999989999999999999999999850699816728999996220799966991057310
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~ 489 (688)
.++||||+.++.+.. +. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~-~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHH-HT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEEECCCHHHHHH-HH-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHHH
T ss_conf 699984144677876-50-----38999999999999999998865221---1245677632113654431320102321
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH-----------
Q ss_conf 015788767776556899889888880101049999820276799999999809999998257898852-----------
Q 005616 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----------- 558 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~i~~~i~----------- 558 (688)
...... ......||+.|+|||++.+..+++++||||+||++|+|++|++||...........
T Consensus 168 ~~~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 168 TAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CCCCCC-------CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHH
T ss_conf 146665-------5332214655558133147777877433356625789865989988897788999999720589879
Q ss_pred -------------CCC-------CCCCC----CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf -------------196-------32235----7878999979999999999872227999999992789
Q 005616 559 -------------CGK-------LSSIL----DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 559 -------------~~~-------l~~~l----d~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.+. ..... .+.....+...+..+.+|+.+||..||.+|||+.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 998765667777641754356664212643335432101333799999999998769945790899996
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=316.89 Aligned_cols=259 Identities=20% Similarity=0.235 Sum_probs=199.2
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCC-CCEEEEECCCCC--CCEEEEE
Q ss_conf 269543403401386589999998--90999999713893346999999999970799-951257053378--7435886
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH-PHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~H-pnIV~l~g~~~~--~~~LV~E 415 (688)
.++|.+...||+|+||.||+|++. |..||||++..... ...+.+|+.++..+.| +|++.+++++.+ ..++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 9806997998417882999999988997999999750258--29999999999996489998779999601881179999
Q ss_pred ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC-----CCCEEEEECCCCCC
Q ss_conf 1789968888612499998999999999999999999985069981672899999622079-----99669910573100
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-----ELSSKICDFGICRL 490 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-----~~~~KL~DFGla~~ 490 (688)
|+ +|+|.+.+.... ..+++..+..++.+++.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EC-CCCHHHHHHHHC--CCHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf 64-888799997520--31106899999999999999999779---6626677131523475434479568723660577
Q ss_pred CCCCCCCC-CCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH-----HHHHHHCCCCCC
Q ss_conf 15788767-776556899889888880101049999820276799999999809999998257-----898852196322
Q 005616 491 VTEDTLYL-PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE-----VRRAVSCGKLSS 564 (688)
Q Consensus 491 ~~~~~~~~-~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~-----i~~~i~~~~l~~ 564 (688)
........ ..........||+.|||||++.+..+++++|||||||++|||+||+.||..... ....+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred CCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCC
T ss_conf 14676654111024676277510267989648888869998983199999986987678853021999999997056799
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 357878999979999999999872227999999992789999998430
Q 005616 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 565 ~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~Le~l~~ 612 (688)
....... .++..+.+++..|+..+|.+||++. .+.+.|+.+..
T Consensus 236 ~~~~l~~----~~p~~l~~ii~~~~~~~~~~rP~y~-~l~~~l~~~~~ 278 (293)
T d1csna_ 236 PLRELCA----GFPEEFYKYMHYARNLAFDATPDYD-YLQGLFSKVLE 278 (293)
T ss_dssp CHHHHTT----TSCHHHHHHHHHHHHCCTTCCCCHH-HHHHHHHHHHH
T ss_pred CHHHHCC----CCCHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHHH
T ss_conf 9589657----9989999999998439930085999-99999999999
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=314.47 Aligned_cols=243 Identities=19% Similarity=0.288 Sum_probs=190.2
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCC-CCCEEEEECCCC----CCCEEEE
Q ss_conf 69543403401386589999998--9099999971389334699999999997079-995125705337----8743588
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACP----EAWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~----~~~~LV~ 414 (688)
++|.+..+||+|+||+||+|+.. |..||||+++.. ....+.+|+.+|..++ ||||+++++++. ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 6718978983174819999998899979999998889---9999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCCCCCC
Q ss_conf 6178996888861249999899999999999999999998506998167289999962207999-669910573100157
Q 005616 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLVTE 493 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-~~KL~DFGla~~~~~ 493 (688)
||+.+|+|.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf 631798589974------68999999999999999998876433---443456441237748998366415654266468
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHH----------------H
Q ss_conf 88767776556899889888880101049-999820276799999999809999998257898----------------8
Q 005616 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR----------------A 556 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ELltG~~P~~~~~~i~~----------------~ 556 (688)
.. ......||+.|+|||.+.+. .++.++||||+||++|+|++|+.||........ .
T Consensus 183 ~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 183 GQ-------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp TC-------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred CC-------CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHH
T ss_conf 87-------44432248642476102688888845232335455587604889998876018999999998788415555
Q ss_pred HHCCC------CCCCCCC---------CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 52196------3223578---------78999979999999999872227999999992789
Q 005616 557 VSCGK------LSSILDP---------LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 557 i~~~~------l~~~ld~---------~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
..... ....... .........+..+.+|+.+||..||.+|||+.+.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L 317 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 54225444743000003334331121155211244899999999998669956890899996
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=315.68 Aligned_cols=243 Identities=26% Similarity=0.348 Sum_probs=193.6
Q ss_pred CCCCCCEEEECCCCEEEEEEEE-----CCEEEEEEEEECCCC----CCHHHHHHHHHHHHCCCC-CCEEEEECCCCC--C
Q ss_conf 6954340340138658999999-----890999999713893----346999999999970799-951257053378--7
Q 005616 342 CNFSESFKVGQGGFGCVYKGEM-----LGRTVAIKMLYSHNM----QGQLEFQQEVRVLSKLQH-PHLVTLLGACPE--A 409 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~-----~g~~VAIK~l~~~~~----~~~~~f~~E~~iL~~l~H-pnIV~l~g~~~~--~ 409 (688)
++|...+.||+|+||+||+|.. .|..||||.+..... .....+.+|+.++.+++| |||+++++++.+ .
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred CEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 43588617899688886124999989999999999999999999850699816728999996220799966991057310
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~ 489 (688)
.++||||+.+|+|.+++.... .+....+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEEECCCCCHHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf 001231234117999987304---5437888888999999998851499---8965477320124699988874132022
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC--CCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCC
Q ss_conf 015788767776556899889888880101049--999820276799999999809999998257--8988521963223
Q 005616 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG--VLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSI 565 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSlGviL~ELltG~~P~~~~~~--i~~~i~~~~l~~~ 565 (688)
.+...... ......|++.|++||.+... .++.++|||||||+||+|++|+.||..... ....+..+...
T Consensus 178 ~~~~~~~~-----~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~-- 250 (322)
T d1vzoa_ 178 EFVADETE-----RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-- 250 (322)
T ss_dssp ECCGGGGG-----GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--
T ss_pred HHCCCCCC-----CCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCC--
T ss_conf 20344443-----22122233333106876057768871325177779999997689998888777799999983356--
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 57878999979999999999872227999999992
Q 005616 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 566 ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
.....+...+..+.+|+.+||+.||.+||++.
T Consensus 251 ---~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~ 282 (322)
T d1vzoa_ 251 ---SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282 (322)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSS
T ss_pred ---CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCC
T ss_conf ---89988654799999999997445898819997
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=306.63 Aligned_cols=249 Identities=20% Similarity=0.225 Sum_probs=194.7
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEE
Q ss_conf 69543403401386589999998--909999997138933--46999999999970799951257053378--7435886
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
++|....+||+|+||+||+|++. |..||||+++..... ....+.+|+.+++.++|||||+++++|.+ ..++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 17899688886124999989999999999999999999850699816728999996220799966991057310015788
Q 005616 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~~~~~ 495 (688)
++.+++|...+... ..+++..+..++.|++.||.|||..+ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ECCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf 02332221121235---65403678999999999987743399---8600146761211337826652046011046887
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHH---HHH--CCC-----C--
Q ss_conf 7677765568998898888801010499-99820276799999999809999998257898---852--196-----3--
Q 005616 496 LYLPSFHRSTAPKGSFPYADPEYHRTGV-LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVS--CGK-----L-- 562 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGviL~ELltG~~P~~~~~~i~~---~i~--~~~-----l-- 562 (688)
. ......+++.|+|||++.... ++.++|||||||++|||++|+.||........ .+. .+. .
T Consensus 156 ~------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 156 R------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp S------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred C------CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 5------1001034431014667506988880444026541889985189999889999999999986118997355134
Q ss_pred -CCC--------C--CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHH
Q ss_conf -223--------5--787899997999999999987222799999999278
Q 005616 563 -SSI--------L--DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 563 -~~~--------l--d~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~ 602 (688)
... . ...........+..+.+|+.+||+.||.+|||+.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~ 280 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 432221133444544310433065689999999999864996689099999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.24 Aligned_cols=247 Identities=23% Similarity=0.275 Sum_probs=193.1
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCCC-------C
Q ss_conf 269543403401386589999998--909999997138933--46999999999970799951257053378-------7
Q 005616 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE-------A 409 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------~ 409 (688)
+++|....+||+|+||+||+|+.. |..||||++...... ....+.+|+.+|..++|||+|++++++.. .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred CEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 43588617899688886124999989999999999999999999850699816728999996220799966991057310
Q 005616 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~ 489 (688)
.+++++|+.+|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEEEECCCCHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHC
T ss_conf 4999996258862320022----45309999999999999999997388---7651667763345543220013210001
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHH--HH--CCCCC-
Q ss_conf 015788767776556899889888880101049-9998202767999999998099999982578988--52--19632-
Q 005616 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VS--CGKLS- 563 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ELltG~~P~~~~~~i~~~--i~--~~~l~- 563 (688)
..... .....|++.|+|||++.+. .++.++|||||||++|+|++|++||......... +. .+...
T Consensus 170 ~~~~~---------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 170 HTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp CCTGG---------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred CCCCC---------CCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCH
T ss_conf 25754---------444345435558355337756785512432058999997688997889889999999973079975
Q ss_pred CC------------CC--CCCCCC-----CHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 23------------57--878999-----979999999999872227999999992789
Q 005616 564 SI------------LD--PLAGDW-----PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 ~~------------ld--~~~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
+. .. +..... ....+..+.+|+.+||..||.+|||+.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL 299 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 77320010244544430355787555662678999999999997758834593899985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-43 Score=290.56 Aligned_cols=249 Identities=21% Similarity=0.261 Sum_probs=186.9
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCC-----------CCCEEEEECCCCC
Q ss_conf 69543403401386589999998--9099999971389334699999999997079-----------9951257053378
Q 005616 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-----------HPHLVTLLGACPE 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-----------HpnIV~l~g~~~~ 408 (688)
++|.+..+||+|+||+||+|+.. |..||||+++.... ....+.+|+.++..++ |+|||++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 857998997507781899999999997999999834313-3689999999999840145555542276764789987631
Q ss_pred ----CCEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCCEEECCCCCCCEEECCCCC----
Q ss_conf ----743588617899688886124999989999999999999999999850-69981672899999622079996----
Q 005616 409 ----AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSELS---- 479 (688)
Q Consensus 409 ----~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~-~~~~~IiHrDIKp~NILLd~~~~---- 479 (688)
..++++.++..+..............+++..+..++.+++.||.|||+ .+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCCC
T ss_conf 2565202343200035420000012234678689999999999999888764058---6465677057056305765644
Q ss_pred --EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHH----
Q ss_conf --69910573100157887677765568998898888801010499998202767999999998099999982578----
Q 005616 480 --SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV---- 553 (688)
Q Consensus 480 --~KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~P~~~~~~i---- 553 (688)
+|++|||.+...... .....||+.|+|||++....+++++||||+||++++|++|+.||......
T Consensus 169 ~~~kl~dfg~s~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH---------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp EEEEECCCTTCEETTBC---------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CEEEEEECCCCCCCCCC---------CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
T ss_conf 30567531442123445---------422366521057132146677764320123789999987889989875543210
Q ss_pred -----HHH-HHCCC--------------------CCCCCC-----------CCCCCCCHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf -----988-52196--------------------322357-----------87899997999999999987222799999
Q 005616 554 -----RRA-VSCGK--------------------LSSILD-----------PLAGDWPTFVARRLVDLGLQCCELYGRER 596 (688)
Q Consensus 554 -----~~~-i~~~~--------------------l~~~ld-----------~~~~~~~~~~~~~l~~Li~~Cl~~dP~~R 596 (688)
... ...+. ....+. +.....+...+..+.+|+.+||..||.+|
T Consensus 240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 319 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319 (362)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHC
T ss_conf 26899999998379987886245322000132012202432357764442100015674358999999999877994579
Q ss_pred CCCCHHH
Q ss_conf 9992789
Q 005616 597 PDITPSL 603 (688)
Q Consensus 597 Ps~~~~i 603 (688)
||+.+.+
T Consensus 320 pta~e~L 326 (362)
T d1q8ya_ 320 ADAGGLV 326 (362)
T ss_dssp BCHHHHH
T ss_pred CCHHHHH
T ss_conf 0899996
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=5.5e-24 Score=166.25 Aligned_cols=164 Identities=20% Similarity=0.146 Sum_probs=119.0
Q ss_pred CCCCEEEECCCCEEEEEEEEC-CEEEEEEEEECCCCC------------------CHHHHHHHHHHHHCCCCCCEEEEEC
Q ss_conf 543403401386589999998-909999997138933------------------4699999999997079995125705
Q 005616 344 FSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ------------------GQLEFQQEVRVLSKLQHPHLVTLLG 404 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~-g~~VAIK~l~~~~~~------------------~~~~f~~E~~iL~~l~HpnIV~l~g 404 (688)
+..+++||+|+||.||+|... |..||||+++..... ....+..|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 02277802485659999997999999999986044346665565630008889999997789999999816999144998
Q ss_pred CCCCCCEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf 33787435886178996888861249999899999999999999999998506998167289999962207999669910
Q 005616 405 ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICD 484 (688)
Q Consensus 405 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~~KL~D 484 (688)
+. ..+++|||++++.+.. ++......++.+++.+|.|||..+ |+||||||+|||++.+ .++|+|
T Consensus 82 ~~--~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 82 WE--GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EE--TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred EC--CCEEEEEEECCCCCCC----------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEEEEE
T ss_conf 62--8889999504565420----------015789999999999999982688---8983689036114289-899987
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH------HHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 57310015788767776556899889888880------1010499998202767999999
Q 005616 485 FGICRLVTEDTLYLPSFHRSTAPKGSFPYADP------EYHRTGVLTPKSDSYSFGLIIL 538 (688)
Q Consensus 485 FGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~AP------E~l~~~~~s~ksDVwSlGviL~ 538 (688)
||+|........ ..|... +++ ...|+.++|+||..--++
T Consensus 146 FG~a~~~~~~~~--------------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGW--------------REILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTH--------------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCCCC--------------HHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHH
T ss_conf 788430899870--------------999987799999997-578998446899999874
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.92 E-value=2.9e-10 Score=79.43 Aligned_cols=71 Identities=30% Similarity=0.482 Sum_probs=65.4
Q ss_pred CCCCCCCCCHHHHHHHCCCCCCCCC-CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 8988765521356431498767898-42232011233205977888755556778899653789999998630
Q 005616 616 RPVPSFFLCPILQEIMHDPQVAADG-FTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCK 687 (688)
Q Consensus 616 ~~~ps~~~~pil~eim~~P~va~dg-~tye~~~I~~wle~g~~~SPmtn~~l~~~~l~Pn~aLr~~~~~~~~~ 687 (688)
..+|..|.|||..++|.+|.+.+.+ .+|+..+|..|+.. +.++|.++.++...+|+||.+||++|++|+.+
T Consensus 17 ~~~P~~f~CPI~~~lm~dPV~~~~~~~ty~r~~I~~~l~~-~~~~P~~~~~l~~~~L~pN~~Lr~~I~~~~~~ 88 (98)
T d1wgma_ 17 ADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLS-DQTDPFNRSPLTMDQIRPNTELKEKIQRWLAE 88 (98)
T ss_dssp CSCCTTTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHTTT-SCBCTTTCSBCCTTTSEECHHHHHHHHHHHHH
T ss_pred CCCCHHHCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHCCHHHHHHHHHHHHHH
T ss_conf 5990774886734688777762355320149999999870-68766555666401120139999999999999
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.84 E-value=4.2e-08 Score=65.70 Aligned_cols=148 Identities=16% Similarity=0.088 Sum_probs=96.8
Q ss_pred HHHHHHHCCCCCCEEEECCCCEEEEEEEECCEEEEEEEEECCCCCCHHHHHHHHHHHHCCC-CCCEEEEECCCC--CCCE
Q ss_conf 8899872695434034013865899999989099999971389334699999999997079-995125705337--8743
Q 005616 335 ADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACP--EAWS 411 (688)
Q Consensus 335 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~--~~~~ 411 (688)
.++...-..|......+.++.+.||+....+..+.+|+...........+.+|...+..+. +-.+.+++.++. +..+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHHHHCEEEEECCCCCCCCCEEEEEECCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEE
T ss_conf 99997513527997678998771899990898699998488765325569999999998760699872899975089649
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---------------------------------
Q ss_conf 58861789968888612499998999999999999999999985069---------------------------------
Q 005616 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK--------------------------------- 458 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--------------------------------- 458 (688)
+||++++|.++........ . ...++.+++..+..||...
T Consensus 87 lv~~~l~G~~~~~~~~~~~-----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ-----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS-----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEECCCCCCCCCCCCCC-----C---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 9998604334354334402-----6---9999998999999985568421435764465655577899877655554303
Q ss_pred -----------------------CCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -----------------------98167289999962207999669910573100
Q 005616 459 -----------------------PEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 459 -----------------------~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
+..++|+|+.|.|||++.++.+-|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 3232005799999999844986781789860047642364996599960231441
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=98.80 E-value=1.1e-09 Score=75.84 Aligned_cols=73 Identities=38% Similarity=0.732 Sum_probs=68.8
Q ss_pred CCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 8988765521356431498767898422320112332059778887555567788996537899999986309
Q 005616 616 RPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCKS 688 (688)
Q Consensus 616 ~~~ps~~~~pil~eim~~P~va~dg~tye~~~I~~wle~g~~~SPmtn~~l~~~~l~Pn~aLr~~~~~~~~~~ 688 (688)
+.+|+.|.|||-.++|.+|.+...|.+|....|..|+..+...+|.++.++...+++||++||++|++|+++.
T Consensus 3 peiP~~l~CpIc~~~m~dPV~~~cgh~fc~~ci~~~~~~~~~~cP~~~~~l~~~~l~pN~~L~~~I~~~~~~~ 75 (78)
T d1t1ha_ 3 PEFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVLKSLIALWCESN 75 (78)
T ss_dssp CCCSSSSSCTTTSCCCSSEEEETTTEEEEHHHHHHHHTTTCCBCTTTCCBCSSCCCEECTTTHHHHHHHHHHS
T ss_pred CCCCCCCCCCCCCCHHHCCEECCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 9899627991718121083372677743399999999988887886556377565624699999999999995
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.76 E-value=1.9e-09 Score=74.20 Aligned_cols=72 Identities=28% Similarity=0.549 Sum_probs=68.1
Q ss_pred CCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 898876552135643149876789842232011233205977888755556778899653789999998630
Q 005616 616 RPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCK 687 (688)
Q Consensus 616 ~~~ps~~~~pil~eim~~P~va~dg~tye~~~I~~wle~g~~~SPmtn~~l~~~~l~Pn~aLr~~~~~~~~~ 687 (688)
..+|..|.||+-.++|.+|.+.+.|.+|....|..|+..++.++|.++.++...+++||.+|+++|++|+++
T Consensus 2 ~eiP~~l~CpIc~~l~~dPv~~~cGhtfc~~ci~~~l~~~~~~cP~c~~~l~~~~l~pN~~L~~~I~~~l~~ 73 (80)
T d2c2la2 2 RDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMKEVIDAFISE 73 (80)
T ss_dssp CCCCSTTBCTTTCSBCSSEEECSSCCEEETTHHHHHHHHTCSSCTTTCCCCCGGGCEECHHHHHHHHHHHTT
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCEECHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 989700118583732340330588685638899999863776578756665423555199999999999998
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.34 E-value=7.1e-06 Score=51.61 Aligned_cols=75 Identities=16% Similarity=0.069 Sum_probs=50.4
Q ss_pred EEEECCCCEEEEEEEEC--CEEEEEEEEECC------C-CCCHHHHHHHHHHHHCCC---CCCEEEEECCCCCCCEEEEE
Q ss_conf 03401386589999998--909999997138------9-334699999999997079---99512570533787435886
Q 005616 348 FKVGQGGFGCVYKGEML--GRTVAIKMLYSH------N-MQGQLEFQQEVRVLSKLQ---HPHLVTLLGACPEAWSLVYE 415 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~------~-~~~~~~f~~E~~iL~~l~---HpnIV~l~g~~~~~~~LV~E 415 (688)
..||.|....||+.... +..|++|.-... . .....+...|...|..+. ...+.+++++..+...+|||
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvmE 111 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVME 111 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEEC
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEECCCCCEEEEE
T ss_conf 98079852768999957998489996177130346777888778999999999986505798855289985988779871
Q ss_pred ECCCCCH
Q ss_conf 1789968
Q 005616 416 YLPNGSL 422 (688)
Q Consensus 416 ~~~~gsL 422 (688)
++.+..+
T Consensus 112 ~L~~~~~ 118 (392)
T d2pula1 112 DLSHLKI 118 (392)
T ss_dssp CCTTSEE
T ss_pred CCCCCCC
T ss_conf 3577653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.06 E-value=1.2e-05 Score=50.09 Aligned_cols=128 Identities=21% Similarity=0.186 Sum_probs=76.8
Q ss_pred EEECCC-CEEEEEEEEC-CEEEEEEEEECCCCCCHHHHHHHHHHHHCCC--CCCEEEEECCCC--CCCEEEEEECCCCCH
Q ss_conf 340138-6589999998-9099999971389334699999999997079--995125705337--874358861789968
Q 005616 349 KVGQGG-FGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ--HPHLVTLLGACP--EAWSLVYEYLPNGSL 422 (688)
Q Consensus 349 ~LG~G~-fG~Vykg~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~--HpnIV~l~g~~~--~~~~LV~E~~~~gsL 422 (688)
.+..|. .+.||+.... +..+.+|........ .+..|...+..+. ...+.++++++. ...++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCHH---HHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 767865477589999389878999958966776---89999999999986599988613222456615999874413554
Q ss_pred HHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC----------------------------------------------
Q ss_conf 8886124999989999999999999999999850----------------------------------------------
Q 005616 423 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS---------------------------------------------- 456 (688)
Q Consensus 423 ~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~---------------------------------------------- 456 (688)
.+.. +. ...++.+++..|.-||.
T Consensus 94 ~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred CCCC--------CC---HHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf 3221--------26---899999999999987368854488755412468899999987541101134011213799999
Q ss_pred -----C----CCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -----6----998167289999962207999669910573100
Q 005616 457 -----S----KPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 457 -----~----~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
. .+..++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 9998718765795678678887635773796589998533265
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.81 E-value=0.0008 Score=38.65 Aligned_cols=157 Identities=11% Similarity=0.073 Sum_probs=81.3
Q ss_pred CCHHHHHHHHCCCCCCEE-----EECCCCEEEEEEEECCEEEEEEEEECCCCCCHHHHHHHHHHHHCCC-----CCCEEE
Q ss_conf 388889987269543403-----4013865899999989099999971389334699999999997079-----995125
Q 005616 332 FSLADLQTATCNFSESFK-----VGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-----HPHLVT 401 (688)
Q Consensus 332 ~~~~el~~at~~f~~~~~-----LG~G~fG~Vykg~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-----HpnIV~ 401 (688)
.+.+++.....+|..+.. |..|.-.+.|.....+..+++|+........ .+..++.++..+. .|..+.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~~--~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKN--DLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CC--HHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCCHH--HHHHHHHHHHHHHHCCCCCCCCCE
T ss_conf 899999999986799985685237888526738999789728999807899988--999999998754302555455641
Q ss_pred EE-CCC----CCCCEEEEEECCCCCHH--------------HHHCCC----CC---CCCCCH-----------------H
Q ss_conf 70-533----78743588617899688--------------886124----99---998999-----------------9
Q 005616 402 LL-GAC----PEAWSLVYEYLPNGSLQ--------------DRLFRK----SN---VSPLLW-----------------K 438 (688)
Q Consensus 402 l~-g~~----~~~~~LV~E~~~~gsL~--------------~~L~~~----~~---~~~l~~-----------------~ 438 (688)
.. |.. ......++.++.+.... ..++.. .. .....+ .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCH
T ss_conf 04897621341255024531146553332046788888998764544432024531011101200245677776531141
Q ss_pred HHHHHHHHHHHHHHHHHC-CCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 999999999999999850-6998167289999962207999669910573100
Q 005616 439 DRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 439 ~~~~ia~qia~aL~yLH~-~~~~~IiHrDIKp~NILLd~~~~~KL~DFGla~~ 490 (688)
.....+......+.-... .-|.++||+|+.++||+++.+...-|.||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 27999999987642048554545033378636564020454126742221236
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.56 E-value=0.00043 Score=40.34 Aligned_cols=71 Identities=14% Similarity=0.238 Sum_probs=47.8
Q ss_pred EEEECCCCEEEEEEEEC---------CEEEEEEEEECCCCCCHHHHHHHHHHHHCCC-CCCEEEEECCCCCCCEEEEEEC
Q ss_conf 03401386589999998---------9099999971389334699999999997079-9951257053378743588617
Q 005616 348 FKVGQGGFGCVYKGEML---------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACPEAWSLVYEYL 417 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~---------g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~~~~LV~E~~ 417 (688)
..|+.|-.-.+|+.... ...|.+++.- . ........+|..++..+. +.-..+++++|.+ .+|++|+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECCC
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C-CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC--CEEEEEE
T ss_conf 991785334348999688775445789817999659-9-61165899999999999757999808998189--5699973
Q ss_pred CCCCH
Q ss_conf 89968
Q 005616 418 PNGSL 422 (688)
Q Consensus 418 ~~gsL 422 (688)
+|.++
T Consensus 124 ~g~~l 128 (395)
T d1nw1a_ 124 PSRPL 128 (395)
T ss_dssp CEEEC
T ss_pred CCCCC
T ss_conf 45548
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.38 E-value=0.002 Score=36.12 Aligned_cols=136 Identities=13% Similarity=0.095 Sum_probs=73.1
Q ss_pred CCCEEEEEEEEC-CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCC--CEEEEECCC-------CCCCEEEEEECCCCCH
Q ss_conf 386589999998-909999997138933469999999999707999--512570533-------7874358861789968
Q 005616 353 GGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP--HLVTLLGAC-------PEAWSLVYEYLPNGSL 422 (688)
Q Consensus 353 G~fG~Vykg~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~Hp--nIV~l~g~~-------~~~~~LV~E~~~~gsL 422 (688)
+.-..||+.... |..|++|+..... ....++..|...+..|... .++..+... ....+.++++++|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred CCCCEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf 61202699983899979999847877-88999999999999998559987875206898056653479999865277688
Q ss_pred H--------------HHHCC----CC--CCCCCCHH----------------------HHHHHHHHHHHHHHHH-HCCCC
Q ss_conf 8--------------88612----49--99989999----------------------9999999999999998-50699
Q 005616 423 Q--------------DRLFR----KS--NVSPLLWK----------------------DRARIAAEIASGLCFL-HSSKP 459 (688)
Q Consensus 423 ~--------------~~L~~----~~--~~~~l~~~----------------------~~~~ia~qia~aL~yL-H~~~~ 459 (688)
. ..++. .. ....+++. .....+..+...+.-+ ....+
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 99999999998999999886303578655677897887665689998747699889899999999999999984545687
Q ss_pred CCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 81672899999622079996699105731001
Q 005616 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 460 ~~IiHrDIKp~NILLd~~~~~KL~DFGla~~~ 491 (688)
..+||+|+.+.|||++.+ ..+.||+-+...
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARNG 221 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred CEEECCCCCCCCEEEECC--CEEEECHHCCCC
T ss_conf 120247888042878389--358865201468
|
| >d2baya1 g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Pre-mRNA splicing factor Prp19 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=95.07 E-value=0.0014 Score=37.15 Aligned_cols=52 Identities=19% Similarity=0.360 Sum_probs=47.0
Q ss_pred CCHHHHHHHCCCCCC-CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 521356431498767-89842232011233205977888755556778899653
Q 005616 623 LCPILQEIMHDPQVA-ADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNH 675 (688)
Q Consensus 623 ~~pil~eim~~P~va-~dg~tye~~~I~~wle~g~~~SPmtn~~l~~~~l~Pn~ 675 (688)
.|||-.+.|.+|.+. ..|.+|..+.|..|+.+ +.++|+++.++...+|+|..
T Consensus 2 ~C~Ic~~~~~~Pv~~~~cGh~fc~~cI~~~l~~-~~~CP~c~~~l~~~dLipik 54 (56)
T d2baya1 2 LCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVEIV 54 (56)
T ss_dssp CCTTTCSCCSSEEEETTTTEEEEHHHHHHHHHH-HSBCTTTCCBCCGGGCEECC
T ss_pred CCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCCCCHHHCEECC
T ss_conf 993678568865745789984559999998760-36798547818877536478
|
| >d1jm7b_ g.44.1.1 (B:) bard1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: bard1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.04 E-value=0.12 Score=24.80 Aligned_cols=83 Identities=16% Similarity=0.156 Sum_probs=62.9
Q ss_pred CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHCCCCCC-CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf 9999999927899999984300578988765521356431498767-898422320112332059778887555567788
Q 005616 592 YGRERPDITPSLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVA-ADGFTYEGKAIRDWLENGRETSPMTNLRLSHLH 670 (688)
Q Consensus 592 dP~~RPs~~~~i~~~Le~l~~~~~~~~ps~~~~pil~eim~~P~va-~dg~tye~~~I~~wle~g~~~SPmtn~~l~~~~ 670 (688)
+|..+-.+. .....|+.+.. .+.|||=.+.+.+|... .=|.+|-...|..|+.+ .+|.-+..+....
T Consensus 2 ~p~~~~~~~-~~~~~l~~l~~--------~l~C~IC~~~~~~pv~~~~CgH~fC~~Ci~~~~~~---~CP~Cr~~~~~~~ 69 (97)
T d1jm7b_ 2 EPDGRGAWA-HSRAALDRLEK--------LLRCSRCTNILREPVCLGGCEHIFCSNCVSDCIGT---GCPVCYTPAWIQD 69 (97)
T ss_dssp CSSTTCCCH-HHHHHHHHHHH--------TTSCSSSCSCCSSCBCCCSSSCCBCTTTGGGGTTT---BCSSSCCBCSCSS
T ss_pred CCCCCCCCH-HHHHHHHHHHH--------CCCCCCCCCHHHCCCEECCCCCCHHHHHHHHHHHC---CCCCCCCCCCHHH
T ss_conf 988666507-67999996212--------28992587221127465889993029999999853---6662278676551
Q ss_pred CCCCHHHHHHHHHHHH
Q ss_conf 9965378999999863
Q 005616 671 LTPNHALRHAIQDWLC 686 (688)
Q Consensus 671 l~Pn~aLr~~~~~~~~ 686 (688)
+.||.+|.++++.+.+
T Consensus 70 l~~n~~l~~lv~~~~~ 85 (97)
T d1jm7b_ 70 LKINRQLDSMIQLCSK 85 (97)
T ss_dssp CCCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHH
T ss_conf 8605899999999999
|
| >d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: brca1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.68 E-value=0.52 Score=20.81 Aligned_cols=65 Identities=14% Similarity=0.319 Sum_probs=55.3
Q ss_pred CCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHCCCC--CCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 55213564314987678984223201123320597--788875555677889965378999999863
Q 005616 622 FLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGR--ETSPMTNLRLSHLHLTPNHALRHAIQDWLC 686 (688)
Q Consensus 622 ~~~pil~eim~~P~va~dg~tye~~~I~~wle~g~--~~SPmtn~~l~~~~l~Pn~aLr~~~~~~~~ 686 (688)
+.||+=.+.+.+|...+=|.+|-..-|..|+.... ..+|+-+..+....+.||..|++.+..+++
T Consensus 22 l~CpIC~~~~~~pv~~~CgH~fC~~Ci~~~~~~~~~~~~CP~Cr~~~~~~~l~~n~~l~~~ve~l~~ 88 (103)
T d1jm7a_ 22 LECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFSQLVEELLK 88 (103)
T ss_dssp TSCSSSCCCCSSCCBCTTSCCCCSHHHHHHHHSSSSSCCCTTTSCCCCTTTCBCCCSSSHHHHHHHH
T ss_pred CCCCCCCCHHCCEEECCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHCCCCHHHHHHHHHHHH
T ss_conf 4997218231891883799864167899999977999809698883875528757899999999999
|